<SEC-DOCUMENT>0001159036-21-000050.txt : 20211102
<SEC-HEADER>0001159036-21-000050.hdr.sgml : 20211102
<ACCEPTANCE-DATETIME>20211102160953
ACCESSION NUMBER:		0001159036-21-000050
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211102
DATE AS OF CHANGE:		20211102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HALOZYME THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001159036
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				880488686
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32335
		FILM NUMBER:		211371392

	BUSINESS ADDRESS:	
		STREET 1:		11388 SORRENTO VALLEY ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121-1345
		BUSINESS PHONE:		(858) 794-8889

	MAIL ADDRESS:	
		STREET 1:		11388 SORRENTO VALLEY ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121-1345

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALOZYME THERAPEUTICS INC
		DATE OF NAME CHANGE:	20040312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL YACHT SERVICES INC
		DATE OF NAME CHANGE:	20010912
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>halo-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:6c74ed58-0fb3-4e7f-8898-7f3e050a41d3,g:ea6d4314-a92d-42b4-b437-e2e1177b3d7b,d:0f52beae0cb245d7843d69f1146dfb6c--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:halo="http://www.halozyme.com/20210930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>halo-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV8xLTEtMS0xLTA_f9f922f5-75a7-490b-b946-437c0353a9e8">0001159036</ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV8yLTEtMS0xLTA_0e0322d6-0e47-4db6-a4a5-83850b3ac4ff">false</ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV8zLTEtMS0xLTA_9f8a0859-e7d4-4dca-92cf-b8350c6b28f1">2021</ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV80LTEtMS0xLTA_15efae5a-147c-4104-8976-87719c08fa83">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV81LTEtMS0xLTA_edc730df-94b1-4db0-84fe-baf1d26d88a6">9/30</ix:nonNumeric><ix:nonNumeric contextRef="ic2b29c8b2930492d851baa19fbc2b1f5_I20210930" format="ixt-sec:durmonth" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181NS9mcmFnOjc1ZmZjYTEwN2ViMDQ5MmFhMzM0NzBjNzcwYmQ4YjZkL3RhYmxlOmU4NmNjMTRjMWRkYzRiYjFhZWVjZmZjMTIwMzBkYzVlL3RhYmxlcmFuZ2U6ZTg2Y2MxNGMxZGRjNGJiMWFlZWNmZmMxMjAzMGRjNWVfMS0xLTEtMS0w_6ac777ca-afe0-491b-9a7b-69a67c61dff0">12</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="halo-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i369088a4f53841368f3952aac246def4_I20211025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e009dc2fa9486680263a15069d178d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2c0f87e3f3f847cc839debee5868ce40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic648a667b4564856a5096920f3df03db_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc326e2cf27f45baac0c0fe72eed59d2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272651d659f84e0a8874d31b762516eb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea7a928fde0046eca6e5a2a01621d057_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i501c9252b83c44809a6ccbddc68fa142_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic64829186658472f9e88de5ccbc70972_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4eef1632dd43799c54c3a51442359c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i353f14d9c0cc433e9597f0fe48db2359_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed821ec9e124f6989a22f8554b1acbf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99adc572639e4c54b1595861c11fec96_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00f1c71dd4ef47f898e2155ae0b735ec_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i247f86e8e166412cb70a5c1492bc28dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62841acca8054be1814600a79b223d76_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32263905767c45de917da63e14f56984_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e89af44e744d99aa39539c76531199_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25334aa547be4cdaaff347b5deaac86e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i601d2a7ba1ff42c88d69d679d48bf478_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84ac7847378b429f9176338d1e7ce9e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41d331fe41f24e9da00e1cf521cc23db_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc5f865f951b41669cfe18b259a0d85d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcaf7ea55080433b89ecd6b1dc21f494_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7beabc966f144dc99430154a2577a780_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ed45201faa485fbbc32a6c3f935988_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a586d0e614542b59729d466bcca9e14_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbfa535e62724f7c90e79d7f774037dc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d99a9ecd955442dbccf9c897a851078_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i178ae7e383b143a6a97d76a52a288a81_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38a5fc0a748f43aeb840f079b1667ce7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c62eaa17c0847168d4711f217c137e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib749d4ed30754a3f9c5e7b5a222e9c73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a17be07a5cc4453aeff021e1cc99bc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if05acc0270554a9682fec68a9903a505_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c4b95062afe4a8880ccae03db28b451_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id97983bc9beb4b1ca46661fdb9b34961_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2484e9b3056245a78e893187e94a2989_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85256e985e1c4b42ac4d454f915a8bd0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic293939d2030450296034697f0724379_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c770b432f2e40caa63dcfeac3352f9d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c21184904734499ada0aa1912871ae4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43f3bfde66344aef8be3f0502fdef7c1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i227c6dc9e3ae40648df2cfd2ac32bb2c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7273c25133442389646e9ae5c7a0f58_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d1f54f1a68e4e809dca7deac8cde021_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id00da01d4ee5429da1ab15a67bd8c92b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ffb579646fc4c0d8197f17b32a7128b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i871d983ec9934312a36ee3536d265db2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5fea2d63902453fabd27c2ad7ff2cfd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic35a7e6ef47d488cada6c8e7fba0110d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b526ab8a3cb471bb556ee04a4fd7e83_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b8bb66e550462093b0b0b019e5c127_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i622c6a2434bf454db942b487a6b7e00a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7968757fc73441ead621b34c559b52b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d81c8e1eb01492f8722125c6a4fb845_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e79cd5f47bc44cd8c4429cf1b065e7f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="collaborator"><xbrli:measure>halo:collaborator</xbrli:measure></xbrli:unit><xbrli:unit id="product"><xbrli:measure>halo:product</xbrli:measure></xbrli:unit><xbrli:context id="ib333d4f3b723420d812af307ac6e7563_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">halo:BaxaltaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6959c5a508d04982a33bfa4c80321de9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">halo:RocheMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1a53e64a7e34f70b0457b035813cd41_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">halo:JanssenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f30dd7e598c4150bb7ab34c0c700764_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7143f1a70f40f4865183995dcdf3c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89efb2eece474b1c9fa2252f912eb2e2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2bf701fe610422f904860a03167563a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bc3fbc4a9c34766bee79a37bf2c3e23_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e231d70787f44a4b04e7ad9caf076a0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id4b36e88a5204ad7a59bf1f1884070f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>halo:segment</xbrli:measure></xbrli:unit><xbrli:context id="i6d5406841f54463587c720f7d0c85362_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaae598c6a0043268b61e55051da6c5b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1eb4955082b47499f0449ca9fa72759_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0240effe3214b81b9ca5b45972c7265_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc6cd4f54794f4496d961d749aef342_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7152e25968740afaabf504783045182_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7658f6494ad24880a34c2dc3979ede85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb0f815ccda14fc69c7000068fc223a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>halo:security</xbrli:measure></xbrli:unit><xbrli:context id="i0b6fe5f945ae43a69e913f0e0b729205_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice6cebbf569a4926bb4ba1f2c0526b8c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af6b80bac9f4ee1a6f77ffcbcb33af1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a6f1d6a6d9a4794ad43347f6f6a845d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i510ee7af7efc47b28c4621b3e4d7c994_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7fd00eb22704a3faadef6bba5e75036_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7228f6a8b874f59a40a9c1c3ae1d319_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23422b52470040bcabe09d7bda533924_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic96e068d375b4d50b976de50785f0a89_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c2fb7c8538d41ddb1d8acd66cc4ef17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71214058490a424b86f59ea8c37c7358_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic98aeee1dd5f44ef88df01be8344928c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8048d79e377f495a99e418c2dd29f1d6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a8d40c51fe947a88cf70e94aa08de05_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e633fec488c477b957a45854ee34341_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3cd1753156549998bd9164c7783c6e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc226000e5b642c1a87036d0b20cf77d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d6e7551a5f4b78aa75bb4fcbf2d798_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f93b93b18047879feba5866a7c1147_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac7d674d62548b09e34061cbb313276_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6c397dd0f5243188600e0dcf051082b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42af265f358f4e47b36e71ac09d1ad01_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad2bda6661fe4c6a8deab6b225439c54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b21d8da7dbc4396942bb05a95ca81f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84b5665294d04912b073fdaefa553c12_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafee32398ddd4184a9e8c6f456c0bad6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffc815cd3d3f45779613868dda56f367_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14b477c24acf478d95230b08574a9bea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dec8fd3aaaf4fd59df1e8d089e118ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf7e115ae39487e96fb9df8b46799e0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31bae321b714f37893eb11b3ee1a813_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8fd7acfa834427a80a945db2878a09_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3465623e8f7d4998b90547f930b814e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17dfb6089521498d8d28b738549dbe12_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a819da17a94fbbbcdb54d76235890e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie330bed0ebb1442dbbdf7b34d7cfe2a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c5ae6e2527f4c99bd2fb6c331a1eab7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e0157ed45314cc1a41caf7282e4da2b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b81ea09c7b4830be62638aea4edab1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c022f7d86dd4437bd0cde070c7fd07c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3968a56145c145baa0c437ec109af06e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92d0ce79c1664094be9d67dacba99869_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d04f05cf4d8411688ffb481e3b6f1a1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266391e004c7456a98a2b58f212c06c1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15658419291646da82621e9c9b2f6dbb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4575b33018d5417da6496f84f9c8b307_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c66125868794895a72167f638f47a8f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if910d54ee4ef4f618d431f133fca2559_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c9ac387aba94bbc9c70dd2c275fd159_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i601a5d810b394d2489e25eea409b2b3d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86cb3d1f5b124e9f81dbf0646d232a5f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17496220ae11435ca516f72c3fe10a18_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e642dc9f3414ad88f5df20dee6948ee_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28450b44187c42f9b071a5816b0ea2e8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491e07317d3346579daea09d068cc6ac_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266af81398ed45eea9c67c4a7856ace4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i569db92c338a4d04800ca2c32dfef65a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f82754b3e354c75b602f455ff70da37_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6dec7f20e549b9b58761c803248054_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8cf86de5f3046a4bae0460346e32c55_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib409cfda9eb34f03b1d3070f5ff73a9f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i941973135edc404780b79a1a8d9197ab_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f47adc8431141e2bd4adfb8ee6c8be3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabeb09e2d5a34f1ab2165e7742136659_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:LicenseFeesAndEventBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72e5a38073c94c808eacadffd14c661c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:LicenseFeesAndEventBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5850452d31564c9b851c823cfbb9d09d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">halo:OthercollaboratorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic47eff917a924a8d88864fdf58cbee25_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b29c8b2930492d851baa19fbc2b1f5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f83dd81a24947c0880845854951b856_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ResearchEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f212c6f63a148cfa348578f6301b88e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ResearchEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fc084111de34f53a1ac7314517c9af2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6773e28d6849430994555cb09743216d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b85e221fa24178bff7cc0b297b9c72_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i856a56291322443ab3ccca37be0c321d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31b90616500947d38963e9030a90b72f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i722f7fc559114e54aeeadc90f492bc78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1155e6c14a0c4e65a515fa1e38dd911c_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c4cf1db12cd4ea3a46151468a622bcc_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="trading_day"><xbrli:measure>halo:trading_day</xbrli:measure></xbrli:unit><xbrli:context id="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd6310c76bae4bd78ad9a40cb2b6f8a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bc7c027cf8d468087b67594cb81b7d1_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412aa96cc1ad40e191bb9fafe16fe2dd_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e626483481f4563b913a234b6554eee_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55a4ed926b904e02ab845282be395019_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92cb63e1a7f24252ad3551517bf1a288_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5af33153364e0e95a999a7eaa312d1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8cb28bb49f44cebedc6e40327ee290_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70f1bbb3227642cd885e12ed12239f7d_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57fd176ba4c740bd84df4e3fe9c28ccb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef2086ff4f2483fbfd62522f9a2ad60_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5074839e1194c76ae4dc87402cb085f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i206c739252224af8a8948489d424ad8f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i686912eb766d40b18a385b1858670232_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73ccd57126f347af88275529acfde43e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5bb0843b04c43068da2dc6c03a064e3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie190bf0480c1487b9eb3d0916f7ffd88_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb4364368aa4364afadbad891bba742_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cd6bdc962914e4c99408077c340d9e7_I20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:RoyaltybackedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05a350efec6041e4ad6404c46e10b7d7_D20160101-20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:RoyaltybackedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc00725d97c48d58939d926e50427aa_D20160101-20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:RoyaltybackedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b79a7919f047598af257757cc3e833_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6935de8b3c224975955d989d869bb9c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if714bbad33ad4917992f139e44fd69a2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23a37442fa874dafb84523a3cca2bb91_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ba5ad85eda24a959bfa0546f86a7844_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia888539718ab4742979a05f4e932df96_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3782dfbd667f4a0687f611f008d2010f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idec1669a6ad4449fb85d6e5157147d08_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d3c879cf61d4eacae3a4dff1a71d41b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie22bc32765cc456cb791da8766cc1e95_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i991a03f67f0b48beb763927b3126b6ee_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad66576159674e89ac18ab298f2dbcdc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56b8f532e5be4b9985264987e5461803_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf0bf4633edb46a299d1efbda6de0f73_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f0e8a1da30a4e6491620fc881ff1298_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i524ae854807442c79db75cfe0fec0661_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id279be3e39fe4e73b119fc76b6f0e3e9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i777756be172547c79ef2d98b14af2e9f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcc6657cf7204e4bb3546eb115b7bb0b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5e243ecce6549b386466103e48f03b8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19137a9706c8440c91b3ac9170020347_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930e92c51aab40ecb52c8e784b177f6d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0c6e310d5c45ff9ba748668cdfb1c4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd817f332517429098def9a226790157_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">halo:A2021ESPPPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia25a711f34284d2cb31197de09c55937_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">halo:A2021ESPPPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96eaae6aa21440828363d019cc8fb175_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">halo:A2021ESPPPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cc8bb9a58ee4f22a7917709a47d0c11_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied5a4b70c0d2418886012876813052b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a10b0624cac49329813b37fc11aefe5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21bf5baccc98495a841b685c19034c72_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c625f6452334fda92249e711cf8c8e6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie68b30dcf1104c92bfe3cf876434fc97_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic605063c80bb49dd8a2679393c11b629_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96692b1d30124ac7860fc3b510b76971_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0eb7b940b8b45069c49b5e764d38ad3_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04b761c127644a42b2eb23927abd636d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74563819caa746e7b4b7466ded794e9c_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i482105c008be423fb640367ac9200980_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">halo:A2020ShareRepurchaseProgramBankOfAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i233725c2ad55441fb034d230594f0b46_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4ffcc29926a492a9b8cfa96fed2704b_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">halo:A2021ShareRepurchaseProgramBankOfAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i188943ac07244920b82f0519b3031931_D20210415-20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-15</xbrli:startDate><xbrli:endDate>2021-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b22b0c2f2646bea792472d7f97d94f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i241b7f6a84b54adbb1af7e7476c1b810_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5299df71ad7b40699940776b16949966_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9a61b1b587a4aad9bbfecff6ad6f475_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i065050ada4e544a2be29ac40313d14cf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia011b61b43c242d5a1e03e0cb7b02a60_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bf62165ab9948da9eaf8cd763bd074a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b1f1cb883146f9a922816ce4291811_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xNzk5_44167482-3579-4351-9ef0-80640cb0c2bc">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6N2YzMGZiNzhhMzhjNDA0MmE5MTA5NjFmMDFhZmQzZjUvdGFibGVyYW5nZTo3ZjMwZmI3OGEzOGM0MDQyYTkxMDk2MWYwMWFmZDNmNV8wLTAtMS0xLTA_a310cdd2-0ab3-48d0-8450-3a336ad1cfba">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xMzQ_5d8b1cf1-a799-4e4f-9a33-174d75c6c775">September&#160;30, 2021</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6MjhjZjlhNzBkYzQwNDkwZWI1MTRmOThlOTUyZDMzZWEvdGFibGVyYW5nZToyOGNmOWE3MGRjNDA0OTBlYjUxNGY5OGU5NTJkMzNlYV8wLTAtMS0xLTA_51e7f9f9-cf06-4d72-91c1-f3d5a7a2790c">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODA0_e50f6f0e-ddc8-4a37-8abb-ac482ff40e6e">001-32335</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">___________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODA1_054c1ad9-af4d-4537-b077-2cc4d78e6d04">HALOZYME THERAPEUTICS, INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Exact name of registrant as specified in its charter</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">___________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18wLTAtMS0xLTA_256bd13c-16df-4746-a9e0-e64294c57138">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18wLTItMS0xLTA_b97fd53b-9abd-4c30-a01e-50c0d15aa5ed">88-0488686</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18zLTAtMS0xLTA_cc93bb6e-34c4-47e6-8ce8-dc251c107ace">11388 Sorrento Valley Road</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18zLTItMS0xLTA_12ace12c-34e8-46f1-8584-1e5104d4ac12">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN180LTAtMS0xLTA_348da67e-9f85-4573-afd5-d9637c2ecbdf">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN181LTAtMS0xLTA_1e81290e-ef8f-4fbd-8d38-ed0a2e2a86d0">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODAw_1fa716ed-bb47-4954-a76b-e809a6fb64c3">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODA2_b0b67ff6-31d7-4ab3-86fe-987853b9201f">794-8889</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.277%"><tr><td style="width:1.0%"></td><td style="width:33.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.010%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.104%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6OWQwNzAxYmVjZjNhNGM5MmFmOTQxYWIwYWRjNTVhYjcvdGFibGVyYW5nZTo5ZDA3MDFiZWNmM2E0YzkyYWY5NDFhYjBhZGM1NWFiN18xLTAtMS0xLTA_eb6160de-db59-4cec-b7a2-4bd46f91e2a2">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6OWQwNzAxYmVjZjNhNGM5MmFmOTQxYWIwYWRjNTVhYjcvdGFibGVyYW5nZTo5ZDA3MDFiZWNmM2E0YzkyYWY5NDFhYjBhZGM1NWFiN18xLTEtMS0xLTA_127dfd9f-6a31-49e4-ba5f-e8e64121e9d6">HALO</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6OWQwNzAxYmVjZjNhNGM5MmFmOTQxYWIwYWRjNTVhYjcvdGFibGVyYW5nZTo5ZDA3MDFiZWNmM2E0YzkyYWY5NDFhYjBhZGM1NWFiN18xLTItMS0xLTA_4d5c2b2c-5e5f-429b-9313-137b1f47d5dd">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODAy_33a81121-af43-47f9-a2b0-0ffe84a4cb7c">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODAx_7520710d-e388-4898-82a8-94dfc1f2a417">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.:</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.277%"><tr><td style="width:1.0%"></td><td style="width:31.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NmI3YmMxMzNiZDJkNGUxZTk2MDY0MWYxYjU1ZDY3YjEvdGFibGVyYW5nZTo2YjdiYzEzM2JkMmQ0ZTFlOTYwNjQxZjFiNTVkNjdiMV8wLTAtMS0xLTA_54d29126-3071-4483-aa65-aaa28f0a38a9">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NmI3YmMxMzNiZDJkNGUxZTk2MDY0MWYxYjU1ZDY3YjEvdGFibGVyYW5nZTo2YjdiYzEzM2JkMmQ0ZTFlOTYwNjQxZjFiNTVkNjdiMV8xLTMtMS0xLTA_a8036711-1c1b-4a09-919e-47986f424b8e">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NmI3YmMxMzNiZDJkNGUxZTk2MDY0MWYxYjU1ZDY3YjEvdGFibGVyYW5nZTo2YjdiYzEzM2JkMmQ0ZTFlOTYwNjQxZjFiNTVkNjdiMV8yLTMtMS0xLTA_ee5ef38b-9bd6-447a-b20e-59f42f84b22b">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.472%"><tr><td style="width:1.0%"></td><td style="width:17.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.894%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#168;</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xNzk4_acb9c9c2-be88-44c2-af3c-6e8fcf06af30">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of outstanding shares of the registrant&#8217;s common stock, par value $0.001 per share, was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i369088a4f53841368f3952aac246def4_I20211025" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xNzgy_78e5bb9e-29e0-434e-95a2-2c93050e9a8b">140,787,020</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> as of October&#160;25, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160; </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:9.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.542%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.559%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_10">PART&#160;I &#8212; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_16">Condensed Consolidated Balance Sheets (Unaudited) - September 30, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_16">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_22">Condensed Consolidated Statements of Operations (Unaudited) - Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_22">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_25">Condensed Consolidated Statements of Comprehensive Income (Unaudited) - Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_25">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_28">Condensed Consolidated Statements of Cash Flows (Unaudited) - Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_28">6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_31">Condensed Consolidated Statements of Stockholders&#8217; Equity (Unaudited) - Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_31">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_34">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_37">8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_79">30</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_97">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_97">59</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_100">59</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_103">PART&#160;II &#8212; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_106">60</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_109">60</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_112">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_112">60</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_115">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_115">60</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_118">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_118">60</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_121">Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_121">60</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_124">Exhibits</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_124">61</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_127">SIGNATURES</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0f52beae0cb245d7843d69f1146dfb6c_127">62</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8212; FINANCIAL INFORMATION</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_13"></div><div style="padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. &#160;&#160;&#160;&#160;Financial Statements</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMy0yLTEtMS0w_920bb19c-6eb6-4caf-a8bc-91b8e64b6854">491,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMy00LTEtMS0w_b567de53-7588-452d-897c-f1e94933e7e0">147,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNC0yLTEtMS0w_32967259-c3bd-4ea7-b2a2-dea7e3699f6c">324,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNC00LTEtMS0w_a1f0512a-4ea5-4926-afef-6fb161128c97">220,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net and other contract assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNS0yLTEtMS0w_88ccf77d-7208-4b70-a9f1-a1a8f36344d8">112,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNS00LTEtMS0w_65ceca2a-714f-4667-9989-95e4c8ceef3a">97,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNi0yLTEtMS0w_ab7d4f3e-f005-4bfd-a29b-abeec85aba65">55,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNi00LTEtMS0w_0db6fb89-8081-473b-a2e7-9c65ad7bb60b">60,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNy0yLTEtMS0w_e21516ca-0013-407e-b4ce-499578add9db">33,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNy00LTEtMS0w_553a69da-372e-4d0d-9e16-84f88a44c166">28,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOC0yLTEtMS0w_91ecda28-41bf-4bcd-9180-b6e49becaf48">1,017,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOC00LTEtMS0w_308112e6-cf5f-4903-a667-50458235fb63">554,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOS0yLTEtMS0w_3df7be3d-24ca-4a71-b8d3-f5bbbd970015">9,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOS00LTEtMS0w_0b8b794c-c529-49c1-9fe3-c772758d29e1">10,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTAtMi0xLTEtMA_4d2d6f1c-f9eb-4654-bb18-d03f1b33064d">15,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTAtNC0xLTEtMA_3116a7de-d1d6-4c01-8202-bf777f9982b2">14,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtMi0xLTEtMTA0MDk_2007115a-b88d-4a7d-9e83-2c3249f2b583">142,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtNC0xLTEtMTA0MTY_36b60259-28d0-499f-884c-977a4cd61d1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtMi0xLTEtMA_09fc46c4-a851-4641-9407-8928644dbdc5"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtMi0xLTEtMA_efe25ab4-f4cb-4c2d-92c7-e01538a007d5">500</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtNC0xLTEtMA_af9e7d53-04ef-4fa7-8bb8-73e3859bbd09">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTItMi0xLTEtMA_e899ecff-98da-4d71-a1b8-7b1956848949">1,185,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTItNC0xLTEtMA_9aa0fde3-b8f1-4d12-830f-89f71ac05fff">579,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTYtMi0xLTEtMA_2e89cf48-e9e6-4606-9d8b-cc58fb6746fe">3,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTYtNC0xLTEtMA_deaea3b8-fdc1-4105-9a72-e32cd83b729a">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTctMi0xLTEtMA_256ccc5d-7ebd-4d85-9204-ecc353491cc6">18,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTctNC0xLTEtMA_e03e92aa-31cd-4425-b849-7be073553010">20,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTgtMi0xLTEtMA_a98c6c45-a6e8-4aef-b46a-c4f77a5c07ac">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTgtNC0xLTEtMA_7150d176-114b-4d5a-a8cb-5ca958e8e8e1">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTktMi0xLTEtMA_22b695c8-bbf5-4c3c-9b2e-59602fec0055">89,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTktNC0xLTEtMA_1a704ec8-e802-484c-89da-c7ec60e69eb3">397,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjAtMi0xLTEtMA_0bc2f600-28d9-4cd1-b300-f13e1434b4fe">113,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjAtNC0xLTEtMA_8f571284-bd07-47e3-9bef-53748f659308">421,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjEtMi0xLTEtMA_497d12d7-bd41-4698-bf52-747d3afb5864">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjEtNC0xLTEtMA_a5f9828f-06c9-4e20-8f9e-78b008355230">4,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjItMi0xLTEtMA_87d51e90-71a8-4b76-b70a-0f0132fc694b">786,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjItNC0xLTEtMA_ad39976a-2330-41e4-a7b8-ba73356f18fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjMtMi0xLTEtMA_80aaee02-bfcd-4112-b558-7b73ec2ea48d">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjMtNC0xLTEtMA_bab543e1-f093-4b54-bb17-c0ef029fb7cc">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjQtMi0xLTEtMA_f354d5a0-dac4-4278-b464-38c537648b31"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjQtNC0xLTEtMA_1ebf8ca9-86d5-439c-ae63-666a9562c5f0"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTA_0818f57f-6972-4880-9446-f1c75c1be6fe"><ix:nonFraction unitRef="usdPerShare" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTA_bf3c0d81-5c28-43ee-91b1-e8f41749a81a">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTk_6e6f0672-347c-4851-b8be-941a7593e836"><ix:nonFraction unitRef="shares" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTk_9a568466-91a3-45d5-a321-2ddd0c9fd109">20,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_11ee9064-2732-4fb0-ad84-df558a3422d4"><ix:nonFraction unitRef="shares" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_204071ee-9e74-47b3-8faa-6c9e1b31cf80"><ix:nonFraction unitRef="shares" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_3090b018-7946-4d4e-b983-0dafa33d3b1c"><ix:nonFraction unitRef="shares" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_9de48e98-6d09-4c03-8123-0a5520de4ad3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;issued and outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMi0xLTEtMA_645ea160-1812-4dca-b10f-70be178eaec0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtNC0xLTEtMA_d24625ef-c328-48a8-866a-1f64fbba83d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk1Mw_27f1be07-4f9a-4c0c-96eb-cec88712b343"><ix:nonFraction unitRef="usdPerShare" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk1Mw_46825fc0-8906-4c4a-b2ba-6d618b369c15">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk2Mw_a7f0e44c-a09b-4aab-9418-8eeba872747c"><ix:nonFraction unitRef="shares" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk2Mw_e025b3c1-da08-4e0c-9373-564139e996b0">300,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_0087817f-a606-4d72-a73e-05b833fa7c57"><ix:nonFraction unitRef="shares" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_5e7f6e0a-2f24-437e-885e-7cd7f06b4982"><ix:nonFraction unitRef="shares" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_9c774149-7c9d-4baa-83d6-f122eed81401"><ix:nonFraction unitRef="shares" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_f7feb667-1ab7-4d3b-a824-1872d2f38e2b">140,966</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i2c0f87e3f3f847cc839debee5868ce40_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk4Ng_d293cad0-18e4-479a-9c62-32a6fd11cdde">135,030</ix:nonFraction> shares issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMi0xLTEtMA_0a6bf4c6-17d5-4154-987f-338ed11eb9d6">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctNC0xLTEtMA_38314a87-fddd-4794-a331-abefe04d4df4">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjgtMi0xLTEtMA_d7eef431-4f01-4c1d-94df-ddcc7ebf8d12">407,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjgtNC0xLTEtMA_4b12b6f4-5fc3-4114-812c-6b0e9f3e96c2">625,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjktMi0xLTEtMA_a339c20c-2cef-4a10-8c79-d3276f40f7f8">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjktNC0xLTEtMA_3c5eebaf-746a-4a3e-851a-b0327b49ad20">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzAtMi0xLTEtMA_2749377d-6832-4cc0-983c-500c11a3350c">125,682</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzAtNC0xLTEtMA_2653c27a-7023-4df9-9cf8-3cd03192bcaf">474,593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzEtMi0xLTEtMA_3a22407c-e0a1-4d76-8085-422f41385c79">281,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzEtNC0xLTEtMA_6daeadc9-f280-470c-a136-9bfcc9023d47">151,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzItMi0xLTEtMA_75d096df-02f0-4776-9822-1c615fe8878e">1,185,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzItNC0xLTEtMA_a71149e1-0d53-4512-ba94-b5c3f380a3c5">579,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.568%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic648a667b4564856a5096920f3df03db_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy0yLTEtMS0w_26b27ea3-43a9-48d5-b18d-bb4b9baf67ad">58,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc326e2cf27f45baac0c0fe72eed59d2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy00LTEtMS0w_4b6d533b-5d93-4cda-ab6e-f0270a9ab5aa">23,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272651d659f84e0a8874d31b762516eb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy02LTEtMS0w_399e9ce5-7949-4e1e-9992-d68220d98655">141,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea7a928fde0046eca6e5a2a01621d057_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy04LTEtMS0w_794ada0d-6c6c-4724-a3e4-440cc6ed9083">56,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501c9252b83c44809a6ccbddc68fa142_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC0yLTEtMS0w_4de3f218-72b8-4cfa-8935-dcc9e8392d45">25,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic64829186658472f9e88de5ccbc70972_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC00LTEtMS0w_2e9abd19-0a3d-47e0-b8c4-b6778a1d2729">9,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4eef1632dd43799c54c3a51442359c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC02LTEtMS0w_b9988d75-6acb-4686-8588-9a4f9b7920f9">77,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353f14d9c0cc433e9597f0fe48db2359_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC04LTEtMS0w_ccf90c7d-3c22-4bfa-8e8b-ab2d1e6d891e">23,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed821ec9e124f6989a22f8554b1acbf_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS0yLTEtMS0w_e0d2ef9d-c7b2-4eef-8c11-0d63d316ce8a">32,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99adc572639e4c54b1595861c11fec96_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS00LTEtMS0w_b68abc74-c990-4e1f-bc45-b3df9615a355">32,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00f1c71dd4ef47f898e2155ae0b735ec_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS02LTEtMS0w_ca37f9a6-9c09-47f1-b6cc-c1c330b67c4f">122,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i247f86e8e166412cb70a5c1492bc28dd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS04LTEtMS0w_9fa0cf35-e6b1-4bae-b858-7bfb68785ab2">65,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi0yLTEtMS0w_754a64a1-e757-468e-a702-552d21b8ecc6">115,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi00LTEtMS0w_b8da280c-074d-4deb-a794-df791a4c1aa6">65,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi02LTEtMS0w_7a6ce43c-fefb-4f7b-92bb-dac12ee300d8">341,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi04LTEtMS0w_ea35745a-193a-4d15-8cef-e85be5f97b14">145,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC0yLTEtMS0w_f5736631-a6f9-4fc1-bdf6-e3e24af88820">18,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC00LTEtMS0w_92a0c495-b2ec-46c6-a846-9ded3f9a6946">5,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC02LTEtMS0w_82f5a91e-8e7d-4c53-9030-7732449ad1fc">59,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC04LTEtMS0w_7c8d02b7-930f-4e39-bea4-18cd666888bd">17,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS0yLTEtMS0w_3653fa11-b53e-473b-af1f-f2d965721c0b">8,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS00LTEtMS0w_95fca19a-84bf-4725-a3a9-ec9237552367">7,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS02LTEtMS0w_c3af0864-1498-42c2-9539-666f83ec09dd">25,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS04LTEtMS0w_f59aa8c7-9bd2-40e0-a836-46b6cc134463">26,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtMi0xLTEtMA_3156ed2a-b439-4257-b3ba-07b5274e1608">13,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtNC0xLTEtMA_f19d9d69-1d44-4ab5-8919-7582709f2f4e">11,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtNi0xLTEtMA_f5eba92f-fff6-460a-9b1e-e39e9d17ae21">36,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtOC0xLTEtMA_992a79e1-c105-4166-8f5c-44f547bb91c2">35,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtMi0xLTEtMA_b2c56fd2-ef70-4e57-a9ec-7eaf44ecf031">40,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtNC0xLTEtMA_be02118e-1e2f-46d5-bc2d-70d37053dbc2">25,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtNi0xLTEtMA_c5255163-239f-4e95-a9bb-2718a5fe6c8a">121,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtOC0xLTEtMA_1d72c93c-51cd-4b55-adf4-b7da54a48e4a">79,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItMi0xLTEtMA_f3dae798-60af-4c29-af8c-e46b174f7317">75,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItNC0xLTEtMA_fc093003-625e-4c90-b2d8-c4fc0f9f7014">40,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItNi0xLTEtMA_8e8792ee-fd2f-4e83-adba-d222c175a8a5">219,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItOC0xLTEtMA_6829f421-8e70-406e-8d22-9cb7246b0591">66,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtMi0xLTEtMA_b11c63c6-7e45-4134-b0ca-83ecbfca5566">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtNC0xLTEtMA_9217d2fd-783b-40e1-a6ac-fff3dcb6fd0c">961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtNi0xLTEtMA_e86adef8-a8be-4c20-afe4-5d5df6e3bf1e">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtOC0xLTEtMA_4da3efc5-7721-454d-ac9f-187461d5ae49">4,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inducement expense related to convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtMi0xLTEtMA_a75ecd0a-8e1c-485e-8a82-079b106cae42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtNC0xLTEtMA_9de401b8-4975-45f5-a821-395b4d126ade">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtNi0xLTEtMA_5f5ca930-05f2-4237-a137-73132f4e15bf">20,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtOC0xLTEtMA_72bf0842-05d0-4957-b372-518f59a6c7b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtMi0xLTEtMA_de8368a0-4fa0-4f05-802e-450b109a716d">1,754</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtNC0xLTEtMA_29368d40-e31a-4cb1-bf3c-c195e07a3355">4,990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtNi0xLTEtMA_f8e48041-5375-4c25-8fce-d57ba3f8571c">5,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtOC0xLTEtMA_e4cd7540-6b26-44d4-bc92-4cd395a7f820">15,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctMi0xLTEtMA_ce420587-b980-4d36-b4b6-b56ca176d3c7">74,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctNC0xLTEtMA_c42a3711-48ac-4c86-a146-db94ccf82f87">36,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctNi0xLTEtMA_745357d4-43e0-4f38-b60e-d6b291ec9782">193,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctOC0xLTEtMA_b779b3d5-af5b-426e-912b-bc232ea6a160">56,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtMi0xLTEtMA_0d3d64d2-55e7-4efb-a6c1-62c0aced845b">142,481</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtNC0xLTEtMA_4553f0f8-f065-4db9-a7d4-bdebaad31b27">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtNi0xLTEtMA_ff6b6265-26e4-4122-954b-e3f1f151b781">142,232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtOC0xLTEtMA_bcf1a6d8-cc66-4a04-9dd8-1ddba0ce6741">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktMi0xLTEtMA_0cd55c30-3648-401f-aa81-de9bd04894a4">216,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktNC0xLTEtMA_7e82f72c-8858-49e0-ba93-e7e248f84907">36,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktNi0xLTEtMA_626e0e05-9fb4-4e0d-a667-35c5ccb104dc">335,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktOC0xLTEtMA_d13ab8d4-bddf-4e82-a298-72bc927072da">55,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItMi0xLTEtMA_f9c2c0f4-e969-4768-8587-876bd23278ff">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItNC0xLTEtMA_871a3ce4-9474-4f7f-b7ea-c8192f337efa">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItNi0xLTEtMA_43fd443f-ab8c-4977-aa91-959ff2eb1c1b">2.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItOC0xLTEtMA_97609c10-6ead-4130-a7a6-d0ff93f6ea02">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtMi0xLTEtMA_115a7135-0b05-495b-b460-a2823c4fffcb">1.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtNC0xLTEtMA_280269a5-4e89-4380-b0f6-3bd869b54a3d">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtNi0xLTEtMA_f25f84ad-dfc4-4ba4-8986-f0046c50146a">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtOC0xLTEtMA_12cdb829-7377-48b3-9d06-06291d07d305">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtMi0xLTEtMA_9e502d26-1d8d-43f9-8a89-8b89d4402e8a">142,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtNC0xLTEtMA_9d91dfbb-728b-4fc4-ae73-216114bb3f0a">136,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtNi0xLTEtMA_4042dcb4-0d1e-4faa-9f88-7c3a1899d0a1">140,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtOC0xLTEtMA_56386064-d80c-4f36-875e-012432938ecd">136,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctMi0xLTEtMA_d7dac9ee-8648-44d0-be06-a1f87236cd96">146,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctNC0xLTEtMA_d4c5b954-b1f6-4a49-8967-1c283ba9349f">142,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctNi0xLTEtMA_eb8a1121-864b-4656-bab8-886d7ecb90ae">147,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctOC0xLTEtMA_01ea0e91-f793-41cb-9757-ec50300c4d50">139,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.959%"><tr><td style="width:1.0%"></td><td style="width:46.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi0yLTEtMS0w_f11ae758-873e-4bda-9b0a-7888b9bbb374">216,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi00LTEtMS0w_329f599b-c7d0-4ad3-bb61-2dbf5918e2e7">36,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi02LTEtMS0w_626e0e05-9fb4-4e0d-a667-35c5ccb104dc">335,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi04LTEtMS0w_d13ab8d4-bddf-4e82-a298-72bc927072da">55,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC0yLTEtMS0w_d512e477-ea40-42fe-a44f-6b28ca10e399">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC00LTEtMS0w_81e38f77-9ffe-41f2-b3d4-082fd974df80">640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC02LTEtMS0w_530bbaf2-d6fa-4ca4-abf3-f8dc03c1846b">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC04LTEtMS0w_57b178e5-e7ca-4715-a0ea-4cad4dc64533">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS0yLTEtMS0w_c3dd456a-5525-46fb-935b-d7658076fba6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS00LTEtMS0w_f1b7d5cc-11d0-4dc2-8062-6e68266ab946">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS02LTEtMS0w_01d3e6ee-0b59-45b3-bef0-72618fffb4e7">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS04LTEtMS0w_28bb1258-4237-4ff0-94da-4a3fad09c79d">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on foreign currency</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi0yLTEtMS0w_ed6532e2-dc4b-476e-afbe-c367837ad26b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi00LTEtMS0w_a575f96f-63b1-4d52-84b7-3c42f649b90c">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi02LTEtMS0w_c32a0819-470e-41fd-a56b-7cdf0501fb13">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi04LTEtMS0w_64f5b716-79de-486f-ac99-fc3b916192c2">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy0yLTEtMS0w_0469cba9-6257-4b58-9b62-bb5dbd785181">216,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy00LTEtMS0w_628cd3a6-a194-4ef2-b86d-72d2d3f9042f">35,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy02LTEtMS0w_55d028e6-149d-42ab-8072-7d05cafe9cf0">335,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy04LTEtMS0w_c483f5e0-0909-4476-b54c-9862469720a2">56,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:77.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.328%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNC0yLTEtMS0w_8b0107d1-863e-4c9a-b903-035eca6f4e15">335,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNC00LTEtMS0w_335e3107-5cc3-49fd-a853-fd19b3e919a2">55,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by (used) in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNi0yLTEtMS0w_f47ee73c-64a9-4a78-a90b-3fb1d8af45f4">15,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNi00LTEtMS0w_4c509982-946a-45fc-984a-7839d82f046d">13,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNy0yLTEtMS0w_37d38eb5-cc1e-47b7-9c22-74878934bad7">2,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNy00LTEtMS0w_fbc2d23c-629f-43d9-abfe-e9b33aee08d6">2,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfOC0yLTEtMS0w_613e1bff-91a4-433e-b736-3649c7ca240b">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfOC00LTEtMS0w_e7901674-6282-44f3-9f9a-35082518b109">10,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discounts on marketable securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTAtMi0xLTEtMA_cf9b57bf-5224-4a2f-8ec9-518acd40752c">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTAtNC0xLTEtMA_1ccb4d46-47a1-4a1a-a4fb-67af0d334d6f">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTItMi0xLTEtMA_ad598837-6b3e-49fa-8313-76f7b2ed7d47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTItNC0xLTEtMA_5f325804-3186-42fb-b660-323bbc5eb579">631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of deferred revenue </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTQtMi0xLTEtMA_bc7df44f-17b3-4837-9774-fff2304317d8">997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTQtNC0xLTEtMA_2a883916-5e67-45ea-ab4c-550b4efb48a4">3,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease payments deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="halo:DeferredRentPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTUtMi0xLTEtMA_dd1d92ae-4fce-46ce-a640-23000082eeeb">568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="halo:DeferredRentPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTUtNC0xLTEtMA_d19dd7d4-e06d-4acf-a78c-5afc0275a16d">759</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment of right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OperatingLeaseImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTYtMi0xLTEtMA_82d1f0b3-3164-4151-9360-947d315b8646">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:OperatingLeaseImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTYtNC0xLTEtMA_c836d918-c22d-40b1-8f06-9a1cc95cce61">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Induced conversion expense related to convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTgtMi0xLTEtMA_abd5d4f5-4e02-42bf-b545-138c79fe6a24">20,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTgtNC0xLTEtMA_44ba77b6-a4e9-4470-a23b-a51590e84afa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes (benefits from valuation allowance release)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktMi0xLTEtMTA2NTU_206177c9-497a-431e-a342-873b52e2559a">142,481</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktNC0xLTEtMTA2NjY_39f7f42e-08f8-4ad8-9597-45e6e1d444c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktMi0xLTEtMA_b9080c10-c777-4081-b699-c79e96e7aebd">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktNC0xLTEtMA_0d6b1402-9d49-4d60-86c0-ad3667275f5b">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net and other contract assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjEtMi0xLTEtMA_e5fdceb1-90d4-4c06-a24f-68b724887311">14,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjEtNC0xLTEtMA_0503eafe-e7bd-4117-bde4-6302ebe47c6a">3,109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjItMi0xLTEtMA_89da4dbe-5be9-4985-a9fa-27c22901a82a">5,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjItNC0xLTEtMA_0b24e8d7-36e3-45fc-9344-579a03b269c8">28,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjMtMi0xLTEtMA_90d769b0-adb6-4eb7-a250-add18b64834a">6,513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjMtNC0xLTEtMA_2c622d90-a70b-4400-b16e-41095d513379">1,567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjQtMi0xLTEtMA_2e7a9792-5b73-4f3a-8116-b4a04821068e">2,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjQtNC0xLTEtMA_5a9d438b-c4c9-4c3d-b7e8-13befb85e5e2">40,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjUtMi0xLTEtMA_5ce71ade-c012-48d2-9a57-2d5774636788">216,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjUtNC0xLTEtMA_ceb8f7ac-4877-4ee9-894e-52ac72251274">4,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjctMi0xLTEtMA_9ba42c28-c28a-45a3-b028-c8a540777f35">283,354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjctNC0xLTEtMA_4aa94181-07af-4acd-9bd4-4684b1d50a1d">161,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjgtMi0xLTEtMA_a0332a59-b5f6-4dcb-b8a4-fcacc518aafa">177,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjgtNC0xLTEtMA_a1998351-4a89-44d6-a0c5-93b9c8af6a45">181,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjktMi0xLTEtMA_73b74393-dc2c-4bf4-8a61-5e5cf2c686ce">1,299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjktNC0xLTEtMA_0398282f-ce94-431d-b2dd-7b857f8f6c36">805</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from disposal of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzAtMi0xLTEtMA_f57a5357-971e-4290-b082-5dd399f3ca60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzAtNC0xLTEtMA_3b5d3e78-eca0-4aa6-87a0-56332cdd6e38">861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzEtMi0xLTEtMA_23152ac0-d621-43da-a3a6-74560eba881a">106,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzEtNC0xLTEtMA_9b9a276f-c998-4703-aadd-a7fde0ced5d1">19,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzQtMi0xLTEtMA_5828cb0a-65c7-4a60-9fed-0484d66bb045">784,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzQtNC0xLTEtMA_137176c4-505b-4bfc-bf26-6ab6d4e8a7c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzUtMi0xLTEtMA_2f90eb42-52a8-47f3-8585-43dc250f9bd5">369,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzUtNC0xLTEtMA_f2194afd-9fd4-49dd-b125-8ce339bfc729">19,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzYtMi0xLTEtMA_6b092387-fd68-47e6-8b4d-44db3be06527">424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzYtNC0xLTEtMA_69a59ceb-39ec-47f0-a9ce-bef2450b41ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzctMi0xLTEtMA_98391745-f5f7-4ff4-9cd5-eca015f4d15a">189,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzctNC0xLTEtMA_59e45e08-a1c4-4ec0-9bb9-e751b482d3e2">109,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzgtMi0xLTEtMA_e608ff0d-ac1c-4c4a-976e-67cf85896c02">8,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzgtNC0xLTEtMA_3e2875fe-144f-42a5-b0bb-7b54d06c0992">50,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzktMi0xLTEtMA_9ce36ad5-5dab-49e4-a53b-05bb22a45e5f">233,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzktNC0xLTEtMA_f90045f5-c9f5-4b36-983e-5ee6da0e5384">78,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDAtMi0xLTEtMA_bbe0be68-7c82-4e9e-94b3-57267b1055e9">343,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDAtNC0xLTEtMA_235855c1-dd62-4377-b62e-8bb55a316fdc">54,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDEtMi0xLTEtMA_1500c9d9-f3a7-43b4-a680-a45c93a1cb85">148,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e89af44e744d99aa39539c76531199_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDEtNC0xLTEtMA_1b59a589-3563-4ef1-8ca1-aa2c0e88a902">120,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDItMi0xLTEtMA_5acf65f4-6f6e-46a9-9a17-694510ae3825">492,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25334aa547be4cdaaff347b5deaac86e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDItNC0xLTEtMA_6eb3dafb-cc21-4748-989c-c80a89d38c1d">66,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosure of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts accrued for purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDUtMi0xLTEtMA_0b7fbb48-a8f1-4406-8530-aaf4e03d069b">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDUtNC0xLTEtMA_1c970159-c7e8-4618-aa76-1f875545587e">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDYtMi0xLTEtMA_033abf2a-6ef9-4a11-9944-41e87b240468">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDYtNC0xLTEtMA_d82a9e1d-3fef-4c06-b662-e5bddad1db89">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pending settlement of common stock repurchase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="halo:PendingSettlementofCommonStockRepurchase" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDctMi0xLTEtMA_9a7437b6-d05d-4dcb-911c-2f5167afb52d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="halo:PendingSettlementofCommonStockRepurchase" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDctNC0xLTEtMA_b6c6616a-88c7-4cbe-a80e-f63b634cf674">2,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for induced conversion related to convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDktMi0xLTEtMA_e0780491-dd77-4b4b-aa25-2e8ebbb644e3">7,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDktNC0xLTEtMA_6a5d8e3a-650f-41d6-a114-6d8c484631aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_31"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) (in thousands)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF JUNE 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i601d2a7ba1ff42c88d69d679d48bf478_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy0yLTEtMS0w_8d22e979-2bc6-4437-a7ec-493e35a97ca4">142,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i601d2a7ba1ff42c88d69d679d48bf478_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy00LTEtMS0w_6b1aa7f4-eb94-45d5-9668-79a8721016c4">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ac7847378b429f9176338d1e7ce9e7_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy02LTEtMS0w_79876008-a5d7-4bb6-a6a3-12005ccb36f4">461,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41d331fe41f24e9da00e1cf521cc23db_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy04LTEtMS0w_ca72c780-1dde-46d6-873f-99a191d36834">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc5f865f951b41669cfe18b259a0d85d_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy0xMC0xLTEtMA_fefc5ae6-2ca1-4427-b315-cdb046cad93c">342,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcaf7ea55080433b89ecd6b1dc21f494_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy0xMi0xLTEtMA_262dd31f-1e7b-4f5e-a9f5-0199dd320c92">119,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNS02LTEtMS0w_0417e5a8-f0bb-48b9-9cdd-d90f262c6673">5,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNS0xMi0xLTEtMA_60f4ff86-afc4-43c4-99b4-4810f190b29e">5,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy0yLTEtMS0w_44b87e94-4bed-43e2-b3d0-19b896aafe03">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy00LTEtMS0w_e8e5f443-e0ea-4aab-8300-7c8457d4468c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy02LTEtMS0w_060faf57-6749-43e9-a6b4-22ac1da5b029">4,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy0xMi0xLTEtMA_f102e030-69c9-4054-a2b1-315ed82150a1">4,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of  common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS0yLTEtMS0w_2dc047d7-d518-4bfa-91f1-9fc02931335a">1,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS00LTEtMS0w_a6b35fbf-eba0-41e6-8464-c50cf44f1184">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS02LTEtMS0w_813e0d33-5c47-4159-b5d6-f3d446fddc28">64,715</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS0xMi0xLTEtMA_3c01111a-fce4-448b-b916-351bb500cfcf">64,716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ed45201faa485fbbc32a6c3f935988_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTAtOC0xLTEtMA_4e715667-a454-41bf-bcf4-1be732b4a89a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTAtMTItMS0xLTA_e3c4cc05-3f52-4124-bb8a-4fce1f8d85ac">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a586d0e614542b59729d466bcca9e14_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTEtMTAtMS0xLTA_35d87d4f-a9ed-4d3b-a459-47481636084d">216,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTEtMTItMS0xLTA_bb17f729-25ce-4013-8f77-37d240e0eed9">216,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF SEPTEMBER 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItMi0xLTEtMA_82a1f056-ce6f-4cde-8431-f01ed375e9f0">140,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItNC0xLTEtMA_780a1f7d-fdb8-458b-8340-6277678b0ff0">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d99a9ecd955442dbccf9c897a851078_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItNi0xLTEtMA_e1ffba0a-6780-41be-b662-2f17f496e63d">407,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i178ae7e383b143a6a97d76a52a288a81_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItOC0xLTEtMA_aafc2a98-8404-434d-bccd-11a00db1ba81">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38a5fc0a748f43aeb840f079b1667ce7_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItMTAtMS0xLTA_2e26d5f8-1ede-437d-95d8-3f0f71246cce">125,682</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItMTItMS0xLTA_fb7779d7-5eca-435a-af24-1a90e09847d4">281,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF DECEMBER 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c0f87e3f3f847cc839debee5868ce40_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctMi0xLTEtMA_d293cad0-18e4-479a-9c62-32a6fd11cdde">135,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0f87e3f3f847cc839debee5868ce40_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctNC0xLTEtMA_b9b58718-6646-4b76-af24-3b408bb336b6">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c62eaa17c0847168d4711f217c137e9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctNi0xLTEtMA_4c87b924-69b1-4806-ba85-159bc2cc732e">625,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib749d4ed30754a3f9c5e7b5a222e9c73_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctOC0xLTEtMA_e9b05205-5649-4d14-b59a-bb8fcfe1b050">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a17be07a5cc4453aeff021e1cc99bc0_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctMTAtMS0xLTA_f7f1a77e-5f4b-4712-8ef4-aa141d84ba57">474,593</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctMTItMS0xLTA_c7159618-656b-411c-8f9a-ebc8074b5395">151,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative adjustment from adoption of ASU 2020-06</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if05acc0270554a9682fec68a9903a505_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTgtNi0xLTEtMA_5cea64a2-2159-4198-90fd-72763a4b2670">65,535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4b95062afe4a8880ccae03db28b451_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTgtMTAtMS0xLTA_4408718d-d1e7-4090-b54c-62c908226c58">12,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id97983bc9beb4b1ca46661fdb9b34961_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTgtMTItMS0xLTA_cfcd9ddb-d764-4c04-9077-b7e82b835ae9">52,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTktNi0xLTEtMA_eceb9f81-ae15-4353-bd52-1fb3f2771065">15,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTktMTItMS0xLTA_a86aec8b-5021-4d46-bfe5-4fb12a98a088">15,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock for the induced conversion related to convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtMi0xLTEtMA_1f75779d-345b-4001-ad47-30a41c7ba569">9,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtNC0xLTEtMA_98bf3dd4-5c30-4ddf-a2ef-cc610a08e96d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtNi0xLTEtMA_d1d11b71-85e0-4813-8532-e304a4f4e0ae">13,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtMTItMS0xLTA_08b6a2ab-5602-47be-9788-103ec8deff8d">13,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtMi0xLTEtMA_0b5300a2-fa4e-48d7-8c9b-b7c4a89eb6b7">1,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtNC0xLTEtMA_33152de9-0bc3-4056-ac85-9af2a5a492f0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtNi0xLTEtMA_9af499b4-87a9-47ae-b20d-28fcd5fdd6f7">8,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtMTItMS0xLTA_95124ba5-c376-40e3-a5a6-94bcbda652b4">8,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtMi0xLTEtMA_e05cc8b3-5eb1-41ff-b3bf-d3a348008f6b">4,376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtNC0xLTEtMA_bc2d1762-9fa4-4403-a1ce-a383f7a18c52">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtNi0xLTEtMA_64ccc9e9-51ee-4f54-add2-16011e53fd00">189,733</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtMTItMS0xLTA_a2c28a27-f6cd-4794-8727-3d213c164699">189,737</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85256e985e1c4b42ac4d454f915a8bd0_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjUtOC0xLTEtMA_2c1a49c9-f735-4ff1-a91d-d48adbb12c7e">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjUtMTItMS0xLTA_5ff357fd-d2ff-492f-b006-5b3868b8a6e6">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic293939d2030450296034697f0724379_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjYtMTAtMS0xLTA_1c03cd15-2288-4a20-9003-0ab69f30ea4b">335,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjYtMTItMS0xLTA_86c5f6aa-5d1b-4fcd-ba7e-aa3c437d8e12">335,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF SEPTEMBER 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctMi0xLTEtMA_d5e8c685-d3a6-4522-adee-b955a65eb7f7">140,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctNC0xLTEtMA_7d449f2f-05e6-49fe-ad7f-4ce461aba6d9">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d99a9ecd955442dbccf9c897a851078_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctNi0xLTEtMA_bb64abd2-d58f-4625-be15-faae3a81d21b">407,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i178ae7e383b143a6a97d76a52a288a81_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctOC0xLTEtMA_89cd9d7d-86ea-4eb8-8f8c-7fd2fd93facb">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38a5fc0a748f43aeb840f079b1667ce7_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctMTAtMS0xLTA_5379d1bb-f275-4c27-b713-c0870f9cc262">125,682</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctMTItMS0xLTA_d9c70c15-b654-471e-b998-152f00fc0ffd">281,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Income</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF JUNE 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c770b432f2e40caa63dcfeac3352f9d_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItMi0xLTEtMA_f572bbf3-056a-4e97-8c87-3e9a470beaa0">136,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c770b432f2e40caa63dcfeac3352f9d_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItNC0xLTEtMA_a5b6df7f-fe19-4391-9050-3e201a2f2e31">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c21184904734499ada0aa1912871ae4_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItNi0xLTEtMA_2d9bd590-4f5b-41ed-81fc-cf02344004a2">688,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43f3bfde66344aef8be3f0502fdef7c1_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItOC0xLTEtMA_01b49149-f613-45ef-99ce-1944b2d2ba39">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i227c6dc9e3ae40648df2cfd2ac32bb2c_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItMTAtMS0xLTA_15090e58-5db2-492c-891d-afced1f7455d">583,964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7273c25133442389646e9ae5c7a0f58_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItMTItMS0xLTA_a269c871-c178-4d08-b145-17b28c8638b4">105,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzQtNi0xLTEtMA_e02a1dcf-3f2e-4b78-ae31-edd58acd9e85">4,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzQtMTItMS0xLTA_567cf526-aeaa-49f8-8d0d-505af292671a">4,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtMi0xLTEtMA_78e53fbe-0335-4f17-a851-f77f40ff188c">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtNC0xLTEtMA_dde72264-157c-444b-a4f7-fe6c37ce694a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtNi0xLTEtMA_0f78b99a-e647-4f80-a5b3-5ac6afa62357">12,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtMTItMS0xLTA_38a3ff9e-80c2-470f-80b1-50a40f6293cb">12,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzYtMi0xLTEtMA_f436082a-c654-493c-9b44-a1d98110fde1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzYtMTItMS0xLTA_1520c277-9698-450c-a6a1-c22d83083c7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctMi0xLTEtMA_22cb31e5-a361-4ed6-8062-47179a6280bf">2,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctNC0xLTEtMA_2f16d4ee-1136-44fb-b4df-a1d37b59f65a">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctNi0xLTEtMA_35b5e49b-bb52-4b60-9929-f17955677abf">58,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctMTItMS0xLTA_f417cbbf-b611-45d2-b8ee-29331ce0886a">58,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d1f54f1a68e4e809dca7deac8cde021_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzktOC0xLTEtMA_806f6d45-f85e-41e6-bd5c-60832bbeb341">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzktMTItMS0xLTA_612427fc-3ef1-42b4-b736-5172722ebd2f">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id00da01d4ee5429da1ab15a67bd8c92b_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDAtMTAtMS0xLTA_a22d37e5-1231-4dd0-849d-a6291d9b74f7">36,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDAtMTItMS0xLTA_2d7effd2-9782-411e-a6a5-e58421b765a7">36,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF SEPTEMBER 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtMi0xLTEtMA_7076274d-5c42-483d-98ee-ba622d7e9cbc">135,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtNC0xLTEtMA_ae77d05b-eece-457a-bb33-539abd195ad4">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ffb579646fc4c0d8197f17b32a7128b_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtNi0xLTEtMA_25d94841-cfcb-4210-a2ce-99be272ec44c">646,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871d983ec9934312a36ee3536d265db2_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtOC0xLTEtMA_19d70ee3-bcc1-4899-abbf-4c7ae14d171a">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5fea2d63902453fabd27c2ad7ff2cfd_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtMTAtMS0xLTA_8180a072-e5f7-4779-a389-3985e2f73b67">547,757</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25334aa547be4cdaaff347b5deaac86e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtMTItMS0xLTA_55a59144-9be6-47b8-8105-68fc99f0fbfe">98,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Income</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF DECEMBER 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic35a7e6ef47d488cada6c8e7fba0110d_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtMi0xLTEtMA_7826958d-0b91-4c3a-8097-8817ad3da5b6">136,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic35a7e6ef47d488cada6c8e7fba0110d_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtNC0xLTEtMA_476066cd-91a2-43d7-91a7-035b8f6d375c">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b526ab8a3cb471bb556ee04a4fd7e83_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtNi0xLTEtMA_87c3af1f-943d-451f-bd00-ab5c2e1728db">695,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b8bb66e550462093b0b0b019e5c127_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtOC0xLTEtMA_e2930444-a938-487c-982a-71b4bc5007d6">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i622c6a2434bf454db942b487a6b7e00a_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtMTAtMS0xLTA_5034030d-10dd-478f-8318-3e2457a4205c">603,678</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e89af44e744d99aa39539c76531199_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtMTItMS0xLTA_310d39c4-1507-403f-8e62-0b69f6f6dd62">91,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDgtNi0xLTEtMA_a3736daf-d21b-49e4-a8c6-212e1c041406">13,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDgtMTItMS0xLTA_c031bcd8-ecac-4b77-bb1b-a4079aec56ce">13,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktMi0xLTEtMA_aecf9b1b-5e79-46e0-90c7-920eb30de43c">4,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktNC0xLTEtMA_0b65de72-7bf4-4f31-8fcd-666634480015">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktNi0xLTEtMA_a5f75e57-2a8a-4830-a38b-f5f227e1282f">50,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktMTItMS0xLTA_eaf30528-00ea-4368-8765-e32c4266ab3c">50,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of restricted stock awards, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTAtMi0xLTEtMA_366e1610-860c-491e-a2a6-e9fcd2d97e65">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTAtMTItMS0xLTA_7efb5a88-fae4-47df-85b2-70f1825358e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtMi0xLTEtMA_8ab571fd-93db-406f-a014-4a40ce5c11ce">5,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtNC0xLTEtMA_ef5f9ee5-c149-4b1a-bcc3-c9402a8a2803">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtNi0xLTEtMA_d32919cb-624f-4478-91ee-c563105f29da">112,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtMTItMS0xLTA_2d43e5a8-3593-40eb-848f-430f27aa2f95">112,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity Component of convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTItNi0xLTEtMA_94d3402a-5604-4563-b99c-5434e6976943">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTItMTItMS0xLTA_0bb0c925-8060-48ce-9847-5452d4bb8b33"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTItMTItMS0xLTA_5abcce5b-f015-4d37-b387-ed7492e01375">65</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d81c8e1eb01492f8722125c6a4fb845_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTMtOC0xLTEtMA_7df91a2c-ceab-413b-9b95-d68a5bbe2ce5">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTMtMTItMS0xLTA_f70805cf-903b-488b-aadd-75dd20ac6ebb">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e79cd5f47bc44cd8c4429cf1b065e7f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTQtMTAtMS0xLTA_c836e7fa-36ec-49f7-932b-8d274c3777c4">55,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTQtMTItMS0xLTA_fce09e88-820f-4f30-9316-f134484fc560">55,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BALANCE AS OF SEPTEMBER 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtMi0xLTEtMA_3860f895-b0a3-43f8-8677-f2c0e2766dd4">135,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtNC0xLTEtMA_ea478462-e593-4be7-8195-8aabff16a653">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ffb579646fc4c0d8197f17b32a7128b_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtNi0xLTEtMA_817624d4-aff0-431a-b322-c563e696092d">646,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871d983ec9934312a36ee3536d265db2_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtOC0xLTEtMA_58fee55e-99bd-4f19-87f3-a20bdcc60c2b">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5fea2d63902453fabd27c2ad7ff2cfd_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtMTAtMS0xLTA_e08927b3-bd16-4822-a917-314dea9de7d0">547,757</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25334aa547be4cdaaff347b5deaac86e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtMTItMS0xLTA_9133137b-e443-41c0-b5a1-f6c41b56212d">98,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfNDE1NQ_7f1581a7-283d-4c65-b762-c33a303f3328" continuedAt="i518b1b4d81284169844f916ebf000559" escape="true">Organization and Business </ix:nonNumeric></span></div><ix:continuation id="i518b1b4d81284169844f916ebf000559"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme Therapeutics, Inc. is a biopharma technology platform company that provides innovative and disruptive solutions with the goal of improving patient experience and outcomes. Our proprietary enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. We license our technology to biopharmaceutical companies to collaboratively develop products that combine our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology with the collaborators&#8217; proprietary compounds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approved product and our collaborators&#8217; approved products and product candidates are based on rHuPH20, our patented recombinant human hyaluronidase enzyme. rHuPH20 is the active ingredient in our first commercially approved product, Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recombinant, (&#8220;Hylenex&#8221;), and it works by breaking down hyaluronan (or &#8220;HA&#8221;), a naturally occurring carbohydrate that is a major component of the extracellular matrix in tissues throughout the body such as skin and cartilage. This temporarily increases dispersion and absorption allowing for improved subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other large therapeutic molecules, as well as small molecules and fluids. We refer to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology (&#8220;ENHANZE&#8221;). We license the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. In the development of proprietary intravenous (IV) drugs combined with our ENHANZE technology, data have been generated supporting the potential for ENHANZE to reduce treatment burden, as a result of shorter duration of subcutaneous (SC) administration. ENHANZE may enable fixed-dose SC dosing compared to weight-based dosing required for IV administration, and potentially allow for lower rates of infusion related reactions.&#160;ENHANZE may enable more flexible treatment options such as home administration by a healthcare professional or potentially the patient. Lastly, certain proprietary drugs co-formulated with ENHANZE have been granted additional exclusivity, extending the patent life of the product beyond the one of the proprietary IV drug.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We currently have ENHANZE collaborations with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc. (&#8220;Roche&#8221;), Baxalta US Inc. and Baxalta GmbH (members of the Takeda group of companies) (&#8220;Baxalta&#8221;), Pfizer Inc. (&#8220;Pfizer&#8221;), Janssen Biotech, Inc. (&#8220;Janssen&#8221;), AbbVie, Inc. (&#8220;AbbVie&#8221;), Eli Lilly and Company (&#8220;Lilly&#8221;), Bristol-Myers Squibb Company (&#8220;BMS&#8221;), Alexion Pharma Holding (AstraZeneca PLC announced the completion of its acquisition of Alexion Pharmaceuticals, Inc. in July 2021) (&#8220;Alexion&#8221;), argenx BVBA (&#8220;argenx&#8221;), Horizon Therapeutics plc. (&#8220;Horizon&#8221;) and ViiV Healthcare (the global specialist HIV company majority owned by GlaxoSmithKline) (&#8220;ViiV&#8221;). We receive royalties from <ix:nonFraction unitRef="collaborator" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="halo:RoyaltiesReceivedNumberOfCollaborators" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjA4NA_488133c3-3686-43c1-af87-f5387fbf71bc">three</ix:nonFraction> of these collaborations, including royalties from sales of <ix:nonFraction unitRef="product" contextRef="ib333d4f3b723420d812af307ac6e7563_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="halo:RoyaltiesReceivedNumberOfProductsSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjA5OQ_b06f35b3-4d57-4aee-aacc-baa3bd29989e">one</ix:nonFraction> product from the Baxalta collaboration, <ix:nonFraction unitRef="product" contextRef="i6959c5a508d04982a33bfa4c80321de9_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="halo:RoyaltiesReceivedNumberOfProductsSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjEwOQ_d18ca442-1bef-4c0a-99b2-dd8d6f802d55">three</ix:nonFraction> products from the Roche collaboration and <ix:nonFraction unitRef="product" contextRef="ie1a53e64a7e34f70b0457b035813cd41_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="halo:RoyaltiesReceivedNumberOfProductsSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjEyMQ_cc90d9cb-559a-4608-ba2e-36a5c2d0533b">one</ix:nonFraction> product from the Janssen collaboration. Future potential revenues from royalties and fees from ENHANZE collaborations and the sales and/or royalties of our approved products will depend on the ability of Halozyme and our collaborators to develop, manufacture, secure and maintain regulatory approvals for approved products and product candidates and commercialize product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except where specifically noted or the context otherwise requires, references to &#8220;Halozyme,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; in these notes to the condensed consolidated financial statements refer to Halozyme Therapeutics, Inc. and its wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#8217;s wholly owned subsidiaries,  Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMjc_cfc8da7f-8b1e-4708-b655-809bc048b79c" continuedAt="ib6a74534acca4b5982e09a39f47ffcd8" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ib6a74534acca4b5982e09a39f47ffcd8" continuedAt="i45c7384ef7014811ab8f9510e65ad5f4"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMDg_ec34aa16-3d0b-405b-a9ba-bc2b34735731" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) related to a quarterly report on Form 10-Q. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for a complete set of financial statements. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;23, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operations for the periods presented, with such adjustments consisting only of normal recurring adjustments. Operating results for interim periods are not necessarily indicative of the operating results for an entire fiscal year.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyNTc_f934961a-93bf-45a6-a637-f658ca1f62b0" escape="true">The accompanying interim unaudited condensed consolidated financial statements include the accounts of Halozyme Therapeutics, Inc. and our wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#8217;s wholly owned subsidiaries, Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH. All intercompany accounts and transactions have been eliminated.</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxNDU_9bb41b22-af2a-4186-a20a-dd543d1db52c" continuedAt="ic1289df6402741b6ade396d0829038dc" escape="true">Use of Estimates</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic1289df6402741b6ade396d0829038dc">The preparation of interim unaudited condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in our interim unaudited condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#8217;s estimates</ix:continuation>.</span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMjk_8a2f55ca-53c5-4470-aedf-63b046474923" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents and Marketable Securities </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of highly liquid investments, readily convertible to cash, that mature within ninety days or less from the date of purchase. As of September&#160;30, 2021, our cash equivalents consisted of money market funds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities are investments with original maturities of more than ninety days from the date of purchase that are specifically identified to fund current operations. Marketable securities are considered available-for-sale. These investments are classified as current assets, even though the stated maturity date may be one year or more beyond the current balance sheet date which reflects management&#8217;s intention to use the proceeds from the sale of these investments to fund our operations, as necessary. Such available-for-sale investments are carried at fair value with unrealized gains and losses recorded in other comprehensive income (loss) and included as a separate component of stockholders&#8217; equity. The cost of marketable securities is adjusted for amortization of premiums or accretion of discounts to maturity, and such amortization or accretion is included in investment and other income, net in the interim unaudited condensed consolidated statements of operations. We use the specific identification method for calculating realized gains and losses on marketable securities sold. None of the realized gains and losses and declines in value judged to be as a result of credit loss on marketable securities, if any, are included in investment and other income, net in the interim unaudited condensed consolidated statements of operations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the leases of our facilities, we are required to maintain letters of credit as security deposits during the terms of such leases. At September&#160;30, 2021 and December&#160;31, 2020, restricted cash of $<ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNDE2Mg_09fc46c4-a851-4641-9407-8928644dbdc5"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNDE2Mg_efe25ab4-f4cb-4c2d-92c7-e01538a007d5">0.5</ix:nonFraction></ix:nonFraction> million was pledged as collateral for the letters of credit.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxOTU_29e6d960-72bf-4252-844a-c99b58a0c7d8" continuedAt="i30861e7e35c245fe8dd1389ef951a2a5" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i45c7384ef7014811ab8f9510e65ad5f4" continuedAt="id311c35e31a44238a0e74645d9202499"><ix:continuation id="i30861e7e35c245fe8dd1389ef951a2a5"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments include cash equivalents, available-for-sale marketable securities, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses and long-term debt. Fair value estimates of these instruments are made at a specific point in time, based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued expenses are generally considered to be representative of their respective fair values because of the short-term nature of those instruments. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consist of asset-backed securities, corporate debt securities, U.S. Treasury securities and commercial paper, and are measured at fair value using Level 1 and Level 2 inputs. Level 2 financial instruments are valued using market prices on less active markets and proprietary pricing valuation models with observable inputs, including interest rates, yield curves, maturity dates, issue dates, settlement dates, reported trades, broker-dealer quotes, issue spreads, benchmark securities or other market related data. We obtain the fair value of Level 2 investments from our investment manager, who obtains these fair values from a third-party pricing source. We validate the fair values of Level 2 financial instruments provided by our investment manager by comparing these fair values to a third-party pricing source.</span></div></ix:continuation><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxODY_79bd85e6-d799-46fb-b1f3-2c72c082d361" continuedAt="i55ba6d61c8904c3d8f41e2af0f2a619a" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventories are reviewed periodically for potential excess, dated or obsolete status. We evaluate the carrying value of inventories on a regular basis, taking into account such factors as historical and anticipated future sales compared to quantities on hand, the price we expect to obtain for products in their respective markets compared with historical cost and the remaining shelf life of goods on hand.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i55ba6d61c8904c3d8f41e2af0f2a619a">As of September&#160;30, 2021, and December&#160;31, 2020, inventories consisted of $<ix:nonFraction unitRef="usd" contextRef="i9f30dd7e598c4150bb7ab34c0c700764_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzEzOQ_7bfaa1b3-d4e0-4c05-aeef-c1d3c8970517">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3d7143f1a70f40f4865183995dcdf3c1_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzE0Ng_d4acac11-e5ee-4ba7-b42f-4c3bff2905ca">1.3</ix:nonFraction> million, respectively, of Hylenex inventory, net and $<ix:nonFraction unitRef="usd" contextRef="i89efb2eece474b1c9fa2252f912eb2e2_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzE5NA_cd4085ba-80df-4db4-9213-061e32a75912">54.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if2bf701fe610422f904860a03167563a_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzIwMQ_347e1b2c-a8f0-45c6-a202-716966ab4ada">59.4</ix:nonFraction> million, respectively, of bulk rHuPH20.</ix:continuation> </span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyNTA_7e7c6e1a-e9e0-4308-9de3-8323184eaf95" continuedAt="i8649d31695af44c19229219b8aacd26a" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has entered into operating leases primarily for real estate and automobiles. These leases have terms which range from <ix:nonNumeric contextRef="i0bc3fbc4a9c34766bee79a37bf2c3e23_I20210930" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzQ1Mg_a9ba574f-2a38-4936-ba91-f6f05d5723c5">3</ix:nonNumeric> years to <ix:nonNumeric contextRef="i5e231d70787f44a4b04e7ad9caf076a0_I20210930" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzQ1OA_dff0314a-ffc0-45df-94b7-cd4662019bbd">6</ix:nonNumeric> years. We determine if an arrangement contains a lease at inception. Right of use (&#8220;ROU&#8221;) assets and liabilities resulting from operating leases are included in property and equipment, accrued expenses and other long-term liabilities on our condensed consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the discount rate to calculate the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our leases often include options to extend or terminate the lease. These options are included in the lease term when it is reasonably certain that we will exercise that option. Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8649d31695af44c19229219b8aacd26a">&#160;&#160;&#160;&#160;We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as automobiles, we account for the lease and non-lease components as a single lease component.</ix:continuation> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id311c35e31a44238a0e74645d9202499" continuedAt="i580677653bfa48ea8084b96b9f7018f7"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxMjc_ea1c4279-ade5-4946-ad07-743ec618f8b6" continuedAt="i8ef2fbf8acaa4010a0faf72096dc8ca3" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenues from payments received under collaborative agreements and product sales. We recognize revenue when we transfer promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers we perform the following five steps: (i) identify the promised goods or services in the contract; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy the performance obligations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues under Collaborative Agreements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these agreements, we grant the collaboration partner a worldwide license to develop and commercialize products using our ENHANZE technology to combine our patented rHuPH20 enzyme with their proprietary biologics directed at up to a specified number of targets. Targets are usually licensed on an exclusive, global basis. Targets selected subsequent to inception of the arrangement require payment of an additional license fee. The collaboration partner is responsible for all development, manufacturing, clinical, regulatory, sales and marketing costs for any products developed under the agreement. We are responsible for supply of bulk rHuPH20 based on the collaboration partner&#8217;s purchase orders and may also be separately engaged to perform research and development services. While these collaboration agreements are similar in that they originate from the same framework, each one is the result of an arms-length negotiation and thus may vary from one to the other.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect an upfront license payment from collaboration partners and are also entitled to receive event-based payments subject to collaboration partners&#8217; achievement of specified development, regulatory and sales-based milestones. In several agreements, collaboration partners pay us annual fees to maintain their exclusive license rights if they are unable to advance product development to specified stages. We earn separate fees for bulk rHuPH20 supplies and research and development services. In addition, collaboration partners will pay us royalties at an on average mid-single digit percent rate of their sales if products under the collaboration are commercialized. All amounts owed to us are noncancelable after the underlying triggering event occurs, and nonrefundable once paid. Unless terminated earlier in accordance with its terms, collaborations generally continue in effect until the last to expire royalty payment term, as determined on a product by product and on a country by country basis, with each royalty term starting on the first commercial sale of that product and ending the later of: (i) a specified period or term set forth in the agreement or (ii) expiration of the last to expire of the valid claims of our patents covering rHuPH20 or other specified patents developed under the collaboration which valid claim covers a product developed under the collaboration. When there are no valid claims during the applicable royalty term in a given country, the royalty rate is reduced for those sales. Collaboration partners may terminate the agreement prior to expiration for any reason in its entirety or on a target-by-target basis generally upon <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:durday" name="halo:RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTI0MzA_9f0f88fc-da4f-4bd6-9d5d-1624eec8777f">90</ix:nonNumeric> days prior written notice to us.&#160;Upon any such termination, the license granted to collaboration partners (in total or with respect to the terminated target, as applicable) will terminate provided, however, that in the event of expiration of the agreement (as opposed to a termination), the on-going licenses granted will become perpetual, non-exclusive and fully paid.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although these agreements are in form identified as collaborative agreements, we concluded for accounting purposes they represent contracts with customers and are not subject to accounting literature on collaborative arrangements. This is because we grant to collaboration partners licenses to our intellectual property and provide supply of bulk rHuPH20 and research and development services which are all outputs of our ongoing activities, in exchange for consideration. Under these collaborative agreements, we do not develop assets jointly with collaboration partners, and do not share in significant risks of their development or commercialization activities. Accordingly, we concluded our collaborative agreements are appropriately accounted for pursuant to ASC Topic 606, Revenue from Contracts with Customers. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under all of our collaborative agreements, we have identified licenses to use functional intellectual property as the only performance obligation. The intellectual property underlying the license is our proprietary ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology which represents application of rHuPH20 to facilitate delivery of drugs or fluids. Each of the licenses grants the collaboration partners rights to use our intellectual property as it exists and is identified on the effective date of the license, because there is no ongoing development of the ENHANZE technology required. Therefore, we recognize revenue from licenses at the point when the license becomes effective and the collaboration partner has received access to our intellectual property, usually at the inception of the agreement.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When collaboration partners can select additional targets to add to the licenses granted, we consider these rights to be options. We evaluate whether such options contain material rights, i.e. have exercise prices that are discounted compared to what we would charge for a similar license to a new collaboration partner. The exercise price of these options includes a combination of the target selection fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, we conclude the option does not contain a material </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i580677653bfa48ea8084b96b9f7018f7" continuedAt="i20145a8430e642f8b624c7f8b58555b7"><ix:continuation id="i8ef2fbf8acaa4010a0faf72096dc8ca3" continuedAt="i9927ccd158cf4c32bda4720749ecf620"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">right, and we consider grants of additional licensing rights upon option exercises to be separate contracts (target selection contracts).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customary indemnification and protection of licensed intellectual property for our customers. These provisions are part of assurance that the licenses meet the agreements&#8217; representations and are not obligations to provide goods or services.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also fulfill purchase orders for supply of bulk rHuPH20 and perform research and development services pursuant to projects authorization forms for our collaboration partners, which represent separate contracts. Additionally, we price our supply of bulk rHuPH20 and research and development services at our regular selling prices, called standalone selling price or &#8220;SSP&#8221;. Therefore, our collaboration partners do not have material rights to order these items at prices not reflective of SSP. Refer to the discussion below regarding recognition of revenue for these separate contracts.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for a contract represents the amount to which we are entitled in exchange for providing goods and services to the customer. Transaction price does not include amounts subject to uncertainties unless it is probable that there will be no significant reversal of revenue when the uncertainty is resolved. Apart from the upfront license payment (or target selection fees in the target selection contracts), all other fees we may earn under our collaborative agreements are subject to significant uncertainties of product development. Achievement of many of the event-based development and regulatory milestones may not be probable until such milestones are actually achieved. This generally relates to milestones such as obtaining marketing authorization approvals. With respect to other development milestones, e.g. dosing of a first patient in a clinical trial, achievement could be considered probable prior to its actual occurrence, based on the progress towards commencement of the trial. In order to evaluate progress towards commencement of a trial, we assess the status of activities leading up to our collaboration partner&#8217;s initiation of a trial such as feedback received from the  applicable regulatory authorities, completion of IND or equivalent filings, readiness and availability of drug, readiness of study sites and our collaboration partner&#8217;s commitment of resources to the program. We do not include any amounts subject to uncertainties into the transaction price until it is probable that the amount will not result in a significant reversal of revenue in the future. At the end of each reporting period, we re-evaluate the probability of achievement of such milestones and any related constraint, and if necessary, adjust our estimate of the overall transaction price.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When target exchange rights are held by collaboration partners, and the amounts attributed to these rights are not refundable, they are included in the transaction price. However, they are recorded as deferred revenues because we have a potential performance obligation to provide a new target upon an exchange right being exercised. These amounts are recognized in revenue when the right of exchange expires or is exercised.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our agreements have one type of performance obligation (licenses) which are typically all transferred at the same time at agreement inception, allocation of transaction price often is not required. However, allocation is required when licenses for some of the individual targets are subject to rights of exchange, because revenue associated with these targets cannot be recognized. We perform an allocation of the upfront amount based on relative SSP of licenses for individual targets. We determine license SSP using income-based valuation approach utilizing risk-adjusted discounted cash flow projections of the estimated return a licensor would receive. When amounts subject to uncertainties, such as milestones and royalties, are included in the transaction price, we attribute them to the specific individual target licenses which generate such milestone or royalty amounts.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also estimate SSP of bulk rHuPH20 and research and development services, to determine that our collaboration partners do not have material rights to order them at discounted prices. For supplies of bulk rHuPH20, because we effectively act as a contract manufacturer to our collaboration partners, we estimate and charge SSP based on the typical contract manufacturer margins consistently with all of our collaborative partners. We determine SSP of research and development services based on a fully-burdened labor rate. Our rates are comparable to those we observe in other collaborative agreements. We also have a history of charging similar rates to all of our collaboration partners. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upfront amounts allocated to licenses to individual targets are recognized as revenue when the license is transferred to the collaboration partner, as discussed above, if the license is not subject to exchange rights, or when the exchange right expires or is exercised. Development milestones and other fees are recognized in revenue when they are included in the transaction price, because by that time we have already transferred the related license to the collaboration partner. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales-based milestones and royalties cannot be recognized until the underlying sales occur. We do not receive final royalty reports from our collaboration partners until after we complete our financial statements for a prior quarter. Therefore, we recognize revenue based on estimates of the royalty earned, which are based on internal estimates and available preliminary reports provided by our collaboration partners. We will record a true-up in the following quarter if necessary, when final royalty reports are received. To date, we have not recorded any material true-ups. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i20145a8430e642f8b624c7f8b58555b7" continuedAt="i23539e7b995341079bac365500960c58"><ix:continuation id="i9927ccd158cf4c32bda4720749ecf620" continuedAt="i29d734d6f5664082a31412a9bd0d0c34"><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contracts to provide research and development services, such services represent the only performance obligation. The fees are charged based on hours worked by our employees and the fixed contractual rate per hour, plus third-party pass-through costs, on a monthly basis. We recognize revenues as the related services are performed based on the amounts billed, as the collaboration partner consumes the benefit of research and development work simultaneously as we perform these services, and the amounts billed reflect the value of these services to the customer. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion on our collaborative arrangements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Sales,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recombinant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell Hylenex recombinant in the U.S. to wholesale pharmaceutical distributors, who sell the product to hospitals and other end-user customers. Sales to wholesalers are made pursuant to purchase orders subject to the terms of a master agreement, and delivery of individual packages of Hylenex recombinant represent performance obligations under each purchase order. We use a contract manufacturer to produce Hylenex recombinant and a third-party logistics (3PL) vendor to process and fulfill orders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We concluded we are the principal in the sales to wholesalers because we control access to services rendered by both vendors and direct their activities. We have no significant obligations to wholesalers to generate pull-through sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling prices initially billed to wholesalers are subject to discounts for prompt payment and subsequent chargebacks when wholesalers sell Hylenex recombinant at negotiated discounted prices to members of certain group purchasing organizations (&#8220;GPOs&#8221;) and government programs. We also pay quarterly distribution fees to certain wholesalers for inventory reporting and chargeback processing, and to GPOs as administrative fees for services and for access to GPO members. We concluded the benefits received in exchange for these fees are not distinct from our sales of Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recombinant, and accordingly we apply these amounts to reduce revenues. Wholesalers also have rights to return unsold product nearing or past the expiration date. Because of the shelf life of Hylenex recombinant and our lengthy return period, there may be a significant period of time between when the product is shipped and when we issue credits on returned product. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the transaction price when we receive each purchase order taking into account the expected reductions of the selling price initially billed to the wholesaler arising from all of the above factors. We have compiled historical experience and data to estimate future returns and chargebacks of Hylenex recombinant and the impact of the other discounts and fees we pay. When estimating these adjustments to the transaction price, we reduce it sufficiently to be able to assert that it is probable that there will be no significant reversal of revenue when the ultimate adjustment amounts are known.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchase order contains only one type of product, and is usually shipped to the wholesaler in a single shipment. Therefore, allocation of the transaction price to individual packages is not required.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from Hylenex recombinant product sales and related cost of sales upon product delivery to the wholesaler location. At that time, the wholesalers take control of the product as they take title, bear the risk of loss of ownership, and have an enforceable obligation to pay us. They also have the ability to direct sales of product to their customers on terms and at prices they negotiate. Although wholesalers have product return rights, we do not believe they have a significant incentive to return the product to us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon recognition of revenue from product sales of Hylenex recombinant, the estimated amounts of credit for product returns, chargebacks, distribution fees, prompt payment discounts, and GPO fees are included in sales reserves, accrued liabilities and net of accounts receivable. We monitor actual product returns, chargebacks, discounts and fees subsequent to the sale. If these amounts differ from our estimates, we make adjustments to these allowances, which are applied to increase or reduce product sales revenue and earnings in the period of adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the orders placed by wholesalers, we incur costs such as commissions to our sales representatives. However, as revenue from product sales is recognized upon delivery to the wholesaler, which occurs shortly after we receive a purchase order, we do not capitalize these commissions and other costs, based on application of the practical expedient allowed within the applicable guidance. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bulk rHuPH20</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell bulk rHuPH20 to collaboration partners for use in research and development; subsequent to receiving marketing approval, we sell it for use in collaboration commercial products. Sales are made pursuant to purchase orders subject to the terms of the collaborative agreement, and delivery of units of bulk rHuPH20 represent performance obligations under each purchase order. We provide a standard warranty that the product conforms to specifications. We use contract manufacturers to produce bulk rHuPH20 and have concluded we are the principal in the sales to collaboration partners. The transaction price for each purchase order of bulk rHuPH20 is fixed based on the cost of production plus a contractual markup, and is not subject to </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i23539e7b995341079bac365500960c58" continuedAt="i9d78187b51c24f5d87b03d1d2eb20398"><ix:continuation id="i29d734d6f5664082a31412a9bd0d0c34"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adjustments. Allocation of the transaction price to individual quantities of the product is usually not required because each order contains only one type of product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from the sale of bulk rHuPH20 as product sales and related cost of sales upon transfer of title to our partners. At that time, the partners take control of the product, bear the risk of loss of ownership, and have an enforceable obligation to pay us. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our statements of operations, we report as revenues under collaborative agreements the upfront payments, event-based development and regulatory milestones and sales milestones. We also include in this category revenues from separate research and development contracts pursuant to project authorization forms. We report royalties received from collaboration partners as a separate line in our statements of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of Hylenex recombinant, bulk rHuPH20 that has alternative future use and ENHANZE drug product are included in product sales, net.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the footnotes to our condensed consolidated financial statements, we provide disaggregated revenue information by type of arrangement (product sales, net, collaborative agreements and research and development services), and additionally, by type of payment stream received under collaborative agreements (upfront license fees, event-based development and regulatory milestones and other fees, sales milestones and royalties).</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Sales</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales consists primarily of raw materials, third-party manufacturing costs, fill and finish costs, freight costs, internal costs and manufacturing overhead associated with the production of Hylenex recombinant and bulk rHuPH20 and ENHANZE drug product. Cost of product sales also consists of the write-down of excess, dated and obsolete inventories and the write-off of inventories that do not meet certain product specifications, if any.</span></div></ix:continuation><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxMzE_166036b9-0523-4156-afae-9223126b10b5" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include salaries and benefits, facilities and other overhead expenses, research related manufacturing services, contract services and other outside expenses. Research and development expenses are charged to operating expenses as incurred when these expenditures relate to our research and development efforts and have no alternative future uses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to make upfront payments upon execution of certain research and development agreements. Advance payments, including nonrefundable amounts, for goods or services that will be used or rendered for future research and development activities are deferred. Such amounts are recognized as expense as the related goods are delivered or the related services are performed or such time when we do not expect the goods to be delivered or services to be performed.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxMzc_931adbdd-3dbc-4b1f-983e-2d3405cd6c75" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record compensation expense associated with stock options, restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;) and shares issued under our employee stock purchase plan (&#8220;ESPP&#8221;) in accordance with the authoritative guidance for stock-based compensation. The cost of employee services received in exchange for an award of an equity instrument is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense on a straight-line basis over the requisite service period of the award. Share-based compensation expense for an award with a performance condition is recognized when the achievement of such performance condition is determined to be probable. If the outcome of such performance condition is not determined to be probable or is not met, no compensation expense is recognized and any previously recognized compensation expense is reversed. Forfeitures are recognized as a reduction of share-based compensation expense as they occur.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9d78187b51c24f5d87b03d1d2eb20398" continuedAt="i3ba9e375ea494ad693d93334c783cb37"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMzg_e507d4db-6ccc-4bff-b681-590c913f591b" escape="true"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for income taxes using the liability method. Under this method, deferred income tax assets and liabilities are determined based on the differences between the financial statement carrying amounts of existing assets and liabilities at each year end and their respective tax bases and are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant judgment is required by management to determine our provision for income taxes, our deferred tax assets and liabilities, and the valuation allowance to record against our net deferred tax assets, which are based on complex and evolving tax regulations throughout the world. Deferred tax assets (&#8220;DTA&#8221;) and other tax benefits are recorded when they are more likely than not to be realized. We maintain a full valuation allowance on our DTAs until there is sufficient evidence to support the reversal of all or some portion of these allowances. On a periodic basis, we reassess the valuation allowance of our DTAs, weighing all positive and negative evidence, to assess if it is more-likely-than-not that some or all of our DTAs will be realized. As of the third quarter of 2021, we have demonstrated profitability and cumulative pretax income and are forecasting income growth. After assessing both the positive and negative evidence, we determined that it was more likely than not that our DTAs would be realized and released the valuation allowance related to federal and state DTAs as of September 30, 2021, resulting in a benefit from income taxes of $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTY0OTI2NzQ5MjIxNg_eb3f78f9-7d03-44db-810a-b6f858604e6f">142.5</ix:nonFraction>&#160;million. We estimated that our annual effective income tax rate to be (<ix:nonFraction unitRef="number" contextRef="id4b36e88a5204ad7a59bf1f1884070f0_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTY0OTI2NzQ5MjIzOQ_12863e53-c725-4a63-aefb-2a4c67beb953">57.63</ix:nonFraction>)% for 2021 compared to the <ix:nonFraction unitRef="number" contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTY0OTI2NzQ5MjIzMw_cb78e208-8a99-4b08-81c6-46fd74a9e68a">0.17</ix:nonFraction>% effective income tax rate for 2020. The primary difference relates to the release of our valuation allowance. We will continue to evaluate the need for valuation allowances for our DTAs.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMzQ_d2a44ee2-682c-4cde-9569-cdff59bcdcff" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-top:3pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our business in <ix:nonFraction unitRef="segment" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzMzNzI_ee840422-ba81-4b85-9c52-55bac9a6932a">one</ix:nonFraction> segment, which includes all activities related to the research, development and commercialization of our proprietary enzymes. This segment also includes revenues and expenses related to (i)&#160;research and development and bulk rHuPH20 manufacturing activities conducted under our collaborative agreements with third parties and (ii)&#160;product sales of Hylenex recombinant. The chief operating decision-maker reviews the operating results on an aggregate basis and manages the operations as a single operating segment.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="i3ba9e375ea494ad693d93334c783cb37" continuedAt="i47651746711e431c82d21fab4f7f3884"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMDY_0951e4b3-4ec0-46ce-b734-fea795b115f5" continuedAt="i6aeaae15ef0046e595c5e0d167a7eb7c" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption and Pending Adoption of Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyNTU_e0ec1073-6db1-47b3-b5da-b7690e32cb37" continuedAt="i82bdb05a1e344064a998cd27cd1a22cb" escape="true">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:</ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt"><ix:continuation id="i47651746711e431c82d21fab4f7f3884"><ix:continuation id="i6aeaae15ef0046e595c5e0d167a7eb7c"><ix:continuation id="i82bdb05a1e344064a998cd27cd1a22cb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.588%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial <br/>Statements or Other Significant Matters</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation.<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022<br/>(Early adoption permitted effective January 1, 2021)<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis, which resulted in an approximately $<ix:nonFraction unitRef="usd" contextRef="i6d5406841f54463587c720f7d0c85362_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0Mjg3Mw_c9d9538e-493b-45d3-b5b8-e153daf9efdb">65.5</ix:nonFraction> million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $<ix:nonFraction unitRef="usd" contextRef="ibaae598c6a0043268b61e55051da6c5b_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0Mjg5Mg_d2a9308f-19da-4e11-a051-5df5e83d5341">52.6</ix:nonFraction> million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $<ix:nonFraction unitRef="usd" contextRef="ie1eb4955082b47499f0449ca9fa72759_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0MjkxMQ_9e8f127b-aa05-4f91-b8dc-13e399e3d99a">13.0</ix:nonFraction> million decrease to the opening balance of accumulated deficit, representing the cumulative non-cash interest expense recognized related to the amortization of the bifurcated conversion option related to the 2024 Convertible Notes. We  derecognized the related deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="ibaae598c6a0043268b61e55051da6c5b_I20201231" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0MjkzMA_6aa331d8-f228-403d-8402-d606ccc037d8">11.8</ix:nonFraction> million with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. As we committed to settle the principal amount of the convertible notes in cash upon conversion, shares used for diluted EPS will continue to be limited to the excess conversion value over the principal amount of the convertible note. Diluted earnings per share is also impacted due to the elimination of non-cash interest expense associated with the amortization of the equity component.</span></div><div><span><br/></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></ix:continuation></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTAxMA_7d2a3f09-8f1d-4c4f-92a0-b943ada13619" continuedAt="idbfe8f28986b4ebfad1e5c83c82004db" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><ix:continuation id="idbfe8f28986b4ebfad1e5c83c82004db" continuedAt="i40d02a4eb5f347d4b577e90c585a4e18"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTAwNA_39f67f81-0ba7-4d0e-9125-ccd2c196f691" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consisted of the following (in thousands):</span></div><div style="margin-top:11pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:52.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi0yLTEtMS0w_6e132236-d3c7-4f09-af02-998c9a0e464b">27,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi00LTEtMS0w_c6362f77-779b-48a5-9592-b06771c746a1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi02LTEtMS0w_79a60fe9-6084-46cf-87ef-a9627ab2fced">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi04LTEtMS0w_99147398-253f-467b-ae09-f3792e4e5bcd">27,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy0yLTEtMS0w_4269513a-27fb-4aa4-ba38-7a4414bc10d6">75,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy00LTEtMS0w_bc2b2ab0-ace0-4e0d-9362-abe19086f543">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy02LTEtMS0w_65e5a303-483e-49ba-867d-c7bc7afd3b79">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy04LTEtMS0w_35d0008c-4372-4292-86b0-e8ec2acf30db">75,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC0yLTEtMS0w_c1bf6fa3-f0f0-44d3-a910-c129793bae6e">60,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC00LTEtMS0w_5b8b9364-3427-4827-a25b-a833983138d9">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC02LTEtMS0w_cad5ee62-45f9-4e40-a957-169d2f05f2d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC04LTEtMS0w_1cf9955c-c7e1-4563-b9b4-c73152fa504b">60,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-US Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS0yLTEtMS0w_c0d5e9e7-570d-4f30-8521-bcfa434637ba">17,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS00LTEtMS0w_aca9040f-a7ac-4304-9b4a-63655c1d38cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS02LTEtMS0w_cd05a089-9ecb-4607-871d-6e8229167db6">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS04LTEtMS0w_d2a598b3-cc91-4860-b480-a2c1ca9ef5c1">17,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi0yLTEtMS0w_9a1d551c-52d8-454b-9bcf-a9efaf67ed9a">143,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi00LTEtMS0w_091a127a-5673-444e-aee7-5da1b93c9109">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi02LTEtMS0w_f07cdbd2-e68b-4061-8323-04301ac8b97b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi04LTEtMS0w_db7bf309-1256-48a8-a2e2-15be112bc196">143,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy0yLTEtMS0w_57456b15-7239-48b5-be0e-fd32a7588d34">324,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy00LTEtMS0w_daa27c12-efc0-4699-b660-4ddbae6fe840">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy02LTEtMS0w_62295902-a90b-4e52-8fee-b995eed62ed3">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy04LTEtMS0w_ff22baec-6565-4599-bc95-7f39c3a002b6">324,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:52.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7152e25968740afaabf504783045182_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi0yLTEtMS0w_48416f0b-4959-4901-b222-60aa19fb4091">17,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7152e25968740afaabf504783045182_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi00LTEtMS0w_eb8080c2-d78a-48e4-af88-5345343a723a">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7152e25968740afaabf504783045182_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi02LTEtMS0w_e4959794-34e3-4037-b559-efd62684348f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7152e25968740afaabf504783045182_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi04LTEtMS0w_205227bd-f167-4a70-927a-cccafa9b847d">17,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy0yLTEtMS0w_c834fece-7af7-4c1c-a704-6b49a7e1ff43">69,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy00LTEtMS0w_461dbb7b-59a8-47de-adbb-dd4466ce8165">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy02LTEtMS0w_b470ec88-76cd-455c-8afc-d4384b6d5e5d">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy04LTEtMS0w_06795108-7703-4d5a-a7e2-da5cf528fc15">69,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC0yLTEtMS0w_aaddcc2d-ca31-47f0-8fbe-62baaaba42d3">45,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC00LTEtMS0w_e478701f-cb7a-4a0d-ad02-a56e7705b576">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC02LTEtMS0w_19e6ed24-4569-43f9-ae8d-799a464ddd3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC04LTEtMS0w_31318787-de5f-4f68-addf-db85e937e126">45,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS0yLTEtMS0w_4724ff06-3b58-4605-8bd7-42ffac8d4aa3">88,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS00LTEtMS0w_00821b45-20cc-4a32-b9c3-264a776b298a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS02LTEtMS0w_053e00dd-755c-42b5-beb0-a7242576dd06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS04LTEtMS0w_542f06bc-c794-4ec4-a5ca-33fc3f14b5bf">88,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi0yLTEtMS0w_75eb1fad-7403-48ef-9928-0da5079a0cf1">220,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi00LTEtMS0w_f57b98f4-be9b-4b36-85d0-f71f116a6c2b">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi02LTEtMS0w_13314b06-2fc3-4a18-ae23-c9961255eef9">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi04LTEtMS0w_6e8e1122-d8a7-435c-bf6c-92aee7460a9b">220,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, <ix:nonFraction unitRef="security" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTI5_2d4d1eb3-65aa-4d06-9364-017d956c4b00">11</ix:nonFraction> available-for-sale marketable securities with a fair market value of $<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMjAx_6644c0f1-36c4-46f6-9a83-526cbb9c54b9">66.0</ix:nonFraction> million were in a gross unrealized loss position of $<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMjQ4_62295902-a90b-4e52-8fee-b995eed62ed3">23</ix:nonFraction> thousand. Based on our review of these marketable securities, we believe <ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMjE5OTAyMzI1NjU3Ng_84e2f0f4-feb3-4f6b-8aa0-82c4adad52aa">none</ix:nonFraction> of the unrealized loss is as a result of a credit loss as of&#160;September&#160;30, 2021, because we do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of their amortized cost basis.</span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfOTkx_e0d3a435-7ef6-4340-a5c3-dfe3aefc2557" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities are as follows (in thousands):</span></div><div style="margin-top:11pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:67.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMi0yLTEtMS0w_0c46b4cd-4b12-40b1-be3b-8bbef104e2db">286,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMi00LTEtMS0w_464a6d89-b81e-4b8d-b687-670b3b267ac3">220,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one but within five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMy0yLTEtMS0w_bf89164f-b483-4dc4-a2e3-1fa54f553b63">37,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMy00LTEtMS0w_bacae50c-5ea6-44a1-bca0-7ec3f532ad29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfNC0yLTEtMS0w_f5875b3b-c956-43fb-aa4a-14f47ffbf58f">324,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfNC00LTEtMS0w_11d8cf34-4939-47c3-af9f-4df5df68b770">220,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i40d02a4eb5f347d4b577e90c585a4e18"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTAwMA_f7cf6536-a94e-4396-9b5b-9c9ef08cd706" continuedAt="id0e4247f771f451291837c1d571aed99" escape="true">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:4.5pt"><ix:continuation id="id0e4247f771f451291837c1d571aed99"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:29.421%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6fe5f945ae43a69e913f0e0b729205_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy0yLTEtMS0w_e7b1ad6d-9d63-45a9-8fa6-2a8f74fe8afb">491,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6cebbf569a4926bb4ba1f2c0526b8c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy00LTEtMS0w_afcc3a83-3e86-47f8-a169-bb1ee02a57b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af6b80bac9f4ee1a6f77ffcbcb33af1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy02LTEtMS0w_addd07ac-8c7e-4c1c-a2fa-aa824f906201">491,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a6f1d6a6d9a4794ad43347f6f6a845d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy04LTEtMS0w_55aef115-099e-467b-b656-d4419def0786">140,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i510ee7af7efc47b28c4621b3e4d7c994_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy0xMC0xLTEtMA_c9ca3139-e895-404f-b6f1-31034a837642">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7fd00eb22704a3faadef6bba5e75036_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy0xMi0xLTEtMA_a7a0b0e0-a196-4659-95e6-1366c0208323">140,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7228f6a8b874f59a40a9c1c3ae1d319_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC0yLTEtMS0w_c998bce0-43fa-4767-aece-2437b1820305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23422b52470040bcabe09d7bda533924_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC00LTEtMS0w_1dcd2f6a-e80a-4443-b6e8-b23db823004a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic96e068d375b4d50b976de50785f0a89_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC02LTEtMS0w_233f8c68-4e22-4bb9-8d9f-4548847e55b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c2fb7c8538d41ddb1d8acd66cc4ef17_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC04LTEtMS0w_8b40b655-6451-4050-b11f-d87e59cc86a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71214058490a424b86f59ea8c37c7358_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC0xMC0xLTEtMA_91e8591d-275f-4dc3-b10e-a31c08c816f1">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98aeee1dd5f44ef88df01be8344928c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC0xMi0xLTEtMA_52412230-3234-4f18-8ff3-6420e9c08d26">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale marketable <br/>&#160;&#160;&#160;securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8048d79e377f495a99e418c2dd29f1d6_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy0yLTEtMS0w_35519de9-399c-48e8-a9c0-61f630b5cd34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8d40c51fe947a88cf70e94aa08de05_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy00LTEtMS0w_7b91a390-fbaa-4ff0-9b35-652c3ec1068e">27,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy02LTEtMS0w_695c114f-6a1d-4b52-9bd4-dfb42dbc01d5">27,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e633fec488c477b957a45854ee34341_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy04LTEtMS0w_6ebaec7d-1f4f-466a-b8f0-633bf58efe6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3cd1753156549998bd9164c7783c6e2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy0xMC0xLTEtMA_771990bf-65ff-4243-9fce-cf326088f376">17,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7152e25968740afaabf504783045182_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy0xMi0xLTEtMA_bcf621b5-c3b8-4677-b0a1-20beb576a4d7">17,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc226000e5b642c1a87036d0b20cf77d_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC0yLTEtMS0w_4ba29add-3f47-47b8-8e70-d54236eec3b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d6e7551a5f4b78aa75bb4fcbf2d798_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC00LTEtMS0w_d0b7d67a-4dfa-4138-b8fa-5aab1f196c2a">75,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC02LTEtMS0w_fabc7d1d-0522-45ac-bcf0-b15ada44aa5c">75,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f93b93b18047879feba5866a7c1147_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC04LTEtMS0w_259f4eae-74dc-4d97-ad29-8b4d226fb8d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac7d674d62548b09e34061cbb313276_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC0xMC0xLTEtMA_f1742156-f0ec-462a-847b-4e2b6dad631e">69,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC0xMi0xLTEtMA_8ae64200-4dd0-4b6d-aeb6-c3c556dd5fda">69,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c397dd0f5243188600e0dcf051082b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS0yLTEtMS0w_e5f913f4-bead-4c77-a8dc-9de66ea29021">60,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42af265f358f4e47b36e71ac09d1ad01_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS00LTEtMS0w_e2151d70-8edf-4002-9d3b-df963691449b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS02LTEtMS0w_421a8c27-8c43-475f-bd09-ba638debeb2d">60,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2bda6661fe4c6a8deab6b225439c54_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS04LTEtMS0w_45a7c4b9-f80c-4c90-b572-4344fa7d559c">45,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b21d8da7dbc4396942bb05a95ca81f8_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS0xMC0xLTEtMA_8fa7d808-c204-4c74-9612-8c0b1b5c08ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS0xMi0xLTEtMA_f405d77a-9ae3-4e19-aa44-9e703c12bec2">45,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-US Government securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b5665294d04912b073fdaefa553c12_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtMi0xLTEtMA_9b6e3bc9-59ea-4563-8730-9b74c7bcd5e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafee32398ddd4184a9e8c6f456c0bad6_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtNC0xLTEtMA_52975b3f-029e-48ed-8bfb-37e8ed64bbb6">17,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtNi0xLTEtMA_0a27dbca-79f7-485b-85b3-8541ab4cf6ba">17,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc815cd3d3f45779613868dda56f367_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtOC0xLTEtMTMzOTI_db911103-ad9e-4b46-a867-c71b6645942e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b477c24acf478d95230b08574a9bea_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtMTAtMS0xLTEzMzky_385de7c3-e77f-4368-83d1-b6b6547ab999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dec8fd3aaaf4fd59df1e8d089e118ec_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtMTItMS0xLTEzMzky_164e897a-776a-4d70-aab8-993c2ee7f614">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf7e115ae39487e96fb9df8b46799e0_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtMi0xLTEtMA_541eed7d-c83d-4016-aeab-95826486b0f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31bae321b714f37893eb11b3ee1a813_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtNC0xLTEtMA_7b008b54-2c23-41db-be7b-b339b78f2bf6">143,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtNi0xLTEtMA_d376777b-41b1-4b6c-9077-8edc84abfc84">143,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8fd7acfa834427a80a945db2878a09_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtOC0xLTEtMA_ebec2b51-4a9a-422c-8ecd-b8f5d1892c78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3465623e8f7d4998b90547f930b814e5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtMTAtMS0xLTA_73cbe655-7e90-4aec-8ca8-1df86d57c7fb">88,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtMTItMS0xLTA_5e284c6b-e4f8-4627-b2d8-9c3c38371cc7">88,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17dfb6089521498d8d28b738549dbe12_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItMi0xLTEtMA_724ab5c5-d842-4fa8-918c-e639aec6d8bb">551,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3a819da17a94fbbbcdb54d76235890e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItNC0xLTEtMA_d4062c7e-f042-406e-ad3a-b7696e2a7529">264,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItNi0xLTEtMA_0f984263-9b63-4dbe-a73b-617d8c5769ff">815,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie330bed0ebb1442dbbdf7b34d7cfe2a6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItOC0xLTEtMA_0f95f439-6cc1-4e20-8d80-f30e25eb95ef">185,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c5ae6e2527f4c99bd2fb6c331a1eab7_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItMTAtMS0xLTA_2b874b88-09c0-4ffa-94f1-607751d3d790">182,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItMTItMS0xLTA_4fceb046-2ce4-4c50-80de-9527af5a2bb4">367,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i0e0157ed45314cc1a41caf7282e4da2b_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfOTE5_7dc89911-b4ff-4b9c-82a4-60e3d7d945a0"><ix:nonFraction unitRef="usd" contextRef="i43b81ea09c7b4830be62638aea4edab1_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfOTE5_d48e0afd-d7c1-420a-8cd0-37ccce3ab510">no</ix:nonFraction></ix:nonFraction> instruments that were classified within Level 3 as of September&#160;30, 2021 and December&#160;31, 2020.</span></div></ix:continuation><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjA2Nw_f241212a-53de-4df1-942a-a9b0f8fbf93a" continuedAt="i65f64d9fbd1641d59cc572026471b56a" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="i65f64d9fbd1641d59cc572026471b56a" continuedAt="i3d47e6fe67494cdeb3639114d057f66f"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjA2Mg_375ee187-87f5-46fe-b127-a49a05a5acaf" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disaggregated revenues were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:57.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic648a667b4564856a5096920f3df03db_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi0yLTEtMS0w_e68e5a7e-e0a4-4da1-b5d5-9d702d85f80e">58,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc326e2cf27f45baac0c0fe72eed59d2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi00LTEtMS0w_ec88909a-ccff-466b-9c04-3a3f2745c29c">23,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272651d659f84e0a8874d31b762516eb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi02LTEtMS0w_2612a149-ab5f-41dc-8afa-eded038a16af">141,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea7a928fde0046eca6e5a2a01621d057_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi04LTEtMS0w_bfbf1868-168a-4a54-8151-9933380c5edd">56,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales of bulk rHuPH20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c022f7d86dd4437bd0cde070c7fd07c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS0yLTEtMS0w_62d52e94-3567-41e5-b40d-2fc935097e3c">18,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3968a56145c145baa0c437ec109af06e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS00LTEtMS0w_b425cbd0-3eba-4aa2-afb8-faf1b5f07581">4,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d0ce79c1664094be9d67dacba99869_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS02LTEtMS0w_bd0ee92f-0ea9-4b2f-9782-ef35a0fee30d">59,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d04f05cf4d8411688ffb481e3b6f1a1_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS04LTEtMS0w_1ee9256d-7a3c-4e43-b4a1-36104cb58e82">11,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales of Hylenex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266391e004c7456a98a2b58f212c06c1_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy0yLTEtMS0w_a21d287f-6004-42b9-9899-98b93b982489">6,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15658419291646da82621e9c9b2f6dbb_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy00LTEtMS0w_236235a9-2f7e-4297-bb91-fbdd17504045">4,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4575b33018d5417da6496f84f9c8b307_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy02LTEtMS0w_ed72c6fa-7407-4a99-951c-fd9b7bc6f703">17,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c66125868794895a72167f638f47a8f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy04LTEtMS0w_9cb3fb48-0407-4155-871c-b33cf04c788e">11,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product sales, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501c9252b83c44809a6ccbddc68fa142_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC0yLTEtMS0w_a5d162a3-7ae9-49c1-af7d-36d8e643c125">25,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic64829186658472f9e88de5ccbc70972_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC00LTEtMS0w_fe5b7fb5-8678-43d5-b683-8b9494e3122d">9,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4eef1632dd43799c54c3a51442359c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC02LTEtMS0w_29e30d65-216f-4ce4-a9d2-bb27d87b09d3">77,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353f14d9c0cc433e9597f0fe48db2359_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC04LTEtMS0w_1cf41688-5172-491f-8cf9-2064cf63bdb9">23,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues under collaborative agreements:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Upfront license and target nomination fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if910d54ee4ef4f618d431f133fca2559_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtMi0xLTEtMA_1c1ec67c-c91e-4569-a704-f684f30bcb64">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9ac387aba94bbc9c70dd2c275fd159_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtNC0xLTEtMA_375f2967-76ef-4931-b94a-a4e40f67d4be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i601a5d810b394d2489e25eea409b2b3d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtNi0xLTEtMA_d7053e00-b608-4a38-86f0-76487913682d">42,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86cb3d1f5b124e9f81dbf0646d232a5f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtOC0xLTEtMA_71dbfcd7-0fdf-4109-97fa-feb8f427c188">7,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Event-based development and regulatory milestones and other fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17496220ae11435ca516f72c3fe10a18_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItMi0xLTEtMA_d3f07a8f-2528-4e7a-99fb-9c273545b198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e642dc9f3414ad88f5df20dee6948ee_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItNC0xLTEtMA_84fce7e7-9ba5-4606-a511-67114e8a3cb8">32,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28450b44187c42f9b071a5816b0ea2e8_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItNi0xLTEtMA_f53e0e87-235d-4522-a356-1c2646260526">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491e07317d3346579daea09d068cc6ac_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItOC0xLTEtMA_1b9dd0c0-4c8b-4760-b031-82b56bd1c917">57,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales-based milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i266af81398ed45eea9c67c4a7856ace4_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtMi0xLTEtMA_2edb7a8e-1fc1-4908-b046-88b3e87a1d06">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569db92c338a4d04800ca2c32dfef65a_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtNC0xLTEtMA_3e7edd3d-a660-4ca9-bff7-0690e743a937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f82754b3e354c75b602f455ff70da37_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtNi0xLTEtMA_86a2a763-d43c-484c-8abc-d1d538724dab">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6dec7f20e549b9b58761c803248054_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtOC0xLTEtMA_058dfd21-4386-4069-adde-309320e1987c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Research and development services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cf86de5f3046a4bae0460346e32c55_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtMi0xLTEtMA_f8647351-0a70-4ca3-bd3c-eee0db055035">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib409cfda9eb34f03b1d3070f5ff73a9f_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtNC0xLTEtMA_5ec53750-9b75-458e-b459-5d6a2f19f277">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i941973135edc404780b79a1a8d9197ab_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtNi0xLTEtMA_b071dcc9-4f05-4342-a67d-de0350066c2d">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f47adc8431141e2bd4adfb8ee6c8be3_D20200101-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtOC0xLTEtMA_5c5385fb-fc7a-458a-a33f-79e2322070b2">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed821ec9e124f6989a22f8554b1acbf_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtMi0xLTEtMA_a69747c4-3750-4bfd-a927-a298a94766a9">32,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99adc572639e4c54b1595861c11fec96_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtNC0xLTEtMA_30bb1119-502f-4390-b8a0-7f9ec31e066d">32,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00f1c71dd4ef47f898e2155ae0b735ec_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtNi0xLTEtMA_309097ba-6911-4adc-9af1-5b1045f37248">122,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i247f86e8e166412cb70a5c1492bc28dd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtOC0xLTEtMA_49e14ece-fcf9-4799-84fa-020579730514">65,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctMi0xLTEtMA_37595b68-4bd5-4c60-ad82-eb74f357f005">115,830</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctNC0xLTEtMA_636e5ad1-d977-4bc7-b00c-00133703c699">65,316</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctNi0xLTEtMA_52147046-df0a-4532-89e0-2399fe57fe7c">341,307</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctOC0xLTEtMA_ff904b9b-f545-43ab-85fb-fdb45ab346eb">145,891</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2021 we recognized revenue related to licenses granted to collaboration partners in prior periods in the amount of $<ix:nonFraction unitRef="usd" contextRef="iabeb09e2d5a34f1ab2165e7742136659_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjE3_72f1d704-5c70-4850-9d77-66bb4329e122">88.6</ix:nonFraction> million. This amount represents royalties and a sales milestone earned in the current period. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="iabeb09e2d5a34f1ab2165e7742136659_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMzI5_d60fe69e-5591-4bca-b7b6-f21ee1ad6d5b">0.5</ix:nonFraction> million during the three months ended September&#160;30, 2021 that had been included in deferred revenues at December&#160;31, 2020. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 we recognized revenue related to licenses granted to collaboration partners in prior periods in the amount of $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="halo:ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfNTU0_1ee36d01-5a54-49f7-b3ff-b2ead7c56b0f">221.3</ix:nonFraction> million. This amount represents royalties and sales milestone earned in the current period in addition to $<ix:nonFraction unitRef="usd" contextRef="i72e5a38073c94c808eacadffd14c661c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="halo:RevenueFromContractWithCustomerVariableConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfNjU1_e868d5f4-a71c-480f-b48e-3cbbb46b46ae">30.0</ix:nonFraction>&#160;million of variable consideration in the contracts where uncertainties have been resolved and the development milestones were expected to be achieved or were achieved. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i72e5a38073c94c808eacadffd14c661c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfODQz_a8b52c0d-1df5-48ab-8c89-25a65432e7a0">1.0</ix:nonFraction> million during the nine months ended September&#160;30, 2021 that had been included in deferred revenues at December&#160;31, 2020. </span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjA1MQ_c93239ed-adc0-4947-8385-655ffb5c8671" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net, and deferred revenues (contract liabilities) from contracts with customers, including collaboration partners, consisted of the following (in thousands): </span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:74.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMS0yLTEtMS0w_db1ba837-593b-4616-9050-053fbf4d56f3">112,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMS00LTEtMS0w_a6a843c6-18f2-4b7d-b71b-3b5b1b254f69">90,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMi0yLTEtMS0w_fdeaac6e-ef58-46c6-afae-274bb5914c36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMi00LTEtMS0w_5a33a23c-de45-4023-b055-d151428842c8">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMy0yLTEtMS0w_628ce13a-5687-49c9-aac0-50b6c35a0c62">4,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMy00LTEtMS0w_e869d9d5-62a4-485f-8466-2103aa6b7b99">5,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3d47e6fe67494cdeb3639114d057f66f">As of September&#160;30, 2021, the amounts included in the transaction price of our contracts with customers, including collaboration partners, and allocated to goods and services not yet provided were $<ix:nonFraction unitRef="usd" contextRef="i5850452d31564c9b851c823cfbb9d09d_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTI5MQ_c6b2d2d5-7ed3-4e5a-8af5-7232543cf3ce">69.8</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ic47eff917a924a8d88864fdf58cbee25_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredCreditsAndOtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTMwNA_fc9067c5-2398-4947-918f-017ffe035b10">65.0</ix:nonFraction> million relates to unfulfilled purchase commitments and $<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredCreditsAndOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTM1NQ_22df7752-d43e-4ebb-bb9a-5a99297b29fd">4.8</ix:nonFraction> million has been collected and is reported as deferred revenues. The unfulfilled purchase commitments are estimated to be delivered by the end of the third quarter of 2022. Of the total deferred revenues of $<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredCreditsAndOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTU1Nw_22df7752-d43e-4ebb-bb9a-5a99297b29fd">4.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic2b29c8b2930492d851baa19fbc2b1f5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTU2MQ_13e14c0a-4e53-4feb-b356-29829bf317d0">2.2</ix:nonFraction> million is expected to be used by our customers within the next 12 months.</ix:continuation> </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no contract assets related to collaborative agreements at September 30, 2021. While we may become entitled to receive additional event-based development and regulatory milestones and other fees under our collaborative agreements, which relate to development milestones deemed probable of receipt for intellectual property licenses granted to collaboration partners in prior periods, no amounts were deemed probable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYyNg_3c32232c-4f59-47b3-b356-5e8ae39054f2" continuedAt="i268d85ff25544eb7a1095ec477c5e0fb" escape="true">Certain Balance Sheet Items</ix:nonNumeric></span></div><ix:continuation id="i268d85ff25544eb7a1095ec477c5e0fb" continuedAt="id957647118424b36a323f65b4e036abc"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYzMw_dc9d6b00-e866-4231-b90a-b603c03de8b2" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:68.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from product sales to collaborators</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromproductsalestocollaborators" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMS0yLTEtMS0w_fcf16ca2-a8b7-40c9-ba12-1f73aa8c11db">18,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromproductsalestocollaborators" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMS00LTEtMS0w_cf05d71c-8b95-45ef-9863-d67642961ec8">25,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromcollaborators" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMi0yLTEtMS0w_af9a913b-3728-4d8d-8266-1f905d4530c4">30,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromcollaborators" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMi00LTEtMS0w_13c52ad7-c4d8-46a2-b89f-d95697dd0bcb">30,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from royalty payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromroyalties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMy0yLTEtMS0w_0179d1ce-0fb6-465a-bbd6-107507b7c805">59,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromroyalties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMy00LTEtMS0w_ec435311-ead3-465a-a8b4-5a4a47922984">32,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from other product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromproductsales" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNC0yLTEtMS0w_b893b5fa-99e9-4b3d-b2c2-40a410d31d27">5,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accountsreceivablefromproductsales" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNC00LTEtMS0w_84ec9a10-a2a5-4f94-8def-3675ce4b1df7">4,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNS0yLTEtMS0w_fdeaac6e-ef58-46c6-afae-274bb5914c36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNS00LTEtMS0w_5a33a23c-de45-4023-b055-d151428842c8">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNi0yLTEtMS0w_eec2f089-943b-47e4-b24b-15254ab6182f">113,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNi00LTEtMS0w_412f5ad4-51ed-4b7f-b3c1-2ab12f6d1bca">98,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for distribution fees and discounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:AllowanceforDistributionFeesandDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNy0yLTEtMS0w_2598460a-eb62-4b68-855f-c78839396d20">1,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:AllowanceforDistributionFeesandDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNy00LTEtMS0w_db649a46-66ec-4f55-97dd-d0490550974f">1,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfOC0yLTEtMS0w_857af87a-0f30-4ee5-a2a8-cc0667ded248">112,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfOC00LTEtMS0w_ceb293d7-3998-476e-ac44-9799df6c4e86">97,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYyMg_3e7502c5-2e91-4992-afec-efa6be603601" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:68.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMS0yLTEtMS0w_ace5fc59-d0c2-402d-81f7-23dc51fc6a64">8,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMS00LTEtMS0w_8cd9f8d7-e719-487d-b887-b87b8d60406a">5,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMi0yLTEtMS0w_dcd5a702-6409-4301-8428-1ee5f8d554ee">21,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMi00LTEtMS0w_85c11cc7-eacd-4a78-a563-6b3c4d7bfc9c">33,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMy0yLTEtMS0w_d62503f9-8c1d-4ce4-a438-df40ac77f683">26,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMy00LTEtMS0w_6ee1a07e-5b2d-4c1a-8a0b-12d345967858">21,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfNC0yLTEtMS0w_cf9fd027-7db6-4c05-9934-27901bc64840">55,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfNC00LTEtMS0w_7d1c5a0c-1125-41ae-bf5c-54d8ab3d26dd">60,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTY0Mw_f371b693-543e-44ab-a410-b35fc8a67971" escape="true"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:68.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid manufacturing expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMS0yLTEtMS0w_9b3fabf3-dfcc-429d-bde0-3328d09b96c9">43,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMS00LTEtMS0w_1c7c0952-3f99-426f-b4c8-6d5357ac45eb">35,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMy0yLTEtMS0w_59d35461-25e5-459a-a12e-bcc0693c677f">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMy00LTEtMS0w_d820edfc-3d3e-414d-a126-f8310eb85f31">2,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNC0yLTEtMS0w_30d21d08-a655-4b90-8aa2-ab2af983965a">2,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNC00LTEtMS0w_0b2af205-9936-4033-8bde-6bd47b0a4414">4,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNS0yLTEtMS0w_6073b337-ef68-414e-87ce-a2396f8bf0dc">48,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNS00LTEtMS0w_9f4431cf-a619-4519-8465-182f6650cdd9">42,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNi0yLTEtMS0w_4658dced-5dc2-4db0-8cbb-2d097f4efd84">15,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNi00LTEtMS0w_6bc01881-0ba1-4b47-b81d-a3eabe79c1d8">14,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNy0yLTEtMS0w_c5b8debc-d0fe-4e75-bb2d-a2c117a375dc">33,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNy00LTEtMS0w_7340b984-a914-4289-948b-3e3254063575">28,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid manufacturing expenses include raw materials, slot reservation fees and other amounts paid to contract manufacturing organizations.&#160;Such amounts are reclassified to work-in-process inventory as materials are used or the contract manufacturing organization services are complete.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYyNA_5f126d69-0212-4d41-be90-7c4393e61224" continuedAt="iccab8643f07c4185ab6848a7b67ef6e6" escape="true">Property and equipment, net consisted of the following (in thousands):</ix:nonNumeric></span></div><div style="text-align:center;text-indent:22.5pt"><ix:continuation id="iccab8643f07c4185ab6848a7b67ef6e6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:68.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f83dd81a24947c0880845854951b856_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMS0yLTEtMS0w_eea60701-b723-4876-98d1-fd8501443053">7,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f212c6f63a148cfa348578f6301b88e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMS00LTEtMS0w_abe52ce7-53b7-4cae-98c2-3f5ecf9e272d">7,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fc084111de34f53a1ac7314517c9af2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMi0yLTEtMS0w_8be98abc-bd46-46de-a8ca-f3581a0fa550">5,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6773e28d6849430994555cb09743216d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMi00LTEtMS0w_ce706628-780a-4d59-b404-c3930603f73f">5,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b85e221fa24178bff7cc0b297b9c72_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMy0yLTEtMS0w_ee3b213d-674d-428c-b987-0644e5da5830">5,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i856a56291322443ab3ccca37be0c321d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMy00LTEtMS0w_ee017673-b41f-4706-acd5-7b0ce4ca8cd2">4,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b90616500947d38963e9030a90b72f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNC0yLTEtMS0w_9ac20246-9a72-4cb4-8bf3-9b6b690db415">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722f7fc559114e54aeeadc90f492bc78_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNC00LTEtMS0w_1b4b7612-48d7-47ba-8dc1-f7022b3a80c5">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNS0yLTEtMS0w_fd6e1df6-a251-4841-a054-cb78c395d7a2">19,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNS00LTEtMS0w_d9bc32a5-5c04-48b1-af13-cb60ed1a9e21">18,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNi0yLTEtMS0w_4c076d08-4f89-4e75-9bd7-69f2ee949098">12,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNi00LTEtMS0w_163052d2-cb7d-49a6-87cd-50a1b6df1034">11,582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNy0yLTEtMS0w_ba93ecbb-c228-4c4d-aaf1-6f232aa305a4">7,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNy00LTEtMS0w_867a4840-a3ba-4f7c-b981-716551554574">7,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOC0yLTEtMS0w_a9b9f5ca-394a-4b52-9168-997537b3275f">2,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOC00LTEtMS0w_2884e60a-4c16-47cc-a2d4-26e5b6f0e9de">3,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOS0yLTEtMS0w_b543abc3-d426-4910-9699-f71024212aeb">9,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOS00LTEtMS0w_d4eb8b56-793b-40bf-98ca-c84a57eb3c60">10,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                            </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was approximately $<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNjg2_c9bda3ec-7dd5-48e7-bba6-dba1d7560b8e">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNjkz_3b4d62a7-ff58-419a-8bdb-d6052a237b2a">0.8</ix:nonFraction> million, inclusive of ROU asset amortization of $<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNzM2_0f1618b5-8bbf-4ee4-8875-a9e30da51dc2">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNzQz_401710e9-92aa-44a0-93e1-92f801ae89d3">0.4</ix:nonFraction> million for the three months ended September&#160;30, 2021 and 2020 respectively. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id957647118424b36a323f65b4e036abc" continuedAt="i6dc5a96d213e473c82c5878513c4f456"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was approximately $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfODUx_15f4ecce-e406-4a5f-929d-a793e9d9ab8d">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfODU4_f67f9f3f-0c53-4447-baff-084c59d8e448">2.5</ix:nonFraction> million, inclusive of ROU asset amortization of $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfOTAx_0bd09dec-5fa7-4d0b-90a7-0b4c6ad2b407">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfOTA4_2a1d1583-4f98-48a6-b419-efadb882e42a">1.3</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020 respectively.</span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTY4Ng_38d37f0f-7a80-4edb-bfb9-971026d4f9c8" escape="true"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:68.485%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and payroll taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMi0yLTEtMS0w_31f3de61-f124-483c-88d2-372182a67910">7,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMi00LTEtMS0w_c7a13465-8610-4665-8666-244bad4c19dd">8,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued outsourced manufacturing expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accruedmanufacturingexpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMy0yLTEtMS0w_2ed64b6a-b9bc-4d7c-b634-e73714f78c92">2,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:Accruedmanufacturingexpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMy00LTEtMS0w_7cda1395-9b04-4a3b-99cb-d8a9153c667c">4,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNC0yLTEtMS0w_45cae66c-2660-48b7-a2c5-a0a4587babe9">6,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNC00LTEtMS0w_3a860846-a7cb-4121-aa2b-07f465917431">6,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNS0yLTEtMS0w_0d35f577-fa42-4648-9476-be68278ce2d8">3,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNS00LTEtMS0w_5d55cb71-6934-4662-b75e-a4b1e64b5e8b">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNi0yLTEtMS0w_3d6e5c20-7ba0-4865-93b1-1efde370745f">19,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNi00LTEtMS0w_d50b883f-9fa0-413f-98d4-0fdfecdc59c3">23,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="halo:AccruedLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNy0yLTEtMS0w_4e975e4f-6923-4b8b-8767-e539b2ad88b0">1,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="halo:AccruedLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNy00LTEtMS0w_0e535539-128d-46e7-a350-6fd85cb78551">3,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued expenses, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfOC0yLTEtMS0w_ca044f5f-f342-4fd6-87d3-cb06b5ad0be6">18,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02e009dc2fa9486680263a15069d178d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfOC00LTEtMS0w_8a3169c7-7c6c-4714-8565-bd6e2cdc8425">20,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense associated with the accretion of the lease liabilities was approximately $<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="halo:OperatingLeaseAccretionOfLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTEwMQ_9dfdb79a-29ce-413c-ac6d-9348ed2882ed">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="halo:OperatingLeaseAccretionOfLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTEwOQ_75c4fa6d-51b0-4735-836e-672a0cf54dc9">0.1</ix:nonFraction> million for the three months ended September&#160;30, 2021 and 2020 respectively. Total lease expense for the three months ended September&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTIxOA_e76d995c-7e35-4368-bdd7-c9840001f68d">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTIyNQ_02885526-04c6-401a-9766-dfdc2aee5469">0.5</ix:nonFraction> million respectively. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense associated with the accretion of the lease liabilities was approximately $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="halo:OperatingLeaseAccretionOfLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTMyNA_90681452-2ae8-47ee-a308-e86c3e82453a">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="halo:OperatingLeaseAccretionOfLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTMzMg_6bcc5d84-8dcf-4983-965c-9f07adc99951">0.4</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020 respectively. Total lease expense for the nine months ended September&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTQ0MQ_ea41fca7-59a6-4cb1-bf1d-d5b5c7daca39">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTQ0OA_e8f376f0-36f1-4fdf-85c8-107368e7e21e">1.7</ix:nonFraction> million respectively. </span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6dc5a96d213e473c82c5878513c4f456">Cash paid for amounts related to leases for the three months ended September&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU0NA_71b487a9-4b1d-46d9-a40b-a3bfec0c5f39">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU1MQ_03ab2748-ad00-4394-ab43-f6fe15b66a71">0.8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU1OQ_f5b6c87e-76d9-44bb-9f68-b7f911749b01">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU2Ng_db2bcb5e-55b3-45ea-a464-907fd57b6ccb">2.5</ix:nonFraction> million for the nine months ended September&#160;30, 2021 and 2020 respectively.</ix:continuation> </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. Long-Term <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI1Ng_a0c8cac5-403b-4feb-99a4-3142a93a7c74" continuedAt="i9a74afbf75764582a539fb1177b22623" escape="true">Debt, Net</ix:nonNumeric></span></div><ix:continuation id="i9a74afbf75764582a539fb1177b22623" continuedAt="iad18ac3c1d1f4da6a888bffb3d2f08f5"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.25% Convertible Notes due 2027</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we completed the sale of $<ix:nonFraction unitRef="usd" contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTAx_f3555944-bb3b-46ec-aad6-9ead75e3f531">805.0</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTM3_1b8376f1-65ba-459d-8354-0428e86496cb">0.25</ix:nonFraction>% Convertible Senior Notes due 2027 (the &#8220;2027 Convertible Notes&#8221; and collectively with the 2024 Convertible Notes the &#8220;Convertible Notes&#8221;). The net proceeds in connection with the issuance of the 2027 Convertible Notes, after deducting the initial purchasers&#8217; fee of $<ix:nonFraction unitRef="usd" contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDA2_4b24a432-df99-47b1-87d2-137f53adfab5">20.1</ix:nonFraction>&#160;million, was approximately $<ix:nonFraction unitRef="usd" contextRef="i1155e6c14a0c4e65a515fa1e38dd911c_D20210301-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDI4_42214d3b-12e0-4721-9dcc-c22f61a22435">784.9</ix:nonFraction>&#160;million. We also incurred additional debt issuance costs totaling $<ix:nonFraction unitRef="usd" contextRef="i0c4cf1db12cd4ea3a46151468a622bcc_D20210301-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDg5_c19a6e4a-1853-41f7-8366-cb755f66005d">0.4</ix:nonFraction>&#160;million. Debt issuance costs and the initial purchasers&#8217; fee are presented as a debt discount.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2027 Convertible Notes pay interest semi-annually in arrears on March 1st and September 1st of each year at an annual rate of <ix:nonFraction unitRef="number" contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNzA5_61c7e0d1-1af6-4d01-b647-786705ea5069">0.25</ix:nonFraction>%. The 2027 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2027 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of our current or future subsidiaries. The 2027 Convertible Notes have a maturity date of March 1, 2027.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2027 Convertible Notes at their option only in the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021, if the last reported sale price per share of  common stock exceeds <ix:nonFraction unitRef="number" contextRef="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTYyNQ_1145d2e1-8588-4e01-adda-ff014e1e8a7d">130</ix:nonFraction>% of the conversion price for each of at least <ix:nonFraction unitRef="trading_day" contextRef="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTY3Mw_7419b2d4-0879-471a-ae82-9db7b6c556f5">20</ix:nonFraction> trading days during the <ix:nonFraction unitRef="trading_day" contextRef="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTcwMA_c2d23c6e-2ce0-4088-a633-d15d05561f61">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the <ix:nonFraction unitRef="trading_day" contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTgzNw_6fee4c25-a5dd-400a-9932-f2ede508c4cb">five</ix:nonFraction> consecutive business days immediately after any <ix:nonFraction unitRef="trading_day" contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTg4OA_828409f0-c862-45f0-a181-a8c0cdfa5e14">five</ix:nonFraction> consecutive trading day period (such <ix:nonFraction unitRef="trading_day" contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTkyOA_db2335cd-ad74-4c42-89e8-1189af335c65">five</ix:nonFraction> consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMjExNA_896f1612-fb2b-4f80-9c72-aa8c7068c25b">98</ix:nonFraction>% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on our common stock, as described in the offering memorandum for the 2027 Convertible Notes; (4) if we call such notes for redemption; and (5) at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately before the maturity date. The Notes will be convertible, regardless of the foregoing circumstances, at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately preceding the maturity date. As of September&#160;30, 2021, the 2027 Convertible Notes are not convertible.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, we will pay cash for the settlement of principal and for the premium, if applicable, we will pay cash, deliver shares of common stock or a combination of cash and shares of common stock, at our election. The initial conversion rate for the 2027 Convertible Notes will be <ix:nonFraction unitRef="number" contextRef="i0c4cf1db12cd4ea3a46151468a622bcc_D20210301-20210331" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzE4Ng_9cdb4500-aa0a-440f-bde7-b8f9636b75f1">12.9576</ix:nonFraction> shares of common stock per $1,000 in principal amount of 2027 Convertible Notes, equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzMyMA_5b17af32-257e-4678-8d4a-ee15a141189d">77.17</ix:nonFraction> per share of our common stock. The conversion rate is subject to adjustment.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we were <ix:nonNumeric contextRef="ibd6310c76bae4bd78ad9a40cb2b6f8a5_D20210101-20210930" name="us-gaap:DebtInstrumentCovenantCompliance" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzQxOA_20470254-3456-4e34-8ea3-b64cf119457c">in compliance</ix:nonNumeric> with all covenants and there was no material adverse change in our business, operations or financial condition. </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.25% Convertible Notes due 2024</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed the sale of $<ix:nonFraction unitRef="usd" contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzYxMA_924ef848-35a7-49ee-9cad-6519f6ab8996">460.0</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzY0Ng_92fc9440-06ab-4651-88c5-2d88de207cfc">1.25</ix:nonFraction>% Convertible Senior Notes due 2024 (&#8220;2024 Convertible Notes&#8221;). The net proceeds in connection with the 2024 Convertible Notes, after deducting  the initial purchasers&#8217; fee of $<ix:nonFraction unitRef="usd" contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzgyMw_57291ae6-aca6-45e4-9e5b-adcf1d907547">12.7</ix:nonFraction>&#160;million, was approximately $<ix:nonFraction unitRef="usd" contextRef="i0bc7c027cf8d468087b67594cb81b7d1_D20191101-20191130" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzg0NQ_4fd62ed6-793e-4f81-babe-7c7c973f372b">447.3</ix:nonFraction> million. We also incurred debt issuance cost totaling $<ix:nonFraction unitRef="usd" contextRef="i412aa96cc1ad40e191bb9fafe16fe2dd_D20191101-20191130" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzg5NA_9cdef1fb-f64f-4aeb-94d6-31978815e750">0.3</ix:nonFraction>&#160;million. Debt issuance costs and the initial purchasers&#8217; fee are presented as a debt discount.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Convertible Notes pay interest semi-annually in arrears on June 1st and December 1st of each year, beginning on June 1, 2020, at an annual rate of <ix:nonFraction unitRef="number" contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDE0MA_c907ab4d-cf6c-4282-b2c3-6c00ac7c1927">1.25</ix:nonFraction>%. The 2024 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2024 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of the our current or future subsidiaries. The 2024 Convertible Notes have a maturity date of December 1, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2024 Convertible Notes at their option only in the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on March&#160;31, 2020, if the last reported sale price per share of common stock exceeds <ix:nonFraction unitRef="number" contextRef="i3e626483481f4563b913a234b6554eee_D20191101-20191130" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTA2Mw_9581f201-206a-457c-8508-343803df6deb">130</ix:nonFraction>% of the conversion price for each of at least <ix:nonFraction unitRef="trading_day" contextRef="i3e626483481f4563b913a234b6554eee_D20191101-20191130" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTExMQ_8d3d2607-f10d-44c8-b777-43c5be0f77ca">20</ix:nonFraction> trading days during the <ix:nonFraction unitRef="trading_day" contextRef="i3e626483481f4563b913a234b6554eee_D20191101-20191130" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTEzOA_d189fdd5-1f69-477f-844c-dc565756f089">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2)&#160;during the <ix:nonFraction unitRef="trading_day" contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTI3NQ_2c8db6cd-1651-4d5b-8d3f-1d3f44530f4f">five</ix:nonFraction> consecutive business days immediately after any <ix:nonFraction unitRef="trading_day" contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTMyNg_4f0425ef-0351-4c69-a1bd-37e79568ca9e">five</ix:nonFraction> consecutive trading day period (such <ix:nonFraction unitRef="trading_day" contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTM2Ng_5521945e-96d8-4ae0-9caa-75955c261aee">five</ix:nonFraction> consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTU1Mg_60e1a757-b2fd-47f9-b5bd-032c829e63ee">98</ix:nonFraction>% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3)&#160;upon the occurrence of certain corporate events or distributions on our common </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iad18ac3c1d1f4da6a888bffb3d2f08f5" continuedAt="i581fb64504d840fa9b6eb911a9fd8865"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock, as described in the offering memorandum for the 2024 Convertible Notes; (4)&#160;if we call such notes for redemption; and (5)&#160;at any time from, and including, June&#160;1, 2024 until the close of business on the scheduled trading day immediately before the maturity date. As of September&#160;30, 2021, the 2024 Convertible Notes are convertible and are classified as a current liability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021 we notified the note holders of our irrevocable election to settle the principal of the 2024 Convertible Notes in cash and for the premium, if applicable, to deliver shares of common stock. The conversion rate for the 2024 Convertible Notes will be <ix:nonFraction unitRef="number" contextRef="i412aa96cc1ad40e191bb9fafe16fe2dd_D20191101-20191130" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjQxMQ_a488b34f-706d-4c29-b815-ba1efb76e9ee">41.9208</ix:nonFraction> shares of common stock per $1,000 in principal amount of 2024 Convertible Notes, equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjU0NQ_a825cc87-1846-4934-9b1d-03fd4cf99129">23.85</ix:nonFraction> per share of our common stock. The conversion rate is subject to adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we completed a privately negotiated induced conversion of $<ix:nonFraction unitRef="usd" contextRef="i55a4ed926b904e02ab845282be395019_D20210301-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjY5OA_bfe7e1b3-e14f-4146-8fb0-30c64dabc1aa">369.1</ix:nonFraction>&#160;million principal amount of the 2024 Convertible Notes (&#8220;Note Repurchases&#8221; or the &#8220;Induced Conversion&#8221;). In connection with the Induced Conversion, we paid approximately $<ix:nonFraction unitRef="usd" contextRef="i55a4ed926b904e02ab845282be395019_D20210301-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjg2Mw_28ed0064-374d-40ef-9008-0232d9b3db1d">370.2</ix:nonFraction>&#160;million in cash, which includes principal and accrued interest, and issued approximately <ix:nonFraction unitRef="shares" contextRef="i55a4ed926b904e02ab845282be395019_D20210301-20210331" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjk0Nw_589253d3-9374-4d20-a75c-c70eada21810">9.08</ix:nonFraction>&#160;million shares of our common stock representing the intrinsic value based on the contractual conversion rate and incremental shares as an inducement for conversion. As a result of the Induced Conversion, we recorded $<ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNzE1OA_31f22cb3-c1af-46a7-843d-9004fd24809b"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InducedConversionOfConvertibleDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNzE1OA_99b04cb7-8352-4e2e-98bb-a83b52b9bad3">21.0</ix:nonFraction></ix:nonFraction> million in induced conversion expense which is included in Other income (expense) of the Condensed Consolidated Statements of Operations for the nine months ended September&#160;30, 2021. The induced conversion expense represents the fair value of the common stock issued upon conversion in excess of the common stock issuable under the original terms of the 2024 Convertible Notes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we were <ix:nonNumeric contextRef="ibd6310c76bae4bd78ad9a40cb2b6f8a5_D20210101-20210930" name="us-gaap:DebtInstrumentCovenantCompliance" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI2OA_20470254-3456-4e34-8ea3-b64cf119457c">in compliance</ix:nonNumeric> with all covenants and there was no material adverse change in our business, operations or financial condition. </span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI2NQ_c875200c-0202-45cc-a157-64bfeaa1c0af" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Carrying Amounts of the Convertible Notes</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and fair value of our Convertible Notes were as follows as of the dates indicated. As disclosed in Note 2, we early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis which adoption is reflected in the following table (in thousands).</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:69.570%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMi0yLTEtMS0w_d842c354-c035-4eab-b1cc-89cb9536d28f">90,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMi00LTEtMS0w_b46fa4e2-d27b-4f11-8744-777d2aec3401">460,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMy0yLTEtMS0w_72d5da3b-f149-4574-bc87-957404f14024">805,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMy00LTEtMS0w_60697ca6-447c-40d2-aa44-e3e7e08f0503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Principal Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNC0yLTEtMS0w_e5e68855-2bed-4e63-bd7a-bd766ac3f88e">895,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNC00LTEtMS0w_46e52d33-bae9-4744-a861-5bcc6388e507">460,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNy0yLTEtMS0w_6e40bdcb-06d3-43bb-a53b-84497181df0a">1,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNy00LTEtMS0w_a15c21d8-3ed0-4800-8ab5-c51734ab33e0">10,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOC0yLTEtMS0w_065e41c5-605f-459c-afc0-308da43b8b50">18,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOC00LTEtMS0w_8ad283b5-f5d8-426e-8f09-cbe65ea62da9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOS0yLTEtMS0w_2c04f137-4be0-4b2c-a4df-8f7b51f00cce">20,231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOS00LTEtMS0w_cc082551-4932-47c8-a6a6-c0f404faccb6">10,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTItMi0xLTEtMA_c87d5101-475f-43ad-85eb-ac0460aedd59">89,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTItNC0xLTEtMA_886d3485-deae-4c91-8072-de4d0070cca2">449,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTMtMi0xLTEtMA_f232fd44-988f-420a-b2c7-456ad6acec62">786,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTMtNC0xLTEtMA_09e82e4c-2616-4497-8286-15958e05612d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTQtMi0xLTEtMA_ef52b34a-cbc3-4cd4-af3f-8e3b6340cb89">875,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTQtNC0xLTEtMA_aff1c087-bb51-42f7-9e33-b2f7682c3a46">449,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value based on trading levels (Level 2):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTctMi0xLTEtMA_362edaa0-3115-4e32-9dc6-3a3881286b2d">162,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTctNC0xLTEtMA_06fcaf2b-f6d8-425d-90ac-ddeb69043baf">861,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTgtMi0xLTEtMA_8164740c-7497-4a11-aac5-be3e870a683f">731,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTgtNC0xLTEtMA_9b19f243-19e0-4d1c-9f56-c1c73e2a3786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTktMi0xLTEtMA_099b94d7-ae77-455b-a71e-6cb0a3ec9e13">893,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTktNC0xLTEtMA_66ddffe7-df28-4a37-8e3b-6ef7ae3beedf">861,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining amortization per period of debt discount (in years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i57fd176ba4c740bd84df4e3fe9c28ccb_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMjItMi0xLTEtMA_7324b156-9f7f-44c6-a535-355e346467b0">3.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaef2086ff4f2483fbfd62522f9a2ad60_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMjItNC0xLTEtMA_cddb6cc5-b289-4831-bd47-66eabd642b08">3.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id5074839e1194c76ae4dc87402cb085f_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMjMtMi0xLTEtMA_399a549a-18b1-484c-8ff4-b2657661860f">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i581fb64504d840fa9b6eb911a9fd8865"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI2Mw_fc54d578-60ce-4a52-ad4a-28eb194c6eac" escape="true"><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our Convertible Notes for the periods shown (in thousands).</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:41.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coupon Interest:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy0yLTEtMS0w_f8b6ccfc-e278-4290-802e-7f922f63f6bf">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy00LTEtMS0w_c97bdb7d-94b4-4a1e-85d9-fa816264809c">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy02LTEtMS0w_4f7bc39c-159c-43b1-ab3f-139085560f34">1,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy04LTEtMS0w_de27b782-2898-4e1a-81a6-1743c1b43c7f">4,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC0yLTEtMS0w_e3db0f49-62c0-4db0-b9f8-8e59ad246055">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC00LTEtMS0w_24063fcc-c87e-4162-a3f9-3e895fddc082">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206c739252224af8a8948489d424ad8f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC02LTEtMS0w_27c73656-1381-4423-a0d1-00cc6672b634">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i686912eb766d40b18a385b1858670232_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC04LTEtMS0w_76d64ff9-554a-4ab8-b1cd-9efe8131910d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Coupon Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS0yLTEtMS0w_674788fe-f8a7-466c-ac3c-13a58782ccde">787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS00LTEtMS0w_72d67cd0-f1da-4d7c-a884-e1d658a51e91">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS02LTEtMS0w_fb30131e-dd3a-44c8-84fa-368cfb7b1ad3">2,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ccd57126f347af88275529acfde43e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentPeriodicPaymentInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS04LTEtMS0w_2c9e3459-58c0-4cba-ba11-3de4081cbc5d">4,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC0yLTEtMS0w_f094216a-3942-4603-9403-66db53986a54">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC00LTEtMS0w_d21b762c-3d5b-4a76-bef7-2f6a6bd9882e">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC02LTEtMS0w_bb535bf5-9060-4b00-b5f2-2bc6c4868f1f">712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC04LTEtMS0w_4f656731-7334-43b5-8878-9d1230d86b1f">10,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS0yLTEtMS0w_9aedb82c-9a4a-4dfe-8ee0-a244e5849603">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS00LTEtMS0w_0179c666-28f5-4093-b790-9e7c4e2f05a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206c739252224af8a8948489d424ad8f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS02LTEtMS0w_628441cc-c034-4c21-b080-6276484acae2">1,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i686912eb766d40b18a385b1858670232_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS04LTEtMS0w_03192223-b123-480e-99c4-d16e101eb4c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization of debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtMi0xLTEtMA_9fabc509-2fa4-47a1-bf8b-f09fbadfc169">968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtNC0xLTEtMA_a2e736a5-94d1-487d-bbca-e6a4ba8ebf8d">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtNi0xLTEtMA_fa2d2baf-b748-4876-831b-ab089f6f8df9">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ccd57126f347af88275529acfde43e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtOC0xLTEtMA_aa2f3043-5c08-4ed1-bb68-3c84a7903d0f">10,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtMi0xLTEtMA_0041978c-f205-46ee-bd53-e0349984954a">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtNC0xLTEtMA_2cab9e86-9a16-48ae-a431-bec939338521">4,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtNi0xLTEtMA_e1a0c268-9a7e-42fb-b065-2344d4a445d7">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtOC0xLTEtMA_c5ccecff-513a-44e5-8ff1-3359db1ce926">14,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtMi0xLTEtMA_36cc38e5-bb49-485e-bf4c-20496dcc8eb0">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtNC0xLTEtMA_a2ee4e6b-8241-4a63-970e-170bb8b43bce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i206c739252224af8a8948489d424ad8f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtNi0xLTEtMA_480f7e1d-3706-46ce-934b-b0811be92f03">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i686912eb766d40b18a385b1858670232_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtOC0xLTEtMA_61397b4e-ca3e-45c0-bfd9-9ed9c6f56bdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtMi0xLTEtMA_bb562589-4bf5-4cd1-add3-987f3508625e">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtNC0xLTEtMA_fc8932f9-42a1-4627-a125-5733b7f5505f">4,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtNi0xLTEtMA_2fe979af-9658-4dc5-8342-eca01b2fe6af">5,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ccd57126f347af88275529acfde43e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtOC0xLTEtMA_e16ff252-ea25-49b4-8953-454a510a6abb">14,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rates:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5bb0843b04c43068da2dc6c03a064e3_I20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtMi0xLTEtMA_39f86d34-e369-451d-8b47-77dd59ce69bb">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie190bf0480c1487b9eb3d0916f7ffd88_I20200930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtNC0xLTEtMA_34eb794b-6c59-4846-a48a-b4f1e701767b">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5bb0843b04c43068da2dc6c03a064e3_I20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtNi0xLTEtMA_f63ab6f9-027d-44b9-be97-ef3cf918e1d1">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie190bf0480c1487b9eb3d0916f7ffd88_I20200930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtOC0xLTEtMA_a905e76a-139c-4b59-bdec-695a71a30050">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0cb4364368aa4364afadbad891bba742_I20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTktMi0xLTEtMA_4a71af13-b0a6-4f04-b957-76321ab19759">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0cb4364368aa4364afadbad891bba742_I20210930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTktNi0xLTEtMA_40fec283-9411-46cf-a207-048a08c646ab">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalty-backed Loan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, through our wholly-owned subsidiary Halozyme Royalty LLC (&#8220;Halozyme Royalty&#8221;), we received a $<ix:nonFraction unitRef="usd" contextRef="i8cd6bdc962914e4c99408077c340d9e7_I20160131" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfODI4MQ_11bb947a-58fe-4170-b80a-abc5b4d2a920">150</ix:nonFraction> million loan (the &#8220;Royalty-backed Loan&#8221;) pursuant to a credit agreement (the &#8220;Credit Agreement&#8221;) with BioPharma Credit Investments IV Sub, LP and Athyrium Opportunities II Acquisition LP (the &#8220;Royalty-backed Lenders&#8221;). Under the terms of the Credit Agreement, Halozyme Therapeutics, Inc. transferred to Halozyme Royalty the right to receive royalty payments from the commercial sales of ENHANZE products owed under the Roche Collaboration and Baxalta Collaboration (&#8220;Collaboration Agreements&#8221;). The royalty payments from the Collaboration Agreements were used to repay the principal and interest on the loan (the &#8220;Royalty Payments&#8221;).&#160; The Royalty-backed Loan bore interest at a per annum rate of <ix:nonFraction unitRef="number" contextRef="i8cd6bdc962914e4c99408077c340d9e7_I20160131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfODk3Mg_9cd7f4ca-4ad8-4cb2-b828-589e5e3c1c54">8.75</ix:nonFraction>% plus the three-month LIBOR rate. The three-month LIBOR rate was subject to a floor of <ix:nonFraction unitRef="number" contextRef="i05a350efec6041e4ad6404c46e10b7d7_D20160101-20160131" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTA2MQ_fc33e3da-c221-475a-a1a4-59fd7f76c3bd">0.7</ix:nonFraction>% and a cap of <ix:nonFraction unitRef="number" contextRef="i6fc00725d97c48d58939d926e50427aa_D20160101-20160131" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTA3Nw_0d67c301-516c-4b01-b461-460b646a7a83">1.5</ix:nonFraction>%.&#160;In June 2020, we paid the full remaining balance and final payment of $<ix:nonFraction unitRef="usd" contextRef="ic9b79a7919f047598af257757cc3e833_D20200601-20200630" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTE1MQ_65607463-bcfc-48a5-8660-7f42c7f4881d">2.93</ix:nonFraction> million thereby satisfying and discharging all obligations under, and terminating, the Royalty-backed Loan.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ2NQ_85cdbe0c-0a58-4743-b365-3e6fa342d4d2" continuedAt="ia49f738e81ad43d09de800dffc391217" escape="true">Share-based Compensation</ix:nonNumeric></span></div><ix:continuation id="ia49f738e81ad43d09de800dffc391217" continuedAt="i4399ff67856a4743af40dc89e83f81d0"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjUwOA_a950007c-f782-4e08-809c-d6de9ba860d0" escape="true"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense related to share-based awards was comprised of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.959%"><tr><td style="width:1.0%"></td><td style="width:57.246%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6935de8b3c224975955d989d869bb9c2_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi0yLTEtMS0w_053e7ce4-659e-469d-a580-3a48b0c10a2b">1,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if714bbad33ad4917992f139e44fd69a2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi00LTEtMS0w_f224818a-bc07-4137-a7f4-a2d4ec6eea07">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a37442fa874dafb84523a3cca2bb91_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi02LTEtMS0w_1c4e07b3-d734-4f05-bac9-e4a8da971515">5,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba5ad85eda24a959bfa0546f86a7844_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi04LTEtMS0w_d9c73152-fa63-441b-994c-80a213cf4a34">4,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia888539718ab4742979a05f4e932df96_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy0yLTEtMS0w_13955304-e866-4023-b65d-dd01aee9f97e">3,557</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3782dfbd667f4a0687f611f008d2010f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy00LTEtMS0w_2dae0fac-3a1e-4aea-91e2-ac4d44a4e3d8">2,958</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec1669a6ad4449fb85d6e5157147d08_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy02LTEtMS0w_79f9fddb-41a9-4e6a-9d26-1e62c8275cf5">10,440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3c879cf61d4eacae3a4dff1a71d41b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy04LTEtMS0w_303a67b0-3d4a-4699-8b7a-539601eaa2dc">8,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC0yLTEtMS0w_0b123e56-0a7b-4aec-8acf-4cbf36b37ff6">5,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC00LTEtMS0w_31b93d83-13ac-4f12-8330-c32175e2ec8f">4,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC02LTEtMS0w_ddcd2cb0-6aa7-4b90-9631-9bce93a69347">15,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC04LTEtMS0w_0c4e704a-24ac-47c9-8a71-3dfcf799083f">13,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ1NA_14ae2121-e63c-4478-9819-534de264adba" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by type of share-based award (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:57.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.473%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22bc32765cc456cb791da8766cc1e95_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi0yLTEtMS0w_960b94a5-7121-4083-b6ac-719e3eefd3bf">2,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i991a03f67f0b48beb763927b3126b6ee_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi00LTEtMS0w_3039593c-b598-4071-aed2-a207a5c40acd">2,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi02LTEtMS0w_3f9db6b2-0014-4365-98e1-f2367b39fce5">7,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi04LTEtMS0w_60ba83e4-3175-465e-8a51-68c4fd0510cf">6,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs, RSUs, PSUs and ESPP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad66576159674e89ac18ab298f2dbcdc_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy0yLTEtMS0w_486101af-7340-4a24-b414-71ca98360014">2,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56b8f532e5be4b9985264987e5461803_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy00LTEtMS0w_3e46ed90-176a-41e4-b475-c262b2c1cf30">2,038</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0bf4633edb46a299d1efbda6de0f73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy02LTEtMS0w_75c4147e-b2bf-4d4b-bd77-b8b4da4e458e">7,947</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0e8a1da30a4e6491620fc881ff1298_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy04LTEtMS0w_a5122d8b-abc7-4c0b-a5fd-9382200077a3">6,242</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC0yLTEtMS0w_1e4cba69-f785-48a0-b006-f9842bb1f5fa">5,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC00LTEtMS0w_c57d45b2-7bb4-46b6-aeec-45e8ac595288">4,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC02LTEtMS0w_571b3ccd-f6dd-4258-839e-c90b2f541233">15,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC04LTEtMS0w_d0f9d6d4-7479-452b-a9af-d60ed6984eae">13,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted stock options to purchase approximately <ix:nonFraction unitRef="shares" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjgy_3ae7a8f1-4f35-4169-887e-5356a22a11e8">32.5</ix:nonFraction> thousand and <ix:nonFraction unitRef="shares" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjg5_6acfb7a5-d313-4c95-925a-c561b0a920b6">34.7</ix:nonFraction> thousand shares of common stock during the three months ended September&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="shares" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMzcx_44bce082-eda8-4b24-a146-05f673f2cabb">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="shares" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMzc4_243bfff7-bceb-4e49-8680-65b48fff406e">1.5</ix:nonFraction> million shares of common stock during the nine months ended September&#160;30, 2021 and 2020, respectively. The exercise price of stock options granted is equal to the closing price of the common stock on the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes-Merton option pricing model (&#8220;Black-Scholes model&#8221;). Expected volatility is based on historical volatility of our common stock. The expected term of options granted is based on analyses of historical employee termination rates and option exercises. The risk-free interest rate is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The dividend yield assumption is based on the expectation of no future dividend payments. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ3Nw_c2cbfa49-0259-4379-acd6-b778cbcc0b46" continuedAt="i917f617d75244d40b5d78264a3d891ec" escape="true">The assumptions used in the Black-Scholes model were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><ix:continuation id="i917f617d75244d40b5d78264a3d891ec"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i524ae854807442c79db75cfe0fec0661_D20210701-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi0yLTEtMS0yNzgvdGV4dHJlZ2lvbjo5YTRjYTk1OTNmNGM0NGE0YjRhYTE5NWI0MGQyMTVhZV8xMDk5NTExNjI3Nzk3_86b23f25-366b-4e64-9e57-753c68e372f7">42.90</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="id279be3e39fe4e73b119fc76b6f0e3e9_D20210701-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi0yLTEtMS0yNzgvdGV4dHJlZ2lvbjo5YTRjYTk1OTNmNGM0NGE0YjRhYTE5NWI0MGQyMTVhZV8xMDk5NTExNjI3ODA4_6b6f94de-747c-4250-891c-2ad8aedca1bf">44.73</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i777756be172547c79ef2d98b14af2e9f_D20200701-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi00LTEtMS0wL3RleHRyZWdpb246YWE2MDkxN2Y0OGJkNDI4YTk1ZjdiM2E0Yjg2N2Q5NTBfMTA5OTUxMTYyNzg0NQ_b63e697c-f78a-4825-b5a2-425b349d5595">50.58</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="ifcc6657cf7204e4bb3546eb115b7bb0b_D20200701-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi00LTEtMS0wL3RleHRyZWdpb246YWE2MDkxN2Y0OGJkNDI4YTk1ZjdiM2E0Yjg2N2Q5NTBfMTA5OTUxMTYyNzgwOQ_20e5d395-d93e-43d5-bd1b-650710cd4b9f">51.82</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5e243ecce6549b386466103e48f03b8_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi02LTEtMS0wL3RleHRyZWdpb246NjMzYmM2ZWI0M2Q3NGIzNWE4MjA4MWZiY2UxZTBjNDRfMTA5OTUxMTYyNzgwOQ_9d58cf9b-8a4c-414a-ba54-0777d50534ee">42.90</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="i19137a9706c8440c91b3ac9170020347_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi02LTEtMS0wL3RleHRyZWdpb246NjMzYmM2ZWI0M2Q3NGIzNWE4MjA4MWZiY2UxZTBjNDRfMTA5OTUxMTYyNzgyMA_502e176e-5f27-46af-a15a-772298581a28">46.45</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i930e92c51aab40ecb52c8e784b177f6d_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi04LTEtMS0wL3RleHRyZWdpb246OTQ2ZTc4ZWNmZWU4NGVmNDllZmNiYTc2ZDY2NzZjZjlfMTA5OTUxMTYyNzgyNw_33854d84-2191-4a40-ab5b-29d9d245a132">50.58</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="i1a0c6e310d5c45ff9ba748668cdfb1c4_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi04LTEtMS0wL3RleHRyZWdpb246OTQ2ZTc4ZWNmZWU4NGVmNDllZmNiYTc2ZDY2NzZjZjlfMTA5OTUxMTYyNzgzNg_e1261e7c-4bbb-41f5-be30-b66b439dbd9b">51.82</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy0yLTEtMS0w_ccd33e6f-ea9a-4e6d-821e-81eac69773b8">4.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy00LTEtMS0w_01995367-8b79-42ea-9688-e94ca2ffa7b4">4.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy02LTEtMS0w_6653bc14-54d3-4f16-9239-0365c1043a3e">4.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy04LTEtMS0w_d24640d9-5588-4d17-9d88-58dcb41bf1aa">5.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC0yLTEtMS01NzIvdGV4dHJlZ2lvbjoyNjk4ZGViMjZjNTU0MTIxOGE4ODZkMGJmNjJjZDBhYl8xMDk5NTExNjI3Nzk3_7c0ba2c1-1294-45fc-ab3e-1426d94556f1">0.66</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC0yLTEtMS01NzIvdGV4dHJlZ2lvbjoyNjk4ZGViMjZjNTU0MTIxOGE4ODZkMGJmNjJjZDBhYl8xMDk5NTExNjI3ODA3_8ba94b80-9726-4240-a8b0-81798f91f53c">0.89</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC00LTEtMS0wL3RleHRyZWdpb246ODQwMjgzN2ZlNmM4NDljOGIxZWJhNmRmZThmMmMxODBfMTA5OTUxMTYyNzc5NA_9dec311f-5514-4a22-b8ab-0a71f6d44850">0.22</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC00LTEtMS0wL3RleHRyZWdpb246ODQwMjgzN2ZlNmM4NDljOGIxZWJhNmRmZThmMmMxODBfMTA5OTUxMTYyNzgwNQ_d4066790-f35f-46f6-8c85-0d3e2bb5876f">0.31</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC02LTEtMS0wL3RleHRyZWdpb246MGVmZTUwNmRkMmQzNDgyMmFlNjk3ZTUzYjk3Y2EwNDlfMTA5OTUxMTYyNzgwMQ_ad1634f4-2d4f-4f7b-9002-1f8ce49ae5dd">0.36</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC02LTEtMS0wL3RleHRyZWdpb246MGVmZTUwNmRkMmQzNDgyMmFlNjk3ZTUzYjk3Y2EwNDlfMTA5OTUxMTYyNzgxMQ_f9288d2a-b09a-4780-b2ec-c1e692a30031">0.89</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC04LTEtMS0wL3RleHRyZWdpb246MjZlMDEyYjBiM2U5NDRmZWI5MDU2NmFhZDBlNjk3NjBfMTA5OTUxMTYyNzgyMA_25dbca59-658c-47cb-a3c9-7697fbeaa826">0.22</ix:nonFraction>-<ix:nonFraction unitRef="number" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC04LTEtMS0wL3RleHRyZWdpb246MjZlMDEyYjBiM2U5NDRmZWI5MDU2NmFhZDBlNjk3NjBfMTA5OTUxMTYyNzgzMA_b3046346-0435-446d-b385-39e08ae29c9f">1.67</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS0yLTEtMS0w_ca2c851e-b56d-4dd2-ae55-80740eb2d198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS00LTEtMS0w_889553c2-b61a-4315-9adb-f6028e710d20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS02LTEtMS0w_22c47667-da3a-4bf4-9f8b-46a7d7883d27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS04LTEtMS0w_78a723e6-58bf-4df3-9ae3-71f40686130b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, our Board of Directors approved our 2021 ESPP and our stockholders approved the plan in May 2021. The ESPP enables eligible employees to purchase shares of our common stock at the end of each offering period at a price equal to <ix:nonFraction unitRef="number" contextRef="icd817f332517429098def9a226790157_D20210201-20210228" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTQ3OQ_75176d2e-30f7-4baf-8aab-99487b9920ea">85</ix:nonFraction>% of the fair market value of the shares on the first business day or the last business day of the offering period, whichever is lower. Share purchases are funded through payroll deduction of at least <ix:nonFraction unitRef="number" contextRef="ia25a711f34284d2cb31197de09c55937_I20210228" decimals="INF" name="halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTY4MQ_0c8fc0eb-38e8-4e21-9bed-8bccb190abe8">1</ix:nonFraction>% and up to <ix:nonFraction unitRef="number" contextRef="ia25a711f34284d2cb31197de09c55937_I20210228" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTY5NA_a01e1cde-a7db-47fa-b4fe-83519329cc37">15</ix:nonFraction>% of an employee&#8217;s compensation for each payroll period, and no employee may purchase shares under the ESPP that exceeds $<ix:nonFraction unitRef="usd" contextRef="icd817f332517429098def9a226790157_D20210201-20210228" decimals="-3" format="ixt:num-dot-decimal" name="halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTgxNg_94ad2825-6fc9-4465-86e7-d497cac4bbf8">25,000</ix:nonFraction> worth of our common stock for a calendar year. As of September&#160;30, 2021, <ix:nonFraction unitRef="shares" contextRef="i96eaae6aa21440828363d019cc8fb175_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTg3Ng_6733c58f-cbc1-4708-b5d3-45ac7205a196">2,700,000</ix:nonFraction> shares were available for future purchase. The offering period is generally for a <ix:nonNumeric contextRef="icd817f332517429098def9a226790157_D20210201-20210228" format="ixt-sec:durwordsen" name="halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ1Nw_5dfbe192-8248-4bd2-ae04-633b163f11a4">six-months</ix:nonNumeric> period and the first offering period commenced on June 16, 2021. Offering periods shall commence on or about the sixteenth day of June and December of each year and end on or about the fifteenth day of the next December and June respectively, occurring thereafter.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4399ff67856a4743af40dc89e83f81d0"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ2NA_aa9564c2-a0b3-458f-9f02-d9f4fdcd3645" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized estimated compensation cost by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):</span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:70.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.246%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized<br/>Expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining<br/>Weighted-Average<br/>Recognition Period<br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc8bb9a58ee4f22a7917709a47d0c11_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfMi0yLTEtMS0w_f72de4a6-1884-4a73-8326-5630266140d4">22,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfMi00LTEtMS0w_9b95f7fa-e25a-470f-9191-e0675f6f54ab">2.42</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied5a4b70c0d2418886012876813052b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNC0yLTEtMS0w_a0f0cc2c-934a-4998-8be2-52ffc1ee5109">20,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNC00LTEtMS0w_f9b270c0-52b8-49c5-bbb5-3502a4c50527">2.28</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a10b0624cac49329813b37fc11aefe5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNS0yLTEtMS0w_66173d8a-cf3a-4a0f-9693-967a972ff78c">2,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i21bf5baccc98495a841b685c19034c72_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNS00LTEtMS0w_795eae64-e06e-43d5-a23c-58b8165a7bdc">2.00</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c625f6452334fda92249e711cf8c8e6_I20210930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNi0yLTEtMS0w_e09749aa-453f-4ee9-bb06-85a62235846a">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie68b30dcf1104c92bfe3cf876434fc97_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNi00LTEtMS0w_0cbec9e7-afa1-4da0-a5f6-54f2b9c482ab">0.21</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjQwMw_b1315c96-bfcc-4ca5-aa66-8675e7a0fe0e" continuedAt="i53cc9721fe844383a85dc30725960ae4" escape="true">Stockholders&#8217; Equity </ix:nonNumeric></span></div><ix:continuation id="i53cc9721fe844383a85dc30725960ae4"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, we issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfOTQ_35f85c7b-d265-4f0d-9889-9a9e9ffe1357">931,749</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTAx_e25272c1-ca07-46b6-bb1a-b36fef38d021">3,952,311</ix:nonFraction> shares of common stock, respectively, in connection with the exercises of stock options at a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjMy_3a9fe837-6a5f-429a-b4b2-7d880b09447e">13.81</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjM5_036eace3-f694-45ca-8cf9-9ad2d0639074">13.54</ix:nonFraction> per share, respectively, for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzAx_d01d4fb9-37e4-4efb-a7fc-c335fbdca724">12.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzA4_04b51850-7d80-4777-bcbd-5f57f114787f">53.5</ix:nonFraction> million, respectively. For the nine months ended September&#160;30, 2021 and 2020, we issued <ix:nonFraction unitRef="shares" contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzcx_2633b2a7-69f0-4f90-b1d6-60c6c537de85">297,696</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzc4_07c03528-f87b-464b-96a5-68b6b21f503c">569,701</ix:nonFraction> shares of common stock, respectively, upon vesting of certain RSUs and PSUs for which <ix:nonFraction unitRef="shares" contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNDY3_eb4b28b7-1ed7-42e9-8481-a888528e0d5b">94,795</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNDc0_7a14176b-1575-4350-9685-3b2eed8a8a76">142,905</ix:nonFraction> RSUs were withheld from the RSU holders, respectively, to pay for minimum withholding taxes totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNTky_b367d4ce-28fa-4c73-97b7-b1ba00df372c">8.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNTk5_cc5662d4-2482-4aa8-af6f-b5f4a37b87f8">5.4</ix:nonFraction> million, respectively. Stock options and unvested restricted units totaling approximately <ix:nonFraction unitRef="shares" contextRef="ic605063c80bb49dd8a2679393c11b629_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNjg0_ee4f5a45-018e-4b4b-a906-a2f11c65b336">6.3</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i96692b1d30124ac7860fc3b510b76971_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNjk4_ddbcd555-00e6-4ebc-8123-bace1ffd2cdd">6.7</ix:nonFraction> million shares of our common stock were outstanding as of September&#160;30, 2021 and December&#160;31, 2020, respectively. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we announced that the Board of Directors has authorized the initiation of a capital return program to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="ie0eb7b940b8b45069c49b5e764d38ad3_I20191130" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfOTMy_889093e0-c9e2-4651-b6d5-6509a6187851">550.0</ix:nonFraction> million of outstanding common stock over a <ix:nonNumeric contextRef="i0bc7c027cf8d468087b67594cb81b7d1_D20191101-20191130" format="ixt-sec:durwordsen" name="us-gaap:StockRepurchaseProgramPeriodInForce1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjQwNA_6fd03a59-b3bb-4082-90f7-2a5be412f12f">three-year</ix:nonNumeric> period. We may utilize a variety of methods including open market purchases, privately negotiated transactions, accelerated share repurchase programs or any combination of such methods. The Board will regularly review this capital return program in connection with a balanced capital allocation strategy. During 2019, we repurchased approximately <ix:nonFraction unitRef="shares" contextRef="i04b761c127644a42b2eb23927abd636d_D20190101-20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTMyNQ_484e524b-a560-4a3a-a88f-35fdb379d69f">11.1</ix:nonFraction>&#160;million shares of common stock for $<ix:nonFraction unitRef="usd" contextRef="i04b761c127644a42b2eb23927abd636d_D20190101-20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTM1NQ_bc31a7b2-608a-44fd-bc25-5eb60671418e">200.0</ix:nonFraction>&#160;million at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i04b761c127644a42b2eb23927abd636d_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTM4MQ_1a2fda70-7a63-4474-9c1a-4b1dd5c1208b">18.03</ix:nonFraction>. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, we repurchased <ix:nonFraction unitRef="shares" contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTQxNA_e2006d39-0b69-4106-b797-d460f8c06a25">6.5</ix:nonFraction>&#160;million shares of common stock for $<ix:nonFraction unitRef="usd" contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTQ0NA_32275efd-ee22-41da-b637-5568f352026c">150.0</ix:nonFraction>&#160;million at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTQ3MA_c9e87a13-a1ca-417e-975d-2b1965b9474e">23.05</ix:nonFraction>. The shares were purchased through open market transactions and through an Accelerated Share Repurchase (ASR) agreement with Bank of America in December 2020, for which we repurchased $<ix:nonFraction unitRef="usd" contextRef="i74563819caa746e7b4b7466ded794e9c_D20201201-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTY1Nw_86dff983-1ac5-4eff-9fe1-5f7bafb45d6a">21.7</ix:nonFraction>&#160;million of common stock and received <ix:nonFraction unitRef="shares" contextRef="i482105c008be423fb640367ac9200980_D20201201-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTY4OQ_a6981f6e-2b52-42e4-a0f2-e81d1155c976">0.5</ix:nonFraction>&#160;million shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2021, we entered into an ASR agreement with Bank of America to repurchase $<ix:nonFraction unitRef="usd" contextRef="i233725c2ad55441fb034d230594f0b46_D20210201-20210228" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTc4Nw_a6fd0f40-bcbe-49d4-89fb-ce27d959f9c6">75.0</ix:nonFraction>&#160;million of common stock. At inception, pursuant to the agreement, we paid $<ix:nonFraction unitRef="usd" contextRef="i233725c2ad55441fb034d230594f0b46_D20210201-20210228" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTg1Ng_b312d5b3-2fe5-46c5-af13-13238a2f9576">75.0</ix:nonFraction>&#160;million to Bank of America and took an initial delivery of <ix:nonFraction unitRef="shares" contextRef="id4ffcc29926a492a9b8cfa96fed2704b_D20210201-20210228" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTkxMA_54f663c4-997c-4eef-b6b6-d2f0429511ca">1.3</ix:nonFraction>&#160;million shares. In April 2021, we finalized the transaction and received an additional <ix:nonFraction unitRef="shares" contextRef="i188943ac07244920b82f0519b3031931_D20210415-20210415" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTk5Mg_0977df58-ef69-4416-bdd5-6b8ce076f00c">0.5</ix:nonFraction>&#160;million shares. We retired the repurchased shares and they resumed the status of authorized and unissued shares.</span></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjQxMQ_818743ff-33f7-458e-9683-6d32eb724737" escape="true"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had the following activity under the approved share repurchase programs (dollars in thousands, except share and per share data):</span></div><div style="margin-top:10pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:44.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Price paid Per Share</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMi0yLTEtMS0w_305f7a06-5b0f-471d-908c-76534a671bac">1,775,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMi00LTEtMS0w_3cec7f73-00d4-4276-936d-6709e47948f4">42.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMi02LTEtMS0w_baf25660-ca1c-4779-97ea-a5ba274c4a19">76,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMy0yLTEtMS0w_882d7eb1-2b09-41f3-b72d-938a4ba021c9">1,037,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMy00LTEtMS0w_97be3ebf-8e0f-4c5e-ba03-27710aeb2aa2">47.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMy02LTEtMS0w_912618b7-a7fa-4c61-888c-ff77c634bef2">48,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNC0yLTEtMS0w_b82bb0b7-04aa-4e73-85d3-01392a5b5999">1,562,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNC00LTEtMS0w_5caa77fa-017c-4e26-ac5c-b18b6913d1c3">41.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNC02LTEtMS0w_9e1bafc5-1eb4-4bab-9b28-e9f2ad65e4d1">64,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNi0yLTEtMS0w_49984bc0-8939-41cd-b81d-b7b5696fb25c">4,376,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNi00LTEtMS0w_4cdf04f6-1ca4-44a4-a2ca-5834a59db668">43.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNi02LTEtMS0w_58b8e1c0-e7c0-4375-ac40-881424550f4b">189,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Included in the total cost of shares purchased is a commission fee of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331" decimals="2" name="halo:TreasuryStockAcquiredFeeCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjMwOA_fda04152-6edc-41a0-a634-18e254dd0689">0.02</ix:nonFraction> per share.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) This includes <ix:nonFraction unitRef="shares" contextRef="i188943ac07244920b82f0519b3031931_D20210415-20210415" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjM0MA_50ab1b62-b777-47a4-be82-58a5aa0ded21">0.5</ix:nonFraction>&#160;million shares delivered in April upon completion of the ASR.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RleHRyZWdpb246ZTA5NzZkMGRkYTU5NDEyMmI1ZWFlOWZhODljMmI5NzlfMTY1MQ_31815e65-97ff-487b-b9a0-a585b93703fd" continuedAt="icaadc5c662f04fb7991c928a66ebf706" escape="true">Net Income per share</ix:nonNumeric></span></div><ix:continuation id="icaadc5c662f04fb7991c928a66ebf706" continuedAt="ieaf3deeb52574120b39bc6517dd4301a"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per common share is computed by dividing net income for the period by the weighted average number of common shares outstanding during the period, without consideration for common stock equivalents. Outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and the Convertible Notes are considered common stock equivalents and are only included in the calculation of diluted earnings per common share when net income is reported and their effect is dilutive. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares issuable upon vesting of stock options, RSAs, RSUs and PSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our Convertible Notes are determined using the if-converted method. Since we have committed to settle the principal amount of the Convertible Notes in cash upon conversion only, the number of shares for the conversion spread will be included as a dilutive common stock equivalent. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RleHRyZWdpb246ZTA5NzZkMGRkYTU5NDEyMmI1ZWFlOWZhODljMmI5NzlfMTY1NA_bb9bbca6-6e31-46c4-a0b5-2679870437e5" continuedAt="ia7e9735d61ba4c12a2873726c28dc0b5" escape="true">A reconciliation of the numerators and the denominators of the basic and diluted net income per common share computations is as follows (in thousands, except per share amounts):</ix:nonNumeric></span></div><div style="margin-top:11pt;text-align:center;text-indent:24.75pt"><ix:continuation id="ia7e9735d61ba4c12a2873726c28dc0b5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:57.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.563%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy0yLTEtMS0w_f11ae758-873e-4bda-9b0a-7888b9bbb374">216,587</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy00LTEtMS0w_329f599b-c7d0-4ad3-bb61-2dbf5918e2e7">36,207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy02LTEtMS0w_626e0e05-9fb4-4e0d-a667-35c5ccb104dc">335,940</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy04LTEtMS0w_d13ab8d4-bddf-4e82-a298-72bc927072da">55,921</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for basic net income per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS0yLTEtMS0w_5aa26652-2b5b-4dce-8aee-43431dc31258">142,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS00LTEtMS0w_03a4e9d7-68ef-4b97-9edb-dfd3e3ceaa91">136,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS02LTEtMS0w_19d1fb97-b697-4467-bc9d-78d4014c04c7">140,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS04LTEtMS0w_3dcca941-63af-4b71-8931-71910f4d45f8">136,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie22bc32765cc456cb791da8766cc1e95_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy0yLTEtMS0w_e35f08a1-b4cd-4770-a276-18b12ca44392">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i991a03f67f0b48beb763927b3126b6ee_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy00LTEtMS0w_7214d9f4-e2fc-47b7-bd63-fdc0d6cf171c">2,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy02LTEtMS0w_e57835d2-6333-4f97-84ea-3ba74c917026">2,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy04LTEtMS0w_b6ba2833-e950-4edb-aee5-bd0b6cc92f0d">1,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs, RSUs, PSUs and ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02b22b0c2f2646bea792472d7f97d94f_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC0yLTEtMS0w_7f497fa1-8e2e-4586-8d53-877997bde7fc">437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i241b7f6a84b54adbb1af7e7476c1b810_D20200701-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC00LTEtMS0w_ceafca04-6d14-42d2-be06-814c2b5df976">553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5299df71ad7b40699940776b16949966_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC02LTEtMS0w_cf166f9b-8995-4902-aade-e8bac31a7116">571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9a61b1b587a4aad9bbfecff6ad6f475_D20200101-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC04LTEtMS0w_2217548b-dec8-4863-b6c0-a88924dd5391">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i065050ada4e544a2be29ac40313d14cf_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS0yLTEtMS0w_db70ae39-4bf9-4562-b87c-e61a69627ab9">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia011b61b43c242d5a1e03e0cb7b02a60_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS00LTEtMS0w_02d8ef65-a01f-434f-9554-98aface8daf1">2,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bf62165ab9948da9eaf8cd763bd074a_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS02LTEtMS0w_5833365e-39de-42eb-a167-34440c0daed3">3,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67b1f1cb883146f9a922816ce4291811_D20200101-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS04LTEtMS0w_bea30e4e-b13a-47ff-a236-e7e74893abf0">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for diluted net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtMi0xLTEtMA_24a81ac4-0229-49c9-a6db-7509f420a72c">146,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtNC0xLTEtMA_91ade34e-fea6-47ae-bc74-7c6f17f3fe6c">142,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtNi0xLTEtMA_7e28f680-154a-412f-ad30-7ffdec31cd47">147,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtOC0xLTEtMA_fec2b9ea-5862-47d5-b907-ebe01a35d51e">139,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItMi0xLTEtMA_f9c2c0f4-e969-4768-8587-876bd23278ff">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItNC0xLTEtMA_871a3ce4-9474-4f7f-b7ea-c8192f337efa">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItNi0xLTEtMA_43fd443f-ab8c-4977-aa91-959ff2eb1c1b">2.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItOC0xLTEtMA_97609c10-6ead-4130-a7a6-d0ff93f6ea02">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtMi0xLTEtMA_115a7135-0b05-495b-b460-a2823c4fffcb">1.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtNC0xLTEtMA_280269a5-4e89-4380-b0f6-3bd869b54a3d">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtNi0xLTEtMA_f25f84ad-dfc4-4ba4-8986-f0046c50146a">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtOC0xLTEtMA_12cdb829-7377-48b3-9d06-06291d07d305">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RleHRyZWdpb246ZTA5NzZkMGRkYTU5NDEyMmI1ZWFlOWZhODljMmI5NzlfMTY1NQ_41a78ee1-a122-459d-8864-aa2a6547cc1c" continuedAt="i5c1a9ff876e44386967a6d73cb12710f" escape="true"><div style="margin-top:11pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares which have been excluded from the calculation of diluted net income per common share because their effect was anti-dilutive, include the following (shares in millions):</span></div><div style="margin-top:11pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:56.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.805%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.805%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi0yLTEtMS0w_b917dd43-5a46-43b6-a052-d4bb40873999">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi0zLTEtMS0w_a2c70059-354e-4ea0-b8b2-676a600f2592">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi01LTEtMS0w_1b7c844c-d2d8-4657-bf7a-47617a111038">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi03LTEtMS0w_8600931d-bb3a-43d2-b57f-3087d2c25125">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieaf3deeb52574120b39bc6517dd4301a"><ix:continuation id="i5c1a9ff876e44386967a6d73cb12710f">(1). The anti-dilutive securities include outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and Convertible Notes</ix:continuation></ix:continuation>.</span></div><div style="height:90pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RleHRyZWdpb246YjM3MWZlY2Q1NTc3NGFhOGE4YzE0MTc4ZjVkYzQ0NTNfMTMwOA_53f0f1ef-eea9-477c-aa88-9b98a0971aac" continuedAt="i0003800c39684f838eb5a06706f17d3d" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i0003800c39684f838eb5a06706f17d3d" continuedAt="i766a6e975f404655aa1f9960e8e8501e"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be involved in disputes, including litigation, relating to claims arising out of operations in the normal course of our business. Any of these claims could subject us to costly legal expenses and, while we generally believe that we have adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage or our policy limits may be inadequate to fully satisfy any damage awards or settlements. If this were to happen, the payment of any such awards could have a material adverse effect on our consolidated results of operations and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and business. We currently are not a party to any legal proceedings, the adverse outcome of which, in management&#8217;s opinion, individually or in the aggregate, would have a material adverse effect on our consolidated results of operations or financial position.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments include payments related to our commenced operating leases. <ix:nonNumeric contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RleHRyZWdpb246YjM3MWZlY2Q1NTc3NGFhOGE4YzE0MTc4ZjVkYzQ0NTNfMTMxNQ_c25294c3-70b0-45e0-a44b-9b2b54f5fa81" continuedAt="i6a01a9147905455d942aed1a6ab4617d" escape="true">Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands; excluding the nine months ended September&#160;30, 2021):</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i6a01a9147905455d942aed1a6ab4617d" continuedAt="i207b4bef10834b48ada71a47053ce3fa">&#160;</ix:continuation></span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i207b4bef10834b48ada71a47053ce3fa"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:84.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Year:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfMS0yLTEtMS0w_fd2777be-b3fe-483c-81d4-f5c85d4a4727">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfMi0yLTEtMS0w_cacad39f-a170-4a4e-84ea-7e5e526a9336">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfMy0yLTEtMS0w_8836b36d-7ec8-4e03-bb95-5f042cbaefb8">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNC0yLTEtMS0w_611f89ec-a2b1-4a65-9125-3abca6376e3a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNS0yLTEtMS0w_ad649a3b-f69b-43f1-857e-5e1f6264090f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNi0yLTEtMS0w_5440df44-7a1e-4e5f-ace0-ff3845d97096">3,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNy0yLTEtMS0w_cd19d65b-2c24-41a1-a959-088b70fffebc">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfOC0yLTEtMS0w_d1b779cb-3e41-458f-a142-788200433565">3,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i766a6e975f404655aa1f9960e8e8501e">The weighted-average remaining lease term of our operating leases is approximately <ix:nonNumeric contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RleHRyZWdpb246YjM3MWZlY2Q1NTc3NGFhOGE4YzE0MTc4ZjVkYzQ0NTNfMTI5Nw_c2c7dffc-d075-4419-8066-313c31d51bc0">1.4</ix:nonNumeric> years.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_82"></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> used in this report, unless the context suggests otherwise, references to &#8220;Halozyme,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; and &#8220;us&#8221; refer to Halozyme Therapeutics, Inc., its wholly owned subsidiary, Halozyme, Inc. and Halozyme Inc.&#8217;s wholly owned subsidiaries, Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH. References to &#8220;Notes&#8221; refer to the Notes to Condensed Consolidated Financial Statements included herein (refer to Item 1 of Part I).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following information should be read in conjunction with the interim unaudited condensed consolidated financial statements and Notes thereto included in Item&#160;1 of this Quarterly Report on Form 10-Q, as well as the audited financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations for the fiscal year ended December&#160;31, 2020, included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020. Past financial or operating performance is not necessarily a reliable indicator of future performance, and our historical performance should not be used to anticipate results or future period trends.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This report contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this report other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221; &#8220;estimate,&#8221; &#8220;think,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; &#8220;potential,&#8221; &#8220;likely,&#8221; &#8220;opportunity,&#8221; &#8220;project&#8221; and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this report. Additionally, statements concerning future matters such as the development or regulatory approval of new partner products, enhancements of existing products or technologies, timing and success of the launch of new products by our collaborators, third party performance under key collaboration agreements, the ability of our bulk drug manufacturers to provide adequate supply for our collaboration partners, revenue, expense and cash burn levels, anticipated amounts and timing of share repurchases, anticipated profitability and expected trends, the potential impact of the COVID-19 global pandemic on our business and trends and other statements regarding matters that are not historical are forward-looking statements. Such statements reflect management&#8217;s current forecast of certain aspects of our future, are based on currently available operating, financial and competitive information and are subject to various risks, uncertainties and assumptions that could cause actual results to differ materially from those anticipated or implied in our forward-looking statements due to a number of factors including, but not limited to, those set forth below under the section entitled &#8220;Risks Factors&#8221; and elsewhere in this Quarterly Report on Form 10-Q and our most recent Annual Report on Form 10-K. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme Therapeutics, Inc. is a biopharma technology platform company that provides innovative and disruptive solutions with the goal of improving patient experience and outcomes. Our proprietary enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. We license our technology to biopharmaceutical companies to collaboratively develop products that combine our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology with the collaborators&#8217; proprietary compounds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approved product and our collaborators&#8217; approved products and product candidates are based on rHuPH20, our patented recombinant human hyaluronidase enzyme. rHuPH20 is the active ingredient in our first commercially approved product, Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recombinant, and it works by breaking down hyaluronan (or HA), a naturally occurring carbohydrate that is a major component of the extracellular matrix in tissues throughout the body such as skin and cartilage. This temporarily increases dispersion and absorption allowing for improved subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other large therapeutic molecules, as well as small molecules and fluids. We refer to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology (ENHANZE). We license the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. In the development of proprietary intravenous (IV) drugs combined with our ENHANZE technology, data have been generated supporting the potential for ENHANZE to reduce treatment burden, as a result of shorter duration of subcutaneous (SC) administration. ENHANZE may enable fixed-dose SC dosing compared to weight-based dosing required for IV administration, and potentially allow for lower rates of infusion-related reactions. ENHANZE may enable more flexible treatment options such as home administration by a healthcare professional or potentially the patient. Lastly, certain proprietary drugs co-formulated with ENHANZE have been granted additional exclusivity, extending the patent life of the product beyond the one of the proprietary IV drug.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have ENHANZE collaborations with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc. (Roche), Baxalta US Inc. and Baxalta GmbH (members of the Takeda group of companies) (Baxalta), Pfizer Inc. (Pfizer), Janssen Biotech, Inc. (Janssen), AbbVie, Inc. (AbbVie), Eli Lilly and Company (Lilly), Bristol Myers Squibb Company (BMS), Alexion Pharma Holding (AstraZeneca PLC announced the completion of its acquisition of Alexion Pharmaceuticals, Inc. in July 2021) (Alexion), argenx BVBA (argenx), Horizon Therapeutics plc. (Horizon) and ViiV Healthcare (the global specialist HIV company majority owned by GlaxoSmithKline) (ViiV). We receive royalties from three of these collaborations, including royalties from sales of one product from the Baxalta collaboration, three products from the Roche collaboration and one product from the Janssen collaboration. Future potential revenues from royalties and fees from ENHANZE collaborations and the sales and/or royalties of our approved products will depend on the ability of Halozyme and our collaborators to develop, manufacture, secure and maintain regulatory approvals for approved products and product candidates and commercialize product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our third quarter of 2021 and recent key events are as follows:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaborators</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October 2021, Janssen&#8217;s DARZALEX FASPRO&#174; was approved by the China National Medical Products Administration (NMPA) for the treatment of primary light chain amyloidosis, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) in newly diagnosed patients. This followed a similar approval Janssen Pharmaceutical K.K. received in August 2021 from Japan&#8217;s Ministry of Health, Labour and Welfare for DARZQURO&#174; (Daratumumab SC) for the additional indication of systemic AL amyloidosis. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2021, Janssen elected the target HIV reverse transcriptase, resulting in a $2.0 million milestone fee.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2021, we announced that Janssen received FDA approval for DARZALEX FASPRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with pomalidomide and dexamethasone (D-Pd) for patients with multiple myeloma after first or subsequent relapse.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the third quarter of 2021 we repurchased 1.6 million shares of common stock in open market purchases for $64.7 million at an average price per share of $41.40. In October 2021, we repurchased an additional 0.3 million shares of common stock for $10.3 million, completing our capital return program that began in November 2019 to repurchase up to $550.0 million of outstanding common stock over a three-year period. Under the program we repurchased a total of 22.3 million shares for $550.0 million at an average price per share of $24.72. </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product and Product Candidates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have one marketed proprietary product and five marketed partnered products. The following table summarizes our proprietary product, marketed partnered products and product candidates under development with our collaborators:</span></div><div style="margin-top:9pt;text-align:center;text-indent:18pt"><img src="halo-20210930_g1.jpg" alt="halo-20210930_g1.jpg" style="height:387px;margin-bottom:5pt;vertical-align:text-bottom;width:610px"/></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:22.5pt"><img src="halo-20210930_g2.jpg" alt="halo-20210930_g2.jpg" style="height:400px;margin-bottom:5pt;vertical-align:text-bottom;width:595px"/></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proprietary Product</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hylenex Recombinant (hyaluronidase human injection)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hylenex recombinant is a formulation of rHuPH20 that facilitates subcutaneous fluid administration for achieving hydration, to increase the dispersion and absorption of other injected drugs and, in subcutaneous urography, to improve resorption of radiopaque agents. Hylenex recombinant is currently the number one prescribed branded hyaluronidase. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ENHANZE Collaborations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Roche Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2006, we and Roche entered into a collaboration and license agreement under which Roche obtained a worldwide license to develop and commercialize product combinations of rHuPH20 and up to thirteen Roche target compounds (the Roche Collaboration). Under this agreement, Roche elected a total of eight targets, two of which are exclusive. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2013, Roche launched a subcutaneous (SC) formulation of Herceptin (trastuzumab) (Herceptin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC) in Europe for the treatment of patients with HER2-positive breast cancer followed by launches in additional countries. This formulation utilizes our ENHANZE technology and is administered in two to five minutes, compared to 30 to 90 minutes with the standard intravenous form. In September 2018, we announced that Roche received approval from Health Canada for Herceptin SC for the treatment of patients with HER2-positive breast cancer. In February 2019, we announced that Roche received approval from the FDA for Herceptin SC under the brand name Herceptin Hylecta&#8482; (trastuzumab and hyaluronidase-oysk). In April 2019, Roche made Herceptin Hylecta available in the U.S. In June 2020, the FDA approved a fixed-dose combination of Perjeta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (pertuzumab) and Herceptin for subcutaneous injection (Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) utilizing ENHANZE technology for the treatment of patients with HER2-positive breast cancer. In December 2020, the European Commission (EC) also approved Phesgo for the treatment of patients with early and metastatic HER2-positive breast cancer.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2014, Roche launched MabThera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC in Europe for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL) followed by launches in additional countries. This formulation utilizes our ENHANZE technology and is administered in approximately five minutes compared to the approximately 1.5 to 4 hour intravenous infusion. In May 2016, Roche announced that the European Medicines Agency (EMA) approved Mabthera SC to treat patients with chronic lymphocytic leukemia (CLL). In June 2017, the FDA approved Genentech&#8217;s RITUXAN HYCELA&#8482;, a combination of rituximab using ENHANZE technology (approved and marketed under the MabThera SC brand in countries outside the U.S. and Canada), for CLL and two types of NHL, follicular lymphoma and diffuse large B-cell lymphoma. In March 2018, Health Canada approved a combination of rituximab and rHuPH20 (approved and marketed under the brand name RITUXAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC) for patients with CLL.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2017, we and Roche entered into an agreement providing Roche the right to develop and commercialize one additional exclusive target using ENHANZE technology. The upfront license payment may be followed by event-based payments subject to Roche&#8217;s achievement of specified development, regulatory and sales-based milestones. In addition, Roche will pay royalties to us if products under the collaboration are commercialized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, we entered into an agreement with Roche for the right to develop and commercialize one additional exclusive target and an option to select two additional targets within four years using ENHANZE technology. The upfront license payment may be followed by event-based payments subject to Roche&#8217;s achievement of specified development, regulatory and sales-based milestones. In addition, Roche will pay royalties to us if products under the collaboration are commercialized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, Roche initiated a Phase 1b/2 study in patients with non-small cell lung cancer for TECENTRIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  (atezolizumab) using ENHANZE technology. In September 2020, Roche presented a poster with data from Part 1 of its Phase 1b study (IMscin001) evaluating TECENTRIQ for subcutaneous administration utilizing ENHANZE technology in patients with locally advanced or metastatic non-small cell lung cancer at the ESMO Virtual Congress 2020. The poster concluded that atezolizumab utilizing ENHANZE technology provided similar exposure as atezolizumab IV and that results support further development of subcutaneous atezolizumab in IMscin001 Part 2, a confirmatory Phase 3 study. In December 2020, Roche initiated a Phase 3 study in patients with non-small cell lung cancer for TECENTRIQ using ENHANZE technology.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, Roche initiated a Phase 1 study evaluating OCREVUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ocrelizumab) with ENHANZE technology in subjects with multiple sclerosis. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, Roche nominated a new undisclosed target to be studied using ENHANZE technology, triggering a $10 million milestone payment. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Baxalta Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2007, we and Baxalta entered into a collaboration and license agreement under which Baxalta obtained a worldwide, exclusive license to develop and commercialize product combinations of rHuPH20 with GAMMAGARD LIQUID (HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (the Baxalta Collaboration). HYQVIA is indicated for the treatment of primary immunodeficiency disorders associated with defects in the immune system.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2013, the European Commission granted Baxalta marketing authorization in all EU Member States for the use of HYQVIA (solution for subcutaneous use) as replacement therapy for adult patients with primary and secondary immunodeficiencies. Baxalta launched HYQVIA in the first EU country in July 2013 and has continued to launch in additional countries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2014, HYQVIA was approved by the FDA for treatment of adult patients with primary immunodeficiency in the U.S. HYQVIA is the first subcutaneous immune globulin (IG) treatment approved for adult primary immunodeficiency patients with a dosing regimen requiring only one infusion up to once per month (every three to four weeks) and one injection site per infusion in most patients, to deliver a full therapeutic dose of IG. The FDA&#8217;s approval of HYQVIA was a significant milestone for us as it represented the first U.S. approved BLA which utilizes our rHuPH20 platform. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2016, Baxalta announced that HYQVIA received a marketing authorization from the European Commission for a pediatric indication, which was launched in Europe to treat primary and certain secondary immunodeficiencies. In September 2020, Takeda announced that the EMA approved a label update for HYQVIA broadening its use and making it the first and only facilitated subcutaneous immunoglobulin replacement therapy in adults, adolescents and children with an expanded range of secondary immunodeficiencies (SID).</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2012, we and Pfizer entered into a collaboration and license agreement, under which Pfizer has the worldwide license to develop and commercialize products combining our rHuPH20 enzyme with Pfizer proprietary biologics in primary care and specialty care indications. Pfizer has elected five targets and has returned two targets. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Janssen Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, we and Janssen entered into a collaboration and license agreement, under which Janssen has the worldwide license to develop and commercialize products combining our rHuPH20 enzyme with Janssen proprietary biologics directed to up to five targets. Targets may be selected on an exclusive basis. Janssen has elected CD38 as the first target on an exclusive basis. Janssen has initiated several Phase 3 studies, Phase 2 studies and Phase 1 studies of DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(daratumumab), directed at CD38, using ENHANZE technology in patients with amyloidosis, smoldering myeloma and multiple myeloma.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In February 2019, Janssen&#8217;s development partner, Genmab, announced positive Phase 3 trial results from the COLUMBA study evaluating subcutaneous DARZALEX in comparison to intravenous DARZALEX in patients with relapsed or refractory multiple myeloma. DARZALEX SC (utilizing ENHANZE technology) was found to be non-inferior to DARZALEX IV with regard the co-primary endpoints of Overall Response Rate and Maximum Trough concentration. In May 2020, we announced that Janssen received US FDA approval and launched the commercial sale of DARZALEX FASPRO in four regimens across five indications in multiple myeloma patients, including newly diagnosed, transplant-ineligible patients as well as relapsed or refractory patients. As a fixed-dose formulation, DARZALEX FASPRO can be administered over three to five minutes, significantly less time than DARZALEX IV which requires multi-hour infusions. In June 2020, we announced that Janssen received European marketing authorization and launched the commercial sale of DARZALEX SC utilizing ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in the European Union.  In March 2021, Janssen announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for the subcutaneous formulation of DARZALEX (known as DARZQURO in Japan) for the treatment of multiple myeloma, and in May 2021 Janssen commenced commercial sale in Japan.  In July 2021, Janssen received FDA approval for DARZALEX FASPRO in combination with pomalidomide and dexamethasone (D-Pd) for patients with multiple myeloma after first or subsequent relapse. In January 2021, Janssen received FDA approval for DARZALEX FASPRO in combination with bortezomib, thalidomide, and dexamethasone in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant. In January 2021, Janssen received accelerated approval from the FDA for DARZALEX FASPRO in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed AL amyloidosis (not recommended for the treatment of patients with AL amyloidosis who have NYHA Class IIIB or Class IV cardiac disease or Mayo Stage IIIB outside of controlled clinical trials). In June 2021, we announced that Janssen received marketing authorization from the EC for DARZALEX SC in two new indications, in combination with D-VCd in newly diagnosed adult patients with AL amyloidosis and in combination with D-Pd in adult patients with relapsed or refractory multiple myeloma. In July 2021, Janssen received FDA approval for DARZALEX FASPRO in combination with D-Pd for patients with multiple myeloma after first or subsequent relapse. In August 2021, Janssen received approval of DARZQURO (Daratumumab SC) for systemic AL amyloidosis in Japan. In October 2021, Janssen&#8217;s DARZALEX FASPRO was approved by the China National Medical Products Administration (NMPA) for the treatment of primary light chain amyloidosis, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) in newly diagnosed patients.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, Janssen elected EGFR and cMET as a bispecific antibody (amivantamab) target on an exclusive basis, which is being studied in solid tumors. In November 2020, Janssen initiated a Phase 1 study of amivantamab and ENHANZE. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, Janssen elected the target HIV reverse transcriptase.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AbbVie Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2015, we and AbbVie entered into a collaboration and license agreement, under which AbbVie has the worldwide license to develop and commercialize products combining our rHuPH20 enzyme with AbbVie proprietary biologics directed to up to nine targets. Targets may be selected on an exclusive basis. AbbVie elected one target on an exclusive basis, TNF alpha, for which it has discontinued development and returned the target.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lilly Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015, we and Lilly entered into a collaboration and license agreement, under which Lilly has the worldwide license to develop and commercialize products combining our rHuPH20 enzyme with Lilly proprietary biologics directed to up to five targets. Targets may be selected on an exclusive basis. Lilly has elected two targets on an exclusive basis and one target on a semi-exclusive basis. In August 2017, Lilly initiated a Phase 1 study of an investigational therapy in combination with rHuPH20.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BMS Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In September 2017, we and BMS entered into a collaboration and license agreement, which became effective in November 2017, under which BMS has the worldwide license to develop and commercialize products combining our rHuPH20 enzyme with BMS products directed at up to eleven targets. Targets may be selected on an exclusive basis; BMS has selected eight targets to-date. BMS has designated multiple immuno-oncology targets including programmed death 1 (PD-1) and has an option to select 3 additional targets by November 2022. In October 2018, BMS dosed the first patient in a Phase 1/2a study  of BMS-986179, an  anti-CD-73 antibody, alone and in combination with nivolumab, using ENHANZE technology. In October 2019, BMS initiated a Phase 1 study of relatlimab, an anti-LAG-3 antibody, in combination with nivolumab using ENHANZE technology. In April 2021, BMS initiated a Phase 1/2 study of BMS-986258, an anti-TIM-3 antibody, alone and in combination with nivolumab in advanced malignant tumors. In June 2021, BMS initiated a Phase 3 study of nivolumab using ENHANZE technology for patients with advanced or metastatic clear cell renal cell carcinoma, leveraging data and insights from Phase 1/2 CA209-8KX study in patients with solid tumors.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Alexion Collaboration </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, we and Alexion entered into a collaboration and license agreement, under which Alexion has the worldwide license to develop and commercialize products combining our rHuPH20 enzyme with Alexion&#8217;s portfolio of products directed at up to four targets. Targets may be selected on an exclusive basis. Alexion elected two targets on an exclusive basis, including a C5 complement inhibitor and has an option to select two additional targets within five years from the effective date. In August 2018, Alexion announced that it initiated a Phase 1 trial to study a next-generation subcutaneous formulation of ALXN1210 using ENHANZE technology (ALXN1810). Following a portfolio prioritization, Alexion has made the decision to discontinue the further development of&#160;ALXN1810. In addition, Alexion has initiated a Phase I study of ALXN1720, a novel anti-C5 albumin-binding bispecific mini-body, in combination with ENHANZE technology.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">argenx Collaboration </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we and argenx entered into an agreement for the right to develop and commercialize one exclusive target, the human neonatal Fc receptor, FcRn, which includes argenx's lead asset efgartigimod (ARGX-113), and an option to select two additional targets using ENHANZE technology. In May 2019, argenx nominated a second target to be studied using ENHANZE technology, a human complement factor C2 associated with the product candidate ARGX-117, which is being developed to treat severe autoimmune diseases in Multifocal Motor Neuropathy (MMN).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, argenx dosed the first subject in a phase 1 clinical trial evaluating the safety, pharmacokinetics and pharmacodynamics of efgartigimod (ARGX-113), using ENHANZE technology. In December 2019, argenx reported that based on data from the phase 1 study and internal company analysis, a one minute injection administered every 2 weeks may be possible. In December 2020, argenx initiated a Phase 3 study of ARGX-113 using ENHANZE technology for patients with immune thrombocytopenia (ITP), an immune disorder in which the blood does not  clot normally. In January 2021, argenx initiated a Phase 3 study of ARGX-113 using ENHANZE technology in pemphigus vulgaris and foliaceus (PV), a rare autoimmune disease that causes painful blisters on the skin and mucous membranes.  In February 2021, argenx initiated a Phase 3 study of ARGX-113 using ENHANZE technology for patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and initiated a Phase 3 study of ARGX-113 using ENHANZE technology in myasthenia gravis (MG), an autoimmune disorder of the musculoskeletal system caused by IgG autoantibodies. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we and argenx entered into agreement to expand the collaboration relationship. Under the newly announced expansion, argenx gained the ability to exclusively access our ENHANZE technology for three additional targets upon nomination for a total of up to six targets under the existing and newly expanded collaboration. </span></div><div style="margin-top:4pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Horizon Collaboration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we and Horizon entered into a global collaboration and license agreement that gives Horizon exclusive access to ENHANZE technology for subcutaneous formulation of medicines targeting IGF-1R. Horizon intends to use ENHANZE to develop a SC formulation of TEPEZZA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (teprotumumab-trbw), indicated for the treatment of thyroid eye disease, a serious, progressive and vision-threatening rare autoimmune disease, potentially shortening drug administration time, reducing healthcare practitioner time and offering additional flexibility and convenience for patients. In March 2021, Horizon completed dosing in a Phase 1 study exploring the SC formulation of TEPEZZA. The trial is a small, single-dose Phase 1 pharmacokinetic trial which includes evaluating ENHANZE technology for a SC formulation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ViiV Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we entered into a global collaboration and license agreement with ViiV. The license gives ViiV exclusive access to our ENHANZE technology for four specific small and large molecule targets for the treatment and prevention of HIV. These targets are integrase inhibitors, reverse transcriptase inhibitors limited to nucleoside reverse transcriptase inhibitors (NRTI) and nucleoside reverse transcriptase translocation inhibitors (NRTTIs), capsid inhibitors and broadly neutralising monoclonal antibodies (bNAbs), that bind to the gp120 CD4 binding site.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NIH CRADA</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, we announced a Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases&#8217; Vaccine Research Center (VRC), part of National Institute of Health (NIH), enabling the VRC&#8217;s use of ENHANZE technology to develop subcutaneous formulations of VRC07-523LS and N6LS broadly neutralizing antibodies (bnAbs) against HIV for HIV treatment. In March 2021, we were notified that the first patient was dosed with N6LS and rHuPH20 in VRC 609 Phase 1 dose-escalation study to evaluate safety, tolerability, and pharmacokinetics of N6LS using ENHANZE technology.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAPRISA</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a collaboration with the Centre for the AIDS Programme of Research in South Africa (CAPRISA), a non-profit company, to evaluate safety, tolerability and pharmacokinetics of a human monoclonal antibody (CAP256V2LS) in HIV-negative and HIV-positive women in South Africa. In October 2020, we were notified that the first patient was dosed with CAP256V2LS and rHuPH20 in CAPRISA 012B Phase 1 dose-escalation study to evaluate safety, tolerability, and pharmacokinetics of CAPR256V2LS alone and in combination with VRC07-523LS using ENHANZE technology. In January 2021, we were notified the first patient was dosed with CAP256V2LS and rHuPH20 in combination with VRC07-523LS and rHuPH20 in CAPRISA 012B Phase 1 study. VRC07-523LS broadly neutralizing antibody was supplied by the NIH/VRC under a research collaboration with CAPRISA.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a further discussion of the collaboration agreements, refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 to our Business</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In March 2020, the World Health Organization declared a disease caused by a strain of novel coronavirus (&#8220;COVID-19&#8221;) to be a pandemic. In an effort to contain COVID-19 or slow its spread, governments around the world have enacted various measures, including orders to close all businesses not deemed &#8220;essential,&#8221; isolate residents to their homes or places of residence, and practice social distancing when engaging in essential activities. In an effort to protect the health and safety of our employees and in compliance with state regulations, we instituted working from home, limited the number of people that work on site at any one time, and suspended employee travel. As an organization we continue to effectively operate with the majority of our employees working from home and not traveling. Importantly, our suppliers continue to operate without interruption related to COVID-19. We recognize that the duration of the pandemic and its continued impact on the global economy as a whole remains unknown at this time. We are not clear the extent to which long term operational and economic impacts of COVID-19, if any, will have on our business, including the effects on our suppliers, collaborators, customers, employees, and prospects. We will continue to monitor the&#160;COVID-19&#160;situation closely.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2021 Compared to Three Months Ended September&#160;30, 2020 </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Royalty revenue was $58.6 million for the three months ended September&#160;30, 2021 compared to $23.9 million for the three months ended September&#160;30, 2020. The increase was mainly driven by sales of DARZALEX FASPRO in the U.S and EU by Janssen due to the product launch in the second quarter of 2020, partially offset by slightly lower sales of Herceptin SC and MabThera SC by Roche. In general, we expect royalty revenue to grow as a result of our recent ENHANZE partner product launches, offsetting the ongoing impact from biosimilars in Europe related to our mature ENHANZE partner products.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Product sales, net were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:55.255%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of bulk rHuPH20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of Hylenex</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product sales, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net increased by $16.0 million in the three months ended September&#160;30, 2021 compared to the same period in 2020, primarily due to higher sales of rHuPH20 to our partners Janssen and Roche. We expect that product sales of bulk rHuPH20 will fluctuate in future periods based on the needs of our collaborators. We expect future product sales of Hylenex to be relatively flat as we experience modest market growth offset by competition for market share. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues Under Collaborative Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Revenues under collaborative agreements were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:55.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront license fees, license fees for the election of additional targets, <br/>&#160;&#160;&#160;&#160;&#160;license maintenance fees and other license fees and event-based<br/>&#160;&#160;&#160;&#160;&#160;payments:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Janssen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roche</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">argenx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,220&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,337&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from license fees for the three months ended September&#160;30, 2021, were comparable to the same period in 2020. Revenue from upfront licenses fees, license fees for the election of additional targets, license maintenance fees and other license fees and event-based payments vary from period to period based on our ENHANZE collaboration activity. We expect these revenues to continue to fluctuate in future periods based on our collaborators&#8217; ability to meet various clinical and regulatory milestones set forth in such agreements and our ability to obtain new collaborative agreements. To date, based on current partner communications, we have not identified any COVID-19 related delays that will materially impact our ENHANZE milestone revenue. We will continue to monitor the ENHANZE development activities of our partners and the impact of their plans on our milestone revenue, as there may be potential for COVID-19 related delays.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Product Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of product sales consists primarily of raw materials, third-party manufacturing costs, fill and finish costs, freight costs, internal costs and manufacturing overhead associated with the production of Hylenex recombinant and bulk rHuPH20. Cost of product sales were $18.6 million for the three months ended September&#160;30, 2021 compared to $5.6 million for the three months ended September&#160;30, 2020. The increase of $13.0 million in cost of product sales was mainly due to an increase in sales of bulk rHuPH20 to Janssen and Roche.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Research and development expenses consist of external costs, salaries and benefits and allocation of facilities and other overhead expenses related to research manufacturing, preclinical and regulatory activities related to our ENHANZE collaborations and our rHuPH20 platform. Research and development expenses were $8.5 million for the three months ended September&#160;30, 2021 compared to $7.7 million for the three months ended September&#160;30, 2020. The increase of $0.8 million is primarily due to an increase in compensation expense, including share-based compensation, for personnel to support additional ENHANZE targets entering clinical development.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:3pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative (SG&amp;A) expenses consist primarily of salaries and related costs for personnel in executive, selling and administrative functions as well as professional fees for legal and accounting, business development, commercial operations support for Hylenex and alliance management and marketing support for ENHANZE. SG&amp;A expenses were $13.2 million for the three months ended September&#160;30, 2021 compared to $11.7 million for the three months ended September&#160;30, 2020. The increase of $1.5 million, or 13%, was primarily due to  an increase in compensation expense, including share-based compensation, for personnel to support additional ENHANZE targets entering clinical development.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Interest expense was $1.8 million for the three months ended September&#160;30, 2021 compared to $5.0 million for the three months ended September&#160;30, 2020. The decrease of $3.2 million was primarily due to a decrease in interest expense related to the Convertible Notes as the non-cash interest expense associated with the amortization of the equity component of the Convertible Notes is eliminated upon adoption of ASU 2020-06.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Income tax benefit was $142.5 million for the three months ended September 30, 2021, compared to income tax expense of  $0.1 million for the three months ended September&#160;30, 2020. The increase in income tax benefit is due to the release of the valuation allowance during the current quarter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September&#160;30, 2021 Compared to Nine Months Ended September&#160;30, 2020 </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Royalty revenue was $141.3 million for the nine months ended September&#160;30, 2021 compared to $56.6 million for the nine months ended September&#160;30, 2020. The increase was mainly driven by sales of DARZALEX FASPRO in the U.S and EU by Janssen due to the product launch in the second quarter of 2020, partially offset by slightly lower sales of Herceptin SC and MabThera SC by Roche. In general, we expect royalty revenue to grow as a result of our recent ENHANZE partner product launches, offsetting the ongoing impact from biosimilars in Europe related to our mature ENHANZE partner products.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Product sales, net were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:55.255%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of bulk rHuPH20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of Hylenex</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product sales, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,173&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,532&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,641&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales, net increased by $53.6 million in the nine months ended September&#160;30, 2021 compared to the same period in 2020, primarily due to higher sales of rHuPH20 to our partners Janssen, Roche and argenx. We expect that product sales of bulk rHuPH20 will fluctuate in future periods based on the needs of our collaborators. We expect that future product sales of Hylenex to be relatively flat as we experience modest market growth offset by competition for market share. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues Under Collaborative Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Revenues under collaborative agreements were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:55.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront license fees, license fees for the election of additional targets, <br/>&#160;&#160;&#160;&#160;&#160;license maintenance fees and other license fees and event-based<br/>&#160;&#160;&#160;&#160;&#160;payments:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Janssen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ViiV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BMS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roche</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">argenx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursements for research and development services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from license fees increased $57.2 million in the nine months ended September&#160;30, 2021, compared to the same period in 2020 mainly due to the recognition of a total of $122.0 million related to the ViiV, BMS and Janssen collaborations in the current year. Revenue from upfront licenses fees, license fees for the election of additional targets, license maintenance fees and other license fees and event-based payments vary from period to period based on our ENHANZE collaboration activity. We expect these revenues to continue to fluctuate in future periods based on our collaborators&#8217; ability to meet various clinical and regulatory milestones set forth in such agreements and our ability to obtain new collaborative agreements. To date, based on current partner communications, we have not identified any COVID-19 related delays that will materially impact our ENHANZE milestone revenue. We will continue to monitor the ENHANZE development activities of our partners and the impact of their plans on our milestone revenue, as there may be potential for COVID-19 related delays.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Product Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of product sales consists primarily of raw materials, third-party manufacturing costs, fill and finish costs, freight costs, internal costs and manufacturing overhead associated with the production of Hylenex recombinant and bulk rHuPH20. Cost of product sales were $59.8 million for the nine months ended September&#160;30, 2021 compared to $17.1 million for the nine months ended September&#160;30, 2020. The increase of $42.7 million in cost of product sales was mainly due to an increase in sales of bulk rHuPH20 to Janssen, Roche and argenx.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses consist of external costs, salaries and benefits and allocation of facilities and other overhead expenses related to research manufacturing, preclinical and regulatory activities related to our ENHANZE collaborations and our rHuPH20 platform. Research and development expenses were $25.6 million for the  nine months ended September&#160;30, 2021 compared to $26.9 million for the nine months ended September&#160;30, 2020. The decrease of $1.3 million is primarily due to the discontinuation of our development activities for PEGPH20 and closure of our oncology operations, partially offset by an increase in  costs to support additional ENHANZE targets entering clinical development.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative (SG&amp;A) expenses consist primarily of salaries and related costs for personnel in executive, selling and administrative functions as well as professional fees for legal and accounting, business development, commercial operations support for Hylenex and alliance management and marketing support for ENHANZE. SG&amp;A expenses were $36.5 million for the nine months ended September&#160;30, 2021 compared to $35.3 million for the nine months ended September&#160;30, 2020. The increase of $1.2 million, or 4%, was primarily due to an increase in compensation expense, including share-based compensation, for personnel to support additional ENHANZE targets entering clinical development, partially offset by one time costs in the prior year related to the  discontinuation of our development activities for PEGPH20 and closure of our oncology operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Interest expense was $5.5 million for the nine months ended September&#160;30, 2021 compared to $15.3 million for the nine months ended September&#160;30, 2020. The decrease of $9.8 million was primarily due to a decrease in interest expense related to the Convertible Notes as the non-cash interest expense associated with the amortization of the equity component of the Convertible Notes is eliminated upon adoption of ASU 2020-06 and discontinuation in interest expense for the Royalty-backed Loan following the repayment of that obligations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Income tax benefit was $142.2 million for the nine months ended September&#160;30, 2021, compared to income tax expense of $0.1 million for the nine months ended September&#160;30, 2020. The increase in income tax benefit is due to the release of the valuation allowance during the current quarter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity are our existing cash, cash equivalents and available-for-sale marketable securities. As of September&#160;30, 2021, we had cash, cash equivalents and marketable securities of $815.9 million. We believe that our current cash, cash equivalents and marketable securities will be sufficient to fund our operations for at least the next twelve months. We expect to fund our operations going forward with existing cash resources, anticipated revenues from our existing collaborations and cash that we may raise through future transactions. We may raise cash through any one of the following financing vehicles: (i) new collaborative agreements; (ii) expansions or revisions to existing collaborative relationships; (iii) private financings; (iv) other equity or debt financings; (v) monetizing assets; and/or (vi) the public offering of securities;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, in the future, offer and sell additional equity, debt securities and warrants to purchase any of such securities, either individually or in units to raise capital to raise funds for additional working capital, capital expenditures, share repurchases, acquisitions or for other general corporate purposes. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operations was $216.9 million for the nine months ended September&#160;30, 2021 compared to $4.5 million cash provided in the nine months ended September&#160;30, 2020. The $212.4 million increase in cash provided by operations was mainly due to an increase in collaboration partner license fees, royalties and product sales and a decrease in working capital spend during the nine months ended September&#160;30, 2021 compared to the corresponding period in the prior year. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $106.8 million for the nine months ended September&#160;30, 2021 compared to $19.9 million cash provided by investing activities for the nine months ended September&#160;30, 2020. The increase in cash used in investing activities was primarily due to an increase in purchase of marketable securities for the nine months ended September&#160;30, 2021. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $233.9 million for the nine months ended September&#160;30, 2021, compared to $78.9 million cash used in by financing activities for the nine months ended September&#160;30, 2020, mainly due to $784.9 million cash received from the 2027 Convertible Notes offering and $19.6 million cash payment for the Royalty-backed loan in the prior year, partially offset by $369.1 million related to the Induced Conversion of the 2024 Convertible Notes, $79.8 million increase in repurchase of common stock and a $42.4 million decrease in net proceeds from the issuance of common stock under equity incentive plans.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the Board of Directors approved a share repurchase program, pursuant to which we may repurchase our issued and outstanding shares of common stock from time to time. The Company retired the repurchased shares. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 8. Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, within the notes to the consolidated financial statements for additional information regarding our share repurchases. In October 2021, we repurchased the remaining shares that had been authorized for repurchase under our November 2019 share repurchase program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.25% Convertible Notes due 2027</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we completed the sale of $805.0&#160;million in aggregate principal amount of 0.25% Convertible Senior Notes due 2027 (the &#8220;2027 Convertible Notes&#8221; and collectively with the 2024 Convertible Notes the &#8220;Convertible Notes&#8221;). The net proceeds in connection with the 2027 Convertible Notes, after deducting the initial purchasers&#8217; fee of $20.1&#160;million, was approximately $784.9&#160;million. We also incurred additional debt issuance costs totaling $0.4&#160;million. Debt issuance costs and the initial purchasers&#8217; fee are presented as a debt discount.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2027 Convertible Notes pay interest semi-annually in arrears on March 1st and September 1st of each year at an annual rate of 0.25%. The 2027 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2027 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indebtedness and other liabilities (including trade payables) of our current or future subsidiaries. The 2027 Convertible Notes have a maturity date of March 1, 2027.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2027 Convertible Notes at their option only in the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021, if the last reported sale price per share of  common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 5 consecutive trading day period (such 5 consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on our common stock, as described in the offering memorandum for the 2027 Convertible Notes; (4) if we call such notes for redemption; and (5) at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately before the maturity date. The Notes will be convertible, regardless of the foregoing circumstances, at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately preceding the maturity date. As of September&#160;30, 2021, the 2027 Convertible Notes are not convertible.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, we will pay cash for the settlement of principal and for the premium, if applicable, we will pay cash, deliver shares of common stock or a combination of cash and shares of common stock, at our election. The initial conversion rate for the 2027 Convertible Notes is 12.9576 shares of common stock per $1,000 in principal amount of 2027 Convertible Notes, equivalent to a conversion price of approximately $77.17 per share of our common stock. The conversion rate is subject to adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.25% Convertible Notes due 2024</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed the sale of $460.0 million in aggregate principal amount of 1.25% Convertible Senior Notes due 2024 (&#8220;2024 Convertible Notes&#8221;). The net proceeds in connection with the issuance of the 2024 Convertible Notes, after deducting the initial purchasers&#8217; fee of $12.7&#160;million, was approximately $447.3 million. We also incurred debt issuance cost totaling $0.3&#160;million. Debt issuance costs and the initial purchasers&#8217; fee are presented as a debt discount.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Convertible Notes pay interest semi-annually in arrears on June 1st and December 1st of each year, beginning on June 1, 2020, at an annual rate of 1.25%. The 2024 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2024 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of the our current or future subsidiaries. The 2024 Convertible Notes have a maturity date of December 1, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2024 Convertible Notes at their option only in the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on March&#160;31, 2020, if the last reported sale price per share of common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2)&#160;during the ### consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3)&#160;upon the occurrence of certain corporate events or distributions on our common stock, as described in the offering memorandum for the 2024 Convertible Notes; (4)&#160;if we call such notes for redemption; and (5)&#160;at any time from, and including, June&#160;1, 2024 until the close of business on the scheduled trading day immediately before the maturity date. As of September&#160;30, 2021, the 2024 Convertible Notes are convertible.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021 we notified the note holders our irrevocable election to settle the principal of the 2024 Convertible Notes in cash and for the premium, if applicable, deliver shares of common stock. The conversion rate for the 2024 Convertible Notes is 41.9208 shares of common stock per $1,000 in principal amount of 2024 Convertible Notes, equivalent to a conversion price of approximately $23.85 per share of our common stock. The conversion rate is subject to adjustment. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we completed a privately negotiated and induced conversion of $369.1 million principal amount of the 2024 Convertibles (&#8220;Note Repurchases&#8221; or the &#8220;Induced Conversion&#8221;). In connection with the Induced Conversion, we paid approximately $370.2&#160;million in cash, which includes principal and accrued interest, and issued approximately 9.08&#160;million shares of our common stock representing the intrinsic value based on the contractual conversion rate and incremental shares as an inducement for conversion. As a result of the Induced Conversion, we recorded $21.0 million in induced conversion expense which is included in Other income (expense) of the Condensed Consolidated Statements of Operations for the three months </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended September&#160;30, 2021. The induced conversion expense represents the fair value of the common stock issued upon conversion in excess of the common stock issuable under the original terms of the 2024 Convertible Notes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalty-backed Loan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, through our wholly-owned subsidiary Halozyme Royalty LLC (Halozyme Royalty), we received a $150 million loan (the Royalty-backed Loan) pursuant to a credit agreement (the Credit Agreement) with BioPharma Credit Investments IV Sub, LP and Athyrium Opportunities II Acquisition LP (the Royalty-backed Lenders). Under the terms of the Credit Agreement, Halozyme Therapeutics, Inc. transferred to Halozyme Royalty the right to receive royalty payments from the commercial sales of ENHANZE products owed under the Roche Collaboration and Baxalta Collaboration (Collaboration Agreements). The royalty payments from the Collaboration Agreements were used to repay the principal and interest on the loan (the Royalty Payments). The Royalty-backed Loan bore interest at a per annum rate of 8.75% plus the three-month LIBOR rate. The three-month LIBOR rate was subject to a floor of 0.7% and a cap of 1.5%.  In June 2020, we paid the full remaining balance and final payment of $2.93 million thereby satisfying and discharging all obligations under, and terminating, the Royalty-backed Loan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we did not engage in trading activities involving non-exchange traded contracts. As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. The preparation of our condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in Note 2 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020. The accounting policies and estimates that are most critical to a full understanding and evaluation of our reported financial results are described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Item 7 of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020. Except for the release during the three months ended September&#160;30, 2021 of our valuation allowance related to federal and state deferred tax assets (which, as described more fully in Note 2 to our condensed consolidated financial statements, resulted in a benefit from income taxes of 142.5 million), there were no material changes to our critical accounting policies or estimates during the nine months ended September&#160;30, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of our condensed consolidated financial statements for a discussion of recent accounting pronouncements and their effect, if any.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related To Our Business</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business interruptions resulting from the COVID-19 outbreak or similar public health crises could cause a disruption of the development of our collaboration partners&#8217; product candidates and commercialization of approved products, impede our ability to supply bulk rHuPH20 to our partners or procure and sell Hylenex and otherwise adversely impact our business and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public health crises such as pandemics or similar outbreaks could adversely impact our business and results of operations by, among other things, disrupting the development of our collaboration partners&#8217; product candidates and commercialization of our partners&#8217; approved products, disrupting our ability to enter into new ENHANZE collaborations with potential partners in a timely manner, causing disruptions in the operations of our third party contract manufacturing organizations upon whom we rely for the production and supply of our commercial product Hylenex and the bulk rHuPH20 we supply to our partners, and causing other disruptions to our operations. &#160;For example, the outbreak of a coronavirus, which causes COVID-19, has rapidly evolved into a global pandemic and has spread to most regions of the world including the city of San Diego, California where our main office is located.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures. The extent to which COVID-19 and its variants impacts our operations and/or those of our collaboration partners will depend on future developments, which are highly uncertain and unpredictable, including the duration or recurrence of the outbreak, additional or modified government actions, new information that will emerge concerning the severity and impact of COVID-19 and the actions to contain COVID-19 or address its impact in the short and long term, among others.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have responded to the COVID-19 pandemic by taking a number of actions including closing our offices in San Diego in March 2020, requesting that most of our personnel work remotely and restricting access to our facilities mostly to personnel who perform critical activities that must be completed on-site in accordance with California&#8217;s initial statewide shelter-in-place order and ongoing guidances. Increased reliance on personnel working from home may have a negative impact on productivity, or disrupt, delay or otherwise adversely impact business, by, among other things, increasing cyber security risk, impeding access to information that would be helpful to pursue our business objectives or disrupting our communications. We are continuing to monitor the situation to determine the timing for all employees to return to working from the office.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business disruptions associated with a global pandemic could impact the business, product development priorities and operations of our collaboration partners, including potential delays in manufacturing their product candidates or approved products.  For example, some of our collaboration partners are conducting or are planning to conduct clinical trials in geographies affected by the COVID-19 pandemic.  The progress or completion of these clinical trials could be adversely impacted by the pandemic. Additionally, interruption or delays in the operations of the FDA, the EMA and other similar foreign regulatory agencies, or changes in regulatory priorities to focus on the COVID-19 pandemic, may affect required regulatory review, inspection, clearance and approval timelines.  Disruptions such as these could result in delays in the development programs of our collaboration products or impede the commercial efforts for approved products, resulting in potential reductions or delays in our revenues from collaborator royalty or milestone payments.  We do not know the extent to which our collaboration partners&#8217; development programs or product commercialization efforts will be impacted or delayed.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third party manufacturers to manufacture the bulk rHuPH20 that we supply to our collaboration partners for their commercial products and product candidates, as well as our commercial product Hylenex. If any such third party manufacturer is adversely impacted by the COVID-19 pandemic and related consequences, including staffing shortages, production slowdowns and disruptions in delivery systems, availability of raw materials, reagents or components or if they divert resources or manufacturing capacity to accommodate the development of coronavirus treatments or vaccines, our supply chain may be disrupted, limiting our ability to sell Hylenex or supply bulk rHuPH20 to our collaboration partners. Any such disruptions could result in reductions or delays in our revenues.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of COVID-19 could worsen in countries that are already afflicted with the coronavirus which could further adversely impact our ability to conduct our business and could have a material adverse impact on our operations, financial condition and results. We do not yet know the full extent of the impact that COVID-19 may or will have on our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the&#160;trading&#160;prices for our common shares and other biopharmaceutical companies have been highly volatile as a result of market and investor reactions to the COVID-19 pandemic and its potential consequences. As a result, access to sources of financing, should those be needed, may be more difficult and/or expensive. In addition, a recession, depression or other sustained adverse market event resulting from the spread of the coronavirus could materially and adversely affect our business and the value of our common shares.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have generated only limited revenues to date and we have a history of net losses and negative cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relative to expenses incurred in our operations, we have generated only limited revenues from product sales, royalties, licensing fees, milestone payments, bulk rHuPH20 supply payments and research reimbursements to date. Through September&#160;30, 2021, we have incurred aggregate net losses of $125.7 million. Although we expect to maintain sustainable profitability, unexpected declines in revenues and increases in expenses could inhibit our ability to sustain profitability.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If partners&#8217; product candidates do not receive and maintain regulatory approvals, or if approvals are not obtained in a timely manner, such failure or delay would substantially impair our ability to generate revenues.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval from the FDA or equivalent health authorities is necessary to manufacture and market pharmaceutical products in the U.S. and the other countries in which we anticipate doing business have similar requirements. The process for obtaining FDA and other regulatory approvals is extensive, time-consuming, risky and costly, and there is no guarantee that the FDA or other regulatory bodies will approve any applications that may be filed with respect to any of our partners&#8217; product candidates, or that the timing of any such approval will be appropriate for the desired product launch schedule for a product candidate. We and our collaborators attempt to provide guidance as to the timing for the filing and acceptance of such regulatory approvals, but such filings and approvals may not occur when we or our collaborators expect, or at all. The FDA or other foreign regulatory agency may refuse or delay approval of our partners&#8217; product candidates for failure to collect sufficient clinical or animal safety data and require our collaborators to conduct additional clinical or animal safety studies which may cause lengthy delays and increased costs to our partners&#8217; development programs. Any such issues associated with rHuPH20 could have an adverse impact on future development of our partners&#8217; products which include rHuPH20, future sales of Hylenex recombinant, or our ability to maintain our existing collaborations or enter into new collaborations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our collaborators may not be successful in obtaining approvals for any additional potential products in a timely manner, or at all. Refer to the risk factor titled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our collaboration product candidates may not receive regulatory approvals or their development may be delayed for a variety of reasons, including delayed or unsuccessful clinical trials, regulatory requirements or safety concerns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information relating to the approval of product candidates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, even with respect to products which have been approved for commercialization, in order to continue to manufacture and market pharmaceutical products, we or our collaborators must maintain our regulatory approvals. If we or any of our collaborators are unsuccessful in maintaining our regulatory approvals, our ability to generate revenues would be adversely affected.</span></div><div style="margin-top:6pt;padding-left:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Hylenex and the products and product candidates of our partners&#8217; could be associated with side effects or adverse events.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with most pharmaceutical products, use of Hylenex and the products and product candidates of our collaborators could be associated with side effects or adverse events which can vary in severity (from minor reactions to death) and frequency (infrequent or prevalent). Side effects or adverse events associated with the use of Hylenex and the products or product candidates of our collaborators may be observed at any time, including in clinical trials or when a product is commercialized, and any such side effects or adverse events may negatively affect our or our collaborators&#8217; ability to obtain or maintain regulatory approval or market such products and product candidates. Side effects such as toxicity or other safety issues associated with the use of Hylenex and the products and product candidates of our collaborators could require us or our collaborators to perform additional studies or halt development or commercialization of these products and product candidates or expose us to product liability lawsuits which will harm our business. For example, we experienced a clinical hold on patient enrollment and dosing in our phase 2 study of PEGPH20 in patients with PDA (a discontinued program), which was not resolved until we implemented steps to address an observed possible difference in TE event rates between the arms of the study. We or our collaborators may be required by regulatory agencies to conduct additional animal or human studies regarding the safety and efficacy of our pharmaceutical products or product candidates which we have not planned or anticipated. Furthermore, there can be no assurance that we or our collaborators will resolve any issues related to any product or product candidate side effects or adverse events to the satisfaction of the FDA or any regulatory agency in a timely manner or ever, which could harm our business, prospects and financial condition.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our contract manufacturers or vendors are unable to manufacture and supply to us bulk rHuPH20 or other raw materials, reagents or components in the quantity and quality required by us or our collaborators for use in the production of Hylenex or our partners&#8217; products and product candidates, our Hylenex commercialization efforts or our partners&#8217; product development and commercialization efforts could be delayed or stopped and our business results of operations and our collaborations could be harmed.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have existing supply agreements with contract manufacturing organizations Avid Bioservices, Inc. (Avid) and Catalent  Indiana LLC (Catalent) to produce bulk rHuPH20.&#160;These manufacturers each produce bulk rHuPH20 under cGMP for use in Hylenex recombinant, and for use in collaboration products and product candidates. We rely on their ability to successfully manufacture bulk rHuPH20 according to product specifications. In addition to supply obligations, our contract manufacturers will also provide support for the chemistry, manufacturing and controls sections for FDA and other regulatory </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filings. We also rely on vendors to supply us with raw materials to produce reagents and other materials for bioanalytical assays used to support our partners&#8217; clinical trials. We also have a commercial manufacturing and supply agreement with Patheon under which Patheon provides the final fill and finishing steps in the production process of Hylenex recombinant. If any of our contract manufacturers or vendors: (i) is unable to retain its status as an FDA approved manufacturing facility; (ii) is unable to otherwise successfully scale up bulk rHuPH20 production to meet corporate or regulatory authority quality standards;  (iii) is unable to procure raw materials, reagents or components necessary to produce bulk rHuPH20, Hylenex recombinant or our bioanalytical assays or (iv) fails to manufacture and supply bulk rHuPH20 in the quantity and quality required by us or our collaborators for use in Hylenex and collaboration products and product candidates for any other reason, our business will be adversely affected. In addition, a significant change in such parties&#8217; or other third party manufacturers&#8217; business or financial condition could adversely affect their abilities to fulfill their contractual obligations to us. We have not established, and may not be able to establish, favorable arrangements with additional bulk rHuPH20 manufacturers and suppliers of the ingredients necessary to manufacture bulk rHuPH20 should the existing manufacturers and suppliers become unavailable or in the event that our existing manufacturers and suppliers are unable to adequately perform their responsibilities. We have attempted to mitigate the impact of a potential supply interruption through the establishment of excess bulk rHuPH20 inventory where possible, but there can be no assurances that this safety stock will be maintained or that it will be sufficient to address any delays, interruptions or other problems experienced by any of our contract manufacturers. Any delays, interruptions or other problems regarding the ability of our contract manufacturers to supply bulk rHuPH20 or the ability of other third party manufacturers, to supply other raw materials or ingredients necessary to produce our products on a timely basis could: (i) cause the delay of our partners&#8217; clinical trials or otherwise delay or prevent the regulatory approval of our partners&#8217; product candidates; (ii) delay or prevent the effective commercialization of Hylenex or collaboration products and product candidates; and/or (iii) cause us to breach contractual obligations to deliver bulk rHuPH20 to our collaborators. Such delays would likely damage our relationship with our collaborators, and they would have a material adverse effect on royalties and thus our business and financial condition. Additionally, we rely on third parties to manufacture, prepare, fill, finish, package, store and ship our product and partners&#8217; product candidates on our behalf. If the third parties we identify fail to perform their obligations, the progress of partners&#8217; clinical trials could be delayed or even suspended and the commercialization of our product and partner products could be delayed or prevented.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or any party to a key collaboration agreement fail to perform material obligations under such agreement, or if&#160;a key collaboration agreement, is terminated for any reason, our business could significantly suffer.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple collaboration agreements under which we may receive significant future payments in the form of milestone payments, target designation fees, maintenance fees and royalties. We are heavily dependent on our collaborators to develop and commercialize product candidates subject to our collaborations in order for us to realize any financial benefits from these collaborations. Our collaborators may not devote the attention and resources to such efforts that we would ourselves, change their clinical development plans, promotional efforts or simultaneously develop and commercialize products in competition to those products we have licensed to them. Any of these actions could not be visible to us immediately and could negatively impact our ability to forecast and our ability to achieve the benefits and revenue we receive from such collaboration. In addition, in the event that a party fails to perform under a key collaboration agreement, or if a key collaboration agreement is terminated, the reduction in anticipated revenues could negatively impact our operations. In addition, the termination of a key collaboration agreement by one or more of our collaborators could have a material adverse impact on our ability to enter into additional collaboration agreements with new collaborators on favorable terms, if at all. In certain circumstances, the termination of a key collaboration agreement would require us to revise our corporate strategy going forward and reevaluate the applications and value of our technology.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hylenex and our partners&#8217; products and product candidates rely on the rHuPH20 enzyme, and any adverse development regarding rHuPH20 could substantially impact multiple areas of our business, including current and potential collaborations, as well as any proprietary programs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rHuPH20 is a key technological component of Hylenex and our ENHANZE technology and most of our collaboration products and product candidates, including the current and future products and product candidates under our ENHANZE collaborations. If there is an adverse development for rHuPH20 (e.g., an adverse regulatory determination relating to rHuPH20, if we are unable to obtain sufficient quantities of rHuPH20, if we are unable to obtain or maintain material proprietary rights to rHuPH20 or if we discover negative characteristics of rHuPH20), multiple areas of our business, including current and potential collaborations, as well as proprietary programs would be substantially impacted. For example, elevated anti-rHuPH20 antibody titers were detected in the registration trial for Baxalta&#8217;s HYQVIA product as well as in a former collaborator&#8217;s product in a Phase 2 clinical trial with rHuPH20, but have not been associated, in either case, with any adverse events. We monitor for antibodies to rHuPH20 in our collaboration and proprietary programs, and although we do not believe at this time that the incidence of non-neutralizing anti-rHuPH20 antibodies in either the HYQVIA program or the former collaborator&#8217;s program will have a significant impact on our proprietary product and our partners&#8217; product and product candidates, there can be no assurance that there will not be other such occurrences in the foregoing programs or that concerns regarding these antibodies </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will not also be raised by the FDA or other health authorities in the future, which could result in delays or discontinuations of our Hylenex commercialization activities, the development or commercialization activities of our partners, or deter our entry into additional collaborations with third parties. </span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business strategy and our strategic focus is currently limited to only a few fields or applications of our technology which may increase the risk for potential negative impact from adverse developments. Future expansion of our strategic focus to additional applications of our technology may require the use of additional resources, result in increased expense and ultimately may not be successful.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We routinely evaluate our business strategy, and may modify this strategy in the future in light of our assessment of unmet medical needs, growth potential, resource requirements, regulatory issues, competition, risks and other factors. As a result of these strategic evaluations, we may focus our resources and efforts on one or a few programs or fields and may suspend or reduce our efforts on other programs and fields. For example, in the fourth quarter of 2019, we decided to focus our resources on our ENHANZE technology and our commercial product, Hylenex. By focusing on these areas, we increase the potential impact on us if one of those partner programs does not successfully complete clinical trials, achieve commercial acceptance or meet expectations regarding sales and revenue. We may also expand our strategic focus by seeking new therapeutics applications of our technology which may require the use of additional resources, increased expense and would require the attention of senior management. There can be no assurance that any such investment of resources would ultimately result in additional approved collaboration products or commercial success of new therapeutic applications of our technology.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our collaboration product candidates may not receive regulatory approvals or their development may be delayed for a variety of reasons, including delayed or unsuccessful clinical trials, regulatory requirements or safety concerns.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical testing of pharmaceutical products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage, including the patient enrollment stage. Even if initial results of preclinical and nonclinical studies or clinical trial results are promising, our collaborators may obtain different results in subsequent trials or studies that fail to show the desired levels of dose safety and efficacy, or our collaborators may not obtain applicable regulatory approval for a variety of other reasons. Preclinical, nonclinical, and clinical trials for collaboration product candidates could be unsuccessful, which would delay or preclude regulatory approval and commercialization of the product candidates. In the U.S. and other jurisdictions, regulatory approval can be delayed, limited or not granted for many reasons, including, among others:</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">during the course of clinical studies, the final data may differ from initial reported data, and clinical results may not meet prescribed endpoints for the studies or otherwise provide sufficient data to support the efficacy of our collaborators&#8217; product candidates;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical and nonclinical test results may reveal inferior pharmacokinetics, side effects, adverse events or unexpected safety issues associated with the use of our collaborators&#8217; product candidates;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory review may not find that the data from preclinical testing and clinical trials justifies approval;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may require that our partners change their studies or conduct additional studies which may significantly delay or make continued pursuit of approval commercially unattractive; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a regulatory agency may reject partner trial data or disagree with their interpretations of either clinical trial data or applicable regulations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a regulatory agency may require additional safety monitoring and reporting through Risk Evaluation and Mitigation Strategies or conditions to assure safe use programs;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a partner may decide to not pursue regulatory approval for such a product;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a regulatory agency may not approve our manufacturing processes or facilities, or the processes or facilities of our collaborators, our contract manufacturers or our raw material suppliers;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a regulatory agency may identify problems or other deficiencies in our existing manufacturing processes or facilities, or the existing processes or facilities of our collaborators, our contract manufacturers or our raw material suppliers; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a regulatory agency may change its formal or informal approval requirements and policies, act contrary to previous guidance, adopt new regulations or raise new issues or concerns late in the approval process; or</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a partner product candidate may be approved only for indications that are narrow or under conditions that place the product at a competitive disadvantage, which may limit the sales and marketing activities for such product candidate or otherwise adversely impact the commercial potential of a product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a collaboration product candidate is not approved in a timely fashion or obtained on commercially viable terms, or if development of any product candidate is terminated due to difficulties or delays encountered in the regulatory approval process, it could have a material adverse impact on our business, and we would become more dependent on the development of other collaboration product candidates and/or our ability to successfully acquire other technologies. There can be no assurances that any collaboration product candidate will receive regulatory approval in a timely manner, or at all. There can be no assurance that partners will be able to gain clarity as to the FDA&#8217;s requirements or that the requirements may be satisfied in a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercially feasible way, in which case our ability to enter into collaborations with third parties or explore other strategic alternatives to exploit an opportunity will be limited or may not be possible.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that certain collaboration products will be marketed, and perhaps manufactured, in foreign countries. The process of obtaining regulatory approvals in foreign countries is subject to delay and failure for the reasons set forth above, as well as for reasons that vary from jurisdiction to jurisdiction. The approval process varies among countries and jurisdictions and can involve additional testing. The time required to obtain approval may differ from that required to obtain FDA approval. Foreign regulatory agencies may not provide approvals on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one foreign regulatory authority does not ensure approval by regulatory authorities in other foreign countries or jurisdictions or by the FDA.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our third party collaborators are responsible for providing certain proprietary materials that are essential components of our collaboration products and product candidates, and any failure to supply these materials could delay the development and commercialization efforts for these collaboration products and product candidates and/or damage our collaborations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our development and commercialization collaborators are responsible for providing certain proprietary materials that are essential components of our collaboration products and product candidates. For example, Roche is responsible for producing the Herceptin and MabThera required for its subcutaneous products and Baxalta is responsible for producing the GAMMAGARD LIQUID for its product HYQVIA. If a collaborator, or any applicable third party service provider of a collaborator, encounters difficulties in the manufacture, storage, delivery, fill, finish or packaging of the collaboration product or product candidate or component of such product or product candidate, such difficulties could (i) cause the delay of clinical trials or otherwise delay or prevent the regulatory approval of collaboration product candidates; and/or (ii) delay or prevent the effective commercialization of collaboration products. Such delays could have a material adverse effect on our business and financial condition. </span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our collaborators fail to comply with regulatory requirements applicable to promotion, sale and manufacturing of approved products, regulatory agencies may take action against us or them, which could significantly harm our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any approved products, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for these products, are subject to continual requirements and review by the FDA, state and foreign regulatory bodies. Regulatory authorities subject a marketed product, its manufacturer and the manufacturing facilities to continual review and periodic inspections. We, our collaborators and our respective contractors, suppliers and vendors, will be subject to ongoing regulatory requirements, including complying with regulations and laws regarding advertising, promotion and sales of drug products, required submissions of safety and other post-market information and reports, registration requirements, cGMP regulations (including requirements relating to quality control and quality assurance, as well as the corresponding maintenance of records and documentation), and the requirements regarding the distribution of samples to physicians and recordkeeping requirements. Regulatory agencies may change existing requirements or adopt new requirements or policies. We, our collaborators and our respective contractors, suppliers and vendors, may be slow to adapt or may not be able to adapt to these changes or new requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, regulatory requirements applicable to pharmaceutical products make the substitution of suppliers and manufacturers costly and time consuming. We have minimal internal manufacturing capabilities and are, and expect to be in the future, entirely dependent on contract manufacturers and suppliers for the manufacture of our products and for their active and other ingredients. The disqualification of these manufacturers and suppliers through their failure to comply with regulatory requirements could negatively impact our business because the delays and costs in obtaining and qualifying alternate suppliers (if such alternative suppliers are available, which we cannot assure) could delay our partners&#8217; clinical trials or otherwise inhibit our or  partners&#8217; ability to bring approved products to market, which would have a material adverse effect on our business and financial condition. Likewise, if we, our collaborators and our respective contractors, suppliers and vendors involved in sales and promotion of our products do not comply with applicable laws and regulations, for example off-label or false or misleading promotion, this could materially harm our business and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with regulatory requirements may result in any of the following:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on our or our partners&#8217; products or manufacturing processes;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">warning letters;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of our or our partners&#8217; products from the market;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">voluntary or mandatory recall;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension or withdrawal of regulatory approvals;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension or termination of any of our partners&#8217; ongoing clinical trials;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to permit the import or export of our or our partners&#8217; products;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to approve pending applications or supplements to approved applications that we submit;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions; or</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">imposition of civil or criminal penalties. </span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need to raise additional capital in the future and there can be no assurance that we will be able to obtain such funds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to raise additional capital in the future to fund our operations and for general corporate purposes if revenues do not occur as expected. Our current cash reserves and expected revenues may not be sufficient for us to fund general operations and conduct our business at the level desired. In addition, if we engage in acquisitions of companies, products or technologies in order to execute our business strategy, we may need to raise additional capital. We may raise additional capital in the future through one or more financing vehicles that may be available to us including (i)&#160;new collaborative agreements;  (ii)&#160;expansions or revisions to existing collaborative relationships; (iii) private financings; (iv) other equity or debt financings; (v)&#160;monetizing assets; and/or (vi) the public offering of securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are required to raise additional capital in the future, it may not be available on favorable financing terms within the time required, or at all. If additional capital is not available on favorable terms when needed, we will be required to raise capital on adverse terms or significantly reduce operating expenses through the restructuring of our operations or deferral of strategic business initiatives. If we raise additional capital through a public offering of securities or equity, a substantial number of additional shares may be issued, which may negatively affect our stock price and these additional shares will dilute the ownership interest of our current investors.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently have significant debt and may incur additional debt. Failure by us to fulfill our obligations under the applicable debt agreements may cause the repayment obligations to accelerate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of our consolidated indebtedness, net of debt discount, as of&#160;September&#160;30, 2021&#160;was $875.7 million, which includes $90.9 million in aggregate principal amount of the 2024 Convertible Notes and $805.0 million in aggregate principal amount of the 2027 Convertible Notes, net of unamortized debt discount of $1.7 million and of $18.5 million, respectively. We also may incur additional indebtedness in the future. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indebtedness may:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it difficult for us to satisfy our financial obligations, including making scheduled principal and interest payments on our indebtedness;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds for working capital, capital expenditures, acquisitions or other general corporate purposes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to use our cash flow or obtain additional financing for future working capital, capital expenditures, acquisitions, share repurchases or other general business purposes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to use a portion of our cash flow from operations to make debt service payments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility to plan for, or react to, changes in our business and industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our less leveraged competitors; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to the impact of adverse economic and industry conditions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make payments on our existing or any future debt will depend on our future operating performance and ability to generate cash and may also depend on our ability to obtain additional debt or equity financing. It will also depend on financial, business or other factors affecting our operations, many of which are beyond our control. We will need to use cash to pay principal and interest on our debt, thereby reducing the funds available to fund operations, strategic initiatives and working capital requirements. If we are unable to generate sufficient cash to service our debt obligations, an event of default may occur under any of our debt instruments which could result in an acceleration of such debt upon which we may be required to repay all the amounts outstanding under some or all of our debt instruments.  Such an acceleration of our debt obligations could harm our financial condition. From time to time, we may seek to retire or repurchase our outstanding debt through cash purchases and/or exchanges for equity or debt, in open-market purchases, privately negotiated transactions or otherwise. Any such repurchases or exchanges would be on such terms and at such prices as we determine, and will depend on current market conditions, our liquidity needs, any restrictions in our contracts and other factors. The amounts involved in such transactions could be material.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the Convertible Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional conversion feature of the Convertible Notes is triggered, holders of the Convertible Notes will be entitled to convert the notes at any time during specified periods at their option. If one or more holders elect to convert their notes, we would be required to settle a portion or all of our conversion obligation in cash, which could adversely affect our liquidity. Even if holders of the Convertible Notes do not elect to convert their notes, we are required under applicable </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounting rules to reclassify all or a portion of the outstanding principal of the notes as a current rather than long-term liability when the conditional conversion feature is triggered, which results in a material reduction of our net working capital. For example, as of September&#160;30, 2021, the conditional conversion feature was triggered and our 2024 Convertible Notes are classified as a current liability. </span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of our Convertible Notes may dilute the ownership interest of existing stockholders or may otherwise depress the price of our common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion of some or all of our Convertible Notes, to the extent we deliver shares upon conversion, will dilute the ownership interests of existing stockholders. Any sales in the public market of the Convertible Notes or our common stock issuable upon conversion of the Convertible Notes could adversely affect prevailing market prices of our common stock. In addition, the existence of the Convertible Notes may encourage short selling by market participants because the conversion of the Convertible Notes could be used to satisfy short positions, or anticipated conversion of the Convertible Notes into shares of our common stock could depress the price of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If collaboration product candidates are approved for marketing but do not gain market acceptance resulting in commercial performance below that which was expected or projected, our business may suffer and we may not be able to fund future operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming that existing or future collaboration product candidates obtain the necessary regulatory approvals for commercial sale, a number of factors may affect the market acceptance of these newly-approved products, including, among others:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the degree to which the use of these products is restricted by the approved product label;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the price of these products relative to other therapies for the same or similar treatments;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which reimbursement for these products and related treatments will be available from third party payors including government insurance programs and private insurers;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction of generic or biosimilar competitors to these products; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the perception by patients, physicians and other members of the health care community of the effectiveness and safety of these products for their prescribed treatments relative to other therapies for the same or similar treatments;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability and willingness of our collaborators to fund sales and marketing efforts; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of the sales and marketing efforts of our collaborators.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If these collaboration products do not gain or maintain market acceptance or experience reduced sales resulting in commercial performance below that which was expected or projected, the royalties we expect to receive from these products will be diminished which could harm our ability to fund future operations, including conduct acquisitions, execute our planned share repurchases, or affect our ability to use funds for other general corporate purposes and cause our business to suffer.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our partners&#8217; product candidates will be restricted to the labels approved by FDA and applicable regulatory bodies, and these restrictions may limit the marketing and promotion of the ultimate products. If the approved labels are restrictive, the sales and marketing efforts for these collaboration products may be negatively affected.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to license our ENHANZE technology to our collaboration partners depends on the validity of our patents and other proprietary rights.&#160;&#160; </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents and other proprietary rights are essential to our business. Our success will depend in part on our ability to obtain and maintain patent protection for our inventions, to preserve our trade secrets and to operate without infringing the proprietary rights of third parties.&#160;We have multiple patents and patent applications throughout the world pertaining to our recombinant human hyaluronidase and methods of use and manufacture, including an issued U.S. patent which expires in 2027 and an issued European patent which expires in 2024, which we believe cover the products and product candidates under our existing collaborations, and Hylenex.&#160;Although we believe our patent filings represent a barrier to entry for potential competitors looking to utilize these hyaluronidases, upon expiration of our patents other pharmaceutical companies may (if they do not infringe our other patents) seek to compete with us by developing, manufacturing and selling biosimilars to the active drug ingredient in our ENHANZE technology used by our collaboration partners in combination with their products.&#160;Any such loss of patent protection or proprietary rights could lead to a reduction or loss of revenues, incentivize one or more of our key ENHANZE collaboration partners to terminate their relationship with us and impact our ability to enter into new collaboration and license agreements.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Developing and marketing pharmaceutical products for human use involves significant product liability risks for which we currently have limited insurance coverage.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The testing, marketing and sale of pharmaceutical products involves the risk of product liability claims by consumers and other third parties. Although we maintain product liability insurance coverage, product liability claims can be high in the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pharmaceutical industry, and our insurance may not sufficiently cover our actual liabilities. If product liability claims were to be made against us, it is possible that the liabilities may exceed the limits of our insurance policy, or our insurance carriers may deny, or attempt to deny, coverage in certain instances. If a lawsuit against us is successful, then the insurance coverage may not be sufficient and could materially and adversely affect our business and financial condition. Furthermore, various distributors of pharmaceutical products require minimum product liability insurance coverage before purchase or acceptance of products for distribution. Failure to satisfy these insurance requirements could impede our ability to achieve broad distribution of our proposed products, and higher insurance requirements could impose additional costs on us. In addition, since many of our collaboration product candidates include the pharmaceutical products of a third party, we run the risk that problems with the third party pharmaceutical product will give rise to liability claims against us.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our collaborators do not achieve projected development, clinical, or regulatory goals in the timeframes publicly announced or otherwise expected, the commercialization of our collaboration products may be delayed and, as a result, our stock price may decline, and we may face lawsuits relating to such declines.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our collaborators may publicly articulate the estimated timing for the accomplishment of certain scientific, clinical, regulatory and other product development goals. The accomplishment of any goal is typically based on numerous assumptions, and the achievement of a particular goal may be delayed for any number of reasons both within and outside of our and our collaborators&#8217; control. If scientific, regulatory, strategic or other factors cause a collaboration partner to not meet a goal, regardless of whether that goal has been publicly articulated or not, our stock price may decline rapidly. Stock price declines may also trigger direct or derivative shareholder lawsuits. As with any litigation proceeding, the eventual outcome of any legal action is difficult to predict. If any such lawsuits occur, we will incur expenses in connection with the defense of these lawsuits, and we may have to pay substantial damages or settlement costs in connection with any resolution thereof. Although we have insurance coverage against which we may claim recovery against some of these expenses and costs, the amount of coverage may not be adequate to cover the full amount or certain expenses and costs may be outside the scope of the policies we maintain. In the event of an adverse outcome or outcomes, our business could be materially harmed from depletion of cash resources, negative impact on our reputation, or restrictions or changes to our governance or other processes that may result from any final disposition of the lawsuit. Moreover, responding to and defending pending litigation significantly diverts management&#8217;s attention from our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the consistent failure to meet publicly announced milestones may erode the credibility of our management team with respect to future milestone estimates. </span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future acquisitions could disrupt our business and harm our financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to augment our product pipeline or otherwise strengthen our business, we may decide to acquire additional businesses, products and technologies. As we have limited experience in evaluating and completing acquisitions, our ability as an organization to make such acquisitions is unproven. Acquisitions could require significant capital infusions and could involve many risks, including, but not limited to, the following:</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may have to issue additional convertible debt or equity securities to complete an acquisition, which would dilute our stockholders and could adversely affect the market price of our common stock;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an acquisition may negatively impact our results of operations because it may require us to amortize or write down amounts related to goodwill and other intangible assets, or incur or assume substantial debt or liabilities, or it may cause adverse tax consequences, substantial depreciation or deferred compensation charges;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may encounter difficulties in assimilating and integrating the business, products, technologies, personnel or operations of companies that we acquire;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain acquisitions may impact our relationship with existing or potential collaborators who are competitive with the acquired business, products or technologies;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisitions may require significant capital infusions and the acquired businesses, products or technologies may not generate sufficient value to justify acquisition costs;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may take on liabilities from the acquired company such as debt, legal liabilities or business risk which could be significant;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an acquisition may disrupt our ongoing business, divert resources, increase our expenses and distract our management;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisitions may involve the entry into a geographic or business market in which we have little or no prior experience; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">key personnel of an acquired company may decide not to work for us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these risks occurred, it could adversely affect our business, financial condition and operating results. There is no assurance that we will be able to identify or consummate any future acquisitions on acceptable terms, or at all. If we do pursue any acquisitions, it is possible that we may not realize the anticipated benefits from such acquisitions or that the market will not view such acquisitions positively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our effective tax rate may fluctuate, and we may incur obligations in tax jurisdictions in excess of accrued amounts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate is derived from a combination of applicable tax rates in the various places that we operate. In preparing our financial statements, we estimate the amount of tax that will become payable in each of such places. Nevertheless, our effective tax rate may be different than experienced in the past due to numerous factors, including changes in the mix of our profitability between different tax jurisdictions, the results of examinations and audits of our tax filings, our inability to secure or sustain acceptable agreements with tax authorities, changes in accounting for income taxes and changes in tax laws. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations and may result in tax obligations in excess of amounts accrued in our financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on September 30, 2021, we determined, based on our facts and circumstances, that it was more likely than not that a substantial portion of our deferred tax assets would be realized and, as a result, substantially all of our valuation allowance against our deferred tax assets was released. This resulted in substantially and disproportionately increasing our reported net income and our earnings per share compared to our operating results for the third quarter of 2021. Historical and future comparisons to these amounts are not, and will not be, indicative of actual profitability trends for our business. Beginning in 2022, we expect to commence recording income tax expense at an estimated tax rate that will likely approximate statutory tax rates, which would result in a significant reduction in our net income and net income per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related To Ownership of Our Common Stock</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is subject to significant volatility.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in a highly dynamic industry which often results in significant volatility in the market price of common stock irrespective of company performance. The high and low sales prices of our common stock during the twelve months ended September&#160;30, 2021 were $56.40 and $25.70, respectively. We expect our stock price to continue to be subject to significant volatility and, in addition to the other risks and uncertainties described elsewhere in this Quarterly Report on Form 10-Q and all other risks and uncertainties that are either not known to us at this time or which we deem to be immaterial, any of the following factors may lead to a significant drop in our stock price:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the presence of competitive products to those being developed by our partners;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure (actual or perceived) of our collaborators to devote attention or resources to the development or commercialization of products or product candidates licensed to such collaborator;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a dispute regarding our failure, or the failure of one of our third party collaborators, to comply with the terms of a collaboration agreement; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the termination, for any reason, of any of our collaboration agreements;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sale of common stock by any significant stockholder, including, but not limited to, direct or indirect sales by members of management or our Board of Directors;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the resignation, or other departure, of members of management or our Board of Directors;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general negative conditions in the healthcare industry;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pandemics or other global crises;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general negative conditions in the financial markets;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost associated with obtaining regulatory approval for any of our collaboration product candidates;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure, for any reason, to secure or defend our intellectual property position;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure or delay of applicable regulatory bodies to approve our partners&#8217; product candidates;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identification of safety or tolerability issues;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of our partners&#8217; clinical trials to meet efficacy endpoints;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspensions or delays in the conduct of our partners&#8217; clinical trials or securing of regulatory approvals;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse regulatory action with respect to our and our collaborators&#8217; products and product candidates such as loss of regulatory approval to commercialize such products, clinical holds, imposition of onerous requirements for approval or product recalls;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure, or the failure of our third party collaborators, to successfully commercialize products approved by applicable regulatory bodies such as the FDA;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure, or the failure of our third party collaborators, to generate product revenues anticipated by investors;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions in our clinical or commercial supply chains, including disruptions caused by problems with a bulk rHuPH20 contract manufacturer or a fill and finish manufacturer for any product or product collaboration candidate; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sale of additional debt and/or equity securities by us;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to obtain financing on acceptable terms or at all; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a restructuring of our operations;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an inability to execute our share repurchase program in the time and manner we expect due to market, business, legal or other considerations; or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a conversion of the Convertible Notes into shares of our common stock.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future transactions where we raise capital may negatively affect our stock price.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently a &#8220;Well-Known Seasoned Issuer&#8221; and may file automatic shelf registration statements at any time with the SEC. Sales of substantial amounts of shares of our common stock or other securities under future shelf registration statements could lower the market price of our common stock and impair our ability to raise capital through the sale of equity securities. </span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents, the Indentures and Delaware law may make an acquisition of us more difficult.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-takeover provisions in our charter documents, the Indentures and Delaware law may make an acquisition of us more difficult. First, our Board of Directors is classified into three classes of directors. Under Delaware law, directors of a corporation with a classified board may be removed only for cause unless the corporation&#8217;s certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation, as amended, does not provide otherwise. In addition, our bylaws limit who may call special meetings of stockholders, permitting only stockholders holding at least 50% of our outstanding shares to call a special meeting of stockholders. Our amended and restated certificate of incorporation does not include a provision for cumulative voting for directors. Under cumulative voting, a minority stockholder holding a sufficient percentage of a class of shares may be able to ensure the election of one or more directors. Finally, our bylaws establish procedures, including advance notice procedures, with regard to the nomination of candidates for election as directors and stockholder proposals.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions in our charter documents may discourage potential takeover attempts, discourage bids for our common stock at a premium over market price or adversely affect the market price of, and the voting and other rights of the holders of, our common stock. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors other than the candidates nominated by our board of directors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, in connection with our Convertible Notes issuances, we entered into an indenture dated as of November&#160;18, 2019 and an indenture dated as of March 1, 2021 (the &#8220;Indentures&#8221;), with The Bank of New York Mellon Trust Company, N.A., as trustee. Certain provisions in the Indentures could make it more difficult or more expensive for a third party to acquire us.  For example, if a takeover would constitute a fundamental change, holders of the Convertible Notes will have the right to require us to repurchase their Convertible Notes in cash.  In addition, if a takeover constitutes a make-whole fundamental change, we may be required to increase the conversion rate for holders who convert their Convertible Notes in connection with such takeover.  In either case, and in other cases, our obligations under the Convertible Notes and the Indentures could increase the cost of acquiring us or otherwise discourage a third party from acquiring us or removing incumbent management.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders from consummating a merger with, or acquisition of, us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may deter an acquisition of us that might otherwise be attractive to stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Industry</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our partners&#8217; products must receive regulatory approval before they can be sold, and compliance with the extensive government regulations is expensive and time consuming and may result in the delay or cancellation of collaboration product sales, introductions or modifications.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Extensive industry regulation has had, and will continue to have, a significant impact on our business. All pharmaceutical companies, including ours, are subject to extensive, complex, costly and evolving regulation by the health regulatory agencies including the FDA (and with respect to controlled drug substances, the U.S. Drug Enforcement Administration (DEA)) and equivalent foreign regulatory agencies and state and local/regional government agencies. The Federal Food, Drug and Cosmetic Act, the Controlled Substances Act and other domestic and foreign statutes and regulations govern or influence the testing, manufacturing, packaging, labeling, storing, recordkeeping, safety, approval, advertising, promotion, sale and distribution of our product and our partners&#8217; products and product candidates. We are dependent on receiving FDA and other governmental approvals, including regulatory approvals in jurisdictions outside the United States, prior to manufacturing, marketing and shipping our products. Consequently, there is always a risk that the FDA or other applicable governmental authorities, including those outside the United States, will not approve our partners&#8217; products or may impose onerous, costly and time-consuming requirements such as additional clinical or animal testing. Regulatory authorities may require that our partners&#8217; change our studies or conduct additional studies, which may significantly delay or make continued pursuit of approval commercially unattractive to our partners. For example, the approval of Baxalta&#8217;s HYQVIA BLA was delayed by the FDA until we and Baxalta provided additional preclinical data sufficient to address concerns regarding non-neutralizing antibodies to rHuPH20 that were detected in the registration trial. Although these antibodies have not been associated with any known adverse clinical effects, and the HYQVIA BLA was ultimately approved by the FDA, the FDA or other foreign regulatory agency may, at any </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time, halt our and our collaborators&#8217; development and commercialization activities due to safety concerns. In addition, even if our product or partners&#8217; products are approved, regulatory agencies may also take post-approval action limiting or revoking our or our partners&#8217; ability to sell these products. Any of these regulatory actions may adversely affect the economic benefit we may derive from our product or our partners&#8217; products and therefore harm our financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain of these regulations, in addition to our partners, we and our contract suppliers and manufacturers are subject to periodic inspection of our or their respective facilities, procedures and operations and/or the testing of products by the FDA, the DEA and other authorities, which conduct periodic inspections to confirm that we and our contract suppliers and manufacturers are in compliance with all applicable regulations. The FDA also conducts pre-approval and post-approval reviews and plant inspections to determine whether our systems, or our contract suppliers&#8217; and manufacturers&#8217; processes, are in compliance with cGMP and other FDA regulations. If our partners, we, or our contract suppliers, fail these inspections, our partners may not be able to commercialize their products in a timely manner without incurring significant additional costs, or at all.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA imposes a number of complex regulatory requirements on entities that advertise and promote pharmaceuticals including, but not limited to, standards and regulations for direct-to-consumer advertising, off-label promotion, industry-sponsored scientific and educational activities, and promotional activities involving the Internet.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject, directly or indirectly, to various broad federal and state healthcare laws. If we are unable to comply, or have not fully complied, with such laws, we could face civil, criminal and administrative penalties, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations and activities may be directly, or indirectly, subject to various broad federal and state healthcare laws, including without limitation, anti-kickback laws, the Foreign Corrupt Practices Act (FCPA), false claims laws, civil monetary penalty laws, data privacy and security laws, tracing and tracking laws, as well as transparency laws regarding payments or other items of value provided to healthcare providers. These laws may restrict or prohibit a wide range of business activities, including, but not limited to, research, manufacturing, distribution, pricing, discounting, marketing and promotion and other business arrangements. These laws may impact, among other things, our current activities with principal investigators and research subjects, as well as sales, marketing and education programs. Many states have similar healthcare fraud and abuse laws, some of which may be broader in scope and may not be limited to items or services for which payment is made by a government health care program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. While we have adopted a healthcare corporate compliance program, it is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws. If our operations or activities are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may be subject to, without limitation, civil, criminal and administrative penalties, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any sales of products outside the U.S. will also likely subject us to the FCPA and foreign equivalents of the healthcare laws mentioned above, among other foreign laws.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be required to initiate or defend against legal proceedings related to intellectual property rights, which may result in substantial expense, delay and/or cessation of the development and commercialization of our products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily rely on patents to protect our intellectual property rights. The strength of this protection, however, is uncertain. For example, it is not certain that:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we will be able to obtain patent protection for our products and technologies;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of any of our issued patents will be sufficient to provide commercially significant exclusivity for our products and technologies;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others will not independently develop similar or alternative technologies or duplicate our technologies and obtain patent protection before we do; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any of our issued patents, or patent pending applications that result in issued patents, will be held valid, enforceable and infringed in the event the patents are asserted against others.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently own or license several patents and also have pending patent applications applicable to rHuPH20 and other proprietary materials. There can be no assurance that our existing patents, or any patents issued to us as a result of our pending patent applications, will provide a basis for commercially viable products, will provide us with any competitive advantages, or will not face third party challenges or be the subject of further proceedings limiting their scope or enforceability. Any weaknesses or limitations in our patent portfolio could have a material adverse effect on our business and financial condition. In addition, if any of our pending patent applications do not result in issued patents, or result in issued patents with narrow or limited claims, this could result in us having no or limited protection against generic or biosimilar competition against our product candidates which would have a material adverse effect on our business and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may become involved in interference proceedings in the U.S. Patent and Trademark Office, or other proceedings in other jurisdictions, to determine the priority, validity or enforceability of our patents. In addition, costly litigation could be necessary to protect our patent position.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trademarks to protect the names of our products (e.g. Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recombinant). We may not be able to obtain trademark protection for any proposed product names we select. In addition, product names for pharmaceutical products must be approved by health regulatory authorities such as the FDA in addition to meeting the legal standards required for trademark protection and product names we propose may not be timely approved by regulatory agencies which may delay product launch. In addition, our trademarks may be challenged by others. If we enforce our trademarks against third parties, such enforcement proceedings may be expensive.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trade secrets, unpatented proprietary know-how and continuing technological innovation that we seek to protect with confidentiality agreements with employees, consultants and others with whom we discuss our business. Disputes may arise concerning the ownership of intellectual property or the applicability or enforceability of these agreements, and we might not be able to resolve these disputes in our favor.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to protecting our own intellectual property rights, third parties may assert patent, trademark or copyright infringement or other intellectual property claims against us. If we become involved in any intellectual property litigation, we may be required to pay substantial damages, including but not limited to treble damages, attorneys&#8217; fees and costs, for past infringement if it is ultimately determined that our products infringe a third party&#8217;s intellectual property rights. Even if infringement claims against us are without merit, defending a lawsuit takes significant time, may be expensive and may divert management&#8217;s attention from other business concerns. Further, we may be stopped from developing, manufacturing or selling our products until we obtain a license from the owner of the relevant technology or other intellectual property rights. If such a license is available at all, it may require us to pay substantial royalties or other fees.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent protection for protein-based therapeutic products and other biotechnology inventions is subject to a great deal of uncertainty, and if patent laws or the interpretation of patent laws change, our competitors may be able to develop and commercialize products based on our discoveries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patent protection for protein-based therapeutic products is highly uncertain and involves complex legal and factual questions. In recent years, there have been significant changes in patent law, including the legal standards that govern the scope of protein and biotechnology patents. Standards for patentability of full-length and partial genes, and their corresponding proteins, are changing. Recent court decisions have made it more difficult to obtain patents, by making it more difficult to satisfy the patentable subject matter requirement and the requirement of non-obviousness, have decreased the availability of injunctions against infringers, and have increased the likelihood of challenging the validity of a patent through a declaratory judgment action. Taken together, these decisions could make it more difficult and costly for us to obtain, license and enforce our patents. In addition, the Leahy-Smith America Invents Act (HR 1249) was signed into law in September 2011, which among other changes to the U.S. patent laws, changes patent priority from &#8220;first to invent&#8221; to &#8220;first to file,&#8221; implements a post-grant opposition system for patents and provides for a prior user defense to infringement. These judicial and legislative changes have introduced significant uncertainty in the patent law landscape and may potentially negatively impact our ability to procure, maintain and enforce patents to provide exclusivity for our products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also have been, and continue to be, policy discussions concerning the scope of patent protection awarded to biotechnology inventions. Social and political opposition to biotechnology patents may lead to narrower patent protection within the biotechnology industry. Social and political opposition to patents on genes and proteins and recent court decisions concerning patentability of isolated genes may lead to narrower patent protection, or narrower claim interpretation, for isolated genes, their corresponding proteins and inventions related to their use, formulation and manufacture. Patent protection relating to biotechnology products is also subject to a great deal of uncertainty outside the U.S., and patent laws are evolving and undergoing revision in many countries. Changes in, or different interpretations of, patent laws worldwide may result in our inability to obtain or enforce patents, and may allow others to use our discoveries to develop and commercialize competitive products, which would impair our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If third party reimbursement and customer contracts are not available, Hylenex and our partners&#8217; products may not be accepted in the market resulting in commercial performance below that which was expected or projected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to earn sufficient returns on Hylenex and our partners&#8217; ability to earn sufficient returns on their products will depend in part on the extent to which reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers, managed care organizations and other healthcare providers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payors are increasingly attempting to limit both the coverage and the level of reimbursement of new drug products to contain costs. Consequently, significant uncertainty exists as to the reimbursement status of newly approved healthcare products. Third party payors may not establish adequate levels of reimbursement for the products that we and our partners commercialize, which could limit their market acceptance and result in a material adverse effect on our revenues and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer contracts, such as with group purchasing organizations and hospital formularies, will often not offer contract or formulary status without either the lowest price or substantial proven clinical differentiation. If, for example, Hylenex is compared to animal-derived hyaluronidases by these entities, it is possible that neither of these conditions will be met, which could limit market acceptance and result in a material adverse effect on our revenues and financial condition.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The rising cost of healthcare and related pharmaceutical product pricing has led to cost containment pressures from third-party payers as well as changes in federal coverage and reimbursement policies and practices that could cause us and our partners to sell our products at lower prices, and impact access to our and our partners&#8217; products, resulting in less revenue to us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of our proprietary or collaboration products that have been, or in the future are, approved by the FDA may be purchased or reimbursed by state and federal government authorities, private health insurers and other organizations, such as health maintenance organizations and managed care organizations. Such third party payors increasingly challenge pharmaceutical product pricing. The trend toward managed healthcare in the U.S., the growth of such organizations, and various legislative proposals and enactments to reform healthcare and government insurance programs, including the Medicare Prescription Drug Modernization Act of 2003 and the Affordable Care Act of 2010 (ACA), could significantly influence the manner in which pharmaceutical products are prescribed and purchased, resulting in lower prices and/or a reduction in demand. Such cost containment measures and healthcare reforms could adversely affect our ability to sell our product and our partners&#8217; ability to sell their products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., our business may be impacted by changes in federal reimbursement policy resulting from executive actions, federal regulations, or federal demonstration projects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal administration and/or agencies, such as CMS, have announced a number of demonstration projects, recommendations and proposals to implement various elements described in the drug pricing blueprint. CMS, the federal agency responsible for administering Medicare and overseeing state Medicaid programs and Health Insurance Marketplaces, has substantial power to implement policy changes or demonstration projects that can quickly and significantly affect how drugs, including our products, are covered and reimbursed. For example, in November 2020, former President Trump announced the interim final rule to implement the Most Favored Nations drug pricing model seeking to tie Medicare payment rates to an international index price.  This final rule is currently subject to a preliminary injunction. Additionally, a number of Congressional committees have also held hearings and evaluated proposed legislation on drug pricing and payment policy which may affect our business. For example, in July 2019, the Senate Finance Committee advanced a bill that in part would penalize pharmaceutical manufacturers for increasing drug list prices covered by Medicare Part B and Part D, faster than the rate of inflation, and cap out-of-pocket expenses for Medicare Part D beneficiaries.  Several other proposals have been introduced that, if enacted and implemented, could affect access to and sales of our and our partners&#8217; products, allow the federal government to engage in price negotiations on certain drugs, and allow importation of prescription medication from Canada or other countries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this dynamic environment, we are unable to predict which or how many federal policy, legislative or regulatory changes may ultimately be enacted. To the extent federal government initiatives decrease or modify the coverage or reimbursement available for our or our partners&#8217; products, limit or impact our decisions regarding the pricing of biopharmaceutical products or otherwise reduce the use of our or our partners&#8217; U.S. products, such actions could have a material adverse effect on our business and results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, individual states are considering proposed legislation and have become increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access, importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third party payors or other restrictions could negatively and materially impact our revenues and financial condition. We anticipate that we will encounter similar regulatory and legislative issues in most other countries outside the U.S.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, private payers in the US, including insurers, pharmacy benefit managers (PBMs), integrated healthcare delivery systems, and group purchasing organizations, are continuously seeking ways to reduce drug costs.  Many payers have developed and continue to develop ways to shift a greater portion of drug costs to patients through, for example, limited benefit plan designs, high deductible plans and higher co-pay or coinsurance obligations. Consolidation in the payer space has also resulted in a few large PBMs and insurers which place greater pressure on pricing and utilization negotiations for our and our partners&#8217; products in the U.S., increasing the need for higher discounts and rebates and limiting patient access and utilization.  Ultimately, additional discounts, rebates and other price reductions, fees, coverage and plan changes, or exclusions imposed by these private payers on our and our partners&#8217; products could have an adverse event on product sales, our business and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face risks relating to the reporting of pricing data that affects the reimbursement of and discounts provided for our products. Government price reporting regulations are complex and may require a manufacturer to update certain previously submitted data. If our submitted pricing data are incorrect, we may become subject to substantial fines and penalties or other government enforcement actions, which could have a material adverse effect on our business and results of operations. In addition, as a result of restating previously reported price data, we also may be required to pay additional rebates and provide additional discounts.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition and rapid technological change that could result in the development of products by others that are competitive with or superior to our proprietary and collaboration products, including those under development.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proprietary and collaboration products have numerous competitors in the U.S. and abroad including, among others, major pharmaceutical and specialized biotechnology firms, universities and other research institutions that have developed competing products. Many of these competitors have substantially more resources and product development, manufacturing and marketing experience and capabilities than we do. The competitors for Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recombinant include, but are not limited to, Valeant Pharmaceuticals International, Inc.&#8217;s FDA-approved product, Vitrase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an ovine (ram) hyaluronidase, and Amphastar Pharmaceuticals, Inc.&#8217;s product, Amphadase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a bovine (bull) hyaluronidase. For our ENHANZE technology, such competitors may include major pharmaceutical and specialized biotechnology firms. These competitors may develop technologies and products that are more effective, safer, or less costly than our current or future proprietary and collaboration products and product candidates or that could render our and our partners&#8217; products, technologies and product candidates obsolete or noncompetitive.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risks</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to attract, hire and retain key management and scientific personnel could negatively affect our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on the performance of key management and scientific employees with relevant experience. We depend substantially on our ability to hire, train, motivate and retain high quality personnel, especially our scientists and management team. If we are unable to identify, hire and retain qualified personnel, our ability to support current and future alliances with strategic collaborators could be adversely impacted. Our use of domestic and international third-party contractors, consultants and staffing agencies also subjects us to potential co-employment liability claims.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if we were to lose key management personnel, we may lose some portion of our institutional knowledge and technical know-how, potentially causing a disruption or delay in one or more of our partnered development programs until adequate replacement personnel could be hired and trained. In addition, we do not have key person life insurance policies on the lives of any of our employees which would help cover the cost of associated with the loss of key employees.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations might be interrupted by the occurrence of a natural disaster or other catastrophic event.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations, including laboratories, offices and other research facilities, are located in multiple buildings in San Diego, California. We depend on our facilities and on our collaborators, contractors and vendors for the continued operation of our business. Natural disasters or other catastrophic events, pandemics, interruptions in the supply of natural resources, political and governmental changes, wildfires and other fires, floods, explosions, actions of animal rights activists, earthquakes and civil unrest could disrupt our operations or those of our collaborators, contractors and vendors. Even though we believe we carry commercially reasonable business interruption and liability insurance, and our contractors may carry liability insurance that protect us in certain events, we may suffer losses as a result of business interruptions that exceed the coverage available under our and our contractors&#8217; insurance policies or for which we or our contractors do not have coverage. Any natural disaster or catastrophic event could have a significant negative impact on our operations and financial results. Moreover, any such event could delay our partners&#8217; research and development programs.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyberattacks, security breaches or system breakdowns may disrupt our operations and harm our operating results and reputation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our partners are subject to increasingly sophisticated attempts to gain unauthorized access to our information technology storage and access systems and are devoting resources to protect against such intrusion. Cyberattacks could render us or our partners unable to utilize key systems or access important data needed to operate our business.&#160;The wrongful use, theft, deliberate sabotage or any other type of security breach with respect to any of our or any of our vendors and partners&#8217; information technology storage and access systems could result in the breakdown or other service interruption, or the disruption of our ability to use such systems or disclosure or dissemination of  proprietary and confidential information that is electronically stored, including intellectual property, trade secrets, financial information, regulatory information, strategic plans, sales trends and forecasts, litigation materials or personal information belonging to us, our staff, our patients, customers and/or other business partners which could result in a material adverse impact on our business, operating results and financial condition. We continue to invest in monitoring, and other security and data recovery measures to protect our critical and sensitive data and systems. However, these may not be adequate to prevent or fully recover systems or data from all breakdowns, service interruptions, attacks or breaches of our systems. In addition, our cybersecurity insurance may not be sufficient to cover us against liability related to any such breaches. Furthermore, any physical break-in or trespass of our facilities could result in the misappropriation, theft, sabotage or any other type of security breach with respect to our proprietary and confidential information, including research or clinical data or damage to our research and development equipment and assets. Such adverse effects could be material and irrevocable to our business, operating results, financial condition and reputation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Quantitative and Qualitative Disclosures About Market Risk </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our market risks during the quarter ended September&#160;30, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, our cash equivalents and marketable securities consisted of investments in money market funds, U.S. Treasury securities, asset-backed securities, corporate debt obligations and commercial paper. These investments were made in accordance with our investment policy which specifies the categories, allocations, and ratings of securities we may consider for investment. The primary objective of our investment activities is to preserve principal while at the same time maximizing the income we receive without significantly increasing risk. Some of the financial instruments that we invest in could be subject to market risk. This means that a change in prevailing interest rates may cause the value of the instruments to fluctuate. For example, if we purchase a security that was issued with a fixed interest rate and the prevailing interest rate later rises, the value of that security will probably decline. Based on our current investment portfolio as of September&#160;30, 2021, we do not believe that our results of operations would be materially impacted by an immediate change of 10% in interest rates. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not hold or issue derivatives, derivative commodity instruments or other financial instruments for speculative trading purposes. Further, we do not believe our cash, cash equivalents and marketable securities have significant risk of default or illiquidity. We made this determination based on discussions with our investment advisors and a review of our holdings. While we believe our cash, cash equivalents and marketable securities do not contain excessive risk, we cannot provide absolute assurance that in the future our investments will not be subject to adverse changes in market value. All of our cash equivalents and marketable securities are recorded at fair market value.</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_100"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Controls and Procedures</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the timelines specified in the Securities and Exchange Commission&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decision regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can only provide reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_106"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be involved in disputes, including litigation, relating to claims arising out of operations in the normal course of our business. Any of these claims could subject us to costly legal expenses and, while we generally believe that we have adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage or our policy limits may be inadequate to fully satisfy any damage awards or settlements. If this were to happen, the payment of any such awards could have a material adverse effect on our consolidated results of operations and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and business. We currently are not a party to any legal proceedings, the adverse outcome of which, in management&#8217;s opinion, individually or in the aggregate, would have a material adverse effect on our consolidated results of operations or financial position.</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_109"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.3pt">Risk Factors </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have provided updated Risk Factors in the section labeled &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;2, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;. Except for the addition of the Risk Factor entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Our effective tax rate may fluctuate, and we may incur obligations in tax jurisdictions in excess of accrued amounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;, we do not believe the updates have materially changed the type or magnitude of risks we face in comparison to the disclosure provided in our most recent Annual Report on Form 10-K.</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_112"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth information regarding repurchases of our common stock during the three months ended September&#160;30, 2021:</span></div><div style="margin-top:11pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:41.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Price paid per share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares That May Yet  Be Purchased under the Programs (thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2021 through July 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2021 through August 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2021 through September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:38.25pt"><span><br/></span></div><div style="margin-top:3pt;text-indent:38.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November, 2019, we announced that our Board of Directors authorized a capital return program to repurchase up to $550.0 million of outstanding common stock during a three-year period. The above repurchases were pursuant to that program. In October 2021, we repurchased 0.3 million shares of common stock for $10.3 million, excluding commissions, completing our November 2019 share repurchase program.</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_115"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_118"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_121"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Other Information</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.52pt">Exhibits</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1159036/000115903619000019/exhibit31.htm">Amended and Restated Certificate of Incorporation (1)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1159036/000115903616000135/exhibit31halozyme-amendeda.htm">Bylaws, as amended (2)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1159036/000119312519294791/d826183dex41.htm">Indenture, dated November 18, 2019, between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, and the Registrant (3)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1159036/000119312519294791/d826183dex42.htm">Form of Note, dated November 18, 2019, between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, and the Registrant (3)</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1159036/000119312521063401/d587130dex41.htm">Indenture, dated March 1, 2021, between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, and the Registrant (4)</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1159036/000119312521063401/d587130dex42.htm">Form of Note, dated March 1, 2021, between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, and the Registrant (4)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31110qq32021.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31210qq32021.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3210qq32021.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instance Document - the instance document does not appear in the interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline Taxonomy Extension Schema Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline Taxonomy Extension Label Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.478%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"># Indicates management contract or compensatory plan or arrangement</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, filed May 3, 2019.</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, filed December 19, 2016.</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, filed November 18, 2019.</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, filed March 1, 2021.</span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i0f52beae0cb245d7843d69f1146dfb6c_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.210%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Halozyme Therapeutics, Inc.,<br/>a Delaware corporation</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Helen I. Torley, M.B. Ch.B., M.R.C.P.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley, M.B. Ch.B., M.R.C.P.<br/>President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Elaine Sun</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elaine Sun<br/>Senior Vice President and Chief Financial Officer<br/>(Principal Financial and Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31110qq32021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i67adb411de814ea2b8b5a16b1718b100_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Helen I. Torley, M.B. Ch.B., M.R.C.P., Chief Executive Officer of Halozyme Therapeutics, Inc. certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this Quarterly Report on Form 10-Q of Halozyme Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.773%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Helen I. Torley, M.B. Ch.B., M.R.C.P.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley, M.B. Ch.B., M.R.C.P</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31210qq32021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i91539f53eb984c50b2816ba355f08062_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Elaine Sun, Chief Financial Officer of Halozyme Therapeutics, Inc. certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">I have reviewed this Quarterly Report on Form 10-Q of Halozyme Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">evaluated the effectiveness of the Registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">disclosed in this report any change in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s most recent fiscal quarter (the Registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The Registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant&#8217;s auditors and the audit committee of the Registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.922%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Elaine Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elaine Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex3210qq32021.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6aae31a41d7f462b93405b039c4d2ec7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Halozyme Therapeutics, Inc. (the &#8220;Registrant&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Helen I. Torley, M.B. Ch.B., M.R.C.P., Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="margin-top:6pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m)&#59; and</font></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.773%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Helen I. Torley, M.B. Ch.B., M.R.C.P.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Halozyme Therapeutics, Inc. (the &#8220;Registrant&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Elaine Sun, Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="margin-top:6pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m)&#59; and</font></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.774%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Elaine Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elaine Sun</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>halo-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6c74ed58-0fb3-4e7f-8898-7f3e050a41d3,g:ea6d4314-a92d-42b4-b437-e2e1177b3d7b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:halo="http://www.halozyme.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.halozyme.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.halozyme.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBusiness" roleURI="http://www.halozyme.com/role/OrganizationandBusiness">
        <link:definition>2101101 - Disclosure - Organization and Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBusinessDetails" roleURI="http://www.halozyme.com/role/OrganizationandBusinessDetails">
        <link:definition>2402401 - Disclosure - Organization and Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRestrictedCashDetails" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRestrictedCashDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesInventoriesDetails" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesLeasesDetails" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails">
        <link:definition>2408404 - Disclosure - Summary of Significant Accounting Policies - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails">
        <link:definition>2409405 - Disclosure - Summary of Significant Accounting Policies - Revenue and Cost of Product Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesIncomeTaxesDetails" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails">
        <link:definition>2410406 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentInformationDetails" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
        <link:definition>2411407 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails" roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails">
        <link:definition>2412408 - Disclosure - Summary of Significant Accounting Policies - Adoption and Pending Adoption of Recent Accounting Pronouncement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://www.halozyme.com/role/FairValueMeasurement">
        <link:definition>2113103 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.halozyme.com/role/FairValueMeasurementTables">
        <link:definition>2314302 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" roleURI="http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails">
        <link:definition>2415409 - Disclosure - Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementNarrativeDetails" roleURI="http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails">
        <link:definition>2416410 - Disclosure - Fair Value Measurement - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails" roleURI="http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails">
        <link:definition>2417411 - Disclosure - Fair Value Measurement - Contractual Maturities of Available for Sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>2418412 - Disclosure - Fair Value Measurement - Assets Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.halozyme.com/role/Revenue">
        <link:definition>2119104 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.halozyme.com/role/RevenueTables">
        <link:definition>2320303 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregatedRevenuesDetails" roleURI="http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails">
        <link:definition>2421413 - Disclosure - Revenue - Disaggregated Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.halozyme.com/role/RevenueNarrativeDetails">
        <link:definition>2422414 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails" roleURI="http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails">
        <link:definition>2423415 - Disclosure - Revenue - Accounts Receivable, net and Deferred Revenues from Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueAdditionalRevenueInformationDetails" roleURI="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails">
        <link:definition>2424416 - Disclosure - Revenue - Additional Revenue Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueAdditionalRevenueInformationDetails_1" roleURI="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails_1">
        <link:definition>2424416 - Disclosure - Revenue - Additional Revenue Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItems" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItems">
        <link:definition>2125105 - Disclosure - Certain Balance Sheet Items</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsTables" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsTables">
        <link:definition>2326304 - Disclosure - Certain Balance Sheet Items (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsAccountsReceivablenetDetails" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails">
        <link:definition>2427417 - Disclosure - Certain Balance Sheet Items - Accounts Receivable, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsInventoriesDetails" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails">
        <link:definition>2428418 - Disclosure - Certain Balance Sheet Items - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails">
        <link:definition>2429419 - Disclosure - Certain Balance Sheet Items - Prepaid Expenses and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1">
        <link:definition>2429419 - Disclosure - Certain Balance Sheet Items - Prepaid Expenses and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsPropertyandEquipmentnetDetails" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails">
        <link:definition>2430420 - Disclosure - Certain Balance Sheet Items - Property and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsAccruedExpensesDetails" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails">
        <link:definition>2431421 - Disclosure - Certain Balance Sheet Items - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CertainBalanceSheetItemsAccruedExpensesDetails_1" roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1">
        <link:definition>2431421 - Disclosure - Certain Balance Sheet Items - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNet" roleURI="http://www.halozyme.com/role/LongTermDebtNet">
        <link:definition>2132106 - Disclosure - Long-Term Debt, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNetTables" roleURI="http://www.halozyme.com/role/LongTermDebtNetTables">
        <link:definition>2333305 - Disclosure - Long-Term Debt, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNetNarrativeDetails" roleURI="http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails">
        <link:definition>2434422 - Disclosure - Long-Term Debt, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNetCarryingAmountofConvertibleNotesDetails" roleURI="http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails">
        <link:definition>2435423 - Disclosure - Long-Term Debt, Net - Carrying Amount of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNetComponentsofInterestExpenseDetails" roleURI="http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails">
        <link:definition>2436424 - Disclosure - Long-Term Debt, Net - Components of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensation" roleURI="http://www.halozyme.com/role/SharebasedCompensation">
        <link:definition>2137107 - Disclosure - Share-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationTables" roleURI="http://www.halozyme.com/role/SharebasedCompensationTables">
        <link:definition>2338306 - Disclosure - Share-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSharebasedCompensationExpenseDetails" roleURI="http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails">
        <link:definition>2439425 - Disclosure - Share-based Compensation - Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationNarrativeDetails" roleURI="http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails">
        <link:definition>2440426 - Disclosure - Share-based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails" roleURI="http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails">
        <link:definition>2441427 - Disclosure - Share-based Compensation - Assumptions Used in the Black-Scholes Model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails" roleURI="http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails">
        <link:definition>2442428 - Disclosure - Share-based Compensation - Unrecognized Estimated Compensation Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.halozyme.com/role/StockholdersEquity">
        <link:definition>2143108 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.halozyme.com/role/StockholdersEquityTables">
        <link:definition>2344307 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.halozyme.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2445429 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareRepurchaseActivityDetails" roleURI="http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails">
        <link:definition>2446430 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.halozyme.com/role/CommitmentsandContingencies">
        <link:definition>2147109 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesTables">
        <link:definition>2348308 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesSummaryDetails" roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails">
        <link:definition>2449431 - Disclosure - Commitments and Contingencies - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesSummaryDetails_1" roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1">
        <link:definition>2449431 - Disclosure - Commitments and Contingencies - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomelosspershare" roleURI="http://www.halozyme.com/role/NetIncomelosspershare">
        <link:definition>2150110 - Disclosure - Net Income (loss) per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomelosspershareTables" roleURI="http://www.halozyme.com/role/NetIncomelosspershareTables">
        <link:definition>2351309 - Disclosure - Net Income (loss) per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomelosspershareSummaryDetails" roleURI="http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails">
        <link:definition>2452432 - Disclosure - Net Income (loss) per share - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomelosspershareAntidilutiveSecuritiesDetails" roleURI="http://www.halozyme.com/role/NetIncomelosspershareAntidilutiveSecuritiesDetails">
        <link:definition>2453433 - Disclosure - Net Income (loss) per share - Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="halo_ResearchEquipmentMember" abstract="true" name="ResearchEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_OperatingLeaseAccretionOfLiability" abstract="false" name="OperatingLeaseAccretionOfLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_DevelopmentFeesMember" abstract="true" name="DevelopmentFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_A2021ShareRepurchaseProgramBankOfAmericaMember" abstract="true" name="A2021ShareRepurchaseProgramBankOfAmericaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_StockOptionsAndRestrictedStockUnitsMember" abstract="true" name="StockOptionsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_A025ConvertibleSeniorNotesDue2027Member" abstract="true" name="A025ConvertibleSeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_RoyaltiesReceivedNumberOfCollaborators" abstract="false" name="RoyaltiesReceivedNumberOfCollaborators" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="halo_RoyaltiesReceivedNumberOfProductsSold" abstract="false" name="RoyaltiesReceivedNumberOfProductsSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="halo_ResearchandDevelopmentServicesMember" abstract="true" name="ResearchandDevelopmentServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_Accountsreceivablefromproductsales" abstract="false" name="Accountsreceivablefromproductsales" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_TreasuryStockAcquiredFeeCostPerShare" abstract="false" name="TreasuryStockAcquiredFeeCostPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" abstract="false" name="AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_ManufacturingEquipmentMember" abstract="true" name="ManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_ComputerAndOfficeEquipmentMember" abstract="true" name="ComputerAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_JanssenMember" abstract="true" name="JanssenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_RocheMember" abstract="true" name="RocheMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" abstract="false" name="RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" abstract="true" name="ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="halo_SalesbasedmilestoneMember" abstract="true" name="SalesbasedmilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_Accountsreceivablefromroyalties" abstract="false" name="Accountsreceivablefromroyalties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_AllowanceforDistributionFeesandDiscounts" abstract="false" name="AllowanceforDistributionFeesandDiscounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_CollaborativeAgreementsMember" abstract="true" name="CollaborativeAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_BaxaltaMember" abstract="true" name="BaxaltaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_LicenseFeesAndEventBasedMember" abstract="true" name="LicenseFeesAndEventBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_HylenexRecombinantMember" abstract="true" name="HylenexRecombinantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_Accruedmanufacturingexpenses" abstract="false" name="Accruedmanufacturingexpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" abstract="false" name="ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_RevenueFromContractWithCustomerVariableConsideration" abstract="false" name="RevenueFromContractWithCustomerVariableConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_Accountsreceivablefromcollaborators" abstract="false" name="Accountsreceivablefromcollaborators" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_BulkrHuPH20Member" abstract="true" name="BulkrHuPH20Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_UpfrontfeesMember" abstract="true" name="UpfrontfeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_PendingSettlementofCommonStockRepurchase" abstract="false" name="PendingSettlementofCommonStockRepurchase" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_A2020ShareRepurchaseProgramBankOfAmericaMember" abstract="true" name="A2020ShareRepurchaseProgramBankOfAmericaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="halo_DeferredRentPayments" abstract="false" name="DeferredRentPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_A1.25ConvertibleSeniorNotesdue2024Member" abstract="true" name="A1.25ConvertibleSeniorNotesdue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_A2021ESPPPlanMember" abstract="true" name="A2021ESPPPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_RSURSAandPRSUawardsMember" abstract="true" name="RSURSAandPRSUawardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_Accountsreceivablefromproductsalestocollaborators" abstract="false" name="Accountsreceivablefromproductsalestocollaborators" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_AccruedLiabilitiesNoncurrent" abstract="false" name="AccruedLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="halo_RoyaltybackedLoanMember" abstract="true" name="RoyaltybackedLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_OthercollaboratorsMember" abstract="true" name="OthercollaboratorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable" abstract="true" name="ScheduleofSharebasedCompensationArrangementsValuationInputsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>halo-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6c74ed58-0fb3-4e7f-8898-7f3e050a41d3,g:ea6d4314-a92d-42b4-b437-e2e1177b3d7b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e44c1bda-4365-4278-8f19-84b4e2ff8000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_feb08d24-4c9b-4d16-9248-e1447de724ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e44c1bda-4365-4278-8f19-84b4e2ff8000" xlink:to="loc_us-gaap_AccountsPayableCurrent_feb08d24-4c9b-4d16-9248-e1447de724ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_175a00df-0710-4aff-a82b-27d83835a07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e44c1bda-4365-4278-8f19-84b4e2ff8000" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_175a00df-0710-4aff-a82b-27d83835a07f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_cbe99d8e-1b81-4dce-8344-fc25d67b3a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e44c1bda-4365-4278-8f19-84b4e2ff8000" xlink:to="loc_us-gaap_DeferredRevenueCurrent_cbe99d8e-1b81-4dce-8344-fc25d67b3a92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9003c3a7-2a4f-484d-abc3-3d2b84297e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e44c1bda-4365-4278-8f19-84b4e2ff8000" xlink:to="loc_us-gaap_LongTermDebtCurrent_9003c3a7-2a4f-484d-abc3-3d2b84297e30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7d095ab4-ee87-432a-950a-bc5dec822f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0364ed59-b07f-4c47-bb03-79c254ab6dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7d095ab4-ee87-432a-950a-bc5dec822f55" xlink:to="loc_us-gaap_CommonStockValue_0364ed59-b07f-4c47-bb03-79c254ab6dcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f2c6ee9b-e4ce-4313-8197-52ab0822d0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7d095ab4-ee87-432a-950a-bc5dec822f55" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f2c6ee9b-e4ce-4313-8197-52ab0822d0f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f288030-ef79-4f62-bf59-fa669d1454f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7d095ab4-ee87-432a-950a-bc5dec822f55" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f288030-ef79-4f62-bf59-fa669d1454f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31df356f-db91-4b83-ad9d-eb77b91b17c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7d095ab4-ee87-432a-950a-bc5dec822f55" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31df356f-db91-4b83-ad9d-eb77b91b17c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_85533be1-b46a-4a9c-9adb-43ee433cea69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7d095ab4-ee87-432a-950a-bc5dec822f55" xlink:to="loc_us-gaap_PreferredStockValue_85533be1-b46a-4a9c-9adb-43ee433cea69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_44a4c09c-747c-4dd4-b86d-86c28e172636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ee24b661-c511-4342-9205-5c70e917cbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_44a4c09c-747c-4dd4-b86d-86c28e172636" xlink:to="loc_us-gaap_AssetsCurrent_ee24b661-c511-4342-9205-5c70e917cbee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e62be66e-32f5-497b-843a-fc13c8ab99ae" xlink:href="halo-20210930.xsd#halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_44a4c09c-747c-4dd4-b86d-86c28e172636" xlink:to="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e62be66e-32f5-497b-843a-fc13c8ab99ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_0b82565d-292f-4810-af82-415f42761c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_44a4c09c-747c-4dd4-b86d-86c28e172636" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_0b82565d-292f-4810-af82-415f42761c83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_f9175de2-8579-4610-9a56-7225e69bc1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_44a4c09c-747c-4dd4-b86d-86c28e172636" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_f9175de2-8579-4610-9a56-7225e69bc1c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e85551ae-8fdc-40ea-af5b-6dc2b33744ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_44a4c09c-747c-4dd4-b86d-86c28e172636" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e85551ae-8fdc-40ea-af5b-6dc2b33744ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d2904b-4f6f-41b1-8c84-a137ba6118e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_199e8744-d996-4e90-a885-3f8aa452c4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d2904b-4f6f-41b1-8c84-a137ba6118e8" xlink:to="loc_us-gaap_LiabilitiesCurrent_199e8744-d996-4e90-a885-3f8aa452c4db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_1a4be8ba-76c6-4909-81d7-d8fd23b02667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d2904b-4f6f-41b1-8c84-a137ba6118e8" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_1a4be8ba-76c6-4909-81d7-d8fd23b02667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9fa4485f-6b2b-42e2-8ad2-352320fcddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d2904b-4f6f-41b1-8c84-a137ba6118e8" xlink:to="loc_us-gaap_LongTermDebt_9fa4485f-6b2b-42e2-8ad2-352320fcddc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3a270122-8cc8-40d1-a4c8-980f7e8bf0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d2904b-4f6f-41b1-8c84-a137ba6118e8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3a270122-8cc8-40d1-a4c8-980f7e8bf0c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd23fd72-dc46-443e-988d-1a9c70ef2c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d2904b-4f6f-41b1-8c84-a137ba6118e8" xlink:to="loc_us-gaap_StockholdersEquity_cd23fd72-dc46-443e-988d-1a9c70ef2c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a0972697-df95-45bf-8ca9-08b20a91f99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e2d2904b-4f6f-41b1-8c84-a137ba6118e8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a0972697-df95-45bf-8ca9-08b20a91f99f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_66a4d18f-7ab3-430c-86cf-67f8873c2a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a4e4bc4-cc14-4630-a3fe-06d749c251e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66a4d18f-7ab3-430c-86cf-67f8873c2a0b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2a4e4bc4-cc14-4630-a3fe-06d749c251e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7130d754-f0b4-49f1-b3f9-3e01d595ea86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66a4d18f-7ab3-430c-86cf-67f8873c2a0b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7130d754-f0b4-49f1-b3f9-3e01d595ea86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dc1e1d7e-af10-4a30-9245-5ce0a174973c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66a4d18f-7ab3-430c-86cf-67f8873c2a0b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dc1e1d7e-af10-4a30-9245-5ce0a174973c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_375415cb-3597-459f-a377-5d62607c2d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66a4d18f-7ab3-430c-86cf-67f8873c2a0b" xlink:to="loc_us-gaap_InventoryNet_375415cb-3597-459f-a377-5d62607c2d6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a039ca57-e00b-4e0b-9cec-8ef479eacd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66a4d18f-7ab3-430c-86cf-67f8873c2a0b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a039ca57-e00b-4e0b-9cec-8ef479eacd55" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2b20aa37-b12e-47da-bd3a-26befa04a320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_fe26ea96-9a3f-4c4c-b744-8ad9483f48b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2b20aa37-b12e-47da-bd3a-26befa04a320" xlink:to="loc_us-gaap_CostsAndExpenses_fe26ea96-9a3f-4c4c-b744-8ad9483f48b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db91991d-dc14-4b1b-bad6-77058d3192a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2b20aa37-b12e-47da-bd3a-26befa04a320" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db91991d-dc14-4b1b-bad6-77058d3192a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1914b6d1-6e4b-4332-b3eb-574da7d1585a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3090a37d-ed53-4876-9a6d-214ba5a5635a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1914b6d1-6e4b-4332-b3eb-574da7d1585a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3090a37d-ed53-4876-9a6d-214ba5a5635a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_60396f92-dd5d-4537-b9bb-5a08fcffd935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1914b6d1-6e4b-4332-b3eb-574da7d1585a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_60396f92-dd5d-4537-b9bb-5a08fcffd935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b5a1da40-acc3-4606-9758-48aa48e4119c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_67ca3216-5be6-4fb6-a495-0c197e9bfe38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b5a1da40-acc3-4606-9758-48aa48e4119c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_67ca3216-5be6-4fb6-a495-0c197e9bfe38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3da18884-9858-415b-b8aa-e001663d672c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b5a1da40-acc3-4606-9758-48aa48e4119c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3da18884-9858-415b-b8aa-e001663d672c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b06e4a90-63ef-4dcb-b99c-ed4a0424507e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b5a1da40-acc3-4606-9758-48aa48e4119c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b06e4a90-63ef-4dcb-b99c-ed4a0424507e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae83c33e-8bed-4c7c-b284-b0897534d530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fe0a19d2-fb87-4023-9ba6-f115b1749e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae83c33e-8bed-4c7c-b284-b0897534d530" xlink:to="loc_us-gaap_OperatingIncomeLoss_fe0a19d2-fb87-4023-9ba6-f115b1749e19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c99ca7e4-04a1-4bf6-8273-9223a22376c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae83c33e-8bed-4c7c-b284-b0897534d530" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c99ca7e4-04a1-4bf6-8273-9223a22376c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0a7bc857-6dea-4669-83cc-3cf592e03f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae83c33e-8bed-4c7c-b284-b0897534d530" xlink:to="loc_us-gaap_InterestExpense_0a7bc857-6dea-4669-83cc-3cf592e03f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_af9c4736-18ed-45b2-a65b-8915c825aeff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae83c33e-8bed-4c7c-b284-b0897534d530" xlink:to="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_af9c4736-18ed-45b2-a65b-8915c825aeff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5229874-2e39-40cb-91db-3c9e8c750714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_75acc97d-7d47-4286-a580-0d084689201e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5229874-2e39-40cb-91db-3c9e8c750714" xlink:to="loc_us-gaap_NetIncomeLoss_75acc97d-7d47-4286-a580-0d084689201e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_34ba6bb3-4bbd-4c56-a80d-0f680876a94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5229874-2e39-40cb-91db-3c9e8c750714" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_34ba6bb3-4bbd-4c56-a80d-0f680876a94d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5e9d430f-2585-4f54-9214-7e5c28c4b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5229874-2e39-40cb-91db-3c9e8c750714" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5e9d430f-2585-4f54-9214-7e5c28c4b6d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_efe8eed2-f5c9-48cd-b0d1-03b6c6d0bc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b5229874-2e39-40cb-91db-3c9e8c750714" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_efe8eed2-f5c9-48cd-b0d1-03b6c6d0bc0d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16f42ed6-6b15-4b18-a3ff-582a2e179f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8cd74b82-dba4-4729-a064-1301273024ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16f42ed6-6b15-4b18-a3ff-582a2e179f61" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8cd74b82-dba4-4729-a064-1301273024ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ffde82a6-028a-4fa0-b809-8218c2c77458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16f42ed6-6b15-4b18-a3ff-582a2e179f61" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ffde82a6-028a-4fa0-b809-8218c2c77458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ac001859-407a-4c1b-aeb2-2d1d7f64466e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16f42ed6-6b15-4b18-a3ff-582a2e179f61" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ac001859-407a-4c1b-aeb2-2d1d7f64466e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_45aa17b5-13b9-4229-8881-41ebf4aadc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16f42ed6-6b15-4b18-a3ff-582a2e179f61" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_45aa17b5-13b9-4229-8881-41ebf4aadc7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_abcacb79-5fb5-4e55-8c09-989f006ec6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_NetIncomeLoss_abcacb79-5fb5-4e55-8c09-989f006ec6dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3a77c139-cc0c-4429-b118-3f98ea83c5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_ShareBasedCompensation_3a77c139-cc0c-4429-b118-3f98ea83c5c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a9b452b5-5bfe-4418-af5d-5e3f77c21568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a9b452b5-5bfe-4418-af5d-5e3f77c21568" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_b4f6bd6e-ef71-48cc-9c96-5a9f11270c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_b4f6bd6e-ef71-48cc-9c96-5a9f11270c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_ad299843-8032-4cc5-ac38-57242aa07aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_ad299843-8032-4cc5-ac38-57242aa07aac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_db7863f0-73ea-4a1c-b1cc-29cad3ed06fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_db7863f0-73ea-4a1c-b1cc-29cad3ed06fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_123fd3a4-b2ee-48c2-a80d-39a58f289a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_123fd3a4-b2ee-48c2-a80d-39a58f289a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_DeferredRentPayments_5f7407b3-4cd0-42e8-ad5f-0410f171c92d" xlink:href="halo-20210930.xsd#halo_DeferredRentPayments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_halo_DeferredRentPayments_5f7407b3-4cd0-42e8-ad5f-0410f171c92d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_026e5969-1044-4bdd-bbac-c1c0e19e5839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_026e5969-1044-4bdd-bbac-c1c0e19e5839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_12318fe7-e4a9-4fb3-b0ec-d1fffa310642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_12318fe7-e4a9-4fb3-b0ec-d1fffa310642" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ae6a3434-27dd-46ed-a28c-3df760ca30d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ae6a3434-27dd-46ed-a28c-3df760ca30d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a1dfc1bf-4af3-4cef-a43e-087285137a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a1dfc1bf-4af3-4cef-a43e-087285137a0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0acb2292-0da6-48c4-8ec9-5b2ce8febfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0acb2292-0da6-48c4-8ec9-5b2ce8febfb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6971b4f4-0a39-413f-a2f6-f016162c5df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6971b4f4-0a39-413f-a2f6-f016162c5df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_0dac5d83-74d5-4d81-b26b-a5da5df82c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_0dac5d83-74d5-4d81-b26b-a5da5df82c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_00f752db-7444-407e-9473-cc58143c7799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22df462e-16a0-4168-9fac-7b2a71c2eb34" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_00f752db-7444-407e-9473-cc58143c7799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5b11bd3-56f5-43b0-816c-bbc03d15e1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_fdb0431d-16ba-4127-99c7-5c825ad05730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5b11bd3-56f5-43b0-816c-bbc03d15e1ce" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_fdb0431d-16ba-4127-99c7-5c825ad05730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_b7f8428c-ec61-4b62-a8fd-ef9028a4cac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5b11bd3-56f5-43b0-816c-bbc03d15e1ce" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_b7f8428c-ec61-4b62-a8fd-ef9028a4cac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_115deee2-1d48-4536-b735-d1a4214eb31e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5b11bd3-56f5-43b0-816c-bbc03d15e1ce" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_115deee2-1d48-4536-b735-d1a4214eb31e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7f6994d1-afa7-4405-b907-958d84f5040d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5b11bd3-56f5-43b0-816c-bbc03d15e1ce" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7f6994d1-afa7-4405-b907-958d84f5040d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c5103df8-4fa0-41a8-97e5-f2bd53a4286b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5b11bd3-56f5-43b0-816c-bbc03d15e1ce" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c5103df8-4fa0-41a8-97e5-f2bd53a4286b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dcf3cc5-2f43-44d9-9120-ef237d6d5376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7d617544-cb91-49fa-a63f-a90e6d43dd38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dcf3cc5-2f43-44d9-9120-ef237d6d5376" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7d617544-cb91-49fa-a63f-a90e6d43dd38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f745e6da-03b6-4187-b35b-612fd825cec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dcf3cc5-2f43-44d9-9120-ef237d6d5376" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f745e6da-03b6-4187-b35b-612fd825cec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64626b0e-cb51-4dae-b4df-ff83051d2285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dcf3cc5-2f43-44d9-9120-ef237d6d5376" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64626b0e-cb51-4dae-b4df-ff83051d2285" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f68646c5-f809-44d1-bc4a-9ca9bc62b661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da627f6d-cd9d-4ac9-92b7-a9631c272694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f68646c5-f809-44d1-bc4a-9ca9bc62b661" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da627f6d-cd9d-4ac9-92b7-a9631c272694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f9875307-def0-45b3-b32a-16541bc03515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f68646c5-f809-44d1-bc4a-9ca9bc62b661" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f9875307-def0-45b3-b32a-16541bc03515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef6d0d7e-e3f2-4c58-8535-f8cdf21cdbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f68646c5-f809-44d1-bc4a-9ca9bc62b661" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ef6d0d7e-e3f2-4c58-8535-f8cdf21cdbbb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_88deddd9-0bc5-48b1-92fd-d1689a20bb11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d22ac915-55e1-48ef-979f-17d21784105e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_88deddd9-0bc5-48b1-92fd-d1689a20bb11" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d22ac915-55e1-48ef-979f-17d21784105e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_15e86937-ebd3-4260-b4cc-ae04c63a4fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_88deddd9-0bc5-48b1-92fd-d1689a20bb11" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_15e86937-ebd3-4260-b4cc-ae04c63a4fca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bdae8839-5b57-4017-85ab-0c0b9e6cedfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_de52f6ec-ebae-4035-b55b-a95158fcf18f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_bdae8839-5b57-4017-85ab-0c0b9e6cedfe" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_de52f6ec-ebae-4035-b55b-a95158fcf18f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3ffeaa38-fd02-47a6-9f12-de533566d5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_bdae8839-5b57-4017-85ab-0c0b9e6cedfe" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3ffeaa38-fd02-47a6-9f12-de533566d5f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsAccountsReceivablenetDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_248bfaf5-52ef-4fd8-af95-9c59070b9e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromproductsalestocollaborators_157507d0-d49c-4525-aace-7f7a6584a20d" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromproductsalestocollaborators"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_248bfaf5-52ef-4fd8-af95-9c59070b9e9b" xlink:to="loc_halo_Accountsreceivablefromproductsalestocollaborators_157507d0-d49c-4525-aace-7f7a6584a20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromcollaborators_22c48b47-ea03-4ecf-8c57-84dd58bc2b08" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromcollaborators"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_248bfaf5-52ef-4fd8-af95-9c59070b9e9b" xlink:to="loc_halo_Accountsreceivablefromcollaborators_22c48b47-ea03-4ecf-8c57-84dd58bc2b08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromroyalties_1a105d5e-2941-43be-a2c2-010f19a2ded7" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromroyalties"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_248bfaf5-52ef-4fd8-af95-9c59070b9e9b" xlink:to="loc_halo_Accountsreceivablefromroyalties_1a105d5e-2941-43be-a2c2-010f19a2ded7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromproductsales_9d4888e8-3873-49d7-b78a-ef8e381b3db5" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromproductsales"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_248bfaf5-52ef-4fd8-af95-9c59070b9e9b" xlink:to="loc_halo_Accountsreceivablefromproductsales_9d4888e8-3873-49d7-b78a-ef8e381b3db5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_96f109ac-e209-46ad-be48-bbc299518965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_248bfaf5-52ef-4fd8-af95-9c59070b9e9b" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_96f109ac-e209-46ad-be48-bbc299518965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a4c4bf8a-849e-4527-a5a2-7271ee78e030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_75cc0957-ab27-48e2-b7b3-f6b70ebe0b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_a4c4bf8a-849e-4527-a5a2-7271ee78e030" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_75cc0957-ab27-48e2-b7b3-f6b70ebe0b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AllowanceforDistributionFeesandDiscounts_63dbf536-22c0-4b29-8832-d0b414c13b78" xlink:href="halo-20210930.xsd#halo_AllowanceforDistributionFeesandDiscounts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_a4c4bf8a-849e-4527-a5a2-7271ee78e030" xlink:to="loc_halo_AllowanceforDistributionFeesandDiscounts_63dbf536-22c0-4b29-8832-d0b414c13b78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_901b53e2-4ed4-4599-aac6-0f330979baa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_959669bd-1e10-45c1-af12-90695f57090b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_901b53e2-4ed4-4599-aac6-0f330979baa1" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_959669bd-1e10-45c1-af12-90695f57090b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f6407cf0-1cfc-46d4-8d2b-3f91eb052b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_901b53e2-4ed4-4599-aac6-0f330979baa1" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f6407cf0-1cfc-46d4-8d2b-3f91eb052b77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d671ca34-c603-4052-aa19-acb00b3bbeba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_901b53e2-4ed4-4599-aac6-0f330979baa1" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d671ca34-c603-4052-aa19-acb00b3bbeba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_19db2173-bc6c-46d1-b5e7-05c1dcb18dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_6053ba70-73b5-49e9-a01f-4acd1671a3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_19db2173-bc6c-46d1-b5e7-05c1dcb18dd7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_6053ba70-73b5-49e9-a01f-4acd1671a3b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_1f9f8191-7b18-4524-bbb1-0a477beb0f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_19db2173-bc6c-46d1-b5e7-05c1dcb18dd7" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_1f9f8191-7b18-4524-bbb1-0a477beb0f4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_a089b3f8-7f61-4996-85cc-e21455f68d33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_19db2173-bc6c-46d1-b5e7-05c1dcb18dd7" xlink:to="loc_us-gaap_OtherAssets_a089b3f8-7f61-4996-85cc-e21455f68d33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_53155ae8-55cf-400f-8813-d1962fb66ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_df9bb7f3-45af-4584-8536-6c234767412c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_53155ae8-55cf-400f-8813-d1962fb66ca8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_df9bb7f3-45af-4584-8536-6c234767412c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_87f4d355-1201-422a-8685-b0ef299fd5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets_53155ae8-55cf-400f-8813-d1962fb66ca8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_87f4d355-1201-422a-8685-b0ef299fd5ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPropertyandEquipmentnetDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5a9121fc-be6e-43b7-8609-6aa4e07ce6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b95c38f1-5c77-4fe1-ae56-35ecbef20486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5a9121fc-be6e-43b7-8609-6aa4e07ce6da" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b95c38f1-5c77-4fe1-ae56-35ecbef20486" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6ecaedbf-3188-4942-a28b-c47e32e37a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5a9121fc-be6e-43b7-8609-6aa4e07ce6da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6ecaedbf-3188-4942-a28b-c47e32e37a56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_dc67ca53-2e67-48d6-b70b-2f4e32ccdb40" xlink:href="halo-20210930.xsd#halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cb6c76e3-b0bf-4037-a7ee-c712b0d520ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_dc67ca53-2e67-48d6-b70b-2f4e32ccdb40" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cb6c76e3-b0bf-4037-a7ee-c712b0d520ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_743f2a48-4c96-4abf-aa5b-fabf100e849f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_dc67ca53-2e67-48d6-b70b-2f4e32ccdb40" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_743f2a48-4c96-4abf-aa5b-fabf100e849f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_26a0c023-2f1d-4096-a9cf-638d76280884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AccruedLiabilitiesNoncurrent_68198831-dd57-4ead-9251-0528290933d4" xlink:href="halo-20210930.xsd#halo_AccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_26a0c023-2f1d-4096-a9cf-638d76280884" xlink:to="loc_halo_AccruedLiabilitiesNoncurrent_68198831-dd57-4ead-9251-0528290933d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6c6260ba-a2ef-4ce3-8d8d-c688d4eb9654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_26a0c023-2f1d-4096-a9cf-638d76280884" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6c6260ba-a2ef-4ce3-8d8d-c688d4eb9654" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsAccruedExpensesDetails_1"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_affeb15d-8c54-402f-99a2-fc4ce128b2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b2363fa4-8f6c-4a2e-af88-a150a5d04f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_affeb15d-8c54-402f-99a2-fc4ce128b2b0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b2363fa4-8f6c-4a2e-af88-a150a5d04f28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accruedmanufacturingexpenses_81442ae5-6ce9-4eb7-957f-6bbe39f477d7" xlink:href="halo-20210930.xsd#halo_Accruedmanufacturingexpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_affeb15d-8c54-402f-99a2-fc4ce128b2b0" xlink:to="loc_halo_Accruedmanufacturingexpenses_81442ae5-6ce9-4eb7-957f-6bbe39f477d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c7f4cb5b-4af5-4c25-9a52-253f5825d9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_affeb15d-8c54-402f-99a2-fc4ce128b2b0" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c7f4cb5b-4af5-4c25-9a52-253f5825d9a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9c48fd21-21fa-4f2e-8732-53d80d6273a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_affeb15d-8c54-402f-99a2-fc4ce128b2b0" xlink:to="loc_us-gaap_OperatingLeaseLiability_9c48fd21-21fa-4f2e-8732-53d80d6273a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CommitmentsandContingenciesSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97b6861e-aa91-4b90-939a-de6072ee7c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6a560ac0-9969-4f4f-93ed-28e87b816e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97b6861e-aa91-4b90-939a-de6072ee7c65" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6a560ac0-9969-4f4f-93ed-28e87b816e52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_65a73ddd-9a5a-4fcd-b2bb-fb9615ed1e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97b6861e-aa91-4b90-939a-de6072ee7c65" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_65a73ddd-9a5a-4fcd-b2bb-fb9615ed1e16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1d19a2d8-192a-4bd6-a9c6-587adf01dac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97b6861e-aa91-4b90-939a-de6072ee7c65" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1d19a2d8-192a-4bd6-a9c6-587adf01dac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3e28b79d-c383-47c2-84a8-b860911e63af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97b6861e-aa91-4b90-939a-de6072ee7c65" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3e28b79d-c383-47c2-84a8-b860911e63af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a7956e46-7580-421d-9f3e-b0196e5731f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97b6861e-aa91-4b90-939a-de6072ee7c65" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a7956e46-7580-421d-9f3e-b0196e5731f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#CommitmentsandContingenciesSummaryDetails_1"/>
  <link:calculationLink xlink:role="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ebbcbf77-7b31-4612-8a84-2272e4c28c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0721e22e-588a-4906-9ad3-a2b2fdfdb646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ebbcbf77-7b31-4612-8a84-2272e4c28c32" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0721e22e-588a-4906-9ad3-a2b2fdfdb646" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5e7272ce-d048-47bf-b130-b2565e195fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ebbcbf77-7b31-4612-8a84-2272e4c28c32" xlink:to="loc_us-gaap_OperatingLeaseLiability_5e7272ce-d048-47bf-b130-b2565e195fcc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>halo-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6c74ed58-0fb3-4e7f-8898-7f3e050a41d3,g:ea6d4314-a92d-42b4-b437-e2e1177b3d7b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" id="i921b410e67f744588e92279203746943_CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f88efae2-9f1d-46d8-ac95-f416d709f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f88efae2-9f1d-46d8-ac95-f416d709f6c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8d4b96d0-d21f-48c4-96e3-74bf606ea671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8d4b96d0-d21f-48c4-96e3-74bf606ea671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ab8fdbf7-6ecb-4c40-bced-a3dfd462d47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockSharesIssued_ab8fdbf7-6ecb-4c40-bced-a3dfd462d47b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cb8c67b2-932e-4ba8-bae0-39eb55b08434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cb8c67b2-932e-4ba8-bae0-39eb55b08434" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7affd5e2-90d9-4676-85b8-88c509b3c6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_SharesOutstanding_7affd5e2-90d9-4676-85b8-88c509b3c6f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_09d894f1-2119-424b-9729-ad5a48c5cbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_StatementTable_09d894f1-2119-424b-9729-ad5a48c5cbce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66e0d455-c3db-424b-aa24-807265048b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_09d894f1-2119-424b-9729-ad5a48c5cbce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66e0d455-c3db-424b-aa24-807265048b1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66e0d455-c3db-424b-aa24-807265048b1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66e0d455-c3db-424b-aa24-807265048b1a" xlink:to="loc_us-gaap_EquityComponentDomain_66e0d455-c3db-424b-aa24-807265048b1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74db0ed3-d7c8-4cf4-a10e-93e0bd15e7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66e0d455-c3db-424b-aa24-807265048b1a" xlink:to="loc_us-gaap_EquityComponentDomain_74db0ed3-d7c8-4cf4-a10e-93e0bd15e7f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c98f9674-ac58-430a-a1d2-bf09907dc091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_74db0ed3-d7c8-4cf4-a10e-93e0bd15e7f9" xlink:to="loc_us-gaap_CommonStockMember_c98f9674-ac58-430a-a1d2-bf09907dc091" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="ie62f28dd806a436d930d901ae147f4f6_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_53b64491-a27a-47ea-9e8a-8f1f08afa1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_RevenuesAbstract_53b64491-a27a-47ea-9e8a-8f1f08afa1e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54b00fee-f917-45ca-87ef-65a28bb6501d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_53b64491-a27a-47ea-9e8a-8f1f08afa1e8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54b00fee-f917-45ca-87ef-65a28bb6501d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ad3087a7-6e94-4609-9d40-da7431cf4dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ad3087a7-6e94-4609-9d40-da7431cf4dec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6d4aee85-8667-4341-b87b-ef8f633858f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6d4aee85-8667-4341-b87b-ef8f633858f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f5bd1409-309e-4bd0-93ec-181c04a576d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f5bd1409-309e-4bd0-93ec-181c04a576d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8a962d85-6d80-4615-9026-c34b3a73f75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_CostsAndExpenses_8a962d85-6d80-4615-9026-c34b3a73f75b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_afdb0550-dddf-4c31-9a4a-15151c7ac4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_OperatingIncomeLoss_afdb0550-dddf-4c31-9a4a-15151c7ac4fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4efd82e0-2517-4083-a295-0debed7165ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4efd82e0-2517-4083-a295-0debed7165ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_a7052fe7-462a-4447-abcf-5d455e7fd2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:to="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_a7052fe7-462a-4447-abcf-5d455e7fd2ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_cb2c3c5a-104c-46a2-b91b-acf7ce582fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:to="loc_us-gaap_InterestExpense_cb2c3c5a-104c-46a2-b91b-acf7ce582fee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70d9d277-3b1d-449e-95ca-2194ef5d566c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70d9d277-3b1d-449e-95ca-2194ef5d566c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5ed566fc-fe99-4a8e-b300-c48cf17ec691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5ed566fc-fe99-4a8e-b300-c48cf17ec691" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4fd1568b-00ff-4744-b608-9ea69c074efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_NetIncomeLoss_4fd1568b-00ff-4744-b608-9ea69c074efe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a568d953-581b-4ca4-91f1-74aec41392ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:to="loc_us-gaap_EarningsPerShareBasic_a568d953-581b-4ca4-91f1-74aec41392ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5771fb78-c586-4781-9d68-ee330f84a4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5771fb78-c586-4781-9d68-ee330f84a4d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_79c54b5e-2d57-4911-bd50-736796e7c822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_79c54b5e-2d57-4911-bd50-736796e7c822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6303b72-3ad2-4f25-b049-1d4c154571d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6303b72-3ad2-4f25-b049-1d4c154571d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f5145a30-2962-4376-a2cc-7e0dcd40bac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_StatementTable_f5145a30-2962-4376-a2cc-7e0dcd40bac4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9bbc57f3-35bb-4c96-b1af-302b87aa6322" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f5145a30-2962-4376-a2cc-7e0dcd40bac4" xlink:to="loc_srt_ProductOrServiceAxis_9bbc57f3-35bb-4c96-b1af-302b87aa6322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9bbc57f3-35bb-4c96-b1af-302b87aa6322_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9bbc57f3-35bb-4c96-b1af-302b87aa6322" xlink:to="loc_srt_ProductsAndServicesDomain_9bbc57f3-35bb-4c96-b1af-302b87aa6322_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9bbc57f3-35bb-4c96-b1af-302b87aa6322" xlink:to="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_4dbba9ed-5657-4ba1-87c3-97b6f899bdca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:to="loc_us-gaap_RoyaltyMember_4dbba9ed-5657-4ba1-87c3-97b6f899bdca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_40672f29-299a-42e7-903e-a39b84546a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:to="loc_us-gaap_ProductMember_40672f29-299a-42e7-903e-a39b84546a7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_CollaborativeAgreementsMember_b51615f1-8a3b-414b-bc3f-18faba46f379" xlink:href="halo-20210930.xsd#halo_CollaborativeAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:to="loc_halo_CollaborativeAgreementsMember_b51615f1-8a3b-414b-bc3f-18faba46f379" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended" id="i3b0273f8791643698c887bba831996a8_CondensedConsolidatedStatementsofStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0370b0ca-c86d-484d-8cdc-93f921523459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0370b0ca-c86d-484d-8cdc-93f921523459" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_fa10629b-eb5c-475e-9506-e278af128f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_SharesOutstanding_fa10629b-eb5c-475e-9506-e278af128f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6cb95753-e96e-4f6d-b66e-c73cd5be5a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockholdersEquity_6cb95753-e96e-4f6d-b66e-c73cd5be5a7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7737fd67-c3e7-422d-8ef1-aca3ec77c367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7737fd67-c3e7-422d-8ef1-aca3ec77c367" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_887bf7be-4483-40e7-bbb1-6631d72c8075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_887bf7be-4483-40e7-bbb1-6631d72c8075" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_79e32f8e-cc34-461c-a169-b01daa428c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_79e32f8e-cc34-461c-a169-b01daa428c23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_747d4219-79d3-4cd6-bca2-bc5fdadc233f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_747d4219-79d3-4cd6-bca2-bc5fdadc233f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_771577a9-1389-4c1e-9139-0f64ebd6e66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_771577a9-1389-4c1e-9139-0f64ebd6e66c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_de26636c-58e7-45e6-bd23-cdd4c064eb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_de26636c-58e7-45e6-bd23-cdd4c064eb06" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_13fe54da-5908-49a1-9479-4edd3a5ceb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_13fe54da-5908-49a1-9479-4edd3a5ceb7e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_15c3509b-876d-48bf-9112-b54cb622393e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_15c3509b-876d-48bf-9112-b54cb622393e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f4d193dd-a063-4947-8de4-dc746cee7f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f4d193dd-a063-4947-8de4-dc746cee7f18" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_826063d7-f3d8-4fe2-af71-f327248e7f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_826063d7-f3d8-4fe2-af71-f327248e7f0e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1eb9fe52-0f5c-439e-b8fc-2d0d1bbe1c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1eb9fe52-0f5c-439e-b8fc-2d0d1bbe1c01" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_64c25c23-14ec-4eb0-b558-05c10606cfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_NetIncomeLoss_64c25c23-14ec-4eb0-b558-05c10606cfd5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f5e7cc5b-ed1a-4acd-9621-d5b66c4331ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9584d5c-5f31-446f-84ad-a322aec565ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0370b0ca-c86d-484d-8cdc-93f921523459" xlink:to="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb" xlink:to="loc_us-gaap_EquityComponentDomain_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb" xlink:to="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9da6ea98-4ad6-4be7-83b9-645a57a63f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_CommonStockMember_9da6ea98-4ad6-4be7-83b9-645a57a63f63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_259af3e1-a02a-42fc-bcb0-095b98085c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_259af3e1-a02a-42fc-bcb0-095b98085c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b5ba5c04-f5cc-46e6-81db-ed909ae1405c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b5ba5c04-f5cc-46e6-81db-ed909ae1405c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3c700f62-653f-47fb-9079-caac3ac278f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_RetainedEarningsMember_3c700f62-653f-47fb-9079-caac3ac278f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e22b3f12-6ee4-4193-b2fc-779532f73110" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e22b3f12-6ee4-4193-b2fc-779532f73110" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e22b3f12-6ee4-4193-b2fc-779532f73110_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e22b3f12-6ee4-4193-b2fc-779532f73110" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e22b3f12-6ee4-4193-b2fc-779532f73110_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_647814dd-8682-4aae-b254-d58a4652e9ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e22b3f12-6ee4-4193-b2fc-779532f73110" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_647814dd-8682-4aae-b254-d58a4652e9ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f46c43b8-b840-4c6d-a78f-f4f9b5689e7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_647814dd-8682-4aae-b254-d58a4652e9ae" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f46c43b8-b840-4c6d-a78f-f4f9b5689e7a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/OrganizationandBusinessDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#OrganizationandBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/OrganizationandBusinessDetails" xlink:type="extended" id="i8564297692c14ad392e866cfc5cec13d_OrganizationandBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltiesReceivedNumberOfCollaborators_b91f2844-6e5b-4bae-bd34-2062a28d21cb" xlink:href="halo-20210930.xsd#halo_RoyaltiesReceivedNumberOfCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:to="loc_halo_RoyaltiesReceivedNumberOfCollaborators_b91f2844-6e5b-4bae-bd34-2062a28d21cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltiesReceivedNumberOfProductsSold_f5165b36-3734-4079-acce-6f548aecb942" xlink:href="halo-20210930.xsd#halo_RoyaltiesReceivedNumberOfProductsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:to="loc_halo_RoyaltiesReceivedNumberOfProductsSold_f5165b36-3734-4079-acce-6f548aecb942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41428006-9c8a-4b6f-8250-88c3a425e7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41428006-9c8a-4b6f-8250-88c3a425e7b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_19f8f221-1df4-4256-9287-5b9cfc315e2e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41428006-9c8a-4b6f-8250-88c3a425e7b7" xlink:to="loc_srt_CounterpartyNameAxis_19f8f221-1df4-4256-9287-5b9cfc315e2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_19f8f221-1df4-4256-9287-5b9cfc315e2e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_19f8f221-1df4-4256-9287-5b9cfc315e2e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_19f8f221-1df4-4256-9287-5b9cfc315e2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_19f8f221-1df4-4256-9287-5b9cfc315e2e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BaxaltaMember_c12931d2-df7e-4e12-9255-1349a61b124e" xlink:href="halo-20210930.xsd#halo_BaxaltaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:to="loc_halo_BaxaltaMember_c12931d2-df7e-4e12-9255-1349a61b124e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RocheMember_78163233-6c92-40b8-a89d-03a6881f3693" xlink:href="halo-20210930.xsd#halo_RocheMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:to="loc_halo_RocheMember_78163233-6c92-40b8-a89d-03a6881f3693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_JanssenMember_02d7ce1a-0454-493b-ad91-c9f9fbde85d4" xlink:href="halo-20210930.xsd#halo_JanssenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:to="loc_halo_JanssenMember_02d7ce1a-0454-493b-ad91-c9f9fbde85d4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesInventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails" xlink:type="extended" id="ibe0b653b09e049b289b7eb34ec588ecc_SummaryofSignificantAccountingPoliciesInventoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_0acdaeed-f0c2-4076-8f6c-6a3cc955fc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_45ccbf25-d63a-4489-b721-a38bd7eecae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_0acdaeed-f0c2-4076-8f6c-6a3cc955fc1a" xlink:to="loc_us-gaap_InventoryNet_45ccbf25-d63a-4489-b721-a38bd7eecae7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_945a8507-e356-40b8-8b71-d94ef4599691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_0acdaeed-f0c2-4076-8f6c-6a3cc955fc1a" xlink:to="loc_us-gaap_InventoryCurrentTable_945a8507-e356-40b8-8b71-d94ef4599691" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_6aab140a-16a0-49f2-b39a-5baf52c0c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_945a8507-e356-40b8-8b71-d94ef4599691" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_6aab140a-16a0-49f2-b39a-5baf52c0c7cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6aab140a-16a0-49f2-b39a-5baf52c0c7cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_6aab140a-16a0-49f2-b39a-5baf52c0c7cf" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6aab140a-16a0-49f2-b39a-5baf52c0c7cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_6aab140a-16a0-49f2-b39a-5baf52c0c7cf" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_HylenexRecombinantMember_29c51b36-c701-46bc-8869-d97b037f6f9c" xlink:href="halo-20210930.xsd#halo_HylenexRecombinantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:to="loc_halo_HylenexRecombinantMember_29c51b36-c701-46bc-8869-d97b037f6f9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BulkrHuPH20Member_16a206f5-9293-4b4a-b6d5-d05c6d29f73c" xlink:href="halo-20210930.xsd#halo_BulkrHuPH20Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:to="loc_halo_BulkrHuPH20Member_16a206f5-9293-4b4a-b6d5-d05c6d29f73c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesLeasesDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="extended" id="i1b101f73f0754871a79e2b5869d38ce8_SummaryofSignificantAccountingPoliciesLeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c37c78cc-b887-4bf7-8720-e4994b34cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fde6b575-22ab-4696-8982-96fb0b3b1c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c37c78cc-b887-4bf7-8720-e4994b34cb31" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fde6b575-22ab-4696-8982-96fb0b3b1c9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b2f0e6f1-26b4-4948-8494-94e392ba74be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c37c78cc-b887-4bf7-8720-e4994b34cb31" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b2f0e6f1-26b4-4948-8494-94e392ba74be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d959387b-6055-417f-9288-c0f6dfc1b7ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b2f0e6f1-26b4-4948-8494-94e392ba74be" xlink:to="loc_srt_RangeAxis_d959387b-6055-417f-9288-c0f6dfc1b7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d959387b-6055-417f-9288-c0f6dfc1b7ef_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d959387b-6055-417f-9288-c0f6dfc1b7ef" xlink:to="loc_srt_RangeMember_d959387b-6055-417f-9288-c0f6dfc1b7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d959387b-6055-417f-9288-c0f6dfc1b7ef" xlink:to="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c81987fc-c52c-4e43-9005-86e0f8caa1fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:to="loc_srt_MinimumMember_c81987fc-c52c-4e43-9005-86e0f8caa1fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_febeb514-a714-423c-87b4-c5829da02541" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:to="loc_srt_MaximumMember_febeb514-a714-423c-87b4-c5829da02541" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="extended" id="ibfd1b03dc13d41ecac2a8aabd7b69a87_SummaryofSignificantAccountingPoliciesIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fea39564-d9e0-42ff-a613-f9308c019801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fea39564-d9e0-42ff-a613-f9308c019801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7297e497-447d-4399-bd7b-fc3587133693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7297e497-447d-4399-bd7b-fc3587133693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_facae4ac-6937-40e5-ae71-1296d1cd7b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_facae4ac-6937-40e5-ae71-1296d1cd7b1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_33c5ce07-5698-49d0-ba91-9adcb37af0f8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_facae4ac-6937-40e5-ae71-1296d1cd7b1e" xlink:to="loc_srt_StatementScenarioAxis_33c5ce07-5698-49d0-ba91-9adcb37af0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_33c5ce07-5698-49d0-ba91-9adcb37af0f8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_33c5ce07-5698-49d0-ba91-9adcb37af0f8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_33c5ce07-5698-49d0-ba91-9adcb37af0f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_735c25ac-9208-4451-b6db-ec01a7a0bc98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_33c5ce07-5698-49d0-ba91-9adcb37af0f8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_735c25ac-9208-4451-b6db-ec01a7a0bc98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_0e83cda1-1d79-4396-9640-a7fa91734933" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_735c25ac-9208-4451-b6db-ec01a7a0bc98" xlink:to="loc_srt_ScenarioForecastMember_0e83cda1-1d79-4396-9640-a7fa91734933" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails" xlink:type="extended" id="i719dae75c9aa4cc3b1299cfd1f37ebcf_SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0823eb6b-55ed-404c-8228-3408f68814c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:to="loc_us-gaap_StockholdersEquity_0823eb6b-55ed-404c-8228-3408f68814c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4136282f-6371-4985-8511-498ebc955302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:to="loc_us-gaap_DeferredTaxLiabilities_4136282f-6371-4985-8511-498ebc955302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c459c4b1-f6ce-49ae-9959-d478c1918597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:to="loc_us-gaap_LongTermDebt_c459c4b1-f6ce-49ae-9959-d478c1918597" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c0890b-da55-44ae-9024-edb640448eca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c0890b-da55-44ae-9024-edb640448eca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1c0890b-da55-44ae-9024-edb640448eca_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c0890b-da55-44ae-9024-edb640448eca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1c0890b-da55-44ae-9024-edb640448eca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fbc4f1aa-bfb8-49c1-b53c-c648d563c63a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c0890b-da55-44ae-9024-edb640448eca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fbc4f1aa-bfb8-49c1-b53c-c648d563c63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f0fa4d33-58de-4f6b-8b68-e9e1a9bbf896" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fbc4f1aa-bfb8-49c1-b53c-c648d563c63a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f0fa4d33-58de-4f6b-8b68-e9e1a9bbf896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_057e7053-8186-4aa9-9b6a-25af0eecde7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_057e7053-8186-4aa9-9b6a-25af0eecde7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_057e7053-8186-4aa9-9b6a-25af0eecde7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_057e7053-8186-4aa9-9b6a-25af0eecde7f" xlink:to="loc_us-gaap_EquityComponentDomain_057e7053-8186-4aa9-9b6a-25af0eecde7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_057e7053-8186-4aa9-9b6a-25af0eecde7f" xlink:to="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_46a847f3-1143-4714-803e-c14ab5e8a116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_46a847f3-1143-4714-803e-c14ab5e8a116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d32ac510-b860-4e42-b5f5-138a45c07f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:to="loc_us-gaap_RetainedEarningsMember_d32ac510-b860-4e42-b5f5-138a45c07f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4c321867-5fd4-42a0-999d-c6043a939262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4c321867-5fd4-42a0-999d-c6043a939262" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_4c321867-5fd4-42a0-999d-c6043a939262_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4c321867-5fd4-42a0-999d-c6043a939262" xlink:to="loc_us-gaap_TypeOfAdoptionMember_4c321867-5fd4-42a0-999d-c6043a939262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_bf30d29d-f258-4b95-b6e8-a7a0d55cd10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4c321867-5fd4-42a0-999d-c6043a939262" xlink:to="loc_us-gaap_TypeOfAdoptionMember_bf30d29d-f258-4b95-b6e8-a7a0d55cd10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_6fe90f6c-f2d2-41b9-b416-503e5f5ac0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_bf30d29d-f258-4b95-b6e8-a7a0d55cd10b" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_6fe90f6c-f2d2-41b9-b416-503e5f5ac0d9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended" id="i0a2fb922a9804e8ab379ebca1c6f41ae_FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f94f169-32e9-4f7a-80d5-d8e1663fe849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f94f169-32e9-4f7a-80d5-d8e1663fe849" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc72de2c-67a5-4891-b403-56051624daf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc72de2c-67a5-4891-b403-56051624daf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e3933385-18b4-41c0-93cb-de57e2543afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e3933385-18b4-41c0-93cb-de57e2543afc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1016c3e9-f8bc-410d-9011-d94d7c70022c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1016c3e9-f8bc-410d-9011-d94d7c70022c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_673ba21d-ca8b-4826-b803-11dc18449a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_673ba21d-ca8b-4826-b803-11dc18449a6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b17ed997-5cae-412c-82c8-56fcb91db4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_673ba21d-ca8b-4826-b803-11dc18449a6a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b17ed997-5cae-412c-82c8-56fcb91db4a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b17ed997-5cae-412c-82c8-56fcb91db4a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b17ed997-5cae-412c-82c8-56fcb91db4a2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b17ed997-5cae-412c-82c8-56fcb91db4a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b17ed997-5cae-412c-82c8-56fcb91db4a2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_8440489d-ee44-451f-bbde-23c43a987f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_8440489d-ee44-451f-bbde-23c43a987f4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a98f2a60-16ab-465a-9f63-b95cafd883dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a98f2a60-16ab-465a-9f63-b95cafd883dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_32c1008f-65eb-42a9-968e-34f445d95435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_32c1008f-65eb-42a9-968e-34f445d95435" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_7c5deaab-f60c-4aaf-9349-386973eba499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_NonUsMember_7c5deaab-f60c-4aaf-9349-386973eba499" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ad1e76aa-d64c-41a0-899d-ecc29de06063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_CommercialPaperMember_ad1e76aa-d64c-41a0-899d-ecc29de06063" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended" id="i720bd49dffe34a0babd206e82df93045_FairValueMeasurementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_172b2e30-6867-4746-bd29-91f7231e98ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_172b2e30-6867-4746-bd29-91f7231e98ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c2c39b3a-0082-44f5-977e-4a3324d03408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c2c39b3a-0082-44f5-977e-4a3324d03408" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4c92bbf9-c21b-42eb-b935-636543cb4e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4c92bbf9-c21b-42eb-b935-636543cb4e9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_341c0a28-7541-4bf0-a389-c22bc5f13b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_341c0a28-7541-4bf0-a389-c22bc5f13b12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_36799c2d-42f0-4772-998c-b2bbd8f52683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_36799c2d-42f0-4772-998c-b2bbd8f52683" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1e48319e-36cb-4912-abe7-d28ff8c93c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1e48319e-36cb-4912-abe7-d28ff8c93c38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89148f5d-ec1d-4db8-b885-f32b2af3f1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1e48319e-36cb-4912-abe7-d28ff8c93c38" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89148f5d-ec1d-4db8-b885-f32b2af3f1f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_89148f5d-ec1d-4db8-b885-f32b2af3f1f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89148f5d-ec1d-4db8-b885-f32b2af3f1f6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_89148f5d-ec1d-4db8-b885-f32b2af3f1f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dc1609d-e44b-43b0-9d3c-26faa2bdb01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89148f5d-ec1d-4db8-b885-f32b2af3f1f6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dc1609d-e44b-43b0-9d3c-26faa2bdb01c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4c99698b-1887-40c3-a423-a9bfddccc523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dc1609d-e44b-43b0-9d3c-26faa2bdb01c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4c99698b-1887-40c3-a423-a9bfddccc523" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i17bf859f874e49f3a4e3201faac08d1a_FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f25a8be0-67f8-4502-afd9-679eeedcea0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f25a8be0-67f8-4502-afd9-679eeedcea0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b07a1fbf-a4f8-4869-8a25-0d5de855b2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b07a1fbf-a4f8-4869-8a25-0d5de855b2ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_589f3e5a-e8c2-4c9c-a41b-b5b77b6c2ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_589f3e5a-e8c2-4c9c-a41b-b5b77b6c2ec6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f63dfd0f-6aca-4a1c-835a-43d6c4310fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f63dfd0f-6aca-4a1c-835a-43d6c4310fe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2981c41a-2dec-4ea0-864f-260d6ff794f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2981c41a-2dec-4ea0-864f-260d6ff794f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2981c41a-2dec-4ea0-864f-260d6ff794f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2981c41a-2dec-4ea0-864f-260d6ff794f4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2981c41a-2dec-4ea0-864f-260d6ff794f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2981c41a-2dec-4ea0-864f-260d6ff794f4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_36d3ea50-9337-41c8-9add-327e467f9ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_36d3ea50-9337-41c8-9add-327e467f9ee6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a1751aa3-dbf1-4b78-85bc-1b2f1b871fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a1751aa3-dbf1-4b78-85bc-1b2f1b871fa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_996d8f1e-9ade-409d-a7b9-d8c2d1d04c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_996d8f1e-9ade-409d-a7b9-d8c2d1d04c88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8def0b9f-fde2-4217-a151-fc803efb1246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8def0b9f-fde2-4217-a151-fc803efb1246" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8def0b9f-fde2-4217-a151-fc803efb1246_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8def0b9f-fde2-4217-a151-fc803efb1246" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8def0b9f-fde2-4217-a151-fc803efb1246_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8def0b9f-fde2-4217-a151-fc803efb1246" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_33bfc7b7-6fb9-46c3-a7eb-10951bfe7bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_33bfc7b7-6fb9-46c3-a7eb-10951bfe7bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3b06013b-b552-4d78-8885-621d723246ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3b06013b-b552-4d78-8885-621d723246ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7eec9a94-a188-4b4a-8fad-515c4f91e2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7eec9a94-a188-4b4a-8fad-515c4f91e2eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_e82c2b6f-601b-442c-be77-d3071c8a8b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_NonUsMember_e82c2b6f-601b-442c-be77-d3071c8a8b54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_49c42020-011d-40e1-8374-b4e59f4fce3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_CommercialPaperMember_49c42020-011d-40e1-8374-b4e59f4fce3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_28871fe6-5127-4aca-96dd-f3ae8f79268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_28871fe6-5127-4aca-96dd-f3ae8f79268c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_28871fe6-5127-4aca-96dd-f3ae8f79268c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_28871fe6-5127-4aca-96dd-f3ae8f79268c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_28871fe6-5127-4aca-96dd-f3ae8f79268c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_28871fe6-5127-4aca-96dd-f3ae8f79268c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_d2ddfe4b-ee2f-474f-9d40-d22cc9b5000d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_d2ddfe4b-ee2f-474f-9d40-d22cc9b5000d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6e265092-7ef4-44d0-91a6-735d39eaa3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:to="loc_us-gaap_CommercialPaperMember_6e265092-7ef4-44d0-91a6-735d39eaa3ee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueDisaggregatedRevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails" xlink:type="extended" id="ia2ebe55e9f4b42d39a81a06d2a9209da_RevenueDisaggregatedRevenuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1da5b2c4-4f5a-46b6-8d8c-db5f76435457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e392da64-ea58-4960-a872-bdce80458249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1da5b2c4-4f5a-46b6-8d8c-db5f76435457" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e392da64-ea58-4960-a872-bdce80458249" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ad3f2297-39c1-4382-b176-7fdb04352a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1da5b2c4-4f5a-46b6-8d8c-db5f76435457" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ad3f2297-39c1-4382-b176-7fdb04352a4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c8dec563-1f7e-4cdd-8628-d37610ac0ce0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ad3f2297-39c1-4382-b176-7fdb04352a4f" xlink:to="loc_srt_ProductOrServiceAxis_c8dec563-1f7e-4cdd-8628-d37610ac0ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c8dec563-1f7e-4cdd-8628-d37610ac0ce0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c8dec563-1f7e-4cdd-8628-d37610ac0ce0" xlink:to="loc_srt_ProductsAndServicesDomain_c8dec563-1f7e-4cdd-8628-d37610ac0ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c8dec563-1f7e-4cdd-8628-d37610ac0ce0" xlink:to="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_1957549c-9a0f-4eb6-9e31-96624e6398be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_us-gaap_RoyaltyMember_1957549c-9a0f-4eb6-9e31-96624e6398be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BulkrHuPH20Member_7ba8819b-3e97-4956-940a-a49e57fd5785" xlink:href="halo-20210930.xsd#halo_BulkrHuPH20Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:to="loc_halo_BulkrHuPH20Member_7ba8819b-3e97-4956-940a-a49e57fd5785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_HylenexRecombinantMember_9ac55a5d-b926-46c5-979d-d40c6c12c973" xlink:href="halo-20210930.xsd#halo_HylenexRecombinantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:to="loc_halo_HylenexRecombinantMember_9ac55a5d-b926-46c5-979d-d40c6c12c973" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:href="halo-20210930.xsd#halo_CollaborativeAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_DevelopmentFeesMember_ff9a00cb-c9a2-4f1f-9b6a-f4147d92e890" xlink:href="halo-20210930.xsd#halo_DevelopmentFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:to="loc_halo_DevelopmentFeesMember_ff9a00cb-c9a2-4f1f-9b6a-f4147d92e890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ResearchandDevelopmentServicesMember_aac0c4cb-4916-4a8a-a8bb-141c735635a7" xlink:href="halo-20210930.xsd#halo_ResearchandDevelopmentServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:to="loc_halo_ResearchandDevelopmentServicesMember_aac0c4cb-4916-4a8a-a8bb-141c735635a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_UpfrontfeesMember_5b49e029-d49b-432a-a289-e43ee3f7a641" xlink:href="halo-20210930.xsd#halo_UpfrontfeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_halo_UpfrontfeesMember_5b49e029-d49b-432a-a289-e43ee3f7a641" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_SalesbasedmilestoneMember_29e0fc72-cf94-4584-997d-0d721f3eeef1" xlink:href="halo-20210930.xsd#halo_SalesbasedmilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_halo_SalesbasedmilestoneMember_29e0fc72-cf94-4584-997d-0d721f3eeef1" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/RevenueNarrativeDetails" xlink:type="extended" id="i4bfd1ed319cf4f2c9c82e6a50d586ee3_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b70ec634-4e80-4097-bb9a-8a45c2152242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b70ec634-4e80-4097-bb9a-8a45c2152242" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RevenueFromContractWithCustomerVariableConsideration_ab329d23-827b-40cd-bb84-baf11558acda" xlink:href="halo-20210930.xsd#halo_RevenueFromContractWithCustomerVariableConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_halo_RevenueFromContractWithCustomerVariableConsideration_ab329d23-827b-40cd-bb84-baf11558acda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5e7ee0a4-b6ff-4c82-8211-a0a2f95cea92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5e7ee0a4-b6ff-4c82-8211-a0a2f95cea92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_a408cd89-c083-4246-9437-54f175e34b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_DeferredRevenue_a408cd89-c083-4246-9437-54f175e34b48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_9d1200da-d390-4cec-8e2b-28139074c71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_9d1200da-d390-4cec-8e2b-28139074c71c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities_aebc79da-d046-4a6c-8d24-b57074160552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilities_aebc79da-d046-4a6c-8d24-b57074160552" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_160a3658-950e-4352-a859-00b238b30cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_160a3658-950e-4352-a859-00b238b30cbd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement_9003d927-1f93-4fc4-a403-04ddc059cfe5" xlink:href="halo-20210930.xsd#halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement_9003d927-1f93-4fc4-a403-04ddc059cfe5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6d27c0f0-373c-424f-9c34-3752c0110d74" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:to="loc_srt_ProductOrServiceAxis_6d27c0f0-373c-424f-9c34-3752c0110d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6d27c0f0-373c-424f-9c34-3752c0110d74_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6d27c0f0-373c-424f-9c34-3752c0110d74" xlink:to="loc_srt_ProductsAndServicesDomain_6d27c0f0-373c-424f-9c34-3752c0110d74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6d27c0f0-373c-424f-9c34-3752c0110d74" xlink:to="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_226e373e-ba00-4298-895b-8d9293a9372d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:to="loc_us-gaap_ProductMember_226e373e-ba00-4298-895b-8d9293a9372d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_LicenseFeesAndEventBasedMember_4953dce2-930b-4b92-8bd5-0e48bd124edf" xlink:href="halo-20210930.xsd#halo_LicenseFeesAndEventBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:to="loc_halo_LicenseFeesAndEventBasedMember_4953dce2-930b-4b92-8bd5-0e48bd124edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_86109244-31fe-470c-8cf4-98994e5ce324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_86109244-31fe-470c-8cf4-98994e5ce324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_OthercollaboratorsMember_625537c4-cd9c-47ef-9879-2e878af8c1f3" xlink:href="halo-20210930.xsd#halo_OthercollaboratorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_86109244-31fe-470c-8cf4-98994e5ce324" xlink:to="loc_halo_OthercollaboratorsMember_625537c4-cd9c-47ef-9879-2e878af8c1f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueAdditionalRevenueInformationDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails" xlink:type="extended" id="i3c0756f5703a4ec1a58a0eabd0895fd8_RevenueAdditionalRevenueInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4f2cea61-1cce-4b42-b0b2-bfdde3a1a0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4f2cea61-1cce-4b42-b0b2-bfdde3a1a0e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_6c9165ed-59b0-4a70-bfd6-8d0fc0b2a533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_6c9165ed-59b0-4a70-bfd6-8d0fc0b2a533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2fb7a5e6-71ea-465b-8863-77b7ea917f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2fb7a5e6-71ea-465b-8863-77b7ea917f5a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueAdditionalRevenueInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails_1" xlink:type="extended" id="i52ad8b1568ef4f06bbc3c2fb4b1bb59c_RevenueAdditionalRevenueInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4f2cea61-1cce-4b42-b0b2-bfdde3a1a0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4f2cea61-1cce-4b42-b0b2-bfdde3a1a0e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_6c9165ed-59b0-4a70-bfd6-8d0fc0b2a533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_6c9165ed-59b0-4a70-bfd6-8d0fc0b2a533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails" xlink:type="extended" id="i9c3e4d2a172543c4b37307d9f240ef48_CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_a52e7404-89d3-4fec-a75e-b0d5d03e1b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_a52e7404-89d3-4fec-a75e-b0d5d03e1b4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_77db6cc3-27bb-4102-88c7-11d7579a4aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_77db6cc3-27bb-4102-88c7-11d7579a4aba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_e5c4631c-1a86-47c6-b57a-f76b5a90f605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_OtherAssets_e5c4631c-1a86-47c6-b57a-f76b5a90f605" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_8bf8a899-963d-4ee6-a13a-91082a4ae6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssets_8bf8a899-963d-4ee6-a13a-91082a4ae6d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_792fc614-4586-4b3e-abcf-e8d59d9d0cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_792fc614-4586-4b3e-abcf-e8d59d9d0cf8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a026c1c2-3008-431c-8a48-22440288aeea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a026c1c2-3008-431c-8a48-22440288aeea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ff46b11b-008d-4ab0-a995-6a44f9f9bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_StatementTable_ff46b11b-008d-4ab0-a995-6a44f9f9bbb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ff46b11b-008d-4ab0-a995-6a44f9f9bbb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6322b847-24ad-45a7-91d5-fb01b2637b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6322b847-24ad-45a7-91d5-fb01b2637b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ComputerAndOfficeEquipmentMember_58f89f64-2a6a-472a-99e3-576ec2631219" xlink:href="halo-20210930.xsd#halo_ComputerAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6322b847-24ad-45a7-91d5-fb01b2637b95" xlink:to="loc_halo_ComputerAndOfficeEquipmentMember_58f89f64-2a6a-472a-99e3-576ec2631219" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPropertyandEquipmentnetDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails" xlink:type="extended" id="id3d8b66fc1cb4ba3a5302917ef68417b_CertainBalanceSheetItemsPropertyandEquipmentnetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a961eb19-b662-49c8-b9eb-1101e1be0820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a961eb19-b662-49c8-b9eb-1101e1be0820" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d26fc9e9-b9cd-486b-b2d7-dace5a906c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d26fc9e9-b9cd-486b-b2d7-dace5a906c45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ae491d1b-5011-43a6-84ec-ee3b8cedccf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ae491d1b-5011-43a6-84ec-ee3b8cedccf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1e4403c4-e6b8-4ade-ad02-338969adec2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1e4403c4-e6b8-4ade-ad02-338969adec2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_64e535d5-6313-4fbe-9656-4b9c967bc4f0" xlink:href="halo-20210930.xsd#halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_64e535d5-6313-4fbe-9656-4b9c967bc4f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a56ef75-dfaa-40f0-996e-6d5628676e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a56ef75-dfaa-40f0-996e-6d5628676e37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_018c21a8-1e1e-48b5-a67a-5f982b1820d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a56ef75-dfaa-40f0-996e-6d5628676e37" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_018c21a8-1e1e-48b5-a67a-5f982b1820d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_018c21a8-1e1e-48b5-a67a-5f982b1820d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_018c21a8-1e1e-48b5-a67a-5f982b1820d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_018c21a8-1e1e-48b5-a67a-5f982b1820d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_018c21a8-1e1e-48b5-a67a-5f982b1820d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ResearchEquipmentMember_63ce3138-1049-4874-b292-96fc044f49f7" xlink:href="halo-20210930.xsd#halo_ResearchEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_halo_ResearchEquipmentMember_63ce3138-1049-4874-b292-96fc044f49f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ManufacturingEquipmentMember_47799c3b-48bf-4eda-a22f-5a8810b55613" xlink:href="halo-20210930.xsd#halo_ManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_halo_ManufacturingEquipmentMember_47799c3b-48bf-4eda-a22f-5a8810b55613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ComputerAndOfficeEquipmentMember_d9b4b512-3cf0-4dac-b22e-9d180e4867c6" xlink:href="halo-20210930.xsd#halo_ComputerAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_halo_ComputerAndOfficeEquipmentMember_d9b4b512-3cf0-4dac-b22e-9d180e4867c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_7ebccb16-489e-421b-b6de-9b9b78b94033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_7ebccb16-489e-421b-b6de-9b9b78b94033" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails" xlink:type="extended" id="i5653c30c54fb47dea8465f6007410ab5_LongTermDebtNetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_177db1bf-6354-4a6c-81cc-f1008d7cd6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_177db1bf-6354-4a6c-81cc-f1008d7cd6ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d59542e2-492d-41cb-997a-bb7f49c7d4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d59542e2-492d-41cb-997a-bb7f49c7d4ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_54c968ae-3c75-4c3c-aa0a-f48462cd4135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_54c968ae-3c75-4c3c-aa0a-f48462cd4135" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_2bc26083-aaa4-4d98-8186-c265f6ee3c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_2bc26083-aaa4-4d98-8186-c265f6ee3c9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_77aa7ed2-4bf9-4c3d-91ed-8884a512af64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_77aa7ed2-4bf9-4c3d-91ed-8884a512af64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4b3eaf1e-d7de-4615-b08f-c8a3070f6afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4b3eaf1e-d7de-4615-b08f-c8a3070f6afb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0614cf62-058f-4136-b061-fc7cf779de03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0614cf62-058f-4136-b061-fc7cf779de03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_af3bac63-8c1a-43e1-8cb3-4fb3199e1f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_af3bac63-8c1a-43e1-8cb3-4fb3199e1f90" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_088e3189-1454-4577-a9a9-68ac4748142e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_088e3189-1454-4577-a9a9-68ac4748142e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ce972438-4a5c-49dc-a04b-e5008656fafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ce972438-4a5c-49dc-a04b-e5008656fafc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_052d54f4-f971-465b-9204-e4a4998c5c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_052d54f4-f971-465b-9204-e4a4998c5c15" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_da31da85-bb80-49f3-98a6-6981f6b62f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_RepaymentsOfDebt_da31da85-bb80-49f3-98a6-6981f6b62f25" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c8b3569b-bff2-44d7-bc3c-744e3d13f16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c8b3569b-bff2-44d7-bc3c-744e3d13f16b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a2828a7c-fbcc-466e-8e5a-7c2ef5b0f9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a2828a7c-fbcc-466e-8e5a-7c2ef5b0f9d3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1a33e25c-77bc-465c-a888-22e47a9dcc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_LongTermDebt_1a33e25c-77bc-465c-a888-22e47a9dcc69" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_b4347366-76bb-455b-a6bc-2391f792eb93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_ConvertibleNotesPayable_b4347366-76bb-455b-a6bc-2391f792eb93" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_60a23c96-bdaf-4fa7-9692-1086df29c2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentFairValue_60a23c96-bdaf-4fa7-9692-1086df29c2d5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_2f0caf8b-938e-428b-a8f5-40f7df55c95c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_2f0caf8b-938e-428b-a8f5-40f7df55c95c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_c198cd82-2cb5-4ecb-9060-76b11e5240d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_c198cd82-2cb5-4ecb-9060-76b11e5240d0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8c83da98-7af6-46ba-ab44-76f9d4c6ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8c83da98-7af6-46ba-ab44-76f9d4c6ed9a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_527e9a36-5190-4f16-a8f4-113265140a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_InterestExpenseDebt_527e9a36-5190-4f16-a8f4-113265140a7d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_223834e3-1ab5-4390-88c9-65e19912914b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_223834e3-1ab5-4390-88c9-65e19912914b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_8999f781-1f9b-4461-b027-67a7b4888485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_8999f781-1f9b-4461-b027-67a7b4888485" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantCompliance_bf9d767d-e4b5-422c-8301-fd9ae6248aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCovenantCompliance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentCovenantCompliance_bf9d767d-e4b5-422c-8301-fd9ae6248aab" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c098fafc-bab0-4a11-8b2b-89c9688fef0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c098fafc-bab0-4a11-8b2b-89c9688fef0b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1a7d2b6a-4382-4067-af93-6d8a8b3d362d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_LongTermDebtCurrent_1a7d2b6a-4382-4067-af93-6d8a8b3d362d" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_401eb56c-5c1c-4541-8a64-46a172e8b756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_401eb56c-5c1c-4541-8a64-46a172e8b756" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_e82c3f94-9b7c-46ad-a21b-7e7e0d09860c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_e82c3f94-9b7c-46ad-a21b-7e7e0d09860c" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_fe2bb83b-ff9b-4528-aeb9-9d03388c62e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_fe2bb83b-ff9b-4528-aeb9-9d03388c62e6" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_bebbce7b-7731-41fe-a766-1a70d230c598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_bebbce7b-7731-41fe-a766-1a70d230c598" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_217fd908-4ab5-408d-accd-6f7c9f8849e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_217fd908-4ab5-408d-accd-6f7c9f8849e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_217fd908-4ab5-408d-accd-6f7c9f8849e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_217fd908-4ab5-408d-accd-6f7c9f8849e3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_217fd908-4ab5-408d-accd-6f7c9f8849e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_217fd908-4ab5-408d-accd-6f7c9f8849e3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9005b067-8b35-4db3-ba5e-aca0f324a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9005b067-8b35-4db3-ba5e-aca0f324a99d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f09c42ef-d876-474c-b75e-4cfd3364a0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f09c42ef-d876-474c-b75e-4cfd3364a0af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_582882dd-3a73-495f-be9b-e721e7ece064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_582882dd-3a73-495f-be9b-e721e7ece064" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_582882dd-3a73-495f-be9b-e721e7ece064_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_582882dd-3a73-495f-be9b-e721e7ece064" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_582882dd-3a73-495f-be9b-e721e7ece064_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_582882dd-3a73-495f-be9b-e721e7ece064" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_16264458-06b9-46a2-8aa9-818fd6b7022a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:to="loc_us-gaap_ConvertibleDebtMember_16264458-06b9-46a2-8aa9-818fd6b7022a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltybackedLoanMember_055271d0-b1d5-4679-b381-9502afef80f6" xlink:href="halo-20210930.xsd#halo_RoyaltybackedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:to="loc_halo_RoyaltybackedLoanMember_055271d0-b1d5-4679-b381-9502afef80f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_2e1059d3-56db-4ed3-a1f9-aaf9f2159264" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_2e1059d3-56db-4ed3-a1f9-aaf9f2159264" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_12cb8285-a873-4e74-b8bb-e1b935bd468b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_srt_RangeAxis_12cb8285-a873-4e74-b8bb-e1b935bd468b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_12cb8285-a873-4e74-b8bb-e1b935bd468b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_12cb8285-a873-4e74-b8bb-e1b935bd468b" xlink:to="loc_srt_RangeMember_12cb8285-a873-4e74-b8bb-e1b935bd468b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_12cb8285-a873-4e74-b8bb-e1b935bd468b" xlink:to="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4c6e7e1d-bea0-4b1f-93b4-68bea7c82e48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:to="loc_srt_MinimumMember_4c6e7e1d-bea0-4b1f-93b4-68bea7c82e48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_641ad705-bf7d-4e22-bf77-87d659bf3561" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:to="loc_srt_MaximumMember_641ad705-bf7d-4e22-bf77-87d659bf3561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_6160f495-7749-4265-80c8-71ba536d59e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_VariableRateAxis_6160f495-7749-4265-80c8-71ba536d59e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6160f495-7749-4265-80c8-71ba536d59e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_6160f495-7749-4265-80c8-71ba536d59e0" xlink:to="loc_us-gaap_VariableRateDomain_6160f495-7749-4265-80c8-71ba536d59e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21f50b70-d5bf-4f5a-b092-51670e01024c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_6160f495-7749-4265-80c8-71ba536d59e0" xlink:to="loc_us-gaap_VariableRateDomain_21f50b70-d5bf-4f5a-b092-51670e01024c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e13edd8-2e01-47f7-92ea-f6ce2b375845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_21f50b70-d5bf-4f5a-b092-51670e01024c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e13edd8-2e01-47f7-92ea-f6ce2b375845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e4358515-9ba7-445c-9c32-d10b89e3a230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_DebtInstrumentAxis_e4358515-9ba7-445c-9c32-d10b89e3a230" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e4358515-9ba7-445c-9c32-d10b89e3a230_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4358515-9ba7-445c-9c32-d10b89e3a230" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e4358515-9ba7-445c-9c32-d10b89e3a230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4358515-9ba7-445c-9c32-d10b89e3a230" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_ba6cca86-ee4c-4b32-acf6-57df4f90a039" xlink:href="halo-20210930.xsd#halo_A1.25ConvertibleSeniorNotesdue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:to="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_ba6cca86-ee4c-4b32-acf6-57df4f90a039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_5143ae07-f77b-4220-b0cb-0d76c692e1c3" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_5143ae07-f77b-4220-b0cb-0d76c692e1c3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNetCarryingAmountofConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails" xlink:type="extended" id="i157de07c79f747eaa3a9e38c829c6ca1_LongTermDebtNetCarryingAmountofConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_dfb07fb1-9235-42d9-9711-341a267c5040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_dfb07fb1-9235-42d9-9711-341a267c5040" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2c78029b-d2df-42f5-8840-7786d0d15c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2c78029b-d2df-42f5-8840-7786d0d15c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_47b4d5f8-375b-4274-84b1-e542687f882b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_LongTermDebtCurrent_47b4d5f8-375b-4274-84b1-e542687f882b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1185dd13-4e35-45a7-afa6-de3a971f0051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_LongTermDebt_1185dd13-4e35-45a7-afa6-de3a971f0051" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_b07f4255-6328-4ca8-b52b-108220cff7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_ConvertibleNotesPayable_b07f4255-6328-4ca8-b52b-108220cff7b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8239e4f8-a976-4b56-bf01-1b78eaceff23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8239e4f8-a976-4b56-bf01-1b78eaceff23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a9d13812-a466-48ac-955b-0fc87b97c9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a9d13812-a466-48ac-955b-0fc87b97c9b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df6af012-0d0e-4511-b5ad-a1992a4d175f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentTable_df6af012-0d0e-4511-b5ad-a1992a4d175f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_95c07c39-cba7-40f0-8314-3408c634f4be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_df6af012-0d0e-4511-b5ad-a1992a4d175f" xlink:to="loc_us-gaap_DebtInstrumentAxis_95c07c39-cba7-40f0-8314-3408c634f4be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95c07c39-cba7-40f0-8314-3408c634f4be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_95c07c39-cba7-40f0-8314-3408c634f4be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95c07c39-cba7-40f0-8314-3408c634f4be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_95c07c39-cba7-40f0-8314-3408c634f4be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_c64ff821-ba61-40ae-b30d-057dce3987c3" xlink:href="halo-20210930.xsd#halo_A1.25ConvertibleSeniorNotesdue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:to="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_c64ff821-ba61-40ae-b30d-057dce3987c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_8f66ef05-a49e-4398-9ee3-833e05db64d1" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_8f66ef05-a49e-4398-9ee3-833e05db64d1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNetComponentsofInterestExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails" xlink:type="extended" id="idfd9bb87aa494111a1148bf0b312de1a_LongTermDebtNetComponentsofInterestExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_b6859b7c-42c4-4a10-95d2-3b7397507e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_b6859b7c-42c4-4a10-95d2-3b7397507e12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_df62109b-fbb2-404a-af7d-f4c0fda77839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_df62109b-fbb2-404a-af7d-f4c0fda77839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_99e0bc54-ef99-4b9c-801a-604c158adc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_InterestExpenseDebt_99e0bc54-ef99-4b9c-801a-604c158adc2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_133cde4f-ff13-4a0a-b632-7365699f9a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_133cde4f-ff13-4a0a-b632-7365699f9a88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:to="loc_us-gaap_DebtInstrumentAxis_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_1dc370b3-cbf8-425c-9cf7-c5fd76e06cb8" xlink:href="halo-20210930.xsd#halo_A1.25ConvertibleSeniorNotesdue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:to="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_1dc370b3-cbf8-425c-9cf7-c5fd76e06cb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_77910ee8-b968-4fe0-80c9-57a080d45b11" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_77910ee8-b968-4fe0-80c9-57a080d45b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6753caa1-f9b7-4cee-a521-09ffe7db73e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6753caa1-f9b7-4cee-a521-09ffe7db73e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6753caa1-f9b7-4cee-a521-09ffe7db73e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6753caa1-f9b7-4cee-a521-09ffe7db73e8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6753caa1-f9b7-4cee-a521-09ffe7db73e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9b05b355-09be-4d3e-89c0-7a97b6a0a713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6753caa1-f9b7-4cee-a521-09ffe7db73e8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9b05b355-09be-4d3e-89c0-7a97b6a0a713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_601b8daf-28c5-4b1f-adb9-5dedde50daf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9b05b355-09be-4d3e-89c0-7a97b6a0a713" xlink:to="loc_us-gaap_ConvertibleDebtMember_601b8daf-28c5-4b1f-adb9-5dedde50daf5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationSharebasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" xlink:type="extended" id="ibdae448a91414525b93ff3b5af3faba2_SharebasedCompensationSharebasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_787d7634-8c11-4360-8da5-29cde33c01b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_787d7634-8c11-4360-8da5-29cde33c01b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_38e123b0-95a6-49e8-89eb-a7d3fcd2133a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_38e123b0-95a6-49e8-89eb-a7d3fcd2133a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1549486b-bf90-4185-a2e7-47899ba934fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1549486b-bf90-4185-a2e7-47899ba934fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1549486b-bf90-4185-a2e7-47899ba934fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1549486b-bf90-4185-a2e7-47899ba934fa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1549486b-bf90-4185-a2e7-47899ba934fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1549486b-bf90-4185-a2e7-47899ba934fa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52dfe0ed-8a21-40ae-a15d-9b9a9620ddd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52dfe0ed-8a21-40ae-a15d-9b9a9620ddd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_427fb35f-85db-4623-af2b-7b8ef59f9523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_427fb35f-85db-4623-af2b-7b8ef59f9523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:to="loc_us-gaap_AwardTypeAxis_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_59f657b2-cbb0-441d-92cd-d6cac1d98a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:to="loc_us-gaap_EmployeeStockOptionMember_59f657b2-cbb0-441d-92cd-d6cac1d98a11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RSURSAandPRSUawardsMember_c3670f61-b3b8-490f-bfcd-a2146edd4ca4" xlink:href="halo-20210930.xsd#halo_RSURSAandPRSUawardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:to="loc_halo_RSURSAandPRSUawardsMember_c3670f61-b3b8-490f-bfcd-a2146edd4ca4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails" xlink:type="extended" id="i8981e30393f544df8b7829f5b5a839bc_SharebasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1d406858-0d0d-4f1b-b834-efe52676508a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1d406858-0d0d-4f1b-b834-efe52676508a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c63db9f4-52f6-4146-903b-f2a3a736a469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c63db9f4-52f6-4146-903b-f2a3a736a469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_39a6ddd4-e599-4582-9f0d-19a1d4bd6cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_39a6ddd4-e599-4582-9f0d-19a1d4bd6cad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_bf99fe0c-6e95-4b94-bcfc-d7892a1fd879" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_bf99fe0c-6e95-4b94-bcfc-d7892a1fd879" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8875352-e803-43b1-8afe-2985cf32264c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8875352-e803-43b1-8afe-2985cf32264c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate_fd63e80d-c23b-43d1-aa76-9b1759f3de8d" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate_fd63e80d-c23b-43d1-aa76-9b1759f3de8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_91a3947e-a289-42a1-b09b-f87276ffce17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_91a3947e-a289-42a1-b09b-f87276ffce17" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_10d8ff7b-b437-4b35-873e-9b2bace41acd" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_10d8ff7b-b437-4b35-873e-9b2bace41acd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ddb04952-65b5-4f13-8c42-745e31b4b4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:to="loc_us-gaap_AwardTypeAxis_ddb04952-65b5-4f13-8c42-745e31b4b4d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddb04952-65b5-4f13-8c42-745e31b4b4d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ddb04952-65b5-4f13-8c42-745e31b4b4d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddb04952-65b5-4f13-8c42-745e31b4b4d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ddb04952-65b5-4f13-8c42-745e31b4b4d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ec212fd5-cd47-47b7-bdcb-cee603e7f25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ec212fd5-cd47-47b7-bdcb-cee603e7f25b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RSURSAandPRSUawardsMember_049332b7-c869-4720-acfc-65be72662c6a" xlink:href="halo-20210930.xsd#halo_RSURSAandPRSUawardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:to="loc_halo_RSURSAandPRSUawardsMember_049332b7-c869-4720-acfc-65be72662c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d5322c02-d664-408f-8ec5-130f40862b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:to="loc_us-gaap_EmployeeStockMember_d5322c02-d664-408f-8ec5-130f40862b7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a1087f85-c472-4a52-b8a5-63cca2372306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:to="loc_us-gaap_PlanNameAxis_a1087f85-c472-4a52-b8a5-63cca2372306" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a1087f85-c472-4a52-b8a5-63cca2372306_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_a1087f85-c472-4a52-b8a5-63cca2372306" xlink:to="loc_us-gaap_PlanNameDomain_a1087f85-c472-4a52-b8a5-63cca2372306_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e9e081ec-05fe-4a87-b92f-d4d5a293ff76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_a1087f85-c472-4a52-b8a5-63cca2372306" xlink:to="loc_us-gaap_PlanNameDomain_e9e081ec-05fe-4a87-b92f-d4d5a293ff76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2021ESPPPlanMember_c9a44b8e-039d-40cf-9f04-62fa84178b2d" xlink:href="halo-20210930.xsd#halo_A2021ESPPPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e9e081ec-05fe-4a87-b92f-d4d5a293ff76" xlink:to="loc_halo_A2021ESPPPlanMember_c9a44b8e-039d-40cf-9f04-62fa84178b2d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails" xlink:type="extended" id="ied78a36181bb4cc1a2199bb81198aa81_SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:href="halo-20210930.xsd#halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54cd271e-1fb5-45a6-8ffb-69132332aaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54cd271e-1fb5-45a6-8ffb-69132332aaaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f814dd49-81a7-4c5a-a5f5-c1a7c4d6ad70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f814dd49-81a7-4c5a-a5f5-c1a7c4d6ad70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_9d03b3e1-8c8a-4be0-ac2d-605232796485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_9d03b3e1-8c8a-4be0-ac2d-605232796485" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_bbbae9db-b113-4219-ab84-09ac16fe1d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_bbbae9db-b113-4219-ab84-09ac16fe1d06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fbe38c6-a145-4122-8c62-d2a68ce101ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fbe38c6-a145-4122-8c62-d2a68ce101ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_69ebcfad-014d-4d2f-9d9c-2085980e5ca7" xlink:href="halo-20210930.xsd#halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_69ebcfad-014d-4d2f-9d9c-2085980e5ca7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_331b2f7f-e933-4a1e-86c5-0ff59d557f4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_69ebcfad-014d-4d2f-9d9c-2085980e5ca7" xlink:to="loc_srt_RangeAxis_331b2f7f-e933-4a1e-86c5-0ff59d557f4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_331b2f7f-e933-4a1e-86c5-0ff59d557f4d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_331b2f7f-e933-4a1e-86c5-0ff59d557f4d" xlink:to="loc_srt_RangeMember_331b2f7f-e933-4a1e-86c5-0ff59d557f4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_331b2f7f-e933-4a1e-86c5-0ff59d557f4d" xlink:to="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8b9ed6ff-7393-4996-af2b-09e811ba7b3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:to="loc_srt_MinimumMember_8b9ed6ff-7393-4996-af2b-09e811ba7b3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_798928de-9ac4-44cf-9d8d-fe2295fbfb9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:to="loc_srt_MaximumMember_798928de-9ac4-44cf-9d8d-fe2295fbfb9a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails" xlink:type="extended" id="ia0f72f8d15ca47358995f206073145fa_SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d731aa52-e3ed-45c5-b8d4-94d50ec265e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d731aa52-e3ed-45c5-b8d4-94d50ec265e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d4ca5d63-5f39-4639-8d63-942eb3e9297e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d4ca5d63-5f39-4639-8d63-942eb3e9297e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bee1719b-3aa5-4d3c-aa0c-39998cb0a66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bee1719b-3aa5-4d3c-aa0c-39998cb0a66c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a9029070-b095-4047-92b1-365d4b638d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bee1719b-3aa5-4d3c-aa0c-39998cb0a66c" xlink:to="loc_us-gaap_AwardTypeAxis_a9029070-b095-4047-92b1-365d4b638d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a9029070-b095-4047-92b1-365d4b638d5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a9029070-b095-4047-92b1-365d4b638d5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a9029070-b095-4047-92b1-365d4b638d5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a9029070-b095-4047-92b1-365d4b638d5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c6a958b2-b27a-4f7c-bb47-d95d8dd3d846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c6a958b2-b27a-4f7c-bb47-d95d8dd3d846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_256a34fc-fdbc-48da-b0f7-574ddd441bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_RestrictedStockMember_256a34fc-fdbc-48da-b0f7-574ddd441bbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9f3a17fb-26c4-4b3c-bd99-5dd0faf19be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9f3a17fb-26c4-4b3c-bd99-5dd0faf19be8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bcdeda82-db80-43a5-a043-578070b80237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_PerformanceSharesMember_bcdeda82-db80-43a5-a043-578070b80237" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_09c3c4ac-d4ed-4bb2-803e-733f82cfb757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_EmployeeStockMember_09c3c4ac-d4ed-4bb2-803e-733f82cfb757" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="ieab63597bc3e493b81ce882ed89b52cb_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b90e11-8815-4af3-bace-2dc8dd2edb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b90e11-8815-4af3-bace-2dc8dd2edb2f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d33192ad-b354-4fa9-8f12-5a039ffaf6de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d33192ad-b354-4fa9-8f12-5a039ffaf6de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1e5da4b7-7923-4175-b874-165c4a1fc059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1e5da4b7-7923-4175-b874-165c4a1fc059" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_253e205e-aa1c-4651-b54f-3d4e726f6e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_253e205e-aa1c-4651-b54f-3d4e726f6e9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6c0fc219-eb6c-40da-8b94-70121251ed92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6c0fc219-eb6c-40da-8b94-70121251ed92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b2e06458-efe9-465f-b79c-4e727f160bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b2e06458-efe9-465f-b79c-4e727f160bf7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_37db5d8f-3462-4d2c-aee5-865ee428808d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_37db5d8f-3462-4d2c-aee5-865ee428808d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a0ad274-cc5c-4628-90b7-b540ed1468bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a0ad274-cc5c-4628-90b7-b540ed1468bf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b8b38d9a-c13d-490d-a917-cd25c59fb9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b8b38d9a-c13d-490d-a917-cd25c59fb9b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_dec0ee38-5be7-4051-9a67-beb7e0076809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_dec0ee38-5be7-4051-9a67-beb7e0076809" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_576448f8-6435-44ef-a195-9e243f635166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_576448f8-6435-44ef-a195-9e243f635166" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_db63cd69-29ea-45ec-ad22-c9d3b66212df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_db63cd69-29ea-45ec-ad22-c9d3b66212df" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_48c156fa-979e-49bd-947f-03a4e99704e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_48c156fa-979e-49bd-947f-03a4e99704e9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b90e11-8815-4af3-bace-2dc8dd2edb2f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a150dd34-84a0-4b2d-89e5-cdf6df730a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:to="loc_us-gaap_AwardTypeAxis_a150dd34-84a0-4b2d-89e5-cdf6df730a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a150dd34-84a0-4b2d-89e5-cdf6df730a57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a150dd34-84a0-4b2d-89e5-cdf6df730a57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a150dd34-84a0-4b2d-89e5-cdf6df730a57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a150dd34-84a0-4b2d-89e5-cdf6df730a57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_18d05c17-16dd-41d3-901e-bcb44ddac0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:to="loc_us-gaap_EmployeeStockOptionMember_18d05c17-16dd-41d3-901e-bcb44ddac0ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_56b0f02d-8749-4524-b3ea-c49d85d528a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_56b0f02d-8749-4524-b3ea-c49d85d528a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_StockOptionsAndRestrictedStockUnitsMember_f635dd54-05d8-4b2b-a9a3-e2a5b1d763f1" xlink:href="halo-20210930.xsd#halo_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:to="loc_halo_StockOptionsAndRestrictedStockUnitsMember_f635dd54-05d8-4b2b-a9a3-e2a5b1d763f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_336747e7-678c-43c4-b5ae-6b4a24261599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_336747e7-678c-43c4-b5ae-6b4a24261599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_336747e7-678c-43c4-b5ae-6b4a24261599_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_336747e7-678c-43c4-b5ae-6b4a24261599" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_336747e7-678c-43c4-b5ae-6b4a24261599_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_336747e7-678c-43c4-b5ae-6b4a24261599" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2020ShareRepurchaseProgramBankOfAmericaMember_9faa74f6-6a83-45c3-b5a9-765e98dbd54e" xlink:href="halo-20210930.xsd#halo_A2020ShareRepurchaseProgramBankOfAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:to="loc_halo_A2020ShareRepurchaseProgramBankOfAmericaMember_9faa74f6-6a83-45c3-b5a9-765e98dbd54e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2021ShareRepurchaseProgramBankOfAmericaMember_8c9729ac-dbec-4c65-81f0-da3b835acbea" xlink:href="halo-20210930.xsd#halo_A2021ShareRepurchaseProgramBankOfAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:to="loc_halo_A2021ShareRepurchaseProgramBankOfAmericaMember_8c9729ac-dbec-4c65-81f0-da3b835acbea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#NetIncomelosspershareSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails" xlink:type="extended" id="i39d832ef30e046448045c5a9f15a4e75_NetIncomelosspershareSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bfeff8b7-ee74-4097-9fae-bfa9faaa576d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_NetIncomeLoss_bfeff8b7-ee74-4097-9fae-bfa9faaa576d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e905e14a-e10d-4418-a39e-8132565f8120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e905e14a-e10d-4418-a39e-8132565f8120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c8d3e901-8437-4d02-bc1e-7ba893b286e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c8d3e901-8437-4d02-bc1e-7ba893b286e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8872f4d2-2f50-4136-b663-269034211b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8872f4d2-2f50-4136-b663-269034211b06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cbec5abe-8fdf-4df5-b72d-9ea1d9b28dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:to="loc_us-gaap_EarningsPerShareBasic_cbec5abe-8fdf-4df5-b72d-9ea1d9b28dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_820c9ed7-ffd2-4ba0-9d0d-e7496a2a80ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_820c9ed7-ffd2-4ba0-9d0d-e7496a2a80ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9343e6c7-524c-4a1f-83cc-199df1a270e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:to="loc_us-gaap_AwardTypeAxis_9343e6c7-524c-4a1f-83cc-199df1a270e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9343e6c7-524c-4a1f-83cc-199df1a270e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9343e6c7-524c-4a1f-83cc-199df1a270e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9343e6c7-524c-4a1f-83cc-199df1a270e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9343e6c7-524c-4a1f-83cc-199df1a270e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5fcf7bfc-1408-42ca-95d6-7003ecf4ac09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5fcf7bfc-1408-42ca-95d6-7003ecf4ac09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8045a51e-d594-42d4-a783-2c6c4b29d25a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:to="loc_us-gaap_RestrictedStockMember_8045a51e-d594-42d4-a783-2c6c4b29d25a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b9c763a8-f512-4389-b0cb-48815d988570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:to="loc_us-gaap_DebtInstrumentAxis_b9c763a8-f512-4389-b0cb-48815d988570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b9c763a8-f512-4389-b0cb-48815d988570_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9c763a8-f512-4389-b0cb-48815d988570" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b9c763a8-f512-4389-b0cb-48815d988570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18f145a6-94c7-41c2-a622-dcf15a35ada8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9c763a8-f512-4389-b0cb-48815d988570" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18f145a6-94c7-41c2-a622-dcf15a35ada8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_61ab494a-d438-453d-a344-a6bdf752e947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f145a6-94c7-41c2-a622-dcf15a35ada8" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_61ab494a-d438-453d-a344-a6bdf752e947" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>halo-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6c74ed58-0fb3-4e7f-8898-7f3e050a41d3,g:ea6d4314-a92d-42b4-b437-e2e1177b3d7b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_halo_DeferredRentPayments_6792aec1-d704-41af-aa79-b82e04f6bfcc_negatedTerseLabel_en-US" xlink:label="lab_halo_DeferredRentPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease payments deferred</link:label>
    <link:label id="lab_halo_DeferredRentPayments_label_en-US" xlink:label="lab_halo_DeferredRentPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Payments</link:label>
    <link:label id="lab_halo_DeferredRentPayments_documentation_en-US" xlink:label="lab_halo_DeferredRentPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_DeferredRentPayments" xlink:href="halo-20210930.xsd#halo_DeferredRentPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_DeferredRentPayments" xlink:to="lab_halo_DeferredRentPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_556b3519-a50f-4f48-a1eb-47f666a54ad1_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_14d2e57c-592e-40b5-894b-cf5e1b726018_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share repurchases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_8ce9eef6-15b4-4d12-9b17-18850790b43c_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_49f5d793-0c32-4977-bd1d-1d8914758910_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b72d1da-50f2-4397-b5e6-9581d5c980e2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_0d1cb920-3063-4ccb-809b-7e31007ea679_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a265d1d7-cb7d-48fc-b9af-9d01ec805c87_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_dbdd0bf3-b086-4eae-9df8-7c17b1c35e7b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_043b5143-2082-4995-bdd5-fc6ddf114e8c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_dce6b695-f5ed-4868-9990-64080a24f608_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_c7441dbd-57b3-465c-a287-5431791e96b5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0c0c5d69-d66b-42d8-978d-db0538fe4b11_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and payroll taxes</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_791b1414-a932-4990-93e1-d52a10039610_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_979d77f9-8e96-42c6-9cb0-d216b167a88a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9f320b78-f287-4200-b421-efa606bdeabf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_c4aa03e1-5095-41f0-8082-397d5b713b7a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ComputerAndOfficeEquipmentMember_72e94e0d-e63c-4db3-8432-3c4f01e1ab29_terseLabel_en-US" xlink:label="lab_halo_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment</link:label>
    <link:label id="lab_halo_ComputerAndOfficeEquipmentMember_label_en-US" xlink:label="lab_halo_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:label id="lab_halo_ComputerAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_halo_ComputerAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ComputerAndOfficeEquipmentMember" xlink:href="halo-20210930.xsd#halo_ComputerAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ComputerAndOfficeEquipmentMember" xlink:to="lab_halo_ComputerAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_132434b9-391a-4a27-9b23-82249db3d153_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ba59805c-49aa-4026-a836-7cf55157bba4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_e118a3ba-e381-4044-8e55-298c2519f768_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_c55224a9-8522-473d-a783-a4e73e2daa10_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_99e0f9d1-302f-4dc3-9901-61427772a0e7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, deferred revenues from contracts with customers, and amounts under collaborative agreements included in transaction price</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_11714b9d-7137-456d-8737-b1accb026f2e_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e60bc29c-fc06-4df8-9a21-06cd6e8b8785_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_fd7a3a86-9a01-4315-acd7-fc5eb986e821_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_076f90f2-14b4-47fa-aa63-48465abdafb9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f34a7c6-9551-4fd8-802f-8903f6a07649_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0fb97402-dce7-4d67-bed9-c280df62eb4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7b9d174d-dd64-4ef0-adc6-d3e77c90c1e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d4444eb7-06b1-4c6a-b31e-34ca0071ec56_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_2fd11f41-ba8e-4671-9096-28a6c57a911d_terseLabel_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contribution amount</link:label>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_label_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount</link:label>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_documentation_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:to="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf7b9046-bd49-423b-855b-47a5bb103005_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_c4451ca5-d2dd-4a3b-a821-14374671f144_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of available-for-sale marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_StockOptionsAndRestrictedStockUnitsMember_dc7b47c5-8716-4425-863f-d7b01588daf9_terseLabel_en-US" xlink:label="lab_halo_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and restricted units</link:label>
    <link:label id="lab_halo_StockOptionsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_halo_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_halo_StockOptionsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_halo_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_StockOptionsAndRestrictedStockUnitsMember" xlink:href="halo-20210930.xsd#halo_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_StockOptionsAndRestrictedStockUnitsMember" xlink:to="lab_halo_StockOptionsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_840a285a-9c76-464c-84a1-b9eb9e91d8ba_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_acfe5aa1-b24d-4b12-9b6c-d5c58ff6075a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9581dab0-8f5a-4292-b2d5-c36f78c55802_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_931a4953-b103-41f3-bcfe-e1de1305444e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from per share calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_OperatingLeaseAccretionOfLiability_ed865a4a-b578-4e70-a1af-d61528c215f6_terseLabel_en-US" xlink:label="lab_halo_OperatingLeaseAccretionOfLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense associated with accretion of lease liabilities</link:label>
    <link:label id="lab_halo_OperatingLeaseAccretionOfLiability_label_en-US" xlink:label="lab_halo_OperatingLeaseAccretionOfLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Accretion Of Liability</link:label>
    <link:label id="lab_halo_OperatingLeaseAccretionOfLiability_documentation_en-US" xlink:label="lab_halo_OperatingLeaseAccretionOfLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Accretion Of Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_OperatingLeaseAccretionOfLiability" xlink:href="halo-20210930.xsd#halo_OperatingLeaseAccretionOfLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_OperatingLeaseAccretionOfLiability" xlink:to="lab_halo_OperatingLeaseAccretionOfLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_445c293f-52be-4c72-bc11-765c729ac9bc_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3180bee7-faa9-4598-86fe-caf2e7294fd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8df5440c-32c7-4005-b9dc-9334c120c893_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_3f0cd120-78f2-4736-9591-9ecc5bb577b0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_ee50b8c3-7c1e-42db-a86e-8cfcd4dc7541_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents and Marketable Securities and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3632a65a-88af-478f-9a5b-3b15b5283d4b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_7977a4da-b661-4338-bcd7-fc2d312ceb35_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_a343eb7e-98e8-40d3-96ab-2dc7910af6cf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued for conversion of debt instrument (shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d4d6383d-8978-4e4c-b2b6-a58f8e5ca2da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_30560ff2-a3ba-442a-9777-ec3b1bd91b7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_e9a54c61-860a-40a1-bb06-42e247cef18e_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_b10769d5-6eba-4c0a-87fc-23ab4382cd84_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of contractual maturities of available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ResearchEquipmentMember_707c6457-ddc0-410d-9c9a-b2aa14a598f3_terseLabel_en-US" xlink:label="lab_halo_ResearchEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research equipment</link:label>
    <link:label id="lab_halo_ResearchEquipmentMember_label_en-US" xlink:label="lab_halo_ResearchEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Equipment [Member]</link:label>
    <link:label id="lab_halo_ResearchEquipmentMember_documentation_en-US" xlink:label="lab_halo_ResearchEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ResearchEquipmentMember" xlink:href="halo-20210930.xsd#halo_ResearchEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ResearchEquipmentMember" xlink:to="lab_halo_ResearchEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5f9ddae2-12da-47a4-9024-1b2d806ddbfd_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_84d21b13-5e40-4345-b41c-453b1e0c5faa_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock - $0.001 par value; 20,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_343897a5-d666-44a9-b480-09c2879f33a1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d01199d0-05f9-4618-9b8d-d518b409097d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ee8eeef1-6923-46a2-9aa7-0e8d377a54d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding stock options and restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9fb2b4bf-b9da-461a-b752-bc2a2585e237_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_71a84d37-b2e9-4d88-a80a-7aa70d258ff5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_011c616f-be13-49f6-b9c0-c14def9d0d49_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_92adbbca-58a3-493c-a5bb-d525a7ccbbd4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1d308ea0-6a74-4eb3-a113-3836803affc3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_e9688606-0489-4677-9852-6eb3ab21ff04_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ManufacturingEquipmentMember_fab6bacb-2ea2-47fd-b38d-18a1d361783f_terseLabel_en-US" xlink:label="lab_halo_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing equipment</link:label>
    <link:label id="lab_halo_ManufacturingEquipmentMember_label_en-US" xlink:label="lab_halo_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment [Member]</link:label>
    <link:label id="lab_halo_ManufacturingEquipmentMember_documentation_en-US" xlink:label="lab_halo_ManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ManufacturingEquipmentMember" xlink:href="halo-20210930.xsd#halo_ManufacturingEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ManufacturingEquipmentMember" xlink:to="lab_halo_ManufacturingEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4ddddcce-053b-4590-9a3d-584ce0265aea_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_ca355a39-377b-4870-9148-a32e4d7d4ac2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_777947ee-aedc-422b-ab3c-795ee8a0ccd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_6384fac0-bd36-405c-9dac-b7e836b02d78_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_5f8b2635-9220-4a61-ab1e-b625b9c6a4d2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net and other contract assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_c0ac8a8a-dbff-4495-acb9-141723b12c58_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts accrued for purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b69a294b-3359-46ff-a5b2-ee659c87349e_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligation</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_b8ba2997-8219-47d4-a052-13b40bd320cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee subscription rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice_e40e7a4c-3dc4-47ff-b04d-74031a9b8c12_terseLabel_en-US" xlink:label="lab_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of contract termination by written notice</link:label>
    <link:label id="lab_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice_label_en-US" xlink:label="lab_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Period Of Termination By Written Notice</link:label>
    <link:label id="lab_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice_documentation_en-US" xlink:label="lab_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Period Of Termination By Written Notice</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" xlink:href="halo-20210930.xsd#halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" xlink:to="lab_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_6bf8da78-61c7-4893-b4ba-e7a0e6dbe95b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_ab80864a-5ebb-4e5c-855b-462af436bd0c_verboseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of RSUs withheld to pay for minimum withholding taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_492a23d8-5ded-4a4e-b767-70ba7a1b15ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_fc3a7f91-4386-4ad4-b50a-2ab54ae362ce_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_f9edd7af-9459-45a5-9d73-6567abbcf5f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_ac25ea79-07b9-4055-bb64-2488f1845b0a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_RoyaltiesReceivedNumberOfCollaborators_9493cdbe-e7a0-43da-b479-571c6269b696_terseLabel_en-US" xlink:label="lab_halo_RoyaltiesReceivedNumberOfCollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties Received, Number of Collaborators</link:label>
    <link:label id="lab_halo_RoyaltiesReceivedNumberOfCollaborators_label_en-US" xlink:label="lab_halo_RoyaltiesReceivedNumberOfCollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties Received, Number of Collaborators</link:label>
    <link:label id="lab_halo_RoyaltiesReceivedNumberOfCollaborators_documentation_en-US" xlink:label="lab_halo_RoyaltiesReceivedNumberOfCollaborators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties Received, Number of Collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltiesReceivedNumberOfCollaborators" xlink:href="halo-20210930.xsd#halo_RoyaltiesReceivedNumberOfCollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_RoyaltiesReceivedNumberOfCollaborators" xlink:to="lab_halo_RoyaltiesReceivedNumberOfCollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_27fc4c08-4cd1-4da8-812c-fcd4225a72f9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8bda2e35-f4b2-4ef5-95f5-eacabbf2edf3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a2321da0-75a3-47b5-894e-82a51986553e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_b7a07d89-58ce-4adf-8d32-695157d0c160_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_cd55481f-4ed0-4d72-b629-f636958fa6ba_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_a3632c5c-40f2-4b95-b980-3e8c5aed61e6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense recognized</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_4cf50411-c9c3-4f7e-9d6a-123af240fe94_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid manufacturing expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9cd2a976-015d-4471-8c83-2d1d7211861d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregation of revenues</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_578c367d-8028-4b7d-b669-7e8c4c67ef6e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b97f0108-a6ef-4df4-911d-30c41957a13a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_049c5cec-a2bd-4d33-b9e1-5d5435a899ab_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_8230846b-0a30-4297-bfcd-26ed1acbe183_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_bc53e6ff-c50c-4c1c-a061-b39fa26114b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts related to leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_8719e19a-8ba8-4347-a1ad-3e33430bce88_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_Accountsreceivablefromcollaborators_844dcfd0-3f04-4305-a397-854645422603_terseLabel_en-US" xlink:label="lab_halo_Accountsreceivablefromcollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from revenues under collaborative agreements</link:label>
    <link:label id="lab_halo_Accountsreceivablefromcollaborators_label_en-US" xlink:label="lab_halo_Accountsreceivablefromcollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from collaborators</link:label>
    <link:label id="lab_halo_Accountsreceivablefromcollaborators_documentation_en-US" xlink:label="lab_halo_Accountsreceivablefromcollaborators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due from collaborators, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromcollaborators" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromcollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_Accountsreceivablefromcollaborators" xlink:to="lab_halo_Accountsreceivablefromcollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_2fd62a57-3bc4-4d7f-a70b-3b134cf2304e_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_9becc03c-11cc-4b58-8e41-5d328117befe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_bd2775e1-a23b-42c8-b6ca-a4e31a5d5d86_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_592760fd-ec07-443d-af07-228ec1578625_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_UpfrontfeesMember_4f97dd08-a2e0-47e8-b9ee-43ad2b3b395e_terseLabel_en-US" xlink:label="lab_halo_UpfrontfeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront License Fees</link:label>
    <link:label id="lab_halo_UpfrontfeesMember_label_en-US" xlink:label="lab_halo_UpfrontfeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront fees [Member]</link:label>
    <link:label id="lab_halo_UpfrontfeesMember_documentation_en-US" xlink:label="lab_halo_UpfrontfeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_UpfrontfeesMember" xlink:href="halo-20210930.xsd#halo_UpfrontfeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_UpfrontfeesMember" xlink:to="lab_halo_UpfrontfeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_2be6165c-e2f9-4f12-8884-89bf99aea9fa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_c8575857-d296-400b-a816-30c20f0e77f8_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_3a7a5da4-c594-4592-bb12-fcecd92a9fc6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets measured on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_a7c45393-a5b9-4d6c-9170-ac82c659bc9e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d70fad14-f321-4074-88de-7246963305d5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_1affb278-06e7-46dc-82ed-ae7d83d7aac2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on foreign currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_b79d7b68-7908-4b9b-a854-d13e74f8b744_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9aaf8084-7679-4461-8580-7e7664c92ac0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1bbbb43d-6269-4764-bb74-6f95f4db62df_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_97399806-b6c6-4002-95de-30b6ad60b7ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_BaxaltaMember_cd1d9ef5-562b-47a9-b095-ebcdb89b4abd_terseLabel_en-US" xlink:label="lab_halo_BaxaltaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baxalta</link:label>
    <link:label id="lab_halo_BaxaltaMember_label_en-US" xlink:label="lab_halo_BaxaltaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baxalta [Member]</link:label>
    <link:label id="lab_halo_BaxaltaMember_documentation_en-US" xlink:label="lab_halo_BaxaltaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baxalta [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BaxaltaMember" xlink:href="halo-20210930.xsd#halo_BaxaltaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_BaxaltaMember" xlink:to="lab_halo_BaxaltaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_d56fe7f4-d02e-49bd-a5f5-ef66d12a51e6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_bab109a9-a0c7-4c69-aa03-7ecc849b957f_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1dfa7193-2711-4c99-82bc-45ff3c35fc05_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options weighted average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_622f103b-51a7-4c63-8d77-157316c56565_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_94799596-7d8a-4a86-9e40-02d37900890f_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_ac83dc56-8b8e-427e-b71c-b4e14250886f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5da6ea4f-90be-4aec-a6c3-695436b51050_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_ee6853a7-b9e7-449d-a8c9-60ddb1d3a8e5_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_51181e6d-93ed-4d9a-aa08-e7628f9546cd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment of right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_95b64ed0-061c-4e55-9bd7-316d7ae3841f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Price paid Per Share (USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_LicenseFeesAndEventBasedMember_a9020431-005c-4fbf-b117-dce02dcce3d0_terseLabel_en-US" xlink:label="lab_halo_LicenseFeesAndEventBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees And Event-Based [Member]</link:label>
    <link:label id="lab_halo_LicenseFeesAndEventBasedMember_label_en-US" xlink:label="lab_halo_LicenseFeesAndEventBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees And Event-Based [Member]</link:label>
    <link:label id="lab_halo_LicenseFeesAndEventBasedMember_documentation_en-US" xlink:label="lab_halo_LicenseFeesAndEventBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees And Event-Based [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_LicenseFeesAndEventBasedMember" xlink:href="halo-20210930.xsd#halo_LicenseFeesAndEventBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_LicenseFeesAndEventBasedMember" xlink:to="lab_halo_LicenseFeesAndEventBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c4e61e26-ffd9-498d-837d-0074958e55d3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_aa65a5e3-2fa0-421e-be20-f99ee5227d48_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_9db3d589-5b09-48c1-a865-2d8c7f0574e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current portion</link:label>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Credits and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:to="lab_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ded12a39-6667-4642-bc8f-459c61941f12_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b0690188-2d37-4e8b-8700-22825c4d7b20_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_6c652e05-ddbd-4ec5-9ec2-c82852c85607_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_afd5cd39-e010-41cc-81a8-f1c77f230465_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_272d8bbb-ed6a-42dc-871f-5e0d4ec0db5e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_0fc0300a-9282-4fa5-85c3-d7958d3f7015_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_002a78e7-d2ce-47fe-9ba8-b3448f81c648_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_271caec7-6d0f-486e-ac98-710c067e579e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_45dd8f96-3c07-4151-a220-c5a732f06e00_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_dab61051-6030-4edb-a521-7008a0415437_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_bcfbc59e-76fc-4db2-ba50-77afec1f40e9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_aa4ac8c1-f37a-4b62-bf6f-bac5890ff762_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_48c2d196-488d-40c8-9b31-3db940c62050_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1aa9abf1-740f-4fe5-a81c-a6b084a0ad86_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_b6b7d1fe-8a33-42c0-a534-02c736372ec2_terseLabel_en-US" xlink:label="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]</link:label>
    <link:label id="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_label_en-US" xlink:label="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]</link:label>
    <link:label id="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_documentation_en-US" xlink:label="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable" xlink:href="halo-20210930.xsd#halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable" xlink:to="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_RoyaltybackedLoanMember_2f461147-c76d-4ebd-9b77-a3aeb19c9245_terseLabel_en-US" xlink:label="lab_halo_RoyaltybackedLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty-backed Loan</link:label>
    <link:label id="lab_halo_RoyaltybackedLoanMember_label_en-US" xlink:label="lab_halo_RoyaltybackedLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty-backed Loan [Member]</link:label>
    <link:label id="lab_halo_RoyaltybackedLoanMember_documentation_en-US" xlink:label="lab_halo_RoyaltybackedLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty-backed Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltybackedLoanMember" xlink:href="halo-20210930.xsd#halo_RoyaltybackedLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_RoyaltybackedLoanMember" xlink:to="lab_halo_RoyaltybackedLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_90e41b74-f39d-49c2-b6af-5f5b56ac4d33_terseLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_3999fe38-7b6a-4820-806e-9c55d68df654_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_624d527c-de65-41e7-9755-62f49bc79674_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_84a62017-e1a2-4183-bbac-295d1779de94_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e3abc80c-24ff-4f2a-b07d-997f98b51772_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_cb36ce32-00bc-4878-a63b-8ac4d8a0c301_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_4c0d9b4a-c9c3-4f9e-a2c7-4f9ea6cd2f4a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_151b5e17-3f50-4a29-8462-8d79cde4def7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c95d55d0-1d0e-4d0a-b969-cb1a5eaa86af_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_e2c43067-3064-405e-81f4-5f1e08df5ed5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_00bd7f2a-f410-44f2-ba28-7519ea7d367b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_93939def-1c26-4567-923b-d08a379a39a8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f2f28387-f00f-4e04-bc20-2059959ef804_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Weighted-Average Recognition Period (years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8d5c7c9a-5e9d-490e-8fe0-fc369ea11b64_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_38f84bc9-12b3-4807-81bd-22f0023c8694_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_5cb71967-f1b3-4a78-98cf-10796137d1cf_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ResearchandDevelopmentServicesMember_77ac253a-a885-4f1c-8aec-3305940d2ab7_terseLabel_en-US" xlink:label="lab_halo_ResearchandDevelopmentServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Services</link:label>
    <link:label id="lab_halo_ResearchandDevelopmentServicesMember_label_en-US" xlink:label="lab_halo_ResearchandDevelopmentServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Services [Member]</link:label>
    <link:label id="lab_halo_ResearchandDevelopmentServicesMember_documentation_en-US" xlink:label="lab_halo_ResearchandDevelopmentServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ResearchandDevelopmentServicesMember" xlink:href="halo-20210930.xsd#halo_ResearchandDevelopmentServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ResearchandDevelopmentServicesMember" xlink:to="lab_halo_ResearchandDevelopmentServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ef23793a-ab76-42d0-8b2c-dd93026ddd4c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_79b5e725-ca98-43ad-98a7-02004452fb9d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_fc49af7d-4a9b-48a9-a077-731efa0541d4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f82aa2dc-c163-4471-8038-5e3ac4cda5ae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_32de73ef-d84d-482b-945c-e3a547811b36_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_7fcbd4ca-da6b-4972-95a5-4c449aeb9750_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_c3dfa1b4-dfdb-433b-9a1c-7ef355e2c245_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance cost</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_f77b754f-05d0-453e-8a30-3da6505d76e2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a5d4154b-2e36-485d-aaf1-2b1f462c7ad9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assumptions used in Black-Scholes model</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_RevenueFromContractWithCustomerVariableConsideration_c98638c7-c97b-4932-942f-3193d59bef36_terseLabel_en-US" xlink:label="lab_halo_RevenueFromContractWithCustomerVariableConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable consideration</link:label>
    <link:label id="lab_halo_RevenueFromContractWithCustomerVariableConsideration_label_en-US" xlink:label="lab_halo_RevenueFromContractWithCustomerVariableConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Variable Consideration</link:label>
    <link:label id="lab_halo_RevenueFromContractWithCustomerVariableConsideration_documentation_en-US" xlink:label="lab_halo_RevenueFromContractWithCustomerVariableConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Variable Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RevenueFromContractWithCustomerVariableConsideration" xlink:href="halo-20210930.xsd#halo_RevenueFromContractWithCustomerVariableConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_RevenueFromContractWithCustomerVariableConsideration" xlink:to="lab_halo_RevenueFromContractWithCustomerVariableConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1018ce35-4362-47d6-9c5a-e50c9cdfc974_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_JanssenMember_23fa265d-0b27-40ed-90ae-48b857a9e25e_terseLabel_en-US" xlink:label="lab_halo_JanssenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Janssen</link:label>
    <link:label id="lab_halo_JanssenMember_label_en-US" xlink:label="lab_halo_JanssenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Janssen [Member]</link:label>
    <link:label id="lab_halo_JanssenMember_documentation_en-US" xlink:label="lab_halo_JanssenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Janssen Collaboration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_JanssenMember" xlink:href="halo-20210930.xsd#halo_JanssenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_JanssenMember" xlink:to="lab_halo_JanssenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bde43709-7866-43df-8e5e-da7df07cf3ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_8add0547-71b2-4c93-a85a-8236acf9faa1_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0e49c02a-a684-47ac-9600-54927051030b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_f703551f-8d4b-416f-b1df-54b5abf13397_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4b47410c-bd52-4776-87ec-7f5bc8a0807b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3115ac98-6f87-4076-b295-aad7ea43826d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_RocheMember_e5d12f24-f862-4c38-b9dd-df1a93222d91_terseLabel_en-US" xlink:label="lab_halo_RocheMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Roche</link:label>
    <link:label id="lab_halo_RocheMember_label_en-US" xlink:label="lab_halo_RocheMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Roche [Member]</link:label>
    <link:label id="lab_halo_RocheMember_documentation_en-US" xlink:label="lab_halo_RocheMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Roche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RocheMember" xlink:href="halo-20210930.xsd#halo_RocheMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_RocheMember" xlink:to="lab_halo_RocheMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c8da1ecd-1744-456f-9515-33fa7354b863_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_20454429-12ef-48f9-99f3-1e709f793472_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid expenses and other assets, current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_6fb68c67-f5c8-49df-a31a-194afa660ba0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_af1570e0-0499-49ec-826e-cda055cf4767_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c868e210-43c8-4ac6-aa0b-ff53bb018a28_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_36d34355-9f42-46a8-8459-c924b80255cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses, current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cdb98ede-7d5d-4da4-b85c-1ab4ff237ed0_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_a43d4477-ea0a-4bdd-951e-b18940ec7187_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b26706c1-820b-4008-8c9b-3a2561daa5b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_A2020ShareRepurchaseProgramBankOfAmericaMember_78dd5800-f21f-4c02-ab99-b3f31f33e02f_terseLabel_en-US" xlink:label="lab_halo_A2020ShareRepurchaseProgramBankOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Share Repurchase Program - Bank of America</link:label>
    <link:label id="lab_halo_A2020ShareRepurchaseProgramBankOfAmericaMember_label_en-US" xlink:label="lab_halo_A2020ShareRepurchaseProgramBankOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Share Repurchase Program - Bank of America [Member]</link:label>
    <link:label id="lab_halo_A2020ShareRepurchaseProgramBankOfAmericaMember_documentation_en-US" xlink:label="lab_halo_A2020ShareRepurchaseProgramBankOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Share Repurchase Program - Bank of America</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2020ShareRepurchaseProgramBankOfAmericaMember" xlink:href="halo-20210930.xsd#halo_A2020ShareRepurchaseProgramBankOfAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_A2020ShareRepurchaseProgramBankOfAmericaMember" xlink:to="lab_halo_A2020ShareRepurchaseProgramBankOfAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_fd46a949-367c-4b74-9707-620997108fc9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_70ad3f43-8774-44a6-8d81-922a5ae5a1ae_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_ef07f974-07ee-4cff-b9b9-0a28f47a67bd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_OthercollaboratorsMember_6e40fd29-0f49-4808-b8b4-f306fbefc1c9_terseLabel_en-US" xlink:label="lab_halo_OthercollaboratorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other collaborators</link:label>
    <link:label id="lab_halo_OthercollaboratorsMember_label_en-US" xlink:label="lab_halo_OthercollaboratorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other collaborators [Member]</link:label>
    <link:label id="lab_halo_OthercollaboratorsMember_documentation_en-US" xlink:label="lab_halo_OthercollaboratorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other collaborators [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_OthercollaboratorsMember" xlink:href="halo-20210930.xsd#halo_OthercollaboratorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_OthercollaboratorsMember" xlink:to="lab_halo_OthercollaboratorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e616b8c3-0f07-4a68-91e5-e8d757c2249f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_05cbc773-4a19-4223-91c1-8f22ea1e85ef_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_471a9b12-566c-4ee9-bb16-362b98463c88_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f97dfd8c-f506-47c7-a2fc-cf402c96aee0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1d44b4ba-f757-4877-93dc-6aec76c58823_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5bf6dd72-a3f2-4885-9ea4-d29eea6258b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_bca13b90-4bf8-4387-9d6f-ccf8fa2aa43f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5396fcd4-c977-4eca-9ff0-4f5f19452bb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_bfadb3ac-325d-4374-9e30-1ef9b6786c07_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one but within five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d6ba0e53-b7af-4516-9c5f-59bd6b3ba086_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bbe547ed-acef-4c07-b6f1-69b8e405436e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss position of debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2a73c79-c5de-4787-be67-3021663634c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0d27af8a-9eb7-4928-8636-196123ac0b59_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_f0f4f595-b7db-4af1-ae51-57700bf40fe2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_f8d9aed9-cb54-4871-8555-32ad3eb23f05_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:to="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1f49b8a9-b079-4e2c-8df4-7db964aeb6dd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e0d1788b-81bd-4585-9bdb-dde650365ce1_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_731d22e7-f47a-4013-b088-44059e286e3e_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4231397a-0429-490f-bccc-4b49dd82ddc6_verboseLabel_en-US" xlink:label="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_dd1b55ef-88dd-4bd1-8169-13284e2abf29_totalLabel_en-US" xlink:label="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="halo-20210930.xsd#halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1cc524e0-9822-4583-976e-f794b9a19336_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6dd8f7b1-436d-42b9-afbf-2f5caabc2879_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes (benefits from valuation allowance release)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b44b03d7-551c-46e7-89a6-7465549d1d28_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_A025ConvertibleSeniorNotesDue2027Member_d3900487-9710-4859-8628-729b514d85e3_terseLabel_en-US" xlink:label="lab_halo_A025ConvertibleSeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.25% Convertible Senior Notes due 2027</link:label>
    <link:label id="lab_halo_A025ConvertibleSeniorNotesDue2027Member_label_en-US" xlink:label="lab_halo_A025ConvertibleSeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.25% Convertible Senior Notes due 2027 [Member]</link:label>
    <link:label id="lab_halo_A025ConvertibleSeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_halo_A025ConvertibleSeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.25% Convertible Senior Notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_A025ConvertibleSeniorNotesDue2027Member" xlink:to="lab_halo_A025ConvertibleSeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_071dafdb-e696-48ae-8ea1-323170cb21bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_686caae6-2abf-4fcb-8f8e-3b7367d60da7_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_42e0d67b-0ae8-4ff5-92b4-d65b318cda95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of adoption and pending adoption of recent accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b90d914a-50cd-4b87-80d7-3dc9e8c8f93a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantCompliance_a5294d83-e66e-4181-9c5e-2453d46ee356_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantCompliance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCovenantCompliance_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCovenantCompliance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantCompliance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCovenantCompliance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCovenantCompliance" xlink:to="lab_us-gaap_DebtInstrumentCovenantCompliance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_236f4c54-086c-4585-9ef3-3acc28700bf4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_64afab19-2f92-4de3-b556-ffc2630e3dfd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for induced conversion related to convertible notes</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9c5fd4ee-ccb6-4e84-a4ef-93e1a663a523_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ef0b95d3-b402-4a2a-b526-b2bc4c38c786_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_07317e5b-4b13-4b24-9772-7dcd0050aff5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InducedConversionOfConvertibleDebtExpense_c6954616-6c7a-4606-9478-22734aba4712_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inducement expense related to convertible notes</link:label>
    <link:label id="lab_us-gaap_InducedConversionOfConvertibleDebtExpense_77ccda78-4a8e-47d0-8c25-4bfcb7bcb5d4_terseLabel_en-US" xlink:label="lab_us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Induced conversion expense related to convertible notes</link:label>
    <link:label id="lab_us-gaap_InducedConversionOfConvertibleDebtExpense_label_en-US" xlink:label="lab_us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Induced Conversion of Convertible Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:to="lab_us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b5123a2c-62e5-410d-9324-79e1244d8a8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accrued expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_203a30fc-d39d-4c4c-8deb-d03cf7a3ae20_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ec2c8741-def2-4518-a40a-726048eb3d7a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e12ec14a-aef9-486c-a9af-d2902576649a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of approximate annual future minimum operating lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_0f72fc94-ab51-4d4e-8ef5-851ac568ba2e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b3e19ce0-6d97-4767-a8cb-fb642db9a6a7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5e9842bd-fe42-4b0d-b120-618505ae9938_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_75966531-5c82-401c-ba8b-fd35aa9c6623_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_65dd96e3-87a5-4732-babc-e438b90edc5c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a6730ade-b8ff-42ae-91c1-475ec406d908_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_3ae99fb9-6abc-4cd9-840c-943c78be9476_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6a26b75b-4b2f-4b4f-8c88-015e9db336ef_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_de7ebf0d-6c9c-42c1-b65b-f42048c68ef8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_5c0c1fea-46ba-46dd-b6d5-c74aced4b3a3_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid for conversion of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_3dfc9957-43a4-41dc-bc2b-2f3842b445d2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_381b6218-0b3f-4e5e-a894-baefeaffdcd0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilities_45c77103-7f1c-4c6e-a754-3d6d51f5abe8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Credits and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:to="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b050d2f9-f37c-4de4-adfd-d1c8aba66a0c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_09d699f0-091f-4f1a-97a9-b219ffa3ddc9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity (deficit) (textual)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_e09209f7-a2ff-4dab-8508-3233002c2a32_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_adfb0261-a6d9-4338-8671-983a9d20dc74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_HylenexRecombinantMember_912ec72d-af1c-4cf8-8eac-1932229d3427_terseLabel_en-US" xlink:label="lab_halo_HylenexRecombinantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hylenex</link:label>
    <link:label id="lab_halo_HylenexRecombinantMember_label_en-US" xlink:label="lab_halo_HylenexRecombinantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hylenex Recombinant [Member]</link:label>
    <link:label id="lab_halo_HylenexRecombinantMember_documentation_en-US" xlink:label="lab_halo_HylenexRecombinantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hylenex Recombinant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_HylenexRecombinantMember" xlink:href="halo-20210930.xsd#halo_HylenexRecombinantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_HylenexRecombinantMember" xlink:to="lab_halo_HylenexRecombinantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_920f9e5e-ea23-478a-9960-26b6843f4582_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1144704b-41a6-400c-9fcc-e2519f17dfd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loan balance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f0cb082f-f13e-4665-ad16-0ac92f66d135_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7b3cecbb-ce87-478e-b927-c6518b6fbc6b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective rate at end of period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_SalesbasedmilestoneMember_be4b3a65-1bde-471b-b515-52d4b895f657_terseLabel_en-US" xlink:label="lab_halo_SalesbasedmilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestone [Member]</link:label>
    <link:label id="lab_halo_SalesbasedmilestoneMember_label_en-US" xlink:label="lab_halo_SalesbasedmilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestone [Member]</link:label>
    <link:label id="lab_halo_SalesbasedmilestoneMember_documentation_en-US" xlink:label="lab_halo_SalesbasedmilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_SalesbasedmilestoneMember" xlink:href="halo-20210930.xsd#halo_SalesbasedmilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_SalesbasedmilestoneMember" xlink:to="lab_halo_SalesbasedmilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_bead4414-5a43-44c5-8f75-82deb5bf4b75_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7d7a98c6-bd75-461b-96af-fef5ccf1d4c1_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_e8d44f57-d7d7-4b08-b533-46cc3982646f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_51daa911-abbe-4025-98cf-1ad0aee7a0d8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_cdae9d8c-a58f-452d-8732-86f4e80b7409_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_09d30e75-ba8a-4b36-99cb-b7c725a81690_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_5d16e5da-6fcc-4d97-872d-4c765b84bf0c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_ada89f53-5c80-497a-88bc-d18408a9dfa2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_bf3ede88-4607-4bcf-939b-1717fd5667fc_terseLabel_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase period (in months)</link:label>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_label_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_documentation_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:to="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_48b353d4-1f14-4bdf-842e-82d63074eb5d_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0c1729f5-14ef-49d5-b6ed-fcf3b39fc01b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a0013102-61c0-45a9-b47b-98a9b0ab0f5f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssets_8f718cdc-c158-4f5f-936e-58eee3bd528f_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_299243db-4e31-41d3-bf60-7af97240d8b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Remaining Discount Amortization Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Remaining Discount Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_30fe60ec-21e1-46f3-b1b3-bf1f4a7d38ba_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bad8fa71-051f-4dcb-bb63-74883b337eef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_df17d89d-e505-4a5e-a51f-6dd543fc06f1_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net and other contract assets</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4f224a2c-3bde-4aa9-826c-24301ad5ad2b_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6d2f51a5-1e89-4fde-b7d7-80fbe060e208_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d5eaa3c2-7327-4b48-b81d-f527360c892f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_01611c76-e83c-4bf9-939f-9a72f70293c9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1587c5f6-fae5-4c15-8c45-76c9f270f0ad_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_5bc953e4-21af-4d8f-bb8d-3ff4ca40a94e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_57832c73-ab11-4f90-abbb-c20bd54a41dd_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing net income per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_81bc8b83-3dff-4466-921c-208d46ea055f_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_5a50abce-8ec9-4703-aa07-7cd0285dd4af_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_d1f62aac-46cf-4b3f-a01e-ec58f5b3bb6d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of deferred tax assets</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_398d3072-9fec-401d-829a-2e3b17ce3d57_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_2118693d-ac04-4ed5-9ab3-b07db6f1e50f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5364d665-6b5e-45f4-9625-3e50d16d0d9f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_b84d84a9-397a-4447-93a8-a8dd33a73757_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_ed9b3049-e15e-4241-a110-d7caecbe78fd_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5fac4d6d-ca0d-4531-bf0e-70c33c3abda0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_1b60698f-b3ac-42f5-969b-c072694b8321_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8166a1de-7ae9-445e-8574-15bcfeb76012_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f7e721d0-c5ef-4afa-890b-63bfaf7a3efe_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_c39f8cb1-3ef8-44ab-8c2e-414ecc9403c9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_CollaborativeAgreementsMember_e229b8b6-28be-4c70-b7f7-b16a253c3113_terseLabel_en-US" xlink:label="lab_halo_CollaborativeAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues under collaborative agreements</link:label>
    <link:label id="lab_halo_CollaborativeAgreementsMember_f774092c-11c3-4c81-8266-de5934b3845a_verboseLabel_en-US" xlink:label="lab_halo_CollaborativeAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreements</link:label>
    <link:label id="lab_halo_CollaborativeAgreementsMember_label_en-US" xlink:label="lab_halo_CollaborativeAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreements [Member]</link:label>
    <link:label id="lab_halo_CollaborativeAgreementsMember_documentation_en-US" xlink:label="lab_halo_CollaborativeAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_CollaborativeAgreementsMember" xlink:href="halo-20210930.xsd#halo_CollaborativeAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_CollaborativeAgreementsMember" xlink:to="lab_halo_CollaborativeAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_7d2c4028-788d-49f9-abba-fe8fa1b0d348_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_be39570e-f292-4c17-a06d-3a6a139c1d33_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b92c84b8-4333-4afc-84b5-dd4582d26df2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_a9758db5-9111-4c26-a1e7-93a05cbf460f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Number of Shares Purchased (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_TreasuryStockAcquiredFeeCostPerShare_2d31f70f-abb5-41ab-9a42-c980b1059d4c_terseLabel_en-US" xlink:label="lab_halo_TreasuryStockAcquiredFeeCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee per share (USD per share)</link:label>
    <link:label id="lab_halo_TreasuryStockAcquiredFeeCostPerShare_label_en-US" xlink:label="lab_halo_TreasuryStockAcquiredFeeCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Fee Cost Per Share</link:label>
    <link:label id="lab_halo_TreasuryStockAcquiredFeeCostPerShare_documentation_en-US" xlink:label="lab_halo_TreasuryStockAcquiredFeeCostPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Fee Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_TreasuryStockAcquiredFeeCostPerShare" xlink:href="halo-20210930.xsd#halo_TreasuryStockAcquiredFeeCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_TreasuryStockAcquiredFeeCostPerShare" xlink:to="lab_halo_TreasuryStockAcquiredFeeCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_8170ecef-9d18-4794-8f56-7398ff224865_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_692daf57-6392-413d-991c-ff5862e80648_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_049f4fe2-78dd-4bce-9d20-570025cf2a6f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8a40bc1-5ba5-4e30-9e4e-50d71a5bd310_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_2038beb7-bda6-4441-8361-890857b9ff15_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_afa8621a-2660-42c1-88d3-52c5c095e948_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock awards, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f5b2db13-2367-4e29-83fc-71b108c9d523_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense by type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0759496d-7eee-4adf-8faf-edd827fbfa35_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dc1e2f97-9ae4-4830-9c3d-d97fbe879b29_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_561ab0bc-e180-496e-aa10-79a32adffe4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_1239aacf-2c43-4802-8d2d-4654f2467af7_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c961147d-f4ce-4a22-abb5-2c1b721a6f1e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a3057faf-84ec-4ec9-964c-affd6a9d91de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_60592671-26bc-4cdc-8025-a0519e9767aa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9285fbbd-01bd-40dc-bf6c-81965c1b4f85_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchase price of common stock, percent of market price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c779f240-ceda-4f3c-80c0-4b9850126eab_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_fecff77c-e8b2-4a41-a7a9-fcfe3ad4cdfa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_bdb7f741-fe86-4d14-a88b-364c0fe57d0a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_536d98a0-bc98-4579-90da-0ae68dda2ac7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e2eb7399-6c7f-41e4-ae19-f51cfefb7a28_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value of gross unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_10f3e5d2-2f01-4a2e-9c90-819b1d793502_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d8d1b119-d170-40e2-9213-70e73ddd4bee_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5151a0cb-b872-452c-8c4a-952b15a1477e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_46d3b46a-5d77-442d-947e-07ab531ff93a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of numerators and denominators of basic and diluted computations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e2a32a7f-d354-4fad-9cb2-14956dd8f9cd_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_31d920f3-cc9e-4c8c-91dd-cd6e6826db43_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_310fe2d0-a9cc-4afe-9598-7542632b759d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2c29fafe-532f-4d20-ba61-118c1fb35813_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_c8b4e729-f806-473d-a023-8cd5fd4a1700_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_6e374abd-1862-4a52-9afc-e3fb61a43e44_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e806d812-2659-4a95-96e4-67f84a77b3e3_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_338c7de2-a748-467c-8db0-6c4bfc7944a6_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a53c6841-b197-4ae9-8b91-0e106033ffea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4a90d26a-2d33-43c5-9443-c6bf8641702a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_d3217ff7-2937-4f5d-90b6-73ddbe57f6ce_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_be2ac28d-b804-4011-923e-c2e57e5c5203_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_2653b0d1-925f-4ddb-a5d8-6e825629277b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_8e4a973d-0ed9-4281-bfc4-ccad0c718e80_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Balance Sheet Items</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_94af3e9c-f328-424f-b684-27e60e7a0b2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4e3cc032-4fae-4fb1-971f-9b1dde86e38c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_9961ba26-78fe-4fc5-8d7c-48d582a40325_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_a9745f86-170a-46af-8389-dfa5b8739c31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less long-term portion</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e60c297e-8585-40cd-90a8-70ce9db82d2d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_5b8fe933-88c5-49b1-b7da-a50608e782c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of unrecognized estimated compensation cost by type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_776c0f2b-45e2-4279-b009-37a17e0e11e1_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_55399d57-0ee8-4bf8-a19c-66f78b2fe928_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, remaining performance obligation, expected timing</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_e230f43a-89dd-4e0e-be78-3b910bb93ce9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_12fba186-9b3c-4482-8280-af73a43d2b22_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_47c717a5-36d6-4442-bcb9-9bd21569931c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_82575642-1367-429f-a781-da781189a4a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4d37bcef-9403-4e8f-8913-82d6d8ff34d9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_A2021ShareRepurchaseProgramBankOfAmericaMember_f86f1ac2-dfc3-4519-845a-a6c9b588881c_terseLabel_en-US" xlink:label="lab_halo_A2021ShareRepurchaseProgramBankOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Share Repurchase Program - Bank of America</link:label>
    <link:label id="lab_halo_A2021ShareRepurchaseProgramBankOfAmericaMember_label_en-US" xlink:label="lab_halo_A2021ShareRepurchaseProgramBankOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Share Repurchase Program - Bank of America [Member]</link:label>
    <link:label id="lab_halo_A2021ShareRepurchaseProgramBankOfAmericaMember_documentation_en-US" xlink:label="lab_halo_A2021ShareRepurchaseProgramBankOfAmericaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Share Repurchase Program - Bank of America</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2021ShareRepurchaseProgramBankOfAmericaMember" xlink:href="halo-20210930.xsd#halo_A2021ShareRepurchaseProgramBankOfAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_A2021ShareRepurchaseProgramBankOfAmericaMember" xlink:to="lab_halo_A2021ShareRepurchaseProgramBankOfAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a76d3f65-bcfd-440c-9670-5466d756e80c_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_c2066d84-3344-4727-ae98-af35fb5a906c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lenders fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f3a06092-5ea4-4d1c-8474-9176f84f1c26_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4d4c5e2-2526-408d-be12-80af47470cb3_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding for basic net income (loss) per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6ffdda34-e4b7-4d74-a642-bb4d95b2ad78_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9207bc51-4dbc-4a3f-bff8-a2297ff03e6b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate_a39522c6-9d98-4be3-9a1e-b3bc024ecef9_terseLabel_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum employee subscription rate</link:label>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Minimum Employee Subscription Rate</link:label>
    <link:label id="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate_documentation_en-US" xlink:label="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Minimum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:to="lab_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_d5063c7f-b17d-4634-b472-cea37ab5b776_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales, net</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_7da0db16-7317-4e97-8643-a186e0296b91_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6251360f-0891-496c-baad-4f10fe8d5ffc_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b9b3bdfa-d459-4ac9-aaf0-7923cb0418d2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4b160277-18e0-482e-b8dc-509c26a8432b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2bb3ca22-9733-436a-b012-58754867988d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_a1a3ff8d-fb44-4f43-b4be-8c53a06c47f3_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_8db8b86c-5311-48c0-be21-deefa515a15a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_746db9b1-d256-4be5-8a80-5dadde00d4b3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_695ebba0-a105-4386-8ec1-04c2dc31ac70_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_92f2d4c5-e311-4c7c-9387-13c4b2c5019b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_83ee5593-f85c-4c8e-897c-e5c6b0fd1111_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_bceb65d9-1560-435f-a719-6e47a188a84c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae69bc8b-9103-4309-9c13-387025d79e6e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_cb687b08-9a6d-41c9-a2ff-6747873bffb3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_b0f11e87-d4f4-44fd-9fbf-e45fbf75fb0b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_DevelopmentFeesMember_d94b1b47-1c02-474b-8b44-621429848722_terseLabel_en-US" xlink:label="lab_halo_DevelopmentFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Event-Based Development Fees</link:label>
    <link:label id="lab_halo_DevelopmentFeesMember_label_en-US" xlink:label="lab_halo_DevelopmentFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Fees [Member]</link:label>
    <link:label id="lab_halo_DevelopmentFeesMember_documentation_en-US" xlink:label="lab_halo_DevelopmentFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_DevelopmentFeesMember" xlink:href="halo-20210930.xsd#halo_DevelopmentFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_DevelopmentFeesMember" xlink:to="lab_halo_DevelopmentFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_74d1af3e-5d63-4b99-930b-f669f905a430_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ac77e5df-592e-4210-b3bd-b2e4011baf12_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_da9b8041-6373-41e1-92ef-23d82f559ef7_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_62103847-fc02-4ab9-9ed2-492392764b4f_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of product sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f51ca5de-b7ca-4524-b2d7-15faeeecb6ee_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales previously expensed as R&amp;D</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_11bf9b47-2419-4b10-a090-a756b529517c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentInterest_dc82161d-4f67-478e-908f-b60448c28778_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_abd6c23b-deda-412e-a30a-ac1ba548a690_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock awards, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_1daf3720-a622-4d9b-be39-20bf6225a0c5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period, shares, restricted stock award, net of forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_Accountsreceivablefromroyalties_66081f0b-a197-441a-89d9-2ace72d96b4f_terseLabel_en-US" xlink:label="lab_halo_Accountsreceivablefromroyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from royalty payments</link:label>
    <link:label id="lab_halo_Accountsreceivablefromroyalties_label_en-US" xlink:label="lab_halo_Accountsreceivablefromroyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from royalties</link:label>
    <link:label id="lab_halo_Accountsreceivablefromroyalties_documentation_en-US" xlink:label="lab_halo_Accountsreceivablefromroyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due from royalties, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromroyalties" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromroyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_Accountsreceivablefromroyalties" xlink:to="lab_halo_Accountsreceivablefromroyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_ee421e6c-4d25-4a06-a660-78f8532455d4_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_7ec04816-688f-4778-aaf0-2fa905a06160_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_7e111fa3-0030-4e06-a0a4-9ac42b50250f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5e23cf5b-bf2a-4af1-af43-92fde23410e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_347e31b1-54c4-44cd-a672-552048bad5cd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ceec1084-22e0-40fc-80eb-d2bc96d8d559_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_88ce6bbd-d1bc-4936-ad4e-256e67190322_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_48b35deb-117f-4ca4-bf68-9810596c0ddc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other prepaid expenses</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_16200bd5-f609-4afb-aca6-ae94075075f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_Accountsreceivablefromproductsalestocollaborators_0a1dc91f-90f5-4b3a-a4dd-6e84241821c9_terseLabel_en-US" xlink:label="lab_halo_Accountsreceivablefromproductsalestocollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from product sales to collaborators</link:label>
    <link:label id="lab_halo_Accountsreceivablefromproductsalestocollaborators_label_en-US" xlink:label="lab_halo_Accountsreceivablefromproductsalestocollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from product sales to collaborators</link:label>
    <link:label id="lab_halo_Accountsreceivablefromproductsalestocollaborators_documentation_en-US" xlink:label="lab_halo_Accountsreceivablefromproductsalestocollaborators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from product sales to collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromproductsalestocollaborators" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromproductsalestocollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_Accountsreceivablefromproductsalestocollaborators" xlink:to="lab_halo_Accountsreceivablefromproductsalestocollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_0d077bf8-6a7a-4781-ae1a-0e4900998898_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_32d16042-4ecf-4527-90ad-8ce54a1e1695_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4065acdd-08f0-4e00-9f6a-0dcc64c6c474_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f63a9899-4b8d-4c2f-a4d9-ee844febc97d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_4dee6aee-38ab-4717-99d0-8002a6f41faf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b23e8f66-2849-4b3e-871e-e230dfb9860f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fd166196-83d6-4651-9613-93eac63be22a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0de03893-1e7c-4be5-9c48-333ec4917bf0_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_01d7280c-f140-45de-b2eb-976e902a120c_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_cc3320b6-3c6c-4528-a718-07a845ed206a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loss positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_cb91576d-8159-4ea7-a48c-0d22e6351654_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_RoyaltiesReceivedNumberOfProductsSold_1d81aeca-c8d2-4f80-ad37-9e9a6213662f_terseLabel_en-US" xlink:label="lab_halo_RoyaltiesReceivedNumberOfProductsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties Received, Number of Products Sold</link:label>
    <link:label id="lab_halo_RoyaltiesReceivedNumberOfProductsSold_label_en-US" xlink:label="lab_halo_RoyaltiesReceivedNumberOfProductsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties Received, Number of Products Sold</link:label>
    <link:label id="lab_halo_RoyaltiesReceivedNumberOfProductsSold_documentation_en-US" xlink:label="lab_halo_RoyaltiesReceivedNumberOfProductsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties Received, Number of Products Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltiesReceivedNumberOfProductsSold" xlink:href="halo-20210930.xsd#halo_RoyaltiesReceivedNumberOfProductsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_RoyaltiesReceivedNumberOfProductsSold" xlink:to="lab_halo_RoyaltiesReceivedNumberOfProductsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_2ee60e23-2d69-401e-8818-dbf0815d5dfd_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_0a0df4fa-1432-4d48-929a-f57dfb93bec8_terseLabel_en-US" xlink:label="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements Valuation Inputs [Line Items]</link:label>
    <link:label id="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_label_en-US" xlink:label="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements Valuation Inputs [Line Items]</link:label>
    <link:label id="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_documentation_en-US" xlink:label="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" xlink:href="halo-20210930.xsd#halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" xlink:to="lab_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_7e00cf4e-8257-4fb9-a121-281c12eeb837_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_RSURSAandPRSUawardsMember_d8d35ddb-273f-4286-ad30-08d048c0574b_verboseLabel_en-US" xlink:label="lab_halo_RSURSAandPRSUawardsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs, RSUs, PSUs and ESPP</link:label>
    <link:label id="lab_halo_RSURSAandPRSUawardsMember_label_en-US" xlink:label="lab_halo_RSURSAandPRSUawardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, RSA, and PRSU awards [Member]</link:label>
    <link:label id="lab_halo_RSURSAandPRSUawardsMember_documentation_en-US" xlink:label="lab_halo_RSURSAandPRSUawardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Unit, Restricted Stock Awards, and Performance Restricted Stock Unit awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RSURSAandPRSUawardsMember" xlink:href="halo-20210930.xsd#halo_RSURSAandPRSUawardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_RSURSAandPRSUawardsMember" xlink:to="lab_halo_RSURSAandPRSUawardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_46066bb6-4cde-42d2-8e80-b44a181693d1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_ac9023ce-3caf-4d1c-9f3f-0432a8a1720d_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_PendingSettlementofCommonStockRepurchase_2d634c2a-606a-485a-9cfa-e89a5a9790e3_terseLabel_en-US" xlink:label="lab_halo_PendingSettlementofCommonStockRepurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending settlement of common stock repurchase</link:label>
    <link:label id="lab_halo_PendingSettlementofCommonStockRepurchase_label_en-US" xlink:label="lab_halo_PendingSettlementofCommonStockRepurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Settlement of Common Stock Repurchase</link:label>
    <link:label id="lab_halo_PendingSettlementofCommonStockRepurchase_documentation_en-US" xlink:label="lab_halo_PendingSettlementofCommonStockRepurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Settlement of Common Stock Repurchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PendingSettlementofCommonStockRepurchase" xlink:href="halo-20210930.xsd#halo_PendingSettlementofCommonStockRepurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_PendingSettlementofCommonStockRepurchase" xlink:to="lab_halo_PendingSettlementofCommonStockRepurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_ac991a73-a396-4bc6-b717-c2d4917c29c1_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of discounts on marketable securities, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_35678c4f-ec62-4bd2-9103-c3030535ea4d_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_fa557017-58a6-46ca-a35f-8ec558649043_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_016f2bab-58af-4140-9b19-3f29d8cddfb3_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_56a06788-3a35-4d91-8446-7cfca41c3975_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d51d2809-46c3-4384-83f4-bb68c86649d1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0db8c5f-de71-4cb3-8b18-1d877ea534a4_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_68fe4689-269c-44f0-8a5b-014be6df9431_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_9ae39416-edc1-4fdf-b9e6-eae14cd4942f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets_5e1de0f0-e9eb-41ed-b159-606c8c6f6182_terseLabel_en-US" xlink:label="lab_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets_label_en-US" xlink:label="lab_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current, excluding Other Contract Assets</link:label>
    <link:label id="lab_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets_documentation_en-US" xlink:label="lab_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current, excluding Other Contract Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" xlink:href="halo-20210930.xsd#halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" xlink:to="lab_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c6bfb4ea-5c84-4ebe-ba81-b2c8b0f812c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_343b8356-7347-4a15-bb75-7fa0717bd0d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_922a5f1e-4cac-41b1-a212-6f0caf49fb5d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2c70f0d0-dc94-4dc6-86c6-2996530193c0_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_824499df-40e9-46a0-814b-f33d72c8d615_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_11958ba3-3929-49e5-9254-c07d9615e793_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_ad4583f6-ba6f-4f6f-b7b1-eba197e466a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_a1c911cf-fe67-4789-84f0-ab48df4c287a_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_a53f5655-cb21-469a-a1df-d61dc402c473_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f28e089b-91a3-47ed-aa14-b2e7a8553bfa_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_80710ab2-38e8-44dc-bfd6-7e2dce461aaf_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f73ca6c4-789a-4b45-ad76-5a4c5def6c6d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of common stock issued as a result of stock option exercises (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ab26a410-15b3-4718-94aa-ea4b46608bcb_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue and Cost of Product Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88ac06b4-789d-4d71-8584-c0740efb74cb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_84052b3f-1d83-44f3-afc4-948879a7ddca_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding for diluted net income (loss) per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_AccruedLiabilitiesNoncurrent_1183cca8-449f-45a1-ac92-623243fe4ffb_negatedTerseLabel_en-US" xlink:label="lab_halo_AccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less long-term portion</link:label>
    <link:label id="lab_halo_AccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_halo_AccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_halo_AccruedLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_halo_AccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AccruedLiabilitiesNoncurrent" xlink:href="halo-20210930.xsd#halo_AccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_AccruedLiabilitiesNoncurrent" xlink:to="lab_halo_AccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_af02e85b-3270-4d1f-b4ac-00b1ef2eee7c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c068e678-497c-4765-b300-368d2101e99f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b6505c41-8093-4cd3-b222-1d7329b01a51_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_506ff31b-176d-4827-8796-ad7211e69923_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_9a6f2159-211a-4341-82be-57ce95f56e26_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible notes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a91d1b12-79e6-4b9b-9dae-14ce03005088_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_218ba1d8-0204-40b8-932f-577aebc18bac_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0f517c1a-2133-4b19-8bea-9079bc667d4c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_AllowanceforDistributionFeesandDiscounts_8910b81d-d342-4c06-859c-309aa02b4bfc_negatedTerseLabel_en-US" xlink:label="lab_halo_AllowanceforDistributionFeesandDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for distribution fees and discounts</link:label>
    <link:label id="lab_halo_AllowanceforDistributionFeesandDiscounts_label_en-US" xlink:label="lab_halo_AllowanceforDistributionFeesandDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Distribution Fees and Discounts</link:label>
    <link:label id="lab_halo_AllowanceforDistributionFeesandDiscounts_documentation_en-US" xlink:label="lab_halo_AllowanceforDistributionFeesandDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Discount and Distribution Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AllowanceforDistributionFeesandDiscounts" xlink:href="halo-20210930.xsd#halo_AllowanceforDistributionFeesandDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_AllowanceforDistributionFeesandDiscounts" xlink:to="lab_halo_AllowanceforDistributionFeesandDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_4a67d7f6-f75f-41ff-854e-76e0a666ec85_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2f42843c-cf6d-4122-87c6-46737398e9cc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0fe77840-c837-4f80-a37b-cb72d5b49b77_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5ae5f3c3-f7a4-4ceb-bef8-3dceea5d8546_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96cce873-ce30-403a-8525-315aabfb6abc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_c3e6eeb1-0ff8-44b3-9f38-6f5c232496f9_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bd02ab81-29f5-46af-8eb6-746557f50e2a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2330aff3-830d-4ad0-84ba-d5015e90939d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8d5de893-24d4-44ab-8684-6db5fcb83f05_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for tax withholding for restricted stock units vested, net</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_2ffe5862-fe56-4497-9ff6-f141cc6f1715_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_A2021ESPPPlanMember_6e709132-75ab-440a-a782-bb18ea2ed0b4_terseLabel_en-US" xlink:label="lab_halo_A2021ESPPPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP Plan</link:label>
    <link:label id="lab_halo_A2021ESPPPlanMember_label_en-US" xlink:label="lab_halo_A2021ESPPPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP Plan [Member]</link:label>
    <link:label id="lab_halo_A2021ESPPPlanMember_documentation_en-US" xlink:label="lab_halo_A2021ESPPPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2021ESPPPlanMember" xlink:href="halo-20210930.xsd#halo_A2021ESPPPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_A2021ESPPPlanMember" xlink:to="lab_halo_A2021ESPPPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_BulkrHuPH20Member_25f00b4c-6805-4c5d-9e8d-d256077b37c6_terseLabel_en-US" xlink:label="lab_halo_BulkrHuPH20Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bulk rHuPH20</link:label>
    <link:label id="lab_halo_BulkrHuPH20Member_label_en-US" xlink:label="lab_halo_BulkrHuPH20Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bulk rHuPH20 [Member]</link:label>
    <link:label id="lab_halo_BulkrHuPH20Member_documentation_en-US" xlink:label="lab_halo_BulkrHuPH20Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bulk rHuPH20 for use in collaboration products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BulkrHuPH20Member" xlink:href="halo-20210930.xsd#halo_BulkrHuPH20Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_BulkrHuPH20Member" xlink:to="lab_halo_BulkrHuPH20Member" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_Accruedmanufacturingexpenses_016c3b6a-034d-44c1-8af4-365ee1290a5b_terseLabel_en-US" xlink:label="lab_halo_Accruedmanufacturingexpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued outsourced manufacturing expenses</link:label>
    <link:label id="lab_halo_Accruedmanufacturingexpenses_label_en-US" xlink:label="lab_halo_Accruedmanufacturingexpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued manufacturing expenses</link:label>
    <link:label id="lab_halo_Accruedmanufacturingexpenses_documentation_en-US" xlink:label="lab_halo_Accruedmanufacturingexpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued manufacturing expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accruedmanufacturingexpenses" xlink:href="halo-20210930.xsd#halo_Accruedmanufacturingexpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_Accruedmanufacturingexpenses" xlink:to="lab_halo_Accruedmanufacturingexpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_5a858c1d-e908-4f07-80ee-da4d16c4306a_verboseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement_c8788adf-bf2f-4d7f-acf8-98a6c0c8c768_terseLabel_en-US" xlink:label="lab_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from partner of license and collaborative agreement</link:label>
    <link:label id="lab_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement_label_en-US" xlink:label="lab_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Partner of License and Collaborative Agreement</link:label>
    <link:label id="lab_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement_documentation_en-US" xlink:label="lab_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from partner of license and collaborative agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" xlink:href="halo-20210930.xsd#halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" xlink:to="lab_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5c0738ae-621d-4a38-aee9-ff7d2125b6b2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0f846f0f-bdae-4862-b6ea-44005a531fdb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5dd4bc58-aed8-4046-b473-528424f594a5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a93dab9d-1f67-4293-8a2b-88ef942916e0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_b4c1844c-b8f0-453d-858c-47d7a820df35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_864a6fcb-c535-4b4d-a768-64a9ae44460d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6c37b74d-4bf5-463f-99c4-6e85ac533dff_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption and Pending Adoption of Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_A1.25ConvertibleSeniorNotesdue2024Member_bfb54cb7-aaae-431d-a751-3f27da998763_terseLabel_en-US" xlink:label="lab_halo_A1.25ConvertibleSeniorNotesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.25% Convertible Senior Notes due 2024</link:label>
    <link:label id="lab_halo_A1.25ConvertibleSeniorNotesdue2024Member_label_en-US" xlink:label="lab_halo_A1.25ConvertibleSeniorNotesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.25% Convertible Senior Notes due 2024 [Member]</link:label>
    <link:label id="lab_halo_A1.25ConvertibleSeniorNotesdue2024Member_documentation_en-US" xlink:label="lab_halo_A1.25ConvertibleSeniorNotesdue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.25% Convertible Senior Notes due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member" xlink:href="halo-20210930.xsd#halo_A1.25ConvertibleSeniorNotesdue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member" xlink:to="lab_halo_A1.25ConvertibleSeniorNotesdue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a03670d9-c7e7-46f5-a8f4-e4c96bfdece9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4cc39b9f-292b-4fdd-8415-eb38cff658f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3f39bc95-7382-4f75-adf3-b0ce9770abfe_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8a38bf62-f086-4fe5-ab27-960f4e4101d1_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_c3503b4e-0f78-489e-9c91-c866fe5a9589_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_8ef257eb-a572-42e4-a5cf-31f36f7e1aef_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_d77ab350-64a6-461b-820b-360ae2f371ae_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_c4e23a39-71c7-417b-a99c-447a39a17013_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_Accountsreceivablefromproductsales_5e5c8058-b24c-4f28-9418-0b1ae9941d62_terseLabel_en-US" xlink:label="lab_halo_Accountsreceivablefromproductsales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from other product sales</link:label>
    <link:label id="lab_halo_Accountsreceivablefromproductsales_label_en-US" xlink:label="lab_halo_Accountsreceivablefromproductsales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from product sales</link:label>
    <link:label id="lab_halo_Accountsreceivablefromproductsales_documentation_en-US" xlink:label="lab_halo_Accountsreceivablefromproductsales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from product sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromproductsales" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromproductsales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_Accountsreceivablefromproductsales" xlink:to="lab_halo_Accountsreceivablefromproductsales" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_0090f597-a188-4b1b-985f-66150c3cc584_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_4dcf9272-4297-432b-a03e-fc83794dd000_verboseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d2c5d0fc-d768-4646-97da-3fcc777fa452_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used) in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d9835bee-fb26-450c-abf2-7bd13ec275bc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_f77da6eb-8192-4df6-a767-7be9e3362382_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_53e5807f-6a07-43c7-8ac8-c1f36a3b2784_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_843afb23-00dd-453b-bb9a-13049e82e738_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_0c18cfd5-cf8b-4d7b-b23e-991f4bbc8413_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_76443765-ec27-42b1-b704-35fa90c27172_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_555d52e2-b00b-4277-a87c-d6199ea48888_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_6d614409-d181-4c34-a7da-3e055452b002_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_21eebc16-7f62-4339-8c8a-697037d5e7bc_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>halo-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6c74ed58-0fb3-4e7f-8898-7f3e050a41d3,g:ea6d4314-a92d-42b4-b437-e2e1177b3d7b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.halozyme.com/role/CoverPage" xlink:type="simple" xlink:href="halo-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bab4d81b-efed-49e1-aa2e-713219ca4f2d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_DocumentType_bab4d81b-efed-49e1-aa2e-713219ca4f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8fc398e9-6a54-44e0-9805-3395a6a2c62d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_DocumentQuarterlyReport_8fc398e9-6a54-44e0-9805-3395a6a2c62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_88632f0e-fe07-4d00-9566-28d63f71f3e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_DocumentPeriodEndDate_88632f0e-fe07-4d00-9566-28d63f71f3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_cec815d8-ebf2-4baa-85c5-58776894045b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_DocumentTransitionReport_cec815d8-ebf2-4baa-85c5-58776894045b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e0dd2790-b88c-45d1-9182-ebe40d719e5b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityFileNumber_e0dd2790-b88c-45d1-9182-ebe40d719e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_48bb7a54-249f-423a-86ca-98d53b57d3a7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityRegistrantName_48bb7a54-249f-423a-86ca-98d53b57d3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_446edfaf-66e6-4493-be4e-7be7b43e71a5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_446edfaf-66e6-4493-be4e-7be7b43e71a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_dbbf34f8-b481-4f36-8e59-61bf1abe3149" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityTaxIdentificationNumber_dbbf34f8-b481-4f36-8e59-61bf1abe3149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d51e791f-fbe5-45b8-a265-4a6906f51129" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityAddressAddressLine1_d51e791f-fbe5-45b8-a265-4a6906f51129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9301eb3d-e064-481f-8fd0-8ecb4d9650d0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityAddressCityOrTown_9301eb3d-e064-481f-8fd0-8ecb4d9650d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_23762377-c3bb-4e83-95a9-8b64b7695bd0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityAddressStateOrProvince_23762377-c3bb-4e83-95a9-8b64b7695bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_149885e6-b4f4-49ba-a6b6-032ef1f6bd91" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityAddressPostalZipCode_149885e6-b4f4-49ba-a6b6-032ef1f6bd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_831157ab-65ba-41f8-b6c2-c4cf8a44d09c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_CityAreaCode_831157ab-65ba-41f8-b6c2-c4cf8a44d09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e3671e3b-6166-4ac4-a133-2d9d716b6448" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_LocalPhoneNumber_e3671e3b-6166-4ac4-a133-2d9d716b6448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b1a4871d-7206-4def-8274-32abe54d239f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_Security12bTitle_b1a4871d-7206-4def-8274-32abe54d239f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_baaf92be-9ab7-4f4c-8d46-0d56bf796c08" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_TradingSymbol_baaf92be-9ab7-4f4c-8d46-0d56bf796c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_40fc04f5-3ee5-42b5-aa99-b524b650d01a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_SecurityExchangeName_40fc04f5-3ee5-42b5-aa99-b524b650d01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_252a76d7-9c25-4a51-88d9-87e9afa76172" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityCurrentReportingStatus_252a76d7-9c25-4a51-88d9-87e9afa76172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7308c9ac-6973-46dd-b88d-2a5abab19d4f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityInteractiveDataCurrent_7308c9ac-6973-46dd-b88d-2a5abab19d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b320da69-c07a-434d-8fd4-b3e0c3f06c05" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntitySmallBusiness_b320da69-c07a-434d-8fd4-b3e0c3f06c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0dc758af-af85-4761-a975-5186dd131dc2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityEmergingGrowthCompany_0dc758af-af85-4761-a975-5186dd131dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2a39e564-23aa-4330-a279-f8ee6cb2b230" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityShellCompany_2a39e564-23aa-4330-a279-f8ee6cb2b230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_50bccc2d-17b2-44b7-b185-2c91df7810c9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_50bccc2d-17b2-44b7-b185-2c91df7810c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8cd3c5a7-3275-452e-95d2-5c6afc94fd11" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityCentralIndexKey_8cd3c5a7-3275-452e-95d2-5c6afc94fd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_39581078-3bd4-489f-acb5-11171d76b877" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_AmendmentFlag_39581078-3bd4-489f-acb5-11171d76b877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_aa958532-3f24-4ad5-81f3-d96bbe779792" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_DocumentFiscalYearFocus_aa958532-3f24-4ad5-81f3-d96bbe779792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_19adb564-1df0-4e0d-97f7-4fd49970d485" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_19adb564-1df0-4e0d-97f7-4fd49970d485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e4314242-3431-4f9b-aa39-b992d553fcca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_CurrentFiscalYearEndDate_e4314242-3431-4f9b-aa39-b992d553fcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9c4eba7d-3af9-4353-838c-45b27a3492b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49430c2a-fd52-45d6-90f3-46b4b24a49d8" xlink:to="loc_dei_EntityFilerCategory_9c4eba7d-3af9-4353-838c-45b27a3492b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_41c4ccb4-d7d3-4a97-8f28-5864703477f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_41c4ccb4-d7d3-4a97-8f28-5864703477f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_73a33236-d613-46ff-87ac-ff7912ebf3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_73a33236-d613-46ff-87ac-ff7912ebf3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dcb1efb0-fcf0-4442-a8a3-76e690733e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dcb1efb0-fcf0-4442-a8a3-76e690733e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6efe1617-fd09-4a6a-b699-2d258617f0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:to="loc_us-gaap_InventoryNet_6efe1617-fd09-4a6a-b699-2d258617f0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_865025bb-d685-4013-8444-f0ca90d821a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_865025bb-d685-4013-8444-f0ca90d821a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5af364ff-cdf1-479a-bb37-d52d967fa298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9d77d88f-49d1-4e67-ba31-81751d40981c" xlink:to="loc_us-gaap_AssetsCurrent_5af364ff-cdf1-479a-bb37-d52d967fa298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_6adbe0bc-3571-44cc-9d64-9d2fbaa24ebc" xlink:href="halo-20210930.xsd#halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:to="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_6adbe0bc-3571-44cc-9d64-9d2fbaa24ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_eab1544a-1320-4b72-af91-6bae749c9562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_eab1544a-1320-4b72-af91-6bae749c9562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_9f218657-4d83-4842-bcc2-3924d0c57ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_9f218657-4d83-4842-bcc2-3924d0c57ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_fc498e05-7e92-4fb1-aaad-f0277187c302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_fc498e05-7e92-4fb1-aaad-f0277187c302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_38540abb-1fbb-4cd5-b883-0f9164c22ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d7fb8837-da74-49b2-8f17-8e69f7d949c8" xlink:to="loc_us-gaap_Assets_38540abb-1fbb-4cd5-b883-0f9164c22ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e0959db4-e533-4c2d-aa01-0f1998bd420e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e0959db4-e533-4c2d-aa01-0f1998bd420e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d0714cd5-7987-4ed8-8d3f-8c691d95a24b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e0959db4-e533-4c2d-aa01-0f1998bd420e" xlink:to="loc_us-gaap_AccountsPayableCurrent_d0714cd5-7987-4ed8-8d3f-8c691d95a24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f546238b-4119-4d9f-9590-089d449ad9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e0959db4-e533-4c2d-aa01-0f1998bd420e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f546238b-4119-4d9f-9590-089d449ad9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_df52f681-2a30-4b5c-aa6a-0b4accf9d452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e0959db4-e533-4c2d-aa01-0f1998bd420e" xlink:to="loc_us-gaap_DeferredRevenueCurrent_df52f681-2a30-4b5c-aa6a-0b4accf9d452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_64e08dbd-ac61-4577-b0ef-1cfe85fa80e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e0959db4-e533-4c2d-aa01-0f1998bd420e" xlink:to="loc_us-gaap_LongTermDebtCurrent_64e08dbd-ac61-4577-b0ef-1cfe85fa80e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5d7a5dfa-65ba-4fb2-bf32-8563b95b3e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e0959db4-e533-4c2d-aa01-0f1998bd420e" xlink:to="loc_us-gaap_LiabilitiesCurrent_5d7a5dfa-65ba-4fb2-bf32-8563b95b3e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_339118a7-c4ab-4562-92ca-521ef2656fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_339118a7-c4ab-4562-92ca-521ef2656fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1a42868c-ea88-4faf-8a5e-6b6a57807228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:to="loc_us-gaap_LongTermDebt_1a42868c-ea88-4faf-8a5e-6b6a57807228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_222c999b-8e69-4d45-bae0-d95859bff64e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_222c999b-8e69-4d45-bae0-d95859bff64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_01c1b1f8-f17f-4390-bd02-9001ef1ab3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:to="loc_us-gaap_CommitmentsAndContingencies_01c1b1f8-f17f-4390-bd02-9001ef1ab3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:to="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f49fc7b9-6d9e-447c-a647-d6cb29dfbda7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:to="loc_us-gaap_PreferredStockValue_f49fc7b9-6d9e-447c-a647-d6cb29dfbda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f4c35756-6f54-407e-8217-2839476a9373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:to="loc_us-gaap_CommonStockValue_f4c35756-6f54-407e-8217-2839476a9373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4f6bd941-cec3-492a-9db2-565cb052e8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4f6bd941-cec3-492a-9db2-565cb052e8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16efc485-082c-4515-ac4a-f2e76808202e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16efc485-082c-4515-ac4a-f2e76808202e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_238b1780-57ab-45ac-addc-6e3c53483138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_238b1780-57ab-45ac-addc-6e3c53483138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_499fc2c6-bfa6-4804-a209-310083e375f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aed215ed-870c-41d7-963e-d1b8a5366a76" xlink:to="loc_us-gaap_StockholdersEquity_499fc2c6-bfa6-4804-a209-310083e375f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fbb54860-424c-4b90-aa03-e0887be7a249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a16588e5-92f2-44b1-ab67-686f9dab6828" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fbb54860-424c-4b90-aa03-e0887be7a249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_920f972e-e481-426f-ba5c-b3a830aac322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_920f972e-e481-426f-ba5c-b3a830aac322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_41a8fe1f-bb78-418c-822a-67589cc1f374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_41a8fe1f-bb78-418c-822a-67589cc1f374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_244669b3-76de-46be-b0fd-5a65baa76724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_244669b3-76de-46be-b0fd-5a65baa76724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9417de81-ba22-486e-9b7e-249ae5890f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_CommonStockSharesIssued_9417de81-ba22-486e-9b7e-249ae5890f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8271b409-9fb6-4a2d-96eb-df5f3d2c6e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8271b409-9fb6-4a2d-96eb-df5f3d2c6e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5ff5e158-3470-4767-9e8f-024f21d499b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_deb049ca-046d-4543-93a9-7f1a6a1796ea" xlink:to="loc_us-gaap_SharesOutstanding_5ff5e158-3470-4767-9e8f-024f21d499b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b35e41e9-e92d-4289-81cb-2317db04728b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b35e41e9-e92d-4289-81cb-2317db04728b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f329575c-f819-4c90-b987-ebb4953a8631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f329575c-f819-4c90-b987-ebb4953a8631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_33c41f99-e333-4b4e-a254-3658ac733ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_33c41f99-e333-4b4e-a254-3658ac733ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_240f2a1a-25b3-47ae-b05d-a8443a6eef93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_240f2a1a-25b3-47ae-b05d-a8443a6eef93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9fa0a645-bad3-438b-86ef-f6e6bdeea32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9fa0a645-bad3-438b-86ef-f6e6bdeea32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f010cc5c-c6d3-40fe-a82f-acc555943302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f010cc5c-c6d3-40fe-a82f-acc555943302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_795a6a0e-be3d-4b91-971c-f90108f4fbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_CommonStockSharesIssued_795a6a0e-be3d-4b91-971c-f90108f4fbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_01eb1887-e017-4c45-96d5-0a5e09da19c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_01eb1887-e017-4c45-96d5-0a5e09da19c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_09d894f1-2119-424b-9729-ad5a48c5cbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43fc75dd-8ebf-4bfc-bef1-b6ab869ec2c3" xlink:to="loc_us-gaap_StatementTable_09d894f1-2119-424b-9729-ad5a48c5cbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66e0d455-c3db-424b-aa24-807265048b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_09d894f1-2119-424b-9729-ad5a48c5cbce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66e0d455-c3db-424b-aa24-807265048b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74db0ed3-d7c8-4cf4-a10e-93e0bd15e7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66e0d455-c3db-424b-aa24-807265048b1a" xlink:to="loc_us-gaap_EquityComponentDomain_74db0ed3-d7c8-4cf4-a10e-93e0bd15e7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c98f9674-ac58-430a-a1d2-bf09907dc091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_74db0ed3-d7c8-4cf4-a10e-93e0bd15e7f9" xlink:to="loc_us-gaap_CommonStockMember_c98f9674-ac58-430a-a1d2-bf09907dc091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_09d894f1-2119-424b-9729-ad5a48c5cbce" xlink:to="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f88efae2-9f1d-46d8-ac95-f416d709f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f88efae2-9f1d-46d8-ac95-f416d709f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8d4b96d0-d21f-48c4-96e3-74bf606ea671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8d4b96d0-d21f-48c4-96e3-74bf606ea671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ab8fdbf7-6ecb-4c40-bced-a3dfd462d47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockSharesIssued_ab8fdbf7-6ecb-4c40-bced-a3dfd462d47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cb8c67b2-932e-4ba8-bae0-39eb55b08434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cb8c67b2-932e-4ba8-bae0-39eb55b08434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7affd5e2-90d9-4676-85b8-88c509b3c6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8f61652-2aae-4fdd-b718-4c7b47d992d6" xlink:to="loc_us-gaap_SharesOutstanding_7affd5e2-90d9-4676-85b8-88c509b3c6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4438527d-7a6c-46ce-be89-5ec2b5dba329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f5145a30-2962-4376-a2cc-7e0dcd40bac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4438527d-7a6c-46ce-be89-5ec2b5dba329" xlink:to="loc_us-gaap_StatementTable_f5145a30-2962-4376-a2cc-7e0dcd40bac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9bbc57f3-35bb-4c96-b1af-302b87aa6322" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f5145a30-2962-4376-a2cc-7e0dcd40bac4" xlink:to="loc_srt_ProductOrServiceAxis_9bbc57f3-35bb-4c96-b1af-302b87aa6322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9bbc57f3-35bb-4c96-b1af-302b87aa6322" xlink:to="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_4dbba9ed-5657-4ba1-87c3-97b6f899bdca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:to="loc_us-gaap_RoyaltyMember_4dbba9ed-5657-4ba1-87c3-97b6f899bdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_40672f29-299a-42e7-903e-a39b84546a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:to="loc_us-gaap_ProductMember_40672f29-299a-42e7-903e-a39b84546a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_CollaborativeAgreementsMember_b51615f1-8a3b-414b-bc3f-18faba46f379" xlink:href="halo-20210930.xsd#halo_CollaborativeAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_44b59493-4048-40e7-9136-520c605ab08d" xlink:to="loc_halo_CollaborativeAgreementsMember_b51615f1-8a3b-414b-bc3f-18faba46f379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f5145a30-2962-4376-a2cc-7e0dcd40bac4" xlink:to="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_53b64491-a27a-47ea-9e8a-8f1f08afa1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_RevenuesAbstract_53b64491-a27a-47ea-9e8a-8f1f08afa1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54b00fee-f917-45ca-87ef-65a28bb6501d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_53b64491-a27a-47ea-9e8a-8f1f08afa1e8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_54b00fee-f917-45ca-87ef-65a28bb6501d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ad3087a7-6e94-4609-9d40-da7431cf4dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ad3087a7-6e94-4609-9d40-da7431cf4dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6d4aee85-8667-4341-b87b-ef8f633858f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6d4aee85-8667-4341-b87b-ef8f633858f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f5bd1409-309e-4bd0-93ec-181c04a576d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f5bd1409-309e-4bd0-93ec-181c04a576d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8a962d85-6d80-4615-9026-c34b3a73f75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_6e04e33a-924e-4cd2-88d0-1925ec6a9c08" xlink:to="loc_us-gaap_CostsAndExpenses_8a962d85-6d80-4615-9026-c34b3a73f75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_afdb0550-dddf-4c31-9a4a-15151c7ac4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_OperatingIncomeLoss_afdb0550-dddf-4c31-9a4a-15151c7ac4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4efd82e0-2517-4083-a295-0debed7165ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4efd82e0-2517-4083-a295-0debed7165ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_a7052fe7-462a-4447-abcf-5d455e7fd2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:to="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_a7052fe7-462a-4447-abcf-5d455e7fd2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_cb2c3c5a-104c-46a2-b91b-acf7ce582fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_242f762b-36c1-4b37-a029-83ac817f76d0" xlink:to="loc_us-gaap_InterestExpense_cb2c3c5a-104c-46a2-b91b-acf7ce582fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70d9d277-3b1d-449e-95ca-2194ef5d566c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70d9d277-3b1d-449e-95ca-2194ef5d566c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5ed566fc-fe99-4a8e-b300-c48cf17ec691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5ed566fc-fe99-4a8e-b300-c48cf17ec691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4fd1568b-00ff-4744-b608-9ea69c074efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_NetIncomeLoss_4fd1568b-00ff-4744-b608-9ea69c074efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a568d953-581b-4ca4-91f1-74aec41392ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:to="loc_us-gaap_EarningsPerShareBasic_a568d953-581b-4ca4-91f1-74aec41392ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5771fb78-c586-4781-9d68-ee330f84a4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5fade5e8-f642-4a47-8d81-f712a58fdd7e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5771fb78-c586-4781-9d68-ee330f84a4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9b2100b8-f9a6-4b75-baa3-5ea3874640f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_79c54b5e-2d57-4911-bd50-736796e7c822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_79c54b5e-2d57-4911-bd50-736796e7c822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6303b72-3ad2-4f25-b049-1d4c154571d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_531d8089-90d7-4a2c-8f1a-7d7c2de4577f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6303b72-3ad2-4f25-b049-1d4c154571d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7eaad52c-4fdc-4014-b843-f1e4b92d33d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d7c4a10-17a7-4c10-82c9-676dbc5307bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7eaad52c-4fdc-4014-b843-f1e4b92d33d7" xlink:to="loc_us-gaap_NetIncomeLoss_5d7c4a10-17a7-4c10-82c9-676dbc5307bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be1a13e9-f122-4382-8405-383bc929d4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7eaad52c-4fdc-4014-b843-f1e4b92d33d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be1a13e9-f122-4382-8405-383bc929d4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_963d433e-b420-436b-b659-1296709f1c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be1a13e9-f122-4382-8405-383bc929d4bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_963d433e-b420-436b-b659-1296709f1c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_ad2a96d8-247c-4008-b032-579d26fcdc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be1a13e9-f122-4382-8405-383bc929d4bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_ad2a96d8-247c-4008-b032-579d26fcdc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_16858f94-a437-48c4-b6e7-8f5dde499bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_be1a13e9-f122-4382-8405-383bc929d4bc" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_16858f94-a437-48c4-b6e7-8f5dde499bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9846eb8-bba4-4b46-bcd0-5bdc6bfa4676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7eaad52c-4fdc-4014-b843-f1e4b92d33d7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9846eb8-bba4-4b46-bcd0-5bdc6bfa4676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_29e05dea-6517-4945-b9f9-3d711e53684b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_29e05dea-6517-4945-b9f9-3d711e53684b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_024ed73a-d9d6-4cf0-9b73-f5e2e94f6331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_29e05dea-6517-4945-b9f9-3d711e53684b" xlink:to="loc_us-gaap_NetIncomeLoss_024ed73a-d9d6-4cf0-9b73-f5e2e94f6331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_29e05dea-6517-4945-b9f9-3d711e53684b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_306bd849-3135-4385-860b-44924cce1da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_ShareBasedCompensation_306bd849-3135-4385-860b-44924cce1da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dd3e85d5-9958-4e65-951e-53db6722678b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dd3e85d5-9958-4e65-951e-53db6722678b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_1a27fdfb-2e09-41a4-b7c0-46bcd8852afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_1a27fdfb-2e09-41a4-b7c0-46bcd8852afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_6ba7ad73-5b0b-4161-99d3-27eb2d575972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_6ba7ad73-5b0b-4161-99d3-27eb2d575972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ab1c5f3f-ed1c-47da-a358-b0d9635d9de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ab1c5f3f-ed1c-47da-a358-b0d9635d9de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_58d8f8c8-0e70-4fb7-abdb-ee468e1d016c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_58d8f8c8-0e70-4fb7-abdb-ee468e1d016c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_DeferredRentPayments_92165450-8056-42da-ac13-51f35b9097bd" xlink:href="halo-20210930.xsd#halo_DeferredRentPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_halo_DeferredRentPayments_92165450-8056-42da-ac13-51f35b9097bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_c147e00c-5671-4cbe-a3ec-f46994be6f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_c147e00c-5671-4cbe-a3ec-f46994be6f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_424cc9c1-14da-469a-95f8-7b053c290e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_424cc9c1-14da-469a-95f8-7b053c290e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_395eae40-1097-497f-bb28-b816f9ecf54e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_395eae40-1097-497f-bb28-b816f9ecf54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_afba8508-5785-47bf-9372-ffa592157a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_afba8508-5785-47bf-9372-ffa592157a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_485ab28a-1026-4ff7-bde8-04d475279aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d59bb94f-fb5f-4435-ad15-6dee5ae9f9e4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_485ab28a-1026-4ff7-bde8-04d475279aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_867af4f1-c62b-401c-a643-3d125405e0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_485ab28a-1026-4ff7-bde8-04d475279aca" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_867af4f1-c62b-401c-a643-3d125405e0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_94790872-6b63-43f4-b276-e4811e9781ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_485ab28a-1026-4ff7-bde8-04d475279aca" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_94790872-6b63-43f4-b276-e4811e9781ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca1ffdfc-1a96-491d-a402-01a7c185496b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_485ab28a-1026-4ff7-bde8-04d475279aca" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca1ffdfc-1a96-491d-a402-01a7c185496b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3480c7f5-9e54-4234-a11e-acaedc1bca4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_485ab28a-1026-4ff7-bde8-04d475279aca" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3480c7f5-9e54-4234-a11e-acaedc1bca4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e89d4bf8-08b8-4239-8515-68fe7b176682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_29e05dea-6517-4945-b9f9-3d711e53684b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e89d4bf8-08b8-4239-8515-68fe7b176682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6823668e-9485-4b4d-a563-7bc850486586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6823668e-9485-4b4d-a563-7bc850486586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_5521e211-7194-435a-8759-e53e4daf322b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6823668e-9485-4b4d-a563-7bc850486586" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_5521e211-7194-435a-8759-e53e4daf322b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9a285ef6-bdb1-4a77-b134-b6d1d1ece6de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6823668e-9485-4b4d-a563-7bc850486586" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9a285ef6-bdb1-4a77-b134-b6d1d1ece6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9260dd50-bd02-4055-9374-2f49eeeee644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6823668e-9485-4b4d-a563-7bc850486586" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9260dd50-bd02-4055-9374-2f49eeeee644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_cfc106e6-7e96-4a8c-b25a-84269e0590e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6823668e-9485-4b4d-a563-7bc850486586" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_cfc106e6-7e96-4a8c-b25a-84269e0590e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b50574d-6386-4ee1-bd9d-97f483895410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6823668e-9485-4b4d-a563-7bc850486586" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b50574d-6386-4ee1-bd9d-97f483895410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_a6747960-60a3-49b2-ae1e-b0b28c3d1726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_a6747960-60a3-49b2-ae1e-b0b28c3d1726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_6ea9b95e-71db-4a92-b204-d09b0708421b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_6ea9b95e-71db-4a92-b204-d09b0708421b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_338e08ae-503a-46a0-b76c-756ea7a790e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_338e08ae-503a-46a0-b76c-756ea7a790e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_29975b7d-4487-4be5-a3a9-9d2687765fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_29975b7d-4487-4be5-a3a9-9d2687765fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3d9fd75f-d202-4dfb-9d02-ba4f028c4560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3d9fd75f-d202-4dfb-9d02-ba4f028c4560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f85d542-71c5-4bf1-a2af-daa79b9d762a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d77be6ad-75b2-47f9-b2a3-cae893c1a741" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8f85d542-71c5-4bf1-a2af-daa79b9d762a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b9153dba-04cd-4d61-a78b-15818d18d14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b9153dba-04cd-4d61-a78b-15818d18d14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4795f4c3-3a5b-4ae7-a996-55d6e4a40cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4795f4c3-3a5b-4ae7-a996-55d6e4a40cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ce6b2143-47c4-4894-9621-30f5ca7df060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ce6b2143-47c4-4894-9621-30f5ca7df060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3eb9835-aba3-4b3e-847f-6ca1d55ffe39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c4a0cbba-7a0d-48f3-8c6b-4cf26e7b3e1a" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3eb9835-aba3-4b3e-847f-6ca1d55ffe39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_fe1472e5-8e65-4fc2-9fc2-234d3edab418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3eb9835-aba3-4b3e-847f-6ca1d55ffe39" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_fe1472e5-8e65-4fc2-9fc2-234d3edab418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9d2ea126-3706-47e3-949f-956732ccc35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3eb9835-aba3-4b3e-847f-6ca1d55ffe39" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9d2ea126-3706-47e3-949f-956732ccc35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PendingSettlementofCommonStockRepurchase_31394479-db6b-4730-a922-cb91693df0af" xlink:href="halo-20210930.xsd#halo_PendingSettlementofCommonStockRepurchase"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3eb9835-aba3-4b3e-847f-6ca1d55ffe39" xlink:to="loc_halo_PendingSettlementofCommonStockRepurchase_31394479-db6b-4730-a922-cb91693df0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_0543ef9a-fa46-4ce8-8c7a-abcff888414c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3eb9835-aba3-4b3e-847f-6ca1d55ffe39" xlink:to="loc_us-gaap_StockIssued1_0543ef9a-fa46-4ce8-8c7a-abcff888414c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="halo-20210930.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_399d271e-1800-4763-afe4-acc60f8195d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_399d271e-1800-4763-afe4-acc60f8195d6" xlink:to="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08b9b3c2-aa3a-4a91-8ad4-bc1fe6aa5efb" xlink:to="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9da6ea98-4ad6-4be7-83b9-645a57a63f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_CommonStockMember_9da6ea98-4ad6-4be7-83b9-645a57a63f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_259af3e1-a02a-42fc-bcb0-095b98085c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_259af3e1-a02a-42fc-bcb0-095b98085c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b5ba5c04-f5cc-46e6-81db-ed909ae1405c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b5ba5c04-f5cc-46e6-81db-ed909ae1405c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3c700f62-653f-47fb-9079-caac3ac278f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aae5ee67-9e8c-4d40-bbf2-5e7778c6b5c3" xlink:to="loc_us-gaap_RetainedEarningsMember_3c700f62-653f-47fb-9079-caac3ac278f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e22b3f12-6ee4-4193-b2fc-779532f73110" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e22b3f12-6ee4-4193-b2fc-779532f73110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_647814dd-8682-4aae-b254-d58a4652e9ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e22b3f12-6ee4-4193-b2fc-779532f73110" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_647814dd-8682-4aae-b254-d58a4652e9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f46c43b8-b840-4c6d-a78f-f4f9b5689e7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_647814dd-8682-4aae-b254-d58a4652e9ae" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f46c43b8-b840-4c6d-a78f-f4f9b5689e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0370b0ca-c86d-484d-8cdc-93f921523459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_09a1eba5-18af-4093-bcd1-0579fece774e" xlink:to="loc_us-gaap_StatementLineItems_0370b0ca-c86d-484d-8cdc-93f921523459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0370b0ca-c86d-484d-8cdc-93f921523459" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_fa10629b-eb5c-475e-9506-e278af128f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_SharesOutstanding_fa10629b-eb5c-475e-9506-e278af128f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6cb95753-e96e-4f6d-b66e-c73cd5be5a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockholdersEquity_6cb95753-e96e-4f6d-b66e-c73cd5be5a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7737fd67-c3e7-422d-8ef1-aca3ec77c367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7737fd67-c3e7-422d-8ef1-aca3ec77c367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_887bf7be-4483-40e7-bbb1-6631d72c8075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_887bf7be-4483-40e7-bbb1-6631d72c8075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_79e32f8e-cc34-461c-a169-b01daa428c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_79e32f8e-cc34-461c-a169-b01daa428c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_747d4219-79d3-4cd6-bca2-bc5fdadc233f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_747d4219-79d3-4cd6-bca2-bc5fdadc233f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_771577a9-1389-4c1e-9139-0f64ebd6e66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_771577a9-1389-4c1e-9139-0f64ebd6e66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_de26636c-58e7-45e6-bd23-cdd4c064eb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_de26636c-58e7-45e6-bd23-cdd4c064eb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_13fe54da-5908-49a1-9479-4edd3a5ceb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_13fe54da-5908-49a1-9479-4edd3a5ceb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_15c3509b-876d-48bf-9112-b54cb622393e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_15c3509b-876d-48bf-9112-b54cb622393e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f4d193dd-a063-4947-8de4-dc746cee7f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f4d193dd-a063-4947-8de4-dc746cee7f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_826063d7-f3d8-4fe2-af71-f327248e7f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_826063d7-f3d8-4fe2-af71-f327248e7f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1eb9fe52-0f5c-439e-b8fc-2d0d1bbe1c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_1eb9fe52-0f5c-439e-b8fc-2d0d1bbe1c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_64c25c23-14ec-4eb0-b558-05c10606cfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_NetIncomeLoss_64c25c23-14ec-4eb0-b558-05c10606cfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f5e7cc5b-ed1a-4acd-9621-d5b66c4331ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_SharesOutstanding_f5e7cc5b-ed1a-4acd-9621-d5b66c4331ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9584d5c-5f31-446f-84ad-a322aec565ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_eb120a16-380c-4cc7-bdb4-76cff9d0b00b" xlink:to="loc_us-gaap_StockholdersEquity_b9584d5c-5f31-446f-84ad-a322aec565ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/OrganizationandBusiness" xlink:type="simple" xlink:href="halo-20210930.xsd#OrganizationandBusiness"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/OrganizationandBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ded5d7f1-9c3f-4d6a-b792-826323ebdf95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_464a6393-9064-4728-b36c-3660122905fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ded5d7f1-9c3f-4d6a-b792-826323ebdf95" xlink:to="loc_us-gaap_NatureOfOperations_464a6393-9064-4728-b36c-3660122905fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/OrganizationandBusinessDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#OrganizationandBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/OrganizationandBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90fa6215-606f-405c-a722-218b68293050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41428006-9c8a-4b6f-8250-88c3a425e7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_90fa6215-606f-405c-a722-218b68293050" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41428006-9c8a-4b6f-8250-88c3a425e7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_19f8f221-1df4-4256-9287-5b9cfc315e2e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41428006-9c8a-4b6f-8250-88c3a425e7b7" xlink:to="loc_srt_CounterpartyNameAxis_19f8f221-1df4-4256-9287-5b9cfc315e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_19f8f221-1df4-4256-9287-5b9cfc315e2e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BaxaltaMember_c12931d2-df7e-4e12-9255-1349a61b124e" xlink:href="halo-20210930.xsd#halo_BaxaltaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:to="loc_halo_BaxaltaMember_c12931d2-df7e-4e12-9255-1349a61b124e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RocheMember_78163233-6c92-40b8-a89d-03a6881f3693" xlink:href="halo-20210930.xsd#halo_RocheMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:to="loc_halo_RocheMember_78163233-6c92-40b8-a89d-03a6881f3693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_JanssenMember_02d7ce1a-0454-493b-ad91-c9f9fbde85d4" xlink:href="halo-20210930.xsd#halo_JanssenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5aaa8db0-9240-46ee-807a-9e1ceb7ec08d" xlink:to="loc_halo_JanssenMember_02d7ce1a-0454-493b-ad91-c9f9fbde85d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_41428006-9c8a-4b6f-8250-88c3a425e7b7" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltiesReceivedNumberOfCollaborators_b91f2844-6e5b-4bae-bd34-2062a28d21cb" xlink:href="halo-20210930.xsd#halo_RoyaltiesReceivedNumberOfCollaborators"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:to="loc_halo_RoyaltiesReceivedNumberOfCollaborators_b91f2844-6e5b-4bae-bd34-2062a28d21cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltiesReceivedNumberOfProductsSold_f5165b36-3734-4079-acce-6f548aecb942" xlink:href="halo-20210930.xsd#halo_RoyaltiesReceivedNumberOfProductsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4f32f5d4-67ac-43ea-b724-60a6bcde5e7e" xlink:to="loc_halo_RoyaltiesReceivedNumberOfProductsSold_f5165b36-3734-4079-acce-6f548aecb942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_349ad7a2-d475-445f-b73d-a159023e0de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c9c53086-5438-4c79-839d-e8e33ab9367b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_349ad7a2-d475-445f-b73d-a159023e0de7" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c9c53086-5438-4c79-839d-e8e33ab9367b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_837be233-3597-45af-a9b5-7c94c9d1a42b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_837be233-3597-45af-a9b5-7c94c9d1a42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_97923c57-b28a-4f38-a119-c8001247bc8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_97923c57-b28a-4f38-a119-c8001247bc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9f72be56-f87a-4eb3-9f5d-79d1f0b2f1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_UseOfEstimates_9f72be56-f87a-4eb3-9f5d-79d1f0b2f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b18c6461-4570-4ff3-a06d-a1203deb4baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b18c6461-4570-4ff3-a06d-a1203deb4baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_3a3a7d4a-0f22-44e5-ad7a-6bfb19deed35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_3a3a7d4a-0f22-44e5-ad7a-6bfb19deed35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_19f91b23-c720-4e01-bf10-26fb9e20bdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_19f91b23-c720-4e01-bf10-26fb9e20bdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_562c97bc-7e8c-4161-a372-420337f46d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_562c97bc-7e8c-4161-a372-420337f46d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_13e7e01d-0d72-48c0-a921-2971bf22aaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_13e7e01d-0d72-48c0-a921-2971bf22aaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_fdc531b0-a58f-4415-bd71-2b19a99aa00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_fdc531b0-a58f-4415-bd71-2b19a99aa00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b98df8cc-615a-4658-a353-85ba826ba97a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b98df8cc-615a-4658-a353-85ba826ba97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_fb13c821-06d7-4a02-9a4e-445325b43849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_fb13c821-06d7-4a02-9a4e-445325b43849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_bc0a4efa-6aa3-418e-8065-0fb1f6e1b982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_bc0a4efa-6aa3-418e-8065-0fb1f6e1b982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b86b3766-7470-4efb-9f40-46d09f84033d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_acfa2966-3b84-4d86-8cf4-cf5cd279406c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b86b3766-7470-4efb-9f40-46d09f84033d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9097ce7a-9889-429b-9f9d-c9ea59049c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fcd9ba0-8095-4383-b77e-50e56f030b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9097ce7a-9889-429b-9f9d-c9ea59049c72" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fcd9ba0-8095-4383-b77e-50e56f030b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ab5ce5e0-82d1-4524-b039-c9dbd0291620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9097ce7a-9889-429b-9f9d-c9ea59049c72" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ab5ce5e0-82d1-4524-b039-c9dbd0291620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_32c976e3-3c07-4dbf-9d20-603ae8ee021c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_179b63c3-58ec-4407-a152-46f481f91fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_32c976e3-3c07-4dbf-9d20-603ae8ee021c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_179b63c3-58ec-4407-a152-46f481f91fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5531d248-50c1-4b33-ae08-1fbc88ddf789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_945a8507-e356-40b8-8b71-d94ef4599691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5531d248-50c1-4b33-ae08-1fbc88ddf789" xlink:to="loc_us-gaap_InventoryCurrentTable_945a8507-e356-40b8-8b71-d94ef4599691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_6aab140a-16a0-49f2-b39a-5baf52c0c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_945a8507-e356-40b8-8b71-d94ef4599691" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_6aab140a-16a0-49f2-b39a-5baf52c0c7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_6aab140a-16a0-49f2-b39a-5baf52c0c7cf" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_HylenexRecombinantMember_29c51b36-c701-46bc-8869-d97b037f6f9c" xlink:href="halo-20210930.xsd#halo_HylenexRecombinantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:to="loc_halo_HylenexRecombinantMember_29c51b36-c701-46bc-8869-d97b037f6f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BulkrHuPH20Member_16a206f5-9293-4b4a-b6d5-d05c6d29f73c" xlink:href="halo-20210930.xsd#halo_BulkrHuPH20Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_add6d8dc-6c72-4e04-8fa0-4e28cc899741" xlink:to="loc_halo_BulkrHuPH20Member_16a206f5-9293-4b4a-b6d5-d05c6d29f73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_0acdaeed-f0c2-4076-8f6c-6a3cc955fc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_945a8507-e356-40b8-8b71-d94ef4599691" xlink:to="loc_us-gaap_InventoryLineItems_0acdaeed-f0c2-4076-8f6c-6a3cc955fc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_45ccbf25-d63a-4489-b721-a38bd7eecae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_0acdaeed-f0c2-4076-8f6c-6a3cc955fc1a" xlink:to="loc_us-gaap_InventoryNet_45ccbf25-d63a-4489-b721-a38bd7eecae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8d5d69a2-3aa4-4431-9b90-c24a91691b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b2f0e6f1-26b4-4948-8494-94e392ba74be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d5d69a2-3aa4-4431-9b90-c24a91691b8a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b2f0e6f1-26b4-4948-8494-94e392ba74be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d959387b-6055-417f-9288-c0f6dfc1b7ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b2f0e6f1-26b4-4948-8494-94e392ba74be" xlink:to="loc_srt_RangeAxis_d959387b-6055-417f-9288-c0f6dfc1b7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d959387b-6055-417f-9288-c0f6dfc1b7ef" xlink:to="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c81987fc-c52c-4e43-9005-86e0f8caa1fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:to="loc_srt_MinimumMember_c81987fc-c52c-4e43-9005-86e0f8caa1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_febeb514-a714-423c-87b4-c5829da02541" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ea7dc58c-ec43-4325-9f11-441d259cec2b" xlink:to="loc_srt_MaximumMember_febeb514-a714-423c-87b4-c5829da02541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_c37c78cc-b887-4bf7-8720-e4994b34cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b2f0e6f1-26b4-4948-8494-94e392ba74be" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_c37c78cc-b887-4bf7-8720-e4994b34cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fde6b575-22ab-4696-8982-96fb0b3b1c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_c37c78cc-b887-4bf7-8720-e4994b34cb31" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fde6b575-22ab-4696-8982-96fb0b3b1c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_49fe6afb-a382-4930-b97e-6f6a370d67fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice_3a8aa1c7-306e-4975-b280-08f532d786ad" xlink:href="halo-20210930.xsd#halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_49fe6afb-a382-4930-b97e-6f6a370d67fc" xlink:to="loc_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice_3a8aa1c7-306e-4975-b280-08f532d786ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_eca42f1b-a7cb-4689-816f-5da281d4f78e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_49fe6afb-a382-4930-b97e-6f6a370d67fc" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_eca42f1b-a7cb-4689-816f-5da281d4f78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ea24c30f-0249-46b6-abd1-11857bf44be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_facae4ac-6937-40e5-ae71-1296d1cd7b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ea24c30f-0249-46b6-abd1-11857bf44be0" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_facae4ac-6937-40e5-ae71-1296d1cd7b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_33c5ce07-5698-49d0-ba91-9adcb37af0f8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_facae4ac-6937-40e5-ae71-1296d1cd7b1e" xlink:to="loc_srt_StatementScenarioAxis_33c5ce07-5698-49d0-ba91-9adcb37af0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_735c25ac-9208-4451-b6db-ec01a7a0bc98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_33c5ce07-5698-49d0-ba91-9adcb37af0f8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_735c25ac-9208-4451-b6db-ec01a7a0bc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_0e83cda1-1d79-4396-9640-a7fa91734933" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_735c25ac-9208-4451-b6db-ec01a7a0bc98" xlink:to="loc_srt_ScenarioForecastMember_0e83cda1-1d79-4396-9640-a7fa91734933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_facae4ac-6937-40e5-ae71-1296d1cd7b1e" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fea39564-d9e0-42ff-a613-f9308c019801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fea39564-d9e0-42ff-a613-f9308c019801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7297e497-447d-4399-bd7b-fc3587133693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_3fea2286-12cc-4ba6-9ff2-c758aa820556" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7297e497-447d-4399-bd7b-fc3587133693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3b1f52c4-2e2d-4328-8dbc-e020f78e421b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_52e808a1-0f32-42bd-87f1-91efef04f4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3b1f52c4-2e2d-4328-8dbc-e020f78e421b" xlink:to="loc_us-gaap_NumberOfOperatingSegments_52e808a1-0f32-42bd-87f1-91efef04f4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9c9e3d71-70c6-4ad7-9442-4ed863c0c28b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9c9e3d71-70c6-4ad7-9442-4ed863c0c28b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c0890b-da55-44ae-9024-edb640448eca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c0890b-da55-44ae-9024-edb640448eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fbc4f1aa-bfb8-49c1-b53c-c648d563c63a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c0890b-da55-44ae-9024-edb640448eca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fbc4f1aa-bfb8-49c1-b53c-c648d563c63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f0fa4d33-58de-4f6b-8b68-e9e1a9bbf896" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_fbc4f1aa-bfb8-49c1-b53c-c648d563c63a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f0fa4d33-58de-4f6b-8b68-e9e1a9bbf896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_057e7053-8186-4aa9-9b6a-25af0eecde7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_057e7053-8186-4aa9-9b6a-25af0eecde7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_057e7053-8186-4aa9-9b6a-25af0eecde7f" xlink:to="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_46a847f3-1143-4714-803e-c14ab5e8a116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_46a847f3-1143-4714-803e-c14ab5e8a116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d32ac510-b860-4e42-b5f5-138a45c07f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f15433af-09e3-440c-9c5f-771a199dd547" xlink:to="loc_us-gaap_RetainedEarningsMember_d32ac510-b860-4e42-b5f5-138a45c07f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4c321867-5fd4-42a0-999d-c6043a939262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4c321867-5fd4-42a0-999d-c6043a939262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_bf30d29d-f258-4b95-b6e8-a7a0d55cd10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4c321867-5fd4-42a0-999d-c6043a939262" xlink:to="loc_us-gaap_TypeOfAdoptionMember_bf30d29d-f258-4b95-b6e8-a7a0d55cd10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_6fe90f6c-f2d2-41b9-b416-503e5f5ac0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_bf30d29d-f258-4b95-b6e8-a7a0d55cd10b" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_6fe90f6c-f2d2-41b9-b416-503e5f5ac0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2abac41c-4268-4d94-b746-3c53d85478f9" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0823eb6b-55ed-404c-8228-3408f68814c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:to="loc_us-gaap_StockholdersEquity_0823eb6b-55ed-404c-8228-3408f68814c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4136282f-6371-4985-8511-498ebc955302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:to="loc_us-gaap_DeferredTaxLiabilities_4136282f-6371-4985-8511-498ebc955302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c459c4b1-f6ce-49ae-9959-d478c1918597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_20a1fe59-8534-483f-b0cf-91230d03b88e" xlink:to="loc_us-gaap_LongTermDebt_c459c4b1-f6ce-49ae-9959-d478c1918597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_76ab445a-c80c-43c5-b3a7-f7e2b7052573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7e59b3fd-7850-472f-a9bd-58f4d3d80b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_76ab445a-c80c-43c5-b3a7-f7e2b7052573" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7e59b3fd-7850-472f-a9bd-58f4d3d80b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f92ab676-276c-4a93-8467-44cfed446157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_d3913dd4-948e-40a8-a699-ff80ab3d5fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f92ab676-276c-4a93-8467-44cfed446157" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_d3913dd4-948e-40a8-a699-ff80ab3d5fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_31c1f010-e4fb-40a3-8eea-67d8d5ca8d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f92ab676-276c-4a93-8467-44cfed446157" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_31c1f010-e4fb-40a3-8eea-67d8d5ca8d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_515dedea-f7de-45a1-ac34-27be338a73f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f92ab676-276c-4a93-8467-44cfed446157" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_515dedea-f7de-45a1-ac34-27be338a73f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2b58e9a9-51a2-4561-9f95-ccd755294883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_673ba21d-ca8b-4826-b803-11dc18449a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2b58e9a9-51a2-4561-9f95-ccd755294883" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_673ba21d-ca8b-4826-b803-11dc18449a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b17ed997-5cae-412c-82c8-56fcb91db4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_673ba21d-ca8b-4826-b803-11dc18449a6a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b17ed997-5cae-412c-82c8-56fcb91db4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b17ed997-5cae-412c-82c8-56fcb91db4a2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_8440489d-ee44-451f-bbde-23c43a987f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_8440489d-ee44-451f-bbde-23c43a987f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a98f2a60-16ab-465a-9f63-b95cafd883dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a98f2a60-16ab-465a-9f63-b95cafd883dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_32c1008f-65eb-42a9-968e-34f445d95435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_32c1008f-65eb-42a9-968e-34f445d95435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_7c5deaab-f60c-4aaf-9349-386973eba499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_NonUsMember_7c5deaab-f60c-4aaf-9349-386973eba499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ad1e76aa-d64c-41a0-899d-ecc29de06063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ef16c59e-939c-4cd1-9503-4864d206e9d8" xlink:to="loc_us-gaap_CommercialPaperMember_ad1e76aa-d64c-41a0-899d-ecc29de06063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_673ba21d-ca8b-4826-b803-11dc18449a6a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f94f169-32e9-4f7a-80d5-d8e1663fe849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f94f169-32e9-4f7a-80d5-d8e1663fe849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc72de2c-67a5-4891-b403-56051624daf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc72de2c-67a5-4891-b403-56051624daf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e3933385-18b4-41c0-93cb-de57e2543afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e3933385-18b4-41c0-93cb-de57e2543afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1016c3e9-f8bc-410d-9011-d94d7c70022c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2b67f71e-33bb-435f-8917-d72e055b1e89" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1016c3e9-f8bc-410d-9011-d94d7c70022c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_322722f1-2e4e-4254-918e-8882de878b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1e48319e-36cb-4912-abe7-d28ff8c93c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_322722f1-2e4e-4254-918e-8882de878b5d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1e48319e-36cb-4912-abe7-d28ff8c93c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89148f5d-ec1d-4db8-b885-f32b2af3f1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1e48319e-36cb-4912-abe7-d28ff8c93c38" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89148f5d-ec1d-4db8-b885-f32b2af3f1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dc1609d-e44b-43b0-9d3c-26faa2bdb01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_89148f5d-ec1d-4db8-b885-f32b2af3f1f6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dc1609d-e44b-43b0-9d3c-26faa2bdb01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4c99698b-1887-40c3-a423-a9bfddccc523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4dc1609d-e44b-43b0-9d3c-26faa2bdb01c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4c99698b-1887-40c3-a423-a9bfddccc523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1e48319e-36cb-4912-abe7-d28ff8c93c38" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_172b2e30-6867-4746-bd29-91f7231e98ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_172b2e30-6867-4746-bd29-91f7231e98ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c2c39b3a-0082-44f5-977e-4a3324d03408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c2c39b3a-0082-44f5-977e-4a3324d03408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4c92bbf9-c21b-42eb-b935-636543cb4e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4c92bbf9-c21b-42eb-b935-636543cb4e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_341c0a28-7541-4bf0-a389-c22bc5f13b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_341c0a28-7541-4bf0-a389-c22bc5f13b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_36799c2d-42f0-4772-998c-b2bbd8f52683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1cee5ab7-229f-41c9-91f7-429f59675cba" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_36799c2d-42f0-4772-998c-b2bbd8f52683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_46faa33f-e5cd-4aaf-82f2-d4352d24c369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_47f99a1c-292a-4006-9746-e12321585fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46faa33f-e5cd-4aaf-82f2-d4352d24c369" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_47f99a1c-292a-4006-9746-e12321585fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_269fee1d-21bf-47be-a4fa-ccd496881442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46faa33f-e5cd-4aaf-82f2-d4352d24c369" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_269fee1d-21bf-47be-a4fa-ccd496881442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7250edbe-a596-4cdf-be56-05edd8855159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46faa33f-e5cd-4aaf-82f2-d4352d24c369" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7250edbe-a596-4cdf-be56-05edd8855159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5d720877-ea2f-46a1-8b6e-c9e75e5867c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5d720877-ea2f-46a1-8b6e-c9e75e5867c1" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2981c41a-2dec-4ea0-864f-260d6ff794f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2981c41a-2dec-4ea0-864f-260d6ff794f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2981c41a-2dec-4ea0-864f-260d6ff794f4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_36d3ea50-9337-41c8-9add-327e467f9ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_36d3ea50-9337-41c8-9add-327e467f9ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a1751aa3-dbf1-4b78-85bc-1b2f1b871fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a1751aa3-dbf1-4b78-85bc-1b2f1b871fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_996d8f1e-9ade-409d-a7b9-d8c2d1d04c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c212b0b-0c4e-4b2b-abdb-c4ee96629da2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_996d8f1e-9ade-409d-a7b9-d8c2d1d04c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8def0b9f-fde2-4217-a151-fc803efb1246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8def0b9f-fde2-4217-a151-fc803efb1246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8def0b9f-fde2-4217-a151-fc803efb1246" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_33bfc7b7-6fb9-46c3-a7eb-10951bfe7bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_33bfc7b7-6fb9-46c3-a7eb-10951bfe7bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3b06013b-b552-4d78-8885-621d723246ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3b06013b-b552-4d78-8885-621d723246ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7eec9a94-a188-4b4a-8fad-515c4f91e2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7eec9a94-a188-4b4a-8fad-515c4f91e2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_e82c2b6f-601b-442c-be77-d3071c8a8b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_NonUsMember_e82c2b6f-601b-442c-be77-d3071c8a8b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_49c42020-011d-40e1-8374-b4e59f4fce3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0758d7-ede2-4f28-83ea-bf0225ab6f85" xlink:to="loc_us-gaap_CommercialPaperMember_49c42020-011d-40e1-8374-b4e59f4fce3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_28871fe6-5127-4aca-96dd-f3ae8f79268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_28871fe6-5127-4aca-96dd-f3ae8f79268c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_28871fe6-5127-4aca-96dd-f3ae8f79268c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_d2ddfe4b-ee2f-474f-9d40-d22cc9b5000d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_d2ddfe4b-ee2f-474f-9d40-d22cc9b5000d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6e265092-7ef4-44d0-91a6-735d39eaa3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_48088027-97a1-429c-820c-8b04322dd48d" xlink:to="loc_us-gaap_CommercialPaperMember_6e265092-7ef4-44d0-91a6-735d39eaa3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9bd1866d-b59d-4ee5-b64f-0f8b30cbe4f7" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f25a8be0-67f8-4502-afd9-679eeedcea0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f25a8be0-67f8-4502-afd9-679eeedcea0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b07a1fbf-a4f8-4869-8a25-0d5de855b2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b07a1fbf-a4f8-4869-8a25-0d5de855b2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_589f3e5a-e8c2-4c9c-a41b-b5b77b6c2ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_589f3e5a-e8c2-4c9c-a41b-b5b77b6c2ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f63dfd0f-6aca-4a1c-835a-43d6c4310fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b4ce7c7-5f85-4177-af5d-9b700f4e83cf" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f63dfd0f-6aca-4a1c-835a-43d6c4310fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/Revenue" xlink:type="simple" xlink:href="halo-20210930.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8f85e121-71e7-4f91-a13d-a5e973849bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4fb7acf5-2520-4025-a904-5769c5020e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8f85e121-71e7-4f91-a13d-a5e973849bc3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4fb7acf5-2520-4025-a904-5769c5020e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueTables" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_643a2579-71cb-4b8a-81ea-26fb32bfbd64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_95f98053-5b9f-40b8-b899-4d57afd88162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_643a2579-71cb-4b8a-81ea-26fb32bfbd64" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_95f98053-5b9f-40b8-b899-4d57afd88162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_47be0a75-0390-4cb8-ae71-0cdde5daf456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_643a2579-71cb-4b8a-81ea-26fb32bfbd64" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_47be0a75-0390-4cb8-ae71-0cdde5daf456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueDisaggregatedRevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c4e21ff-364b-4274-81a5-5aa9976cde09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ad3f2297-39c1-4382-b176-7fdb04352a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c4e21ff-364b-4274-81a5-5aa9976cde09" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ad3f2297-39c1-4382-b176-7fdb04352a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c8dec563-1f7e-4cdd-8628-d37610ac0ce0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ad3f2297-39c1-4382-b176-7fdb04352a4f" xlink:to="loc_srt_ProductOrServiceAxis_c8dec563-1f7e-4cdd-8628-d37610ac0ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c8dec563-1f7e-4cdd-8628-d37610ac0ce0" xlink:to="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_1957549c-9a0f-4eb6-9e31-96624e6398be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_us-gaap_RoyaltyMember_1957549c-9a0f-4eb6-9e31-96624e6398be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_BulkrHuPH20Member_7ba8819b-3e97-4956-940a-a49e57fd5785" xlink:href="halo-20210930.xsd#halo_BulkrHuPH20Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:to="loc_halo_BulkrHuPH20Member_7ba8819b-3e97-4956-940a-a49e57fd5785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_HylenexRecombinantMember_9ac55a5d-b926-46c5-979d-d40c6c12c973" xlink:href="halo-20210930.xsd#halo_HylenexRecombinantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_58d11565-f97a-47f1-8c3d-a478e12d4516" xlink:to="loc_halo_HylenexRecombinantMember_9ac55a5d-b926-46c5-979d-d40c6c12c973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:href="halo-20210930.xsd#halo_CollaborativeAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_DevelopmentFeesMember_ff9a00cb-c9a2-4f1f-9b6a-f4147d92e890" xlink:href="halo-20210930.xsd#halo_DevelopmentFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:to="loc_halo_DevelopmentFeesMember_ff9a00cb-c9a2-4f1f-9b6a-f4147d92e890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ResearchandDevelopmentServicesMember_aac0c4cb-4916-4a8a-a8bb-141c735635a7" xlink:href="halo-20210930.xsd#halo_ResearchandDevelopmentServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_CollaborativeAgreementsMember_b27aa2fa-f5b0-46e8-b042-e5c7a8f0e403" xlink:to="loc_halo_ResearchandDevelopmentServicesMember_aac0c4cb-4916-4a8a-a8bb-141c735635a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_UpfrontfeesMember_5b49e029-d49b-432a-a289-e43ee3f7a641" xlink:href="halo-20210930.xsd#halo_UpfrontfeesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_halo_UpfrontfeesMember_5b49e029-d49b-432a-a289-e43ee3f7a641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_SalesbasedmilestoneMember_29e0fc72-cf94-4584-997d-0d721f3eeef1" xlink:href="halo-20210930.xsd#halo_SalesbasedmilestoneMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_883bc24b-94fd-42fb-ba9e-80f021641de6" xlink:to="loc_halo_SalesbasedmilestoneMember_29e0fc72-cf94-4584-997d-0d721f3eeef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1da5b2c4-4f5a-46b6-8d8c-db5f76435457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ad3f2297-39c1-4382-b176-7fdb04352a4f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1da5b2c4-4f5a-46b6-8d8c-db5f76435457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e392da64-ea58-4960-a872-bdce80458249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1da5b2c4-4f5a-46b6-8d8c-db5f76435457" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e392da64-ea58-4960-a872-bdce80458249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_43d3f691-d152-492c-a6ae-56b1f1ee6118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_43d3f691-d152-492c-a6ae-56b1f1ee6118" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6d27c0f0-373c-424f-9c34-3752c0110d74" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:to="loc_srt_ProductOrServiceAxis_6d27c0f0-373c-424f-9c34-3752c0110d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6d27c0f0-373c-424f-9c34-3752c0110d74" xlink:to="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_226e373e-ba00-4298-895b-8d9293a9372d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:to="loc_us-gaap_ProductMember_226e373e-ba00-4298-895b-8d9293a9372d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_LicenseFeesAndEventBasedMember_4953dce2-930b-4b92-8bd5-0e48bd124edf" xlink:href="halo-20210930.xsd#halo_LicenseFeesAndEventBasedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ec422235-e6a7-401d-afaf-83e9031a2981" xlink:to="loc_halo_LicenseFeesAndEventBasedMember_4953dce2-930b-4b92-8bd5-0e48bd124edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_86109244-31fe-470c-8cf4-98994e5ce324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7ea249c1-8b51-4b2c-b9ed-64592a94b9ab" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_86109244-31fe-470c-8cf4-98994e5ce324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_OthercollaboratorsMember_625537c4-cd9c-47ef-9879-2e878af8c1f3" xlink:href="halo-20210930.xsd#halo_OthercollaboratorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_86109244-31fe-470c-8cf4-98994e5ce324" xlink:to="loc_halo_OthercollaboratorsMember_625537c4-cd9c-47ef-9879-2e878af8c1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d21246ae-f173-4f67-821d-afe9b1621856" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b70ec634-4e80-4097-bb9a-8a45c2152242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b70ec634-4e80-4097-bb9a-8a45c2152242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RevenueFromContractWithCustomerVariableConsideration_ab329d23-827b-40cd-bb84-baf11558acda" xlink:href="halo-20210930.xsd#halo_RevenueFromContractWithCustomerVariableConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_halo_RevenueFromContractWithCustomerVariableConsideration_ab329d23-827b-40cd-bb84-baf11558acda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5e7ee0a4-b6ff-4c82-8211-a0a2f95cea92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5e7ee0a4-b6ff-4c82-8211-a0a2f95cea92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_a408cd89-c083-4246-9437-54f175e34b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_DeferredRevenue_a408cd89-c083-4246-9437-54f175e34b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_9d1200da-d390-4cec-8e2b-28139074c71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent_9d1200da-d390-4cec-8e2b-28139074c71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities_aebc79da-d046-4a6c-8d24-b57074160552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilities_aebc79da-d046-4a6c-8d24-b57074160552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_160a3658-950e-4352-a859-00b238b30cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_160a3658-950e-4352-a859-00b238b30cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement_9003d927-1f93-4fc4-a403-04ddc059cfe5" xlink:href="halo-20210930.xsd#halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1cfcedf8-2364-456c-a7ca-4d215e96b106" xlink:to="loc_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement_9003d927-1f93-4fc4-a403-04ddc059cfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ab1a070-ddec-4f9e-9471-430ab4b9408e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets_d5dcb16c-4dbc-4e58-89d0-cc365f5a75bb" xlink:href="halo-20210930.xsd#halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ab1a070-ddec-4f9e-9471-430ab4b9408e" xlink:to="loc_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets_d5dcb16c-4dbc-4e58-89d0-cc365f5a75bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_990afb76-b88a-409b-aef7-94b15de914e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ab1a070-ddec-4f9e-9471-430ab4b9408e" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_990afb76-b88a-409b-aef7-94b15de914e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_ca1aa181-d9fb-4f7e-adf0-26774bbb7f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ab1a070-ddec-4f9e-9471-430ab4b9408e" xlink:to="loc_us-gaap_DeferredRevenue_ca1aa181-d9fb-4f7e-adf0-26774bbb7f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueAdditionalRevenueInformationDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d8b9c37-3de6-4985-8d18-fac2c442437e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5d8b9c37-3de6-4985-8d18-fac2c442437e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2fb7a5e6-71ea-465b-8863-77b7ea917f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2fb7a5e6-71ea-465b-8863-77b7ea917f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a91ca0e-9031-432c-810f-57ae1968684f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4f2cea61-1cce-4b42-b0b2-bfdde3a1a0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_4f2cea61-1cce-4b42-b0b2-bfdde3a1a0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_6c9165ed-59b0-4a70-bfd6-8d0fc0b2a533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_511e62d2-08ef-43bf-bb53-c56dbdb3aab6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_6c9165ed-59b0-4a70-bfd6-8d0fc0b2a533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#RevenueAdditionalRevenueInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItems" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItems"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItems" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f11a09f1-87b9-4ead-a0d7-36eb1c8e3ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_35014ee6-385b-49f0-9de5-74ba5b6c600d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f11a09f1-87b9-4ead-a0d7-36eb1c8e3ccf" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_35014ee6-385b-49f0-9de5-74ba5b6c600d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsTables" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_314314fd-30cf-4645-979c-360356e92751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_c6546255-e5b5-4ddd-a9d4-a34d6983c9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_314314fd-30cf-4645-979c-360356e92751" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_c6546255-e5b5-4ddd-a9d4-a34d6983c9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_4aaa6cea-3c13-4d1c-966a-7f26801bb333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_314314fd-30cf-4645-979c-360356e92751" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_4aaa6cea-3c13-4d1c-966a-7f26801bb333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_ba1aa660-996a-44ff-92d8-7ad3c1d1f7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_314314fd-30cf-4645-979c-360356e92751" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_ba1aa660-996a-44ff-92d8-7ad3c1d1f7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7e878b8c-b9a7-44da-87fd-6ec1f6ecf3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_314314fd-30cf-4645-979c-360356e92751" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7e878b8c-b9a7-44da-87fd-6ec1f6ecf3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_51434e74-1d2a-4fa0-a99f-174d400cf568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_314314fd-30cf-4645-979c-360356e92751" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_51434e74-1d2a-4fa0-a99f-174d400cf568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsAccountsReceivablenetDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromproductsalestocollaborators_b84fe394-cfd1-4727-9a83-55b0956ac835" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromproductsalestocollaborators"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_halo_Accountsreceivablefromproductsalestocollaborators_b84fe394-cfd1-4727-9a83-55b0956ac835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromcollaborators_aa39e7ef-43dc-41c7-8197-cf2eab4d3d54" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromcollaborators"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_halo_Accountsreceivablefromcollaborators_aa39e7ef-43dc-41c7-8197-cf2eab4d3d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromroyalties_f086fba8-66cb-4b4f-b39d-7bfdf0082ce5" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromroyalties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_halo_Accountsreceivablefromroyalties_f086fba8-66cb-4b4f-b39d-7bfdf0082ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accountsreceivablefromproductsales_bc92c7cb-f94e-4d1c-befc-57469170e122" xlink:href="halo-20210930.xsd#halo_Accountsreceivablefromproductsales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_halo_Accountsreceivablefromproductsales_bc92c7cb-f94e-4d1c-befc-57469170e122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e6c3daa3-4a30-43a1-905f-4bfbc767cc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e6c3daa3-4a30-43a1-905f-4bfbc767cc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_41dd94a8-2619-4e4f-a265-38195e30ea7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_41dd94a8-2619-4e4f-a265-38195e30ea7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AllowanceforDistributionFeesandDiscounts_51b64fff-e8a2-42ce-9de2-f71dc1f8b751" xlink:href="halo-20210930.xsd#halo_AllowanceforDistributionFeesandDiscounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_halo_AllowanceforDistributionFeesandDiscounts_51b64fff-e8a2-42ce-9de2-f71dc1f8b751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_095b91b4-7064-4f99-94a2-c4880cb0e0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_23aec6f8-cbfe-4730-a532-f3ea6698b5e6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_095b91b4-7064-4f99-94a2-c4880cb0e0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2503147b-addb-45f5-a058-56b4873bf896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8195bc5f-edad-4bcb-9bf4-680d34368957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2503147b-addb-45f5-a058-56b4873bf896" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8195bc5f-edad-4bcb-9bf4-680d34368957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9e4a44fa-adfb-4d9f-abba-ee20fe6ed8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2503147b-addb-45f5-a058-56b4873bf896" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9e4a44fa-adfb-4d9f-abba-ee20fe6ed8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8756ed11-4622-472e-9259-f11ed895ec27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2503147b-addb-45f5-a058-56b4873bf896" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8756ed11-4622-472e-9259-f11ed895ec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c36415a0-35cb-46a9-bc63-0a9cd7c8dd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2503147b-addb-45f5-a058-56b4873bf896" xlink:to="loc_us-gaap_InventoryNet_c36415a0-35cb-46a9-bc63-0a9cd7c8dd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f04a4e23-37d9-4168-8bd0-e669e5762387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ff46b11b-008d-4ab0-a995-6a44f9f9bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f04a4e23-37d9-4168-8bd0-e669e5762387" xlink:to="loc_us-gaap_StatementTable_ff46b11b-008d-4ab0-a995-6a44f9f9bbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff46b11b-008d-4ab0-a995-6a44f9f9bbb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6322b847-24ad-45a7-91d5-fb01b2637b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3fcbc469-4b2d-4cc2-b662-ae0baa2ac55b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6322b847-24ad-45a7-91d5-fb01b2637b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ComputerAndOfficeEquipmentMember_58f89f64-2a6a-472a-99e3-576ec2631219" xlink:href="halo-20210930.xsd#halo_ComputerAndOfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6322b847-24ad-45a7-91d5-fb01b2637b95" xlink:to="loc_halo_ComputerAndOfficeEquipmentMember_58f89f64-2a6a-472a-99e3-576ec2631219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff46b11b-008d-4ab0-a995-6a44f9f9bbb4" xlink:to="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_a52e7404-89d3-4fec-a75e-b0d5d03e1b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_a52e7404-89d3-4fec-a75e-b0d5d03e1b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_77db6cc3-27bb-4102-88c7-11d7579a4aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_77db6cc3-27bb-4102-88c7-11d7579a4aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_e5c4631c-1a86-47c6-b57a-f76b5a90f605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_OtherAssets_e5c4631c-1a86-47c6-b57a-f76b5a90f605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssets_8bf8a899-963d-4ee6-a13a-91082a4ae6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssets_8bf8a899-963d-4ee6-a13a-91082a4ae6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_792fc614-4586-4b3e-abcf-e8d59d9d0cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_792fc614-4586-4b3e-abcf-e8d59d9d0cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a026c1c2-3008-431c-8a48-22440288aeea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c5f53cf1-2b91-4fa1-ba7f-a4d3e4e110a6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a026c1c2-3008-431c-8a48-22440288aeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsPropertyandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c7737033-2950-48aa-951b-dacaedbe5eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a56ef75-dfaa-40f0-996e-6d5628676e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c7737033-2950-48aa-951b-dacaedbe5eb2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a56ef75-dfaa-40f0-996e-6d5628676e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_018c21a8-1e1e-48b5-a67a-5f982b1820d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a56ef75-dfaa-40f0-996e-6d5628676e37" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_018c21a8-1e1e-48b5-a67a-5f982b1820d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_018c21a8-1e1e-48b5-a67a-5f982b1820d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ResearchEquipmentMember_63ce3138-1049-4874-b292-96fc044f49f7" xlink:href="halo-20210930.xsd#halo_ResearchEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_halo_ResearchEquipmentMember_63ce3138-1049-4874-b292-96fc044f49f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ManufacturingEquipmentMember_47799c3b-48bf-4eda-a22f-5a8810b55613" xlink:href="halo-20210930.xsd#halo_ManufacturingEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_halo_ManufacturingEquipmentMember_47799c3b-48bf-4eda-a22f-5a8810b55613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ComputerAndOfficeEquipmentMember_d9b4b512-3cf0-4dac-b22e-9d180e4867c6" xlink:href="halo-20210930.xsd#halo_ComputerAndOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_halo_ComputerAndOfficeEquipmentMember_d9b4b512-3cf0-4dac-b22e-9d180e4867c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_7ebccb16-489e-421b-b6de-9b9b78b94033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaf60a1a-2e60-42ab-947f-ff1265f35564" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_7ebccb16-489e-421b-b6de-9b9b78b94033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4a56ef75-dfaa-40f0-996e-6d5628676e37" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a961eb19-b662-49c8-b9eb-1101e1be0820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a961eb19-b662-49c8-b9eb-1101e1be0820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d26fc9e9-b9cd-486b-b2d7-dace5a906c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d26fc9e9-b9cd-486b-b2d7-dace5a906c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ae491d1b-5011-43a6-84ec-ee3b8cedccf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ae491d1b-5011-43a6-84ec-ee3b8cedccf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1e4403c4-e6b8-4ade-ad02-338969adec2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1e4403c4-e6b8-4ade-ad02-338969adec2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_64e535d5-6313-4fbe-9656-4b9c967bc4f0" xlink:href="halo-20210930.xsd#halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3cb03176-39a9-482e-94f5-cd2ae9bb74b4" xlink:to="loc_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_64e535d5-6313-4fbe-9656-4b9c967bc4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_297dfd18-3c0b-4cb3-8266-395b7c95c3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c7737033-2950-48aa-951b-dacaedbe5eb2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_297dfd18-3c0b-4cb3-8266-395b7c95c3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2efb72b4-cc62-45a9-b57c-5f6e40760cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c7737033-2950-48aa-951b-dacaedbe5eb2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2efb72b4-cc62-45a9-b57c-5f6e40760cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e01fa91c-610e-49c1-b89a-6ace4e51ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e01fa91c-610e-49c1-b89a-6ace4e51ffdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_Accruedmanufacturingexpenses_f5836663-ab97-4d0a-8080-a1372d948e47" xlink:href="halo-20210930.xsd#halo_Accruedmanufacturingexpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_halo_Accruedmanufacturingexpenses_f5836663-ab97-4d0a-8080-a1372d948e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3f59a389-9f49-47f7-aff4-34c51c92d7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3f59a389-9f49-47f7-aff4-34c51c92d7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bbf0d4a5-37d5-4537-a549-357ee9b30cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_us-gaap_OperatingLeaseLiability_bbf0d4a5-37d5-4537-a549-357ee9b30cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3fcf19a3-6be7-4bcf-88db-f5af6f57b09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3fcf19a3-6be7-4bcf-88db-f5af6f57b09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_AccruedLiabilitiesNoncurrent_7d618f81-5906-43c2-a1a6-15daaeba6552" xlink:href="halo-20210930.xsd#halo_AccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_halo_AccruedLiabilitiesNoncurrent_7d618f81-5906-43c2-a1a6-15daaeba6552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_88cc9f9d-c13b-4f57-b323-0c54ad143320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_88cc9f9d-c13b-4f57-b323-0c54ad143320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_OperatingLeaseAccretionOfLiability_5ef821a4-3277-4d0c-8fae-654d4b2a3ab1" xlink:href="halo-20210930.xsd#halo_OperatingLeaseAccretionOfLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_halo_OperatingLeaseAccretionOfLiability_5ef821a4-3277-4d0c-8fae-654d4b2a3ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_74eb05b0-39b7-4fa5-9f27-6b324052f15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_us-gaap_OperatingLeaseCost_74eb05b0-39b7-4fa5-9f27-6b324052f15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_583649ee-afa5-46a2-a416-76f72225fba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_783a4829-58f3-4160-a591-c2b3a3e1cefd" xlink:to="loc_us-gaap_OperatingLeasePayments_583649ee-afa5-46a2-a416-76f72225fba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#CertainBalanceSheetItemsAccruedExpensesDetails_1"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNet" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNet"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/LongTermDebtNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_17917a81-8425-4e9b-bc7a-b1a002a36bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_fbcdf901-2ca9-46a3-b927-df7b8eb389a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17917a81-8425-4e9b-bc7a-b1a002a36bba" xlink:to="loc_us-gaap_LongTermDebtTextBlock_fbcdf901-2ca9-46a3-b927-df7b8eb389a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNetTables" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNetTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/LongTermDebtNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_db7b2b5a-c83d-4238-9658-52e6017e3c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_092674c1-afd9-416f-b6a6-7d5f87d81092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db7b2b5a-c83d-4238-9658-52e6017e3c37" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_092674c1-afd9-416f-b6a6-7d5f87d81092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_398a37f1-883f-4fa3-9722-8e397c61d60a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db7b2b5a-c83d-4238-9658-52e6017e3c37" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_398a37f1-883f-4fa3-9722-8e397c61d60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_28a44313-6dff-49a6-8529-66ba57a91005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_28a44313-6dff-49a6-8529-66ba57a91005" xlink:to="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_217fd908-4ab5-408d-accd-6f7c9f8849e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_217fd908-4ab5-408d-accd-6f7c9f8849e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_217fd908-4ab5-408d-accd-6f7c9f8849e3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9005b067-8b35-4db3-ba5e-aca0f324a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_9005b067-8b35-4db3-ba5e-aca0f324a99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f09c42ef-d876-474c-b75e-4cfd3364a0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5fb8c5ca-a377-4244-bb99-c935f02c0f45" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f09c42ef-d876-474c-b75e-4cfd3364a0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_582882dd-3a73-495f-be9b-e721e7ece064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_582882dd-3a73-495f-be9b-e721e7ece064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_582882dd-3a73-495f-be9b-e721e7ece064" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_16264458-06b9-46a2-8aa9-818fd6b7022a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:to="loc_us-gaap_ConvertibleDebtMember_16264458-06b9-46a2-8aa9-818fd6b7022a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RoyaltybackedLoanMember_055271d0-b1d5-4679-b381-9502afef80f6" xlink:href="halo-20210930.xsd#halo_RoyaltybackedLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:to="loc_halo_RoyaltybackedLoanMember_055271d0-b1d5-4679-b381-9502afef80f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_2e1059d3-56db-4ed3-a1f9-aaf9f2159264" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_05d2656e-9146-46a3-a634-ca2df85d8ad0" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_2e1059d3-56db-4ed3-a1f9-aaf9f2159264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_12cb8285-a873-4e74-b8bb-e1b935bd468b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_srt_RangeAxis_12cb8285-a873-4e74-b8bb-e1b935bd468b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_12cb8285-a873-4e74-b8bb-e1b935bd468b" xlink:to="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4c6e7e1d-bea0-4b1f-93b4-68bea7c82e48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:to="loc_srt_MinimumMember_4c6e7e1d-bea0-4b1f-93b4-68bea7c82e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_641ad705-bf7d-4e22-bf77-87d659bf3561" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7df55940-1bef-48ba-ac8c-e9509b18af4f" xlink:to="loc_srt_MaximumMember_641ad705-bf7d-4e22-bf77-87d659bf3561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_6160f495-7749-4265-80c8-71ba536d59e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_VariableRateAxis_6160f495-7749-4265-80c8-71ba536d59e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21f50b70-d5bf-4f5a-b092-51670e01024c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_6160f495-7749-4265-80c8-71ba536d59e0" xlink:to="loc_us-gaap_VariableRateDomain_21f50b70-d5bf-4f5a-b092-51670e01024c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e13edd8-2e01-47f7-92ea-f6ce2b375845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_21f50b70-d5bf-4f5a-b092-51670e01024c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e13edd8-2e01-47f7-92ea-f6ce2b375845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e4358515-9ba7-445c-9c32-d10b89e3a230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_DebtInstrumentAxis_e4358515-9ba7-445c-9c32-d10b89e3a230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e4358515-9ba7-445c-9c32-d10b89e3a230" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_ba6cca86-ee4c-4b32-acf6-57df4f90a039" xlink:href="halo-20210930.xsd#halo_A1.25ConvertibleSeniorNotesdue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:to="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_ba6cca86-ee4c-4b32-acf6-57df4f90a039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_5143ae07-f77b-4220-b0cb-0d76c692e1c3" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_380b25f2-76af-4b8c-b2b0-fa68b3241056" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_5143ae07-f77b-4220-b0cb-0d76c692e1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_35133c1f-2a6f-45db-ad8f-fcb4d0f67da5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_177db1bf-6354-4a6c-81cc-f1008d7cd6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_177db1bf-6354-4a6c-81cc-f1008d7cd6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d59542e2-492d-41cb-997a-bb7f49c7d4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d59542e2-492d-41cb-997a-bb7f49c7d4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_54c968ae-3c75-4c3c-aa0a-f48462cd4135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_54c968ae-3c75-4c3c-aa0a-f48462cd4135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_2bc26083-aaa4-4d98-8186-c265f6ee3c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_2bc26083-aaa4-4d98-8186-c265f6ee3c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_77aa7ed2-4bf9-4c3d-91ed-8884a512af64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_77aa7ed2-4bf9-4c3d-91ed-8884a512af64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4b3eaf1e-d7de-4615-b08f-c8a3070f6afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_4b3eaf1e-d7de-4615-b08f-c8a3070f6afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0614cf62-058f-4136-b061-fc7cf779de03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0614cf62-058f-4136-b061-fc7cf779de03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_af3bac63-8c1a-43e1-8cb3-4fb3199e1f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_af3bac63-8c1a-43e1-8cb3-4fb3199e1f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_088e3189-1454-4577-a9a9-68ac4748142e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_088e3189-1454-4577-a9a9-68ac4748142e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ce972438-4a5c-49dc-a04b-e5008656fafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ce972438-4a5c-49dc-a04b-e5008656fafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_052d54f4-f971-465b-9204-e4a4998c5c15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_052d54f4-f971-465b-9204-e4a4998c5c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_da31da85-bb80-49f3-98a6-6981f6b62f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_RepaymentsOfDebt_da31da85-bb80-49f3-98a6-6981f6b62f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c8b3569b-bff2-44d7-bc3c-744e3d13f16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c8b3569b-bff2-44d7-bc3c-744e3d13f16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a2828a7c-fbcc-466e-8e5a-7c2ef5b0f9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a2828a7c-fbcc-466e-8e5a-7c2ef5b0f9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1a33e25c-77bc-465c-a888-22e47a9dcc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_LongTermDebt_1a33e25c-77bc-465c-a888-22e47a9dcc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_b4347366-76bb-455b-a6bc-2391f792eb93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_ConvertibleNotesPayable_b4347366-76bb-455b-a6bc-2391f792eb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_60a23c96-bdaf-4fa7-9692-1086df29c2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentFairValue_60a23c96-bdaf-4fa7-9692-1086df29c2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_2f0caf8b-938e-428b-a8f5-40f7df55c95c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_2f0caf8b-938e-428b-a8f5-40f7df55c95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_c198cd82-2cb5-4ecb-9060-76b11e5240d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_c198cd82-2cb5-4ecb-9060-76b11e5240d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8c83da98-7af6-46ba-ab44-76f9d4c6ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8c83da98-7af6-46ba-ab44-76f9d4c6ed9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_527e9a36-5190-4f16-a8f4-113265140a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_InterestExpenseDebt_527e9a36-5190-4f16-a8f4-113265140a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_223834e3-1ab5-4390-88c9-65e19912914b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_223834e3-1ab5-4390-88c9-65e19912914b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_8999f781-1f9b-4461-b027-67a7b4888485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_8999f781-1f9b-4461-b027-67a7b4888485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCovenantCompliance_bf9d767d-e4b5-422c-8301-fd9ae6248aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCovenantCompliance"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentCovenantCompliance_bf9d767d-e4b5-422c-8301-fd9ae6248aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c098fafc-bab0-4a11-8b2b-89c9688fef0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c098fafc-bab0-4a11-8b2b-89c9688fef0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1a7d2b6a-4382-4067-af93-6d8a8b3d362d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_LongTermDebtCurrent_1a7d2b6a-4382-4067-af93-6d8a8b3d362d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_401eb56c-5c1c-4541-8a64-46a172e8b756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_InducedConversionOfConvertibleDebtExpense_401eb56c-5c1c-4541-8a64-46a172e8b756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_e82c3f94-9b7c-46ad-a21b-7e7e0d09860c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_e82c3f94-9b7c-46ad-a21b-7e7e0d09860c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_fe2bb83b-ff9b-4528-aeb9-9d03388c62e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_fe2bb83b-ff9b-4528-aeb9-9d03388c62e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_bebbce7b-7731-41fe-a766-1a70d230c598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5da73257-113c-45d0-870c-6dfe18cb70e8" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_bebbce7b-7731-41fe-a766-1a70d230c598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNetCarryingAmountofConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b37ac0e1-ca2a-42be-8aaa-93c4ec3b4bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_df6af012-0d0e-4511-b5ad-a1992a4d175f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b37ac0e1-ca2a-42be-8aaa-93c4ec3b4bf4" xlink:to="loc_us-gaap_DebtInstrumentTable_df6af012-0d0e-4511-b5ad-a1992a4d175f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_95c07c39-cba7-40f0-8314-3408c634f4be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df6af012-0d0e-4511-b5ad-a1992a4d175f" xlink:to="loc_us-gaap_DebtInstrumentAxis_95c07c39-cba7-40f0-8314-3408c634f4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_95c07c39-cba7-40f0-8314-3408c634f4be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_c64ff821-ba61-40ae-b30d-057dce3987c3" xlink:href="halo-20210930.xsd#halo_A1.25ConvertibleSeniorNotesdue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:to="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_c64ff821-ba61-40ae-b30d-057dce3987c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_8f66ef05-a49e-4398-9ee3-833e05db64d1" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d060741f-2752-4795-a341-2c3db7d60108" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_8f66ef05-a49e-4398-9ee3-833e05db64d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_df6af012-0d0e-4511-b5ad-a1992a4d175f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_dfb07fb1-9235-42d9-9711-341a267c5040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_dfb07fb1-9235-42d9-9711-341a267c5040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2c78029b-d2df-42f5-8840-7786d0d15c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2c78029b-d2df-42f5-8840-7786d0d15c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_47b4d5f8-375b-4274-84b1-e542687f882b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_LongTermDebtCurrent_47b4d5f8-375b-4274-84b1-e542687f882b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1185dd13-4e35-45a7-afa6-de3a971f0051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_LongTermDebt_1185dd13-4e35-45a7-afa6-de3a971f0051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_b07f4255-6328-4ca8-b52b-108220cff7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_ConvertibleNotesPayable_b07f4255-6328-4ca8-b52b-108220cff7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8239e4f8-a976-4b56-bf01-1b78eaceff23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8239e4f8-a976-4b56-bf01-1b78eaceff23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a9d13812-a466-48ac-955b-0fc87b97c9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27e7cf1e-4e37-415b-921f-8e69bcfbc748" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a9d13812-a466-48ac-955b-0fc87b97c9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#LongTermDebtNetComponentsofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_06e51bd4-6c45-4d66-b17a-40edcd15b164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_06e51bd4-6c45-4d66-b17a-40edcd15b164" xlink:to="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:to="loc_us-gaap_DebtInstrumentAxis_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_79521f7a-8ae2-4e6c-8406-dc1fc4cacdf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_1dc370b3-cbf8-425c-9cf7-c5fd76e06cb8" xlink:href="halo-20210930.xsd#halo_A1.25ConvertibleSeniorNotesdue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:to="loc_halo_A1.25ConvertibleSeniorNotesdue2024Member_1dc370b3-cbf8-425c-9cf7-c5fd76e06cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A025ConvertibleSeniorNotesDue2027Member_77910ee8-b968-4fe0-80c9-57a080d45b11" xlink:href="halo-20210930.xsd#halo_A025ConvertibleSeniorNotesDue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9f4ddca0-dd56-4468-b077-a67800437a7f" xlink:to="loc_halo_A025ConvertibleSeniorNotesDue2027Member_77910ee8-b968-4fe0-80c9-57a080d45b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6753caa1-f9b7-4cee-a521-09ffe7db73e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6753caa1-f9b7-4cee-a521-09ffe7db73e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9b05b355-09be-4d3e-89c0-7a97b6a0a713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6753caa1-f9b7-4cee-a521-09ffe7db73e8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9b05b355-09be-4d3e-89c0-7a97b6a0a713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_601b8daf-28c5-4b1f-adb9-5dedde50daf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9b05b355-09be-4d3e-89c0-7a97b6a0a713" xlink:to="loc_us-gaap_ConvertibleDebtMember_601b8daf-28c5-4b1f-adb9-5dedde50daf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_edcf4edf-73bc-4532-a204-495bacddf75c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_b6859b7c-42c4-4a10-95d2-3b7397507e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentInterest_b6859b7c-42c4-4a10-95d2-3b7397507e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_df62109b-fbb2-404a-af7d-f4c0fda77839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_df62109b-fbb2-404a-af7d-f4c0fda77839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_99e0bc54-ef99-4b9c-801a-604c158adc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_InterestExpenseDebt_99e0bc54-ef99-4b9c-801a-604c158adc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_133cde4f-ff13-4a0a-b632-7365699f9a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_66dce7ae-b6f4-423b-a176-67a44a7c449e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_133cde4f-ff13-4a0a-b632-7365699f9a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensation"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SharebasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_73a3e599-b756-4507-a520-a0e7528ee09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_225311b4-8083-4bd1-8746-6cbb7a582dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_73a3e599-b756-4507-a520-a0e7528ee09f" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_225311b4-8083-4bd1-8746-6cbb7a582dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_099a0ba3-c0d1-4030-85f1-36fbe3ac8543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_745ec945-c3bb-46f3-8cf1-88713576129a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_099a0ba3-c0d1-4030-85f1-36fbe3ac8543" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_745ec945-c3bb-46f3-8cf1-88713576129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b3a8f8a8-c93b-43f2-8b11-ab6df19929b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_099a0ba3-c0d1-4030-85f1-36fbe3ac8543" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b3a8f8a8-c93b-43f2-8b11-ab6df19929b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3f135e3a-4406-4858-9da2-9d1b71b4e984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_099a0ba3-c0d1-4030-85f1-36fbe3ac8543" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3f135e3a-4406-4858-9da2-9d1b71b4e984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_41d46378-6f9e-407d-8bfa-87a4ad876e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_099a0ba3-c0d1-4030-85f1-36fbe3ac8543" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_41d46378-6f9e-407d-8bfa-87a4ad876e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_4c39a1a3-b6dc-4f31-be90-ed613ba5d6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_4c39a1a3-b6dc-4f31-be90-ed613ba5d6e0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1549486b-bf90-4185-a2e7-47899ba934fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1549486b-bf90-4185-a2e7-47899ba934fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1549486b-bf90-4185-a2e7-47899ba934fa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52dfe0ed-8a21-40ae-a15d-9b9a9620ddd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52dfe0ed-8a21-40ae-a15d-9b9a9620ddd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_427fb35f-85db-4623-af2b-7b8ef59f9523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_95a0fbf7-43ec-4ffe-8a19-6e7d963dd185" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_427fb35f-85db-4623-af2b-7b8ef59f9523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:to="loc_us-gaap_AwardTypeAxis_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_81de0c3f-f461-4dcd-aea6-1c5f6b00f7ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_59f657b2-cbb0-441d-92cd-d6cac1d98a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:to="loc_us-gaap_EmployeeStockOptionMember_59f657b2-cbb0-441d-92cd-d6cac1d98a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RSURSAandPRSUawardsMember_c3670f61-b3b8-490f-bfcd-a2146edd4ca4" xlink:href="halo-20210930.xsd#halo_RSURSAandPRSUawardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_311dad03-636c-4949-8cf3-395b6dba1563" xlink:to="loc_halo_RSURSAandPRSUawardsMember_c3670f61-b3b8-490f-bfcd-a2146edd4ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_9e16ac64-f840-4aef-ae24-cb8d54f53838" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_787d7634-8c11-4360-8da5-29cde33c01b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_787d7634-8c11-4360-8da5-29cde33c01b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_38e123b0-95a6-49e8-89eb-a7d3fcd2133a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b4bbd3a1-9b12-442d-a4ac-4eadee3a894c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_38e123b0-95a6-49e8-89eb-a7d3fcd2133a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_737d4f94-00d6-4fbe-9791-5931a825ee29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_737d4f94-00d6-4fbe-9791-5931a825ee29" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ddb04952-65b5-4f13-8c42-745e31b4b4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:to="loc_us-gaap_AwardTypeAxis_ddb04952-65b5-4f13-8c42-745e31b4b4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ddb04952-65b5-4f13-8c42-745e31b4b4d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ec212fd5-cd47-47b7-bdcb-cee603e7f25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ec212fd5-cd47-47b7-bdcb-cee603e7f25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_RSURSAandPRSUawardsMember_049332b7-c869-4720-acfc-65be72662c6a" xlink:href="halo-20210930.xsd#halo_RSURSAandPRSUawardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:to="loc_halo_RSURSAandPRSUawardsMember_049332b7-c869-4720-acfc-65be72662c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d5322c02-d664-408f-8ec5-130f40862b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3646dad3-922b-44db-8130-dc2dd25a429b" xlink:to="loc_us-gaap_EmployeeStockMember_d5322c02-d664-408f-8ec5-130f40862b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a1087f85-c472-4a52-b8a5-63cca2372306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:to="loc_us-gaap_PlanNameAxis_a1087f85-c472-4a52-b8a5-63cca2372306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e9e081ec-05fe-4a87-b92f-d4d5a293ff76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_a1087f85-c472-4a52-b8a5-63cca2372306" xlink:to="loc_us-gaap_PlanNameDomain_e9e081ec-05fe-4a87-b92f-d4d5a293ff76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2021ESPPPlanMember_c9a44b8e-039d-40cf-9f04-62fa84178b2d" xlink:href="halo-20210930.xsd#halo_A2021ESPPPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e9e081ec-05fe-4a87-b92f-d4d5a293ff76" xlink:to="loc_halo_A2021ESPPPlanMember_c9a44b8e-039d-40cf-9f04-62fa84178b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e087c3de-02bc-4b3d-9879-efe84e57a0d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1d406858-0d0d-4f1b-b834-efe52676508a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1d406858-0d0d-4f1b-b834-efe52676508a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c63db9f4-52f6-4146-903b-f2a3a736a469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c63db9f4-52f6-4146-903b-f2a3a736a469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_39a6ddd4-e599-4582-9f0d-19a1d4bd6cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_39a6ddd4-e599-4582-9f0d-19a1d4bd6cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_bf99fe0c-6e95-4b94-bcfc-d7892a1fd879" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_bf99fe0c-6e95-4b94-bcfc-d7892a1fd879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8875352-e803-43b1-8afe-2985cf32264c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8875352-e803-43b1-8afe-2985cf32264c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate_fd63e80d-c23b-43d1-aa76-9b1759f3de8d" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate_fd63e80d-c23b-43d1-aa76-9b1759f3de8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_91a3947e-a289-42a1-b09b-f87276ffce17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_91a3947e-a289-42a1-b09b-f87276ffce17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_10d8ff7b-b437-4b35-873e-9b2bace41acd" xlink:href="halo-20210930.xsd#halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5804f583-9e37-4979-8ae7-5bd6e470b31b" xlink:to="loc_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_10d8ff7b-b437-4b35-873e-9b2bace41acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_8aef108d-fdc7-4435-afad-27a9a4b16d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_69ebcfad-014d-4d2f-9d9c-2085980e5ca7" xlink:href="halo-20210930.xsd#halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_8aef108d-fdc7-4435-afad-27a9a4b16d24" xlink:to="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_69ebcfad-014d-4d2f-9d9c-2085980e5ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_331b2f7f-e933-4a1e-86c5-0ff59d557f4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_69ebcfad-014d-4d2f-9d9c-2085980e5ca7" xlink:to="loc_srt_RangeAxis_331b2f7f-e933-4a1e-86c5-0ff59d557f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_331b2f7f-e933-4a1e-86c5-0ff59d557f4d" xlink:to="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8b9ed6ff-7393-4996-af2b-09e811ba7b3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:to="loc_srt_MinimumMember_8b9ed6ff-7393-4996-af2b-09e811ba7b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_798928de-9ac4-44cf-9d8d-fe2295fbfb9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b3044bb-9b6a-413e-8846-cdaa95e3fb25" xlink:to="loc_srt_MaximumMember_798928de-9ac4-44cf-9d8d-fe2295fbfb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:href="halo-20210930.xsd#halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable_69ebcfad-014d-4d2f-9d9c-2085980e5ca7" xlink:to="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54cd271e-1fb5-45a6-8ffb-69132332aaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54cd271e-1fb5-45a6-8ffb-69132332aaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f814dd49-81a7-4c5a-a5f5-c1a7c4d6ad70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f814dd49-81a7-4c5a-a5f5-c1a7c4d6ad70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_9d03b3e1-8c8a-4be0-ac2d-605232796485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_9d03b3e1-8c8a-4be0-ac2d-605232796485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_bbbae9db-b113-4219-ab84-09ac16fe1d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_bbbae9db-b113-4219-ab84-09ac16fe1d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fbe38c6-a145-4122-8c62-d2a68ce101ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems_ecdb4180-c153-4bf4-9f14-f11065abecc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6fbe38c6-a145-4122-8c62-d2a68ce101ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_572af471-afc7-47b3-86b0-abc95e4e2396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bee1719b-3aa5-4d3c-aa0c-39998cb0a66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_572af471-afc7-47b3-86b0-abc95e4e2396" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bee1719b-3aa5-4d3c-aa0c-39998cb0a66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a9029070-b095-4047-92b1-365d4b638d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bee1719b-3aa5-4d3c-aa0c-39998cb0a66c" xlink:to="loc_us-gaap_AwardTypeAxis_a9029070-b095-4047-92b1-365d4b638d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a9029070-b095-4047-92b1-365d4b638d5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c6a958b2-b27a-4f7c-bb47-d95d8dd3d846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c6a958b2-b27a-4f7c-bb47-d95d8dd3d846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_256a34fc-fdbc-48da-b0f7-574ddd441bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_RestrictedStockMember_256a34fc-fdbc-48da-b0f7-574ddd441bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9f3a17fb-26c4-4b3c-bd99-5dd0faf19be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9f3a17fb-26c4-4b3c-bd99-5dd0faf19be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_bcdeda82-db80-43a5-a043-578070b80237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_PerformanceSharesMember_bcdeda82-db80-43a5-a043-578070b80237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_09c3c4ac-d4ed-4bb2-803e-733f82cfb757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3ea74185-1f23-47dc-bf4a-de20b43256ff" xlink:to="loc_us-gaap_EmployeeStockMember_09c3c4ac-d4ed-4bb2-803e-733f82cfb757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bee1719b-3aa5-4d3c-aa0c-39998cb0a66c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d731aa52-e3ed-45c5-b8d4-94d50ec265e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d731aa52-e3ed-45c5-b8d4-94d50ec265e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d4ca5d63-5f39-4639-8d63-942eb3e9297e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fed21635-2f05-40db-86c8-991428d57072" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d4ca5d63-5f39-4639-8d63-942eb3e9297e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/StockholdersEquity" xlink:type="simple" xlink:href="halo-20210930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ac07c863-44cd-4080-9de1-62d64050263c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_90445c55-defd-42b6-8a9a-80a0ca65883b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac07c863-44cd-4080-9de1-62d64050263c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_90445c55-defd-42b6-8a9a-80a0ca65883b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="halo-20210930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2a48ca5b-4b08-45ae-8232-58be93890ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_771e2c1e-282a-4d38-932a-006b92848b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2a48ca5b-4b08-45ae-8232-58be93890ee4" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_771e2c1e-282a-4d38-932a-006b92848b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d9ccba83-0a54-4e12-9f33-ea4f04d5c72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d9ccba83-0a54-4e12-9f33-ea4f04d5c72a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a150dd34-84a0-4b2d-89e5-cdf6df730a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:to="loc_us-gaap_AwardTypeAxis_a150dd34-84a0-4b2d-89e5-cdf6df730a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a150dd34-84a0-4b2d-89e5-cdf6df730a57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_18d05c17-16dd-41d3-901e-bcb44ddac0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:to="loc_us-gaap_EmployeeStockOptionMember_18d05c17-16dd-41d3-901e-bcb44ddac0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_56b0f02d-8749-4524-b3ea-c49d85d528a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_56b0f02d-8749-4524-b3ea-c49d85d528a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_StockOptionsAndRestrictedStockUnitsMember_f635dd54-05d8-4b2b-a9a3-e2a5b1d763f1" xlink:href="halo-20210930.xsd#halo_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef9a8cea-b8a8-44ae-8dbe-3587785cb597" xlink:to="loc_halo_StockOptionsAndRestrictedStockUnitsMember_f635dd54-05d8-4b2b-a9a3-e2a5b1d763f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_336747e7-678c-43c4-b5ae-6b4a24261599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_336747e7-678c-43c4-b5ae-6b4a24261599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_336747e7-678c-43c4-b5ae-6b4a24261599" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2020ShareRepurchaseProgramBankOfAmericaMember_9faa74f6-6a83-45c3-b5a9-765e98dbd54e" xlink:href="halo-20210930.xsd#halo_A2020ShareRepurchaseProgramBankOfAmericaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:to="loc_halo_A2020ShareRepurchaseProgramBankOfAmericaMember_9faa74f6-6a83-45c3-b5a9-765e98dbd54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_A2021ShareRepurchaseProgramBankOfAmericaMember_8c9729ac-dbec-4c65-81f0-da3b835acbea" xlink:href="halo-20210930.xsd#halo_A2021ShareRepurchaseProgramBankOfAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a58f4099-eed0-41dc-af22-65196e53eec2" xlink:to="loc_halo_A2021ShareRepurchaseProgramBankOfAmericaMember_8c9729ac-dbec-4c65-81f0-da3b835acbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b90e11-8815-4af3-bace-2dc8dd2edb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c78e2d09-56de-46b7-84a6-3fd7d5f63f92" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b90e11-8815-4af3-bace-2dc8dd2edb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b90e11-8815-4af3-bace-2dc8dd2edb2f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d33192ad-b354-4fa9-8f12-5a039ffaf6de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d33192ad-b354-4fa9-8f12-5a039ffaf6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1e5da4b7-7923-4175-b874-165c4a1fc059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1e5da4b7-7923-4175-b874-165c4a1fc059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_253e205e-aa1c-4651-b54f-3d4e726f6e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_253e205e-aa1c-4651-b54f-3d4e726f6e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6c0fc219-eb6c-40da-8b94-70121251ed92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6c0fc219-eb6c-40da-8b94-70121251ed92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b2e06458-efe9-465f-b79c-4e727f160bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b2e06458-efe9-465f-b79c-4e727f160bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_37db5d8f-3462-4d2c-aee5-865ee428808d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_37db5d8f-3462-4d2c-aee5-865ee428808d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a0ad274-cc5c-4628-90b7-b540ed1468bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a0ad274-cc5c-4628-90b7-b540ed1468bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b8b38d9a-c13d-490d-a917-cd25c59fb9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b8b38d9a-c13d-490d-a917-cd25c59fb9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_dec0ee38-5be7-4051-9a67-beb7e0076809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_dec0ee38-5be7-4051-9a67-beb7e0076809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_576448f8-6435-44ef-a195-9e243f635166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_576448f8-6435-44ef-a195-9e243f635166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_db63cd69-29ea-45ec-ad22-c9d3b66212df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_db63cd69-29ea-45ec-ad22-c9d3b66212df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_48c156fa-979e-49bd-947f-03a4e99704e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f4a72a79-fead-4c7e-b0b3-9508a6a434a4" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_48c156fa-979e-49bd-947f-03a4e99704e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#StockholdersEquityShareRepurchaseActivityDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_273f4650-a46e-4374-ab9d-67707efc4103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5b8c8841-e9a1-4823-946e-c27dc51781ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_273f4650-a46e-4374-ab9d-67707efc4103" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5b8c8841-e9a1-4823-946e-c27dc51781ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_021e88a4-fc53-4af6-8fa9-420348c8698a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_273f4650-a46e-4374-ab9d-67707efc4103" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_021e88a4-fc53-4af6-8fa9-420348c8698a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_948f2719-8c07-43ec-a502-66a8671e6b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_273f4650-a46e-4374-ab9d-67707efc4103" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_948f2719-8c07-43ec-a502-66a8671e6b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_TreasuryStockAcquiredFeeCostPerShare_79fbd413-903d-48ed-9923-f8a70d54bd85" xlink:href="halo-20210930.xsd#halo_TreasuryStockAcquiredFeeCostPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_273f4650-a46e-4374-ab9d-67707efc4103" xlink:to="loc_halo_TreasuryStockAcquiredFeeCostPerShare_79fbd413-903d-48ed-9923-f8a70d54bd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e1d1dea9-f063-438a-841b-2a4e6600ac30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_273f4650-a46e-4374-ab9d-67707efc4103" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e1d1dea9-f063-438a-841b-2a4e6600ac30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="halo-20210930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f2667634-eb12-4918-94d1-82d37cb4b4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a21332ad-43ee-4859-9038-3eff16b04920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f2667634-eb12-4918-94d1-82d37cb4b4c7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a21332ad-43ee-4859-9038-3eff16b04920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="halo-20210930.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0f1ed2fc-56f6-4ba1-babc-a9cf0b31be3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a4fca721-bec1-4ab2-be13-1c6803a492e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0f1ed2fc-56f6-4ba1-babc-a9cf0b31be3f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a4fca721-bec1-4ab2-be13-1c6803a492e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#CommitmentsandContingenciesSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cab28e9f-c5c0-4ae6-8c1f-f401909131ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cab28e9f-c5c0-4ae6-8c1f-f401909131ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c380a4fe-1035-4085-92b2-117f54a76146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c380a4fe-1035-4085-92b2-117f54a76146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d9fabdb5-8035-4ac3-89f5-6cb130bd654e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d9fabdb5-8035-4ac3-89f5-6cb130bd654e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d169c1b7-4351-4c30-82f1-8f1fd740b383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d169c1b7-4351-4c30-82f1-8f1fd740b383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f4287bc1-e734-4709-b788-10674a4f0970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f4287bc1-e734-4709-b788-10674a4f0970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5f54f39c-ed79-436a-86eb-333f5baa928e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5f54f39c-ed79-436a-86eb-333f5baa928e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af46c6f8-e507-42dd-868d-150f8429e41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af46c6f8-e507-42dd-868d-150f8429e41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_05033525-eac1-46f5-a6e7-135a009cb5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_OperatingLeaseLiability_05033525-eac1-46f5-a6e7-135a009cb5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_06d1401f-7d81-4309-b933-99be52439dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f3853e1f-0e70-4e7f-9955-4f2965d68fe3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_06d1401f-7d81-4309-b933-99be52439dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1" xlink:type="simple" xlink:href="halo-20210930.xsd#CommitmentsandContingenciesSummaryDetails_1"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.halozyme.com/role/NetIncomelosspershare" xlink:type="simple" xlink:href="halo-20210930.xsd#NetIncomelosspershare"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/NetIncomelosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8238cc05-2e1d-41c0-8148-0e12c11f1e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_30f299a0-69b7-4491-be24-85831983ba45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8238cc05-2e1d-41c0-8148-0e12c11f1e6d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_30f299a0-69b7-4491-be24-85831983ba45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/NetIncomelosspershareTables" xlink:type="simple" xlink:href="halo-20210930.xsd#NetIncomelosspershareTables"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/NetIncomelosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b7577e6c-0c80-4eb3-812b-f400cd619845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3bd2d153-1ac9-4160-ab71-38dbd8bd42a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b7577e6c-0c80-4eb3-812b-f400cd619845" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3bd2d153-1ac9-4160-ab71-38dbd8bd42a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_eb92305f-4cbb-435f-99e7-025a5660b7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b7577e6c-0c80-4eb3-812b-f400cd619845" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_eb92305f-4cbb-435f-99e7-025a5660b7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#NetIncomelosspershareSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d74d9c85-971c-46f4-bff0-665a70ee3b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d74d9c85-971c-46f4-bff0-665a70ee3b2b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9343e6c7-524c-4a1f-83cc-199df1a270e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:to="loc_us-gaap_AwardTypeAxis_9343e6c7-524c-4a1f-83cc-199df1a270e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9343e6c7-524c-4a1f-83cc-199df1a270e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5fcf7bfc-1408-42ca-95d6-7003ecf4ac09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5fcf7bfc-1408-42ca-95d6-7003ecf4ac09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8045a51e-d594-42d4-a783-2c6c4b29d25a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4804e09-1039-4085-b88b-5a349f1ff3ac" xlink:to="loc_us-gaap_RestrictedStockMember_8045a51e-d594-42d4-a783-2c6c4b29d25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b9c763a8-f512-4389-b0cb-48815d988570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:to="loc_us-gaap_DebtInstrumentAxis_b9c763a8-f512-4389-b0cb-48815d988570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18f145a6-94c7-41c2-a622-dcf15a35ada8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b9c763a8-f512-4389-b0cb-48815d988570" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18f145a6-94c7-41c2-a622-dcf15a35ada8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_61ab494a-d438-453d-a344-a6bdf752e947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f145a6-94c7-41c2-a622-dcf15a35ada8" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_61ab494a-d438-453d-a344-a6bdf752e947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_6ea3004c-b63b-4386-9c8d-05199a6ffeb0" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bfeff8b7-ee74-4097-9fae-bfa9faaa576d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_NetIncomeLoss_bfeff8b7-ee74-4097-9fae-bfa9faaa576d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e905e14a-e10d-4418-a39e-8132565f8120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e905e14a-e10d-4418-a39e-8132565f8120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c8d3e901-8437-4d02-bc1e-7ba893b286e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c8d3e901-8437-4d02-bc1e-7ba893b286e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8872f4d2-2f50-4136-b663-269034211b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8872f4d2-2f50-4136-b663-269034211b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_5baf4b80-2479-4fdf-8923-907a04dee7a3" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cbec5abe-8fdf-4df5-b72d-9ea1d9b28dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:to="loc_us-gaap_EarningsPerShareBasic_cbec5abe-8fdf-4df5-b72d-9ea1d9b28dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_820c9ed7-ffd2-4ba0-9d0d-e7496a2a80ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_8b07740b-5be0-4e1d-99aa-cb4b33e1fd5a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_820c9ed7-ffd2-4ba0-9d0d-e7496a2a80ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.halozyme.com/role/NetIncomelosspershareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="halo-20210930.xsd#NetIncomelosspershareAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/NetIncomelosspershareAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_acfa219e-2055-4124-b3bb-a39e62df2cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b16aa894-bdb9-4bdd-b083-68bda4ff4fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_acfa219e-2055-4124-b3bb-a39e62df2cff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b16aa894-bdb9-4bdd-b083-68bda4ff4fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>halo-20210930_g1.jpg
<TEXT>
begin 644 halo-20210930_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#F17AI9@  34T *@    @ ! $[  (
M   )   (2H=I  0    !   (5)R=  $    2   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 &=Y97-E9V%T
M    !9 #  (    4   0HI $  (    4   0MI*1  (    #-S<  )*2  (
M   #-S<  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H
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M?_Z>?A_P3Y-HKZRHH_MK_IW^/_ #_5__ *>?A_P3Y-HKZRHH_MK_ *=_C_P
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M5]944?VU_P!._P ?^ '^K_\ T\_#_@A1117SQ]0%%%% !1110 4444 %%%%
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M!85G79G<-Q("R9 ^<@9ZG&>??H:YKPYI.JZ?>1O?W%Q*AM6602W;RCS?,)!
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M7T-+^R:*^W^0UG==[4_S/H__ (2OP[_T'M+_ / R/_&C_A*_#O\ T'M+_P#
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M3;R.ZF&8X'@8.X]E(R>AI?V31_G_ "'_ &W7_P"??YGT?_PE?AW_ *#VE_\
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M_(CZ<_X2OP[_ -![2_\ P,C_ ,:/^$K\._\ 0>TO_P #(_\ &OF.BC^QJ?\
M,P_MZK_(CZ<_X2OP[_T'M+_\#(_\:/\ A*_#O_0>TO\ \#(_\:^=?^$<UO;$
MW]C:AMF.(S]E?#\9XXYX!/T%0V^D:E=^5]DT^ZG\\,8O*@9O,"G#%<#G!ZXZ
M5']DT?\ GY^1?]M8C;V?YGTA_P )7X=_Z#VE_P#@9'_C1_PE?AW_ *#VE_\
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M)I.HR7<=K'873W$J"2.%86+NI&0P7&2,<YH_LFC_ ,_/R#^VL1_S[_,^D?\
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M**** "BBHI[F&U0-<2I&"<#<<9/MZTFTE=@2T53&JV?\<IC'9I8V13^) %7
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M7!.T_,"1CH0>N>&HJWA^:7.WKI^%_P#,SCBG&#@EIK^*2_0****ZCB"BBB@
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MDN1(8C'/&Z/L!+C>K%<@ Y&<TVS\+ZO?V\4UO:KMGSY"R31QO-@9.Q&8,_\
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M"ZA)>W+S(L;?,ACVJH9APK$\GD^E5O\ A5WB_P#Z!0_\"8O_ (JC_A5WB_\
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M_P#BJVIUL-3CRQFOO1A5P^+JRYI4W]S.1HKKO^%7>+_^@4/_  )B_P#BJ/\
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MA-QC:,',>"S,V1D@Y_.K_P#PJ[Q?_P! H?\ @3%_\51_PJ[Q?_T"A_X$Q?\
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MUW_"KO%__0*'_@3%_P#%4?\ "KO%_P#T"A_X$Q?_ !5'UK#_ ,Z^]!]3Q/\
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MJ*- U(?M47]X_P#?)_PH^U1?WC_WR?\ "IJ*- U(1=PD9#$CU"FC[5%_>/\
MWR?\*=;_ /'NGTJ2C0-2'[5%_>/_ 'R?\*/M47]X_P#?)_PJ:BC0-2$W<(!)
M8@#J=IH^U1?WC_WR?\*=<_\ 'K)_NFI*- U(?M47]X_]\G_"C[5%_>/_ 'R?
M\*FHHT#4A^U1?WC_ -\G_"@W<(&2Q'_ 34U1W'^I_P"!+_,4:!J-^U1?WC_W
MR?\ "C[5%_>/_?)_PJ:BC0-2'[5%_>/_ 'R?\*/M47]X_P#?)_PJ:BC0-2'[
M7#G&XY/0;31]JB_O'_OD_P"%.?\ X^8_HW]*DHT#4A^U1?WC_P!\G_"C[5%_
M>/\ WR?\*FHHT#4A^U1?WC_WR?\ "GQS1R,0C9(YP013ZB/_ !]C_</\Q1H&
MI+1112&%%%% !1110 57.G636\MNUG;F&9S)+&8EVNQ.2Q&,$D\Y/>K%%.[0
MFD]RE-HVF7$#P7&FVDL4DIF>-X%96D/5R".6]^M2QV%G"8#%:0(;9"D&V,#R
ME.,A?0' X'H*L44<S[BY8]BE-HNEW&?/TVSEW,S'? IR6 #'D=2 ,^N*0Z'I
M)N9+@Z79&>52DDOV=-SJ1@@G&2".,>E7J*?-+N')'L5TT^SB\WR[2!/.4)+M
MC WJ!@ \<@#C![5%%HVF0/&\.FVD;1L&1D@4%"%V@CC@A0!].*NT4<S[ARQ[
M$,=G;0PO##;Q1Q2%F=%0!6+?>)'?/?UJ*32M/EM8K:6PMG@A&(HFA4K'QCY1
MC X)''8U;HI<S'RKL0_8[;= ?LT.;;B ^6/W7&WY?[O''':F-IE@]U]I>RMV
MGWB3S3$I;<!M#9QG('&?2K-%%V'*NQ4MM)TZRNI+FST^UM[B7/F2Q0JKODY.
M2!D\\TK:7I[PW$3V-LT=TV^=#"I65O5ACYCP.35JBGS/>XN6-K6,T^&]#*Q
MZ-I^(?\ 5#[*GR<YXXXYYXJ]+;03R1230QR/"VZ)G0$H<8R#V.#CBI**'*3W
M8*,5LBL^FV,EQY\EG;O-YBR^8T2EMZC"MG'4 D ]LTR#2--MKN:ZMM/M8;B?
M/FS1P*KR9.3N(&3D\G-7**7,^X<L>Q2M-%TNPCFCL=-L[9)QMF6&!4$@YX8
M<]3U]32C1],73FT]=.M!9,<FV$"^63G/W<8ZC-7**?-+N')':Q4@TG3K:.%+
M;3[6%('+PK'"JB-CP2N!P3D\BK=%%)MO<:26P4444AA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %1K_P ?4G^XO\VJ2LRZUW1].U!X;_5+
M*UFV*2D]PB''/8G--)O1"<E%7;-.BLG_ (2SP[_T']+_ / R/_&C_A+/#O\
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M0#%@:YII.1TNX_4>]'LY]@]I#NC9HK*_X2CP_P#]!S3?_ N/_&C_ (2C0/\
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M8!.565CN! XY!'&[D\-E^,/ANWFM8[P369N%$CB\FM[=X(V8A':*242$,H#
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M-$]U;VOE_:IXH?-D$4?F.%WN>BC/4GTH EHHHH **** "BBB@ HHHH ****
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MKOA*37?&:2W]@MSI+26K3!V7:XCBNP0RYR5W2Q @C!#$<C-37'AN6X^&>M:
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M"N!%(P(Y(QGGO@C-=A41_P"/L?[A_F*N%2<'>+L9SI0J*TU<EHHHJ#0****
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M&XM_%6H:?>V&DW]U=C3;_P"S3PQ7323E%0>6/,6Z@(8#:S9E#$ME@237K5%
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ME@M+2_B?-J4,MPWAZ[@MI85ELI9(KF-7WNJHLKRP)'&3YBG*/*,!\$X&X ]
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M'K0^F6$EU]IDLK9I]ZOYK1*6W*,*V<9R 2 >U;?6*;7P_P!:?Y&'U:HGI/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)1_IL
MA]8T'ZM4M1K_ ,?4G^XO\VH DHHHH *:_P#JV^AIU-?_ %;?0T -MUV6T:CL
MHJ2F0_ZE/]T?RI] !1110!#=KNLYE/=#4U17/_'K+_NFI: "BBB@ J&[7?:N
M#[']:FJ.X_X]VH DHHHH **** (9%S=PMZ*W]*FJ-_\ CXC^C?TJ2@ HHHH
M*A*_Z<K=_+(_45-49_X^E_W#_,4 24444 %%%% !1110 5R4'Q&T*?48M/\
M[0T];W[==6MS;?;D,ELD F)E=>H!$(ZX WCGCGK:Q+KPEIE]IJV%Z)9[7[1<
MW#Q,PQ)]H$RR(<#.W$[@8P>G/J 5G\?^'8H4DNKJXM/,G2WC2[L+B"221PQ0
M*CH&8-M8 @$$C .>*EB\;:#,TP6[E58E+K)):3)'. <9A=D"S<D8\LMG(QG(
MK,\/?#'1?#NH17EJ_F30S"9"+"RM\$1R1X)@@C)&)2><\@8QSF>3P!97.ES:
M7?:EJ-YI;1>5;V%P8FAM5!!7:/+_ 'FW:N/-,@XYSDY +;^.-#CM8YG>^#22
M&)+?^S+G[06 W$>1Y?F?=Y^[TYZ55F\>6+ZA:VFG1O/]JBCD2::*>*,%KA(2
MC-Y1VR L04."&&UMO)&=9?#*+1S:IH6J3:?LF>62ZM;2S@EY3:%"QVXC8=?O
MJ2,\'@8VX_!UA'%;*UQ=R/"RNTKNI::07"W!=OEQEI$Y   !(4*,8 ,'Q)\5
M])T[PS/J&CSQ/*$#Q2ZE#<6UN5) ,@;RB90I905C!.6"\$BM1_&$W_"#6/B"
M&TL<W84L9M0VVL(.?G:<1GY.  VSDLN<#)&M8:!:Z=_9GD23-_9EBUC#O8'=
M&?+Y; Y;]RO3 Y/'I)K&EOJMJD<.I7NFRQOO6>S9-W0@@JZLC @GAE/8C! (
M ,R37==NKEXM%T""3[,$%W_:&H?9S'(R*_EILCD#LJL,G*KD@ MSC2N]6:TM
M+&1[259KR5(Q;N06CRI=P=FX$JBN<+D$@ 'G-9:^"XK2.&/0]9U31HDACADC
MLVA99EC0(A82QOM8*H7<FTD 9)VKC2O-,D(TD63Y&GW"OBXE9RZ>6\9RYRS-
MM<G).21R>2: ,33_ (E^'KN"+[1/-:7DEN;K['):3>;Y?FF($(4#'<XV@8R6
M90 21F[;^.M"NI4A@DOFG:?R#;_V9<B:-\*WSQF/<BX=#N8!<,IS@BC_ (0S
M3Q#.L4]U%++#!&LZ,F^(PRR2QNN5P2'E8X8%3@ @@D&I_P (%&]Q%/=Z_JMW
M*MZE[*\ZVQ,KHJJHXA'E@*N/W6P_,W.230!<T/QEIVM:?<W06XM?LQG,D=Q;
M2QL(XY73?AT4\["<8R#D=12V7C;0]0UTZ/;S7:WP('ES:?<1*<AV4AW0*01%
M(00<'8<9J&^\$V]W$T<&JZG8K*;@7'V9X_WZ32M(Z-N1L %F 9=K '[W>JZ>
M 1'=WES%XEUI)KFX%RCC[-FWD "@H3#D@1@Q[7W+M8\;OF !<N_'?AZQNC;W
M-[*K+N,CK:3-'"!*\1:1PA6-=\;C<Q ^7.<<T'QQH@M5F#:@S-(T?V9-*NFN
M%*A2Q: 1^8J@.GS%0/G7GYAE;;P=96]C=6S75Y.;R!89YI74NY$DLI?A0 Q>
M9R<#:.   *6^\)I<ZG+J5CJVH:7?2L2T]IY+':4C4IMEC=<'RD.<;@0<$ D$
M I1_$?0'G?-Q(UIY,5PEW#;RRQB)U)$LK*A$*<'YI" 0K'.%.-_3=0^W_:U:
M+RI+6Y>!U#;AQ@J<X'564X[9QSC)YY/A[;06WV6TUW6;>UDMTM;F!)HV%S&H
M*X9FC+J2"P+HRL<YSD*1O:18R627;3B,2W-U),1$25"_=3J!SL5,CL<C)'-
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MTP/F7-;3O'FD7D-AY[S03W<,#N%MY9(;>25%98GG">6KG>F%8J3O3CYER_\
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M@K@G@CD<<YYK-'A!I89(]1\1:SJ VCR#-)"GV9@P9741QJ'8,JD&0/@K[MD
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MV4GV3[-=&XT[SDF!8NSJHD7:Y9F))+ \9!P*2Z^&>FW3SQM>7(M)M--F;<$
M"4Q>0;G(P?,\D"/TVCIS52;Q_*]C':Z1-IL^L0B1;NU;<?LQ658U\Q0=R EA
MC=U'(S4&N:YXIL)H?-U#36ETV\F\XPV4L:72_899D!7SCM *L""6R=C#&W!
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MP#QNP-"Q\5:5J.K:E?V&N0W6F&VM[>&6TF$RFY!G=TC R&EV&,[5!8_+QTH
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M ,:/9S[,/:0[HT;G_CUE_P!TU+6+<>*?#[6\@&NZ:25. +R/_&I?^$J\/?\
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M$DNZ,Y61R23N<$YYSFD?P3H+RVKFUF46D444<:7DR1LL7,6] X60J<$%P2"
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M)(V[GX7=GG:,E_B,8;BYFET._-@(;1[:7=;Q^89]^,L\P51E0HW%<MP,EER
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MAU=]1D.GWUE!%Y:_+/9O*W5NXE7^5:=1K_Q]2?[B_P VIIV$TFK,S/LWB/\
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M($;YNGRMM.=^7W(/9KS^]FS]G\1_]!+2_P#P7R?_ !ZCR/$?_02TO_P7R?\
MQZJ>M^*7T/6K".ZLR--FMI);NXSEK/#1J&8#(* OAB/N_>/RAB,*X^(\MGIM
MZ]S:RM=1Z4EY;_9].N9HO,;S>)'0%47,:_>9>,G..0<[\ON0>S7G][.I\CQ'
M_P!!'2__  7R?_'JCG@\1>0V=1TPCVL)/_CU6M(OY]2L[F201H\=W<0)M4XP
MDC(I(SR< 9_I7.Z?X\2_MK=)-,U"2-A;17&IK!'%;+--%'(@V&5I!GS4' <
MM@L<9HYWY?<@]FO/[V;GD>(_^@CI?_@!)_\ 'J/(\1_]!'2__ "3_P"/5B:G
MXFU2W\9SZ=!-'':P1HWE_P!AW5R9"RDG-RCB.+I_$/?O6QIFL7-[=Z?'+'&$
MN=-%VY53PY*\#GI\Q]_>CG?E]R#V:\_O8_R/$?\ T$-+_P# "3_X]1Y'B/\
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MG)"@#JI/YYY]QJ,_\?2_[A_F*WHXF5)MI+4PKX6-9)-M6\R2BBBN4ZPHHHH
M**** "N/5/"FK3ZGIT^NV-W+:7DEUY=K?^3<Z<3A9 9(Y Z'>9 2"O#E#QG/
M85YL/"GB!9-56\>YOH+F2]EL(-]ND=F9+AFP< .V]2""6;&6!"D D U--LO
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M PSN#8W@XP<  9.GP^(-;T&TUO4QJ>J07@"FST74C:,T:+MBG1C+&-KGS)"
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M=RX<<!*5YHGC:728EM(=92$7<S2P37K/=RY">5(634(PJ@"12J2A"Q#"$<;
M#UNBJ&A)?1^'[!-6D:2^6W07#O&J,7VC.Y5=U!SUPS#.<$BK] !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !4:_\ 'U)_N+_-JDJ-?^/J3_<7^;4 2444
M4 5DT^UCU2745C/VJ:)(7D+D_(I8@ $X'+$G &>,YP*Y?3/ ?AV&YOKJT>2>
M%KLR+;Q7TWD1LB(GEO&)-C[6C) 9?EX4 !171ZS+?PZ-<MHT GORFV!&8!0Y
M. S9(^5<[CW(!QDX%>8R^&/$'@^WBT\3R:G8ZC<1O,=')T^5I54B3+-.27F7
MYBP91NC.=I;=0!V6E_#_ $6VLP+I+B\=TD!$MW,8E\S.YHXBY2-B&(+( ?F;
MGYCG2N?"FD7>L?VG/!,9S(DKHMU*L,LB !7>$,(W<;4PS*2-B<_*N.#>TU=+
MS2K2[L/$MQ8R0WDT.F6VN>7=Q(#:A3+-YZ[\,92!YS8$BCG&%O1^'?%:V]U=
MZI>:M>EI84;3K341$TD A3=Y4@9-LAEQEBR9$;[=N\[@#KY?"NC2I?@6?DMJ
M%P+FXEMY7AD:4*J!PZ$,AVJ!E2._J<P2>#-'FM8(9?[1;[/NV3'5;KSBK'+(
MTOF;V0D#Y&8KP..*Y[^Q/%1L[?\ LZ>^LXKMWM)K>^U S365JV")=X9@TRD.
M 0S'$JY9M@K+@T3Q_#XBU Q7=VI>.Y2&Z9MUNP*-Y(&^[D"$'R_G%KG*G.X%
MBP!WK:9I4-C::=#'&!I42M:P"0DPKY;1*<9R1M+KSGOW%9^C^&/"S_Z7I&+Q
M(9/+B8:A+<1VQCD#&.(%V6)0\:91-H^101\H S?#.DW=OJNKW4NF:SIUE-91
M0QIJ^IB[F+JTI<JPEE95PR8R_7.%'5LM?#&M:9IEA916FNW2Q6>VU^Q:V8_L
MER78L\Y>4&1#F/ _>@!&&P9PX!Z+)8VTMXMU)$&F6)H0Q)QL8@L,=#DJ/RKG
M-.;P-/8ZCIFD7^E2V\5F+2]M[6^4B"!=R[6"M^[ W,,\?I4>F^'-8/A;6[?5
M=1GN=0U*:YV"YFW111EW$:(%^ZA4@G^+YL=@!7U1=3UGP_=6,?@N2SEM[*6.
M!II[; 8H5"6^USP>F7\H8Q]* .AT_1M,T[6;R>QEN!=3_O9X&OY9(UWL3O$+
M.43<RMRJC.&]ZKV^CZ$FEW%AIJ1/#;W$/FQQSES'+"L7EAN2056.+@]0 3G)
MS2L;S56\6-?3>&-3@@O[2"!FDFM3]F:.2<DR!9CD$2*1LW>^#Q5'5/#>J:OK
MEZ;^\U2'31YS0+::D]N"Q2 1G]VX; (FP#\N221R* -/7(/"^D:K'KNOZJ-*
MED94#SZQ):P3%0<!H_,6-SC/!4\58T+3?#VDJUSHTZLER5A5VOGG4 9*Q1[W
M8(HSPB8'/ K'\16GB&?3_#]S!'JOV^!#]L.DFS\Y7:(!O^/D^65W9SCGICBG
M6ECJ_P#:,%C/I=UY'V\:@^HRS0;=NS.QE5MWF;N" NSJ0W:@#2'@3P_]HDF:
MUN'+I(BQR7T[1Q*XPZQQE]L8([( .!Z"K>I^&=*U>=I[R&9;A@@\^WNI8)5"
M[L;7C967[[ X(R#@YKF/$VF:]<:]/)96FM32-+ ;*[LM6%O:V\(V^8DL1E7>
MQ(E.?+?(=!N7'R*?#?B"UM?M5C>ZG)J%R;E;H3ZFS((RQ:,(C,8XVP%565<C
M/S9Y- '0IH>BI8_\(^D$;VH1I'M7E+LH=RP<DDL,N&(;/5>.G&9I]AX*;4+[
M0[74H+[4Y(S'<P3ZN]U>1JISC<\C2QA20PP1M;D8/-5O"^D7L.L:G,]EJVEV
M]S9Q0V_]J7ZW<ZLIE+'>)9#@%P0"YZ]N@6"RU.XL-+T$^%SIZZ=<02_;Q-";
M9!$X9FA 8REF *_,B\.V3V8 L3^'?!D&F0S7=RJ6PBDNC=3:M+FXA.S>TLID
MS-%CRP0Y9,;!C&!71Z6(#IZ36=ZU]!<DW$=P9A('5SN&UAQLP1MQQC%<,FE:
MR=.L;6;P]=M_8FG?8ED2[@5KIQ) 5EM\L1E?L^\"79R5![X[#PW%=P^'[==1
MMUMKDEV>,(BGEV(+A"4\P@@OM)7<6QQ0!J5&?^/I?]P_S%25&?\ CZ7_ '#_
M #% $E%%% !1110 4444 %<+:>--7L[>&76=,@-G<7$D,%U]L D;;/LR\8C"
MHNW<P(=B0HR%)..ZJK+I>GSVWV>:QMI(,.OE/"I7#@AQC&/F!(/KDYH Y[4?
M%NI+KUQI.AZ1:WT]N9?,:XU P*H2.!SG$;D$_:% &/0]#Q7B\;ZG.+:)-#MT
MN]2$4FF12Z@0KQR+(_[YA$?*<)$V502#<0 Q'S#I=/T/2=)@CATO2[*RBB5U
MCCMK=(U0.07 "@8!*@GUP/2DN]"TB_L6L[[2[*YM6C6)H)K='0HIRJ[2,8!
M('0&@#EHO'&N79>"P\.V4MU;BY-T'U;$2>0X1@CB(EB2> 57H=VT\5O^'M4D
MU5M2D9F:".Y06Y90&\M[>&4 X]#(P_#O5RST;2].@6'3]-M+6)4,:I! J*%.
M,J !TX''M3M/TV#35G6WW8FE,C9  'RA0H    554>P'6@#E%\1:BNC:C>37
M@4C0?[3AW*@$3,9F';D*HC7G/09R22;OB;4+^RN=/DAU)[6&%#+>I!'%*P&5
MP\B-\QAX<,8R&!*XR-V-%/"NC-:65O>Z?;Z@-/D,EF]Y DK6Y+9&PE?EQP 1
MSA1R3S4T_AS1+FYBN+G1]/FFAN/M44LEJC,DW'[P$C(?Y5^8<_*/2@!);NXC
M\66EF&S;7%E/*RE1\KQO$ 0>O(E/'^R/>M.J%MHUG9Z@;JUC6'Y'588T58U+
MN7D< #.YVP6)/.T'KDF_0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5&O_'U)_N+_-JD
MJ-?^/J3_ '%_FU #I)$AB:25U2-%+,[' 4#J2>PKS/2OB9?--J,M[93O'=21
MS:5#=V<UBJQM,L'EF22,!SM:.8D;L&5UZ("?2;JUM[ZTEM;V".XMYD*2PRH'
M212,%2IX(([&J6MZ!IWB&UA@U6VCG2"XCN(]\:L59&!XW XR,J?568=Z ,"7
MQAK,6H1:.=$T\ZU+*$$0U5OLX4QO(#YOD[MV(V^7R\CY3]T[JIM\1;Q[BXMD
M\/@FWA5)Y_MRB%;I[J2U6(/MR5,D1._&0N<J'Q&=Z;P-X:FLK>Q.AZ>FGV\K
M2BP2TC%N[,,9:/;@GH?J!6B=&TR/3I;./3K1;5[86K0"!0C0@$"(KC!0!F&W
MI\Q]: .8E\?2:+"3XDTV*U2W)BN9+.Z-RJ2&(20JOR*6+C<N"%._8H#;P:@M
M_B->G6!9WGAJ[CBB80W4EO%=3^3-M&X!A;B)D!.-YE4X!.WM75Z?H>DV&D0V
M%CIEG;6:,LJV\-NB1JX8.&"@8!# -GKD ]:2;PWH=QK2:Q/HVGRZG'C9>O:H
M9EP,#$A&X8'O0!BZ/XBU?4O$^GP7MI:V=G>:9/>0K;W@N#*H> (S_(NU@)&X
M4LIW?>.!5#1_$?B:6:XM19V5]?SWM[)#'<:CY,,-M#,(0%9;<N6W=BK>I<;E
M2NJT_P /:+I-Y-=:7H]A97,Y8RS6UJD;R%B"=S* 3D@$Y]*34/#FB:O:+:ZK
MHVGWUNDK3+#<VJ2(LC$EG"L"-Q+,2>IR?6@#$T'Q?/XJL=3N+?2I+2P@@B:"
MZDG1S.TD*RD!5R,*'4%LD$GC(YK$EU;7-#\*6M_)XEGU*YU+29K@17<%N'@D
M2V,HEC\J-/D# *P<,,O'R.C=_+;00VMP(H8T\T%I-J ;SM R?4X 'T JA8^$
M/#6F074.F^'M*M(KR,Q7,=O91QK.A!!5P%^88)X/')H P/%&M:MI_C"W6TGO
M8].MX;>:Z$,=NT"HT[*YEW#S3\BG;Y7\0^;BI[";4+ZW37YO%OV2,W/EOI[0
MP?983YGE^0Y*B7S0?D)\P?O/X<?)5^;PMX4TFU2^7PUI48TM6GMS#81!H,?.
M3'P-IR,\8YIT-AX=N_%:WXT2S.L_9DN1J#6D?G!6!0#S/O9P"/IQ0!<\.7<]
M_P"'+*ZNW\R:6/<[8 R<^@XK$O6U#5M0U;R_$LND1Z9(J?9K>*!@5V*_F3&5
M&.TY.-A3@'G/1_A2R\.WQ.JZ5X7&CR&3[0DAM8XOM&]6"S9C)5B5=Q\QWKN8
M$+NYU=9\.Z)J[Q76K:/87UQ;?ZB:YM4D>+G/RE@2.>>* ,A=<OFTR\F2]BF,
M>L65M'-#&NQHI&M@VT<\,)'P<DC=UX!K8UW5;K3ELX=-M(;N]OIS#!'<7!@B
MR$:0EG".1\J-@!22>P&2&W/A+PY>WES=WGA_2[BYO$\NYFELHV>=>/E=B,L/
ME7@_W1Z5-)X=T6;1%T:;1["32U "V+6J& 8.1B/&W@\].M '+0^/=8NK662S
M\/6DDEG%/)> ZK\B>3*\3+&PB.\DQDC(4?WBIXJQ<>+-3N;RT>PL[>+2YM32
MR%R;L&=F#8<&$I@*=K8(<MC!V@$D=+:Z-I=C:_9K+3;.V@$7D^5# J+Y?/R8
M QMY/'3FHCX<T,ZL-4.C:>=0"JHO/LJ>< N,#?C.!@8YXP* .1\2ZKKEOXKU
M+[#-JJVECIIF7[.EF;9'\N0YD\P><3E5QLR.!GO75:O>RVNCVEPDLJ,]W:1L
M8B@+"2>-"#N5A@[N< ''0J<$7)K2VDN&\RWB?[1&4FW(#YBXQAO48)X/J:AL
M-!T?2[#[#IFE6-G:>:)OL]O;)''Y@((?: !N!53GKD#TH R/"_BC4=::R.JZ
M/!IR:C8_;K/RKTSL4&S<)!Y:A&'FIT+ Y/(QSA6'BOQ=F5IM,L;N2%;R2:'[
M?LC1(KET 5_)W,V%V@%0"%RS G%=]%96L'D^1;0Q_9XC##LC \N/CY%QT7Y5
MX''RCTIJV%FF_9:0+O#!\1@;@S%F!]<L23ZDDT <E8_$-]1\3)8VNAWKZ>TW
MD?;!:W1(?^\<0>2$S_%YV?:NQ/\ Q]+_ +A_F*SSX8T ZO'JIT/33J,0 CO#
M:1^<@ VC#XW# XZ]*T#_ ,?2_P"X?YB@"2BBB@ HHHH **** "BBO&+#XG:W
MH^O>(GUQYKZS2YNX=-MY5AB5WCOA;JJ.BY5%$L8=I<GNN<&@#V>BO+-7^,5]
MX=_M'^VO#MDITZ]2QF%MK*ONDDA$D17S(T!7G#DD%!EL, <6=3^*&IVA?R]#
MLVMX]5M]&GG75/G2XE5"6C0P_O(U\P8)*E@,[0* /2J*\5\$_$_Q3<VT"ZK!
M:ZI<:@=/M[+S+@6ZB66U:9V<K"=H(1CP&.<*!CD>E>"_$TOBK0I;ZYL8[&:&
M\GM)(8KGSTW12%"5?:N02N1Q0!T%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5&O_'U)_N+_-JDJ-?^/J3_ '%_FU $E%%% !37_P!6WT-.IK_ZMOH: $A_
MU*?[H_E3Z9#_ *E/]T?RI] !1110!%<_\>LO^Z:EJ*Y_X]9?]TU+0!#=VR7M
ME/:S9\N>-HWVG!PPP<?G6'IN@ZS:223W6LVL]PT<-M&\>GF,) C,2,&1LR-N
M^]G:,+\G4'HJ* .<T'P]J6CS3RR:E92M<W DN%AT\PI(H#9;:)2!,[,"T@X8
M*!L!YK?N/^/=JDJ.X_X]VH DHHHH **** (W_P"/B/Z-_2I*C?\ X^(_HW]*
MDH **** "HS_ ,?2_P"X?YBI*C/_ !]+_N'^8H DHHHH **** "BBB@ KEI;
M?P786][J']D6"C4Y+BVNWATS?)>,GF-,CJJ%I/\ 52$Y!W$<9R,]37'V'@?[
M#K%GJ8N;AKB+5;R\F1]1N'A\N;[1M"0LWEJP\U,X4=&P3GD 9!'\/-)2:;3]
M)TB$0HJEK'3%8O\ :$R(T\M#YC.@!*+EBI4D8*Y;:6WP]O[RQE30--CO$E2V
MMA=:+Y$T#*I:-=LD8:,80["< X^6K4'A>ZTG2H/[%BT]+NTU&ZO(H&!2&5)9
M),(65<H=CJ-P5L;<8(K/@\,^*=2M]5/B2YL%N9(H_P"S);>8R-;R1R/(AD/E
M1AL,4Y"CY1C&<LP!K16/@V]FN?#T>DZ;*  L]H=/7RF$(CP#E=C;!+& .<9P
M.AQ3@\6^#?#OABRN=!A7^RKJ=X[>/1=.>125?$C;(EX"X8DXY .,G ,%SX*U
M5M)LK.SOXH9I+.XM]1O%8K(7N)87FEB^4_,=DFW/W25ZXQ4$7PKL9;B6UUJY
MN=6TPM'=0&2X-K-!<* AVBV6)=A1(\< AD)YW9 !W#WEO'I[7K2?Z,L1F,@!
M/R8SG'7I4.FZO9ZM$9+%Y"%5&9987B90RAERK@$'!'!&1WJ/6+<_\(Q?VUM&
MS'[')'&B@DGY" !W)KEH?!EIXBU*UU+6K"VO=-DM]PM+ZW8.&,42C=%(HP1L
M;@\C([] #NJ*\]M_AC;AM&CO+/39[>..-]71U+_;YUAE4R/E?WI+29W/R1G/
MI3Q\.VT^V@ET2VTV"^A=G9SN7SU2X26WB9PN[8JQJ@ZB, !00,4 =_17#KX$
M&NZR-1\::9I5TLGVEY+$,US%&[K;1H0710Q"6[$L54@O@#J:QM/^'&OVWBS3
M=5O;Z*[D@\AIKP7$*SKL10\:EK-I#&2&R/.3<';@9.0#N]6\3Z9HUTEM=M=2
MW#IYGD65E-=R*F<!F6%&*J2" 2 "0<=#5G3M8T_5MQTVZ2Y"HKEH\D8;..>G
M\)&.V.:R-7T_Q!;WM[<>&OL4O]H1!9!<W#6\EO(%VB2-_*E5N,?(R8!!.3DB
ML&7P3KMS;K+K3:=XDF.QI[+4W"PSD>9@.4AVGR]Z[6\K#;<E4)!4 [Q+R![^
M6R5\W$,22NF#PCE@ISTY,;?E]*+V\@T^PN+V\?R[>VB:65\$[449)P.3P.U>
M</\ #O4!-&\NC^']20V*6\4=W<2A=,833R#R/W;9"+,B*1Y9Q&,;!@"]?^#_
M !#=:;/HHDTZ2Q!N9H[V6>3SYI)8)4VO'LPN))2Q<.W"XV\\ '=6MREW!YL2
MRJNYDQ+"T;95BI^5@#C(X.,$8(R"#2&[@%\MF7_TAHS*$P?N@@$YZ=2*X>X^
M'"WDNK7=Y;V$]_)!*-+N) 6:TF-S<S)(I*_(1YT7S+SE3U &=?Q-X3_X2/5[
M*2Z2WGL(@HN()B?WH$@;:1C# XP0>#T/!- &Y+J=K#JUOIKM(;JXC>5%6%V4
M*N,EF VKU&-Q&>V:LR.(HFD8,0JEB%4L>/0#DGV%<$_PY6VO'N]+LM)BEM03
MIRF/:(@MPD\<60N4CW*P.W.W>< ]*9=^#M:U36;?5-0T[11=&\>X<_:FF6V4
MQ1180/;Y9B(0V]3$5.!\P!# '?PRK/;QS('"R*&42(48 C/*L 0?8@$4^O/[
M3P+?V^L64TEEI$LL$L$O]MM*_P!M@2,+N@C79RC!63_6*-LC91CD/I>$O \'
MA1M,:PM;.V=-,^S:D]NI#7<X\O;(QQE\8E^9N?G]S@ UYO%.E06MY</+.5LK
MK['*B6DKR&;"G:D84M)PP.5!!'/0&LR[^)/A>RCCDEN[N1'B\TM;Z9<S", %
MBKE(SY;J%8LC890.0*DO="U)+NZU'3A:372ZJM_;0SRM&DB_9%MV5W",5.-Y
M!"MT7U..=O?AK=7Z+=R&"+4 S7KB"^GCCEN6F:0I\N @56*"=5\TY##;MVL
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MRM9_.\^VAD^T1"&;?&#YD?/R-GJOS-P>/F/K0!SFJ>-5TW0WO_L:RNES>P&
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M_P"/I?\ </\ ,54:U2.TF3*A2EO%$E%%%9&P4444 %%%% !7'CX<:%%="_\
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M95$OEKRPCE&0J[PPW 9($&G> K^V>,?V=HEG+#- TVI6LTIN-3*7$<C2S H
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M);S%X8C;P">UHH Y_P )Z9JFF6URFJ+;6\;2#[/:6MU)<1PC')5G52BDGB(
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M]>ZOHHU>_P#,C347^TVMK(BJ;:W('EJ<#.XJ [ DX9V4' % &W1110 4444
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MDO+78WS. Q\Z3<1YD?#%49=CAUWV=3\"V'C*TGT_PA8KX;TG"O-]LT-DAEN
MP*M':2^7APFX-)MPP95RVWY #:N_@_X?O+6RCEE<RVD)@$\FGV,S/'O9U7;)
M;LD84NV!&J#!YS@8[(:7;KJ%I=IN1K2VDMHT4 )L<QD\ =O*7&,#KQZ8^I6
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M^I3_ '1_*GT >8:KH/CR?1R[WL\L\4ZVQ@M)V#7%M&K!9OEN+?;([D.V)%P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4:
M_P#'U)_N+_-JDJ-?^/J3_<7^;4 24444 %-?_5M]#3J:_P#JV^AH 2'_ %*?
M[H_E3Z9#_J4_W1_*GT %%%% $5S_ ,>LO^Z:EJ*Y_P"/67_=-2T %%%% !4=
MQ_Q[M4E1W'_'NU $E%%% !1110!&_P#Q\1_1OZ5)4;_\?$?T;^E24 %%%% !
M49_X^E_W#_,5)49_X^E_W#_,4 24444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !4:_P#'U)_N+_-JDJ-?^/J3_<7^
M;4 24444 %-?_5M]#3J:_P#JV^AH 2'_ %*?[H_E3Z9#_J4_W1_*GT %%%%
M$5S_ ,>LO^Z:EJ*Y_P"/67_=-2T %%%% !4=Q_Q[M4E1W'_'NU $E%%% !11
M10!&_P#Q\1_1OZ5)4;_\?$?T;^E24 %%%% !49_X^E_W#_,5)49_X^E_W#_,
M4 24444 %%%% !1110 445GZKK=GH[VBWK,#=3")-JYVY_B;T49&3VR*:3;L
MA-J*NS0HK/MM9M[K5IM.C2430[MS,!M.W9G'/_30?K4=EXDTF_5C!?VX(G>
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M/EEV%S1[EZBJ]G?V>HP>?I]U!=19V^9!('7/ID58J;-;C33U04444#"BBB@
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MR"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"HU_X^I/]Q?YM4E1K_Q]2?[B_P VH DHHHH *:_^K;Z&G4U_]6WT- "0_P"I
M3_='\J?3(?\ 4I_NC^5/H **** (KG_CUE_W34M17/\ QZR_[IJ6@ HHHH *
MCN/^/=JDJ.X_X]VH DHHHH **** (W_X^(_HW]*DJ-_^/B/Z-_2I* "BBB@
?J,_\?2_[A_F*DJ,_\?2_[A_F* )**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>halo-20210930_g2.jpg
<TEXT>
begin 644 halo-20210930_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#F17AI9@  34T *@    @ ! $[  (
M   )   (2H=I  0    !   (5)R=  $    2   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 &=Y97-E9V%T
M    !9 #  (    4   0HI $  (    4   0MI*1  (    #.#4  )*2  (
M   #.#4  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"&.,6]Z+:2V629H@YC>*0EXB<Y4,>>0<$#=DOXJ\41V>H:@UUI)MK7P\NKI
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MO-':7"6DMW!%&T7GNBLD:Y<.Q8NBY"[06&XJ,D65\8(]BCQZ-J;ZBUP]N=*
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M_P "_E0!+1110 4444 %1#_C\/\ US'\S4M1#_C\/_7,?S- $M%%% !1110
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MS^2K?8V"Y\WRMOVCS-IE!!<Q^7PH/S<9/5W6LPV>IO;W&R.W@LWN[FYDDVK
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M7A2'5K& S^;I<2V^(Y6?*3;)&6-OE!7.=R[N!RV.UTO4#J-O,[Q"&2&XE@=
MV[&QRH.<#J &]MV*NT >:6/@R\@L3=WEF]I=6.DSI9$3M/\ 9YVDF(8;,L[!
M7&&"EOF.!DD53T2"PU_4;O\ X0>PM]$9=&N;62XL[N%L3NT6PEH6<*V$;#M\
MYP25^49]7HH \OL_ LI\,>(K2+1[R!+W3GBBLKY=/C26XP2C!+9 F0P7#LV0
M>PP#6K=Z4-&U[6-2_L2UATZ/3'5;LQQ%D"QHJ11$?.JX5@8RNW(!5N2M=W10
M!5TN"2UTBSMYO]9# B/SGD* :M444 %%%% !1110 444C,J*6<A549))P *
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M698Y!E1/"\3CZHX##\0*FH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"(?\?K_ /7-?YFI:B'_ !^O_P!<U_F:EH **** "HKK_CTE_P!TU+45
MU_QZ2_[IH EHHHH **** "HIO]9!_P!=/_96J6HIO]9!_P!=/_96H EHHHH
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M?9;1QNL]NHA>0#<7(D(*A6(5<'C'/'8T %%%% !1110 4444 %%%% !1110
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MC_PH_P"$EL?^>&J?^"FZ_P#C='_"2V/_ #PU3_P4W7_QNC]]Y_B'[CR_ /\
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M;'I^AS:Q>W,5GI[ZDT8@O)5B0S%& (20XW8("\'L!4UO'IM[;B>T2UN(7C,
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M )7^'^9KT5D?9O$?_05TO_P62?\ Q^C[-XC_ .@KI?\ X+)/_C]'*OYE^/\
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M_P!<U_F:EK+NM/N;G4W>'6+VS7RU_=P)"5ZG^_&Q_6F?V-??]#+JG_?NU_\
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MHY&C=&'1E=2&4^X(/)I--TRVTJU,%F)-I8NSS3/-([>K.Y+,< #DG  '0 4
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M#_KI_P"RM4M13?ZR#_KI_P"RM0!+1110 4444 %12?\ 'S#_ ,"_E4M12?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH B'_ !^O_P!<U_F:EJ(?\?C^OEK_ #-2T %%%% !
M45U_QZ2_[IJ6HKK_ (])?]TT 2T444 %%%% !44W^L@_ZZ?^RM4M13?ZR#_K
MI_[*U $M%%% !1110 5%)_Q\P_\  OY5+44G_'S#_P "_E0!+1110 4444 %
M1#_C\/\ US'\S4M1#_C\/_7,?S- $M%%% !1110 5$?^/Q?^N9_F*EJ(_P#'
MXO\ US/\Q0!+1110 4444 %<E<>.5@TSQ)=R6T,*Z%>BU+3SN$ERL9W$I&S+
M_K,8"MT]^.MKA-3^'E[J-KXELEUJ"*RUZX%RRFP9I(7'ECA_- 88CZ;0>>O%
M $</Q6M%UNXM-2L39VEO-?1RW8E:38MM(J;MBIG#;\G^[COUKL;76;"^U.[T
M^TG\VYLUC:=51MJ!QN7YL;22.< YQCU%<?!\-DL-9O-5EN?[225M1D:P\D)Y
MPNF#&/>7P,;=N3C.<\5J?#CPO+X4\%VMI?%FU"8>=>,[AV\P@#:6'7:H5<_[
M- #]4\3ZE;1O+I>E6EU$NHK8!KB^:'<6*(&&(GX$C.I';9GG.!>E\4Z7:Z@+
M"\F:.Z4HDQ2"5X(9' *H\P38I.Y<!BI.Y>/F&:\>@S3V<]I.WD+'JXOHY,!O
M,42K-C&>.<KSTQG!&,LOO#%Y=S7=M#JD46DWTPFN;9K0M-GY=RI+O 56V\Y1
MB-S8(^7: /A\96#3ZPES'=0+IEZMGDVLS-<,8U;]VNS+G+-PN[Y0&^ZP-36O
MBJPU&2T&F%YUFOFLI?,C>%H)%@:4AD=0<X4#!QC=[8J.Z\-SO/=W=CJ"P7DF
MH+?P/)!YB1L+=8"K+N!<%5;H5/S#TY9IWAJ[M[I;O4=3CN[DZD;^1H[7RE.;
M;R @7<< #!R23Q@YZT 6]2\4:1I%Y]FO[B1'55>5DMY)$@0D@-*ZJ5B7@_,Y
M48!.< U'IWB%M1\4ZII*6;QQ:<$!N'60>8S*&P,H%P 1R')/ICFH=5\/:A=W
M%[_9FK165OJ2!+Q)+3SG^[L+1-O 1BN!\RN,@''7.AIFCIIEY?30R9CNFC*Q
M[?\ 5A(U0#.>?NYH S=+\5_VKXNU'1[==/\ +T]RDG^GYNB0J$MY 3A-S[=Q
M;J.E6-0\7Z+IE_-9WEQ,);95>X,=I-(ENA&0\CJI6-< G<Q ^5N>#A(=$U%]
M:@N]4U6&[M[-Y'M8TLQ'*"X*_/(&(8!6(PJKG@G)%4KK0M<N-:U>2QU*&PM+
MX1QL9+03.5$84M&0Z[&Y(^<.O"G;UW &E?>*=(TZ^%K=7+AP%:1TMY)(X0WW
M3)(JE(P?5R..:KKXOL5U+5[6YCN(%TQHU:0VTI\XN. @V?,V3@*NXGM5>\\)
MW3Q7-EIFIQVFF7T:QW<$EJ992HC6(^7)O 0F-%'S*^",TNK^#+?5H[]97@<7
M$L$T4=S;":)&B7: Z$_.I[C@\\$'! !;?QAHL6GK>2SSQHTXMA$]G,LWFE2P
M3RBF\$@9 V\Y&,Y&8;SQA:02Z0MM!<3KJDLD:.;:91$41B=XV$H=R[2&P1\Q
MQ\IJ#1O!D.E"U91IT+PWINW33M-2UB;]R\04*"3_ ![LLS'.<8& +2^&6#6I
M:]+?9[ZZNQF/J)A*-G7C;YO7OCH,T 12>.=&L]-M[K4IVC\RUCN9FMK>>>*!
M77(+R"/Y%ZX+A21S@5IVFK)<MJ7[M@EC,(]R N9 88Y<A0,Y_>8P,DX]\5ST
MG@K4HM#DTG2]=AMK:ZM([:[,MAYK,RQ+$7C.\!"R(H(8....^>CTW3?[/EO7
M\WS/M<ZRXVXV8ACCQUY_U>?QQVH Q['QUIESH-CJ5S%>0M>1LZVT=E/-* IP
MS;%CW;02/GVA>1SR*L1>-_#DUS;P1ZI&7N;4WD9V,%, WYE+8PJ#RV^8D#I_
M>7-:'POJ&FVMC_8FKP075M:_99'N;(S1RIG<#L$BE6!S@[B,,<@\$01>"VL]
M'OH!=&]GGTQ+)&*K"VY'F??N 8*291QM(&WH0<  TK/QEHEZTRI<S0-#;FYD
M6[M)K8B(''F8D1?EST/?!QT-5[_QQIUIH-_J4$-[*]D@9[66QGAE()P#L:/=
MM)!^;:1P>>#6-9Z!K?B>2^?Q?&UNDEB;-$-M#'G+A]^Q9IP>5&=S8/ V]2UR
MR\ 16VEZG;XT>TEOX1!OTK1TM$102<D;V9B2>[XX& #DD U;KQ5:)#?BRANK
MFXL;9KAXVM9HTX0/L,I3:'PP^7.X9Y YK:1UDC5XSN5@"I]0:Y?4_#FH"ZUN
M_LKL3/?V4EO%:)&(\R,%57D;=M?;MP#M#!202V% Z>&)8(4B3.V-0HSZ 8H
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MW,GE0++(%,K]=J@]3QT%'V^T_M'^S_M4/VWRO/\ LWF#S/+SMW[>NW/&>F:
M)Z*** "BF&>(7 MS*GG%"XCW#<5!P3CKC)'/O3Z "BF33Q6Z!YY4B4LJ!G8*
M"S,%4<]R2 !W) IMO=V]VKM:3Q3K'(T3F)PP5U.&4XZ$$8([&@"6BF>=%YYA
M\Q/-"[S'N&X+G&<>F1UHBGBF,@AE20QOL<(P.QL X/H<$<>] #Z*** "BBF0
M3Q7-O'/;2I-#*H>.2-@RNI&001P01WH ?13()XKFWCGMI4FAE4/')&P974C(
M((X(([T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** (A_Q^/\ ]<U_F:EJ(?\ 'Z__ %S7^9J6
M@ HHHH *BNO^/27_ '34M177_'I+_NF@"6BBB@ HHHH *BF_UD'_ %T_]E:I
M:BF_UD'_ %T_]E:@"6BBB@ HHHH *BD_X^8?^!?RJ6HI/^/F'_@7\J ):***
M "BBB@ J(?\ 'X?^N8_F:EJ(?\?A_P"N8_F: ):*** "BBB@ J(_\?B_]<S_
M #%2U$?^/Q?^N9_F* ):*** "BBB@ KQ^UT[5;3XM76HQ:?J,PCU>>78]FZV
MXMVM%5I4EV@,Y9 @7<WLO>O8*Q_^$HT[[+K$RM(S:-O-U"% <!5+94$\@@$
M]"01U!P >%#P5XND\-MHYL;U+6:S/B-F\MMRWHB(%OC'WB^UMG7VKOKR"]D^
M)^F:II>G:EYEV]N-2M;RP9K4H(F(N(Y3\L4D>2A4D,2< ?WO0;35K:[O9[,,
ML=Q"[+Y331L[JNW+A58D+\ZCYL$9&0,C,<GB/1(I;2*76=/22].VU1KI ;@Y
MVX09^;GCC/- R#4.?%NC!^4$=RR@_P#/3" 'Z[2_YFN>-O<V_A^RCOX]5AT_
M^T+QKQ-/699R#-*8CB+][L)(/R<_=S\NZNKBOK*^U*:U*H;FQF(42!=V[RD8
MNG? 6=5)X^\1WY9/XDT.U:!;G6=/A:XV^2)+I%,NXD+MR><D$#'7!H$<M::9
M=WUYX<NKI=5,-KJ5PUN9Y9DD6V\J3RS,,@GD* 9/F((#<LP-2P%X^K:2,>)/
M[1+3#5Q.+@V9/D2=-W[K;YFW;Y7&,9YQ7<6^N:3=V]U/:ZI93PV987,D=PC+
M 5&6#D'"X'7/2JC>+=#:P^VVNIVEY;"2.-Y;6X218][[ S$' 7(.3_LGTH S
M)XKN'P+HL3I?Q0QQ0+J"62N+E8A'R%"?.#OV@[?FV[L<UE)ID^J1Z?A=9;38
M=:5[,W4MQ'<+$(6W%RQ$FWS-P!DYP?[I6NWT[5-/UBU^U:3?6U];[BOG6TRR
M)D=1E21FK5 &+XEMY+BWT_R(7E9-1MG;8I)51("3QT QDTMS;R-XYTRY6%C$
MFFW<;RA3M5C+;%5)]3M8@>Q]#6S10!QGBN2(^*[&'49=<%@+.1VCTEK@9DWJ
M%+BW/F$8+=/E]>U5)Q=_9+$^)CXA^Q?9G\H:?Y_G[_,.SS_LWS[_ "MG^QNW
MYYVUW?DQ>>)O+3S0NP2;1N"YSC/ID=*?0!Y_)I?B&2>WU)!=+KH\/RQK(TA*
M+.2NT,@80F3DDCA2P] "*.F6FN/I&J1V6JZP\<D<2HS6%Y!)%(9%RR&[FD<D
M+G(4;/4]17IU% '":OH,LVGW>DJNK26D.JZ?+ YO;EY"IFB\PB7=O*J-Q^\0
MI&>" 1%<FZ\UQXB'B'^SOM%YY1TW[3YF_P ]MF[R/WFWR_N?P8SGG97H%% '
M(^#X=1$UI-JD=[YQTM$DDO%_>%_-<X8CC=@C@<>G%9KZ7+IHU-Y$UH:?<:TT
MEW]DFN'G:+REVLFTF39YA&?*YP /NAA7H%% 'G>E6&IZC?6<(N_$5MIBZE/*
M#<O+'+) J1F-'9OG"%@<9PQ&0W):H-*O)9]8\/2VMUK<FHW$\IU SRS&QE/V
M:8_)D^4R;PI7RLC &><5Z75&VT/2;+4I]1L]+LK>]N,^=<Q6Z+)+DY.Y@,G)
M //I0!PWA*RUR76-FJZEJ<C202)J4<EC>6ZAR,'9+)<-&#NR0;90/3 VT[PW
M8WFF2^$+.2UUAHUTN%98WGN5CMGV,SLQW;&.["&.7&T;=G0K7HM(RJZE7 96
M&"",@B@#'\)?\BK9$?ZME9HO^N98E,>VTBMFFQ11P0I%"BQQQJ%1$& H'  '
M84Z@ HHHH **** "BBB@ HHHH **YA/'-M(L=XND:I_8DI&S6O+C^S%3TDV[
M_-$9/\9CVX^?.SYZUSX@T9=:31VU:Q&IR9*61N4\YL#<<1YW'@$].@H T**S
MX]?T>;6I-'AU:QDU.)=TEBMRAF08!R8\[@,$'IW%1?\ "3Z+(=1CM-3M+RXT
MQ'>[MK:X226';G(90<J<@CG'- &K16:/$>C?VE;:;)JEG%J-U&)8;&2X03NI
M!.1'G<> >@['THE\2:'!JQTN?6=/CU$;<V;W2";YB OR$YY+*!QSD>M &E15
M6+4["=;9H;VWD6[S]G*2J1-@$G9S\V ">.PJU0 4444 %%%% !1110 4444
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M@EB([I?/^WIYV?LGER&,?PY;>PRO RH)[ 'HZ "BBB@ HHHH **** "BBB@
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MQ_Y[ZI_X-KK_ ..4?\(U8_\ /?5/_!M=?_'*UJ*S]I/NS7V4/Y49/_"-6/\
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M"*[1[MK.$ 7>P+8 YX%<=%K6KM866HR3VU]=16M]Y-S:[KA9$#0CS/ECC$I
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MM%%% !1110 5%)_Q\P_\"_E4M12?\?,/_ OY4 2T444 %%%% !40_P"/P_\
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M?(XS&Q[C.S:VNMIJFF;-,N+*3R8DN[I+F)X)(Q%\RNA.[S5?(4JI& N7()4
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M 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXF5I&;<8PV<.IR2>3GD9'?-+J/B36H$N+^VN=)2SM=02PDM9XG$SL75"V_S
M%)WAE3:<KM^;YN.N^Q6ILTM#;0_9HPH2'RQL4+C: O08P,>F!56X\/Z-=ZFF
MI7>D6,]\@ 6ZEMD:51Z!R,CJ>] '-P>(O$5T[Q_\2JU^UZK/8:?+)&[A5A>7
M<SKO&YF$6 @*]&;./E%63Q?XB\DV5G:VE]J7]HSV8FM(E,>V)%8GRY)X\N23
M\OF97#?>VDGIM<\,6&N:.VFRYMH&E,Q$,<;*S%BS%HY%:-\L2?F4_-\PPP!#
M;/PEH]MX?71KBR@O[,,&:.[MXV5V'0E H08P  J@  8 H Y]-:UV\G\.75S+
M;:<!<W<5] Q#+)Y2R DM',RI]PY4E]C<$G;S8TK6M1OX]'FO[E#>?VDUM=6]
MO;O;B/-J[F-E,CA\':X=3M(P5X.3U4.GV=O%;1P6D$4=H-MNB1 "$8VX0 ?+
MQQQVJI!X?TVT>S^P6L5E#9R/+%;6T:QQ[W4J6*@=<,W_ 'T<YXH TZ*** "B
MBB@ HHHH **** "BJ-OK-A=+8-!/N&HQ>=:_(P\Q-H;/(XX8'G%7J "BJ,^L
M6=O?FR=I6N0(F,<5O)(561V1&.U3@95LD\*!DX'-7J "BH7O($OXK)GQ<31/
M*B8/*(5#'/3@R+^?UJ:@ HHJ"]O;?3K1[F\D\N%" S;2<9( X'/4B@">BBB@
M HHHH **** "BBB@ HJC-K-A!'=/+/M6TG2WG.QCLD<(5'3G(D3D<<^QJ]0
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M*ZX*/Y63G.TY12/F(SA2P!V5%<?%XZFG\2&PAT.\DLA=M9FZ2VN20ZN49O\
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M?-@L0<*-U;FEWUS/K&H6URZ.$C@GC"$,L8=2"@; W#=&S9(S\WI@  UZ***
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M_?RU_P#CU']LWW_0MZI_W\M?_CU'(_+[T+VB\_N9K5%=?\>DO^Z:SO[9OO\
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MD_VS??\ 0MZI_P!_+7_X]1_;-]_T+>J?]_+7_P"/4<C\OO0>T7G]S-:HI/\
MCYA_X%_*L[^V;[_H6]4_[^6O_P >KR;XC>,]?3Q3]EMWO-(BMD4I")%5V)&2
MS%&(/IC)''KFMJ.&E6ERIHPKXJ%"',T_N/;Z*P_!FJW6M^#M.U#4!BXFC.\X
MQN(8KNQ[XS^-;E82BXR<7T.F$E.*DNH4445)05$/^/P_]<Q_,U+40_X_#_US
M'\S0!+1110 4444 %1'_ (_%_P"N9_F*EJ(_\?B_]<S_ #% $M%%% !1110
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M@/&RM@]QG!P,]!4.J^'[34] CT?RTALT> B)4^4)%(CA  1CA, CIU[5JT4
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M?RJVX#_CXQ'M Q_RTJYXK_M$:7J*W/\ PE0U<6*_V0=(^TF/=Y(SO\O]WO\
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M);_9=W>7[0MIS'NW%T\P$G:"P0D ]!TK3SIMM*CR^=)-<2SO)MVY+N6 QD]
M0O\ P&KM<+%?:M<RVVGQQ:REWI\]Y)=N;=U26/;*L025\1RDEXV50QQ@;MI!
MQJ^ ?-'A=1/#?1LLSKYE]+<N\X&!Y@6Y_>QAL9V-]WG!888@%Z_\6^'-*\G^
MT]?TNS\\L(OM%[''YFT[6VY(S@\''0UHI>VL@N#'<PN+9BD^V0'RF"AB&_NG
M!!P>Q!K@M'T.[UC3_#[1:GJ&G6[>'X5FDM(X2)RP4E6:2-^>I^7!Y)S5G7]
MNX=4CTS1K:4:7KT,=G?O'DBV2+&6)SD&2#?%NSPRQ]>: .SM;ZTOD+V5U#<J
M-I+0R!P-RAEZ>JL"/4$'O4]8FGJ%\8ZOY("PK:6B%5& ) 92?_'#'^&*VZ (
MA_Q^O_US7^9J6LV\EU.._P#^);:6EPIB&XW%TT1!R>F(VS^E1_:?$7_0*TO_
M ,&<G_QBK4&U?]40YI.WZ,UJ*R?M/B+_ *!6E_\ @SD_^,4?:?$7_0*TO_P9
MR?\ QBCD?E]Z%[1>?W,UJBNO^/27_=-9WVGQ%_T"M+_\&<G_ ,8J*YN?$/V6
M3=I>F ;3G&I2'_VA1R/R^]![1>?W,VZ*R?M/B+_H%:7_ .#.3_XQ1]I\1?\
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M'Y>^!0!N3^(-&M7N5NM6L86M$\RY$ERBF%.FY\GY1R.3ZU!_PD'AR#2QK?\
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M!G/%9FF>&]<AU+P_'>VNC1V6@F1(KF"60SSH86C!V% (\Y4LNY\GO\OS1_\
M"#7<MG:6]VUG+'$EJLB,6*MY5XL[<%>1M7 SW]N: .CAU[P]!X=&K6^JZ9'H
MR<"\CN8Q;K\VW[X.W[QQUZ\=:NV&I6.JVHN=+O;>]@.,2V\JR*<@$<J2.A!^
MA%<?XEM=3T>XEUJ&T74MFKK=P6ZQ22!8S:) 2WEH\BL'#$,D<G! ( +,FEX$
MM[I-)O;V^M([.34KZ2\$"1/'L#!1RKJK9R"2652<Y*KG  .CCMX89)7AB2-Y
MWWRLJ@&1MH7<Q[G:JC)[ #M4E%% $0_X_7_ZYK_,U+6;>1:G)?\ _$MN[2W4
M1#<+BU:4DY/3$BX_6HOLWB/_ *"NE_\ @LD_^/U:BFM_S(<FGM^7^9KT5D?9
MO$?_ $%=+_\ !9)_\?H^S>(_^@KI?_@LD_\ C]'*OYE^/^0N=_RO\/\ ,UZB
MNO\ CTE_W36;]F\1_P#05TO_ ,%DG_Q^H[FV\1?99-VJ:81M.<:;(/\ VO1R
MK^9?C_D'._Y7^'^9MT5D?9O$?_05TO\ \%DG_P ?H^S>(_\ H*Z7_P""R3_X
M_1RK^9?C_D'._P"5_A_F:]%9'V;Q'_T%=+_\%DG_ ,?H^S>(_P#H*Z7_ ."R
M3_X_1RK^9?C_ )!SO^5_A_F:]13?ZR#_ *Z?^RM6;]F\1_\ 05TO_P %DG_Q
M^HY;;Q%YD.=4TS[_ !_Q+9/[I_Z;T<J_F7X_Y!SO^5_A_F;=%9'V;Q'_ -!7
M2_\ P62?_'Z/LWB/_H*Z7_X+)/\ X_1RK^9?C_D'._Y7^'^9KT5D?9O$?_05
MTO\ \%DG_P ?H^S>(_\ H*Z7_P""R3_X_1RK^9?C_D'._P"5_A_F:]<KKVN>
M$8=?MK77)K!KR/IY\(<Q9Y&6P0OKR1ZUI_9O$?\ T%=+_P#!9)_\?KRCQ)\,
M/$MWXKGFA-O=QWLK2FX#")4+')!0DL ,]MW&*Z</3I2D^>=OZ\SEQ56K&"]G
M"_\ 7D>W Y&1R**JZ99G3M(L[(R&4VT"1&0C[VU0,_CBK5<CWT.U7MJ%%%%(
M85$/^/P_]<Q_,U+40_X_#_US'\S0!+1110 4444 %1'_ (_%_P"N9_F*EJ(_
M\?B_]<S_ #% $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@"6BBB@ HHHH *BF_P!9!_UT_P#96J6HIO\ 60?]=/\ V5J ):*** "BBB@
MJ*3_ (^8?^!?RJ6HI/\ CYA_X%_*@"6BBB@ HHHH *B'_'X?^N8_F:EJ(?\
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M ";JX]-5L[+^U_\ A6]GH-I:^7$L>HZ/=&:V$K3QH%E@2-81(0[9*NS[57)
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I'4M&RJQ0D$!EQE?<9XI:*
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MA:-;:98[O(MTVJ6.23G))]R23^-7J**R;;=V;)**L@HHHI#"HIO]9!_UT_\
M96J6HIO]9!_UT_\ 96H EHHHH **** "HI/^/F'_ (%_*I:BD_X^8?\ @7\J
M ):*** "BBB@ J(?\?A_ZYC^9J6HA_Q^'_KF/YF@"6BBB@ HHHH *B/_ !^+
M_P!<S_,5+41_X_%_ZYG^8H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV-K"D-M%&(TB08"KC&!0!P,'C;7Y/#RAM,!N(-)MKVYOH[A"&>7[J*C*H+,
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MM%N\MW48PS*6&U<'Y1BRV@Z:\<"-;96"YENHQYC?++*) [=><B:3CH-W&,#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% $0_X_7_ZYK_,U+40_P"/U_\
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M8V[C<O!^M3U2T;31I&BVFGB4RBWB";]NT''H/X5[ =A@=JNT %%%% !1110
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M"%RQPJCBJFC^&=9MDTVWUS6[.]LM-1!!!::<UN9&1=JM(S2R;L=<*%YP>V*
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M&>,U/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 45S.G>/='O5L(I7FBO;JWMYI(([>65;?SE!022*FU <X#,5!(..A
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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;B@ HHHH *B/_ !^+_P!<S_,444 2T444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>halo-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:halo="http://www.halozyme.com/20210930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="halo-20210930.xsd" xlink:type="simple"/>
    <context id="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i369088a4f53841368f3952aac246def4_I20211025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2021-10-25</instant>
        </period>
    </context>
    <context id="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i02e009dc2fa9486680263a15069d178d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c0f87e3f3f847cc839debee5868ce40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic648a667b4564856a5096920f3df03db_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icc326e2cf27f45baac0c0fe72eed59d2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i272651d659f84e0a8874d31b762516eb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iea7a928fde0046eca6e5a2a01621d057_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i501c9252b83c44809a6ccbddc68fa142_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic64829186658472f9e88de5ccbc70972_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc4eef1632dd43799c54c3a51442359c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i353f14d9c0cc433e9597f0fe48db2359_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6ed821ec9e124f6989a22f8554b1acbf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i99adc572639e4c54b1595861c11fec96_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i00f1c71dd4ef47f898e2155ae0b735ec_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i247f86e8e166412cb70a5c1492bc28dd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:CollaborativeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i62841acca8054be1814600a79b223d76_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i32263905767c45de917da63e14f56984_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic3e89af44e744d99aa39539c76531199_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i25334aa547be4cdaaff347b5deaac86e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i601d2a7ba1ff42c88d69d679d48bf478_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i84ac7847378b429f9176338d1e7ce9e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i41d331fe41f24e9da00e1cf521cc23db_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icc5f865f951b41669cfe18b259a0d85d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idcaf7ea55080433b89ecd6b1dc21f494_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7beabc966f144dc99430154a2577a780_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i58ed45201faa485fbbc32a6c3f935988_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a586d0e614542b59729d466bcca9e14_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icbfa535e62724f7c90e79d7f774037dc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7d99a9ecd955442dbccf9c897a851078_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i178ae7e383b143a6a97d76a52a288a81_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i38a5fc0a748f43aeb840f079b1667ce7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3c62eaa17c0847168d4711f217c137e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib749d4ed30754a3f9c5e7b5a222e9c73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a17be07a5cc4453aeff021e1cc99bc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if05acc0270554a9682fec68a9903a505_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c4b95062afe4a8880ccae03db28b451_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id97983bc9beb4b1ca46661fdb9b34961_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2484e9b3056245a78e893187e94a2989_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i85256e985e1c4b42ac4d454f915a8bd0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic293939d2030450296034697f0724379_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3c770b432f2e40caa63dcfeac3352f9d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7c21184904734499ada0aa1912871ae4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i43f3bfde66344aef8be3f0502fdef7c1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i227c6dc9e3ae40648df2cfd2ac32bb2c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib7273c25133442389646e9ae5c7a0f58_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4d1f54f1a68e4e809dca7deac8cde021_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id00da01d4ee5429da1ab15a67bd8c92b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6ffb579646fc4c0d8197f17b32a7128b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i871d983ec9934312a36ee3536d265db2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie5fea2d63902453fabd27c2ad7ff2cfd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic35a7e6ef47d488cada6c8e7fba0110d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0b526ab8a3cb471bb556ee04a4fd7e83_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95b8bb66e550462093b0b0b019e5c127_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i622c6a2434bf454db942b487a6b7e00a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic7968757fc73441ead621b34c559b52b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d81c8e1eb01492f8722125c6a4fb845_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4e79cd5f47bc44cd8c4429cf1b065e7f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib333d4f3b723420d812af307ac6e7563_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">halo:BaxaltaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6959c5a508d04982a33bfa4c80321de9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">halo:RocheMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie1a53e64a7e34f70b0457b035813cd41_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">halo:JanssenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f30dd7e598c4150bb7ab34c0c700764_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3d7143f1a70f40f4865183995dcdf3c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89efb2eece474b1c9fa2252f912eb2e2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if2bf701fe610422f904860a03167563a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bc3fbc4a9c34766bee79a37bf2c3e23_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5e231d70787f44a4b04e7ad9caf076a0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id4b36e88a5204ad7a59bf1f1884070f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d5406841f54463587c720f7d0c85362_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibaae598c6a0043268b61e55051da6c5b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1eb4955082b47499f0449ca9fa72759_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie0240effe3214b81b9ca5b45972c7265_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iadc6cd4f54794f4496d961d749aef342_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if7152e25968740afaabf504783045182_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7658f6494ad24880a34c2dc3979ede85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb0f815ccda14fc69c7000068fc223a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b6fe5f945ae43a69e913f0e0b729205_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ice6cebbf569a4926bb4ba1f2c0526b8c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7af6b80bac9f4ee1a6f77ffcbcb33af1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9a6f1d6a6d9a4794ad43347f6f6a845d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i510ee7af7efc47b28c4621b3e4d7c994_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7fd00eb22704a3faadef6bba5e75036_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7228f6a8b874f59a40a9c1c3ae1d319_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i23422b52470040bcabe09d7bda533924_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic96e068d375b4d50b976de50785f0a89_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4c2fb7c8538d41ddb1d8acd66cc4ef17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71214058490a424b86f59ea8c37c7358_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic98aeee1dd5f44ef88df01be8344928c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8048d79e377f495a99e418c2dd29f1d6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4a8d40c51fe947a88cf70e94aa08de05_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0e633fec488c477b957a45854ee34341_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3cd1753156549998bd9164c7783c6e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc226000e5b642c1a87036d0b20cf77d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic9d6e7551a5f4b78aa75bb4fcbf2d798_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib6f93b93b18047879feba5866a7c1147_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idac7d674d62548b09e34061cbb313276_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6c397dd0f5243188600e0dcf051082b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i42af265f358f4e47b36e71ac09d1ad01_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iad2bda6661fe4c6a8deab6b225439c54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b21d8da7dbc4396942bb05a95ca81f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84b5665294d04912b073fdaefa553c12_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iafee32398ddd4184a9e8c6f456c0bad6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iffc815cd3d3f45779613868dda56f367_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14b477c24acf478d95230b08574a9bea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7dec8fd3aaaf4fd59df1e8d089e118ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bf7e115ae39487e96fb9df8b46799e0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia31bae321b714f37893eb11b3ee1a813_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icd8fd7acfa834427a80a945db2878a09_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3465623e8f7d4998b90547f930b814e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17dfb6089521498d8d28b738549dbe12_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib3a819da17a94fbbbcdb54d76235890e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie330bed0ebb1442dbbdf7b34d7cfe2a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c5ae6e2527f4c99bd2fb6c331a1eab7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e0157ed45314cc1a41caf7282e4da2b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i43b81ea09c7b4830be62638aea4edab1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c022f7d86dd4437bd0cde070c7fd07c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3968a56145c145baa0c437ec109af06e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i92d0ce79c1664094be9d67dacba99869_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d04f05cf4d8411688ffb481e3b6f1a1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:BulkrHuPH20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i266391e004c7456a98a2b58f212c06c1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15658419291646da82621e9c9b2f6dbb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4575b33018d5417da6496f84f9c8b307_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c66125868794895a72167f638f47a8f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:HylenexRecombinantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if910d54ee4ef4f618d431f133fca2559_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c9ac387aba94bbc9c70dd2c275fd159_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i601a5d810b394d2489e25eea409b2b3d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i86cb3d1f5b124e9f81dbf0646d232a5f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:UpfrontfeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i17496220ae11435ca516f72c3fe10a18_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e642dc9f3414ad88f5df20dee6948ee_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i28450b44187c42f9b071a5816b0ea2e8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i491e07317d3346579daea09d068cc6ac_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:DevelopmentFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i266af81398ed45eea9c67c4a7856ace4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i569db92c338a4d04800ca2c32dfef65a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f82754b3e354c75b602f455ff70da37_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f6dec7f20e549b9b58761c803248054_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:SalesbasedmilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id8cf86de5f3046a4bae0460346e32c55_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib409cfda9eb34f03b1d3070f5ff73a9f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i941973135edc404780b79a1a8d9197ab_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f47adc8431141e2bd4adfb8ee6c8be3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:ResearchandDevelopmentServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iabeb09e2d5a34f1ab2165e7742136659_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:LicenseFeesAndEventBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i72e5a38073c94c808eacadffd14c661c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">halo:LicenseFeesAndEventBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5850452d31564c9b851c823cfbb9d09d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">halo:OthercollaboratorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic47eff917a924a8d88864fdf58cbee25_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic2b29c8b2930492d851baa19fbc2b1f5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7f83dd81a24947c0880845854951b856_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ResearchEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2f212c6f63a148cfa348578f6301b88e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ResearchEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6fc084111de34f53a1ac7314517c9af2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6773e28d6849430994555cb09743216d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35b85e221fa24178bff7cc0b297b9c72_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i856a56291322443ab3ccca37be0c321d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">halo:ComputerAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31b90616500947d38963e9030a90b72f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i722f7fc559114e54aeeadc90f492bc78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1155e6c14a0c4e65a515fa1e38dd911c_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c4cf1db12cd4ea3a46151468a622bcc_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd6310c76bae4bd78ad9a40cb2b6f8a5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i0bc7c027cf8d468087b67594cb81b7d1_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i412aa96cc1ad40e191bb9fafe16fe2dd_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i3e626483481f4563b913a234b6554eee_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i55a4ed926b904e02ab845282be395019_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i92cb63e1a7f24252ad3551517bf1a288_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="idc5af33153364e0e95a999a7eaa312d1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icd8cb28bb49f44cebedc6e40327ee290_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i70f1bbb3227642cd885e12ed12239f7d_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i57fd176ba4c740bd84df4e3fe9c28ccb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaef2086ff4f2483fbfd62522f9a2ad60_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id5074839e1194c76ae4dc87402cb085f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i206c739252224af8a8948489d424ad8f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i686912eb766d40b18a385b1858670232_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i73ccd57126f347af88275529acfde43e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic5bb0843b04c43068da2dc6c03a064e3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie190bf0480c1487b9eb3d0916f7ffd88_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A1.25ConvertibleSeniorNotesdue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0cb4364368aa4364afadbad891bba742_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">halo:A025ConvertibleSeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8cd6bdc962914e4c99408077c340d9e7_I20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:RoyaltybackedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-31</instant>
        </period>
    </context>
    <context id="i05a350efec6041e4ad6404c46e10b7d7_D20160101-20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:RoyaltybackedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="i6fc00725d97c48d58939d926e50427aa_D20160101-20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">halo:RoyaltybackedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="ic9b79a7919f047598af257757cc3e833_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6935de8b3c224975955d989d869bb9c2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if714bbad33ad4917992f139e44fd69a2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i23a37442fa874dafb84523a3cca2bb91_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0ba5ad85eda24a959bfa0546f86a7844_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia888539718ab4742979a05f4e932df96_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3782dfbd667f4a0687f611f008d2010f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idec1669a6ad4449fb85d6e5157147d08_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3d3c879cf61d4eacae3a4dff1a71d41b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie22bc32765cc456cb791da8766cc1e95_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i991a03f67f0b48beb763927b3126b6ee_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iad66576159674e89ac18ab298f2dbcdc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i56b8f532e5be4b9985264987e5461803_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icf0bf4633edb46a299d1efbda6de0f73_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f0e8a1da30a4e6491620fc881ff1298_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:RSURSAandPRSUawardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i524ae854807442c79db75cfe0fec0661_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id279be3e39fe4e73b119fc76b6f0e3e9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i777756be172547c79ef2d98b14af2e9f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifcc6657cf7204e4bb3546eb115b7bb0b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if5e243ecce6549b386466103e48f03b8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i19137a9706c8440c91b3ac9170020347_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i930e92c51aab40ecb52c8e784b177f6d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1a0c6e310d5c45ff9ba748668cdfb1c4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icd817f332517429098def9a226790157_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">halo:A2021ESPPPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ia25a711f34284d2cb31197de09c55937_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">halo:A2021ESPPPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i96eaae6aa21440828363d019cc8fb175_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">halo:A2021ESPPPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5cc8bb9a58ee4f22a7917709a47d0c11_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ied5a4b70c0d2418886012876813052b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a10b0624cac49329813b37fc11aefe5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i21bf5baccc98495a841b685c19034c72_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c625f6452334fda92249e711cf8c8e6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie68b30dcf1104c92bfe3cf876434fc97_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic605063c80bb49dd8a2679393c11b629_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i96692b1d30124ac7860fc3b510b76971_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">halo:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0eb7b940b8b45069c49b5e764d38ad3_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i04b761c127644a42b2eb23927abd636d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i74563819caa746e7b4b7466ded794e9c_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i482105c008be423fb640367ac9200980_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">halo:A2020ShareRepurchaseProgramBankOfAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i233725c2ad55441fb034d230594f0b46_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="id4ffcc29926a492a9b8cfa96fed2704b_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">halo:A2021ShareRepurchaseProgramBankOfAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i188943ac07244920b82f0519b3031931_D20210415-20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-04-15</startDate>
            <endDate>2021-04-15</endDate>
        </period>
    </context>
    <context id="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i02b22b0c2f2646bea792472d7f97d94f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i241b7f6a84b54adbb1af7e7476c1b810_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5299df71ad7b40699940776b16949966_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if9a61b1b587a4aad9bbfecff6ad6f475_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i065050ada4e544a2be29ac40313d14cf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia011b61b43c242d5a1e03e0cb7b02a60_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9bf62165ab9948da9eaf8cd763bd074a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i67b1f1cb883146f9a922816ce4291811_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="collaborator">
        <measure>halo:collaborator</measure>
    </unit>
    <unit id="product">
        <measure>halo:product</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>halo:segment</measure>
    </unit>
    <unit id="security">
        <measure>halo:security</measure>
    </unit>
    <unit id="trading_day">
        <measure>halo:trading_day</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV8xLTEtMS0xLTA_f9f922f5-75a7-490b-b946-437c0353a9e8">0001159036</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV8yLTEtMS0xLTA_0e0322d6-0e47-4db6-a4a5-83850b3ac4ff">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV8zLTEtMS0xLTA_9f8a0859-e7d4-4dca-92cf-b8350c6b28f1">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV80LTEtMS0xLTA_15efae5a-147c-4104-8976-87719c08fa83">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180L2ZyYWc6OTcwODJiZTYyMTMxNDJlZTg2YTllMDJkM2IyYjA2OTIvdGFibGU6NWNkNzRjNDA4NjkwNDAyOThjNTdkZDMzOWM2YzhlMGEvdGFibGVyYW5nZTo1Y2Q3NGM0MDg2OTA0MDI5OGM1N2RkMzM5YzZjOGUwYV81LTEtMS0xLTA_edc730df-94b1-4db0-84fe-baf1d26d88a6">--09-30</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ic2b29c8b2930492d851baa19fbc2b1f5_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181NS9mcmFnOjc1ZmZjYTEwN2ViMDQ5MmFhMzM0NzBjNzcwYmQ4YjZkL3RhYmxlOmU4NmNjMTRjMWRkYzRiYjFhZWVjZmZjMTIwMzBkYzVlL3RhYmxlcmFuZ2U6ZTg2Y2MxNGMxZGRjNGJiMWFlZWNmZmMxMjAzMGRjNWVfMS0xLTEtMS0w_6ac777ca-afe0-491b-9a7b-69a67c61dff0">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <dei:DocumentType
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xNzk5_44167482-3579-4351-9ef0-80640cb0c2bc">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6N2YzMGZiNzhhMzhjNDA0MmE5MTA5NjFmMDFhZmQzZjUvdGFibGVyYW5nZTo3ZjMwZmI3OGEzOGM0MDQyYTkxMDk2MWYwMWFmZDNmNV8wLTAtMS0xLTA_a310cdd2-0ab3-48d0-8450-3a336ad1cfba">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xMzQ_5d8b1cf1-a799-4e4f-9a33-174d75c6c775">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6MjhjZjlhNzBkYzQwNDkwZWI1MTRmOThlOTUyZDMzZWEvdGFibGVyYW5nZToyOGNmOWE3MGRjNDA0OTBlYjUxNGY5OGU5NTJkMzNlYV8wLTAtMS0xLTA_51e7f9f9-cf06-4d72-91c1-f3d5a7a2790c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODA0_e50f6f0e-ddc8-4a37-8abb-ac482ff40e6e">001-32335</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODA1_054c1ad9-af4d-4537-b077-2cc4d78e6d04">HALOZYME THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18wLTAtMS0xLTA_256bd13c-16df-4746-a9e0-e64294c57138">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18wLTItMS0xLTA_b97fd53b-9abd-4c30-a01e-50c0d15aa5ed">88-0488686</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18zLTAtMS0xLTA_cc93bb6e-34c4-47e6-8ce8-dc251c107ace">11388 Sorrento Valley Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN18zLTItMS0xLTA_12ace12c-34e8-46f1-8584-1e5104d4ac12">92121</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN180LTAtMS0xLTA_348da67e-9f85-4573-afd5-d9637c2ecbdf">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NjE5NjQyYzZkM2I5NDEzNDg4YTVmNGZmODZhZDA3YzcvdGFibGVyYW5nZTo2MTk2NDJjNmQzYjk0MTM0ODhhNWY0ZmY4NmFkMDdjN181LTAtMS0xLTA_1e81290e-ef8f-4fbd-8d38-ed0a2e2a86d0">CA</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODAw_1fa716ed-bb47-4954-a76b-e809a6fb64c3">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODA2_b0b67ff6-31d7-4ab3-86fe-987853b9201f">794-8889</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6OWQwNzAxYmVjZjNhNGM5MmFmOTQxYWIwYWRjNTVhYjcvdGFibGVyYW5nZTo5ZDA3MDFiZWNmM2E0YzkyYWY5NDFhYjBhZGM1NWFiN18xLTAtMS0xLTA_eb6160de-db59-4cec-b7a2-4bd46f91e2a2">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6OWQwNzAxYmVjZjNhNGM5MmFmOTQxYWIwYWRjNTVhYjcvdGFibGVyYW5nZTo5ZDA3MDFiZWNmM2E0YzkyYWY5NDFhYjBhZGM1NWFiN18xLTEtMS0xLTA_127dfd9f-6a31-49e4-ba5f-e8e64121e9d6">HALO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6OWQwNzAxYmVjZjNhNGM5MmFmOTQxYWIwYWRjNTVhYjcvdGFibGVyYW5nZTo5ZDA3MDFiZWNmM2E0YzkyYWY5NDFhYjBhZGM1NWFiN18xLTItMS0xLTA_4d5c2b2c-5e5f-429b-9313-137b1f47d5dd">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODAy_33a81121-af43-47f9-a2b0-0ffe84a4cb7c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xODAx_7520710d-e388-4898-82a8-94dfc1f2a417">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NmI3YmMxMzNiZDJkNGUxZTk2MDY0MWYxYjU1ZDY3YjEvdGFibGVyYW5nZTo2YjdiYzEzM2JkMmQ0ZTFlOTYwNjQxZjFiNTVkNjdiMV8wLTAtMS0xLTA_54d29126-3071-4483-aa65-aaa28f0a38a9">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NmI3YmMxMzNiZDJkNGUxZTk2MDY0MWYxYjU1ZDY3YjEvdGFibGVyYW5nZTo2YjdiYzEzM2JkMmQ0ZTFlOTYwNjQxZjFiNTVkNjdiMV8xLTMtMS0xLTA_a8036711-1c1b-4a09-919e-47986f424b8e">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGFibGU6NmI3YmMxMzNiZDJkNGUxZTk2MDY0MWYxYjU1ZDY3YjEvdGFibGVyYW5nZTo2YjdiYzEzM2JkMmQ0ZTFlOTYwNjQxZjFiNTVkNjdiMV8yLTMtMS0xLTA_ee5ef38b-9bd6-447a-b20e-59f42f84b22b">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xNzk4_acb9c9c2-be88-44c2-af3c-6e8fcf06af30">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i369088a4f53841368f3952aac246def4_I20211025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xL2ZyYWc6OWUyMmZjMTdlODU2NGRhMmFjYjU0MTUyNmJiNWU5NTUvdGV4dHJlZ2lvbjo5ZTIyZmMxN2U4NTY0ZGEyYWNiNTQxNTI2YmI1ZTk1NV8xNzgy_78e5bb9e-29e0-434e-95a2-2c93050e9a8b"
      unitRef="shares">140787020</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMy0yLTEtMS0w_920bb19c-6eb6-4caf-a8bc-91b8e64b6854"
      unitRef="usd">491683000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMy00LTEtMS0w_b567de53-7588-452d-897c-f1e94933e7e0"
      unitRef="usd">147703000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNC0yLTEtMS0w_32967259-c3bd-4ea7-b2a2-dea7e3699f6c"
      unitRef="usd">324237000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNC00LTEtMS0w_a1f0512a-4ea5-4926-afef-6fb161128c97"
      unitRef="usd">220310000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNS0yLTEtMS0w_88ccf77d-7208-4b70-a9f1-a1a8f36344d8"
      unitRef="usd">112099000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNS00LTEtMS0w_65ceca2a-714f-4667-9989-95e4c8ceef3a"
      unitRef="usd">97730000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNi0yLTEtMS0w_ab7d4f3e-f005-4bfd-a29b-abeec85aba65"
      unitRef="usd">55978000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNi00LTEtMS0w_0db6fb89-8081-473b-a2e7-9c65ad7bb60b"
      unitRef="usd">60747000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNy0yLTEtMS0w_e21516ca-0013-407e-b4ce-499578add9db"
      unitRef="usd">33302000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfNy00LTEtMS0w_553a69da-372e-4d0d-9e16-84f88a44c166"
      unitRef="usd">28274000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOC0yLTEtMS0w_91ecda28-41bf-4bcd-9180-b6e49becaf48"
      unitRef="usd">1017299000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOC00LTEtMS0w_308112e6-cf5f-4903-a667-50458235fb63"
      unitRef="usd">554764000</us-gaap:AssetsCurrent>
    <halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOS0yLTEtMS0w_3df7be3d-24ca-4a71-b8d3-f5bbbd970015"
      unitRef="usd">9588000</halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfOS00LTEtMS0w_0b8b794c-c529-49c1-9fe3-c772758d29e1"
      unitRef="usd">10593000</halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTAtMi0xLTEtMA_4d2d6f1c-f9eb-4654-bb18-d03f1b33064d"
      unitRef="usd">15552000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTAtNC0xLTEtMA_3116a7de-d1d6-4c01-8202-bf777f9982b2"
      unitRef="usd">14067000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtMi0xLTEtMTA0MDk_2007115a-b88d-4a7d-9e83-2c3249f2b583"
      unitRef="usd">142481000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtNC0xLTEtMTA0MTY_36b60259-28d0-499f-884c-977a4cd61d1b"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtMi0xLTEtMA_09fc46c4-a851-4641-9407-8928644dbdc5"
      unitRef="usd">500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtMi0xLTEtMA_efe25ab4-f4cb-4c2d-92c7-e01538a007d5"
      unitRef="usd">500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTEtNC0xLTEtMA_af9e7d53-04ef-4fa7-8bb8-73e3859bbd09"
      unitRef="usd">500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:Assets
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTItMi0xLTEtMA_e899ecff-98da-4d71-a1b8-7b1956848949"
      unitRef="usd">1185420000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTItNC0xLTEtMA_9aa0fde3-b8f1-4d12-830f-89f71ac05fff"
      unitRef="usd">579924000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTYtMi0xLTEtMA_2e89cf48-e9e6-4606-9d8b-cc58fb6746fe"
      unitRef="usd">3322000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTYtNC0xLTEtMA_deaea3b8-fdc1-4105-9a72-e32cd83b729a"
      unitRef="usd">1928000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTctMi0xLTEtMA_256ccc5d-7ebd-4d85-9204-ecc353491cc6"
      unitRef="usd">18335000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTctNC0xLTEtMA_e03e92aa-31cd-4425-b849-7be073553010"
      unitRef="usd">20483000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTgtMi0xLTEtMA_a98c6c45-a6e8-4aef-b46a-c4f77a5c07ac"
      unitRef="usd">2245000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTgtNC0xLTEtMA_7150d176-114b-4d5a-a8cb-5ca958e8e8e1"
      unitRef="usd">1746000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTktMi0xLTEtMA_22b695c8-bbf5-4c3c-9b2e-59602fec0055"
      unitRef="usd">89251000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMTktNC0xLTEtMA_1a704ec8-e802-484c-89da-c7ec60e69eb3"
      unitRef="usd">397228000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjAtMi0xLTEtMA_0bc2f600-28d9-4cd1-b300-f13e1434b4fe"
      unitRef="usd">113153000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjAtNC0xLTEtMA_8f571284-bd07-47e3-9bef-53748f659308"
      unitRef="usd">421385000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjEtMi0xLTEtMA_497d12d7-bd41-4698-bf52-747d3afb5864"
      unitRef="usd">2530000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjEtNC0xLTEtMA_a5f9828f-06c9-4e20-8f9e-78b008355230"
      unitRef="usd">4026000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjItMi0xLTEtMA_87d51e90-71a8-4b76-b70a-0f0132fc694b"
      unitRef="usd">786454000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjItNC0xLTEtMA_ad39976a-2330-41e4-a7b8-ba73356f18fa"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjMtMi0xLTEtMA_80aaee02-bfcd-4112-b558-7b73ec2ea48d"
      unitRef="usd">1609000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjMtNC0xLTEtMA_bab543e1-f093-4b54-bb17-c0ef029fb7cc"
      unitRef="usd">3466000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjQtMi0xLTEtMA_f354d5a0-dac4-4278-b464-38c537648b31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjQtNC0xLTEtMA_1ebf8ca9-86d5-439c-ae63-666a9562c5f0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTA_0818f57f-6972-4880-9446-f1c75c1be6fe"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTA_bf3c0d81-5c28-43ee-91b1-e8f41749a81a"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTk_6e6f0672-347c-4851-b8be-941a7593e836"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc4OTk_9a568466-91a3-45d5-a321-2ddd0c9fd109"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_11ee9064-2732-4fb0-ad84-df558a3422d4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_204071ee-9e74-47b3-8faa-6c9e1b31cf80"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_3090b018-7946-4d4e-b983-0dafa33d3b1c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZTI0MmUyNDZmMzQ4NWI5YjBjOGE1ZDJkOWYwNDhlXzEwOTk1MTE2Mjc5MjE_9de48e98-6d09-4c03-8123-0a5520de4ad3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtMi0xLTEtMA_645ea160-1812-4dca-b10f-70be178eaec0"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjYtNC0xLTEtMA_d24625ef-c328-48a8-866a-1f64fbba83d4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk1Mw_27f1be07-4f9a-4c0c-96eb-cec88712b343"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk1Mw_46825fc0-8906-4c4a-b2ba-6d618b369c15"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk2Mw_a7f0e44c-a09b-4aab-9418-8eeba872747c"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk2Mw_e025b3c1-da08-4e0c-9373-564139e996b0"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_0087817f-a606-4d72-a73e-05b833fa7c57"
      unitRef="shares">140966000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_5e7f6e0a-2f24-437e-885e-7cd7f06b4982"
      unitRef="shares">140966000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_9c774149-7c9d-4baa-83d6-f122eed81401"
      unitRef="shares">140966000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk3NQ_f7feb667-1ab7-4d3b-a824-1872d2f38e2b"
      unitRef="shares">140966000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i2c0f87e3f3f847cc839debee5868ce40_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMC0xLTEtMzg3L3RleHRyZWdpb246ZDUyNTY2Y2E4YjUzNDg2MjlmNzQxZWYwZDU2ODJhNTZfMTA5OTUxMTYyNzk4Ng_d293cad0-18e4-479a-9c62-32a6fd11cdde"
      unitRef="shares">135030000</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctMi0xLTEtMA_0a6bf4c6-17d5-4154-987f-338ed11eb9d6"
      unitRef="usd">141000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjctNC0xLTEtMA_38314a87-fddd-4794-a331-abefe04d4df4"
      unitRef="usd">135000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjgtMi0xLTEtMA_d7eef431-4f01-4c1d-94df-ddcc7ebf8d12"
      unitRef="usd">407229000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjgtNC0xLTEtMA_4b12b6f4-5fc3-4114-812c-6b0e9f3e96c2"
      unitRef="usd">625483000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjktMi0xLTEtMA_a339c20c-2cef-4a10-8c79-d3276f40f7f8"
      unitRef="usd">-14000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMjktNC0xLTEtMA_3c5eebaf-746a-4a3e-851a-b0327b49ad20"
      unitRef="usd">22000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzAtMi0xLTEtMA_2749377d-6832-4cc0-983c-500c11a3350c"
      unitRef="usd">-125682000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzAtNC0xLTEtMA_2653c27a-7023-4df9-9cf8-3cd03192bcaf"
      unitRef="usd">-474593000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzEtMi0xLTEtMA_3a22407c-e0a1-4d76-8085-422f41385c79"
      unitRef="usd">281674000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzEtNC0xLTEtMA_6daeadc9-f280-470c-a136-9bfcc9023d47"
      unitRef="usd">151047000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzItMi0xLTEtMA_75d096df-02f0-4776-9822-1c615fe8878e"
      unitRef="usd">1185420000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18xNi9mcmFnOmU0Y2RhMzc4M2YzZTRiZTE5MTc0NjA1ZjhhN2ZlMWQ3L3RhYmxlOmQ0OWM5MjA0NDVkMDRhOTk5YzI0YWQ5YWUzMjc5YjdjL3RhYmxlcmFuZ2U6ZDQ5YzkyMDQ0NWQwNGE5OTljMjRhZDlhZTMyNzliN2NfMzItNC0xLTEtMA_a71149e1-0d53-4512-ba94-b5c3f380a3c5"
      unitRef="usd">579924000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic648a667b4564856a5096920f3df03db_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy0yLTEtMS0w_26b27ea3-43a9-48d5-b18d-bb4b9baf67ad"
      unitRef="usd">58563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc326e2cf27f45baac0c0fe72eed59d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy00LTEtMS0w_4b6d533b-5d93-4cda-ab6e-f0270a9ab5aa"
      unitRef="usd">23931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i272651d659f84e0a8874d31b762516eb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy02LTEtMS0w_399e9ce5-7949-4e1e-9992-d68220d98655"
      unitRef="usd">141264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea7a928fde0046eca6e5a2a01621d057_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMy04LTEtMS0w_794ada0d-6c6c-4724-a3e4-440cc6ed9083"
      unitRef="usd">56599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i501c9252b83c44809a6ccbddc68fa142_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC0yLTEtMS0w_4de3f218-72b8-4cfa-8935-dcc9e8392d45"
      unitRef="usd">25047000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic64829186658472f9e88de5ccbc70972_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC00LTEtMS0w_2e9abd19-0a3d-47e0-b8c4-b6778a1d2729"
      unitRef="usd">9048000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc4eef1632dd43799c54c3a51442359c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC02LTEtMS0w_b9988d75-6acb-4686-8588-9a4f9b7920f9"
      unitRef="usd">77173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i353f14d9c0cc433e9597f0fe48db2359_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNC04LTEtMS0w_ccf90c7d-3c22-4bfa-8e8b-ab2d1e6d891e"
      unitRef="usd">23532000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ed821ec9e124f6989a22f8554b1acbf_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS0yLTEtMS0w_e0d2ef9d-c7b2-4eef-8c11-0d63d316ce8a"
      unitRef="usd">32220000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99adc572639e4c54b1595861c11fec96_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS00LTEtMS0w_b68abc74-c990-4e1f-bc45-b3df9615a355"
      unitRef="usd">32337000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00f1c71dd4ef47f898e2155ae0b735ec_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS02LTEtMS0w_ca37f9a6-9c09-47f1-b6cc-c1c330b67c4f"
      unitRef="usd">122870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i247f86e8e166412cb70a5c1492bc28dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNS04LTEtMS0w_9fa0cf35-e6b1-4bae-b858-7bfb68785ab2"
      unitRef="usd">65760000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi0yLTEtMS0w_754a64a1-e757-468e-a702-552d21b8ecc6"
      unitRef="usd">115830000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi00LTEtMS0w_b8da280c-074d-4deb-a794-df791a4c1aa6"
      unitRef="usd">65316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi02LTEtMS0w_7a6ce43c-fefb-4f7b-92bb-dac12ee300d8"
      unitRef="usd">341307000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfNi04LTEtMS0w_ea35745a-193a-4d15-8cef-e85be5f97b14"
      unitRef="usd">145891000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC0yLTEtMS0w_f5736631-a6f9-4fc1-bdf6-e3e24af88820"
      unitRef="usd">18589000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC00LTEtMS0w_92a0c495-b2ec-46c6-a846-9ded3f9a6946"
      unitRef="usd">5568000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC02LTEtMS0w_82f5a91e-8e7d-4c53-9030-7732449ad1fc"
      unitRef="usd">59826000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOC04LTEtMS0w_7c8d02b7-930f-4e39-bea4-18cd666888bd"
      unitRef="usd">17095000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS0yLTEtMS0w_3653fa11-b53e-473b-af1f-f2d965721c0b"
      unitRef="usd">8486000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS00LTEtMS0w_95fca19a-84bf-4725-a3a9-ec9237552367"
      unitRef="usd">7747000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS02LTEtMS0w_c3af0864-1498-42c2-9539-666f83ec09dd"
      unitRef="usd">25564000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfOS04LTEtMS0w_f59aa8c7-9bd2-40e0-a836-46b6cc134463"
      unitRef="usd">26856000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtMi0xLTEtMA_3156ed2a-b439-4257-b3ba-07b5274e1608"
      unitRef="usd">13169000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtNC0xLTEtMA_f19d9d69-1d44-4ab5-8919-7582709f2f4e"
      unitRef="usd">11702000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtNi0xLTEtMA_f5eba92f-fff6-460a-9b1e-e39e9d17ae21"
      unitRef="usd">36549000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTAtOC0xLTEtMA_992a79e1-c105-4166-8f5c-44f547bb91c2"
      unitRef="usd">35309000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtMi0xLTEtMA_b2c56fd2-ef70-4e57-a9ec-7eaf44ecf031"
      unitRef="usd">40244000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtNC0xLTEtMA_be02118e-1e2f-46d5-bc2d-70d37053dbc2"
      unitRef="usd">25017000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtNi0xLTEtMA_c5255163-239f-4e95-a9bb-2718a5fe6c8a"
      unitRef="usd">121939000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTEtOC0xLTEtMA_1d72c93c-51cd-4b55-adf4-b7da54a48e4a"
      unitRef="usd">79260000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItMi0xLTEtMA_f3dae798-60af-4c29-af8c-e46b174f7317"
      unitRef="usd">75586000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItNC0xLTEtMA_fc093003-625e-4c90-b2d8-c4fc0f9f7014"
      unitRef="usd">40299000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItNi0xLTEtMA_8e8792ee-fd2f-4e83-adba-d222c175a8a5"
      unitRef="usd">219368000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTItOC0xLTEtMA_6829f421-8e70-406e-8d22-9cb7246b0591"
      unitRef="usd">66631000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtMi0xLTEtMA_b11c63c6-7e45-4134-b0ca-83ecbfca5566"
      unitRef="usd">274000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtNC0xLTEtMA_9217d2fd-783b-40e1-a6ac-fff3dcb6fd0c"
      unitRef="usd">961000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtNi0xLTEtMA_e86adef8-a8be-4c20-afe4-5d5df6e3bf1e"
      unitRef="usd">771000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTQtOC0xLTEtMA_4da3efc5-7721-454d-ac9f-187461d5ae49"
      unitRef="usd">4764000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtMi0xLTEtMA_a75ecd0a-8e1c-485e-8a82-079b106cae42"
      unitRef="usd">0</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtNC0xLTEtMA_9de401b8-4975-45f5-a821-395b4d126ade"
      unitRef="usd">0</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtNi0xLTEtMA_5f5ca930-05f2-4237-a137-73132f4e15bf"
      unitRef="usd">20960000</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTUtOC0xLTEtMA_72bf0842-05d0-4957-b372-518f59a6c7b6"
      unitRef="usd">0</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:InterestExpense
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtMi0xLTEtMA_de8368a0-4fa0-4f05-802e-450b109a716d"
      unitRef="usd">1754000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtNC0xLTEtMA_29368d40-e31a-4cb1-bf3c-c195e07a3355"
      unitRef="usd">4990000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtNi0xLTEtMA_f8e48041-5375-4c25-8fce-d57ba3f8571c"
      unitRef="usd">5471000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTYtOC0xLTEtMA_e4cd7540-6b26-44d4-bc92-4cd395a7f820"
      unitRef="usd">15342000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctMi0xLTEtMA_ce420587-b980-4d36-b4b6-b56ca176d3c7"
      unitRef="usd">74106000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctNC0xLTEtMA_c42a3711-48ac-4c86-a146-db94ccf82f87"
      unitRef="usd">36270000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctNi0xLTEtMA_745357d4-43e0-4f38-b60e-d6b291ec9782"
      unitRef="usd">193708000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTctOC0xLTEtMA_b779b3d5-af5b-426e-912b-bc232ea6a160"
      unitRef="usd">56053000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtMi0xLTEtMA_0d3d64d2-55e7-4efb-a6c1-62c0aced845b"
      unitRef="usd">-142481000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtNC0xLTEtMA_4553f0f8-f065-4db9-a7d4-bdebaad31b27"
      unitRef="usd">63000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtNi0xLTEtMA_ff6b6265-26e4-4122-954b-e3f1f151b781"
      unitRef="usd">-142232000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTgtOC0xLTEtMA_bcf1a6d8-cc66-4a04-9dd8-1ddba0ce6741"
      unitRef="usd">132000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktMi0xLTEtMA_0cd55c30-3648-401f-aa81-de9bd04894a4"
      unitRef="usd">216587000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktNC0xLTEtMA_7e82f72c-8858-49e0-ba93-e7e248f84907"
      unitRef="usd">36207000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktNi0xLTEtMA_626e0e05-9fb4-4e0d-a667-35c5ccb104dc"
      unitRef="usd">335940000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMTktOC0xLTEtMA_d13ab8d4-bddf-4e82-a298-72bc927072da"
      unitRef="usd">55921000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItMi0xLTEtMA_f9c2c0f4-e969-4768-8587-876bd23278ff"
      unitRef="usdPerShare">1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItNC0xLTEtMA_871a3ce4-9474-4f7f-b7ea-c8192f337efa"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItNi0xLTEtMA_43fd443f-ab8c-4977-aa91-959ff2eb1c1b"
      unitRef="usdPerShare">2.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjItOC0xLTEtMA_97609c10-6ead-4130-a7a6-d0ff93f6ea02"
      unitRef="usdPerShare">0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtMi0xLTEtMA_115a7135-0b05-495b-b460-a2823c4fffcb"
      unitRef="usdPerShare">1.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtNC0xLTEtMA_280269a5-4e89-4380-b0f6-3bd869b54a3d"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtNi0xLTEtMA_f25f84ad-dfc4-4ba4-8986-f0046c50146a"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjMtOC0xLTEtMA_12cdb829-7377-48b3-9d06-06291d07d305"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtMi0xLTEtMA_9e502d26-1d8d-43f9-8a89-8b89d4402e8a"
      unitRef="shares">142021000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtNC0xLTEtMA_9d91dfbb-728b-4fc4-ae73-216114bb3f0a"
      unitRef="shares">136578000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtNi0xLTEtMA_4042dcb4-0d1e-4faa-9f88-7c3a1899d0a1"
      unitRef="shares">140815000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjYtOC0xLTEtMA_56386064-d80c-4f36-875e-012432938ecd"
      unitRef="shares">136575000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctMi0xLTEtMA_d7dac9ee-8648-44d0-be06-a1f87236cd96"
      unitRef="shares">146690000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctNC0xLTEtMA_d4c5b954-b1f6-4a49-8967-1c283ba9349f"
      unitRef="shares">142081000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctNi0xLTEtMA_eb8a1121-864b-4656-bab8-886d7ecb90ae"
      unitRef="shares">147652000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yMi9mcmFnOjAzMTAzNDU0M2VmZjQzZjE4NmE4ZDUxMjQ2N2NkODM0L3RhYmxlOjJlYzFjODRhZTk2NzRiNmM5MmNmZDM0YjFjMjU0NmM3L3RhYmxlcmFuZ2U6MmVjMWM4NGFlOTY3NGI2YzkyY2ZkMzRiMWMyNTQ2YzdfMjctOC0xLTEtMA_01ea0e91-f793-41cb-9757-ec50300c4d50"
      unitRef="shares">139971000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi0yLTEtMS0w_f11ae758-873e-4bda-9b0a-7888b9bbb374"
      unitRef="usd">216587000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi00LTEtMS0w_329f599b-c7d0-4ad3-bb61-2dbf5918e2e7"
      unitRef="usd">36207000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi02LTEtMS0w_626e0e05-9fb4-4e0d-a667-35c5ccb104dc"
      unitRef="usd">335940000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfMi04LTEtMS0w_d13ab8d4-bddf-4e82-a298-72bc927072da"
      unitRef="usd">55921000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC0yLTEtMS0w_d512e477-ea40-42fe-a44f-6b28ca10e399"
      unitRef="usd">8000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC00LTEtMS0w_81e38f77-9ffe-41f2-b3d4-082fd974df80"
      unitRef="usd">-640000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC02LTEtMS0w_530bbaf2-d6fa-4ca4-abf3-f8dc03c1846b"
      unitRef="usd">-76000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNC04LTEtMS0w_57b178e5-e7ca-4715-a0ea-4cad4dc64533"
      unitRef="usd">203000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS0yLTEtMS0w_c3dd456a-5525-46fb-935b-d7658076fba6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS00LTEtMS0w_f1b7d5cc-11d0-4dc2-8062-6e68266ab946"
      unitRef="usd">13000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS02LTEtMS0w_01d3e6ee-0b59-45b3-bef0-72618fffb4e7"
      unitRef="usd">-15000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNS04LTEtMS0w_28bb1258-4237-4ff0-94da-4a3fad09c79d"
      unitRef="usd">8000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi0yLTEtMS0w_ed6532e2-dc4b-476e-afbe-c367837ad26b"
      unitRef="usd">2000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi00LTEtMS0w_a575f96f-63b1-4d52-84b7-3c42f649b90c"
      unitRef="usd">-7000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi02LTEtMS0w_c32a0819-470e-41fd-a56b-7cdf0501fb13"
      unitRef="usd">25000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNi04LTEtMS0w_64f5b716-79de-486f-ac99-fc3b916192c2"
      unitRef="usd">-9000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy0yLTEtMS0w_0469cba9-6257-4b58-9b62-bb5dbd785181"
      unitRef="usd">216597000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy00LTEtMS0w_628cd3a6-a194-4ef2-b86d-72d2d3f9042f"
      unitRef="usd">35547000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy02LTEtMS0w_55d028e6-149d-42ab-8072-7d05cafe9cf0"
      unitRef="usd">335904000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yNS9mcmFnOjMzY2VmYTQ0YzhmNzQxMjc5ZTE5MTQ2MDU5YzAzNDJiL3RhYmxlOjdhNTQ4NWRjOTY3ZDQ0NDRhNjBiNTc0NzgyZmU2NTVjL3RhYmxlcmFuZ2U6N2E1NDg1ZGM5NjdkNDQ0NGE2MGI1NzQ3ODJmZTY1NWNfNy04LTEtMS0w_c483f5e0-0909-4476-b54c-9862469720a2"
      unitRef="usd">56107000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNC0yLTEtMS0w_8b0107d1-863e-4c9a-b903-035eca6f4e15"
      unitRef="usd">335940000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNC00LTEtMS0w_335e3107-5cc3-49fd-a853-fd19b3e919a2"
      unitRef="usd">55921000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNi0yLTEtMS0w_f47ee73c-64a9-4a78-a90b-3fb1d8af45f4"
      unitRef="usd">15694000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNi00LTEtMS0w_4c509982-946a-45fc-984a-7839d82f046d"
      unitRef="usd">13008000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNy0yLTEtMS0w_37d38eb5-cc1e-47b7-9c22-74878934bad7"
      unitRef="usd">2224000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNy00LTEtMS0w_fbc2d23c-629f-43d9-abfe-e9b33aee08d6"
      unitRef="usd">2484000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfOC0yLTEtMS0w_613e1bff-91a4-433e-b736-3649c7ca240b"
      unitRef="usd">2674000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfOC00LTEtMS0w_e7901674-6282-44f3-9f9a-35082518b109"
      unitRef="usd">10540000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTAtMi0xLTEtMA_cf9b57bf-5224-4a2f-8ec9-518acd40752c"
      unitRef="usd">-1518000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTAtNC0xLTEtMA_1ccb4d46-47a1-4a1a-a4fb-67af0d334d6f"
      unitRef="usd">-477000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTItMi0xLTEtMA_ad598837-6b3e-49fa-8313-76f7b2ed7d47"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTItNC0xLTEtMA_5f325804-3186-42fb-b660-323bbc5eb579"
      unitRef="usd">631000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTQtMi0xLTEtMA_bc7df44f-17b3-4837-9774-fff2304317d8"
      unitRef="usd">997000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTQtNC0xLTEtMA_2a883916-5e67-45ea-ab4c-550b4efb48a4"
      unitRef="usd">3870000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <halo:DeferredRentPayments
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTUtMi0xLTEtMA_dd1d92ae-4fce-46ce-a640-23000082eeeb"
      unitRef="usd">568000</halo:DeferredRentPayments>
    <halo:DeferredRentPayments
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTUtNC0xLTEtMA_d19dd7d4-e06d-4acf-a78c-5afc0275a16d"
      unitRef="usd">759000</halo:DeferredRentPayments>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTYtMi0xLTEtMA_82d1f0b3-3164-4151-9360-947d315b8646"
      unitRef="usd">0</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTYtNC0xLTEtMA_c836d918-c22d-40b1-8f06-9a1cc95cce61"
      unitRef="usd">525000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTgtMi0xLTEtMA_abd5d4f5-4e02-42bf-b545-138c79fe6a24"
      unitRef="usd">20960000</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTgtNC0xLTEtMA_44ba77b6-a4e9-4470-a23b-a51590e84afa"
      unitRef="usd">0</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktMi0xLTEtMTA2NTU_206177c9-497a-431e-a342-873b52e2559a"
      unitRef="usd">142481000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktNC0xLTEtMTA2NjY_39f7f42e-08f8-4ad8-9597-45e6e1d444c8"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktMi0xLTEtMA_b9080c10-c777-4081-b699-c79e96e7aebd"
      unitRef="usd">-4000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMTktNC0xLTEtMA_0d6b1402-9d49-4d60-86c0-ad3667275f5b"
      unitRef="usd">-13000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjEtMi0xLTEtMA_e5fdceb1-90d4-4c06-a24f-68b724887311"
      unitRef="usd">14369000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjEtNC0xLTEtMA_0503eafe-e7bd-4117-bde4-6302ebe47c6a"
      unitRef="usd">3109000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjItMi0xLTEtMA_89da4dbe-5be9-4985-a9fa-27c22901a82a"
      unitRef="usd">-5152000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjItNC0xLTEtMA_0b24e8d7-36e3-45fc-9344-579a03b269c8"
      unitRef="usd">28338000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjMtMi0xLTEtMA_90d769b0-adb6-4eb7-a250-add18b64834a"
      unitRef="usd">6513000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjMtNC0xLTEtMA_2c622d90-a70b-4400-b16e-41095d513379"
      unitRef="usd">1567000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjQtMi0xLTEtMA_2e7a9792-5b73-4f3a-8116-b4a04821068e"
      unitRef="usd">-2306000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjQtNC0xLTEtMA_5a9d438b-c4c9-4c3d-b7e8-13befb85e5e2"
      unitRef="usd">-40134000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjUtMi0xLTEtMA_5ce71ade-c012-48d2-9a57-2d5774636788"
      unitRef="usd">216924000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjUtNC0xLTEtMA_ceb8f7ac-4877-4ee9-894e-52ac72251274"
      unitRef="usd">4534000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjctMi0xLTEtMA_9ba42c28-c28a-45a3-b028-c8a540777f35"
      unitRef="usd">283354000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjctNC0xLTEtMA_4aa94181-07af-4acd-9bd4-4684b1d50a1d"
      unitRef="usd">161488000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjgtMi0xLTEtMA_a0332a59-b5f6-4dcb-b8a4-fcacc518aafa"
      unitRef="usd">177833000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjgtNC0xLTEtMA_a1998351-4a89-44d6-a0c5-93b9c8af6a45"
      unitRef="usd">181345000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjktMi0xLTEtMA_73b74393-dc2c-4bf4-8a61-5e5cf2c686ce"
      unitRef="usd">1299000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMjktNC0xLTEtMA_0398282f-ce94-431d-b2dd-7b857f8f6c36"
      unitRef="usd">805000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzAtMi0xLTEtMA_f57a5357-971e-4290-b082-5dd399f3ca60"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzAtNC0xLTEtMA_3b5d3e78-eca0-4aa6-87a0-56332cdd6e38"
      unitRef="usd">861000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzEtMi0xLTEtMA_23152ac0-d621-43da-a3a6-74560eba881a"
      unitRef="usd">-106820000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzEtNC0xLTEtMA_9b9a276f-c998-4703-aadd-a7fde0ced5d1"
      unitRef="usd">19913000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzQtMi0xLTEtMA_5828cb0a-65c7-4a60-9fed-0484d66bb045"
      unitRef="usd">784875000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzQtNC0xLTEtMA_137176c4-505b-4bfc-bf26-6ab6d4e8a7c8"
      unitRef="usd">0</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzUtMi0xLTEtMA_2f90eb42-52a8-47f3-8585-43dc250f9bd5"
      unitRef="usd">369064000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzUtNC0xLTEtMA_f2194afd-9fd4-49dd-b125-8ce339bfc729"
      unitRef="usd">19560000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzYtMi0xLTEtMA_6b092387-fd68-47e6-8b4d-44db3be06527"
      unitRef="usd">424000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzYtNC0xLTEtMA_69a59ceb-39ec-47f0-a9ce-bef2450b41ac"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzctMi0xLTEtMA_98391745-f5f7-4ff4-9cd5-eca015f4d15a"
      unitRef="usd">189737000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzctNC0xLTEtMA_59e45e08-a1c4-4ec0-9bb9-e751b482d3e2"
      unitRef="usd">109970000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzgtMi0xLTEtMA_e608ff0d-ac1c-4c4a-976e-67cf85896c02"
      unitRef="usd">8226000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzgtNC0xLTEtMA_3e2875fe-144f-42a5-b0bb-7b54d06c0992"
      unitRef="usd">50645000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzktMi0xLTEtMA_9ce36ad5-5dab-49e4-a53b-05bb22a45e5f"
      unitRef="usd">233876000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfMzktNC0xLTEtMA_f90045f5-c9f5-4b36-983e-5ee6da0e5384"
      unitRef="usd">-78885000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDAtMi0xLTEtMA_bbe0be68-7c82-4e9e-94b3-57267b1055e9"
      unitRef="usd">343980000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDAtNC0xLTEtMA_235855c1-dd62-4377-b62e-8bb55a316fdc"
      unitRef="usd">-54438000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDEtMi0xLTEtMA_1500c9d9-f3a7-43b4-a680-a45c93a1cb85"
      unitRef="usd">148203000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic3e89af44e744d99aa39539c76531199_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDEtNC0xLTEtMA_1b59a589-3563-4ef1-8ca1-aa2c0e88a902"
      unitRef="usd">120679000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDItMi0xLTEtMA_5acf65f4-6f6e-46a9-9a17-694510ae3825"
      unitRef="usd">492183000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i25334aa547be4cdaaff347b5deaac86e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDItNC0xLTEtMA_6eb3dafb-cc21-4748-989c-c80a89d38c1d"
      unitRef="usd">66241000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDUtMi0xLTEtMA_0b7fbb48-a8f1-4406-8530-aaf4e03d069b"
      unitRef="usd">102000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDUtNC0xLTEtMA_1c970159-c7e8-4618-aa76-1f875545587e"
      unitRef="usd">531000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDYtMi0xLTEtMA_033abf2a-6ef9-4a11-9944-41e87b240468"
      unitRef="usd">318000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDYtNC0xLTEtMA_d82a9e1d-3fef-4c06-b662-e5bddad1db89"
      unitRef="usd">1661000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <halo:PendingSettlementofCommonStockRepurchase
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDctMi0xLTEtMA_9a7437b6-d05d-4dcb-911c-2f5167afb52d"
      unitRef="usd">0</halo:PendingSettlementofCommonStockRepurchase>
    <halo:PendingSettlementofCommonStockRepurchase
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDctNC0xLTEtMA_b6c6616a-88c7-4cbe-a80e-f63b634cf674"
      unitRef="usd">2502000</halo:PendingSettlementofCommonStockRepurchase>
    <us-gaap:StockIssued1
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDktMi0xLTEtMA_e0780491-dd77-4b4b-aa25-2e8ebbb644e3"
      unitRef="usd">7865000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18yOC9mcmFnOmMzZGU0OGYwYTkyMjRlMWE4ZWFjODRmZDUzYTc2ODMwL3RhYmxlOjliYmNmYTczZDIyZTQxNGM5ZjVlNDA1ZTAwMjk2ODBhL3RhYmxlcmFuZ2U6OWJiY2ZhNzNkMjJlNDE0YzlmNWU0MDVlMDAyOTY4MGFfNDktNC0xLTEtMA_6a5d8e3a-650f-41d6-a114-6d8c484631aa"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:SharesOutstanding
      contextRef="i601d2a7ba1ff42c88d69d679d48bf478_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy0yLTEtMS0w_8d22e979-2bc6-4437-a7ec-493e35a97ca4"
      unitRef="shares">142181000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i601d2a7ba1ff42c88d69d679d48bf478_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy00LTEtMS0w_6b1aa7f4-eb94-45d5-9668-79a8721016c4"
      unitRef="usd">142000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84ac7847378b429f9176338d1e7ce9e7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy02LTEtMS0w_79876008-a5d7-4bb6-a6a3-12005ccb36f4"
      unitRef="usd">461897000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41d331fe41f24e9da00e1cf521cc23db_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy04LTEtMS0w_ca72c780-1dde-46d6-873f-99a191d36834"
      unitRef="usd">-24000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc5f865f951b41669cfe18b259a0d85d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy0xMC0xLTEtMA_fefc5ae6-2ca1-4427-b315-cdb046cad93c"
      unitRef="usd">-342269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idcaf7ea55080433b89ecd6b1dc21f494_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMy0xMi0xLTEtMA_262dd31f-1e7b-4f5e-a9f5-0199dd320c92"
      unitRef="usd">119746000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNS02LTEtMS0w_0417e5a8-f0bb-48b9-9cdd-d90f262c6673"
      unitRef="usd">5399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNS0xMi0xLTEtMA_60f4ff86-afc4-43c4-99b4-4810f190b29e"
      unitRef="usd">5399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy0yLTEtMS0w_44b87e94-4bed-43e2-b3d0-19b896aafe03"
      unitRef="shares">348000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy00LTEtMS0w_e8e5f443-e0ea-4aab-8300-7c8457d4468c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy02LTEtMS0w_060faf57-6749-43e9-a6b4-22ac1da5b029"
      unitRef="usd">4648000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNy0xMi0xLTEtMA_f102e030-69c9-4054-a2b1-315ed82150a1"
      unitRef="usd">4648000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS0yLTEtMS0w_2dc047d7-d518-4bfa-91f1-9fc02931335a"
      unitRef="shares">1563000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i7beabc966f144dc99430154a2577a780_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS00LTEtMS0w_a6b35fbf-eba0-41e6-8464-c50cf44f1184"
      unitRef="usd">1000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i223b32c63244435b9f8d405dfafdd6d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS02LTEtMS0w_813e0d33-5c47-4159-b5d6-f3d446fddc28"
      unitRef="usd">64715000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfOS0xMi0xLTEtMA_3c01111a-fce4-448b-b916-351bb500cfcf"
      unitRef="usd">64716000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i58ed45201faa485fbbc32a6c3f935988_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTAtOC0xLTEtMA_4e715667-a454-41bf-bcf4-1be732b4a89a"
      unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTAtMTItMS0xLTA_e3c4cc05-3f52-4124-bb8a-4fce1f8d85ac"
      unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:NetIncomeLoss
      contextRef="i8a586d0e614542b59729d466bcca9e14_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTEtMTAtMS0xLTA_35d87d4f-a9ed-4d3b-a459-47481636084d"
      unitRef="usd">216587000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTEtMTItMS0xLTA_bb17f729-25ce-4013-8f77-37d240e0eed9"
      unitRef="usd">216587000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItMi0xLTEtMA_82a1f056-ce6f-4cde-8431-f01ed375e9f0"
      unitRef="shares">140966000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItNC0xLTEtMA_780a1f7d-fdb8-458b-8340-6277678b0ff0"
      unitRef="usd">141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d99a9ecd955442dbccf9c897a851078_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItNi0xLTEtMA_e1ffba0a-6780-41be-b662-2f17f496e63d"
      unitRef="usd">407229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i178ae7e383b143a6a97d76a52a288a81_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItOC0xLTEtMA_aafc2a98-8404-434d-bccd-11a00db1ba81"
      unitRef="usd">-14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i38a5fc0a748f43aeb840f079b1667ce7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItMTAtMS0xLTA_2e26d5f8-1ede-437d-95d8-3f0f71246cce"
      unitRef="usd">-125682000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTItMTItMS0xLTA_fb7779d7-5eca-435a-af24-1a90e09847d4"
      unitRef="usd">281674000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i2c0f87e3f3f847cc839debee5868ce40_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctMi0xLTEtMA_d293cad0-18e4-479a-9c62-32a6fd11cdde"
      unitRef="shares">135030000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2c0f87e3f3f847cc839debee5868ce40_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctNC0xLTEtMA_b9b58718-6646-4b76-af24-3b408bb336b6"
      unitRef="usd">135000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c62eaa17c0847168d4711f217c137e9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctNi0xLTEtMA_4c87b924-69b1-4806-ba85-159bc2cc732e"
      unitRef="usd">625483000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib749d4ed30754a3f9c5e7b5a222e9c73_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctOC0xLTEtMA_e9b05205-5649-4d14-b59a-bb8fcfe1b050"
      unitRef="usd">22000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a17be07a5cc4453aeff021e1cc99bc0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctMTAtMS0xLTA_f7f1a77e-5f4b-4712-8ef4-aa141d84ba57"
      unitRef="usd">-474593000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTctMTItMS0xLTA_c7159618-656b-411c-8f9a-ebc8074b5395"
      unitRef="usd">151047000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if05acc0270554a9682fec68a9903a505_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTgtNi0xLTEtMA_5cea64a2-2159-4198-90fd-72763a4b2670"
      unitRef="usd">-65535000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5c4b95062afe4a8880ccae03db28b451_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTgtMTAtMS0xLTA_4408718d-d1e7-4090-b54c-62c908226c58"
      unitRef="usd">12971000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id97983bc9beb4b1ca46661fdb9b34961_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTgtMTItMS0xLTA_cfcd9ddb-d764-4c04-9077-b7e82b835ae9"
      unitRef="usd">-52564000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTktNi0xLTEtMA_eceb9f81-ae15-4353-bd52-1fb3f2771065"
      unitRef="usd">15694000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMTktMTItMS0xLTA_a86aec8b-5021-4d46-bfe5-4fb12a98a088"
      unitRef="usd">15694000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtMi0xLTEtMA_1f75779d-345b-4001-ad47-30a41c7ba569"
      unitRef="shares">9083000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtNC0xLTEtMA_98bf3dd4-5c30-4ddf-a2ef-cc610a08e96d"
      unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtNi0xLTEtMA_d1d11b71-85e0-4813-8532-e304a4f4e0ae"
      unitRef="usd">13095000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjAtMTItMS0xLTA_08b6a2ab-5602-47be-9788-103ec8deff8d"
      unitRef="usd">13104000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtMi0xLTEtMA_0b5300a2-fa4e-48d7-8c9b-b7c4a89eb6b7"
      unitRef="shares">1229000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtNC0xLTEtMA_33152de9-0bc3-4056-ac85-9af2a5a492f0"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtNi0xLTEtMA_9af499b4-87a9-47ae-b20d-28fcd5fdd6f7"
      unitRef="usd">8225000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjEtMTItMS0xLTA_95124ba5-c376-40e3-a5a6-94bcbda652b4"
      unitRef="usd">8226000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtMi0xLTEtMA_e05cc8b3-5eb1-41ff-b3bf-d3a348008f6b"
      unitRef="shares">4376000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2ecd4fcd1518433cbec72607b3d26dc9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtNC0xLTEtMA_bc2d1762-9fa4-4403-a1ce-a383f7a18c52"
      unitRef="usd">4000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2484e9b3056245a78e893187e94a2989_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtNi0xLTEtMA_64ccc9e9-51ee-4f54-add2-16011e53fd00"
      unitRef="usd">189733000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjMtMTItMS0xLTA_a2c28a27-f6cd-4794-8727-3d213c164699"
      unitRef="usd">189737000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i85256e985e1c4b42ac4d454f915a8bd0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjUtOC0xLTEtMA_2c1a49c9-f735-4ff1-a91d-d48adbb12c7e"
      unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjUtMTItMS0xLTA_5ff357fd-d2ff-492f-b006-5b3868b8a6e6"
      unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:NetIncomeLoss
      contextRef="ic293939d2030450296034697f0724379_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjYtMTAtMS0xLTA_1c03cd15-2288-4a20-9003-0ab69f30ea4b"
      unitRef="usd">335940000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjYtMTItMS0xLTA_86c5f6aa-5d1b-4fcd-ba7e-aa3c437d8e12"
      unitRef="usd">335940000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctMi0xLTEtMA_d5e8c685-d3a6-4522-adee-b955a65eb7f7"
      unitRef="shares">140966000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icbfa535e62724f7c90e79d7f774037dc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctNC0xLTEtMA_7d449f2f-05e6-49fe-ad7f-4ce461aba6d9"
      unitRef="usd">141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d99a9ecd955442dbccf9c897a851078_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctNi0xLTEtMA_bb64abd2-d58f-4625-be15-faae3a81d21b"
      unitRef="usd">407229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i178ae7e383b143a6a97d76a52a288a81_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctOC0xLTEtMA_89cd9d7d-86ea-4eb8-8f8c-7fd2fd93facb"
      unitRef="usd">-14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i38a5fc0a748f43aeb840f079b1667ce7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctMTAtMS0xLTA_5379d1bb-f275-4c27-b713-c0870f9cc262"
      unitRef="usd">-125682000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMjctMTItMS0xLTA_d9c70c15-b654-471e-b998-152f00fc0ffd"
      unitRef="usd">281674000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i3c770b432f2e40caa63dcfeac3352f9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItMi0xLTEtMA_f572bbf3-056a-4e97-8c87-3e9a470beaa0"
      unitRef="shares">136671000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3c770b432f2e40caa63dcfeac3352f9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItNC0xLTEtMA_a5b6df7f-fe19-4391-9050-3e201a2f2e31"
      unitRef="usd">137000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c21184904734499ada0aa1912871ae4_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItNi0xLTEtMA_2d9bd590-4f5b-41ed-81fc-cf02344004a2"
      unitRef="usd">688318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i43f3bfde66344aef8be3f0502fdef7c1_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItOC0xLTEtMA_01b49149-f613-45ef-99ce-1944b2d2ba39"
      unitRef="usd">1086000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i227c6dc9e3ae40648df2cfd2ac32bb2c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItMTAtMS0xLTA_15090e58-5db2-492c-891d-afced1f7455d"
      unitRef="usd">-583964000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7273c25133442389646e9ae5c7a0f58_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzItMTItMS0xLTA_a269c871-c178-4d08-b145-17b28c8638b4"
      unitRef="usd">105577000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzQtNi0xLTEtMA_e02a1dcf-3f2e-4b78-ae31-edd58acd9e85"
      unitRef="usd">4220000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzQtMTItMS0xLTA_567cf526-aeaa-49f8-8d0d-505af292671a"
      unitRef="usd">4220000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtMi0xLTEtMA_78e53fbe-0335-4f17-a851-f77f40ff188c"
      unitRef="shares">833000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtNC0xLTEtMA_dde72264-157c-444b-a4f7-fe6c37ce694a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtNi0xLTEtMA_0f78b99a-e647-4f80-a5b3-5ac6afa62357"
      unitRef="usd">12546000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzUtMTItMS0xLTA_38a3ff9e-80c2-470f-80b1-50a40f6293cb"
      unitRef="usd">12546000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzYtMi0xLTEtMA_f436082a-c654-493c-9b44-a1d98110fde1"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzYtMTItMS0xLTA_1520c277-9698-450c-a6a1-c22d83083c7c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctMi0xLTEtMA_22cb31e5-a361-4ed6-8062-47179a6280bf"
      unitRef="shares">2135000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i10b40f33ef264737a92adb2081668d5e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctNC0xLTEtMA_2f16d4ee-1136-44fb-b4df-a1d37b59f65a"
      unitRef="usd">2000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0dc40e942d724fa5b28348c9e795f485_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctNi0xLTEtMA_35b5e49b-bb52-4b60-9929-f17955677abf"
      unitRef="usd">58900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzctMTItMS0xLTA_f417cbbf-b611-45d2-b8ee-29331ce0886a"
      unitRef="usd">58902000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i4d1f54f1a68e4e809dca7deac8cde021_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzktOC0xLTEtMA_806f6d45-f85e-41e6-bd5c-60832bbeb341"
      unitRef="usd">-660000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfMzktMTItMS0xLTA_612427fc-3ef1-42b4-b736-5172722ebd2f"
      unitRef="usd">-660000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:NetIncomeLoss
      contextRef="id00da01d4ee5429da1ab15a67bd8c92b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDAtMTAtMS0xLTA_a22d37e5-1231-4dd0-849d-a6291d9b74f7"
      unitRef="usd">36207000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDAtMTItMS0xLTA_2d7effd2-9782-411e-a6a5-e58421b765a7"
      unitRef="usd">36207000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtMi0xLTEtMA_7076274d-5c42-483d-98ee-ba622d7e9cbc"
      unitRef="shares">135369000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtNC0xLTEtMA_ae77d05b-eece-457a-bb33-539abd195ad4"
      unitRef="usd">135000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ffb579646fc4c0d8197f17b32a7128b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtNi0xLTEtMA_25d94841-cfcb-4210-a2ce-99be272ec44c"
      unitRef="usd">646184000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i871d983ec9934312a36ee3536d265db2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtOC0xLTEtMA_19d70ee3-bcc1-4899-abbf-4c7ae14d171a"
      unitRef="usd">426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie5fea2d63902453fabd27c2ad7ff2cfd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtMTAtMS0xLTA_8180a072-e5f7-4779-a389-3985e2f73b67"
      unitRef="usd">-547757000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25334aa547be4cdaaff347b5deaac86e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDEtMTItMS0xLTA_55a59144-9be6-47b8-8105-68fc99f0fbfe"
      unitRef="usd">98988000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ic35a7e6ef47d488cada6c8e7fba0110d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtMi0xLTEtMA_7826958d-0b91-4c3a-8097-8817ad3da5b6"
      unitRef="shares">136713000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic35a7e6ef47d488cada6c8e7fba0110d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtNC0xLTEtMA_476066cd-91a2-43d7-91a7-035b8f6d375c"
      unitRef="usd">137000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0b526ab8a3cb471bb556ee04a4fd7e83_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtNi0xLTEtMA_87c3af1f-943d-451f-bd00-ab5c2e1728db"
      unitRef="usd">695066000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i95b8bb66e550462093b0b0b019e5c127_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtOC0xLTEtMA_e2930444-a938-487c-982a-71b4bc5007d6"
      unitRef="usd">240000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i622c6a2434bf454db942b487a6b7e00a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtMTAtMS0xLTA_5034030d-10dd-478f-8318-3e2457a4205c"
      unitRef="usd">-603678000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic3e89af44e744d99aa39539c76531199_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDYtMTItMS0xLTA_310d39c4-1507-403f-8e62-0b69f6f6dd62"
      unitRef="usd">91765000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDgtNi0xLTEtMA_a3736daf-d21b-49e4-a8c6-212e1c041406"
      unitRef="usd">13008000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDgtMTItMS0xLTA_c031bcd8-ecac-4b77-bb1b-a4079aec56ce"
      unitRef="usd">13008000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktMi0xLTEtMA_aecf9b1b-5e79-46e0-90c7-920eb30de43c"
      unitRef="shares">4522000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktNC0xLTEtMA_0b65de72-7bf4-4f31-8fcd-666634480015"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktNi0xLTEtMA_a5f75e57-2a8a-4830-a38b-f5f227e1282f"
      unitRef="usd">50641000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNDktMTItMS0xLTA_eaf30528-00ea-4368-8765-e32c4266ab3c"
      unitRef="usd">50645000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTAtMi0xLTEtMA_366e1610-860c-491e-a2a6-e9fcd2d97e65"
      unitRef="shares">61000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTAtMTItMS0xLTA_7efb5a88-fae4-47df-85b2-70f1825358e8"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtMi0xLTEtMA_8ab571fd-93db-406f-a014-4a40ce5c11ce"
      unitRef="shares">5927000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if545c18c55e94c2eb7a9a1785b0c9a8c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtNC0xLTEtMA_ef5f9ee5-c149-4b1a-bcc3-c9402a8a2803"
      unitRef="usd">6000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtNi0xLTEtMA_d32919cb-624f-4478-91ee-c563105f29da"
      unitRef="usd">112466000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTEtMTItMS0xLTA_2d43e5a8-3593-40eb-848f-430f27aa2f95"
      unitRef="usd">112472000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ic7968757fc73441ead621b34c559b52b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTItNi0xLTEtMA_94d3402a-5604-4563-b99c-5434e6976943"
      unitRef="usd">-65000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTItMTItMS0xLTA_0bb0c925-8060-48ce-9847-5452d4bb8b33"
      unitRef="usd">-65000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTItMTItMS0xLTA_5abcce5b-f015-4d37-b387-ed7492e01375"
      unitRef="usd">-65000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i1d81c8e1eb01492f8722125c6a4fb845_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTMtOC0xLTEtMA_7df91a2c-ceab-413b-9b95-d68a5bbe2ce5"
      unitRef="usd">186000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTMtMTItMS0xLTA_f70805cf-903b-488b-aadd-75dd20ac6ebb"
      unitRef="usd">186000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:NetIncomeLoss
      contextRef="i4e79cd5f47bc44cd8c4429cf1b065e7f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTQtMTAtMS0xLTA_c836e7fa-36ec-49f7-932b-8d274c3777c4"
      unitRef="usd">55921000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTQtMTItMS0xLTA_fce09e88-820f-4f30-9316-f134484fc560"
      unitRef="usd">55921000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtMi0xLTEtMA_3860f895-b0a3-43f8-8677-f2c0e2766dd4"
      unitRef="shares">135369000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia72f20c0a5124bed9be4e1b8bb8562a7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtNC0xLTEtMA_ea478462-e593-4be7-8195-8aabff16a653"
      unitRef="usd">135000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ffb579646fc4c0d8197f17b32a7128b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtNi0xLTEtMA_817624d4-aff0-431a-b322-c563e696092d"
      unitRef="usd">646184000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i871d983ec9934312a36ee3536d265db2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtOC0xLTEtMA_58fee55e-99bd-4f19-87f3-a20bdcc60c2b"
      unitRef="usd">426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie5fea2d63902453fabd27c2ad7ff2cfd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtMTAtMS0xLTA_e08927b3-bd16-4822-a917-314dea9de7d0"
      unitRef="usd">-547757000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25334aa547be4cdaaff347b5deaac86e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zMS9mcmFnOjcyZTAwYzZlMzg3YzQwYWI4YzY5Y2RkMWNiYzA5MzNiL3RhYmxlOmRiNGM0NTkxNzkwMzQ5MzE4MDhlOTA0Zjg1YWExYThlL3RhYmxlcmFuZ2U6ZGI0YzQ1OTE3OTAzNDkzMTgwOGU5MDRmODVhYTFhOGVfNTUtMTItMS0xLTA_9133137b-e443-41c0-b5a1-f6c41b56212d"
      unitRef="usd">98988000</us-gaap:StockholdersEquity>
    <us-gaap:NatureOfOperations
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfNDE1NQ_7f1581a7-283d-4c65-b762-c33a303f3328">Organization and Business &lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Halozyme Therapeutics, Inc. is a biopharma technology platform company that provides innovative and disruptive solutions with the goal of improving patient experience and outcomes. Our proprietary enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. We license our technology to biopharmaceutical companies to collaboratively develop products that combine our ENHANZE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; drug delivery&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;technology with the collaborators&#x2019; proprietary compounds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our approved product and our collaborators&#x2019; approved products and product candidates are based on rHuPH20, our patented recombinant human hyaluronidase enzyme. rHuPH20 is the active ingredient in our first commercially approved product, Hylenex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; recombinant, (&#x201c;Hylenex&#x201d;), and it works by breaking down hyaluronan (or &#x201c;HA&#x201d;), a naturally occurring carbohydrate that is a major component of the extracellular matrix in tissues throughout the body such as skin and cartilage. This temporarily increases dispersion and absorption allowing for improved subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other large therapeutic molecules, as well as small molecules and fluids. We refer to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as our ENHANZE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; drug delivery technology (&#x201c;ENHANZE&#x201d;). We license the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. In the development of proprietary intravenous (IV) drugs combined with our ENHANZE technology, data have been generated supporting the potential for ENHANZE to reduce treatment burden, as a result of shorter duration of subcutaneous (SC) administration. ENHANZE may enable fixed-dose SC dosing compared to weight-based dosing required for IV administration, and potentially allow for lower rates of infusion related reactions.&#160;ENHANZE may enable more flexible treatment options such as home administration by a healthcare professional or potentially the patient. Lastly, certain proprietary drugs co-formulated with ENHANZE have been granted additional exclusivity, extending the patent life of the product beyond the one of the proprietary IV drug.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We currently have ENHANZE collaborations with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc. (&#x201c;Roche&#x201d;), Baxalta US Inc. and Baxalta GmbH (members of the Takeda group of companies) (&#x201c;Baxalta&#x201d;), Pfizer Inc. (&#x201c;Pfizer&#x201d;), Janssen Biotech, Inc. (&#x201c;Janssen&#x201d;), AbbVie, Inc. (&#x201c;AbbVie&#x201d;), Eli Lilly and Company (&#x201c;Lilly&#x201d;), Bristol-Myers Squibb Company (&#x201c;BMS&#x201d;), Alexion Pharma Holding (AstraZeneca PLC announced the completion of its acquisition of Alexion Pharmaceuticals, Inc. in July 2021) (&#x201c;Alexion&#x201d;), argenx BVBA (&#x201c;argenx&#x201d;), Horizon Therapeutics plc. (&#x201c;Horizon&#x201d;) and ViiV Healthcare (the global specialist HIV company majority owned by GlaxoSmithKline) (&#x201c;ViiV&#x201d;). We receive royalties from three of these collaborations, including royalties from sales of one product from the Baxalta collaboration, three products from the Roche collaboration and one product from the Janssen collaboration. Future potential revenues from royalties and fees from ENHANZE collaborations and the sales and/or royalties of our approved products will depend on the ability of Halozyme and our collaborators to develop, manufacture, secure and maintain regulatory approvals for approved products and product candidates and commercialize product candidates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except where specifically noted or the context otherwise requires, references to &#x201c;Halozyme,&#x201d; &#x201c;the Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; and &#x201c;us&#x201d; in these notes to the condensed consolidated financial statements refer to Halozyme Therapeutics, Inc. and its wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#x2019;s wholly owned subsidiaries,  Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <halo:RoyaltiesReceivedNumberOfCollaborators
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjA4NA_488133c3-3686-43c1-af87-f5387fbf71bc"
      unitRef="collaborator">3</halo:RoyaltiesReceivedNumberOfCollaborators>
    <halo:RoyaltiesReceivedNumberOfProductsSold
      contextRef="ib333d4f3b723420d812af307ac6e7563_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjA5OQ_b06f35b3-4d57-4aee-aacc-baa3bd29989e"
      unitRef="product">1</halo:RoyaltiesReceivedNumberOfProductsSold>
    <halo:RoyaltiesReceivedNumberOfProductsSold
      contextRef="i6959c5a508d04982a33bfa4c80321de9_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjEwOQ_d18ca442-1bef-4c0a-99b2-dd8d6f802d55"
      unitRef="product">3</halo:RoyaltiesReceivedNumberOfProductsSold>
    <halo:RoyaltiesReceivedNumberOfProductsSold
      contextRef="ie1a53e64a7e34f70b0457b035813cd41_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y18zNy9mcmFnOmVkMjVkYTRiMWZkMDQ0NWM4MzUwNWJmMTE0ZDY5OGU3L3RleHRyZWdpb246ZWQyNWRhNGIxZmQwNDQ1YzgzNTA1YmYxMTRkNjk4ZTdfMTY0OTI2NzQ0NjEyMQ_cc90d9cb-559a-4608-ba2e-36a5c2d0533b"
      unitRef="product">1</halo:RoyaltiesReceivedNumberOfProductsSold>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMjc_cfc8da7f-8b1e-4708-b655-809bc048b79c">Summary of Significant Accounting Policies&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) related to a quarterly report on Form 10-Q. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for a complete set of financial statements. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;23, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operations for the periods presented, with such adjustments consisting only of normal recurring adjustments. Operating results for interim periods are not necessarily indicative of the operating results for an entire fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim unaudited condensed consolidated financial statements include the accounts of Halozyme Therapeutics, Inc. and our wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#x2019;s wholly owned subsidiaries, Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH. All intercompany accounts and transactions have been eliminated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of interim unaudited condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect the amounts reported in our interim unaudited condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents and Marketable Securities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of highly liquid investments, readily convertible to cash, that mature within ninety days or less from the date of purchase. As of September&#160;30, 2021, our cash equivalents consisted of money market funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities are investments with original maturities of more than ninety days from the date of purchase that are specifically identified to fund current operations. Marketable securities are considered available-for-sale. These investments are classified as current assets, even though the stated maturity date may be one year or more beyond the current balance sheet date which reflects management&#x2019;s intention to use the proceeds from the sale of these investments to fund our operations, as necessary. Such available-for-sale investments are carried at fair value with unrealized gains and losses recorded in other comprehensive income (loss) and included as a separate component of stockholders&#x2019; equity. The cost of marketable securities is adjusted for amortization of premiums or accretion of discounts to maturity, and such amortization or accretion is included in investment and other income, net in the interim unaudited condensed consolidated statements of operations. We use the specific identification method for calculating realized gains and losses on marketable securities sold. None of the realized gains and losses and declines in value judged to be as a result of credit loss on marketable securities, if any, are included in investment and other income, net in the interim unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the leases of our facilities, we are required to maintain letters of credit as security deposits during the terms of such leases. At September&#160;30, 2021 and December&#160;31, 2020, restricted cash of $0.5 million was pledged as collateral for the letters of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments include cash equivalents, available-for-sale marketable securities, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses and long-term debt. Fair value estimates of these instruments are made at a specific point in time, based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued expenses are generally considered to be representative of their respective fair values because of the short-term nature of those instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale marketable securities consist of asset-backed securities, corporate debt securities, U.S. Treasury securities and commercial paper, and are measured at fair value using Level 1 and Level 2 inputs. Level 2 financial instruments are valued using market prices on less active markets and proprietary pricing valuation models with observable inputs, including interest rates, yield curves, maturity dates, issue dates, settlement dates, reported trades, broker-dealer quotes, issue spreads, benchmark securities or other market related data. We obtain the fair value of Level 2 investments from our investment manager, who obtains these fair values from a third-party pricing source. We validate the fair values of Level 2 financial instruments provided by our investment manager by comparing these fair values to a third-party pricing source.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventories are reviewed periodically for potential excess, dated or obsolete status. We evaluate the carrying value of inventories on a regular basis, taking into account such factors as historical and anticipated future sales compared to quantities on hand, the price we expect to obtain for products in their respective markets compared with historical cost and the remaining shelf life of goods on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, and December&#160;31, 2020, inventories consisted of $1.6 million and $1.3 million, respectively, of Hylenex inventory, net and $54.4 million and $59.4 million, respectively, of bulk rHuPH20. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has entered into operating leases primarily for real estate and automobiles. These leases have terms which range from 3 years to 6 years. We determine if an arrangement contains a lease at inception. Right of use (&#x201c;ROU&#x201d;) assets and liabilities resulting from operating leases are included in property and equipment, accrued expenses and other long-term liabilities on our condensed consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the discount rate to calculate the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our leases often include options to extend or terminate the lease. These options are included in the lease term when it is reasonably certain that we will exercise that option. Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as automobiles, we account for the lease and non-lease components as a single lease component. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenues from payments received under collaborative agreements and product sales. We recognize revenue when we transfer promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers we perform the following five steps: (i) identify the promised goods or services in the contract; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy the performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenues under Collaborative Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under these agreements, we grant the collaboration partner a worldwide license to develop and commercialize products using our ENHANZE technology to combine our patented rHuPH20 enzyme with their proprietary biologics directed at up to a specified number of targets. Targets are usually licensed on an exclusive, global basis. Targets selected subsequent to inception of the arrangement require payment of an additional license fee. The collaboration partner is responsible for all development, manufacturing, clinical, regulatory, sales and marketing costs for any products developed under the agreement. We are responsible for supply of bulk rHuPH20 based on the collaboration partner&#x2019;s purchase orders and may also be separately engaged to perform research and development services. While these collaboration agreements are similar in that they originate from the same framework, each one is the result of an arms-length negotiation and thus may vary from one to the other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We collect an upfront license payment from collaboration partners and are also entitled to receive event-based payments subject to collaboration partners&#x2019; achievement of specified development, regulatory and sales-based milestones. In several agreements, collaboration partners pay us annual fees to maintain their exclusive license rights if they are unable to advance product development to specified stages. We earn separate fees for bulk rHuPH20 supplies and research and development services. In addition, collaboration partners will pay us royalties at an on average mid-single digit percent rate of their sales if products under the collaboration are commercialized. All amounts owed to us are noncancelable after the underlying triggering event occurs, and nonrefundable once paid. Unless terminated earlier in accordance with its terms, collaborations generally continue in effect until the last to expire royalty payment term, as determined on a product by product and on a country by country basis, with each royalty term starting on the first commercial sale of that product and ending the later of: (i) a specified period or term set forth in the agreement or (ii) expiration of the last to expire of the valid claims of our patents covering rHuPH20 or other specified patents developed under the collaboration which valid claim covers a product developed under the collaboration. When there are no valid claims during the applicable royalty term in a given country, the royalty rate is reduced for those sales. Collaboration partners may terminate the agreement prior to expiration for any reason in its entirety or on a target-by-target basis generally upon 90 days prior written notice to us.&#160;Upon any such termination, the license granted to collaboration partners (in total or with respect to the terminated target, as applicable) will terminate provided, however, that in the event of expiration of the agreement (as opposed to a termination), the on-going licenses granted will become perpetual, non-exclusive and fully paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although these agreements are in form identified as collaborative agreements, we concluded for accounting purposes they represent contracts with customers and are not subject to accounting literature on collaborative arrangements. This is because we grant to collaboration partners licenses to our intellectual property and provide supply of bulk rHuPH20 and research and development services which are all outputs of our ongoing activities, in exchange for consideration. Under these collaborative agreements, we do not develop assets jointly with collaboration partners, and do not share in significant risks of their development or commercialization activities. Accordingly, we concluded our collaborative agreements are appropriately accounted for pursuant to ASC Topic 606, Revenue from Contracts with Customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under all of our collaborative agreements, we have identified licenses to use functional intellectual property as the only performance obligation. The intellectual property underlying the license is our proprietary ENHANZE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;technology which represents application of rHuPH20 to facilitate delivery of drugs or fluids. Each of the licenses grants the collaboration partners rights to use our intellectual property as it exists and is identified on the effective date of the license, because there is no ongoing development of the ENHANZE technology required. Therefore, we recognize revenue from licenses at the point when the license becomes effective and the collaboration partner has received access to our intellectual property, usually at the inception of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When collaboration partners can select additional targets to add to the licenses granted, we consider these rights to be options. We evaluate whether such options contain material rights, i.e. have exercise prices that are discounted compared to what we would charge for a similar license to a new collaboration partner. The exercise price of these options includes a combination of the target selection fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, we conclude the option does not contain a material &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;right, and we consider grants of additional licensing rights upon option exercises to be separate contracts (target selection contracts).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide customary indemnification and protection of licensed intellectual property for our customers. These provisions are part of assurance that the licenses meet the agreements&#x2019; representations and are not obligations to provide goods or services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also fulfill purchase orders for supply of bulk rHuPH20 and perform research and development services pursuant to projects authorization forms for our collaboration partners, which represent separate contracts. Additionally, we price our supply of bulk rHuPH20 and research and development services at our regular selling prices, called standalone selling price or &#x201c;SSP&#x201d;. Therefore, our collaboration partners do not have material rights to order these items at prices not reflective of SSP. Refer to the discussion below regarding recognition of revenue for these separate contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price for a contract represents the amount to which we are entitled in exchange for providing goods and services to the customer. Transaction price does not include amounts subject to uncertainties unless it is probable that there will be no significant reversal of revenue when the uncertainty is resolved. Apart from the upfront license payment (or target selection fees in the target selection contracts), all other fees we may earn under our collaborative agreements are subject to significant uncertainties of product development. Achievement of many of the event-based development and regulatory milestones may not be probable until such milestones are actually achieved. This generally relates to milestones such as obtaining marketing authorization approvals. With respect to other development milestones, e.g. dosing of a first patient in a clinical trial, achievement could be considered probable prior to its actual occurrence, based on the progress towards commencement of the trial. In order to evaluate progress towards commencement of a trial, we assess the status of activities leading up to our collaboration partner&#x2019;s initiation of a trial such as feedback received from the  applicable regulatory authorities, completion of IND or equivalent filings, readiness and availability of drug, readiness of study sites and our collaboration partner&#x2019;s commitment of resources to the program. We do not include any amounts subject to uncertainties into the transaction price until it is probable that the amount will not result in a significant reversal of revenue in the future. At the end of each reporting period, we re-evaluate the probability of achievement of such milestones and any related constraint, and if necessary, adjust our estimate of the overall transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When target exchange rights are held by collaboration partners, and the amounts attributed to these rights are not refundable, they are included in the transaction price. However, they are recorded as deferred revenues because we have a potential performance obligation to provide a new target upon an exchange right being exercised. These amounts are recognized in revenue when the right of exchange expires or is exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because our agreements have one type of performance obligation (licenses) which are typically all transferred at the same time at agreement inception, allocation of transaction price often is not required. However, allocation is required when licenses for some of the individual targets are subject to rights of exchange, because revenue associated with these targets cannot be recognized. We perform an allocation of the upfront amount based on relative SSP of licenses for individual targets. We determine license SSP using income-based valuation approach utilizing risk-adjusted discounted cash flow projections of the estimated return a licensor would receive. When amounts subject to uncertainties, such as milestones and royalties, are included in the transaction price, we attribute them to the specific individual target licenses which generate such milestone or royalty amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also estimate SSP of bulk rHuPH20 and research and development services, to determine that our collaboration partners do not have material rights to order them at discounted prices. For supplies of bulk rHuPH20, because we effectively act as a contract manufacturer to our collaboration partners, we estimate and charge SSP based on the typical contract manufacturer margins consistently with all of our collaborative partners. We determine SSP of research and development services based on a fully-burdened labor rate. Our rates are comparable to those we observe in other collaborative agreements. We also have a history of charging similar rates to all of our collaboration partners. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upfront amounts allocated to licenses to individual targets are recognized as revenue when the license is transferred to the collaboration partner, as discussed above, if the license is not subject to exchange rights, or when the exchange right expires or is exercised. Development milestones and other fees are recognized in revenue when they are included in the transaction price, because by that time we have already transferred the related license to the collaboration partner. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales-based milestones and royalties cannot be recognized until the underlying sales occur. We do not receive final royalty reports from our collaboration partners until after we complete our financial statements for a prior quarter. Therefore, we recognize revenue based on estimates of the royalty earned, which are based on internal estimates and available preliminary reports provided by our collaboration partners. We will record a true-up in the following quarter if necessary, when final royalty reports are received. To date, we have not recorded any material true-ups. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In contracts to provide research and development services, such services represent the only performance obligation. The fees are charged based on hours worked by our employees and the fixed contractual rate per hour, plus third-party pass-through costs, on a monthly basis. We recognize revenues as the related services are performed based on the amounts billed, as the collaboration partner consumes the benefit of research and development work simultaneously as we perform these services, and the amounts billed reflect the value of these services to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion on our collaborative arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Sales,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Hylenex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recombinant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell Hylenex recombinant in the U.S. to wholesale pharmaceutical distributors, who sell the product to hospitals and other end-user customers. Sales to wholesalers are made pursuant to purchase orders subject to the terms of a master agreement, and delivery of individual packages of Hylenex recombinant represent performance obligations under each purchase order. We use a contract manufacturer to produce Hylenex recombinant and a third-party logistics (3PL) vendor to process and fulfill orders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We concluded we are the principal in the sales to wholesalers because we control access to services rendered by both vendors and direct their activities. We have no significant obligations to wholesalers to generate pull-through sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling prices initially billed to wholesalers are subject to discounts for prompt payment and subsequent chargebacks when wholesalers sell Hylenex recombinant at negotiated discounted prices to members of certain group purchasing organizations (&#x201c;GPOs&#x201d;) and government programs. We also pay quarterly distribution fees to certain wholesalers for inventory reporting and chargeback processing, and to GPOs as administrative fees for services and for access to GPO members. We concluded the benefits received in exchange for these fees are not distinct from our sales of Hylenex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recombinant, and accordingly we apply these amounts to reduce revenues. Wholesalers also have rights to return unsold product nearing or past the expiration date. Because of the shelf life of Hylenex recombinant and our lengthy return period, there may be a significant period of time between when the product is shipped and when we issue credits on returned product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the transaction price when we receive each purchase order taking into account the expected reductions of the selling price initially billed to the wholesaler arising from all of the above factors. We have compiled historical experience and data to estimate future returns and chargebacks of Hylenex recombinant and the impact of the other discounts and fees we pay. When estimating these adjustments to the transaction price, we reduce it sufficiently to be able to assert that it is probable that there will be no significant reversal of revenue when the ultimate adjustment amounts are known.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each purchase order contains only one type of product, and is usually shipped to the wholesaler in a single shipment. Therefore, allocation of the transaction price to individual packages is not required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from Hylenex recombinant product sales and related cost of sales upon product delivery to the wholesaler location. At that time, the wholesalers take control of the product as they take title, bear the risk of loss of ownership, and have an enforceable obligation to pay us. They also have the ability to direct sales of product to their customers on terms and at prices they negotiate. Although wholesalers have product return rights, we do not believe they have a significant incentive to return the product to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon recognition of revenue from product sales of Hylenex recombinant, the estimated amounts of credit for product returns, chargebacks, distribution fees, prompt payment discounts, and GPO fees are included in sales reserves, accrued liabilities and net of accounts receivable. We monitor actual product returns, chargebacks, discounts and fees subsequent to the sale. If these amounts differ from our estimates, we make adjustments to these allowances, which are applied to increase or reduce product sales revenue and earnings in the period of adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the orders placed by wholesalers, we incur costs such as commissions to our sales representatives. However, as revenue from product sales is recognized upon delivery to the wholesaler, which occurs shortly after we receive a purchase order, we do not capitalize these commissions and other costs, based on application of the practical expedient allowed within the applicable guidance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Bulk rHuPH20&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell bulk rHuPH20 to collaboration partners for use in research and development; subsequent to receiving marketing approval, we sell it for use in collaboration commercial products. Sales are made pursuant to purchase orders subject to the terms of the collaborative agreement, and delivery of units of bulk rHuPH20 represent performance obligations under each purchase order. We provide a standard warranty that the product conforms to specifications. We use contract manufacturers to produce bulk rHuPH20 and have concluded we are the principal in the sales to collaboration partners. The transaction price for each purchase order of bulk rHuPH20 is fixed based on the cost of production plus a contractual markup, and is not subject to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;adjustments. Allocation of the transaction price to individual quantities of the product is usually not required because each order contains only one type of product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from the sale of bulk rHuPH20 as product sales and related cost of sales upon transfer of title to our partners. At that time, the partners take control of the product, bear the risk of loss of ownership, and have an enforceable obligation to pay us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In our statements of operations, we report as revenues under collaborative agreements the upfront payments, event-based development and regulatory milestones and sales milestones. We also include in this category revenues from separate research and development contracts pursuant to project authorization forms. We report royalties received from collaboration partners as a separate line in our statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales of Hylenex recombinant, bulk rHuPH20 that has alternative future use and ENHANZE drug product are included in product sales, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the footnotes to our condensed consolidated financial statements, we provide disaggregated revenue information by type of arrangement (product sales, net, collaborative agreements and research and development services), and additionally, by type of payment stream received under collaborative agreements (upfront license fees, event-based development and regulatory milestones and other fees, sales milestones and royalties).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of product sales consists primarily of raw materials, third-party manufacturing costs, fill and finish costs, freight costs, internal costs and manufacturing overhead associated with the production of Hylenex recombinant and bulk rHuPH20 and ENHANZE drug product. Cost of product sales also consists of the write-down of excess, dated and obsolete inventories and the write-off of inventories that do not meet certain product specifications, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expenses include salaries and benefits, facilities and other overhead expenses, research related manufacturing services, contract services and other outside expenses. Research and development expenses are charged to operating expenses as incurred when these expenditures relate to our research and development efforts and have no alternative future uses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are obligated to make upfront payments upon execution of certain research and development agreements. Advance payments, including nonrefundable amounts, for goods or services that will be used or rendered for future research and development activities are deferred. Such amounts are recognized as expense as the related goods are delivered or the related services are performed or such time when we do not expect the goods to be delivered or services to be performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record compensation expense associated with stock options, restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;), performance stock units (&#x201c;PSUs&#x201d;) and shares issued under our employee stock purchase plan (&#x201c;ESPP&#x201d;) in accordance with the authoritative guidance for stock-based compensation. The cost of employee services received in exchange for an award of an equity instrument is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense on a straight-line basis over the requisite service period of the award. Share-based compensation expense for an award with a performance condition is recognized when the achievement of such performance condition is determined to be probable. If the outcome of such performance condition is not determined to be probable or is not met, no compensation expense is recognized and any previously recognized compensation expense is reversed. Forfeitures are recognized as a reduction of share-based compensation expense as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for income taxes using the liability method. Under this method, deferred income tax assets and liabilities are determined based on the differences between the financial statement carrying amounts of existing assets and liabilities at each year end and their respective tax bases and are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant judgment is required by management to determine our provision for income taxes, our deferred tax assets and liabilities, and the valuation allowance to record against our net deferred tax assets, which are based on complex and evolving tax regulations throughout the world. Deferred tax assets (&#x201c;DTA&#x201d;) and other tax benefits are recorded when they are more likely than not to be realized. We maintain a full valuation allowance on our DTAs until there is sufficient evidence to support the reversal of all or some portion of these allowances. On a periodic basis, we reassess the valuation allowance of our DTAs, weighing all positive and negative evidence, to assess if it is more-likely-than-not that some or all of our DTAs will be realized. As of the third quarter of 2021, we have demonstrated profitability and cumulative pretax income and are forecasting income growth. After assessing both the positive and negative evidence, we determined that it was more likely than not that our DTAs would be realized and released the valuation allowance related to federal and state DTAs as of September 30, 2021, resulting in a benefit from income taxes of $142.5&#160;million. We estimated that our annual effective income tax rate to be (57.63)% for 2021 compared to the 0.17% effective income tax rate for 2020. The primary difference relates to the release of our valuation allowance. We will continue to evaluate the need for valuation allowances for our DTAs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate our business in one segment, which includes all activities related to the research, development and commercialization of our proprietary enzymes. This segment also includes revenues and expenses related to (i)&#160;research and development and bulk rHuPH20 manufacturing activities conducted under our collaborative agreements with third parties and (ii)&#160;product sales of Hylenex recombinant. The chief operating decision-maker reviews the operating results on an aggregate basis and manages the operations as a single operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adoption and Pending Adoption of Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial &lt;br/&gt;Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2022&lt;br/&gt;(Early adoption permitted effective January 1, 2021)&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis, which resulted in an approximately $65.5 million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $52.6 million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $13.0 million decrease to the opening balance of accumulated deficit, representing the cumulative non-cash interest expense recognized related to the amortization of the bifurcated conversion option related to the 2024 Convertible Notes. We  derecognized the related deferred tax liabilities of $11.8 million with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. As we committed to settle the principal amount of the convertible notes in cash upon conversion, shares used for diluted EPS will continue to be limited to the excess conversion value over the principal amount of the convertible note. Diluted earnings per share is also impacted due to the elimination of non-cash interest expense associated with the amortization of the equity component.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMDg_ec34aa16-3d0b-405b-a9ba-bc2b34735731">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) related to a quarterly report on Form 10-Q. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for a complete set of financial statements. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;23, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operations for the periods presented, with such adjustments consisting only of normal recurring adjustments. Operating results for interim periods are not necessarily indicative of the operating results for an entire fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyNTc_f934961a-93bf-45a6-a637-f658ca1f62b0">The accompanying interim unaudited condensed consolidated financial statements include the accounts of Halozyme Therapeutics, Inc. and our wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#x2019;s wholly owned subsidiaries, Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH. All intercompany accounts and transactions have been eliminated.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxNDU_9bb41b22-af2a-4186-a20a-dd543d1db52c">Use of EstimatesThe preparation of interim unaudited condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect the amounts reported in our interim unaudited condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#x2019;s estimates</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMjk_8a2f55ca-53c5-4470-aedf-63b046474923">&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents and Marketable Securities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist of highly liquid investments, readily convertible to cash, that mature within ninety days or less from the date of purchase. As of September&#160;30, 2021, our cash equivalents consisted of money market funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities are investments with original maturities of more than ninety days from the date of purchase that are specifically identified to fund current operations. Marketable securities are considered available-for-sale. These investments are classified as current assets, even though the stated maturity date may be one year or more beyond the current balance sheet date which reflects management&#x2019;s intention to use the proceeds from the sale of these investments to fund our operations, as necessary. Such available-for-sale investments are carried at fair value with unrealized gains and losses recorded in other comprehensive income (loss) and included as a separate component of stockholders&#x2019; equity. The cost of marketable securities is adjusted for amortization of premiums or accretion of discounts to maturity, and such amortization or accretion is included in investment and other income, net in the interim unaudited condensed consolidated statements of operations. We use the specific identification method for calculating realized gains and losses on marketable securities sold. None of the realized gains and losses and declines in value judged to be as a result of credit loss on marketable securities, if any, are included in investment and other income, net in the interim unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the leases of our facilities, we are required to maintain letters of credit as security deposits during the terms of such leases. At September&#160;30, 2021 and December&#160;31, 2020, restricted cash of $0.5 million was pledged as collateral for the letters of credit.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNDE2Mg_09fc46c4-a851-4641-9407-8928644dbdc5"
      unitRef="usd">500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNDE2Mg_efe25ab4-f4cb-4c2d-92c7-e01538a007d5"
      unitRef="usd">500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxOTU_29e6d960-72bf-4252-844a-c99b58a0c7d8">&lt;div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments include cash equivalents, available-for-sale marketable securities, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses and long-term debt. Fair value estimates of these instruments are made at a specific point in time, based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued expenses are generally considered to be representative of their respective fair values because of the short-term nature of those instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale marketable securities consist of asset-backed securities, corporate debt securities, U.S. Treasury securities and commercial paper, and are measured at fair value using Level 1 and Level 2 inputs. Level 2 financial instruments are valued using market prices on less active markets and proprietary pricing valuation models with observable inputs, including interest rates, yield curves, maturity dates, issue dates, settlement dates, reported trades, broker-dealer quotes, issue spreads, benchmark securities or other market related data. We obtain the fair value of Level 2 investments from our investment manager, who obtains these fair values from a third-party pricing source. We validate the fair values of Level 2 financial instruments provided by our investment manager by comparing these fair values to a third-party pricing source.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxODY_79bd85e6-d799-46fb-b1f3-2c72c082d361">&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventories are reviewed periodically for potential excess, dated or obsolete status. We evaluate the carrying value of inventories on a regular basis, taking into account such factors as historical and anticipated future sales compared to quantities on hand, the price we expect to obtain for products in their respective markets compared with historical cost and the remaining shelf life of goods on hand.&lt;/span&gt;&lt;/div&gt;As of September&#160;30, 2021, and December&#160;31, 2020, inventories consisted of $1.6 million and $1.3 million, respectively, of Hylenex inventory, net and $54.4 million and $59.4 million, respectively, of bulk rHuPH20.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="i9f30dd7e598c4150bb7ab34c0c700764_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzEzOQ_7bfaa1b3-d4e0-4c05-aeef-c1d3c8970517"
      unitRef="usd">1600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i3d7143f1a70f40f4865183995dcdf3c1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzE0Ng_d4acac11-e5ee-4ba7-b42f-4c3bff2905ca"
      unitRef="usd">1300000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i89efb2eece474b1c9fa2252f912eb2e2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzE5NA_cd4085ba-80df-4db4-9213-061e32a75912"
      unitRef="usd">54400000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if2bf701fe610422f904860a03167563a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzIwMQ_347e1b2c-a8f0-45c6-a202-716966ab4ada"
      unitRef="usd">59400000</us-gaap:InventoryNet>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyNTA_7e7c6e1a-e9e0-4308-9de3-8323184eaf95">&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has entered into operating leases primarily for real estate and automobiles. These leases have terms which range from 3 years to 6 years. We determine if an arrangement contains a lease at inception. Right of use (&#x201c;ROU&#x201d;) assets and liabilities resulting from operating leases are included in property and equipment, accrued expenses and other long-term liabilities on our condensed consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the discount rate to calculate the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our leases often include options to extend or terminate the lease. These options are included in the lease term when it is reasonably certain that we will exercise that option. Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as automobiles, we account for the lease and non-lease components as a single lease component.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i0bc3fbc4a9c34766bee79a37bf2c3e23_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzQ1Mg_a9ba574f-2a38-4936-ba91-f6f05d5723c5">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i5e231d70787f44a4b04e7ad9caf076a0_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfNzQ1OA_dff0314a-ffc0-45df-94b7-cd4662019bbd">P6Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxMjc_ea1c4279-ade5-4946-ad07-743ec618f8b6">&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenues from payments received under collaborative agreements and product sales. We recognize revenue when we transfer promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers we perform the following five steps: (i) identify the promised goods or services in the contract; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy the performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenues under Collaborative Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under these agreements, we grant the collaboration partner a worldwide license to develop and commercialize products using our ENHANZE technology to combine our patented rHuPH20 enzyme with their proprietary biologics directed at up to a specified number of targets. Targets are usually licensed on an exclusive, global basis. Targets selected subsequent to inception of the arrangement require payment of an additional license fee. The collaboration partner is responsible for all development, manufacturing, clinical, regulatory, sales and marketing costs for any products developed under the agreement. We are responsible for supply of bulk rHuPH20 based on the collaboration partner&#x2019;s purchase orders and may also be separately engaged to perform research and development services. While these collaboration agreements are similar in that they originate from the same framework, each one is the result of an arms-length negotiation and thus may vary from one to the other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We collect an upfront license payment from collaboration partners and are also entitled to receive event-based payments subject to collaboration partners&#x2019; achievement of specified development, regulatory and sales-based milestones. In several agreements, collaboration partners pay us annual fees to maintain their exclusive license rights if they are unable to advance product development to specified stages. We earn separate fees for bulk rHuPH20 supplies and research and development services. In addition, collaboration partners will pay us royalties at an on average mid-single digit percent rate of their sales if products under the collaboration are commercialized. All amounts owed to us are noncancelable after the underlying triggering event occurs, and nonrefundable once paid. Unless terminated earlier in accordance with its terms, collaborations generally continue in effect until the last to expire royalty payment term, as determined on a product by product and on a country by country basis, with each royalty term starting on the first commercial sale of that product and ending the later of: (i) a specified period or term set forth in the agreement or (ii) expiration of the last to expire of the valid claims of our patents covering rHuPH20 or other specified patents developed under the collaboration which valid claim covers a product developed under the collaboration. When there are no valid claims during the applicable royalty term in a given country, the royalty rate is reduced for those sales. Collaboration partners may terminate the agreement prior to expiration for any reason in its entirety or on a target-by-target basis generally upon 90 days prior written notice to us.&#160;Upon any such termination, the license granted to collaboration partners (in total or with respect to the terminated target, as applicable) will terminate provided, however, that in the event of expiration of the agreement (as opposed to a termination), the on-going licenses granted will become perpetual, non-exclusive and fully paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although these agreements are in form identified as collaborative agreements, we concluded for accounting purposes they represent contracts with customers and are not subject to accounting literature on collaborative arrangements. This is because we grant to collaboration partners licenses to our intellectual property and provide supply of bulk rHuPH20 and research and development services which are all outputs of our ongoing activities, in exchange for consideration. Under these collaborative agreements, we do not develop assets jointly with collaboration partners, and do not share in significant risks of their development or commercialization activities. Accordingly, we concluded our collaborative agreements are appropriately accounted for pursuant to ASC Topic 606, Revenue from Contracts with Customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under all of our collaborative agreements, we have identified licenses to use functional intellectual property as the only performance obligation. The intellectual property underlying the license is our proprietary ENHANZE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;technology which represents application of rHuPH20 to facilitate delivery of drugs or fluids. Each of the licenses grants the collaboration partners rights to use our intellectual property as it exists and is identified on the effective date of the license, because there is no ongoing development of the ENHANZE technology required. Therefore, we recognize revenue from licenses at the point when the license becomes effective and the collaboration partner has received access to our intellectual property, usually at the inception of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When collaboration partners can select additional targets to add to the licenses granted, we consider these rights to be options. We evaluate whether such options contain material rights, i.e. have exercise prices that are discounted compared to what we would charge for a similar license to a new collaboration partner. The exercise price of these options includes a combination of the target selection fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, we conclude the option does not contain a material &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;right, and we consider grants of additional licensing rights upon option exercises to be separate contracts (target selection contracts).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide customary indemnification and protection of licensed intellectual property for our customers. These provisions are part of assurance that the licenses meet the agreements&#x2019; representations and are not obligations to provide goods or services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also fulfill purchase orders for supply of bulk rHuPH20 and perform research and development services pursuant to projects authorization forms for our collaboration partners, which represent separate contracts. Additionally, we price our supply of bulk rHuPH20 and research and development services at our regular selling prices, called standalone selling price or &#x201c;SSP&#x201d;. Therefore, our collaboration partners do not have material rights to order these items at prices not reflective of SSP. Refer to the discussion below regarding recognition of revenue for these separate contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price for a contract represents the amount to which we are entitled in exchange for providing goods and services to the customer. Transaction price does not include amounts subject to uncertainties unless it is probable that there will be no significant reversal of revenue when the uncertainty is resolved. Apart from the upfront license payment (or target selection fees in the target selection contracts), all other fees we may earn under our collaborative agreements are subject to significant uncertainties of product development. Achievement of many of the event-based development and regulatory milestones may not be probable until such milestones are actually achieved. This generally relates to milestones such as obtaining marketing authorization approvals. With respect to other development milestones, e.g. dosing of a first patient in a clinical trial, achievement could be considered probable prior to its actual occurrence, based on the progress towards commencement of the trial. In order to evaluate progress towards commencement of a trial, we assess the status of activities leading up to our collaboration partner&#x2019;s initiation of a trial such as feedback received from the  applicable regulatory authorities, completion of IND or equivalent filings, readiness and availability of drug, readiness of study sites and our collaboration partner&#x2019;s commitment of resources to the program. We do not include any amounts subject to uncertainties into the transaction price until it is probable that the amount will not result in a significant reversal of revenue in the future. At the end of each reporting period, we re-evaluate the probability of achievement of such milestones and any related constraint, and if necessary, adjust our estimate of the overall transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When target exchange rights are held by collaboration partners, and the amounts attributed to these rights are not refundable, they are included in the transaction price. However, they are recorded as deferred revenues because we have a potential performance obligation to provide a new target upon an exchange right being exercised. These amounts are recognized in revenue when the right of exchange expires or is exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because our agreements have one type of performance obligation (licenses) which are typically all transferred at the same time at agreement inception, allocation of transaction price often is not required. However, allocation is required when licenses for some of the individual targets are subject to rights of exchange, because revenue associated with these targets cannot be recognized. We perform an allocation of the upfront amount based on relative SSP of licenses for individual targets. We determine license SSP using income-based valuation approach utilizing risk-adjusted discounted cash flow projections of the estimated return a licensor would receive. When amounts subject to uncertainties, such as milestones and royalties, are included in the transaction price, we attribute them to the specific individual target licenses which generate such milestone or royalty amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also estimate SSP of bulk rHuPH20 and research and development services, to determine that our collaboration partners do not have material rights to order them at discounted prices. For supplies of bulk rHuPH20, because we effectively act as a contract manufacturer to our collaboration partners, we estimate and charge SSP based on the typical contract manufacturer margins consistently with all of our collaborative partners. We determine SSP of research and development services based on a fully-burdened labor rate. Our rates are comparable to those we observe in other collaborative agreements. We also have a history of charging similar rates to all of our collaboration partners. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upfront amounts allocated to licenses to individual targets are recognized as revenue when the license is transferred to the collaboration partner, as discussed above, if the license is not subject to exchange rights, or when the exchange right expires or is exercised. Development milestones and other fees are recognized in revenue when they are included in the transaction price, because by that time we have already transferred the related license to the collaboration partner. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales-based milestones and royalties cannot be recognized until the underlying sales occur. We do not receive final royalty reports from our collaboration partners until after we complete our financial statements for a prior quarter. Therefore, we recognize revenue based on estimates of the royalty earned, which are based on internal estimates and available preliminary reports provided by our collaboration partners. We will record a true-up in the following quarter if necessary, when final royalty reports are received. To date, we have not recorded any material true-ups. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In contracts to provide research and development services, such services represent the only performance obligation. The fees are charged based on hours worked by our employees and the fixed contractual rate per hour, plus third-party pass-through costs, on a monthly basis. We recognize revenues as the related services are performed based on the amounts billed, as the collaboration partner consumes the benefit of research and development work simultaneously as we perform these services, and the amounts billed reflect the value of these services to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further discussion on our collaborative arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Sales,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Hylenex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recombinant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell Hylenex recombinant in the U.S. to wholesale pharmaceutical distributors, who sell the product to hospitals and other end-user customers. Sales to wholesalers are made pursuant to purchase orders subject to the terms of a master agreement, and delivery of individual packages of Hylenex recombinant represent performance obligations under each purchase order. We use a contract manufacturer to produce Hylenex recombinant and a third-party logistics (3PL) vendor to process and fulfill orders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We concluded we are the principal in the sales to wholesalers because we control access to services rendered by both vendors and direct their activities. We have no significant obligations to wholesalers to generate pull-through sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling prices initially billed to wholesalers are subject to discounts for prompt payment and subsequent chargebacks when wholesalers sell Hylenex recombinant at negotiated discounted prices to members of certain group purchasing organizations (&#x201c;GPOs&#x201d;) and government programs. We also pay quarterly distribution fees to certain wholesalers for inventory reporting and chargeback processing, and to GPOs as administrative fees for services and for access to GPO members. We concluded the benefits received in exchange for these fees are not distinct from our sales of Hylenex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recombinant, and accordingly we apply these amounts to reduce revenues. Wholesalers also have rights to return unsold product nearing or past the expiration date. Because of the shelf life of Hylenex recombinant and our lengthy return period, there may be a significant period of time between when the product is shipped and when we issue credits on returned product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the transaction price when we receive each purchase order taking into account the expected reductions of the selling price initially billed to the wholesaler arising from all of the above factors. We have compiled historical experience and data to estimate future returns and chargebacks of Hylenex recombinant and the impact of the other discounts and fees we pay. When estimating these adjustments to the transaction price, we reduce it sufficiently to be able to assert that it is probable that there will be no significant reversal of revenue when the ultimate adjustment amounts are known.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each purchase order contains only one type of product, and is usually shipped to the wholesaler in a single shipment. Therefore, allocation of the transaction price to individual packages is not required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from Hylenex recombinant product sales and related cost of sales upon product delivery to the wholesaler location. At that time, the wholesalers take control of the product as they take title, bear the risk of loss of ownership, and have an enforceable obligation to pay us. They also have the ability to direct sales of product to their customers on terms and at prices they negotiate. Although wholesalers have product return rights, we do not believe they have a significant incentive to return the product to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon recognition of revenue from product sales of Hylenex recombinant, the estimated amounts of credit for product returns, chargebacks, distribution fees, prompt payment discounts, and GPO fees are included in sales reserves, accrued liabilities and net of accounts receivable. We monitor actual product returns, chargebacks, discounts and fees subsequent to the sale. If these amounts differ from our estimates, we make adjustments to these allowances, which are applied to increase or reduce product sales revenue and earnings in the period of adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the orders placed by wholesalers, we incur costs such as commissions to our sales representatives. However, as revenue from product sales is recognized upon delivery to the wholesaler, which occurs shortly after we receive a purchase order, we do not capitalize these commissions and other costs, based on application of the practical expedient allowed within the applicable guidance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Bulk rHuPH20&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell bulk rHuPH20 to collaboration partners for use in research and development; subsequent to receiving marketing approval, we sell it for use in collaboration commercial products. Sales are made pursuant to purchase orders subject to the terms of the collaborative agreement, and delivery of units of bulk rHuPH20 represent performance obligations under each purchase order. We provide a standard warranty that the product conforms to specifications. We use contract manufacturers to produce bulk rHuPH20 and have concluded we are the principal in the sales to collaboration partners. The transaction price for each purchase order of bulk rHuPH20 is fixed based on the cost of production plus a contractual markup, and is not subject to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;adjustments. Allocation of the transaction price to individual quantities of the product is usually not required because each order contains only one type of product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from the sale of bulk rHuPH20 as product sales and related cost of sales upon transfer of title to our partners. At that time, the partners take control of the product, bear the risk of loss of ownership, and have an enforceable obligation to pay us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In our statements of operations, we report as revenues under collaborative agreements the upfront payments, event-based development and regulatory milestones and sales milestones. We also include in this category revenues from separate research and development contracts pursuant to project authorization forms. We report royalties received from collaboration partners as a separate line in our statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales of Hylenex recombinant, bulk rHuPH20 that has alternative future use and ENHANZE drug product are included in product sales, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the footnotes to our condensed consolidated financial statements, we provide disaggregated revenue information by type of arrangement (product sales, net, collaborative agreements and research and development services), and additionally, by type of payment stream received under collaborative agreements (upfront license fees, event-based development and regulatory milestones and other fees, sales milestones and royalties).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of product sales consists primarily of raw materials, third-party manufacturing costs, fill and finish costs, freight costs, internal costs and manufacturing overhead associated with the production of Hylenex recombinant and bulk rHuPH20 and ENHANZE drug product. Cost of product sales also consists of the write-down of excess, dated and obsolete inventories and the write-off of inventories that do not meet certain product specifications, if any.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <halo:RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTI0MzA_9f0f88fc-da4f-4bd6-9d5d-1624eec8777f">P90D</halo:RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxMzE_166036b9-0523-4156-afae-9223126b10b5">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expenses include salaries and benefits, facilities and other overhead expenses, research related manufacturing services, contract services and other outside expenses. Research and development expenses are charged to operating expenses as incurred when these expenditures relate to our research and development efforts and have no alternative future uses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are obligated to make upfront payments upon execution of certain research and development agreements. Advance payments, including nonrefundable amounts, for goods or services that will be used or rendered for future research and development activities are deferred. Such amounts are recognized as expense as the related goods are delivered or the related services are performed or such time when we do not expect the goods to be delivered or services to be performed.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQxMzc_931adbdd-3dbc-4b1f-983e-2d3405cd6c75">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record compensation expense associated with stock options, restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;), performance stock units (&#x201c;PSUs&#x201d;) and shares issued under our employee stock purchase plan (&#x201c;ESPP&#x201d;) in accordance with the authoritative guidance for stock-based compensation. The cost of employee services received in exchange for an award of an equity instrument is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense on a straight-line basis over the requisite service period of the award. Share-based compensation expense for an award with a performance condition is recognized when the achievement of such performance condition is determined to be probable. If the outcome of such performance condition is not determined to be probable or is not met, no compensation expense is recognized and any previously recognized compensation expense is reversed. Forfeitures are recognized as a reduction of share-based compensation expense as they occur.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMzg_e507d4db-6ccc-4bff-b681-590c913f591b">&lt;div style="margin-top:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for income taxes using the liability method. Under this method, deferred income tax assets and liabilities are determined based on the differences between the financial statement carrying amounts of existing assets and liabilities at each year end and their respective tax bases and are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant judgment is required by management to determine our provision for income taxes, our deferred tax assets and liabilities, and the valuation allowance to record against our net deferred tax assets, which are based on complex and evolving tax regulations throughout the world. Deferred tax assets (&#x201c;DTA&#x201d;) and other tax benefits are recorded when they are more likely than not to be realized. We maintain a full valuation allowance on our DTAs until there is sufficient evidence to support the reversal of all or some portion of these allowances. On a periodic basis, we reassess the valuation allowance of our DTAs, weighing all positive and negative evidence, to assess if it is more-likely-than-not that some or all of our DTAs will be realized. As of the third quarter of 2021, we have demonstrated profitability and cumulative pretax income and are forecasting income growth. After assessing both the positive and negative evidence, we determined that it was more likely than not that our DTAs would be realized and released the valuation allowance related to federal and state DTAs as of September 30, 2021, resulting in a benefit from income taxes of $142.5&#160;million. We estimated that our annual effective income tax rate to be (57.63)% for 2021 compared to the 0.17% effective income tax rate for 2020. The primary difference relates to the release of our valuation allowance. We will continue to evaluate the need for valuation allowances for our DTAs.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTY0OTI2NzQ5MjIxNg_eb3f78f9-7d03-44db-810a-b6f858604e6f"
      unitRef="usd">-142500000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id4b36e88a5204ad7a59bf1f1884070f0_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTY0OTI2NzQ5MjIzOQ_12863e53-c725-4a63-aefb-2a4c67beb953"
      unitRef="number">-0.5763</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMTY0OTI2NzQ5MjIzMw_cb78e208-8a99-4b08-81c6-46fd74a9e68a"
      unitRef="number">0.0017</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMzQ_d2a44ee2-682c-4cde-9569-cdff59bcdcff">&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate our business in one segment, which includes all activities related to the research, development and commercialization of our proprietary enzymes. This segment also includes revenues and expenses related to (i)&#160;research and development and bulk rHuPH20 manufacturing activities conducted under our collaborative agreements with third parties and (ii)&#160;product sales of Hylenex recombinant. The chief operating decision-maker reviews the operating results on an aggregate basis and manages the operations as a single operating segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzMzNzI_ee840422-ba81-4b85-9c52-55bac9a6932a"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyMDY_0951e4b3-4ec0-46ce-b734-fea795b115f5">&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adoption and Pending Adoption of Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial &lt;br/&gt;Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2022&lt;br/&gt;(Early adoption permitted effective January 1, 2021)&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis, which resulted in an approximately $65.5 million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $52.6 million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $13.0 million decrease to the opening balance of accumulated deficit, representing the cumulative non-cash interest expense recognized related to the amortization of the bifurcated conversion option related to the 2024 Convertible Notes. We  derecognized the related deferred tax liabilities of $11.8 million with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. As we committed to settle the principal amount of the convertible notes in cash upon conversion, shares used for diluted EPS will continue to be limited to the excess conversion value over the principal amount of the convertible note. Diluted earnings per share is also impacted due to the elimination of non-cash interest expense associated with the amortization of the equity component.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RleHRyZWdpb246MTdjOTE3OGY5NzdkNGY3NGI3ZTA5MWFjOTI1MmIzM2VfMzQyNTU_e0ec1073-6db1-47b3-b5da-b7690e32cb37">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect on the Financial &lt;br/&gt;Statements or Other Significant Matters&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1, 2022&lt;br/&gt;(Early adoption permitted effective January 1, 2021)&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;We early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis, which resulted in an approximately $65.5 million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $52.6 million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $13.0 million decrease to the opening balance of accumulated deficit, representing the cumulative non-cash interest expense recognized related to the amortization of the bifurcated conversion option related to the 2024 Convertible Notes. We  derecognized the related deferred tax liabilities of $11.8 million with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. As we committed to settle the principal amount of the convertible notes in cash upon conversion, shares used for diluted EPS will continue to be limited to the excess conversion value over the principal amount of the convertible note. Diluted earnings per share is also impacted due to the elimination of non-cash interest expense associated with the amortization of the equity component.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i6d5406841f54463587c720f7d0c85362_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0Mjg3Mw_c9d9538e-493b-45d3-b5b8-e153daf9efdb"
      unitRef="usd">65500000</us-gaap:StockholdersEquity>
    <us-gaap:LongTermDebt
      contextRef="ibaae598c6a0043268b61e55051da6c5b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0Mjg5Mg_d2a9308f-19da-4e11-a051-5df5e83d5341"
      unitRef="usd">52600000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquity
      contextRef="ie1eb4955082b47499f0449ca9fa72759_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0MjkxMQ_9e8f127b-aa05-4f91-b8dc-13e399e3d99a"
      unitRef="usd">13000000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ibaae598c6a0043268b61e55051da6c5b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180MC9mcmFnOjE3YzkxNzhmOTc3ZDRmNzRiN2UwOTFhYzkyNTJiMzNlL3RhYmxlOmE3YjlhM2JjMjVjMTRjNzA4ZTM3MjZmMjI3ZGFkZjE0L3RhYmxlcmFuZ2U6YTdiOWEzYmMyNWMxNGM3MDhlMzcyNmYyMjdkYWRmMTRfMi02LTEtMS0xMjU3L3RleHRyZWdpb246NmU2MTNjYjNjOGYzNDZmMjhiMWU3NmQ2N2RhNGJmODRfMTY0OTI2NzQ0MjkzMA_6aa331d8-f228-403d-8402-d606ccc037d8"
      unitRef="usd">11800000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTAxMA_7d2a3f09-8f1d-4c4f-92a0-b943ada13619">Fair Value Measurement&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale marketable securities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-US Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, 11 available-for-sale marketable securities with a fair market value of $66.0 million were in a gross unrealized loss position of $23 thousand. Based on our review of these marketable securities, we believe none of the unrealized loss is as a result of a credit loss as of&#160;September&#160;30, 2021, because we do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of available-for-sale debt securities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one but within five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable &lt;br/&gt;&#160;&#160;&#160;securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-US Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no instruments that were classified within Level 3 as of September&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTAwNA_39f67f81-0ba7-4d0e-9125-ccd2c196f691">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale marketable securities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-US Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi0yLTEtMS0w_6e132236-d3c7-4f09-af02-998c9a0e464b"
      unitRef="usd">27827000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi00LTEtMS0w_c6362f77-779b-48a5-9592-b06771c746a1"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi02LTEtMS0w_79a60fe9-6084-46cf-87ef-a9627ab2fced"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMi04LTEtMS0w_99147398-253f-467b-ae09-f3792e4e5bcd"
      unitRef="usd">27817000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy0yLTEtMS0w_4269513a-27fb-4aa4-ba38-7a4414bc10d6"
      unitRef="usd">75686000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy00LTEtMS0w_bc2b2ab0-ace0-4e0d-9362-abe19086f543"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy02LTEtMS0w_65e5a303-483e-49ba-867d-c7bc7afd3b79"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfMy04LTEtMS0w_35d0008c-4372-4292-86b0-e8ec2acf30db"
      unitRef="usd">75683000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC0yLTEtMS0w_c1bf6fa3-f0f0-44d3-a910-c129793bae6e"
      unitRef="usd">60178000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC00LTEtMS0w_5b8b9364-3427-4827-a25b-a833983138d9"
      unitRef="usd">29000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC02LTEtMS0w_cad5ee62-45f9-4e40-a957-169d2f05f2d3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNC04LTEtMS0w_1cf9955c-c7e1-4563-b9b4-c73152fa504b"
      unitRef="usd">60207000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS0yLTEtMS0w_c0d5e9e7-570d-4f30-8521-bcfa434637ba"
      unitRef="usd">17291000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS00LTEtMS0w_aca9040f-a7ac-4304-9b4a-63655c1d38cc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS02LTEtMS0w_cd05a089-9ecb-4607-871d-6e8229167db6"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNS04LTEtMS0w_d2a598b3-cc91-4860-b480-a2c1ca9ef5c1"
      unitRef="usd">17289000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi0yLTEtMS0w_9a1d551c-52d8-454b-9bcf-a9efaf67ed9a"
      unitRef="usd">143241000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi00LTEtMS0w_091a127a-5673-444e-aee7-5da1b93c9109"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi02LTEtMS0w_f07cdbd2-e68b-4061-8323-04301ac8b97b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNi04LTEtMS0w_db7bf309-1256-48a8-a2e2-15be112bc196"
      unitRef="usd">143241000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy0yLTEtMS0w_57456b15-7239-48b5-be0e-fd32a7588d34"
      unitRef="usd">324223000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy00LTEtMS0w_daa27c12-efc0-4699-b660-4ddbae6fe840"
      unitRef="usd">37000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy02LTEtMS0w_62295902-a90b-4e52-8fee-b995eed62ed3"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmFjNmNlNGYxMWNiZTQ2NGVhMmM0MmQzZDhmYmU2YjY4L3RhYmxlcmFuZ2U6YWM2Y2U0ZjExY2JlNDY0ZWEyYzQyZDNkOGZiZTZiNjhfNy04LTEtMS0w_ff22baec-6565-4599-bc95-7f39c3a002b6"
      unitRef="usd">324237000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if7152e25968740afaabf504783045182_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi0yLTEtMS0w_48416f0b-4959-4901-b222-60aa19fb4091"
      unitRef="usd">17013000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if7152e25968740afaabf504783045182_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi00LTEtMS0w_eb8080c2-d78a-48e4-af88-5345343a723a"
      unitRef="usd">49000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if7152e25968740afaabf504783045182_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi02LTEtMS0w_e4959794-34e3-4037-b559-efd62684348f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if7152e25968740afaabf504783045182_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMi04LTEtMS0w_205227bd-f167-4a70-927a-cccafa9b847d"
      unitRef="usd">17062000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy0yLTEtMS0w_c834fece-7af7-4c1c-a704-6b49a7e1ff43"
      unitRef="usd">69755000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy00LTEtMS0w_461dbb7b-59a8-47de-adbb-dd4466ce8165"
      unitRef="usd">42000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy02LTEtMS0w_b470ec88-76cd-455c-8afc-d4384b6d5e5d"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfMy04LTEtMS0w_06795108-7703-4d5a-a7e2-da5cf528fc15"
      unitRef="usd">69789000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC0yLTEtMS0w_aaddcc2d-ca31-47f0-8fbe-62baaaba42d3"
      unitRef="usd">45110000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC00LTEtMS0w_e478701f-cb7a-4a0d-ad02-a56e7705b576"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC02LTEtMS0w_19e6ed24-4569-43f9-ae8d-799a464ddd3b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNC04LTEtMS0w_31318787-de5f-4f68-addf-db85e937e126"
      unitRef="usd">45117000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS0yLTEtMS0w_4724ff06-3b58-4605-8bd7-42ffac8d4aa3"
      unitRef="usd">88342000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS00LTEtMS0w_00821b45-20cc-4a32-b9c3-264a776b298a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS02LTEtMS0w_053e00dd-755c-42b5-beb0-a7242576dd06"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNS04LTEtMS0w_542f06bc-c794-4ec4-a5ca-33fc3f14b5bf"
      unitRef="usd">88342000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi0yLTEtMS0w_75eb1fad-7403-48ef-9928-0da5079a0cf1"
      unitRef="usd">220220000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi00LTEtMS0w_f57b98f4-be9b-4b36-85d0-f71f116a6c2b"
      unitRef="usd">98000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi02LTEtMS0w_13314b06-2fc3-4a18-ae23-c9961255eef9"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmI2YmNjMTlmZTgxNTRhMDc4ODM4NDhkNzMxNTg2NzAyL3RhYmxlcmFuZ2U6YjZiY2MxOWZlODE1NGEwNzg4Mzg0OGQ3MzE1ODY3MDJfNi04LTEtMS0w_6e8e1122-d8a7-435c-bf6c-92aee7460a9b"
      unitRef="usd">220310000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTI5_2d4d1eb3-65aa-4d06-9364-017d956c4b00"
      unitRef="security">11</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMjAx_6644c0f1-36c4-46f6-9a83-526cbb9c54b9"
      unitRef="usd">66000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMjQ4_62295902-a90b-4e52-8fee-b995eed62ed3"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMjE5OTAyMzI1NjU3Ng_84e2f0f4-feb3-4f6b-8aa0-82c4adad52aa"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfOTkx_e0d3a435-7ef6-4340-a5c3-dfe3aefc2557">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of available-for-sale debt securities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one but within five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMi0yLTEtMS0w_0c46b4cd-4b12-40b1-be3b-8bbef104e2db"
      unitRef="usd">286672000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMi00LTEtMS0w_464a6d89-b81e-4b8d-b687-670b3b267ac3"
      unitRef="usd">220310000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMy0yLTEtMS0w_bf89164f-b483-4dc4-a2e3-1fa54f553b63"
      unitRef="usd">37565000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfMy00LTEtMS0w_bacae50c-5ea6-44a1-bca0-7ec3f532ad29"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfNC0yLTEtMS0w_f5875b3b-c956-43fb-aa4a-14f47ffbf58f"
      unitRef="usd">324237000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOjg4ZGQ1YmZkY2Y3NDRmYjlhNjgwOGNlYWNmMDZlYTQ5L3RhYmxlcmFuZ2U6ODhkZDViZmRjZjc0NGZiOWE2ODA4Y2VhY2YwNmVhNDlfNC00LTEtMS0w_11d8cf34-4939-47c3-af9f-4df5df68b770"
      unitRef="usd">220310000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfMTAwMA_f7cf6536-a94e-4396-9b5b-9c9ef08cd706">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.337%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable &lt;br/&gt;&#160;&#160;&#160;securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-US Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0b6fe5f945ae43a69e913f0e0b729205_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy0yLTEtMS0w_e7b1ad6d-9d63-45a9-8fa6-2a8f74fe8afb"
      unitRef="usd">491661000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ice6cebbf569a4926bb4ba1f2c0526b8c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy00LTEtMS0w_afcc3a83-3e86-47f8-a169-bb1ee02a57b5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7af6b80bac9f4ee1a6f77ffcbcb33af1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy02LTEtMS0w_addd07ac-8c7e-4c1c-a2fa-aa824f906201"
      unitRef="usd">491661000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9a6f1d6a6d9a4794ad43347f6f6a845d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy04LTEtMS0w_55aef115-099e-467b-b656-d4419def0786"
      unitRef="usd">140571000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i510ee7af7efc47b28c4621b3e4d7c994_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy0xMC0xLTEtMA_c9ca3139-e895-404f-b6f1-31034a837642"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if7fd00eb22704a3faadef6bba5e75036_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMy0xMi0xLTEtMA_a7a0b0e0-a196-4659-95e6-1366c0208323"
      unitRef="usd">140571000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic7228f6a8b874f59a40a9c1c3ae1d319_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC0yLTEtMS0w_c998bce0-43fa-4767-aece-2437b1820305"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i23422b52470040bcabe09d7bda533924_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC00LTEtMS0w_1dcd2f6a-e80a-4443-b6e8-b23db823004a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic96e068d375b4d50b976de50785f0a89_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC02LTEtMS0w_233f8c68-4e22-4bb9-8d9f-4548847e55b2"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4c2fb7c8538d41ddb1d8acd66cc4ef17_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC04LTEtMS0w_8b40b655-6451-4050-b11f-d87e59cc86a8"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i71214058490a424b86f59ea8c37c7358_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC0xMC0xLTEtMA_91e8591d-275f-4dc3-b10e-a31c08c816f1"
      unitRef="usd">7000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic98aeee1dd5f44ef88df01be8344928c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNC0xMi0xLTEtMA_52412230-3234-4f18-8ff3-6420e9c08d26"
      unitRef="usd">7000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8048d79e377f495a99e418c2dd29f1d6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy0yLTEtMS0w_35519de9-399c-48e8-a9c0-61f630b5cd34"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a8d40c51fe947a88cf70e94aa08de05_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy00LTEtMS0w_7b91a390-fbaa-4ff0-9b35-652c3ec1068e"
      unitRef="usd">27817000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i88d1289f5e4b4e1aa03bd2b5b8dc64a4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy02LTEtMS0w_695c114f-6a1d-4b52-9bd4-dfb42dbc01d5"
      unitRef="usd">27817000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0e633fec488c477b957a45854ee34341_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy04LTEtMS0w_6ebaec7d-1f4f-466a-b8f0-633bf58efe6d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib3cd1753156549998bd9164c7783c6e2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy0xMC0xLTEtMA_771990bf-65ff-4243-9fce-cf326088f376"
      unitRef="usd">17062000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if7152e25968740afaabf504783045182_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfNy0xMi0xLTEtMA_bcf621b5-c3b8-4677-b0a1-20beb576a4d7"
      unitRef="usd">17062000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc226000e5b642c1a87036d0b20cf77d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC0yLTEtMS0w_4ba29add-3f47-47b8-8e70-d54236eec3b3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic9d6e7551a5f4b78aa75bb4fcbf2d798_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC00LTEtMS0w_d0b7d67a-4dfa-4138-b8fa-5aab1f196c2a"
      unitRef="usd">75683000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d98f273dbc0466dbd8f6091d971bcbd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC02LTEtMS0w_fabc7d1d-0522-45ac-bcf0-b15ada44aa5c"
      unitRef="usd">75683000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6f93b93b18047879feba5866a7c1147_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC04LTEtMS0w_259f4eae-74dc-4d97-ad29-8b4d226fb8d6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idac7d674d62548b09e34061cbb313276_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC0xMC0xLTEtMA_f1742156-f0ec-462a-847b-4e2b6dad631e"
      unitRef="usd">69789000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7658f6494ad24880a34c2dc3979ede85_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOC0xMi0xLTEtMA_8ae64200-4dd0-4b6d-aeb6-c3c556dd5fda"
      unitRef="usd">69789000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic6c397dd0f5243188600e0dcf051082b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS0yLTEtMS0w_e5f913f4-bead-4c77-a8dc-9de66ea29021"
      unitRef="usd">60207000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i42af265f358f4e47b36e71ac09d1ad01_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS00LTEtMS0w_e2151d70-8edf-4002-9d3b-df963691449b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie0240effe3214b81b9ca5b45972c7265_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS02LTEtMS0w_421a8c27-8c43-475f-bd09-ba638debeb2d"
      unitRef="usd">60207000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iad2bda6661fe4c6a8deab6b225439c54_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS04LTEtMS0w_45a7c4b9-f80c-4c90-b572-4344fa7d559c"
      unitRef="usd">45117000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b21d8da7dbc4396942bb05a95ca81f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS0xMC0xLTEtMA_8fa7d808-c204-4c74-9612-8c0b1b5c08ce"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb0f815ccda14fc69c7000068fc223a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfOS0xMi0xLTEtMA_f405d77a-9ae3-4e19-aa44-9e703c12bec2"
      unitRef="usd">45117000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i84b5665294d04912b073fdaefa553c12_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtMi0xLTEtMA_9b6e3bc9-59ea-4563-8730-9b74c7bcd5e0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iafee32398ddd4184a9e8c6f456c0bad6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtNC0xLTEtMA_52975b3f-029e-48ed-8bfb-37e8ed64bbb6"
      unitRef="usd">17289000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iadc6cd4f54794f4496d961d749aef342_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtNi0xLTEtMA_0a27dbca-79f7-485b-85b3-8541ab4cf6ba"
      unitRef="usd">17289000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iffc815cd3d3f45779613868dda56f367_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtOC0xLTEtMTMzOTI_db911103-ad9e-4b46-a867-c71b6645942e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i14b477c24acf478d95230b08574a9bea_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtMTAtMS0xLTEzMzky_385de7c3-e77f-4368-83d1-b6b6547ab999"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7dec8fd3aaaf4fd59df1e8d089e118ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTAtMTItMS0xLTEzMzky_164e897a-776a-4d70-aab8-993c2ee7f614"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5bf7e115ae39487e96fb9df8b46799e0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtMi0xLTEtMA_541eed7d-c83d-4016-aeab-95826486b0f4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia31bae321b714f37893eb11b3ee1a813_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtNC0xLTEtMA_7b008b54-2c23-41db-be7b-b339b78f2bf6"
      unitRef="usd">143241000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc9e685f6c1c4beda8a6e661c8c86b1e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtNi0xLTEtMA_d376777b-41b1-4b6c-9077-8edc84abfc84"
      unitRef="usd">143241000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icd8fd7acfa834427a80a945db2878a09_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtOC0xLTEtMA_ebec2b51-4a9a-422c-8ecd-b8f5d1892c78"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3465623e8f7d4998b90547f930b814e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtMTAtMS0xLTA_73cbe655-7e90-4aec-8ca8-1df86d57c7fb"
      unitRef="usd">88342000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5c8d4af187842f4a7efbd4c679c1ffa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTEtMTItMS0xLTA_5e284c6b-e4f8-4627-b2d8-9c3c38371cc7"
      unitRef="usd">88342000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i17dfb6089521498d8d28b738549dbe12_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItMi0xLTEtMA_724ab5c5-d842-4fa8-918c-e639aec6d8bb"
      unitRef="usd">551868000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib3a819da17a94fbbbcdb54d76235890e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItNC0xLTEtMA_d4062c7e-f042-406e-ad3a-b7696e2a7529"
      unitRef="usd">264030000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItNi0xLTEtMA_0f984263-9b63-4dbe-a73b-617d8c5769ff"
      unitRef="usd">815898000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie330bed0ebb1442dbbdf7b34d7cfe2a6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItOC0xLTEtMA_0f95f439-6cc1-4e20-8d80-f30e25eb95ef"
      unitRef="usd">185688000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c5ae6e2527f4c99bd2fb6c331a1eab7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItMTAtMS0xLTA_2b874b88-09c0-4ffa-94f1-607751d3d790"
      unitRef="usd">182193000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RhYmxlOmM3NzQyNTJmMzY4NjQ5ODJiZTUxMDk4YzE3MmZjNTExL3RhYmxlcmFuZ2U6Yzc3NDI1MmYzNjg2NDk4MmJlNTEwOThjMTcyZmM1MTFfMTItMTItMS0xLTA_4fceb046-2ce4-4c50-80de-9527af5a2bb4"
      unitRef="usd">367881000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0e0157ed45314cc1a41caf7282e4da2b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfOTE5_7dc89911-b4ff-4b9c-82a4-60e3d7d945a0"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i43b81ea09c7b4830be62638aea4edab1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y180Ni9mcmFnOjdlMDA5NGQ1NGU3NzQxMDY4NWMwNjRjZmViNTIzZmRiL3RleHRyZWdpb246N2UwMDk0ZDU0ZTc3NDEwNjg1YzA2NGNmZWI1MjNmZGJfOTE5_d48e0afd-d7c1-420a-8cd0-37ccce3ab510"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjA2Nw_f241212a-53de-4df1-942a-a9b0f8fbf93a">Revenue&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our disaggregated revenues were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Sales of bulk rHuPH20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Sales of Hylenex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues under collaborative agreements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Upfront license and target nomination fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Event-based development and regulatory milestones and other fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Sales-based milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Research and development services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues under collaborative agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September&#160;30, 2021 we recognized revenue related to licenses granted to collaboration partners in prior periods in the amount of $88.6 million. This amount represents royalties and a sales milestone earned in the current period. We recognized revenue of $0.5 million during the three months ended September&#160;30, 2021 that had been included in deferred revenues at December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021 we recognized revenue related to licenses granted to collaboration partners in prior periods in the amount of $221.3 million. This amount represents royalties and sales milestone earned in the current period in addition to $30.0&#160;million of variable consideration in the contracts where uncertainties have been resolved and the development milestones were expected to be achieved or were achieved. We recognized revenue of $1.0 million during the nine months ended September&#160;30, 2021 that had been included in deferred revenues at December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net, and deferred revenues (contract liabilities) from contracts with customers, including collaboration partners, consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.857%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of September&#160;30, 2021, the amounts included in the transaction price of our contracts with customers, including collaboration partners, and allocated to goods and services not yet provided were $69.8 million, of which $65.0 million relates to unfulfilled purchase commitments and $4.8 million has been collected and is reported as deferred revenues. The unfulfilled purchase commitments are estimated to be delivered by the end of the third quarter of 2022. Of the total deferred revenues of $4.8 million, $2.2 million is expected to be used by our customers within the next 12 months.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjA2Mg_375ee187-87f5-46fe-b127-a49a05a5acaf">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our disaggregated revenues were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Sales of bulk rHuPH20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Sales of Hylenex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues under collaborative agreements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Upfront license and target nomination fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Event-based development and regulatory milestones and other fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Sales-based milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Research and development services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues under collaborative agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic648a667b4564856a5096920f3df03db_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi0yLTEtMS0w_e68e5a7e-e0a4-4da1-b5d5-9d702d85f80e"
      unitRef="usd">58563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc326e2cf27f45baac0c0fe72eed59d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi00LTEtMS0w_ec88909a-ccff-466b-9c04-3a3f2745c29c"
      unitRef="usd">23931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i272651d659f84e0a8874d31b762516eb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi02LTEtMS0w_2612a149-ab5f-41dc-8afa-eded038a16af"
      unitRef="usd">141264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea7a928fde0046eca6e5a2a01621d057_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMi04LTEtMS0w_bfbf1868-168a-4a54-8151-9933380c5edd"
      unitRef="usd">56599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c022f7d86dd4437bd0cde070c7fd07c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS0yLTEtMS0w_62d52e94-3567-41e5-b40d-2fc935097e3c"
      unitRef="usd">18862000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3968a56145c145baa0c437ec109af06e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS00LTEtMS0w_b425cbd0-3eba-4aa2-afb8-faf1b5f07581"
      unitRef="usd">4104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92d0ce79c1664094be9d67dacba99869_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS02LTEtMS0w_bd0ee92f-0ea9-4b2f-9782-ef35a0fee30d"
      unitRef="usd">59719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d04f05cf4d8411688ffb481e3b6f1a1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNS04LTEtMS0w_1ee9256d-7a3c-4e43-b4a1-36104cb58e82"
      unitRef="usd">11963000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i266391e004c7456a98a2b58f212c06c1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy0yLTEtMS0w_a21d287f-6004-42b9-9899-98b93b982489"
      unitRef="usd">6185000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15658419291646da82621e9c9b2f6dbb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy00LTEtMS0w_236235a9-2f7e-4297-bb91-fbdd17504045"
      unitRef="usd">4944000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4575b33018d5417da6496f84f9c8b307_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy02LTEtMS0w_ed72c6fa-7407-4a99-951c-fd9b7bc6f703"
      unitRef="usd">17454000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c66125868794895a72167f638f47a8f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfNy04LTEtMS0w_9cb3fb48-0407-4155-871c-b33cf04c788e"
      unitRef="usd">11569000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i501c9252b83c44809a6ccbddc68fa142_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC0yLTEtMS0w_a5d162a3-7ae9-49c1-af7d-36d8e643c125"
      unitRef="usd">25047000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic64829186658472f9e88de5ccbc70972_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC00LTEtMS0w_fe5b7fb5-8678-43d5-b683-8b9494e3122d"
      unitRef="usd">9048000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc4eef1632dd43799c54c3a51442359c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC02LTEtMS0w_29e30d65-216f-4ce4-a9d2-bb27d87b09d3"
      unitRef="usd">77173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i353f14d9c0cc433e9597f0fe48db2359_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfOC04LTEtMS0w_1cf41688-5172-491f-8cf9-2064cf63bdb9"
      unitRef="usd">23532000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if910d54ee4ef4f618d431f133fca2559_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtMi0xLTEtMA_1c1ec67c-c91e-4569-a704-f684f30bcb64"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c9ac387aba94bbc9c70dd2c275fd159_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtNC0xLTEtMA_375f2967-76ef-4931-b94a-a4e40f67d4be"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i601a5d810b394d2489e25eea409b2b3d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtNi0xLTEtMA_d7053e00-b608-4a38-86f0-76487913682d"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86cb3d1f5b124e9f81dbf0646d232a5f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTEtOC0xLTEtMA_71dbfcd7-0fdf-4109-97fa-feb8f427c188"
      unitRef="usd">7264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17496220ae11435ca516f72c3fe10a18_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItMi0xLTEtMA_d3f07a8f-2528-4e7a-99fb-9c273545b198"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e642dc9f3414ad88f5df20dee6948ee_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItNC0xLTEtMA_84fce7e7-9ba5-4606-a511-67114e8a3cb8"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28450b44187c42f9b071a5816b0ea2e8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItNi0xLTEtMA_f53e0e87-235d-4522-a356-1c2646260526"
      unitRef="usd">30000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i491e07317d3346579daea09d068cc6ac_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTItOC0xLTEtMA_1b9dd0c0-4c8b-4760-b031-82b56bd1c917"
      unitRef="usd">57500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i266af81398ed45eea9c67c4a7856ace4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtMi0xLTEtMA_2edb7a8e-1fc1-4908-b046-88b3e87a1d06"
      unitRef="usd">30000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i569db92c338a4d04800ca2c32dfef65a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtNC0xLTEtMA_3e7edd3d-a660-4ca9-bff7-0690e743a937"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f82754b3e354c75b602f455ff70da37_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtNi0xLTEtMA_86a2a763-d43c-484c-8abc-d1d538724dab"
      unitRef="usd">50000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f6dec7f20e549b9b58761c803248054_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTMtOC0xLTEtMA_058dfd21-4386-4069-adde-309320e1987c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8cf86de5f3046a4bae0460346e32c55_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtMi0xLTEtMA_f8647351-0a70-4ca3-bd3c-eee0db055035"
      unitRef="usd">220000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib409cfda9eb34f03b1d3070f5ff73a9f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtNC0xLTEtMA_5ec53750-9b75-458e-b459-5d6a2f19f277"
      unitRef="usd">337000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i941973135edc404780b79a1a8d9197ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtNi0xLTEtMA_b071dcc9-4f05-4342-a67d-de0350066c2d"
      unitRef="usd">870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f47adc8431141e2bd4adfb8ee6c8be3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTQtOC0xLTEtMA_5c5385fb-fc7a-458a-a33f-79e2322070b2"
      unitRef="usd">996000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ed821ec9e124f6989a22f8554b1acbf_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtMi0xLTEtMA_a69747c4-3750-4bfd-a927-a298a94766a9"
      unitRef="usd">32220000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99adc572639e4c54b1595861c11fec96_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtNC0xLTEtMA_30bb1119-502f-4390-b8a0-7f9ec31e066d"
      unitRef="usd">32337000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00f1c71dd4ef47f898e2155ae0b735ec_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtNi0xLTEtMA_309097ba-6911-4adc-9af1-5b1045f37248"
      unitRef="usd">122870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i247f86e8e166412cb70a5c1492bc28dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTUtOC0xLTEtMA_49e14ece-fcf9-4799-84fa-020579730514"
      unitRef="usd">65760000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctMi0xLTEtMA_37595b68-4bd5-4c60-ad82-eb74f357f005"
      unitRef="usd">115830000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctNC0xLTEtMA_636e5ad1-d977-4bc7-b00c-00133703c699"
      unitRef="usd">65316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctNi0xLTEtMA_52147046-df0a-4532-89e0-2399fe57fe7c"
      unitRef="usd">341307000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmNkNDlmNjI3NjUwNDQzYjE4MTcxOGM4MTM4ZjU0ZmI5L3RhYmxlcmFuZ2U6Y2Q0OWY2Mjc2NTA0NDNiMTgxNzE4YzgxMzhmNTRmYjlfMTctOC0xLTEtMA_ff904b9b-f545-43ab-85fb-fdb45ab346eb"
      unitRef="usd">145891000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabeb09e2d5a34f1ab2165e7742136659_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjE3_72f1d704-5c70-4850-9d77-66bb4329e122"
      unitRef="usd">88600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="iabeb09e2d5a34f1ab2165e7742136659_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMzI5_d60fe69e-5591-4bca-b7b6-f21ee1ad6d5b"
      unitRef="usd">500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <halo:ProceedsFromPartnerOfLicenseAndCollaborativeAgreement
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfNTU0_1ee36d01-5a54-49f7-b3ff-b2ead7c56b0f"
      unitRef="usd">221300000</halo:ProceedsFromPartnerOfLicenseAndCollaborativeAgreement>
    <halo:RevenueFromContractWithCustomerVariableConsideration
      contextRef="i72e5a38073c94c808eacadffd14c661c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfNjU1_e868d5f4-a71c-480f-b48e-3cbbb46b46ae"
      unitRef="usd">30000000</halo:RevenueFromContractWithCustomerVariableConsideration>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i72e5a38073c94c808eacadffd14c661c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfODQz_a8b52c0d-1df5-48ab-8c89-25a65432e7a0"
      unitRef="usd">1000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMjA1MQ_c93239ed-adc0-4947-8385-655ffb5c8671">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net, and deferred revenues (contract liabilities) from contracts with customers, including collaboration partners, consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.857%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMS0yLTEtMS0w_db1ba837-593b-4616-9050-053fbf4d56f3"
      unitRef="usd">112099000</halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets>
    <halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMS00LTEtMS0w_a6a843c6-18f2-4b7d-b71b-3b5b1b254f69"
      unitRef="usd">90730000</halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMi0yLTEtMS0w_fdeaac6e-ef58-46c6-afae-274bb5914c36"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMi00LTEtMS0w_5a33a23c-de45-4023-b055-d151428842c8"
      unitRef="usd">7000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:DeferredRevenue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMy0yLTEtMS0w_628ce13a-5687-49c9-aac0-50b6c35a0c62"
      unitRef="usd">4775000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RhYmxlOmFhNDgzNGJiZTU5YTQwZjE4YWRjZmE0MjEwNDQxMjgyL3RhYmxlcmFuZ2U6YWE0ODM0YmJlNTlhNDBmMThhZGNmYTQyMTA0NDEyODJfMy00LTEtMS0w_e869d9d5-62a4-485f-8466-2103aa6b7b99"
      unitRef="usd">5772000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i5850452d31564c9b851c823cfbb9d09d_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTI5MQ_c6b2d2d5-7ed3-4e5a-8af5-7232543cf3ce"
      unitRef="usd">69800000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredCreditsAndOtherLiabilitiesCurrent
      contextRef="ic47eff917a924a8d88864fdf58cbee25_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTMwNA_fc9067c5-2398-4947-918f-017ffe035b10"
      unitRef="usd">65000000</us-gaap:DeferredCreditsAndOtherLiabilitiesCurrent>
    <us-gaap:DeferredCreditsAndOtherLiabilities
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTM1NQ_22df7752-d43e-4ebb-bb9a-5a99297b29fd"
      unitRef="usd">4800000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <us-gaap:DeferredCreditsAndOtherLiabilities
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTU1Nw_22df7752-d43e-4ebb-bb9a-5a99297b29fd"
      unitRef="usd">4800000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ic2b29c8b2930492d851baa19fbc2b1f5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181Mi9mcmFnOmI1Mjg3Zjg0NGE2NDQ4MzFhNjc1MDc0NGFlYzhkMTU2L3RleHRyZWdpb246YjUyODdmODQ0YTY0NDgzMWE2NzUwNzQ0YWVjOGQxNTZfMTU2MQ_13e14c0a-4e53-4feb-b356-29829bf317d0"
      unitRef="usd">2200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYyNg_3c32232c-4f59-47b3-b356-5e8ae39054f2">Certain Balance Sheet Items&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from product sales to collaborators&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from revenues under collaborative agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from royalty payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from other product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for distribution fees and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid manufacturing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid manufacturing expenses include raw materials, slot reservation fees and other amounts paid to contract manufacturing organizations.&#160;Such amounts are reclassified to work-in-process inventory as materials are used or the contract manufacturing organization services are complete.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;                            &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense was approximately $0.7 million and $0.8 million, inclusive of ROU asset amortization of $0.4 million and $0.4 million for the three months ended September&#160;30, 2021 and 2020 respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense was approximately $2.2 million and $2.5 million, inclusive of ROU asset amortization of $1.2 million and $1.3 million for the nine months ended September&#160;30, 2021 and 2020 respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued outsourced manufacturing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued expenses, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expense associated with the accretion of the lease liabilities was approximately $0.1 million and $0.1 million for the three months ended September&#160;30, 2021 and 2020 respectively. Total lease expense for the three months ended September&#160;30, 2021 and 2020 was $0.5 million and $0.5 million respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expense associated with the accretion of the lease liabilities was approximately $0.3 million and $0.4 million for the nine months ended September&#160;30, 2021 and 2020 respectively. Total lease expense for the nine months ended September&#160;30, 2021 and 2020 was $1.5 million and $1.7 million respectively. &lt;/span&gt;&lt;/div&gt;Cash paid for amounts related to leases for the three months ended September&#160;30, 2021 and 2020 was $0.6 million and $0.8 million, and $2.0 million and $2.5 million for the nine months ended September&#160;30, 2021 and 2020 respectively.</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYzMw_dc9d6b00-e866-4231-b90a-b603c03de8b2">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from product sales to collaborators&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from revenues under collaborative agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from royalty payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable from other product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for distribution fees and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <halo:Accountsreceivablefromproductsalestocollaborators
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMS0yLTEtMS0w_fcf16ca2-a8b7-40c9-ba12-1f73aa8c11db"
      unitRef="usd">18172000</halo:Accountsreceivablefromproductsalestocollaborators>
    <halo:Accountsreceivablefromproductsalestocollaborators
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMS00LTEtMS0w_cf05d71c-8b95-45ef-9863-d67642961ec8"
      unitRef="usd">25198000</halo:Accountsreceivablefromproductsalestocollaborators>
    <halo:Accountsreceivablefromcollaborators
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMi0yLTEtMS0w_af9a913b-3728-4d8d-8266-1f905d4530c4"
      unitRef="usd">30407000</halo:Accountsreceivablefromcollaborators>
    <halo:Accountsreceivablefromcollaborators
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMi00LTEtMS0w_13c52ad7-c4d8-46a2-b89f-d95697dd0bcb"
      unitRef="usd">30404000</halo:Accountsreceivablefromcollaborators>
    <halo:Accountsreceivablefromroyalties
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMy0yLTEtMS0w_0179d1ce-0fb6-465a-bbd6-107507b7c805"
      unitRef="usd">59095000</halo:Accountsreceivablefromroyalties>
    <halo:Accountsreceivablefromroyalties
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfMy00LTEtMS0w_ec435311-ead3-465a-a8b4-5a4a47922984"
      unitRef="usd">32098000</halo:Accountsreceivablefromroyalties>
    <halo:Accountsreceivablefromproductsales
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNC0yLTEtMS0w_b893b5fa-99e9-4b3d-b2c2-40a410d31d27"
      unitRef="usd">5621000</halo:Accountsreceivablefromproductsales>
    <halo:Accountsreceivablefromproductsales
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNC00LTEtMS0w_84ec9a10-a2a5-4f94-8def-3675ce4b1df7"
      unitRef="usd">4033000</halo:Accountsreceivablefromproductsales>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNS0yLTEtMS0w_fdeaac6e-ef58-46c6-afae-274bb5914c36"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNS00LTEtMS0w_5a33a23c-de45-4023-b055-d151428842c8"
      unitRef="usd">7000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNi0yLTEtMS0w_eec2f089-943b-47e4-b24b-15254ab6182f"
      unitRef="usd">113295000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNi00LTEtMS0w_412f5ad4-51ed-4b7f-b3c1-2ab12f6d1bca"
      unitRef="usd">98733000</us-gaap:AccountsReceivableGrossCurrent>
    <halo:AllowanceforDistributionFeesandDiscounts
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNy0yLTEtMS0w_2598460a-eb62-4b68-855f-c78839396d20"
      unitRef="usd">1196000</halo:AllowanceforDistributionFeesandDiscounts>
    <halo:AllowanceforDistributionFeesandDiscounts
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfNy00LTEtMS0w_db649a46-66ec-4f55-97dd-d0490550974f"
      unitRef="usd">1003000</halo:AllowanceforDistributionFeesandDiscounts>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfOC0yLTEtMS0w_857af87a-0f30-4ee5-a2a8-cc0667ded248"
      unitRef="usd">112099000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjRlZDY0NmM1ODAwYzQ4NDU4OGY5YTQ3N2EzNDhkOGRiL3RhYmxlcmFuZ2U6NGVkNjQ2YzU4MDBjNDg0NTg4ZjlhNDc3YTM0OGQ4ZGJfOC00LTEtMS0w_ceb293d7-3998-476e-ac44-9799df6c4e86"
      unitRef="usd">97730000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYyMg_3e7502c5-2e91-4992-afec-efa6be603601">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMS0yLTEtMS0w_ace5fc59-d0c2-402d-81f7-23dc51fc6a64"
      unitRef="usd">8109000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMS00LTEtMS0w_8cd9f8d7-e719-487d-b887-b87b8d60406a"
      unitRef="usd">5813000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMi0yLTEtMS0w_dcd5a702-6409-4301-8428-1ee5f8d554ee"
      unitRef="usd">21722000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMi00LTEtMS0w_85c11cc7-eacd-4a78-a563-6b3c4d7bfc9c"
      unitRef="usd">33738000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMy0yLTEtMS0w_d62503f9-8c1d-4ce4-a438-df40ac77f683"
      unitRef="usd">26147000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfMy00LTEtMS0w_6ee1a07e-5b2d-4c1a-8a0b-12d345967858"
      unitRef="usd">21196000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfNC0yLTEtMS0w_cf9fd027-7db6-4c05-9934-27901bc64840"
      unitRef="usd">55978000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjY5MGRhNWM5M2RiYTQ0MTk4NDk3YThjOGMyYTAwODliL3RhYmxlcmFuZ2U6NjkwZGE1YzkzZGJhNDQxOTg0OTdhOGM4YzJhMDA4OWJfNC00LTEtMS0w_7d1c5a0c-1125-41ae-bf5c-54d8ab3d26dd"
      unitRef="usd">60747000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTY0Mw_f371b693-543e-44ab-a410-b35fc8a67971">&lt;div style="margin-top:12pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid manufacturing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMS0yLTEtMS0w_9b3fabf3-dfcc-429d-bde0-3328d09b96c9"
      unitRef="usd">43324000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMS00LTEtMS0w_1c7c0952-3f99-426f-b4c8-6d5357ac45eb"
      unitRef="usd">35048000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMy0yLTEtMS0w_59d35461-25e5-459a-a12e-bcc0693c677f"
      unitRef="usd">3156000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfMy00LTEtMS0w_d820edfc-3d3e-414d-a126-f8310eb85f31"
      unitRef="usd">2510000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssets
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNC0yLTEtMS0w_30d21d08-a655-4b90-8aa2-ab2af983965a"
      unitRef="usd">2374000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNC00LTEtMS0w_0b2af205-9936-4033-8bde-6bd47b0a4414"
      unitRef="usd">4783000</us-gaap:OtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNS0yLTEtMS0w_6073b337-ef68-414e-87ce-a2396f8bf0dc"
      unitRef="usd">48854000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNS00LTEtMS0w_9f4431cf-a619-4519-8465-182f6650cdd9"
      unitRef="usd">42341000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNi0yLTEtMS0w_4658dced-5dc2-4db0-8cbb-2d097f4efd84"
      unitRef="usd">15552000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNi00LTEtMS0w_6bc01881-0ba1-4b47-b81d-a3eabe79c1d8"
      unitRef="usd">14067000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNy0yLTEtMS0w_c5b8debc-d0fe-4e75-bb2d-a2c117a375dc"
      unitRef="usd">33302000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOmYyMTE4NDUxZDk0ZTRkYTViYzM5NWZjNTMwOWY2NGM2L3RhYmxlcmFuZ2U6ZjIxMTg0NTFkOTRlNGRhNWJjMzk1ZmM1MzA5ZjY0YzZfNy00LTEtMS0w_7340b984-a914-4289-948b-3e3254063575"
      unitRef="usd">28274000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTYyNA_5f126d69-0212-4d41-be90-7c4393e61224">Property and equipment, net consisted of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7f83dd81a24947c0880845854951b856_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMS0yLTEtMS0w_eea60701-b723-4876-98d1-fd8501443053"
      unitRef="usd">7195000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2f212c6f63a148cfa348578f6301b88e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMS00LTEtMS0w_abe52ce7-53b7-4cae-98c2-3f5ecf9e272d"
      unitRef="usd">7085000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6fc084111de34f53a1ac7314517c9af2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMi0yLTEtMS0w_8be98abc-bd46-46de-a8ca-f3581a0fa550"
      unitRef="usd">5719000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6773e28d6849430994555cb09743216d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMi00LTEtMS0w_ce706628-780a-4d59-b404-c3930603f73f"
      unitRef="usd">5336000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i35b85e221fa24178bff7cc0b297b9c72_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMy0yLTEtMS0w_ee3b213d-674d-428c-b987-0644e5da5830"
      unitRef="usd">5221000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i856a56291322443ab3ccca37be0c321d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfMy00LTEtMS0w_ee017673-b41f-4706-acd5-7b0ce4ca8cd2"
      unitRef="usd">4826000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i31b90616500947d38963e9030a90b72f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNC0yLTEtMS0w_9ac20246-9a72-4cb4-8bf3-9b6b690db415"
      unitRef="usd">1628000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i722f7fc559114e54aeeadc90f492bc78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNC00LTEtMS0w_1b4b7612-48d7-47ba-8dc1-f7022b3a80c5"
      unitRef="usd">1628000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNS0yLTEtMS0w_fd6e1df6-a251-4841-a054-cb78c395d7a2"
      unitRef="usd">19763000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNS00LTEtMS0w_d9bc32a5-5c04-48b1-af13-cb60ed1a9e21"
      unitRef="usd">18875000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNi0yLTEtMS0w_4c076d08-4f89-4e75-9bd7-69f2ee949098"
      unitRef="usd">12600000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNi00LTEtMS0w_163052d2-cb7d-49a6-87cd-50a1b6df1034"
      unitRef="usd">11582000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNy0yLTEtMS0w_ba93ecbb-c228-4c4d-aaf1-6f232aa305a4"
      unitRef="usd">7163000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfNy00LTEtMS0w_867a4840-a3ba-4f7c-b981-716551554574"
      unitRef="usd">7293000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOC0yLTEtMS0w_a9b9f5ca-394a-4b52-9168-997537b3275f"
      unitRef="usd">2425000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOC00LTEtMS0w_2884e60a-4c16-47cc-a2d4-26e5b6f0e9de"
      unitRef="usd">3300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOS0yLTEtMS0w_b543abc3-d426-4910-9699-f71024212aeb"
      unitRef="usd">9588000</halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjA0OTIxYjQyMTNiNTQyZTQ4OGU4ZWFiM2RjNDU0OGJiL3RhYmxlcmFuZ2U6MDQ5MjFiNDIxM2I1NDJlNDg4ZThlYWIzZGM0NTQ4YmJfOS00LTEtMS0w_d4eb8b56-793b-40bf-98ca-c84a57eb3c60"
      unitRef="usd">10593000</halo:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNjg2_c9bda3ec-7dd5-48e7-bba6-dba1d7560b8e"
      unitRef="usd">700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNjkz_3b4d62a7-ff58-419a-8bdb-d6052a237b2a"
      unitRef="usd">800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNzM2_0f1618b5-8bbf-4ee4-8875-a9e30da51dc2"
      unitRef="usd">400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfNzQz_401710e9-92aa-44a0-93e1-92f801ae89d3"
      unitRef="usd">400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfODUx_15f4ecce-e406-4a5f-929d-a793e9d9ab8d"
      unitRef="usd">2200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfODU4_f67f9f3f-0c53-4447-baff-084c59d8e448"
      unitRef="usd">2500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfOTAx_0bd09dec-5fa7-4d0b-90a7-0b4c6ad2b407"
      unitRef="usd">1200000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfOTA4_2a1d1583-4f98-48a6-b419-efadb882e42a"
      unitRef="usd">1300000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTY4Ng_38d37f0f-7a80-4edb-bfb9-971026d4f9c8">&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued outsourced manufacturing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued expenses, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMi0yLTEtMS0w_31f3de61-f124-483c-88d2-372182a67910"
      unitRef="usd">7652000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMi00LTEtMS0w_c7a13465-8610-4665-8666-244bad4c19dd"
      unitRef="usd">8078000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <halo:Accruedmanufacturingexpenses
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMy0yLTEtMS0w_2ed64b6a-b9bc-4d7c-b634-e73714f78c92"
      unitRef="usd">2839000</halo:Accruedmanufacturingexpenses>
    <halo:Accruedmanufacturingexpenses
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfMy00LTEtMS0w_7cda1395-9b04-4a3b-99cb-d8a9153c667c"
      unitRef="usd">4535000</halo:Accruedmanufacturingexpenses>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNC0yLTEtMS0w_45cae66c-2660-48b7-a2c5-a0a4587babe9"
      unitRef="usd">6029000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNC00LTEtMS0w_3a860846-a7cb-4121-aa2b-07f465917431"
      unitRef="usd">6468000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNS0yLTEtMS0w_0d35f577-fa42-4648-9476-be68278ce2d8"
      unitRef="usd">3424000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNS00LTEtMS0w_5d55cb71-6934-4662-b75e-a4b1e64b5e8b"
      unitRef="usd">4868000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNi0yLTEtMS0w_3d6e5c20-7ba0-4865-93b1-1efde370745f"
      unitRef="usd">19944000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNi00LTEtMS0w_d50b883f-9fa0-413f-98d4-0fdfecdc59c3"
      unitRef="usd">23949000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <halo:AccruedLiabilitiesNoncurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNy0yLTEtMS0w_4e975e4f-6923-4b8b-8767-e539b2ad88b0"
      unitRef="usd">1609000</halo:AccruedLiabilitiesNoncurrent>
    <halo:AccruedLiabilitiesNoncurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfNy00LTEtMS0w_0e535539-128d-46e7-a350-6fd85cb78551"
      unitRef="usd">3466000</halo:AccruedLiabilitiesNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfOC0yLTEtMS0w_ca044f5f-f342-4fd6-87d3-cb06b5ad0be6"
      unitRef="usd">18335000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i02e009dc2fa9486680263a15069d178d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RhYmxlOjBiNDRlNjdlZDEyZTRjODNhMjBhNGViYjVhZWYxYTY2L3RhYmxlcmFuZ2U6MGI0NGU2N2VkMTJlNGM4M2EyMGE0ZWJiNWFlZjFhNjZfOC00LTEtMS0w_8a3169c7-7c6c-4714-8565-bd6e2cdc8425"
      unitRef="usd">20483000</us-gaap:AccruedLiabilitiesCurrent>
    <halo:OperatingLeaseAccretionOfLiability
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTEwMQ_9dfdb79a-29ce-413c-ac6d-9348ed2882ed"
      unitRef="usd">100000</halo:OperatingLeaseAccretionOfLiability>
    <halo:OperatingLeaseAccretionOfLiability
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTEwOQ_75c4fa6d-51b0-4735-836e-672a0cf54dc9"
      unitRef="usd">100000</halo:OperatingLeaseAccretionOfLiability>
    <us-gaap:OperatingLeaseCost
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTIxOA_e76d995c-7e35-4368-bdd7-c9840001f68d"
      unitRef="usd">500000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTIyNQ_02885526-04c6-401a-9766-dfdc2aee5469"
      unitRef="usd">500000</us-gaap:OperatingLeaseCost>
    <halo:OperatingLeaseAccretionOfLiability
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTMyNA_90681452-2ae8-47ee-a308-e86c3e82453a"
      unitRef="usd">300000</halo:OperatingLeaseAccretionOfLiability>
    <halo:OperatingLeaseAccretionOfLiability
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTMzMg_6bcc5d84-8dcf-4983-965c-9f07adc99951"
      unitRef="usd">400000</halo:OperatingLeaseAccretionOfLiability>
    <us-gaap:OperatingLeaseCost
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTQ0MQ_ea41fca7-59a6-4cb1-bf1d-d5b5c7daca39"
      unitRef="usd">1500000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTQ0OA_e8f376f0-36f1-4fdf-85c8-107368e7e21e"
      unitRef="usd">1700000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU0NA_71b487a9-4b1d-46d9-a40b-a3bfec0c5f39"
      unitRef="usd">600000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU1MQ_03ab2748-ad00-4394-ab43-f6fe15b66a71"
      unitRef="usd">800000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU1OQ_f5b6c87e-76d9-44bb-9f68-b7f911749b01"
      unitRef="usd">2000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y181OC9mcmFnOjJkMmZiZTUxODRhMzRmMGJhYzRhNTJhZmYwMGM0ODlkL3RleHRyZWdpb246MmQyZmJlNTE4NGEzNGYwYmFjNGE1MmFmZjAwYzQ4OWRfMTU2Ng_db2bcb5e-55b3-45ea-a464-907fd57b6ccb"
      unitRef="usd">2500000</us-gaap:OperatingLeasePayments>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI1Ng_a0c8cac5-403b-4feb-99a4-3142a93a7c74">Debt, Net&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;0.25% Convertible Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, we completed the sale of $805.0&#160;million in aggregate principal amount of 0.25% Convertible Senior Notes due 2027 (the &#x201c;2027 Convertible Notes&#x201d; and collectively with the 2024 Convertible Notes the &#x201c;Convertible Notes&#x201d;). The net proceeds in connection with the issuance of the 2027 Convertible Notes, after deducting the initial purchasers&#x2019; fee of $20.1&#160;million, was approximately $784.9&#160;million. We also incurred additional debt issuance costs totaling $0.4&#160;million. Debt issuance costs and the initial purchasers&#x2019; fee are presented as a debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2027 Convertible Notes pay interest semi-annually in arrears on March 1st and September 1st of each year at an annual rate of 0.25%. The 2027 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2027 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of our current or future subsidiaries. The 2027 Convertible Notes have a maturity date of March 1, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their 2027 Convertible Notes at their option only in the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021, if the last reported sale price per share of  common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the &#x201c;measurement period&#x201d;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on our common stock, as described in the offering memorandum for the 2027 Convertible Notes; (4) if we call such notes for redemption; and (5) at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately before the maturity date. The Notes will be convertible, regardless of the foregoing circumstances, at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately preceding the maturity date. As of September&#160;30, 2021, the 2027 Convertible Notes are not convertible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion, we will pay cash for the settlement of principal and for the premium, if applicable, we will pay cash, deliver shares of common stock or a combination of cash and shares of common stock, at our election. The initial conversion rate for the 2027 Convertible Notes will be 12.9576 shares of common stock per $1,000 in principal amount of 2027 Convertible Notes, equivalent to a conversion price of approximately $77.17 per share of our common stock. The conversion rate is subject to adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, we were in compliance with all covenants and there was no material adverse change in our business, operations or financial condition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;1.25% Convertible Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we completed the sale of $460.0 million in aggregate principal amount of 1.25% Convertible Senior Notes due 2024 (&#x201c;2024 Convertible Notes&#x201d;). The net proceeds in connection with the 2024 Convertible Notes, after deducting  the initial purchasers&#x2019; fee of $12.7&#160;million, was approximately $447.3 million. We also incurred debt issuance cost totaling $0.3&#160;million. Debt issuance costs and the initial purchasers&#x2019; fee are presented as a debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Convertible Notes pay interest semi-annually in arrears on June 1st and December 1st of each year, beginning on June 1, 2020, at an annual rate of 1.25%. The 2024 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2024 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of the our current or future subsidiaries. The 2024 Convertible Notes have a maturity date of December 1, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their 2024 Convertible Notes at their option only in the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on March&#160;31, 2020, if the last reported sale price per share of common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2)&#160;during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the &#x201c;measurement period&#x201d;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3)&#160;upon the occurrence of certain corporate events or distributions on our common &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;stock, as described in the offering memorandum for the 2024 Convertible Notes; (4)&#160;if we call such notes for redemption; and (5)&#160;at any time from, and including, June&#160;1, 2024 until the close of business on the scheduled trading day immediately before the maturity date. As of September&#160;30, 2021, the 2024 Convertible Notes are convertible and are classified as a current liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021 we notified the note holders of our irrevocable election to settle the principal of the 2024 Convertible Notes in cash and for the premium, if applicable, to deliver shares of common stock. The conversion rate for the 2024 Convertible Notes will be 41.9208 shares of common stock per $1,000 in principal amount of 2024 Convertible Notes, equivalent to a conversion price of approximately $23.85 per share of our common stock. The conversion rate is subject to adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, we completed a privately negotiated induced conversion of $369.1&#160;million principal amount of the 2024 Convertible Notes (&#x201c;Note Repurchases&#x201d; or the &#x201c;Induced Conversion&#x201d;). In connection with the Induced Conversion, we paid approximately $370.2&#160;million in cash, which includes principal and accrued interest, and issued approximately 9.08&#160;million shares of our common stock representing the intrinsic value based on the contractual conversion rate and incremental shares as an inducement for conversion. As a result of the Induced Conversion, we recorded $21.0 million in induced conversion expense which is included in Other income (expense) of the Condensed Consolidated Statements of Operations for the nine months ended September&#160;30, 2021. The induced conversion expense represents the fair value of the common stock issued upon conversion in excess of the common stock issuable under the original terms of the 2024 Convertible Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, we were in compliance with all covenants and there was no material adverse change in our business, operations or financial condition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Carrying Amounts of the Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount and fair value of our Convertible Notes were as follows as of the dates indicated. As disclosed in Note 2, we early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis which adoption is reflected in the following table (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value based on trading levels (Level 2):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining amortization per period of debt discount (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our Convertible Notes for the periods shown (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coupon Interest:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Coupon Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rates:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalty-backed Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2016, through our wholly-owned subsidiary Halozyme Royalty LLC (&#x201c;Halozyme Royalty&#x201d;), we received a $150 million loan (the &#x201c;Royalty-backed Loan&#x201d;) pursuant to a credit agreement (the &#x201c;Credit Agreement&#x201d;) with BioPharma Credit Investments IV Sub, LP and Athyrium Opportunities II Acquisition LP (the &#x201c;Royalty-backed Lenders&#x201d;). Under the terms of the Credit Agreement, Halozyme Therapeutics, Inc. transferred to Halozyme Royalty the right to receive royalty payments from the commercial sales of ENHANZE products owed under the Roche Collaboration and Baxalta Collaboration (&#x201c;Collaboration Agreements&#x201d;). The royalty payments from the Collaboration Agreements were used to repay the principal and interest on the loan (the &#x201c;Royalty Payments&#x201d;).&#160; The Royalty-backed Loan bore interest at a per annum rate of 8.75% plus the three-month LIBOR rate. The three-month LIBOR rate was subject to a floor of 0.7% and a cap of 1.5%.&#160;In June 2020, we paid the full remaining balance and final payment of $2.93 million thereby satisfying and discharging all obligations under, and terminating, the Royalty-backed Loan.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTAx_f3555944-bb3b-46ec-aad6-9ead75e3f531"
      unitRef="usd">805000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTM3_1b8376f1-65ba-459d-8354-0428e86496cb"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDA2_4b24a432-df99-47b1-87d2-137f53adfab5"
      unitRef="usd">20100000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i1155e6c14a0c4e65a515fa1e38dd911c_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDI4_42214d3b-12e0-4721-9dcc-c22f61a22435"
      unitRef="usd">784900000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i0c4cf1db12cd4ea3a46151468a622bcc_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDg5_c19a6e4a-1853-41f7-8366-cb755f66005d"
      unitRef="usd">400000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNzA5_61c7e0d1-1af6-4d01-b647-786705ea5069"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTYyNQ_1145d2e1-8588-4e01-adda-ff014e1e8a7d"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTY3Mw_7419b2d4-0879-471a-ae82-9db7b6c556f5"
      unitRef="trading_day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i7dc581c114814ebaae9b21ece1ceed55_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTcwMA_c2d23c6e-2ce0-4088-a633-d15d05561f61"
      unitRef="trading_day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTgzNw_6fee4c25-a5dd-400a-9932-f2ede508c4cb"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTg4OA_828409f0-c862-45f0-a181-a8c0cdfa5e14"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMTkyOA_db2335cd-ad74-4c42-89e8-1189af335c65"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="if78ade0bf1ca4e2bb2672bec40431e27_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMjExNA_896f1612-fb2b-4f80-9c72-aa8c7068c25b"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i0c4cf1db12cd4ea3a46151468a622bcc_D20210301-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzE4Ng_9cdb4500-aa0a-440f-bde7-b8f9636b75f1"
      unitRef="number">12.9576</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="id1b8854ddc4245fe8fa6364a2d16e5c9_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzMyMA_5b17af32-257e-4678-8d4a-ee15a141189d"
      unitRef="usdPerShare">77.17</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentCovenantCompliance
      contextRef="ibd6310c76bae4bd78ad9a40cb2b6f8a5_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzQxOA_20470254-3456-4e34-8ea3-b64cf119457c">in compliance</us-gaap:DebtInstrumentCovenantCompliance>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzYxMA_924ef848-35a7-49ee-9cad-6519f6ab8996"
      unitRef="usd">460000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzY0Ng_92fc9440-06ab-4651-88c5-2d88de207cfc"
      unitRef="number">0.0125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzgyMw_57291ae6-aca6-45e4-9e5b-adcf1d907547"
      unitRef="usd">12700000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i0bc7c027cf8d468087b67594cb81b7d1_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzg0NQ_4fd62ed6-793e-4f81-babe-7c7c973f372b"
      unitRef="usd">447300000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i412aa96cc1ad40e191bb9fafe16fe2dd_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfMzg5NA_9cdef1fb-f64f-4aeb-94d6-31978815e750"
      unitRef="usd">300000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNDE0MA_c907ab4d-cf6c-4282-b2c3-6c00ac7c1927"
      unitRef="number">0.0125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i3e626483481f4563b913a234b6554eee_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTA2Mw_9581f201-206a-457c-8508-343803df6deb"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3e626483481f4563b913a234b6554eee_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTExMQ_8d3d2607-f10d-44c8-b777-43c5be0f77ca"
      unitRef="trading_day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3e626483481f4563b913a234b6554eee_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTEzOA_d189fdd5-1f69-477f-844c-dc565756f089"
      unitRef="trading_day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTI3NQ_2c8db6cd-1651-4d5b-8d3f-1d3f44530f4f"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTMyNg_4f0425ef-0351-4c69-a1bd-37e79568ca9e"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTM2Ng_5521945e-96d8-4ae0-9caa-75955c261aee"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i4a42caa6fab847b0af7f0a13c6582d03_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNTU1Mg_60e1a757-b2fd-47f9-b5bd-032c829e63ee"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i412aa96cc1ad40e191bb9fafe16fe2dd_D20191101-20191130"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjQxMQ_a488b34f-706d-4c29-b815-ba1efb76e9ee"
      unitRef="number">41.9208</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i393fdf8c6c074ff4af6c97a05f547bc5_I20191130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjU0NQ_a825cc87-1846-4934-9b1d-03fd4cf99129"
      unitRef="usdPerShare">23.85</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i55a4ed926b904e02ab845282be395019_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjY5OA_bfe7e1b3-e14f-4146-8fb0-30c64dabc1aa"
      unitRef="usd">369100000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i55a4ed926b904e02ab845282be395019_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjg2Mw_28ed0064-374d-40ef-9008-0232d9b3db1d"
      unitRef="usd">370200000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i55a4ed926b904e02ab845282be395019_D20210301-20210331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNjk0Nw_589253d3-9374-4d20-a75c-c70eada21810"
      unitRef="shares">9080000.00</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNzE1OA_31f22cb3-c1af-46a7-843d-9004fd24809b"
      unitRef="usd">21000000</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:InducedConversionOfConvertibleDebtExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfNzE1OA_99b04cb7-8352-4e2e-98bb-a83b52b9bad3"
      unitRef="usd">21000000</us-gaap:InducedConversionOfConvertibleDebtExpense>
    <us-gaap:DebtInstrumentCovenantCompliance
      contextRef="ibd6310c76bae4bd78ad9a40cb2b6f8a5_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI2OA_20470254-3456-4e34-8ea3-b64cf119457c">in compliance</us-gaap:DebtInstrumentCovenantCompliance>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI2NQ_c875200c-0202-45cc-a157-64bfeaa1c0af">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Carrying Amounts of the Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount and fair value of our Convertible Notes were as follows as of the dates indicated. As disclosed in Note 2, we early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis which adoption is reflected in the following table (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value based on trading levels (Level 2):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of outstanding notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining amortization per period of debt discount (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMi0yLTEtMS0w_d842c354-c035-4eab-b1cc-89cb9536d28f"
      unitRef="usd">90936000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMi00LTEtMS0w_b46fa4e2-d27b-4f11-8744-777d2aec3401"
      unitRef="usd">460000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMy0yLTEtMS0w_72d5da3b-f149-4574-bc87-957404f14024"
      unitRef="usd">805000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMy00LTEtMS0w_60697ca6-447c-40d2-aa44-e3e7e08f0503"
      unitRef="usd">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNC0yLTEtMS0w_e5e68855-2bed-4e63-bd7a-bd766ac3f88e"
      unitRef="usd">895936000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNC00LTEtMS0w_46e52d33-bae9-4744-a861-5bcc6388e507"
      unitRef="usd">460000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNy0yLTEtMS0w_6e40bdcb-06d3-43bb-a53b-84497181df0a"
      unitRef="usd">1685000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfNy00LTEtMS0w_a15c21d8-3ed0-4800-8ab5-c51734ab33e0"
      unitRef="usd">10211000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOC0yLTEtMS0w_065e41c5-605f-459c-afc0-308da43b8b50"
      unitRef="usd">18546000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOC00LTEtMS0w_8ad283b5-f5d8-426e-8f09-cbe65ea62da9"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOS0yLTEtMS0w_2c04f137-4be0-4b2c-a4df-8f7b51f00cce"
      unitRef="usd">20231000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfOS00LTEtMS0w_cc082551-4932-47c8-a6a6-c0f404faccb6"
      unitRef="usd">10211000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebtCurrent
      contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTItMi0xLTEtMA_c87d5101-475f-43ad-85eb-ac0460aedd59"
      unitRef="usd">89251000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTItNC0xLTEtMA_886d3485-deae-4c91-8072-de4d0070cca2"
      unitRef="usd">449789000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebt
      contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTMtMi0xLTEtMA_f232fd44-988f-420a-b2c7-456ad6acec62"
      unitRef="usd">786454000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTMtNC0xLTEtMA_09e82e4c-2616-4497-8286-15958e05612d"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTQtMi0xLTEtMA_ef52b34a-cbc3-4cd4-af3f-8e3b6340cb89"
      unitRef="usd">875705000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTQtNC0xLTEtMA_aff1c087-bb51-42f7-9e33-b2f7682c3a46"
      unitRef="usd">449789000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i92cb63e1a7f24252ad3551517bf1a288_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTctMi0xLTEtMA_362edaa0-3115-4e32-9dc6-3a3881286b2d"
      unitRef="usd">162068000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i54214aa1ec4a42d1b45a0d558cf1548c_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTctNC0xLTEtMA_06fcaf2b-f6d8-425d-90ac-ddeb69043baf"
      unitRef="usd">861738000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idc5af33153364e0e95a999a7eaa312d1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTgtMi0xLTEtMA_8164740c-7497-4a11-aac5-be3e870a683f"
      unitRef="usd">731351000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icd8cb28bb49f44cebedc6e40327ee290_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTgtNC0xLTEtMA_9b19f243-19e0-4d1c-9f56-c1c73e2a3786"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTktMi0xLTEtMA_099b94d7-ae77-455b-a71e-6cb0a3ec9e13"
      unitRef="usd">893419000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i70f1bbb3227642cd885e12ed12239f7d_I20210101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMTktNC0xLTEtMA_66ddffe7-df28-4a37-8e3b-6ef7ae3beedf"
      unitRef="usd">861738000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="i57fd176ba4c740bd84df4e3fe9c28ccb_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMjItMi0xLTEtMA_7324b156-9f7f-44c6-a535-355e346467b0">P3Y2M12D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="iaef2086ff4f2483fbfd62522f9a2ad60_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMjItNC0xLTEtMA_cddb6cc5-b289-4831-bd47-66eabd642b08">P3Y10M24D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="id5074839e1194c76ae4dc87402cb085f_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjllNTAzNTIxODA1NTQ4N2I5NzVjZmFlYzllYzg2N2U2L3RhYmxlcmFuZ2U6OWU1MDM1MjE4MDU1NDg3Yjk3NWNmYWVjOWVjODY3ZTZfMjMtMi0xLTEtMA_399a549a-18b1-484c-8ff4-b2657661860f">P5Y4M24D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTI2Mw_fc54d578-60ce-4a52-ad4a-28eb194c6eac">&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for each of our Convertible Notes for the periods shown (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coupon Interest:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Coupon Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective interest rates:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy0yLTEtMS0w_f8b6ccfc-e278-4290-802e-7f922f63f6bf"
      unitRef="usd">284000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy00LTEtMS0w_c97bdb7d-94b4-4a1e-85d9-fa816264809c"
      unitRef="usd">1438000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy02LTEtMS0w_4f7bc39c-159c-43b1-ab3f-139085560f34"
      unitRef="usd">1621000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMy04LTEtMS0w_de27b782-2898-4e1a-81a6-1743c1b43c7f"
      unitRef="usd">4313000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC0yLTEtMS0w_e3db0f49-62c0-4db0-b9f8-8e59ad246055"
      unitRef="usd">503000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC00LTEtMS0w_24063fcc-c87e-4162-a3f9-3e895fddc082"
      unitRef="usd">0</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i206c739252224af8a8948489d424ad8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC02LTEtMS0w_27c73656-1381-4423-a0d1-00cc6672b634"
      unitRef="usd">1174000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i686912eb766d40b18a385b1858670232_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNC04LTEtMS0w_76d64ff9-554a-4ab8-b1cd-9efe8131910d"
      unitRef="usd">0</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS0yLTEtMS0w_674788fe-f8a7-466c-ac3c-13a58782ccde"
      unitRef="usd">787000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS00LTEtMS0w_72d67cd0-f1da-4d7c-a884-e1d658a51e91"
      unitRef="usd">1438000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS02LTEtMS0w_fb30131e-dd3a-44c8-84fa-368cfb7b1ad3"
      unitRef="usd">2795000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:DebtInstrumentPeriodicPaymentInterest
      contextRef="i73ccd57126f347af88275529acfde43e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfNS04LTEtMS0w_2c9e3459-58c0-4cba-ba11-3de4081cbc5d"
      unitRef="usd">4313000</us-gaap:DebtInstrumentPeriodicPaymentInterest>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC0yLTEtMS0w_f094216a-3942-4603-9403-66db53986a54"
      unitRef="usd">126000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC00LTEtMS0w_d21b762c-3d5b-4a76-bef7-2f6a6bd9882e"
      unitRef="usd">3552000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC02LTEtMS0w_bb535bf5-9060-4b00-b5f2-2bc6c4868f1f"
      unitRef="usd">712000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOC04LTEtMS0w_4f656731-7334-43b5-8878-9d1230d86b1f"
      unitRef="usd">10522000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS0yLTEtMS0w_9aedb82c-9a4a-4dfe-8ee0-a244e5849603"
      unitRef="usd">842000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS00LTEtMS0w_0179c666-28f5-4093-b790-9e7c4e2f05a1"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i206c739252224af8a8948489d424ad8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS02LTEtMS0w_628441cc-c034-4c21-b080-6276484acae2"
      unitRef="usd">1962000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i686912eb766d40b18a385b1858670232_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfOS04LTEtMS0w_03192223-b123-480e-99c4-d16e101eb4c2"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtMi0xLTEtMA_9fabc509-2fa4-47a1-bf8b-f09fbadfc169"
      unitRef="usd">968000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtNC0xLTEtMA_a2e736a5-94d1-487d-bbca-e6a4ba8ebf8d"
      unitRef="usd">3552000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtNi0xLTEtMA_fa2d2baf-b748-4876-831b-ab089f6f8df9"
      unitRef="usd">2674000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i73ccd57126f347af88275529acfde43e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTAtOC0xLTEtMA_aa2f3043-5c08-4ed1-bb68-3c84a7903d0f"
      unitRef="usd">10522000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="id7fa739339fb4a6a8e7f88bcfee873fb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtMi0xLTEtMA_0041978c-f205-46ee-bd53-e0349984954a"
      unitRef="usd">410000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i2bcb8beeed974876967151c7a4b11721_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtNC0xLTEtMA_2cab9e86-9a16-48ae-a431-bec939338521"
      unitRef="usd">4990000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i81bf436bc9c1499789ae8abb819b12c6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtNi0xLTEtMA_e1a0c268-9a7e-42fb-b065-2344d4a445d7"
      unitRef="usd">2333000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ibb94bd45186f406e95b75ee9961af104_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTMtOC0xLTEtMA_c5ccecff-513a-44e5-8ff1-3359db1ce926"
      unitRef="usd">14835000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i9d916fefd9284e4f8edd671a84e1217e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtMi0xLTEtMA_36cc38e5-bb49-485e-bf4c-20496dcc8eb0"
      unitRef="usd">1345000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ie7e0a2ee6e604c0abf559d6be9fce735_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtNC0xLTEtMA_a2ee4e6b-8241-4a63-970e-170bb8b43bce"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i206c739252224af8a8948489d424ad8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtNi0xLTEtMA_480f7e1d-3706-46ce-934b-b0811be92f03"
      unitRef="usd">3136000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i686912eb766d40b18a385b1858670232_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTQtOC0xLTEtMA_61397b4e-ca3e-45c0-bfd9-9ed9c6f56bdb"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i318f55fcb02b4a91823230c8dd273566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtMi0xLTEtMA_bb562589-4bf5-4cd1-add3-987f3508625e"
      unitRef="usd">1755000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ia13fad8cc19d4c45ba25db276b5b65b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtNC0xLTEtMA_fc8932f9-42a1-4627-a125-5733b7f5505f"
      unitRef="usd">4990000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i85f8efd761a24e769372c4fb05953d41_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtNi0xLTEtMA_2fe979af-9658-4dc5-8342-eca01b2fe6af"
      unitRef="usd">5469000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i73ccd57126f347af88275529acfde43e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTUtOC0xLTEtMA_e16ff252-ea25-49b4-8953-454a510a6abb"
      unitRef="usd">14835000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic5bb0843b04c43068da2dc6c03a064e3_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtMi0xLTEtMA_39f86d34-e369-451d-8b47-77dd59ce69bb"
      unitRef="number">0.018</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ie190bf0480c1487b9eb3d0916f7ffd88_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtNC0xLTEtMA_34eb794b-6c59-4846-a48a-b4f1e701767b"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic5bb0843b04c43068da2dc6c03a064e3_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtNi0xLTEtMA_f63ab6f9-027d-44b9-be97-ef3cf918e1d1"
      unitRef="number">0.018</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ie190bf0480c1487b9eb3d0916f7ffd88_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTgtOC0xLTEtMA_a905e76a-139c-4b59-bdec-695a71a30050"
      unitRef="number">0.051</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i0cb4364368aa4364afadbad891bba742_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTktMi0xLTEtMA_4a71af13-b0a6-4f04-b957-76321ab19759"
      unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i0cb4364368aa4364afadbad891bba742_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RhYmxlOjA1ODAyOTgxMzc3MDRmMDY4ZjQwZGZmYTU1NTc4Mjk3L3RhYmxlcmFuZ2U6MDU4MDI5ODEzNzcwNGYwNjhmNDBkZmZhNTU1NzgyOTdfMTktNi0xLTEtMA_40fec283-9411-46cf-a207-048a08c646ab"
      unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8cd6bdc962914e4c99408077c340d9e7_I20160131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfODI4MQ_11bb947a-58fe-4170-b80a-abc5b4d2a920"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8cd6bdc962914e4c99408077c340d9e7_I20160131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfODk3Mg_9cd7f4ca-4ad8-4cb2-b828-589e5e3c1c54"
      unitRef="number">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i05a350efec6041e4ad6404c46e10b7d7_D20160101-20160131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTA2MQ_fc33e3da-c221-475a-a1a4-59fd7f76c3bd"
      unitRef="number">0.007</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6fc00725d97c48d58939d926e50427aa_D20160101-20160131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTA3Nw_0d67c301-516c-4b01-b461-460b646a7a83"
      unitRef="number">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:RepaymentsOfDebt
      contextRef="ic9b79a7919f047598af257757cc3e833_D20200601-20200630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182MS9mcmFnOjA3YTJkMDg3Yzk3YTRlZWRhNDNmZmU3NDMxMGMxOTk2L3RleHRyZWdpb246MDdhMmQwODdjOTdhNGVlZGE0M2ZmZTc0MzEwYzE5OTZfOTE1MQ_65607463-bcfc-48a5-8660-7f42c7f4881d"
      unitRef="usd">2930000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ2NQ_85cdbe0c-0a58-4743-b365-3e6fa342d4d2">Share-based Compensation&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense related to share-based awards was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by type of share-based award (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs, RSUs, PSUs and ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We granted stock options to purchase approximately 32.5 thousand and 34.7 thousand shares of common stock during the three months ended September&#160;30, 2021 and 2020, respectively, and $0.7 million and $1.5 million shares of common stock during the nine months ended September&#160;30, 2021 and 2020, respectively. The exercise price of stock options granted is equal to the closing price of the common stock on the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes-Merton option pricing model (&#x201c;Black-Scholes model&#x201d;). Expected volatility is based on historical volatility of our common stock. The expected term of options granted is based on analyses of historical employee termination rates and option exercises. The risk-free interest rate is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The dividend yield assumption is based on the expectation of no future dividend payments. The assumptions used in the Black-Scholes model were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.90-44.73%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.58-51.82%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.90-46.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.58-51.82%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66-0.89%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22-0.31%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36-0.89%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22-1.67%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, our Board of Directors approved our 2021 ESPP and our stockholders approved the plan in May 2021. The ESPP enables eligible employees to purchase shares of our common stock at the end of each offering period at a price equal to 85% of the fair market value of the shares on the first business day or the last business day of the offering period, whichever is lower. Share purchases are funded through payroll deduction of at least 1% and up to 15% of an employee&#x2019;s compensation for each payroll period, and no employee may purchase shares under the ESPP that exceeds $25,000 worth of our common stock for a calendar year. As of September&#160;30, 2021, 2,700,000 shares were available for future purchase. The offering period is generally for a six-months period and the first offering period commenced on June 16, 2021. Offering periods shall commence on or about the sixteenth day of June and December of each year and end on or about the fifteenth day of the next December and June respectively, occurring thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unrecognized estimated compensation cost by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized&lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining&lt;br/&gt;Weighted-Average&lt;br/&gt;Recognition Period&lt;br/&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjUwOA_a950007c-f782-4e08-809c-d6de9ba860d0">&lt;div style="margin-top:6pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense related to share-based awards was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6935de8b3c224975955d989d869bb9c2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi0yLTEtMS0w_053e7ce4-659e-469d-a580-3a48b0c10a2b"
      unitRef="usd">1842000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if714bbad33ad4917992f139e44fd69a2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi00LTEtMS0w_f224818a-bc07-4137-a7f4-a2d4ec6eea07"
      unitRef="usd">1262000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i23a37442fa874dafb84523a3cca2bb91_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi02LTEtMS0w_1c4e07b3-d734-4f05-bac9-e4a8da971515"
      unitRef="usd">5254000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0ba5ad85eda24a959bfa0546f86a7844_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMi04LTEtMS0w_d9c73152-fa63-441b-994c-80a213cf4a34"
      unitRef="usd">4115000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia888539718ab4742979a05f4e932df96_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy0yLTEtMS0w_13955304-e866-4023-b65d-dd01aee9f97e"
      unitRef="usd">3557000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3782dfbd667f4a0687f611f008d2010f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy00LTEtMS0w_2dae0fac-3a1e-4aea-91e2-ac4d44a4e3d8"
      unitRef="usd">2958000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idec1669a6ad4449fb85d6e5157147d08_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy02LTEtMS0w_79f9fddb-41a9-4e6a-9d26-1e62c8275cf5"
      unitRef="usd">10440000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3d3c879cf61d4eacae3a4dff1a71d41b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfMy04LTEtMS0w_303a67b0-3d4a-4699-8b7a-539601eaa2dc"
      unitRef="usd">8893000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC0yLTEtMS0w_0b123e56-0a7b-4aec-8acf-4cbf36b37ff6"
      unitRef="usd">5399000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC00LTEtMS0w_31b93d83-13ac-4f12-8330-c32175e2ec8f"
      unitRef="usd">4220000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC02LTEtMS0w_ddcd2cb0-6aa7-4b90-9631-9bce93a69347"
      unitRef="usd">15694000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjQ1ZGI0ZDk4NmIxNjQxNDY4NmNmMTdhYjcyODhkMjQxL3RhYmxlcmFuZ2U6NDVkYjRkOTg2YjE2NDE0Njg2Y2YxN2FiNzI4OGQyNDFfNC04LTEtMS0w_0c4e704a-24ac-47c9-8a71-3dfcf799083f"
      unitRef="usd">13008000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ1NA_14ae2121-e63c-4478-9819-534de264adba">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by type of share-based award (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs, RSUs, PSUs and ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie22bc32765cc456cb791da8766cc1e95_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi0yLTEtMS0w_960b94a5-7121-4083-b6ac-719e3eefd3bf"
      unitRef="usd">2629000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i991a03f67f0b48beb763927b3126b6ee_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi00LTEtMS0w_3039593c-b598-4071-aed2-a207a5c40acd"
      unitRef="usd">2182000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi02LTEtMS0w_3f9db6b2-0014-4365-98e1-f2367b39fce5"
      unitRef="usd">7747000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMi04LTEtMS0w_60ba83e4-3175-465e-8a51-68c4fd0510cf"
      unitRef="usd">6766000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iad66576159674e89ac18ab298f2dbcdc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy0yLTEtMS0w_486101af-7340-4a24-b414-71ca98360014"
      unitRef="usd">2770000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i56b8f532e5be4b9985264987e5461803_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy00LTEtMS0w_3e46ed90-176a-41e4-b475-c262b2c1cf30"
      unitRef="usd">2038000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icf0bf4633edb46a299d1efbda6de0f73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy02LTEtMS0w_75c4147e-b2bf-4d4b-bd77-b8b4da4e458e"
      unitRef="usd">7947000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9f0e8a1da30a4e6491620fc881ff1298_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfMy04LTEtMS0w_a5122d8b-abc7-4c0b-a5fd-9382200077a3"
      unitRef="usd">6242000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC0yLTEtMS0w_1e4cba69-f785-48a0-b006-f9842bb1f5fa"
      unitRef="usd">5399000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC00LTEtMS0w_c57d45b2-7bb4-46b6-aeec-45e8ac595288"
      unitRef="usd">4220000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC02LTEtMS0w_571b3ccd-f6dd-4258-839e-c90b2f541233"
      unitRef="usd">15694000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjIyMGIwNGIxNzI0ODQwMzRhZTAxOWUxZTczMzQyZmMxL3RhYmxlcmFuZ2U6MjIwYjA0YjE3MjQ4NDAzNGFlMDE5ZTFlNzMzNDJmYzFfNC04LTEtMS0w_d0f9d6d4-7479-452b-a9af-d60ed6984eae"
      unitRef="usd">13008000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjgy_3ae7a8f1-4f35-4169-887e-5356a22a11e8"
      unitRef="shares">32500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjg5_6acfb7a5-d313-4c95-925a-c561b0a920b6"
      unitRef="shares">34700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMzcx_44bce082-eda8-4b24-a146-05f673f2cabb"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMzc4_243bfff7-bceb-4e49-8680-65b48fff406e"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ3Nw_c2cbfa49-0259-4379-acd6-b778cbcc0b46">The assumptions used in the Black-Scholes model were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.187%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.90-44.73%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.58-51.82%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.90-46.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.58-51.82%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66-0.89%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22-0.31%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.36-0.89%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.22-1.67%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i524ae854807442c79db75cfe0fec0661_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi0yLTEtMS0yNzgvdGV4dHJlZ2lvbjo5YTRjYTk1OTNmNGM0NGE0YjRhYTE5NWI0MGQyMTVhZV8xMDk5NTExNjI3Nzk3_86b23f25-366b-4e64-9e57-753c68e372f7"
      unitRef="number">0.4290</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="id279be3e39fe4e73b119fc76b6f0e3e9_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi0yLTEtMS0yNzgvdGV4dHJlZ2lvbjo5YTRjYTk1OTNmNGM0NGE0YjRhYTE5NWI0MGQyMTVhZV8xMDk5NTExNjI3ODA4_6b6f94de-747c-4250-891c-2ad8aedca1bf"
      unitRef="number">0.4473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i777756be172547c79ef2d98b14af2e9f_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi00LTEtMS0wL3RleHRyZWdpb246YWE2MDkxN2Y0OGJkNDI4YTk1ZjdiM2E0Yjg2N2Q5NTBfMTA5OTUxMTYyNzg0NQ_b63e697c-f78a-4825-b5a2-425b349d5595"
      unitRef="number">0.5058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ifcc6657cf7204e4bb3546eb115b7bb0b_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi00LTEtMS0wL3RleHRyZWdpb246YWE2MDkxN2Y0OGJkNDI4YTk1ZjdiM2E0Yjg2N2Q5NTBfMTA5OTUxMTYyNzgwOQ_20e5d395-d93e-43d5-bd1b-650710cd4b9f"
      unitRef="number">0.5182</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="if5e243ecce6549b386466103e48f03b8_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi02LTEtMS0wL3RleHRyZWdpb246NjMzYmM2ZWI0M2Q3NGIzNWE4MjA4MWZiY2UxZTBjNDRfMTA5OTUxMTYyNzgwOQ_9d58cf9b-8a4c-414a-ba54-0777d50534ee"
      unitRef="number">0.4290</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i19137a9706c8440c91b3ac9170020347_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi02LTEtMS0wL3RleHRyZWdpb246NjMzYmM2ZWI0M2Q3NGIzNWE4MjA4MWZiY2UxZTBjNDRfMTA5OTUxMTYyNzgyMA_502e176e-5f27-46af-a15a-772298581a28"
      unitRef="number">0.4645</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i930e92c51aab40ecb52c8e784b177f6d_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi04LTEtMS0wL3RleHRyZWdpb246OTQ2ZTc4ZWNmZWU4NGVmNDllZmNiYTc2ZDY2NzZjZjlfMTA5OTUxMTYyNzgyNw_33854d84-2191-4a40-ab5b-29d9d245a132"
      unitRef="number">0.5058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i1a0c6e310d5c45ff9ba748668cdfb1c4_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMi04LTEtMS0wL3RleHRyZWdpb246OTQ2ZTc4ZWNmZWU4NGVmNDllZmNiYTc2ZDY2NzZjZjlfMTA5OTUxMTYyNzgzNg_e1261e7c-4bbb-41f5-be30-b66b439dbd9b"
      unitRef="number">0.5182</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy0yLTEtMS0w_ccd33e6f-ea9a-4e6d-821e-81eac69773b8">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy00LTEtMS0w_01995367-8b79-42ea-9688-e94ca2ffa7b4">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy02LTEtMS0w_6653bc14-54d3-4f16-9239-0365c1043a3e">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfMy04LTEtMS0w_d24640d9-5588-4d17-9d88-58dcb41bf1aa">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC0yLTEtMS01NzIvdGV4dHJlZ2lvbjoyNjk4ZGViMjZjNTU0MTIxOGE4ODZkMGJmNjJjZDBhYl8xMDk5NTExNjI3Nzk3_7c0ba2c1-1294-45fc-ab3e-1426d94556f1"
      unitRef="number">0.0066</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC0yLTEtMS01NzIvdGV4dHJlZ2lvbjoyNjk4ZGViMjZjNTU0MTIxOGE4ODZkMGJmNjJjZDBhYl8xMDk5NTExNjI3ODA3_8ba94b80-9726-4240-a8b0-81798f91f53c"
      unitRef="number">0.0089</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC00LTEtMS0wL3RleHRyZWdpb246ODQwMjgzN2ZlNmM4NDljOGIxZWJhNmRmZThmMmMxODBfMTA5OTUxMTYyNzc5NA_9dec311f-5514-4a22-b8ab-0a71f6d44850"
      unitRef="number">0.0022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC00LTEtMS0wL3RleHRyZWdpb246ODQwMjgzN2ZlNmM4NDljOGIxZWJhNmRmZThmMmMxODBfMTA5OTUxMTYyNzgwNQ_d4066790-f35f-46f6-8c85-0d3e2bb5876f"
      unitRef="number">0.0031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC02LTEtMS0wL3RleHRyZWdpb246MGVmZTUwNmRkMmQzNDgyMmFlNjk3ZTUzYjk3Y2EwNDlfMTA5OTUxMTYyNzgwMQ_ad1634f4-2d4f-4f7b-9002-1f8ce49ae5dd"
      unitRef="number">0.0036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC02LTEtMS0wL3RleHRyZWdpb246MGVmZTUwNmRkMmQzNDgyMmFlNjk3ZTUzYjk3Y2EwNDlfMTA5OTUxMTYyNzgxMQ_f9288d2a-b09a-4780-b2ec-c1e692a30031"
      unitRef="number">0.0089</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC04LTEtMS0wL3RleHRyZWdpb246MjZlMDEyYjBiM2U5NDRmZWI5MDU2NmFhZDBlNjk3NjBfMTA5OTUxMTYyNzgyMA_25dbca59-658c-47cb-a3c9-7697fbeaa826"
      unitRef="number">0.0022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNC04LTEtMS0wL3RleHRyZWdpb246MjZlMDEyYjBiM2U5NDRmZWI5MDU2NmFhZDBlNjk3NjBfMTA5OTUxMTYyNzgzMA_b3046346-0435-446d-b385-39e08ae29c9f"
      unitRef="number">0.0167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS0yLTEtMS0w_ca2c851e-b56d-4dd2-ae55-80740eb2d198"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS00LTEtMS0w_889553c2-b61a-4315-9adb-f6028e710d20"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS02LTEtMS0w_22c47667-da3a-4bf4-9f8b-46a7d7883d27"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOjc0ZmQ0YjM1ZDI4YjRmMzI5MmM0MmIxMDUwZTdhOTlhL3RhYmxlcmFuZ2U6NzRmZDRiMzVkMjhiNGYzMjkyYzQyYjEwNTBlN2E5OWFfNS04LTEtMS0w_78a723e6-58bf-4df3-9ae3-71f40686130b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="icd817f332517429098def9a226790157_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTQ3OQ_75176d2e-30f7-4baf-8aab-99487b9920ea"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate
      contextRef="ia25a711f34284d2cb31197de09c55937_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTY4MQ_0c8fc0eb-38e8-4e21-9bed-8bccb190abe8"
      unitRef="number">0.01</halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="ia25a711f34284d2cb31197de09c55937_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTY5NA_a01e1cde-a7db-47fa-b4fe-83519329cc37"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount
      contextRef="icd817f332517429098def9a226790157_D20210201-20210228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTgxNg_94ad2825-6fc9-4465-86e7-d497cac4bbf8"
      unitRef="usd">25000</halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i96eaae6aa21440828363d019cc8fb175_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMTg3Ng_6733c58f-cbc1-4708-b5d3-45ac7205a196"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod
      contextRef="icd817f332517429098def9a226790157_D20210201-20210228"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ1Nw_5dfbe192-8248-4bd2-ae04-633b163f11a4">P6M</halo:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RleHRyZWdpb246NWNkZjczODAzOTA0NDUxZGJhNTgwZjMwZjMxNThkMTJfMjQ2NA_aa9564c2-a0b3-458f-9f02-d9f4fdcd3645">&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unrecognized estimated compensation cost by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized&lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining&lt;br/&gt;Weighted-Average&lt;br/&gt;Recognition Period&lt;br/&gt;(years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i5cc8bb9a58ee4f22a7917709a47d0c11_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfMi0yLTEtMS0w_f72de4a6-1884-4a73-8326-5630266140d4"
      unitRef="usd">22361000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfMi00LTEtMS0w_9b95f7fa-e25a-470f-9191-e0675f6f54ab">P2Y5M1D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ied5a4b70c0d2418886012876813052b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNC0yLTEtMS0w_a0f0cc2c-934a-4998-8be2-52ffc1ee5109"
      unitRef="usd">20211000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNC00LTEtMS0w_f9b270c0-52b8-49c5-bbb5-3502a4c50527">P2Y3M10D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i4a10b0624cac49329813b37fc11aefe5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNS0yLTEtMS0w_66173d8a-cf3a-4a0f-9693-967a972ff78c"
      unitRef="usd">2234000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i21bf5baccc98495a841b685c19034c72_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNS00LTEtMS0w_795eae64-e06e-43d5-a23c-58b8165a7bdc">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i7c625f6452334fda92249e711cf8c8e6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNi0yLTEtMS0w_e09749aa-453f-4ee9-bb06-85a62235846a"
      unitRef="usd">78000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie68b30dcf1104c92bfe3cf876434fc97_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y182NC9mcmFnOjVjZGY3MzgwMzkwNDQ1MWRiYTU4MGYzMGYzMTU4ZDEyL3RhYmxlOmViOTg5ODNiMTMxYTRjOTI4NjhjOWQwMzM0YzhlMjE0L3RhYmxlcmFuZ2U6ZWI5ODk4M2IxMzFhNGM5Mjg2OGM5ZDAzMzRjOGUyMTRfNi00LTEtMS0w_0cbec9e7-afa1-4da0-a5f6-54f2b9c482ab">P0Y2M15D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjQwMw_b1315c96-bfcc-4ca5-aa66-8675e7a0fe0e">Stockholders&#x2019; Equity &lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021 and 2020, we issued an aggregate of 931,749 and 3,952,311 shares of common stock, respectively, in connection with the exercises of stock options at a weighted average exercise price of $13.81 and $13.54 per share, respectively, for net proceeds of approximately $12.9 million and $53.5 million, respectively. For the nine months ended September&#160;30, 2021 and 2020, we issued 297,696 and 569,701 shares of common stock, respectively, upon vesting of certain RSUs and PSUs for which 94,795 and 142,905 RSUs were withheld from the RSU holders, respectively, to pay for minimum withholding taxes totaling approximately $8.2 million and $5.4 million, respectively. Stock options and unvested restricted units totaling approximately 6.3 million shares and 6.7 million shares of our common stock were outstanding as of September&#160;30, 2021 and December&#160;31, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we announced that the Board of Directors has authorized the initiation of a capital return program to repurchase up to $550.0 million of outstanding common stock over a three-year period. We may utilize a variety of methods including open market purchases, privately negotiated transactions, accelerated share repurchase programs or any combination of such methods. The Board will regularly review this capital return program in connection with a balanced capital allocation strategy. During 2019, we repurchased approximately 11.1&#160;million shares of common stock for $200.0&#160;million at an average price of $18.03. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2020, we repurchased 6.5&#160;million shares of common stock for $150.0&#160;million at an average price of $23.05. The shares were purchased through open market transactions and through an Accelerated Share Repurchase (ASR) agreement with Bank of America in December 2020, for which we repurchased $21.7&#160;million of common stock and received 0.5&#160;million shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In February 2021, we entered into an ASR agreement with Bank of America to repurchase $75.0&#160;million of common stock. At inception, pursuant to the agreement, we paid $75.0&#160;million to Bank of America and took an initial delivery of 1.3&#160;million shares. In April 2021, we finalized the transaction and received an additional 0.5&#160;million shares. We retired the repurchased shares and they resumed the status of authorized and unissued shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had the following activity under the approved share repurchase programs (dollars in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number of Shares Purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Price paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First quarter &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,376,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Included in the total cost of shares purchased is a commission fee of $0.02 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) This includes 0.5&#160;million shares delivered in April upon completion of the ASR.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfOTQ_35f85c7b-d265-4f0d-9889-9a9e9ffe1357"
      unitRef="shares">931749</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTAx_e25272c1-ca07-46b6-bb1a-b36fef38d021"
      unitRef="shares">3952311</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjMy_3a9fe837-6a5f-429a-b4b2-7d880b09447e"
      unitRef="usdPerShare">13.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjM5_036eace3-f694-45ca-8cf9-9ad2d0639074"
      unitRef="usdPerShare">13.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzAx_d01d4fb9-37e4-4efb-a7fc-c335fbdca724"
      unitRef="usd">12900000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzA4_04b51850-7d80-4777-bcbd-5f57f114787f"
      unitRef="usd">53500000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzcx_2633b2a7-69f0-4f90-b1d6-60c6c537de85"
      unitRef="shares">297696</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMzc4_07c03528-f87b-464b-96a5-68b6b21f503c"
      unitRef="shares">569701</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNDY3_eb4b28b7-1ed7-42e9-8481-a888528e0d5b"
      unitRef="shares">94795</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNDc0_7a14176b-1575-4350-9685-3b2eed8a8a76"
      unitRef="shares">142905</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie9a75e0ffe634cebb62740f8e9b4835c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNTky_b367d4ce-28fa-4c73-97b7-b1ba00df372c"
      unitRef="usd">8200000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ida1bbd437347471cb4c885b3d224600c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNTk5_cc5662d4-2482-4aa8-af6f-b5f4a37b87f8"
      unitRef="usd">5400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic605063c80bb49dd8a2679393c11b629_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNjg0_ee4f5a45-018e-4b4b-a906-a2f11c65b336"
      unitRef="shares">6300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i96692b1d30124ac7860fc3b510b76971_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfNjk4_ddbcd555-00e6-4ebc-8123-bace1ffd2cdd"
      unitRef="shares">6700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ie0eb7b940b8b45069c49b5e764d38ad3_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfOTMy_889093e0-c9e2-4651-b6d5-6509a6187851"
      unitRef="usd">550000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i0bc7c027cf8d468087b67594cb81b7d1_D20191101-20191130"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjQwNA_6fd03a59-b3bb-4082-90f7-2a5be412f12f">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i04b761c127644a42b2eb23927abd636d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTMyNQ_484e524b-a560-4a3a-a88f-35fdb379d69f"
      unitRef="shares">11100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i04b761c127644a42b2eb23927abd636d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTM1NQ_bc31a7b2-608a-44fd-bc25-5eb60671418e"
      unitRef="usd">200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i04b761c127644a42b2eb23927abd636d_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTM4MQ_1a2fda70-7a63-4474-9c1a-4b1dd5c1208b"
      unitRef="usdPerShare">18.03</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTQxNA_e2006d39-0b69-4106-b797-d460f8c06a25"
      unitRef="shares">6500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTQ0NA_32275efd-ee22-41da-b637-5568f352026c"
      unitRef="usd">150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ice5aa96afd4b4efaaf07e38c4b0a06b2_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTQ3MA_c9e87a13-a1ca-417e-975d-2b1965b9474e"
      unitRef="usdPerShare">23.05</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i74563819caa746e7b4b7466ded794e9c_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTY1Nw_86dff983-1ac5-4eff-9fe1-5f7bafb45d6a"
      unitRef="usd">21700000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i482105c008be423fb640367ac9200980_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTY4OQ_a6981f6e-2b52-42e4-a0f2-e81d1155c976"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i233725c2ad55441fb034d230594f0b46_D20210201-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTc4Nw_a6fd0f40-bcbe-49d4-89fb-ce27d959f9c6"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i233725c2ad55441fb034d230594f0b46_D20210201-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTg1Ng_b312d5b3-2fe5-46c5-af13-13238a2f9576"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id4ffcc29926a492a9b8cfa96fed2704b_D20210201-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTkxMA_54f663c4-997c-4eef-b6b6-d2f0429511ca"
      unitRef="shares">1300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i188943ac07244920b82f0519b3031931_D20210415-20210415"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMTk5Mg_0977df58-ef69-4416-bdd5-6b8ce076f00c"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjQxMQ_818743ff-33f7-458e-9683-6d32eb724737">&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had the following activity under the approved share repurchase programs (dollars in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.287%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number of Shares Purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Price paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First quarter &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Second quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Third quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,376,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Included in the total cost of shares purchased is a commission fee of $0.02 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) This includes 0.5&#160;million shares delivered in April upon completion of the ASR.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMi0yLTEtMS0w_305f7a06-5b0f-471d-908c-76534a671bac"
      unitRef="shares">1775945</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMi00LTEtMS0w_3cec7f73-00d4-4276-936d-6709e47948f4"
      unitRef="usdPerShare">42.89</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMi02LTEtMS0w_baf25660-ca1c-4779-97ea-a5ba274c4a19"
      unitRef="usd">76179000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMy0yLTEtMS0w_882d7eb1-2b09-41f3-b72d-938a4ba021c9"
      unitRef="shares">1037547</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMy00LTEtMS0w_97be3ebf-8e0f-4c5e-ba03-27710aeb2aa2"
      unitRef="usdPerShare">47.05</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i12541dc57c734ab99430c5498d50e74b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfMy02LTEtMS0w_912618b7-a7fa-4c61-888c-ff77c634bef2"
      unitRef="usd">48842000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNC0yLTEtMS0w_b82bb0b7-04aa-4e73-85d3-01392a5b5999"
      unitRef="shares">1562613</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNC00LTEtMS0w_5caa77fa-017c-4e26-ac5c-b18b6913d1c3"
      unitRef="usdPerShare">41.40</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNC02LTEtMS0w_9e1bafc5-1eb4-4bab-9b28-e9f2ad65e4d1"
      unitRef="usd">64717000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNi0yLTEtMS0w_49984bc0-8939-41cd-b81d-b7b5696fb25c"
      unitRef="shares">4376105</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNi00LTEtMS0w_4cdf04f6-1ca4-44a4-a2ca-5834a59db668"
      unitRef="usdPerShare">43.35</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RhYmxlOjg2NWYwOTBhNjQzZTQ5NDE5MzcwZjFiMTFmZjdlNWNmL3RhYmxlcmFuZ2U6ODY1ZjA5MGE2NDNlNDk0MTkzNzBmMWIxMWZmN2U1Y2ZfNi02LTEtMS0w_58b8e1c0-e7c0-4375-ac40-881424550f4b"
      unitRef="usd">189738000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <halo:TreasuryStockAcquiredFeeCostPerShare
      contextRef="i2cff740f25a64292882ca5818bca4c59_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjMwOA_fda04152-6edc-41a0-a634-18e254dd0689"
      unitRef="usdPerShare">0.02</halo:TreasuryStockAcquiredFeeCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i188943ac07244920b82f0519b3031931_D20210415-20210415"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183MC9mcmFnOjUxYTdiMmMxNGNkNzQ2MzBiZGJlYjRiN2U1YmNkOTgxL3RleHRyZWdpb246NTFhN2IyYzE0Y2Q3NDYzMGJkYmViNGI3ZTViY2Q5ODFfMjM0MA_50ab1b62-b777-47a4-be82-58a5aa0ded21"
      unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RleHRyZWdpb246ZTA5NzZkMGRkYTU5NDEyMmI1ZWFlOWZhODljMmI5NzlfMTY1MQ_31815e65-97ff-487b-b9a0-a585b93703fd">Net Income per share&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per common share is computed by dividing net income for the period by the weighted average number of common shares outstanding during the period, without consideration for common stock equivalents. Outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and the Convertible Notes are considered common stock equivalents and are only included in the calculation of diluted earnings per common share when net income is reported and their effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares issuable upon vesting of stock options, RSAs, RSUs and PSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our Convertible Notes are determined using the if-converted method. Since we have committed to settle the principal amount of the Convertible Notes in cash upon conversion only, the number of shares for the conversion spread will be included as a dilutive common stock equivalent. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerators and the denominators of the basic and diluted net income per common share computations is as follows (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs, RSUs, PSUs and ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding for diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares which have been excluded from the calculation of diluted net income per common share because their effect was anti-dilutive, include the following (shares in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1). The anti-dilutive securities include outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and Convertible Notes</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RleHRyZWdpb246ZTA5NzZkMGRkYTU5NDEyMmI1ZWFlOWZhODljMmI5NzlfMTY1NA_bb9bbca6-6e31-46c4-a0b5-2679870437e5">A reconciliation of the numerators and the denominators of the basic and diluted net income per common share computations is as follows (in thousands, except per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive potential common stock outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSAs, RSUs, PSUs and ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding for diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy0yLTEtMS0w_f11ae758-873e-4bda-9b0a-7888b9bbb374"
      unitRef="usd">216587000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy00LTEtMS0w_329f599b-c7d0-4ad3-bb61-2dbf5918e2e7"
      unitRef="usd">36207000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy02LTEtMS0w_626e0e05-9fb4-4e0d-a667-35c5ccb104dc"
      unitRef="usd">335940000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMy04LTEtMS0w_d13ab8d4-bddf-4e82-a298-72bc927072da"
      unitRef="usd">55921000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS0yLTEtMS0w_5aa26652-2b5b-4dce-8aee-43431dc31258"
      unitRef="shares">142021000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS00LTEtMS0w_03a4e9d7-68ef-4b97-9edb-dfd3e3ceaa91"
      unitRef="shares">136578000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS02LTEtMS0w_19d1fb97-b697-4467-bc9d-78d4014c04c7"
      unitRef="shares">140815000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNS04LTEtMS0w_3dcca941-63af-4b71-8931-71910f4d45f8"
      unitRef="shares">136575000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie22bc32765cc456cb791da8766cc1e95_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy0yLTEtMS0w_e35f08a1-b4cd-4770-a276-18b12ca44392"
      unitRef="shares">2595000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i991a03f67f0b48beb763927b3126b6ee_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy00LTEtMS0w_7214d9f4-e2fc-47b7-bd63-fdc0d6cf171c"
      unitRef="shares">2182000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4fc5ffb8118d4efda4e7c7f4216f0e05_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy02LTEtMS0w_e57835d2-6333-4f97-84ea-3ba74c917026"
      unitRef="shares">2913000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0f509e5bd99d4208b94e9068a58f6b7b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfNy04LTEtMS0w_b6ba2833-e950-4edb-aee5-bd0b6cc92f0d"
      unitRef="shares">1936000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i02b22b0c2f2646bea792472d7f97d94f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC0yLTEtMS0w_7f497fa1-8e2e-4586-8d53-877997bde7fc"
      unitRef="shares">437000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i241b7f6a84b54adbb1af7e7476c1b810_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC00LTEtMS0w_ceafca04-6d14-42d2-be06-814c2b5df976"
      unitRef="shares">553000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5299df71ad7b40699940776b16949966_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC02LTEtMS0w_cf166f9b-8995-4902-aade-e8bac31a7116"
      unitRef="shares">571000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if9a61b1b587a4aad9bbfecff6ad6f475_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOC04LTEtMS0w_2217548b-dec8-4863-b6c0-a88924dd5391"
      unitRef="shares">538000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i065050ada4e544a2be29ac40313d14cf_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS0yLTEtMS0w_db70ae39-4bf9-4562-b87c-e61a69627ab9"
      unitRef="shares">1637000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia011b61b43c242d5a1e03e0cb7b02a60_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS00LTEtMS0w_02d8ef65-a01f-434f-9554-98aface8daf1"
      unitRef="shares">2768000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9bf62165ab9948da9eaf8cd763bd074a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS02LTEtMS0w_5833365e-39de-42eb-a167-34440c0daed3"
      unitRef="shares">3353000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i67b1f1cb883146f9a922816ce4291811_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfOS04LTEtMS0w_bea30e4e-b13a-47ff-a236-e7e74893abf0"
      unitRef="shares">922000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtMi0xLTEtMA_24a81ac4-0229-49c9-a6db-7509f420a72c"
      unitRef="shares">146690000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtNC0xLTEtMA_91ade34e-fea6-47ae-bc74-7c6f17f3fe6c"
      unitRef="shares">142081000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtNi0xLTEtMA_7e28f680-154a-412f-ad30-7ffdec31cd47"
      unitRef="shares">147652000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTAtOC0xLTEtMA_fec2b9ea-5862-47d5-b907-ebe01a35d51e"
      unitRef="shares">139971000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItMi0xLTEtMA_f9c2c0f4-e969-4768-8587-876bd23278ff"
      unitRef="usdPerShare">1.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItNC0xLTEtMA_871a3ce4-9474-4f7f-b7ea-c8192f337efa"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItNi0xLTEtMA_43fd443f-ab8c-4977-aa91-959ff2eb1c1b"
      unitRef="usdPerShare">2.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTItOC0xLTEtMA_97609c10-6ead-4130-a7a6-d0ff93f6ea02"
      unitRef="usdPerShare">0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtMi0xLTEtMA_115a7135-0b05-495b-b460-a2823c4fffcb"
      unitRef="usdPerShare">1.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtNC0xLTEtMA_280269a5-4e89-4380-b0f6-3bd869b54a3d"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtNi0xLTEtMA_f25f84ad-dfc4-4ba4-8986-f0046c50146a"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmYzNjBjYzI2Mjc4NDRiOWM5NzM1ZTRiYzI5NGUxZmQzL3RhYmxlcmFuZ2U6ZjM2MGNjMjYyNzg0NGI5Yzk3MzVlNGJjMjk0ZTFmZDNfMTMtOC0xLTEtMA_12cdb829-7377-48b3-9d06-06291d07d305"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RleHRyZWdpb246ZTA5NzZkMGRkYTU5NDEyMmI1ZWFlOWZhODljMmI5NzlfMTY1NQ_41a78ee1-a122-459d-8864-aa2a6547cc1c">&lt;div style="margin-top:11pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares which have been excluded from the calculation of diluted net income per common share because their effect was anti-dilutive, include the following (shares in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;&#160;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1). The anti-dilutive securities include outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and Convertible Notes</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi0yLTEtMS0w_b917dd43-5a46-43b6-a052-d4bb40873999"
      unitRef="shares">13600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i62841acca8054be1814600a79b223d76_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi0zLTEtMS0w_a2c70059-354e-4ea0-b8b2-676a600f2592"
      unitRef="shares">17600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi01LTEtMS0w_1b7c844c-d2d8-4657-bf7a-47617a111038"
      unitRef="shares">13500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i32263905767c45de917da63e14f56984_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183My9mcmFnOmUwOTc2ZDBkZGE1OTQxMjJiNWVhZTlmYTg5YzJiOTc5L3RhYmxlOmQ1YTA3MmMzZWFkYTRkOTE4M2E2OWYwNTJiNGI4MjhmL3RhYmxlcmFuZ2U6ZDVhMDcyYzNlYWRhNGQ5MTgzYTY5ZjA1MmI0YjgyOGZfMi03LTEtMS0w_8600931d-bb3a-43d2-b57f-3087d2c25125"
      unitRef="shares">9100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RleHRyZWdpb246YjM3MWZlY2Q1NTc3NGFhOGE4YzE0MTc4ZjVkYzQ0NTNfMTMwOA_53f0f1ef-eea9-477c-aa88-9b98a0971aac">Commitments and Contingencies&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may be involved in disputes, including litigation, relating to claims arising out of operations in the normal course of our business. Any of these claims could subject us to costly legal expenses and, while we generally believe that we have adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage or our policy limits may be inadequate to fully satisfy any damage awards or settlements. If this were to happen, the payment of any such awards could have a material adverse effect on our consolidated results of operations and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and business. We currently are not a party to any legal proceedings, the adverse outcome of which, in management&#x2019;s opinion, individually or in the aggregate, would have a material adverse effect on our consolidated results of operations or financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commitments include payments related to our commenced operating leases. Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands; excluding the nine months ended September&#160;30, 2021):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted-average remaining lease term of our operating leases is approximately 1.4 years.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RleHRyZWdpb246YjM3MWZlY2Q1NTc3NGFhOGE4YzE0MTc4ZjVkYzQ0NTNfMTMxNQ_c25294c3-70b0-45e0-a44b-9b2b54f5fa81">Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands; excluding the nine months ended September&#160;30, 2021):&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfMS0yLTEtMS0w_fd2777be-b3fe-483c-81d4-f5c85d4a4727"
      unitRef="usd">664000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfMi0yLTEtMS0w_cacad39f-a170-4a4e-84ea-7e5e526a9336"
      unitRef="usd">2711000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfMy0yLTEtMS0w_8836b36d-7ec8-4e03-bb95-5f042cbaefb8"
      unitRef="usd">215000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNC0yLTEtMS0w_611f89ec-a2b1-4a65-9125-3abca6376e3a"
      unitRef="usd">18000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNS0yLTEtMS0w_ad649a3b-f69b-43f1-857e-5e1f6264090f"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNi0yLTEtMS0w_5440df44-7a1e-4e5f-ace0-ff3845d97096"
      unitRef="usd">3608000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfNy0yLTEtMS0w_cd19d65b-2c24-41a1-a959-088b70fffebc"
      unitRef="usd">184000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RhYmxlOmEzYzk4MTE1ZDgzYjQ5MDNhYzJhZGFjNjFkY2EwMmZkL3RhYmxlcmFuZ2U6YTNjOTgxMTVkODNiNDkwM2FjMmFkYWM2MWRjYTAyZmRfOC0yLTEtMS0w_d1b779cb-3e41-458f-a142-788200433565"
      unitRef="usd">3424000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjBmNTJiZWFlMGNiMjQ1ZDc4NDNkNjlmMTE0NmRmYjZjL3NlYzowZjUyYmVhZTBjYjI0NWQ3ODQzZDY5ZjExNDZkZmI2Y183Ni9mcmFnOmIzNzFmZWNkNTU3NzRhYThhOGMxNDE3OGY1ZGM0NDUzL3RleHRyZWdpb246YjM3MWZlY2Q1NTc3NGFhOGE4YzE0MTc4ZjVkYzQ0NTNfMTI5Nw_c2c7dffc-d075-4419-8066-313c31d51bc0">P1Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208406792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HALOZYME THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0488686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11388 Sorrento Valley Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">794-8889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HALO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,787,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001159036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288915224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 491,683<span></span>
</td>
<td class="nump">$ 147,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, available-for-sale</a></td>
<td class="nump">324,237<span></span>
</td>
<td class="nump">220,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net and other contract assets</a></td>
<td class="nump">112,099<span></span>
</td>
<td class="nump">97,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">55,978<span></span>
</td>
<td class="nump">60,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other assets</a></td>
<td class="nump">33,302<span></span>
</td>
<td class="nump">28,274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,017,299<span></span>
</td>
<td class="nump">554,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">9,588<span></span>
</td>
<td class="nump">10,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent', window );">Prepaid expenses and other assets</a></td>
<td class="nump">15,552<span></span>
</td>
<td class="nump">14,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">142,481<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,185,420<span></span>
</td>
<td class="nump">579,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,322<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">18,335<span></span>
</td>
<td class="nump">20,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue, current portion</a></td>
<td class="nump">2,245<span></span>
</td>
<td class="nump">1,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt, net</a></td>
<td class="nump">89,251<span></span>
</td>
<td class="nump">397,228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">113,153<span></span>
</td>
<td class="nump">421,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">2,530<span></span>
</td>
<td class="nump">4,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">786,454<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,609<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock - $0.001 par value; 20,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">407,229<span></span>
</td>
<td class="nump">625,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(125,682)<span></span>
</td>
<td class="num">(474,593)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">281,674<span></span>
</td>
<td class="nump">151,047<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,185,420<span></span>
</td>
<td class="nump">$ 579,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">140,966,000<span></span>
</td>
<td class="nump">140,966,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">140,966,000<span></span>
</td>
<td class="nump">140,966,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208460952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">140,966,000<span></span>
</td>
<td class="nump">140,966,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">140,966,000<span></span>
</td>
<td class="nump">140,966,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">140,966,000<span></span>
</td>
<td class="nump">140,966,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">140,966,000<span></span>
</td>
<td class="nump">140,966,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding</a></td>
<td class="nump">140,966,000<span></span>
</td>
<td class="nump">135,030,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208471928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 115,830<span></span>
</td>
<td class="nump">$ 65,316<span></span>
</td>
<td class="nump">$ 341,307<span></span>
</td>
<td class="nump">$ 145,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of product sales</a></td>
<td class="nump">18,589<span></span>
</td>
<td class="nump">5,568<span></span>
</td>
<td class="nump">59,826<span></span>
</td>
<td class="nump">17,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">8,486<span></span>
</td>
<td class="nump">7,747<span></span>
</td>
<td class="nump">25,564<span></span>
</td>
<td class="nump">26,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">13,169<span></span>
</td>
<td class="nump">11,702<span></span>
</td>
<td class="nump">36,549<span></span>
</td>
<td class="nump">35,309<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">40,244<span></span>
</td>
<td class="nump">25,017<span></span>
</td>
<td class="nump">121,939<span></span>
</td>
<td class="nump">79,260<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">75,586<span></span>
</td>
<td class="nump">40,299<span></span>
</td>
<td class="nump">219,368<span></span>
</td>
<td class="nump">66,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Investment and other income, net</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">961<span></span>
</td>
<td class="nump">771<span></span>
</td>
<td class="nump">4,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InducedConversionOfConvertibleDebtExpense', window );">Inducement expense related to convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(20,960)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,754)<span></span>
</td>
<td class="num">(4,990)<span></span>
</td>
<td class="num">(5,471)<span></span>
</td>
<td class="num">(15,342)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net income before income taxes</a></td>
<td class="nump">74,106<span></span>
</td>
<td class="nump">36,270<span></span>
</td>
<td class="nump">193,708<span></span>
</td>
<td class="nump">56,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">(142,481)<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="num">(142,232)<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 216,587<span></span>
</td>
<td class="nump">$ 36,207<span></span>
</td>
<td class="nump">$ 335,940<span></span>
</td>
<td class="nump">$ 55,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 1.53<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="nump">$ 2.39<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 1.48<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Shares used in computing net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">142,021<span></span>
</td>
<td class="nump">136,578<span></span>
</td>
<td class="nump">140,815<span></span>
</td>
<td class="nump">136,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">146,690<span></span>
</td>
<td class="nump">142,081<span></span>
</td>
<td class="nump">147,652<span></span>
</td>
<td class="nump">139,971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 58,563<span></span>
</td>
<td class="nump">$ 23,931<span></span>
</td>
<td class="nump">$ 141,264<span></span>
</td>
<td class="nump">$ 56,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">25,047<span></span>
</td>
<td class="nump">9,048<span></span>
</td>
<td class="nump">77,173<span></span>
</td>
<td class="nump">23,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_CollaborativeAgreementsMember', window );">Revenues under collaborative agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 32,220<span></span>
</td>
<td class="nump">$ 32,337<span></span>
</td>
<td class="nump">$ 122,870<span></span>
</td>
<td class="nump">$ 65,760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InducedConversionOfConvertibleDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 40<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123467568&amp;loc=d3e6835-112609<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InducedConversionOfConvertibleDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_CollaborativeAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_CollaborativeAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045371749000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 216,587<span></span>
</td>
<td class="nump">$ 36,207<span></span>
</td>
<td class="nump">$ 335,940<span></span>
</td>
<td class="nump">$ 55,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(640)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized gain (loss) on foreign currency</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">$ 216,597<span></span>
</td>
<td class="nump">$ 35,547<span></span>
</td>
<td class="nump">$ 335,904<span></span>
</td>
<td class="nump">$ 56,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208578808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 335,940<span></span>
</td>
<td class="nump">$ 55,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used) in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">15,694<span></span>
</td>
<td class="nump">13,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,224<span></span>
</td>
<td class="nump">2,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">10,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of discounts on marketable securities, net</a></td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on disposal of equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(631)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Recognition of deferred revenue</a></td>
<td class="num">(997)<span></span>
</td>
<td class="num">(3,870)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_DeferredRentPayments', window );">Lease payments deferred</a></td>
<td class="num">(568)<span></span>
</td>
<td class="num">(759)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Loss on impairment of right-of-use asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InducedConversionOfConvertibleDebtExpense', window );">Induced conversion expense related to convertible notes</a></td>
<td class="nump">20,960<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes (benefits from valuation allowance release)</a></td>
<td class="num">(142,481)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net and other contract assets</a></td>
<td class="num">(14,369)<span></span>
</td>
<td class="num">(3,109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">5,152<span></span>
</td>
<td class="num">(28,338)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(6,513)<span></span>
</td>
<td class="num">(1,567)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(2,306)<span></span>
</td>
<td class="num">(40,134)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">216,924<span></span>
</td>
<td class="nump">4,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(283,354)<span></span>
</td>
<td class="num">(161,488)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">177,833<span></span>
</td>
<td class="nump">181,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,299)<span></span>
</td>
<td class="num">(805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">861<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(106,820)<span></span>
</td>
<td class="nump">19,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance of long-term debt, net</a></td>
<td class="nump">784,875<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(369,064)<span></span>
</td>
<td class="num">(19,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance cost</a></td>
<td class="num">(424)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(189,737)<span></span>
</td>
<td class="num">(109,970)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement</a></td>
<td class="nump">8,226<span></span>
</td>
<td class="nump">50,645<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">233,876<span></span>
</td>
<td class="num">(78,885)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">343,980<span></span>
</td>
<td class="num">(54,438)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">148,203<span></span>
</td>
<td class="nump">120,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">492,183<span></span>
</td>
<td class="nump">66,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Amounts accrued for purchases of property and equipment</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligation</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_PendingSettlementofCommonStockRepurchase', window );">Pending settlement of common stock repurchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued for induced conversion related to convertible notes</a></td>
<td class="nump">$ 7,865<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_DeferredRentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Rent Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_DeferredRentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_PendingSettlementofCommonStockRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pending Settlement of Common Stock Repurchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_PendingSettlementofCommonStockRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InducedConversionOfConvertibleDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 40<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123467568&amp;loc=d3e6835-112609<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InducedConversionOfConvertibleDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045203623832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 91,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="nump">$ 695,066,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="num">$ (603,678,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">13,008,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,008,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</a></td>
<td class="nump">50,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">50,641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock awards, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock awards, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(112,472,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,000)<span></span>
</td>
<td class="num">(112,466,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible notes</a></td>
<td class="num">(65,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">186,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">55,921,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,921,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2020</a></td>
<td class="nump">98,988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">646,184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">426,000<span></span>
</td>
<td class="num">(547,757,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Jun. 30, 2020</a></td>
<td class="nump">105,577,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="nump">688,318,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,086,000<span></span>
</td>
<td class="num">(583,964,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">4,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</a></td>
<td class="nump">12,546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">12,546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock awards, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock awards, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(58,902,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,000)<span></span>
</td>
<td class="num">(58,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(660,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(660,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">36,207,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,207,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2020</a></td>
<td class="nump">98,988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">646,184,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">426,000<span></span>
</td>
<td class="num">(547,757,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Dec. 31, 2020</a></td>
<td class="nump">151,047,000<span></span>
</td>
<td class="num">$ (52,564,000)<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">625,483,000<span></span>
</td>
<td class="num">$ (65,535,000)<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="num">(474,593,000)<span></span>
</td>
<td class="nump">$ 12,971,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">15,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock Issued During Period, Value, Conversion of Convertible Securities</a></td>
<td class="nump">13,104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="nump">13,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</a></td>
<td class="nump">8,226,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">8,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,376)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(189,737,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="num">(189,733,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(36,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">335,940,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">335,940,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2021</a></td>
<td class="nump">281,674,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000<span></span>
</td>
<td class="nump">407,229,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
<td class="num">(125,682,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Jun. 30, 2021</a></td>
<td class="nump">119,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,000<span></span>
</td>
<td class="nump">461,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,000)<span></span>
</td>
<td class="num">(342,269,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">5,399,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,399,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net</a></td>
<td class="nump">4,648,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">4,648,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,563)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(64,716,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(64,715,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">216,587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 281,674,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000<span></span>
</td>
<td class="nump">$ 407,229,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,000)<span></span>
</td>
<td class="num">$ (125,682,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045287856728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Business</a></td>
<td class="text">Organization and Business <div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme Therapeutics, Inc. is a biopharma technology platform company that provides innovative and disruptive solutions with the goal of improving patient experience and outcomes. Our proprietary enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. We license our technology to biopharmaceutical companies to collaboratively develop products that combine our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology with the collaborators&#8217; proprietary compounds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approved product and our collaborators&#8217; approved products and product candidates are based on rHuPH20, our patented recombinant human hyaluronidase enzyme. rHuPH20 is the active ingredient in our first commercially approved product, Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recombinant, (&#8220;Hylenex&#8221;), and it works by breaking down hyaluronan (or &#8220;HA&#8221;), a naturally occurring carbohydrate that is a major component of the extracellular matrix in tissues throughout the body such as skin and cartilage. This temporarily increases dispersion and absorption allowing for improved subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other large therapeutic molecules, as well as small molecules and fluids. We refer to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology (&#8220;ENHANZE&#8221;). We license the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. In the development of proprietary intravenous (IV) drugs combined with our ENHANZE technology, data have been generated supporting the potential for ENHANZE to reduce treatment burden, as a result of shorter duration of subcutaneous (SC) administration. ENHANZE may enable fixed-dose SC dosing compared to weight-based dosing required for IV administration, and potentially allow for lower rates of infusion related reactions.&#160;ENHANZE may enable more flexible treatment options such as home administration by a healthcare professional or potentially the patient. Lastly, certain proprietary drugs co-formulated with ENHANZE have been granted additional exclusivity, extending the patent life of the product beyond the one of the proprietary IV drug.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We currently have ENHANZE collaborations with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc. (&#8220;Roche&#8221;), Baxalta US Inc. and Baxalta GmbH (members of the Takeda group of companies) (&#8220;Baxalta&#8221;), Pfizer Inc. (&#8220;Pfizer&#8221;), Janssen Biotech, Inc. (&#8220;Janssen&#8221;), AbbVie, Inc. (&#8220;AbbVie&#8221;), Eli Lilly and Company (&#8220;Lilly&#8221;), Bristol-Myers Squibb Company (&#8220;BMS&#8221;), Alexion Pharma Holding (AstraZeneca PLC announced the completion of its acquisition of Alexion Pharmaceuticals, Inc. in July 2021) (&#8220;Alexion&#8221;), argenx BVBA (&#8220;argenx&#8221;), Horizon Therapeutics plc. (&#8220;Horizon&#8221;) and ViiV Healthcare (the global specialist HIV company majority owned by GlaxoSmithKline) (&#8220;ViiV&#8221;). We receive royalties from three of these collaborations, including royalties from sales of one product from the Baxalta collaboration, three products from the Roche collaboration and one product from the Janssen collaboration. Future potential revenues from royalties and fees from ENHANZE collaborations and the sales and/or royalties of our approved products will depend on the ability of Halozyme and our collaborators to develop, manufacture, secure and maintain regulatory approvals for approved products and product candidates and commercialize product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except where specifically noted or the context otherwise requires, references to &#8220;Halozyme,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; in these notes to the condensed consolidated financial statements refer to Halozyme Therapeutics, Inc. and its wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#8217;s wholly owned subsidiaries,  Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045202074584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) related to a quarterly report on Form 10-Q. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for a complete set of financial statements. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;23, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operations for the periods presented, with such adjustments consisting only of normal recurring adjustments. Operating results for interim periods are not necessarily indicative of the operating results for an entire fiscal year.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed consolidated financial statements include the accounts of Halozyme Therapeutics, Inc. and our wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#8217;s wholly owned subsidiaries, Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH. All intercompany accounts and transactions have been eliminated. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of interim unaudited condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in our interim unaudited condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#8217;s estimates.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents and Marketable Securities </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of highly liquid investments, readily convertible to cash, that mature within ninety days or less from the date of purchase. As of September&#160;30, 2021, our cash equivalents consisted of money market funds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities are investments with original maturities of more than ninety days from the date of purchase that are specifically identified to fund current operations. Marketable securities are considered available-for-sale. These investments are classified as current assets, even though the stated maturity date may be one year or more beyond the current balance sheet date which reflects management&#8217;s intention to use the proceeds from the sale of these investments to fund our operations, as necessary. Such available-for-sale investments are carried at fair value with unrealized gains and losses recorded in other comprehensive income (loss) and included as a separate component of stockholders&#8217; equity. The cost of marketable securities is adjusted for amortization of premiums or accretion of discounts to maturity, and such amortization or accretion is included in investment and other income, net in the interim unaudited condensed consolidated statements of operations. We use the specific identification method for calculating realized gains and losses on marketable securities sold. None of the realized gains and losses and declines in value judged to be as a result of credit loss on marketable securities, if any, are included in investment and other income, net in the interim unaudited condensed consolidated statements of operations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the leases of our facilities, we are required to maintain letters of credit as security deposits during the terms of such leases. At September&#160;30, 2021 and December&#160;31, 2020, restricted cash of $0.5 million was pledged as collateral for the letters of credit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments include cash equivalents, available-for-sale marketable securities, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses and long-term debt. Fair value estimates of these instruments are made at a specific point in time, based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued expenses are generally considered to be representative of their respective fair values because of the short-term nature of those instruments. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consist of asset-backed securities, corporate debt securities, U.S. Treasury securities and commercial paper, and are measured at fair value using Level 1 and Level 2 inputs. Level 2 financial instruments are valued using market prices on less active markets and proprietary pricing valuation models with observable inputs, including interest rates, yield curves, maturity dates, issue dates, settlement dates, reported trades, broker-dealer quotes, issue spreads, benchmark securities or other market related data. We obtain the fair value of Level 2 investments from our investment manager, who obtains these fair values from a third-party pricing source. We validate the fair values of Level 2 financial instruments provided by our investment manager by comparing these fair values to a third-party pricing source.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventories are reviewed periodically for potential excess, dated or obsolete status. We evaluate the carrying value of inventories on a regular basis, taking into account such factors as historical and anticipated future sales compared to quantities on hand, the price we expect to obtain for products in their respective markets compared with historical cost and the remaining shelf life of goods on hand.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, and December&#160;31, 2020, inventories consisted of $1.6 million and $1.3 million, respectively, of Hylenex inventory, net and $54.4 million and $59.4 million, respectively, of bulk rHuPH20. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has entered into operating leases primarily for real estate and automobiles. These leases have terms which range from 3 years to 6 years. We determine if an arrangement contains a lease at inception. Right of use (&#8220;ROU&#8221;) assets and liabilities resulting from operating leases are included in property and equipment, accrued expenses and other long-term liabilities on our condensed consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the discount rate to calculate the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our leases often include options to extend or terminate the lease. These options are included in the lease term when it is reasonably certain that we will exercise that option. Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as automobiles, we account for the lease and non-lease components as a single lease component. &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenues from payments received under collaborative agreements and product sales. We recognize revenue when we transfer promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers we perform the following five steps: (i) identify the promised goods or services in the contract; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy the performance obligations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues under Collaborative Agreements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these agreements, we grant the collaboration partner a worldwide license to develop and commercialize products using our ENHANZE technology to combine our patented rHuPH20 enzyme with their proprietary biologics directed at up to a specified number of targets. Targets are usually licensed on an exclusive, global basis. Targets selected subsequent to inception of the arrangement require payment of an additional license fee. The collaboration partner is responsible for all development, manufacturing, clinical, regulatory, sales and marketing costs for any products developed under the agreement. We are responsible for supply of bulk rHuPH20 based on the collaboration partner&#8217;s purchase orders and may also be separately engaged to perform research and development services. While these collaboration agreements are similar in that they originate from the same framework, each one is the result of an arms-length negotiation and thus may vary from one to the other.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect an upfront license payment from collaboration partners and are also entitled to receive event-based payments subject to collaboration partners&#8217; achievement of specified development, regulatory and sales-based milestones. In several agreements, collaboration partners pay us annual fees to maintain their exclusive license rights if they are unable to advance product development to specified stages. We earn separate fees for bulk rHuPH20 supplies and research and development services. In addition, collaboration partners will pay us royalties at an on average mid-single digit percent rate of their sales if products under the collaboration are commercialized. All amounts owed to us are noncancelable after the underlying triggering event occurs, and nonrefundable once paid. Unless terminated earlier in accordance with its terms, collaborations generally continue in effect until the last to expire royalty payment term, as determined on a product by product and on a country by country basis, with each royalty term starting on the first commercial sale of that product and ending the later of: (i) a specified period or term set forth in the agreement or (ii) expiration of the last to expire of the valid claims of our patents covering rHuPH20 or other specified patents developed under the collaboration which valid claim covers a product developed under the collaboration. When there are no valid claims during the applicable royalty term in a given country, the royalty rate is reduced for those sales. Collaboration partners may terminate the agreement prior to expiration for any reason in its entirety or on a target-by-target basis generally upon 90 days prior written notice to us.&#160;Upon any such termination, the license granted to collaboration partners (in total or with respect to the terminated target, as applicable) will terminate provided, however, that in the event of expiration of the agreement (as opposed to a termination), the on-going licenses granted will become perpetual, non-exclusive and fully paid.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although these agreements are in form identified as collaborative agreements, we concluded for accounting purposes they represent contracts with customers and are not subject to accounting literature on collaborative arrangements. This is because we grant to collaboration partners licenses to our intellectual property and provide supply of bulk rHuPH20 and research and development services which are all outputs of our ongoing activities, in exchange for consideration. Under these collaborative agreements, we do not develop assets jointly with collaboration partners, and do not share in significant risks of their development or commercialization activities. Accordingly, we concluded our collaborative agreements are appropriately accounted for pursuant to ASC Topic 606, Revenue from Contracts with Customers. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under all of our collaborative agreements, we have identified licenses to use functional intellectual property as the only performance obligation. The intellectual property underlying the license is our proprietary ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology which represents application of rHuPH20 to facilitate delivery of drugs or fluids. Each of the licenses grants the collaboration partners rights to use our intellectual property as it exists and is identified on the effective date of the license, because there is no ongoing development of the ENHANZE technology required. Therefore, we recognize revenue from licenses at the point when the license becomes effective and the collaboration partner has received access to our intellectual property, usually at the inception of the agreement.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When collaboration partners can select additional targets to add to the licenses granted, we consider these rights to be options. We evaluate whether such options contain material rights, i.e. have exercise prices that are discounted compared to what we would charge for a similar license to a new collaboration partner. The exercise price of these options includes a combination of the target selection fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, we conclude the option does not contain a material </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">right, and we consider grants of additional licensing rights upon option exercises to be separate contracts (target selection contracts).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customary indemnification and protection of licensed intellectual property for our customers. These provisions are part of assurance that the licenses meet the agreements&#8217; representations and are not obligations to provide goods or services.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also fulfill purchase orders for supply of bulk rHuPH20 and perform research and development services pursuant to projects authorization forms for our collaboration partners, which represent separate contracts. Additionally, we price our supply of bulk rHuPH20 and research and development services at our regular selling prices, called standalone selling price or &#8220;SSP&#8221;. Therefore, our collaboration partners do not have material rights to order these items at prices not reflective of SSP. Refer to the discussion below regarding recognition of revenue for these separate contracts.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for a contract represents the amount to which we are entitled in exchange for providing goods and services to the customer. Transaction price does not include amounts subject to uncertainties unless it is probable that there will be no significant reversal of revenue when the uncertainty is resolved. Apart from the upfront license payment (or target selection fees in the target selection contracts), all other fees we may earn under our collaborative agreements are subject to significant uncertainties of product development. Achievement of many of the event-based development and regulatory milestones may not be probable until such milestones are actually achieved. This generally relates to milestones such as obtaining marketing authorization approvals. With respect to other development milestones, e.g. dosing of a first patient in a clinical trial, achievement could be considered probable prior to its actual occurrence, based on the progress towards commencement of the trial. In order to evaluate progress towards commencement of a trial, we assess the status of activities leading up to our collaboration partner&#8217;s initiation of a trial such as feedback received from the  applicable regulatory authorities, completion of IND or equivalent filings, readiness and availability of drug, readiness of study sites and our collaboration partner&#8217;s commitment of resources to the program. We do not include any amounts subject to uncertainties into the transaction price until it is probable that the amount will not result in a significant reversal of revenue in the future. At the end of each reporting period, we re-evaluate the probability of achievement of such milestones and any related constraint, and if necessary, adjust our estimate of the overall transaction price.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When target exchange rights are held by collaboration partners, and the amounts attributed to these rights are not refundable, they are included in the transaction price. However, they are recorded as deferred revenues because we have a potential performance obligation to provide a new target upon an exchange right being exercised. These amounts are recognized in revenue when the right of exchange expires or is exercised.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our agreements have one type of performance obligation (licenses) which are typically all transferred at the same time at agreement inception, allocation of transaction price often is not required. However, allocation is required when licenses for some of the individual targets are subject to rights of exchange, because revenue associated with these targets cannot be recognized. We perform an allocation of the upfront amount based on relative SSP of licenses for individual targets. We determine license SSP using income-based valuation approach utilizing risk-adjusted discounted cash flow projections of the estimated return a licensor would receive. When amounts subject to uncertainties, such as milestones and royalties, are included in the transaction price, we attribute them to the specific individual target licenses which generate such milestone or royalty amounts.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also estimate SSP of bulk rHuPH20 and research and development services, to determine that our collaboration partners do not have material rights to order them at discounted prices. For supplies of bulk rHuPH20, because we effectively act as a contract manufacturer to our collaboration partners, we estimate and charge SSP based on the typical contract manufacturer margins consistently with all of our collaborative partners. We determine SSP of research and development services based on a fully-burdened labor rate. Our rates are comparable to those we observe in other collaborative agreements. We also have a history of charging similar rates to all of our collaboration partners. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upfront amounts allocated to licenses to individual targets are recognized as revenue when the license is transferred to the collaboration partner, as discussed above, if the license is not subject to exchange rights, or when the exchange right expires or is exercised. Development milestones and other fees are recognized in revenue when they are included in the transaction price, because by that time we have already transferred the related license to the collaboration partner. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales-based milestones and royalties cannot be recognized until the underlying sales occur. We do not receive final royalty reports from our collaboration partners until after we complete our financial statements for a prior quarter. Therefore, we recognize revenue based on estimates of the royalty earned, which are based on internal estimates and available preliminary reports provided by our collaboration partners. We will record a true-up in the following quarter if necessary, when final royalty reports are received. To date, we have not recorded any material true-ups. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contracts to provide research and development services, such services represent the only performance obligation. The fees are charged based on hours worked by our employees and the fixed contractual rate per hour, plus third-party pass-through costs, on a monthly basis. We recognize revenues as the related services are performed based on the amounts billed, as the collaboration partner consumes the benefit of research and development work simultaneously as we perform these services, and the amounts billed reflect the value of these services to the customer. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion on our collaborative arrangements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Sales,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recombinant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell Hylenex recombinant in the U.S. to wholesale pharmaceutical distributors, who sell the product to hospitals and other end-user customers. Sales to wholesalers are made pursuant to purchase orders subject to the terms of a master agreement, and delivery of individual packages of Hylenex recombinant represent performance obligations under each purchase order. We use a contract manufacturer to produce Hylenex recombinant and a third-party logistics (3PL) vendor to process and fulfill orders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We concluded we are the principal in the sales to wholesalers because we control access to services rendered by both vendors and direct their activities. We have no significant obligations to wholesalers to generate pull-through sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling prices initially billed to wholesalers are subject to discounts for prompt payment and subsequent chargebacks when wholesalers sell Hylenex recombinant at negotiated discounted prices to members of certain group purchasing organizations (&#8220;GPOs&#8221;) and government programs. We also pay quarterly distribution fees to certain wholesalers for inventory reporting and chargeback processing, and to GPOs as administrative fees for services and for access to GPO members. We concluded the benefits received in exchange for these fees are not distinct from our sales of Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recombinant, and accordingly we apply these amounts to reduce revenues. Wholesalers also have rights to return unsold product nearing or past the expiration date. Because of the shelf life of Hylenex recombinant and our lengthy return period, there may be a significant period of time between when the product is shipped and when we issue credits on returned product. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the transaction price when we receive each purchase order taking into account the expected reductions of the selling price initially billed to the wholesaler arising from all of the above factors. We have compiled historical experience and data to estimate future returns and chargebacks of Hylenex recombinant and the impact of the other discounts and fees we pay. When estimating these adjustments to the transaction price, we reduce it sufficiently to be able to assert that it is probable that there will be no significant reversal of revenue when the ultimate adjustment amounts are known.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchase order contains only one type of product, and is usually shipped to the wholesaler in a single shipment. Therefore, allocation of the transaction price to individual packages is not required.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from Hylenex recombinant product sales and related cost of sales upon product delivery to the wholesaler location. At that time, the wholesalers take control of the product as they take title, bear the risk of loss of ownership, and have an enforceable obligation to pay us. They also have the ability to direct sales of product to their customers on terms and at prices they negotiate. Although wholesalers have product return rights, we do not believe they have a significant incentive to return the product to us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon recognition of revenue from product sales of Hylenex recombinant, the estimated amounts of credit for product returns, chargebacks, distribution fees, prompt payment discounts, and GPO fees are included in sales reserves, accrued liabilities and net of accounts receivable. We monitor actual product returns, chargebacks, discounts and fees subsequent to the sale. If these amounts differ from our estimates, we make adjustments to these allowances, which are applied to increase or reduce product sales revenue and earnings in the period of adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the orders placed by wholesalers, we incur costs such as commissions to our sales representatives. However, as revenue from product sales is recognized upon delivery to the wholesaler, which occurs shortly after we receive a purchase order, we do not capitalize these commissions and other costs, based on application of the practical expedient allowed within the applicable guidance. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bulk rHuPH20</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell bulk rHuPH20 to collaboration partners for use in research and development; subsequent to receiving marketing approval, we sell it for use in collaboration commercial products. Sales are made pursuant to purchase orders subject to the terms of the collaborative agreement, and delivery of units of bulk rHuPH20 represent performance obligations under each purchase order. We provide a standard warranty that the product conforms to specifications. We use contract manufacturers to produce bulk rHuPH20 and have concluded we are the principal in the sales to collaboration partners. The transaction price for each purchase order of bulk rHuPH20 is fixed based on the cost of production plus a contractual markup, and is not subject to </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adjustments. Allocation of the transaction price to individual quantities of the product is usually not required because each order contains only one type of product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from the sale of bulk rHuPH20 as product sales and related cost of sales upon transfer of title to our partners. At that time, the partners take control of the product, bear the risk of loss of ownership, and have an enforceable obligation to pay us. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our statements of operations, we report as revenues under collaborative agreements the upfront payments, event-based development and regulatory milestones and sales milestones. We also include in this category revenues from separate research and development contracts pursuant to project authorization forms. We report royalties received from collaboration partners as a separate line in our statements of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of Hylenex recombinant, bulk rHuPH20 that has alternative future use and ENHANZE drug product are included in product sales, net.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the footnotes to our condensed consolidated financial statements, we provide disaggregated revenue information by type of arrangement (product sales, net, collaborative agreements and research and development services), and additionally, by type of payment stream received under collaborative agreements (upfront license fees, event-based development and regulatory milestones and other fees, sales milestones and royalties).</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Sales</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales consists primarily of raw materials, third-party manufacturing costs, fill and finish costs, freight costs, internal costs and manufacturing overhead associated with the production of Hylenex recombinant and bulk rHuPH20 and ENHANZE drug product. Cost of product sales also consists of the write-down of excess, dated and obsolete inventories and the write-off of inventories that do not meet certain product specifications, if any.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include salaries and benefits, facilities and other overhead expenses, research related manufacturing services, contract services and other outside expenses. Research and development expenses are charged to operating expenses as incurred when these expenditures relate to our research and development efforts and have no alternative future uses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to make upfront payments upon execution of certain research and development agreements. Advance payments, including nonrefundable amounts, for goods or services that will be used or rendered for future research and development activities are deferred. Such amounts are recognized as expense as the related goods are delivered or the related services are performed or such time when we do not expect the goods to be delivered or services to be performed.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record compensation expense associated with stock options, restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;) and shares issued under our employee stock purchase plan (&#8220;ESPP&#8221;) in accordance with the authoritative guidance for stock-based compensation. The cost of employee services received in exchange for an award of an equity instrument is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense on a straight-line basis over the requisite service period of the award. Share-based compensation expense for an award with a performance condition is recognized when the achievement of such performance condition is determined to be probable. If the outcome of such performance condition is not determined to be probable or is not met, no compensation expense is recognized and any previously recognized compensation expense is reversed. Forfeitures are recognized as a reduction of share-based compensation expense as they occur.</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for income taxes using the liability method. Under this method, deferred income tax assets and liabilities are determined based on the differences between the financial statement carrying amounts of existing assets and liabilities at each year end and their respective tax bases and are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant judgment is required by management to determine our provision for income taxes, our deferred tax assets and liabilities, and the valuation allowance to record against our net deferred tax assets, which are based on complex and evolving tax regulations throughout the world. Deferred tax assets (&#8220;DTA&#8221;) and other tax benefits are recorded when they are more likely than not to be realized. We maintain a full valuation allowance on our DTAs until there is sufficient evidence to support the reversal of all or some portion of these allowances. On a periodic basis, we reassess the valuation allowance of our DTAs, weighing all positive and negative evidence, to assess if it is more-likely-than-not that some or all of our DTAs will be realized. As of the third quarter of 2021, we have demonstrated profitability and cumulative pretax income and are forecasting income growth. After assessing both the positive and negative evidence, we determined that it was more likely than not that our DTAs would be realized and released the valuation allowance related to federal and state DTAs as of September 30, 2021, resulting in a benefit from income taxes of $142.5&#160;million. We estimated that our annual effective income tax rate to be (57.63)% for 2021 compared to the 0.17% effective income tax rate for 2020. The primary difference relates to the release of our valuation allowance. We will continue to evaluate the need for valuation allowances for our DTAs.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-top:3pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our business in one segment, which includes all activities related to the research, development and commercialization of our proprietary enzymes. This segment also includes revenues and expenses related to (i)&#160;research and development and bulk rHuPH20 manufacturing activities conducted under our collaborative agreements with third parties and (ii)&#160;product sales of Hylenex recombinant. The chief operating decision-maker reviews the operating results on an aggregate basis and manages the operations as a single operating segment.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption and Pending Adoption of Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.588%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial <br/>Statements or Other Significant Matters</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation.<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022<br/>(Early adoption permitted effective January 1, 2021)<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis, which resulted in an approximately $65.5 million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $52.6 million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $13.0 million decrease to the opening balance of accumulated deficit, representing the cumulative non-cash interest expense recognized related to the amortization of the bifurcated conversion option related to the 2024 Convertible Notes. We  derecognized the related deferred tax liabilities of $11.8 million with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. As we committed to settle the principal amount of the convertible notes in cash upon conversion, shares used for diluted EPS will continue to be limited to the excess conversion value over the principal amount of the convertible note. Diluted earnings per share is also impacted due to the elimination of non-cash interest expense associated with the amortization of the equity component.</span></div><div><span><br/></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204285128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consisted of the following (in thousands):</span></div><div style="margin-top:11pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:52.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-US Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,223&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:52.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, 11 available-for-sale marketable securities with a fair market value of $66.0 million were in a gross unrealized loss position of $23 thousand. Based on our review of these marketable securities, we believe none of the unrealized loss is as a result of a credit loss as of&#160;September&#160;30, 2021, because we do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of their amortized cost basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities are as follows (in thousands):</span></div><div style="margin-top:11pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:67.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,672&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one but within five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:29.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale marketable <br/>&#160;&#160;&#160;securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-US Government securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,688&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no instruments that were classified within Level 3 as of September&#160;30, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045287944056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disaggregated revenues were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:57.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales of bulk rHuPH20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales of Hylenex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product sales, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,047&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues under collaborative agreements:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Upfront license and target nomination fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Event-based development and regulatory milestones and other fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales-based milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Research and development services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,830&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,316&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,307&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,891&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2021 we recognized revenue related to licenses granted to collaboration partners in prior periods in the amount of $88.6 million. This amount represents royalties and a sales milestone earned in the current period. We recognized revenue of $0.5 million during the three months ended September&#160;30, 2021 that had been included in deferred revenues at December&#160;31, 2020. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 we recognized revenue related to licenses granted to collaboration partners in prior periods in the amount of $221.3 million. This amount represents royalties and sales milestone earned in the current period in addition to $30.0&#160;million of variable consideration in the contracts where uncertainties have been resolved and the development milestones were expected to be achieved or were achieved. We recognized revenue of $1.0 million during the nine months ended September&#160;30, 2021 that had been included in deferred revenues at December&#160;31, 2020. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net, and deferred revenues (contract liabilities) from contracts with customers, including collaboration partners, consisted of the following (in thousands): </span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:74.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>As of September&#160;30, 2021, the amounts included in the transaction price of our contracts with customers, including collaboration partners, and allocated to goods and services not yet provided were $69.8 million, of which $65.0 million relates to unfulfilled purchase commitments and $4.8 million has been collected and is reported as deferred revenues. The unfulfilled purchase commitments are estimated to be delivered by the end of the third quarter of 2022. Of the total deferred revenues of $4.8 million, $2.2 million is expected to be used by our customers within the next 12 months.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204658552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Certain Balance Sheet Items<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Certain Balance Sheet Items</a></td>
<td class="text">Certain Balance Sheet Items<div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from product sales to collaborators</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from royalty payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from other product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for distribution fees and discounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,099&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid manufacturing expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,067)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,302&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid manufacturing expenses include raw materials, slot reservation fees and other amounts paid to contract manufacturing organizations.&#160;Such amounts are reclassified to work-in-process inventory as materials are used or the contract manufacturing organization services are complete.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,085&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,588&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,593&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                            </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was approximately $0.7 million and $0.8 million, inclusive of ROU asset amortization of $0.4 million and $0.4 million for the three months ended September&#160;30, 2021 and 2020 respectively. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was approximately $2.2 million and $2.5 million, inclusive of ROU asset amortization of $1.2 million and $1.3 million for the nine months ended September&#160;30, 2021 and 2020 respectively.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and payroll taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued outsourced manufacturing expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued expenses, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense associated with the accretion of the lease liabilities was approximately $0.1 million and $0.1 million for the three months ended September&#160;30, 2021 and 2020 respectively. Total lease expense for the three months ended September&#160;30, 2021 and 2020 was $0.5 million and $0.5 million respectively. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense associated with the accretion of the lease liabilities was approximately $0.3 million and $0.4 million for the nine months ended September&#160;30, 2021 and 2020 respectively. Total lease expense for the nine months ended September&#160;30, 2021 and 2020 was $1.5 million and $1.7 million respectively. </span></div>Cash paid for amounts related to leases for the three months ended September&#160;30, 2021 and 2020 was $0.6 million and $0.8 million, and $2.0 million and $2.5 million for the nine months ended September&#160;30, 2021 and 2020 respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204010536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt, Net</a></td>
<td class="text">Debt, Net<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">0.25% Convertible Notes due 2027</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we completed the sale of $805.0&#160;million in aggregate principal amount of 0.25% Convertible Senior Notes due 2027 (the &#8220;2027 Convertible Notes&#8221; and collectively with the 2024 Convertible Notes the &#8220;Convertible Notes&#8221;). The net proceeds in connection with the issuance of the 2027 Convertible Notes, after deducting the initial purchasers&#8217; fee of $20.1&#160;million, was approximately $784.9&#160;million. We also incurred additional debt issuance costs totaling $0.4&#160;million. Debt issuance costs and the initial purchasers&#8217; fee are presented as a debt discount.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2027 Convertible Notes pay interest semi-annually in arrears on March 1st and September 1st of each year at an annual rate of 0.25%. The 2027 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2027 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of our current or future subsidiaries. The 2027 Convertible Notes have a maturity date of March 1, 2027.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2027 Convertible Notes at their option only in the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021, if the last reported sale price per share of  common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on our common stock, as described in the offering memorandum for the 2027 Convertible Notes; (4) if we call such notes for redemption; and (5) at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately before the maturity date. The Notes will be convertible, regardless of the foregoing circumstances, at any time from, and including, September 1, 2026 until the close of business on the scheduled trading day immediately preceding the maturity date. As of September&#160;30, 2021, the 2027 Convertible Notes are not convertible.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, we will pay cash for the settlement of principal and for the premium, if applicable, we will pay cash, deliver shares of common stock or a combination of cash and shares of common stock, at our election. The initial conversion rate for the 2027 Convertible Notes will be 12.9576 shares of common stock per $1,000 in principal amount of 2027 Convertible Notes, equivalent to a conversion price of approximately $77.17 per share of our common stock. The conversion rate is subject to adjustment.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we were in compliance with all covenants and there was no material adverse change in our business, operations or financial condition. </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1.25% Convertible Notes due 2024</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed the sale of $460.0 million in aggregate principal amount of 1.25% Convertible Senior Notes due 2024 (&#8220;2024 Convertible Notes&#8221;). The net proceeds in connection with the 2024 Convertible Notes, after deducting  the initial purchasers&#8217; fee of $12.7&#160;million, was approximately $447.3 million. We also incurred debt issuance cost totaling $0.3&#160;million. Debt issuance costs and the initial purchasers&#8217; fee are presented as a debt discount.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Convertible Notes pay interest semi-annually in arrears on June 1st and December 1st of each year, beginning on June 1, 2020, at an annual rate of 1.25%. The 2024 Convertible Notes are general unsecured obligations and will rank senior in right of payment to all indebtedness that is expressly subordinated in right of payment to the 2024 Convertible Notes, will rank equally in right of payment with all existing and future liabilities that are not so subordinated, will be effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness and will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of the our current or future subsidiaries. The 2024 Convertible Notes have a maturity date of December 1, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their 2024 Convertible Notes at their option only in the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on March&#160;31, 2020, if the last reported sale price per share of common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2)&#160;during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (3)&#160;upon the occurrence of certain corporate events or distributions on our common </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock, as described in the offering memorandum for the 2024 Convertible Notes; (4)&#160;if we call such notes for redemption; and (5)&#160;at any time from, and including, June&#160;1, 2024 until the close of business on the scheduled trading day immediately before the maturity date. As of September&#160;30, 2021, the 2024 Convertible Notes are convertible and are classified as a current liability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021 we notified the note holders of our irrevocable election to settle the principal of the 2024 Convertible Notes in cash and for the premium, if applicable, to deliver shares of common stock. The conversion rate for the 2024 Convertible Notes will be 41.9208 shares of common stock per $1,000 in principal amount of 2024 Convertible Notes, equivalent to a conversion price of approximately $23.85 per share of our common stock. The conversion rate is subject to adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we completed a privately negotiated induced conversion of $369.1&#160;million principal amount of the 2024 Convertible Notes (&#8220;Note Repurchases&#8221; or the &#8220;Induced Conversion&#8221;). In connection with the Induced Conversion, we paid approximately $370.2&#160;million in cash, which includes principal and accrued interest, and issued approximately 9.08&#160;million shares of our common stock representing the intrinsic value based on the contractual conversion rate and incremental shares as an inducement for conversion. As a result of the Induced Conversion, we recorded $21.0 million in induced conversion expense which is included in Other income (expense) of the Condensed Consolidated Statements of Operations for the nine months ended September&#160;30, 2021. The induced conversion expense represents the fair value of the common stock issued upon conversion in excess of the common stock issuable under the original terms of the 2024 Convertible Notes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we were in compliance with all covenants and there was no material adverse change in our business, operations or financial condition. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Carrying Amounts of the Convertible Notes</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and fair value of our Convertible Notes were as follows as of the dates indicated. As disclosed in Note 2, we early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis which adoption is reflected in the following table (in thousands).</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:69.570%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.474%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Principal Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,211)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,705&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,789&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value based on trading levels (Level 2):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining amortization per period of debt discount (in years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our Convertible Notes for the periods shown (in thousands).</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:41.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coupon Interest:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Coupon Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization of debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rates:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalty-backed Loan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, through our wholly-owned subsidiary Halozyme Royalty LLC (&#8220;Halozyme Royalty&#8221;), we received a $150 million loan (the &#8220;Royalty-backed Loan&#8221;) pursuant to a credit agreement (the &#8220;Credit Agreement&#8221;) with BioPharma Credit Investments IV Sub, LP and Athyrium Opportunities II Acquisition LP (the &#8220;Royalty-backed Lenders&#8221;). Under the terms of the Credit Agreement, Halozyme Therapeutics, Inc. transferred to Halozyme Royalty the right to receive royalty payments from the commercial sales of ENHANZE products owed under the Roche Collaboration and Baxalta Collaboration (&#8220;Collaboration Agreements&#8221;). The royalty payments from the Collaboration Agreements were used to repay the principal and interest on the loan (the &#8220;Royalty Payments&#8221;).&#160; The Royalty-backed Loan bore interest at a per annum rate of 8.75% plus the three-month LIBOR rate. The three-month LIBOR rate was subject to a floor of 0.7% and a cap of 1.5%.&#160;In June 2020, we paid the full remaining balance and final payment of $2.93 million thereby satisfying and discharging all obligations under, and terminating, the Royalty-backed Loan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204747096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Compensation</a></td>
<td class="text">Share-based Compensation<div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense related to share-based awards was comprised of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.959%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,557&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by type of share-based award (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"/><td style="width:57.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.473%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs, RSUs, PSUs and ESPP</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted stock options to purchase approximately 32.5 thousand and 34.7 thousand shares of common stock during the three months ended September&#160;30, 2021 and 2020, respectively, and $0.7 million and $1.5 million shares of common stock during the nine months ended September&#160;30, 2021 and 2020, respectively. The exercise price of stock options granted is equal to the closing price of the common stock on the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes-Merton option pricing model (&#8220;Black-Scholes model&#8221;). Expected volatility is based on historical volatility of our common stock. The expected term of options granted is based on analyses of historical employee termination rates and option exercises. The risk-free interest rate is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The dividend yield assumption is based on the expectation of no future dividend payments. The assumptions used in the Black-Scholes model were as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.90-44.73%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.58-51.82%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.90-46.45%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.58-51.82%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66-0.89%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22-0.31%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36-0.89%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22-1.67%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, our Board of Directors approved our 2021 ESPP and our stockholders approved the plan in May 2021. The ESPP enables eligible employees to purchase shares of our common stock at the end of each offering period at a price equal to 85% of the fair market value of the shares on the first business day or the last business day of the offering period, whichever is lower. Share purchases are funded through payroll deduction of at least 1% and up to 15% of an employee&#8217;s compensation for each payroll period, and no employee may purchase shares under the ESPP that exceeds $25,000 worth of our common stock for a calendar year. As of September&#160;30, 2021, 2,700,000 shares were available for future purchase. The offering period is generally for a six-months period and the first offering period commenced on June 16, 2021. Offering periods shall commence on or about the sixteenth day of June and December of each year and end on or about the fifteenth day of the next December and June respectively, occurring thereafter.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized estimated compensation cost by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):</span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:70.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized<br/>Expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining<br/>Weighted-Average<br/>Recognition Period<br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.42</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045291907208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity <div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 and 2020, we issued an aggregate of 931,749 and 3,952,311 shares of common stock, respectively, in connection with the exercises of stock options at a weighted average exercise price of $13.81 and $13.54 per share, respectively, for net proceeds of approximately $12.9 million and $53.5 million, respectively. For the nine months ended September&#160;30, 2021 and 2020, we issued 297,696 and 569,701 shares of common stock, respectively, upon vesting of certain RSUs and PSUs for which 94,795 and 142,905 RSUs were withheld from the RSU holders, respectively, to pay for minimum withholding taxes totaling approximately $8.2 million and $5.4 million, respectively. Stock options and unvested restricted units totaling approximately 6.3 million shares and 6.7 million shares of our common stock were outstanding as of September&#160;30, 2021 and December&#160;31, 2020, respectively. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we announced that the Board of Directors has authorized the initiation of a capital return program to repurchase up to $550.0 million of outstanding common stock over a three-year period. We may utilize a variety of methods including open market purchases, privately negotiated transactions, accelerated share repurchase programs or any combination of such methods. The Board will regularly review this capital return program in connection with a balanced capital allocation strategy. During 2019, we repurchased approximately 11.1&#160;million shares of common stock for $200.0&#160;million at an average price of $18.03. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, we repurchased 6.5&#160;million shares of common stock for $150.0&#160;million at an average price of $23.05. The shares were purchased through open market transactions and through an Accelerated Share Repurchase (ASR) agreement with Bank of America in December 2020, for which we repurchased $21.7&#160;million of common stock and received 0.5&#160;million shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2021, we entered into an ASR agreement with Bank of America to repurchase $75.0&#160;million of common stock. At inception, pursuant to the agreement, we paid $75.0&#160;million to Bank of America and took an initial delivery of 1.3&#160;million shares. In April 2021, we finalized the transaction and received an additional 0.5&#160;million shares. We retired the repurchased shares and they resumed the status of authorized and unissued shares.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had the following activity under the approved share repurchase programs (dollars in thousands, except share and per share data):</span></div><div style="margin-top:10pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:44.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Price paid Per Share</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,376,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,738&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Included in the total cost of shares purchased is a commission fee of $0.02 per share.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) This includes 0.5&#160;million shares delivered in April upon completion of the ASR.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045294556264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be involved in disputes, including litigation, relating to claims arising out of operations in the normal course of our business. Any of these claims could subject us to costly legal expenses and, while we generally believe that we have adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage or our policy limits may be inadequate to fully satisfy any damage awards or settlements. If this were to happen, the payment of any such awards could have a material adverse effect on our consolidated results of operations and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and business. We currently are not a party to any legal proceedings, the adverse outcome of which, in management&#8217;s opinion, individually or in the aggregate, would have a material adverse effect on our consolidated results of operations or financial position.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitments include payments related to our commenced operating leases. Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands; excluding the nine months ended September&#160;30, 2021):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:84.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.023%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Year:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,424&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The weighted-average remaining lease term of our operating leases is approximately 1.4 years.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208539720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (loss) per share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (loss) per share</a></td>
<td class="text">Net Income per share<div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per common share is computed by dividing net income for the period by the weighted average number of common shares outstanding during the period, without consideration for common stock equivalents. Outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and the Convertible Notes are considered common stock equivalents and are only included in the calculation of diluted earnings per common share when net income is reported and their effect is dilutive. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares issuable upon vesting of stock options, RSAs, RSUs and PSUs are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our Convertible Notes are determined using the if-converted method. Since we have committed to settle the principal amount of the Convertible Notes in cash upon conversion only, the number of shares for the conversion spread will be included as a dilutive common stock equivalent. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerators and the denominators of the basic and diluted net income per common share computations is as follows (in thousands, except per share amounts):</span></div><div style="margin-top:11pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:57.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,940&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for basic net income per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs, RSUs, PSUs and ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for diluted net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:11pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares which have been excluded from the calculation of diluted net income per common share because their effect was anti-dilutive, include the following (shares in millions):</span></div><div style="margin-top:11pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:56.918%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.805%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.805%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1). The anti-dilutive securities include outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and Convertible Notes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208584200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and with the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) related to a quarterly report on Form 10-Q. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for a complete set of financial statements. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;23, 2021. The unaudited financial information for the interim periods presented herein reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the financial condition and results of operations for the periods presented, with such adjustments consisting only of normal recurring adjustments. Operating results for interim periods are not necessarily indicative of the operating results for an entire fiscal year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The accompanying interim unaudited condensed consolidated financial statements include the accounts of Halozyme Therapeutics, Inc. and our wholly owned subsidiary, Halozyme, Inc., and Halozyme, Inc.&#8217;s wholly owned subsidiaries, Halozyme Switzerland GmbH and Halozyme Switzerland Holdings GmbH. All intercompany accounts and transactions have been eliminated.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesThe preparation of interim unaudited condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in our interim unaudited condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management&#8217;s estimates<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash Equivalents and Marketable Securities and Restricted Cash</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents and Marketable Securities </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of highly liquid investments, readily convertible to cash, that mature within ninety days or less from the date of purchase. As of September&#160;30, 2021, our cash equivalents consisted of money market funds.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities are investments with original maturities of more than ninety days from the date of purchase that are specifically identified to fund current operations. Marketable securities are considered available-for-sale. These investments are classified as current assets, even though the stated maturity date may be one year or more beyond the current balance sheet date which reflects management&#8217;s intention to use the proceeds from the sale of these investments to fund our operations, as necessary. Such available-for-sale investments are carried at fair value with unrealized gains and losses recorded in other comprehensive income (loss) and included as a separate component of stockholders&#8217; equity. The cost of marketable securities is adjusted for amortization of premiums or accretion of discounts to maturity, and such amortization or accretion is included in investment and other income, net in the interim unaudited condensed consolidated statements of operations. We use the specific identification method for calculating realized gains and losses on marketable securities sold. None of the realized gains and losses and declines in value judged to be as a result of credit loss on marketable securities, if any, are included in investment and other income, net in the interim unaudited condensed consolidated statements of operations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the leases of our facilities, we are required to maintain letters of credit as security deposits during the terms of such leases. At September&#160;30, 2021 and December&#160;31, 2020, restricted cash of $0.5 million was pledged as collateral for the letters of credit.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments include cash equivalents, available-for-sale marketable securities, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses and long-term debt. Fair value estimates of these instruments are made at a specific point in time, based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable and accrued expenses are generally considered to be representative of their respective fair values because of the short-term nature of those instruments. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consist of asset-backed securities, corporate debt securities, U.S. Treasury securities and commercial paper, and are measured at fair value using Level 1 and Level 2 inputs. Level 2 financial instruments are valued using market prices on less active markets and proprietary pricing valuation models with observable inputs, including interest rates, yield curves, maturity dates, issue dates, settlement dates, reported trades, broker-dealer quotes, issue spreads, benchmark securities or other market related data. We obtain the fair value of Level 2 investments from our investment manager, who obtains these fair values from a third-party pricing source. We validate the fair values of Level 2 financial instruments provided by our investment manager by comparing these fair values to a third-party pricing source.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventories are reviewed periodically for potential excess, dated or obsolete status. We evaluate the carrying value of inventories on a regular basis, taking into account such factors as historical and anticipated future sales compared to quantities on hand, the price we expect to obtain for products in their respective markets compared with historical cost and the remaining shelf life of goods on hand.</span></div>As of September&#160;30, 2021, and December&#160;31, 2020, inventories consisted of $1.6 million and $1.3 million, respectively, of Hylenex inventory, net and $54.4 million and $59.4 million, respectively, of bulk rHuPH20.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has entered into operating leases primarily for real estate and automobiles. These leases have terms which range from 3 years to 6 years. We determine if an arrangement contains a lease at inception. Right of use (&#8220;ROU&#8221;) assets and liabilities resulting from operating leases are included in property and equipment, accrued expenses and other long-term liabilities on our condensed consolidated balance sheets. Operating lease ROU assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the discount rate to calculate the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Our leases often include options to extend or terminate the lease. These options are included in the lease term when it is reasonably certain that we will exercise that option. Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div>&#160;&#160;&#160;&#160;We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, such as automobiles, we account for the lease and non-lease components as a single lease component.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue and Cost of Product Sales</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenues from payments received under collaborative agreements and product sales. We recognize revenue when we transfer promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers we perform the following five steps: (i) identify the promised goods or services in the contract; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy the performance obligations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues under Collaborative Agreements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these agreements, we grant the collaboration partner a worldwide license to develop and commercialize products using our ENHANZE technology to combine our patented rHuPH20 enzyme with their proprietary biologics directed at up to a specified number of targets. Targets are usually licensed on an exclusive, global basis. Targets selected subsequent to inception of the arrangement require payment of an additional license fee. The collaboration partner is responsible for all development, manufacturing, clinical, regulatory, sales and marketing costs for any products developed under the agreement. We are responsible for supply of bulk rHuPH20 based on the collaboration partner&#8217;s purchase orders and may also be separately engaged to perform research and development services. While these collaboration agreements are similar in that they originate from the same framework, each one is the result of an arms-length negotiation and thus may vary from one to the other.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect an upfront license payment from collaboration partners and are also entitled to receive event-based payments subject to collaboration partners&#8217; achievement of specified development, regulatory and sales-based milestones. In several agreements, collaboration partners pay us annual fees to maintain their exclusive license rights if they are unable to advance product development to specified stages. We earn separate fees for bulk rHuPH20 supplies and research and development services. In addition, collaboration partners will pay us royalties at an on average mid-single digit percent rate of their sales if products under the collaboration are commercialized. All amounts owed to us are noncancelable after the underlying triggering event occurs, and nonrefundable once paid. Unless terminated earlier in accordance with its terms, collaborations generally continue in effect until the last to expire royalty payment term, as determined on a product by product and on a country by country basis, with each royalty term starting on the first commercial sale of that product and ending the later of: (i) a specified period or term set forth in the agreement or (ii) expiration of the last to expire of the valid claims of our patents covering rHuPH20 or other specified patents developed under the collaboration which valid claim covers a product developed under the collaboration. When there are no valid claims during the applicable royalty term in a given country, the royalty rate is reduced for those sales. Collaboration partners may terminate the agreement prior to expiration for any reason in its entirety or on a target-by-target basis generally upon 90 days prior written notice to us.&#160;Upon any such termination, the license granted to collaboration partners (in total or with respect to the terminated target, as applicable) will terminate provided, however, that in the event of expiration of the agreement (as opposed to a termination), the on-going licenses granted will become perpetual, non-exclusive and fully paid.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although these agreements are in form identified as collaborative agreements, we concluded for accounting purposes they represent contracts with customers and are not subject to accounting literature on collaborative arrangements. This is because we grant to collaboration partners licenses to our intellectual property and provide supply of bulk rHuPH20 and research and development services which are all outputs of our ongoing activities, in exchange for consideration. Under these collaborative agreements, we do not develop assets jointly with collaboration partners, and do not share in significant risks of their development or commercialization activities. Accordingly, we concluded our collaborative agreements are appropriately accounted for pursuant to ASC Topic 606, Revenue from Contracts with Customers. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under all of our collaborative agreements, we have identified licenses to use functional intellectual property as the only performance obligation. The intellectual property underlying the license is our proprietary ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology which represents application of rHuPH20 to facilitate delivery of drugs or fluids. Each of the licenses grants the collaboration partners rights to use our intellectual property as it exists and is identified on the effective date of the license, because there is no ongoing development of the ENHANZE technology required. Therefore, we recognize revenue from licenses at the point when the license becomes effective and the collaboration partner has received access to our intellectual property, usually at the inception of the agreement.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When collaboration partners can select additional targets to add to the licenses granted, we consider these rights to be options. We evaluate whether such options contain material rights, i.e. have exercise prices that are discounted compared to what we would charge for a similar license to a new collaboration partner. The exercise price of these options includes a combination of the target selection fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, we conclude the option does not contain a material </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">right, and we consider grants of additional licensing rights upon option exercises to be separate contracts (target selection contracts).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customary indemnification and protection of licensed intellectual property for our customers. These provisions are part of assurance that the licenses meet the agreements&#8217; representations and are not obligations to provide goods or services.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also fulfill purchase orders for supply of bulk rHuPH20 and perform research and development services pursuant to projects authorization forms for our collaboration partners, which represent separate contracts. Additionally, we price our supply of bulk rHuPH20 and research and development services at our regular selling prices, called standalone selling price or &#8220;SSP&#8221;. Therefore, our collaboration partners do not have material rights to order these items at prices not reflective of SSP. Refer to the discussion below regarding recognition of revenue for these separate contracts.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for a contract represents the amount to which we are entitled in exchange for providing goods and services to the customer. Transaction price does not include amounts subject to uncertainties unless it is probable that there will be no significant reversal of revenue when the uncertainty is resolved. Apart from the upfront license payment (or target selection fees in the target selection contracts), all other fees we may earn under our collaborative agreements are subject to significant uncertainties of product development. Achievement of many of the event-based development and regulatory milestones may not be probable until such milestones are actually achieved. This generally relates to milestones such as obtaining marketing authorization approvals. With respect to other development milestones, e.g. dosing of a first patient in a clinical trial, achievement could be considered probable prior to its actual occurrence, based on the progress towards commencement of the trial. In order to evaluate progress towards commencement of a trial, we assess the status of activities leading up to our collaboration partner&#8217;s initiation of a trial such as feedback received from the  applicable regulatory authorities, completion of IND or equivalent filings, readiness and availability of drug, readiness of study sites and our collaboration partner&#8217;s commitment of resources to the program. We do not include any amounts subject to uncertainties into the transaction price until it is probable that the amount will not result in a significant reversal of revenue in the future. At the end of each reporting period, we re-evaluate the probability of achievement of such milestones and any related constraint, and if necessary, adjust our estimate of the overall transaction price.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When target exchange rights are held by collaboration partners, and the amounts attributed to these rights are not refundable, they are included in the transaction price. However, they are recorded as deferred revenues because we have a potential performance obligation to provide a new target upon an exchange right being exercised. These amounts are recognized in revenue when the right of exchange expires or is exercised.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our agreements have one type of performance obligation (licenses) which are typically all transferred at the same time at agreement inception, allocation of transaction price often is not required. However, allocation is required when licenses for some of the individual targets are subject to rights of exchange, because revenue associated with these targets cannot be recognized. We perform an allocation of the upfront amount based on relative SSP of licenses for individual targets. We determine license SSP using income-based valuation approach utilizing risk-adjusted discounted cash flow projections of the estimated return a licensor would receive. When amounts subject to uncertainties, such as milestones and royalties, are included in the transaction price, we attribute them to the specific individual target licenses which generate such milestone or royalty amounts.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also estimate SSP of bulk rHuPH20 and research and development services, to determine that our collaboration partners do not have material rights to order them at discounted prices. For supplies of bulk rHuPH20, because we effectively act as a contract manufacturer to our collaboration partners, we estimate and charge SSP based on the typical contract manufacturer margins consistently with all of our collaborative partners. We determine SSP of research and development services based on a fully-burdened labor rate. Our rates are comparable to those we observe in other collaborative agreements. We also have a history of charging similar rates to all of our collaboration partners. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upfront amounts allocated to licenses to individual targets are recognized as revenue when the license is transferred to the collaboration partner, as discussed above, if the license is not subject to exchange rights, or when the exchange right expires or is exercised. Development milestones and other fees are recognized in revenue when they are included in the transaction price, because by that time we have already transferred the related license to the collaboration partner. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales-based milestones and royalties cannot be recognized until the underlying sales occur. We do not receive final royalty reports from our collaboration partners until after we complete our financial statements for a prior quarter. Therefore, we recognize revenue based on estimates of the royalty earned, which are based on internal estimates and available preliminary reports provided by our collaboration partners. We will record a true-up in the following quarter if necessary, when final royalty reports are received. To date, we have not recorded any material true-ups. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contracts to provide research and development services, such services represent the only performance obligation. The fees are charged based on hours worked by our employees and the fixed contractual rate per hour, plus third-party pass-through costs, on a monthly basis. We recognize revenues as the related services are performed based on the amounts billed, as the collaboration partner consumes the benefit of research and development work simultaneously as we perform these services, and the amounts billed reflect the value of these services to the customer. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further discussion on our collaborative arrangements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Sales,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recombinant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell Hylenex recombinant in the U.S. to wholesale pharmaceutical distributors, who sell the product to hospitals and other end-user customers. Sales to wholesalers are made pursuant to purchase orders subject to the terms of a master agreement, and delivery of individual packages of Hylenex recombinant represent performance obligations under each purchase order. We use a contract manufacturer to produce Hylenex recombinant and a third-party logistics (3PL) vendor to process and fulfill orders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We concluded we are the principal in the sales to wholesalers because we control access to services rendered by both vendors and direct their activities. We have no significant obligations to wholesalers to generate pull-through sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling prices initially billed to wholesalers are subject to discounts for prompt payment and subsequent chargebacks when wholesalers sell Hylenex recombinant at negotiated discounted prices to members of certain group purchasing organizations (&#8220;GPOs&#8221;) and government programs. We also pay quarterly distribution fees to certain wholesalers for inventory reporting and chargeback processing, and to GPOs as administrative fees for services and for access to GPO members. We concluded the benefits received in exchange for these fees are not distinct from our sales of Hylenex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recombinant, and accordingly we apply these amounts to reduce revenues. Wholesalers also have rights to return unsold product nearing or past the expiration date. Because of the shelf life of Hylenex recombinant and our lengthy return period, there may be a significant period of time between when the product is shipped and when we issue credits on returned product. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the transaction price when we receive each purchase order taking into account the expected reductions of the selling price initially billed to the wholesaler arising from all of the above factors. We have compiled historical experience and data to estimate future returns and chargebacks of Hylenex recombinant and the impact of the other discounts and fees we pay. When estimating these adjustments to the transaction price, we reduce it sufficiently to be able to assert that it is probable that there will be no significant reversal of revenue when the ultimate adjustment amounts are known.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each purchase order contains only one type of product, and is usually shipped to the wholesaler in a single shipment. Therefore, allocation of the transaction price to individual packages is not required.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from Hylenex recombinant product sales and related cost of sales upon product delivery to the wholesaler location. At that time, the wholesalers take control of the product as they take title, bear the risk of loss of ownership, and have an enforceable obligation to pay us. They also have the ability to direct sales of product to their customers on terms and at prices they negotiate. Although wholesalers have product return rights, we do not believe they have a significant incentive to return the product to us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon recognition of revenue from product sales of Hylenex recombinant, the estimated amounts of credit for product returns, chargebacks, distribution fees, prompt payment discounts, and GPO fees are included in sales reserves, accrued liabilities and net of accounts receivable. We monitor actual product returns, chargebacks, discounts and fees subsequent to the sale. If these amounts differ from our estimates, we make adjustments to these allowances, which are applied to increase or reduce product sales revenue and earnings in the period of adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the orders placed by wholesalers, we incur costs such as commissions to our sales representatives. However, as revenue from product sales is recognized upon delivery to the wholesaler, which occurs shortly after we receive a purchase order, we do not capitalize these commissions and other costs, based on application of the practical expedient allowed within the applicable guidance. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bulk rHuPH20</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell bulk rHuPH20 to collaboration partners for use in research and development; subsequent to receiving marketing approval, we sell it for use in collaboration commercial products. Sales are made pursuant to purchase orders subject to the terms of the collaborative agreement, and delivery of units of bulk rHuPH20 represent performance obligations under each purchase order. We provide a standard warranty that the product conforms to specifications. We use contract manufacturers to produce bulk rHuPH20 and have concluded we are the principal in the sales to collaboration partners. The transaction price for each purchase order of bulk rHuPH20 is fixed based on the cost of production plus a contractual markup, and is not subject to </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adjustments. Allocation of the transaction price to individual quantities of the product is usually not required because each order contains only one type of product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from the sale of bulk rHuPH20 as product sales and related cost of sales upon transfer of title to our partners. At that time, the partners take control of the product, bear the risk of loss of ownership, and have an enforceable obligation to pay us. </span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our statements of operations, we report as revenues under collaborative agreements the upfront payments, event-based development and regulatory milestones and sales milestones. We also include in this category revenues from separate research and development contracts pursuant to project authorization forms. We report royalties received from collaboration partners as a separate line in our statements of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of Hylenex recombinant, bulk rHuPH20 that has alternative future use and ENHANZE drug product are included in product sales, net.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the footnotes to our condensed consolidated financial statements, we provide disaggregated revenue information by type of arrangement (product sales, net, collaborative agreements and research and development services), and additionally, by type of payment stream received under collaborative agreements (upfront license fees, event-based development and regulatory milestones and other fees, sales milestones and royalties).</span></div><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Sales</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product sales consists primarily of raw materials, third-party manufacturing costs, fill and finish costs, freight costs, internal costs and manufacturing overhead associated with the production of Hylenex recombinant and bulk rHuPH20 and ENHANZE drug product. Cost of product sales also consists of the write-down of excess, dated and obsolete inventories and the write-off of inventories that do not meet certain product specifications, if any.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include salaries and benefits, facilities and other overhead expenses, research related manufacturing services, contract services and other outside expenses. Research and development expenses are charged to operating expenses as incurred when these expenditures relate to our research and development efforts and have no alternative future uses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to make upfront payments upon execution of certain research and development agreements. Advance payments, including nonrefundable amounts, for goods or services that will be used or rendered for future research and development activities are deferred. Such amounts are recognized as expense as the related goods are delivered or the related services are performed or such time when we do not expect the goods to be delivered or services to be performed.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record compensation expense associated with stock options, restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;) and shares issued under our employee stock purchase plan (&#8220;ESPP&#8221;) in accordance with the authoritative guidance for stock-based compensation. The cost of employee services received in exchange for an award of an equity instrument is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense on a straight-line basis over the requisite service period of the award. Share-based compensation expense for an award with a performance condition is recognized when the achievement of such performance condition is determined to be probable. If the outcome of such performance condition is not determined to be probable or is not met, no compensation expense is recognized and any previously recognized compensation expense is reversed. Forfeitures are recognized as a reduction of share-based compensation expense as they occur.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for income taxes using the liability method. Under this method, deferred income tax assets and liabilities are determined based on the differences between the financial statement carrying amounts of existing assets and liabilities at each year end and their respective tax bases and are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant judgment is required by management to determine our provision for income taxes, our deferred tax assets and liabilities, and the valuation allowance to record against our net deferred tax assets, which are based on complex and evolving tax regulations throughout the world. Deferred tax assets (&#8220;DTA&#8221;) and other tax benefits are recorded when they are more likely than not to be realized. We maintain a full valuation allowance on our DTAs until there is sufficient evidence to support the reversal of all or some portion of these allowances. On a periodic basis, we reassess the valuation allowance of our DTAs, weighing all positive and negative evidence, to assess if it is more-likely-than-not that some or all of our DTAs will be realized. As of the third quarter of 2021, we have demonstrated profitability and cumulative pretax income and are forecasting income growth. After assessing both the positive and negative evidence, we determined that it was more likely than not that our DTAs would be realized and released the valuation allowance related to federal and state DTAs as of September 30, 2021, resulting in a benefit from income taxes of $142.5&#160;million. We estimated that our annual effective income tax rate to be (57.63)% for 2021 compared to the 0.17% effective income tax rate for 2020. The primary difference relates to the release of our valuation allowance. We will continue to evaluate the need for valuation allowances for our DTAs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-top:3pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our business in one segment, which includes all activities related to the research, development and commercialization of our proprietary enzymes. This segment also includes revenues and expenses related to (i)&#160;research and development and bulk rHuPH20 manufacturing activities conducted under our collaborative agreements with third parties and (ii)&#160;product sales of Hylenex recombinant. The chief operating decision-maker reviews the operating results on an aggregate basis and manages the operations as a single operating segment.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Adoption and Pending Adoption of Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption and Pending Adoption of Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.588%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial <br/>Statements or Other Significant Matters</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation.<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022<br/>(Early adoption permitted effective January 1, 2021)<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis, which resulted in an approximately $65.5 million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $52.6 million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $13.0 million decrease to the opening balance of accumulated deficit, representing the cumulative non-cash interest expense recognized related to the amortization of the bifurcated conversion option related to the 2024 Convertible Notes. We  derecognized the related deferred tax liabilities of $11.8 million with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. As we committed to settle the principal amount of the convertible notes in cash upon conversion, shares used for diluted EPS will continue to be limited to the excess conversion value over the principal amount of the convertible note. Diluted earnings per share is also impacted due to the elimination of non-cash interest expense associated with the amortization of the equity component.</span></div><div><span><br/></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204279928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of reconciliation of numerators and denominators of basic and diluted computations</a></td>
<td class="text">A reconciliation of the numerators and the denominators of the basic and diluted net income per common share computations is as follows (in thousands, except per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:57.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,940&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for basic net income per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs, RSUs, PSUs and ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for diluted net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of adoption and pending adoption of recent accounting pronouncements</a></td>
<td class="text">The following table provides a brief description of recently issued accounting standards, those adopted in the current period and those not yet adopted:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.588%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Standard</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect on the Financial <br/>Statements or Other Significant Matters</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation.<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022<br/>(Early adoption permitted effective January 1, 2021)<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis, which resulted in an approximately $65.5 million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $52.6 million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $13.0 million decrease to the opening balance of accumulated deficit, representing the cumulative non-cash interest expense recognized related to the amortization of the bifurcated conversion option related to the 2024 Convertible Notes. We  derecognized the related deferred tax liabilities of $11.8 million with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. As we committed to settle the principal amount of the convertible notes in cash upon conversion, shares used for diluted EPS will continue to be limited to the excess conversion value over the principal amount of the convertible note. Diluted earnings per share is also impacted due to the elimination of non-cash interest expense associated with the amortization of the equity component.</span></div><div><span><br/></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045201919208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of available-for-sale marketable securities</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale marketable securities consisted of the following (in thousands):</span></div><div style="margin-top:11pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:52.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-US Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,223&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:52.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.772%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of contractual maturities of available-for-sale debt securities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities are as follows (in thousands):</span></div><div style="margin-top:11pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:67.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,672&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one but within five years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of assets measured at fair value on a recurring basis</a></td>
<td class="text">The following table summarizes, by major security type, our cash equivalents and available-for-sale marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:29.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total estimated fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale marketable <br/>&#160;&#160;&#160;securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-US Government securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,688&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204147576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of revenues</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disaggregated revenues were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:57.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales of bulk rHuPH20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales of Hylenex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product sales, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,047&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues under collaborative agreements:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Upfront license and target nomination fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Event-based development and regulatory milestones and other fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Sales-based milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Research and development services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,830&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,316&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,307&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,891&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of accounts receivable, deferred revenues from contracts with customers, and amounts under collaborative agreements included in transaction price</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net, and deferred revenues (contract liabilities) from contracts with customers, including collaboration partners, consisted of the following (in thousands): </span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"/><td style="width:74.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045203991992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Certain Balance Sheet Items (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from product sales to collaborators</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from revenues under collaborative agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from royalty payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable from other product sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other contract assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for distribution fees and discounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,099&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,747&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of prepaid expenses and other assets</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other assets consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid manufacturing expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,067)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total prepaid expenses and other assets, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,302&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, net</a></td>
<td class="text">Property and equipment, net consisted of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,085&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Subtotal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,588&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,593&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:68.485%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and payroll taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued outsourced manufacturing expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued expenses, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288596936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Carrying Amounts of the Convertible Notes</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and fair value of our Convertible Notes were as follows as of the dates indicated. As disclosed in Note 2, we early adopted ASU 2020-06 as of January 1, 2021 on a modified retrospective basis which adoption is reflected in the following table (in thousands).</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:69.570%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.474%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Principal Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unamortized debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,211)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,705&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,789&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value based on trading levels (Level 2):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of outstanding notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining amortization per period of debt discount (in years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Interest Income and Interest Expense Disclosure</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for each of our Convertible Notes for the periods shown (in thousands).</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:41.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coupon Interest:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Coupon Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization of debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective interest rates:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Convertible Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204161960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of share-based compensation expense</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense related to share-based awards was comprised of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.959%"><tr><td style="width:1.0%"/><td style="width:57.246%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,557&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of share-based compensation expense by type</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by type of share-based award (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"/><td style="width:57.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.473%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs, RSUs, PSUs and ESPP</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,399&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used in Black-Scholes model</a></td>
<td class="text">The assumptions used in the Black-Scholes model were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.90-44.73%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.58-51.82%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.90-46.45%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.58-51.82%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66-0.89%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22-0.31%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36-0.89%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22-1.67%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of unrecognized estimated compensation cost by type</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized estimated compensation cost by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):</span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:70.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized<br/>Expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining<br/>Weighted-Average<br/>Recognition Period<br/>(years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.42</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045200401464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of share repurchases</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had the following activity under the approved share repurchase programs (dollars in thousands, except share and per share data):</span></div><div style="margin-top:10pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:44.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Price paid Per Share</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third quarter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,376,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,738&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Included in the total cost of shares purchased is a commission fee of $0.02 per share.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) This includes 0.5&#160;million shares delivered in April upon completion of the ASR.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045202004552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of approximate annual future minimum operating lease payments</a></td>
<td class="text">Approximate annual future minimum operating lease payments as of September&#160;30, 2021 are as follows (in thousands; excluding the nine months ended September&#160;30, 2021):&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:84.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.023%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Year:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,424&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045202036888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (loss) per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of reconciliation of numerators and denominators of basic and diluted computations</a></td>
<td class="text">A reconciliation of the numerators and the denominators of the basic and diluted net income per common share computations is as follows (in thousands, except per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:57.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,940&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for basic net income per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential common stock outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSAs, RSUs, PSUs and ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding for diluted net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:11pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares which have been excluded from the calculation of diluted net income per common share because their effect was anti-dilutive, include the following (shares in millions):</span></div><div style="margin-top:11pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:56.918%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.805%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.805%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>&#160;September 30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1). The anti-dilutive securities include outstanding stock options, unvested RSAs, unvested RSUs, unvested PSUs, common shares expected to be issued under our ESPP and Convertible Notes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204673672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>product </div>
<div>collaborator</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_RoyaltiesReceivedNumberOfCollaborators', window );">Royalties Received, Number of Collaborators | collaborator</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=halo_BaxaltaMember', window );">Baxalta</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_RoyaltiesReceivedNumberOfProductsSold', window );">Royalties Received, Number of Products Sold</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=halo_RocheMember', window );">Roche</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_RoyaltiesReceivedNumberOfProductsSold', window );">Royalties Received, Number of Products Sold</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=halo_JanssenMember', window );">Janssen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_RoyaltiesReceivedNumberOfProductsSold', window );">Royalties Received, Number of Products Sold</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_RoyaltiesReceivedNumberOfCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties Received, Number of Collaborators</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_RoyaltiesReceivedNumberOfCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_RoyaltiesReceivedNumberOfProductsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties Received, Number of Products Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_RoyaltiesReceivedNumberOfProductsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=halo_BaxaltaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=halo_BaxaltaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=halo_RocheMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=halo_RocheMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=halo_JanssenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=halo_JanssenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204699560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045203548360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 55,978<span></span>
</td>
<td class="nump">$ 60,747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=halo_HylenexRecombinantMember', window );">Hylenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=halo_BulkrHuPH20Member', window );">bulk rHuPH20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 54,400<span></span>
</td>
<td class="nump">$ 59,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=halo_HylenexRecombinantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=halo_HylenexRecombinantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=halo_BulkrHuPH20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=halo_BulkrHuPH20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204040184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Leases (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of leases</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of leases</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045200553160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue and Cost of Product Sales (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice', window );">Period of contract termination by written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales previously expensed as R&amp;D</a></td>
<td class="nump">$ 18,589<span></span>
</td>
<td class="nump">$ 5,568<span></span>
</td>
<td class="nump">$ 59,826<span></span>
</td>
<td class="nump">$ 17,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Period Of Termination By Written Notice</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204619448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Value of deferred tax assets</a></td>
<td class="nump">$ 142.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.17%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57.63%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045200494136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment Information (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204615000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Adoption and Pending Adoption of Recent Accounting Pronouncement (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">$ 281,674,000<span></span>
</td>
<td class="nump">$ 119,746,000<span></span>
</td>
<td class="nump">$ 151,047,000<span></span>
</td>
<td class="nump">$ 98,988,000<span></span>
</td>
<td class="nump">$ 105,577,000<span></span>
</td>
<td class="nump">$ 91,765,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">786,454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">407,229,000<span></span>
</td>
<td class="nump">461,897,000<span></span>
</td>
<td class="nump">625,483,000<span></span>
</td>
<td class="nump">646,184,000<span></span>
</td>
<td class="nump">688,318,000<span></span>
</td>
<td class="nump">695,066,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">$ (125,682,000)<span></span>
</td>
<td class="num">$ (342,269,000)<span></span>
</td>
<td class="num">(474,593,000)<span></span>
</td>
<td class="num">$ (547,757,000)<span></span>
</td>
<td class="num">$ (583,964,000)<span></span>
</td>
<td class="num">$ (603,678,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,564,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,535,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital | Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit | Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208998248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 324,223<span></span>
</td>
<td class="nump">$ 220,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">324,237<span></span>
</td>
<td class="nump">220,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">27,827<span></span>
</td>
<td class="nump">17,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">27,817<span></span>
</td>
<td class="nump">17,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">75,686<span></span>
</td>
<td class="nump">69,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">75,683<span></span>
</td>
<td class="nump">69,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">60,178<span></span>
</td>
<td class="nump">45,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">60,207<span></span>
</td>
<td class="nump">45,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">17,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">17,289<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">143,241<span></span>
</td>
<td class="nump">88,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 143,241<span></span>
</td>
<td class="nump">$ 88,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204670008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of loss positions | security</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair market value of gross unrealized loss position</a></td>
<td class="nump">$ 66,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized loss position of debt securities</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, Fair Value Disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045202547064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Contractual Maturities of Available for Sale Debt Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">$ 286,672<span></span>
</td>
<td class="nump">$ 220,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">After one but within five years</a></td>
<td class="nump">37,565<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 324,237<span></span>
</td>
<td class="nump">$ 220,310<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045206864664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 324,237,000<span></span>
</td>
<td class="nump">$ 220,310,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets measured on a recurring basis</a></td>
<td class="nump">815,898,000<span></span>
</td>
<td class="nump">367,881,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">491,661,000<span></span>
</td>
<td class="nump">140,571,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">27,817,000<span></span>
</td>
<td class="nump">17,062,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">75,683,000<span></span>
</td>
<td class="nump">69,789,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">60,207,000<span></span>
</td>
<td class="nump">45,117,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">17,289,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">143,241,000<span></span>
</td>
<td class="nump">88,342,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets measured on a recurring basis</a></td>
<td class="nump">551,868,000<span></span>
</td>
<td class="nump">185,688,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">491,661,000<span></span>
</td>
<td class="nump">140,571,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">60,207,000<span></span>
</td>
<td class="nump">45,117,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets measured on a recurring basis</a></td>
<td class="nump">264,030,000<span></span>
</td>
<td class="nump">182,193,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">27,817,000<span></span>
</td>
<td class="nump">17,062,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">75,683,000<span></span>
</td>
<td class="nump">69,789,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">17,289,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">143,241,000<span></span>
</td>
<td class="nump">88,342,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, Fair Value Disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288868664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregated Revenues (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 115,830<span></span>
</td>
<td class="nump">$ 65,316<span></span>
</td>
<td class="nump">$ 341,307<span></span>
</td>
<td class="nump">$ 145,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">58,563<span></span>
</td>
<td class="nump">23,931<span></span>
</td>
<td class="nump">141,264<span></span>
</td>
<td class="nump">56,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">25,047<span></span>
</td>
<td class="nump">9,048<span></span>
</td>
<td class="nump">77,173<span></span>
</td>
<td class="nump">23,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_BulkrHuPH20Member', window );">bulk rHuPH20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">18,862<span></span>
</td>
<td class="nump">4,104<span></span>
</td>
<td class="nump">59,719<span></span>
</td>
<td class="nump">11,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_HylenexRecombinantMember', window );">Hylenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">6,185<span></span>
</td>
<td class="nump">4,944<span></span>
</td>
<td class="nump">17,454<span></span>
</td>
<td class="nump">11,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_CollaborativeAgreementsMember', window );">Collaborative Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">32,220<span></span>
</td>
<td class="nump">32,337<span></span>
</td>
<td class="nump">122,870<span></span>
</td>
<td class="nump">65,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_DevelopmentFeesMember', window );">Event-Based Development Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">57,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_ResearchandDevelopmentServicesMember', window );">Research and Development Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_UpfrontfeesMember', window );">Upfront License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="nump">7,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_SalesbasedmilestoneMember', window );">Sales-based milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_BulkrHuPH20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_BulkrHuPH20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_HylenexRecombinantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_HylenexRecombinantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_CollaborativeAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_CollaborativeAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_DevelopmentFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_DevelopmentFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_ResearchandDevelopmentServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_ResearchandDevelopmentServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_UpfrontfeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_UpfrontfeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_SalesbasedmilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_SalesbasedmilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288302088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 115,830<span></span>
</td>
<td class="nump">$ 65,316<span></span>
</td>
<td class="nump">$ 341,307<span></span>
</td>
<td class="nump">$ 145,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(997)<span></span>
</td>
<td class="num">(3,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenues</a></td>
<td class="nump">4,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCreditsAndOtherLiabilities', window );">Deferred revenues</a></td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement', window );">Proceeds from partner of license and collaborative agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=halo_OthercollaboratorsMember', window );">Other collaborators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenues</a></td>
<td class="nump">69,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">25,047<span></span>
</td>
<td class="nump">$ 9,048<span></span>
</td>
<td class="nump">77,173<span></span>
</td>
<td class="nump">$ 23,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent', window );">Deferred revenue, current portion</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=halo_LicenseFeesAndEventBasedMember', window );">License Fees And Event-Based [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">88,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_RevenueFromContractWithCustomerVariableConsideration', window );">Variable consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="num">$ (500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from partner of license and collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_RevenueFromContractWithCustomerVariableConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Variable Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_RevenueFromContractWithCustomerVariableConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCreditsAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCreditsAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income during the current period and current obligations not separately disclosed in the balance sheet (other liabilities, current).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=halo_OthercollaboratorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=halo_OthercollaboratorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=halo_LicenseFeesAndEventBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=halo_LicenseFeesAndEventBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045200533864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Accounts Receivable, net and Deferred Revenues from Contracts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets', window );">Accounts receivable, net</a></td>
<td class="nump">$ 112,099<span></span>
</td>
<td class="nump">$ 90,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Other contract assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenues</a></td>
<td class="nump">$ 4,775<span></span>
</td>
<td class="nump">$ 5,772<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, after Allowance for Credit Loss, Current, excluding Other Contract Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208600152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Additional Revenue Information (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-01<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue, remaining performance obligation, expected timing</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue, remaining performance obligation</a></td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045287904920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Certain Balance Sheet Items - Accounts Receivable, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_Accountsreceivablefromproductsalestocollaborators', window );">Accounts receivable from product sales to collaborators</a></td>
<td class="nump">$ 18,172<span></span>
</td>
<td class="nump">$ 25,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_Accountsreceivablefromcollaborators', window );">Accounts receivable from revenues under collaborative agreements</a></td>
<td class="nump">30,407<span></span>
</td>
<td class="nump">30,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_Accountsreceivablefromroyalties', window );">Accounts receivable from royalty payments</a></td>
<td class="nump">59,095<span></span>
</td>
<td class="nump">32,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_Accountsreceivablefromproductsales', window );">Accounts receivable from other product sales</a></td>
<td class="nump">5,621<span></span>
</td>
<td class="nump">4,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Other contract assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Subtotal</a></td>
<td class="nump">113,295<span></span>
</td>
<td class="nump">98,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_AllowanceforDistributionFeesandDiscounts', window );">Allowance for distribution fees and discounts</a></td>
<td class="num">(1,196)<span></span>
</td>
<td class="num">(1,003)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 112,099<span></span>
</td>
<td class="nump">$ 97,730<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_Accountsreceivablefromcollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from collaborators, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_Accountsreceivablefromcollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_Accountsreceivablefromproductsales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from product sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_Accountsreceivablefromproductsales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_Accountsreceivablefromproductsalestocollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from product sales to collaborators</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_Accountsreceivablefromproductsalestocollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_Accountsreceivablefromroyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from royalties, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_Accountsreceivablefromroyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_AllowanceforDistributionFeesandDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for Discount and Distribution Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_AllowanceforDistributionFeesandDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045201902856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Certain Balance Sheet Items - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 8,109<span></span>
</td>
<td class="nump">$ 5,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">21,722<span></span>
</td>
<td class="nump">33,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">26,147<span></span>
</td>
<td class="nump">21,196<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 55,978<span></span>
</td>
<td class="nump">$ 60,747<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045202033704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Certain Balance Sheet Items - Prepaid Expenses and Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid manufacturing expenses</a></td>
<td class="nump">$ 43,324<span></span>
</td>
<td class="nump">$ 35,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other prepaid expenses</a></td>
<td class="nump">3,156<span></span>
</td>
<td class="nump">2,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">2,374<span></span>
</td>
<td class="nump">4,783<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Total prepaid expenses and other assets</a></td>
<td class="nump">48,854<span></span>
</td>
<td class="nump">42,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent', window );">Less long-term portion</a></td>
<td class="num">(15,552)<span></span>
</td>
<td class="num">(14,067)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other assets, current</a></td>
<td class="nump">$ 33,302<span></span>
</td>
<td class="nump">$ 28,274<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204705640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Certain Balance Sheet Items - Property and Equipment, net (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 19,763,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,763,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(12,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,582,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Subtotal</a></td>
<td class="nump">7,163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,293,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">2,425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">9,588,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,588,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,593,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">2,224,000<span></span>
</td>
<td class="nump">$ 2,484,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Right-of-use asset amortization</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ResearchEquipmentMember', window );">Research equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">7,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,085,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ManufacturingEquipmentMember', window );">Manufacturing equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,336,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ComputerAndOfficeEquipmentMember', window );">Computer and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,826,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 1,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,628,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ResearchEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ResearchEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ComputerAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=halo_ComputerAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288369848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Certain Balance Sheet Items - Accrued Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and payroll taxes</a></td>
<td class="nump">$ 7,652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,078,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_Accruedmanufacturingexpenses', window );">Accrued outsourced manufacturing expenses</a></td>
<td class="nump">2,839,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,535,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">6,029,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,029,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,468,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">3,424,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,424,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,868,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses</a></td>
<td class="nump">19,944,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,944,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,949,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_AccruedLiabilitiesNoncurrent', window );">Less long-term portion</a></td>
<td class="num">(1,609,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,609,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,466,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses, current</a></td>
<td class="nump">18,335,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,335,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,483,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_OperatingLeaseAccretionOfLiability', window );">Expense associated with accretion of lease liabilities</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Total operating lease cost</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts related to leases</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_AccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_AccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_Accruedmanufacturingexpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued manufacturing expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_Accruedmanufacturingexpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_OperatingLeaseAccretionOfLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Accretion Of Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_OperatingLeaseAccretionOfLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045190369032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt, Net - Narrative (Details)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>trading_day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($) </div>
<div>trading_day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 895,936,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 895,936,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 447,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,737,000<span></span>
</td>
<td class="nump">$ 109,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 21,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,717,000<span></span>
</td>
<td class="nump">$ 48,842,000<span></span>
</td>
<td class="nump">$ 76,179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,738,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchased (shares) | shares</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,930,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">786,454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">786,454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">875,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">875,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">449,789,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">893,419,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">893,419,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">861,738,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,674,000<span></span>
</td>
<td class="nump">10,540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,231,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,231,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,211,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 397,228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 397,228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InducedConversionOfConvertibleDebtExpense', window );">Induced conversion expense related to convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,960,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 369,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Amount paid for conversion of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Stock issued for conversion of debt instrument (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member', window );">1.25% Convertible Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,936,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,936,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">861,738,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Debt Instrument, Convertible, Remaining Discount Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,685,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,685,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,211,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">449,789,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member', window );">0.25% Convertible Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 784,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">786,454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">786,454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 731,351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Debt Instrument, Convertible, Remaining Discount Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,546,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,546,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,990,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,469,000<span></span>
</td>
<td class="nump">14,835,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Debt Instrument, Periodic Payment, Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,438,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,795,000<span></span>
</td>
<td class="nump">4,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 968,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,674,000<span></span>
</td>
<td class="nump">$ 10,522,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 1.25% Convertible Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt Instrument, Convertible, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.9208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Lenders fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,990,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,333,000<span></span>
</td>
<td class="nump">$ 14,835,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Debt Instrument, Periodic Payment, Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,438,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,621,000<span></span>
</td>
<td class="nump">4,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 712,000<span></span>
</td>
<td class="nump">10,522,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 0.25% Convertible Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 805,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 805,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt Instrument, Convertible, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.9576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Lenders fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,136,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Debt Instrument, Periodic Payment, Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,174,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 842,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,962,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=halo_RoyaltybackedLoanMember', window );">Royalty-backed Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=halo_RoyaltybackedLoanMember', window );">Royalty-backed Loan | Minimum | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=halo_RoyaltybackedLoanMember', window );">Royalty-backed Loan | Maximum | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=halo_A025ConvertibleSeniorNotesDue2027Member', window );">0.25% Convertible Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCovenantCompliance', window );">Debt Instrument, Covenant Compliance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">in compliance<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember', window );">Period Two | Convertible Debt | 1.25% Convertible Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt Instrument, Convertible, Threshold Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt Instrument, Convertible, Threshold Consecutive Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember', window );">Period Two | Convertible Debt | 0.25% Convertible Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt Instrument, Convertible, Threshold Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt Instrument, Convertible, Threshold Consecutive Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">Period One | Convertible Debt | 1.25% Convertible Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt Instrument, Convertible, Threshold Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt Instrument, Convertible, Threshold Consecutive Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">Period One | Convertible Debt | 0.25% Convertible Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt Instrument, Convertible, Threshold Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt Instrument, Convertible, Threshold Consecutive Trading Days | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCovenantCompliance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>States whether the entity was in compliance with the debt covenants throughout the reporting period, and describes facts and circumstances of any compliance failure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCovenantCompliance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InducedConversionOfConvertibleDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 40<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123467568&amp;loc=d3e6835-112609<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InducedConversionOfConvertibleDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=halo_RoyaltybackedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=halo_RoyaltybackedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=halo_A025ConvertibleSeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=halo_A025ConvertibleSeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288703448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt, Net - Carrying Amount of Convertible Notes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 895,936<span></span>
</td>
<td class="nump">$ 460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,231<span></span>
</td>
<td class="nump">10,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 397,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">786,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">875,705<span></span>
</td>
<td class="nump">449,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">893,419<span></span>
</td>
<td class="nump">861,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member', window );">1.25% Convertible Senior Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,936<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,685<span></span>
</td>
<td class="nump">10,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,251<span></span>
</td>
<td class="nump">449,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,068<span></span>
</td>
<td class="nump">861,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Debt Instrument, Convertible, Remaining Discount Amortization Period</a></td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member', window );">0.25% Convertible Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 805,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,546<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">786,454<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 731,351<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Debt Instrument, Convertible, Remaining Discount Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045203602824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt, Net - Components of Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,674<span></span>
</td>
<td class="nump">$ 10,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Debt Instrument, Periodic Payment, Interest</a></td>
<td class="nump">$ 787<span></span>
</td>
<td class="nump">$ 1,438<span></span>
</td>
<td class="nump">2,795<span></span>
</td>
<td class="nump">4,313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="nump">968<span></span>
</td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">10,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense recognized</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">4,990<span></span>
</td>
<td class="nump">5,469<span></span>
</td>
<td class="nump">14,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member', window );">1.25% Convertible Senior Notes due 2024 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Debt Instrument, Periodic Payment, Interest</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">1,621<span></span>
</td>
<td class="nump">4,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="nump">10,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense recognized</a></td>
<td class="nump">$ 410<span></span>
</td>
<td class="nump">$ 4,990<span></span>
</td>
<td class="nump">$ 2,333<span></span>
</td>
<td class="nump">$ 14,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective rate at end of period</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member', window );">0.25% Convertible Senior Notes due 2027 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentInterest', window );">Debt Instrument, Periodic Payment, Interest</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,174<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="nump">842<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,962<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense recognized</a></td>
<td class="nump">$ 1,345<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,136<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective rate at end of period</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=halo_A1.25ConvertibleSeniorNotesdue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=halo_A025ConvertibleSeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288163064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Share-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="nump">32,500<span></span>
</td>
<td class="nump">34,700<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 5,399<span></span>
</td>
<td class="nump">$ 4,220<span></span>
</td>
<td class="nump">$ 15,694<span></span>
</td>
<td class="nump">$ 13,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">2,629<span></span>
</td>
<td class="nump">2,182<span></span>
</td>
<td class="nump">7,747<span></span>
</td>
<td class="nump">6,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=halo_RSURSAandPRSUawardsMember', window );">RSAs, RSUs, PSUs and ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">2,770<span></span>
</td>
<td class="nump">2,038<span></span>
</td>
<td class="nump">7,947<span></span>
</td>
<td class="nump">6,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">1,842<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">5,254<span></span>
</td>
<td class="nump">4,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 3,557<span></span>
</td>
<td class="nump">$ 2,958<span></span>
</td>
<td class="nump">$ 10,440<span></span>
</td>
<td class="nump">$ 8,893<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=halo_RSURSAandPRSUawardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=halo_RSURSAandPRSUawardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288514376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,399<span></span>
</td>
<td class="nump">$ 4,220<span></span>
</td>
<td class="nump">$ 15,694<span></span>
</td>
<td class="nump">$ 13,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
<td class="nump">34,700<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,629<span></span>
</td>
<td class="nump">$ 2,182<span></span>
</td>
<td class="nump">$ 7,747<span></span>
</td>
<td class="nump">$ 6,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=halo_RSURSAandPRSUawardsMember', window );">RSAs, RSUs, PSUs and ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,770<span></span>
</td>
<td class="nump">$ 2,038<span></span>
</td>
<td class="nump">$ 7,947<span></span>
</td>
<td class="nump">$ 6,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock | 2021 ESPP Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">ESPP purchase price of common stock, percent of market price</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount', window );">Maximum contribution amount</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate', window );">Minimum employee subscription rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum employee subscription rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod', window );">Purchase period (in months)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Minimum Employee Subscription Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=halo_RSURSAandPRSUawardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=halo_RSURSAandPRSUawardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=halo_A2021ESPPPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=halo_A2021ESPPPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208597368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Assumptions Used in the Black-Scholes Model (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems', window );"><strong>Schedule of Share-based Compensation Arrangements Valuation Inputs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Average expected term (in years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">0.66%<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
<td class="nump">0.36%<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">0.89%<span></span>
</td>
<td class="nump">0.31%<span></span>
</td>
<td class="nump">0.89%<span></span>
</td>
<td class="nump">1.67%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems', window );"><strong>Schedule of Share-based Compensation Arrangements Valuation Inputs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">42.90%<span></span>
</td>
<td class="nump">50.58%<span></span>
</td>
<td class="nump">42.90%<span></span>
</td>
<td class="nump">50.58%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems', window );"><strong>Schedule of Share-based Compensation Arrangements Valuation Inputs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">44.73%<span></span>
</td>
<td class="nump">51.82%<span></span>
</td>
<td class="nump">46.45%<span></span>
</td>
<td class="nump">51.82%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045287871928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Unrecognized Estimated Compensation Cost (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 22,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining Weighted-Average Recognition Period (years)</a></td>
<td class="text">2 years 5 months 1 day<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 20,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining Weighted-Average Recognition Period (years)</a></td>
<td class="text">2 years 3 months 10 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 2,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining Weighted-Average Recognition Period (years)</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Remaining Weighted-Average Recognition Period (years)</a></td>
<td class="text">2 months 15 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045202965528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 15, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit) (textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock Repurchase Program, Period in Force</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchased (shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 21,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,717,000<span></span>
</td>
<td class="nump">$ 48,842,000<span></span>
</td>
<td class="nump">$ 76,179,000<span></span>
</td>
<td class="nump">$ 189,738,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Weighted-Average Price paid Per Share (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.40<span></span>
</td>
<td class="nump">$ 47.05<span></span>
</td>
<td class="nump">$ 42.89<span></span>
</td>
<td class="nump">$ 43.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.05<span></span>
</td>
<td class="nump">$ 18.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=halo_A2020ShareRepurchaseProgramBankOfAmericaMember', window );">2020 Share Repurchase Program - Bank of America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit) (textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchased (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=halo_A2021ShareRepurchaseProgramBankOfAmericaMember', window );">2021 Share Repurchase Program - Bank of America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit) (textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchased (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit) (textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares of common stock issued as a result of stock option exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">931,749<span></span>
</td>
<td class="nump">3,952,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Stock options weighted average exercise price (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.81<span></span>
</td>
<td class="nump">$ 13.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,900,000<span></span>
</td>
<td class="nump">$ 53,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit) (textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Stock issued during period, shares, restricted stock award, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,696<span></span>
</td>
<td class="nump">569,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Number of RSUs withheld to pay for minimum withholding taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,795<span></span>
</td>
<td class="nump">142,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for tax withholding for restricted stock units vested, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200,000<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=halo_StockOptionsAndRestrictedStockUnitsMember', window );">Stock options and restricted units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit) (textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding stock options and restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=halo_A2020ShareRepurchaseProgramBankOfAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=halo_A2020ShareRepurchaseProgramBankOfAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=halo_A2021ShareRepurchaseProgramBankOfAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=halo_A2021ShareRepurchaseProgramBankOfAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=halo_StockOptionsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=halo_StockOptionsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208396232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Share Repurchase Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 15, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Total Number of Shares Purchased (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,562,613<span></span>
</td>
<td class="nump">1,037,547<span></span>
</td>
<td class="nump">1,775,945<span></span>
</td>
<td class="nump">4,376,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Weighted-Average Price paid Per Share (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.40<span></span>
</td>
<td class="nump">$ 47.05<span></span>
</td>
<td class="nump">$ 42.89<span></span>
</td>
<td class="nump">$ 43.35<span></span>
</td>
<td class="nump">$ 23.05<span></span>
</td>
<td class="nump">$ 18.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 21,700<span></span>
</td>
<td class="nump">$ 64,717<span></span>
</td>
<td class="nump">$ 48,842<span></span>
</td>
<td class="nump">$ 76,179<span></span>
</td>
<td class="nump">$ 189,738<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_halo_TreasuryStockAcquiredFeeCostPerShare', window );">Fee per share (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Stock repurchased (shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_halo_TreasuryStockAcquiredFeeCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired, Fee Cost Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">halo_TreasuryStockAcquiredFeeCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>halo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045288950104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Summary (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2020</a></td>
<td class="nump">$ 664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">3,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 3,424<span></span>
</td>
<td class="nump">$ 4,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045208471976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (loss) per share - Summary (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 216,587<span></span>
</td>
<td class="nump">$ 36,207<span></span>
</td>
<td class="nump">$ 335,940<span></span>
</td>
<td class="nump">$ 55,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding for basic net income (loss) per share (shares)</a></td>
<td class="nump">142,021<span></span>
</td>
<td class="nump">136,578<span></span>
</td>
<td class="nump">140,815<span></span>
</td>
<td class="nump">136,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding for diluted net income (loss) per share (shares)</a></td>
<td class="nump">146,690<span></span>
</td>
<td class="nump">142,081<span></span>
</td>
<td class="nump">147,652<span></span>
</td>
<td class="nump">139,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 1.53<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="nump">$ 2.39<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 1.48<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">2,768<span></span>
</td>
<td class="nump">3,353<span></span>
</td>
<td class="nump">922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">2,595<span></span>
</td>
<td class="nump">2,182<span></span>
</td>
<td class="nump">2,913<span></span>
</td>
<td class="nump">1,936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common stock outstanding (shares)</a></td>
<td class="nump">437<span></span>
</td>
<td class="nump">553<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140045204828680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (loss) per share - Antidilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from per share calculation (in shares)</a></td>
<td class="nump">13,600<span></span>
</td>
<td class="nump">17,600<span></span>
</td>
<td class="nump">13,500<span></span>
</td>
<td class="nump">9,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MP _4?F-O?Z+E.M\;FTNM99P?K@0/A#(/P/V%E/IX8EY0;*\._P-02P,$%
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M&L+:U<V5?G8G;JYX+VO6TCL1='W3$/']/:WYP_4J6CT^^,P.1ZD>;&ZN3N1
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M42[)>5PD KV1M=%5R5L4-Q)C\@Y1?(*(AR,H(;MV>-N.HJZG<TS] -/3V1.
MCV[QT2/QC<!TT<7V=S!%./"YYWE;5!UXTQ#3P#"[,LW\B'N^;UA>FY:$>8;9
MC6DV]3TY;.&NZ6#@V';@6.M++0-W6R125-1R'N4HM5=OU6H'+I'__ECF.9*D
M_!Q7Z7\<6<6WC7/GK-VKO)DJ<D]1(BM.EEO<:@;Q15T+:*XXD#^>%YJ3,,)P
M -K?@O:=H&_K>M-FEJRVI%L_:S5::+VIU"\-:DK9 5$E6=T:=;]V95DC22'H
M2=2-RE'YHZR;ILH25=Z=W:;(FOH$%5(8[I065$F^T4'&"8$[%VP[%_P<G8.F
M-C Z)(N& 648&.7 S/F'HV'K_(?;(0I'#Y'1P5B5QLOT.>8N-,#Y&(85;6%%
MKP(+&OC(0&,9(^QI'>8YX7P4,F.295R;J>0:ES[J+I0ICTA@@;,C"_&1<$ Y
MATT4&!,6$#,7>]N]M=G(1EO((2D,>Z?)&8]AYW8)+0M)^%T?BR=1-=E#+E!1
M-@+6K28;3P'>NSIL-T2N:1N[>;M36\E ;66%O)>$E$O5!27)11]SL+2' +D>
MMANBUIR)F1/U/V1U=RA!>,Q<>60.8Y/6QU@.(6IFQ6YJ?1%$HD@=:NU>K*4R
M\I0R(AY8CQ"+<NI'%GR:1+&;12WX1F"ZP";Q16$4FA)@WEL.]1J4WF9$G_DX
M-%GE&C!EQ,R]&\!NRED0\, ^N9JDL9NE1ZOQ7S?%@?DU65+*<:G'+1 U26(W
M2SH%^2%8%]CD1^QQ'IA:>]Z;'M3D0$@_#"DVT^8:;!U88&X PRD/:>0S^R1K
M/L?1]U?F1!,X<1/X,=J<F.S-"#&?9ZY&& YA:Z(G;J+_:=0Y,0D_I):G7++S
M&.YF^A^JSPGP[$XX,PMCWEON%J61 B."#0=)BPKB%A6OHM")*1YLP+1N(&[=
M\"T:G9A:P89'BP3B%@E'BG1BBH(ID<1J@:,U 7%K@J\3Z01BV##R (U.3!TP
M-<VN;!$=ZY*F;.*F[*.$+C'9>=H^,.PSU@C#(6[-X\3-XVZI2TP"I#[Q3/J]
M&6,YA*B)DKB??%])ZA+S*=@E=:EF4NIFTF^0NM3D28O4[2T/2ET@HDWJ J:@
MU 7L#DE=JOF<NOG\F(UG>'ZI2<AJA*@-HN9D>NS>^ A8%Q3@08X]9M;0)359
M=<H)]\VYFP.F<#J8K?N2A4-JF'Z 6O<Y!Z)> U&)N=[> &93%C >F:W?0ATB
M46!_5*8[1P?T^PMMJD4!=8N"8X0V-<4 YGX$[(*.L1P"U^J!'MB];X6"TC3J
M;&I3J<SO#J).T.]QOA$GZA#V20Z?ZHUD],N=+:E[D4B/)H/WI2BT[2"+ DAT
M;I[= *, '@9$]ATLJD4+=8L6URBT4UL?/0QS"NQT>*'MJ$QK$?J3;/(?>D:B
MP.X#(3;"U9J%CM^A_^X/2=04.B$!:'-.@8T+('/!<([$U;*)NF73D>*?FC)I
MRFC@6XXAM4IBQQX80*/, ,V!PR@ =G[FS)1&4V"EM(:DUL%F6L8PMXPY2OXS
MX,R  OO<A^V&J+6R86YEXQ;_S*1O2GD$G5^/,AV"U/3-QAW]CY?_&,IK!AP6
M,"_R;8F]<\#NYO=Q\A_"=,%,\B8A]@. !WO3P6K"@/4$",F\0"ZZ0%J9IE-L
M-GT#VDE9&A+[[&J1P<:=8WS55C<\P8 &8 2'EJUNIA4 &W>4<7"K&YYCD^,Q
MC@)H5XT!QQD,V,< 0JI'O,A<&Z\!TRF!YABPHTSR6F2?8ZU'6/#]!3C3<H&Y
MY<(Q IR9M,QI!"C/$89#V)J_V?@#_Q^JXIBI""@+X>YQK0>X6P_\4!''@:T/
MGP';+MS4%L9[2(=C#8=(BPI^[$L-3@7'H5<1N&]YK.!:+7"W6O@Z!<>A5PI8
M@(%UCP,[#P"UV2+:Q3+7(H/_']Y3X("D #9O#YH-,6OAP;_E+04.: OL\Q#8
MNQUE.@2Y\P;@:[^G )([A\C=KMZX)G?^&N\I@,S.3;JVJ3? %%1O@)U-O0&F
MH'H#[2SJ;;;S8K[ZWY&_QY64/#7*Q4(Z>^\".?Y5]^\8W4U3KMMW]1_*IBE7
M[>52Q)+0E8'\?5&6S<N->OU_^T\QY_\#4$L#!!0    ( #>!8E,N5(>.D@@
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M[?=.S_,%SU?UK<>_Q:T\^^SIO:*:_-@?=3#MX-AT\O_RH\(A&?#71RL#GNB
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MO9&W.OU4?J39$V>&!''QVXC?)"5:<@G-/RZO(XJ=*H#+_-4FE@K$2>YJ,YR
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MJ%[(1*ZVLOK[L8QHK%U9634&V<!6"SFL31RC0+="6XG: )5:JRNEH44:"K?
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MTHYTK8OO,KS76W<T#M"A;_05M:L&)Q#>R'\"A!VBLLK%1I0;X:M P04YDR+
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M.F%%N16Z+Q8.F:P4(-A-+5SE+TZ!FW\5@6,I$41T*-!$#*&ZB6]+4)%[_IX
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M<R]S:&5E=#$U+GAM;*576V_;-A3^*X07;"F@RKKZTB4!G%ZP/K0(DG9]&/;
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MKO_+XT/"GLS30Z:.G?+9RA#'A!V:'B6Z[3B @4$C8K!D?6FXS(_P('=LWE8
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ME2/C'B/./TJME%B!0%!>@&FLU[*/9.9Y7$D.!D<GNK1*HAA^.@FJMD'.,M0
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M0Q:P:*@L;UA_I'/KR]^]C*;E[4KBP7RD)';(#M$?V"83^0;)*-@@.I/HR<E
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M)5XCXFG95R,70&)^GB<VV\D#4Q^FM\C$\?HKIQ54FOD^#2&1H/IZMU5\B;,
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MCN8X>_10*"K-(&3,M3\PS;PGV=ON"\M!,<OQB"8UP\Z4/G-=^,.,WB^C#DF
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MAMU6M68'PF<8J<R</!RZ-GNZ]M$&SKS2^>.MB;4MQ=<F3Z4_S"J"B6$D"A3
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MF_UH\]#;D/D#&VB[@3K>C2/'\CVS[.I"JQW1: UH.'"ANMU 3D@\E$>K857
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M!H=CS2N[7MM-4#2VORT%ZFYIAZ6^GX T ?K]2@C<3 R!N_&D?P!02P,$%
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MB$#W8]\'5K5A<@[*NCD,R]K]*5#[!'=>*F7/@1_&\=^3_P502P,$%     @
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M'NH=$,TYVQ2*5_:H6G&E#SX[+/35!,( ]'K.N3H4YO1SEUWZ!U!+ P04
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M=C=N]4;AYHB(7BVBURCB/LO0EQ2ZD=YIIT$SBU=0H$Y0VF/I:.:,6NW!>4.
M^K6V?B,/%2Q,F+$-5(.::O ?,SJLK0S_?3"GS9P7O4&KWSF_/"8O/*AG.>JE
M[PL&?$DJWVZ]6K>>6U]Q/ZQ/J265'>2=INQGCTPON30@,"/*J#6@U.NR1Y03
MJPI?-5^5I1KLARMJJZC= =K/E++[B3-0-^K)'U!+ P04    "  W@6)32^8+
M418"  !\!   &0   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q]5-N.TS 0
M_14K3R!!G:8MEU4:J=T%L0^+JJV !\2#FTP2:WT)]J19_AY?TE"D;5\2CSWG
MG!G[V/F@S9-M 9 \2Z'L.FD1NQM*;=F"9':F.U!NI=9&,G2A::CM#+ J@*2@
M69J^HY)QE11YF-N9(M<]"JY@9XCMI63FSQ:$'M;)/#E-//*F13]!B[QC#>P!
MOW4[XR(ZL51<@K)<*V*@7B>;^<UVZ?-#PG<.@ST;$]_)0>LG']Q7ZR3U!8&
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M4+=*;545M7N8]F"2 ZPZ<68[T%;[XW=V0D9+DKV.!^(?=]_[W/E7M!/R66T
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M:0QP?B6$WG?,U5Z_Y),_4$L#!!0    ( #>!8E.+GB!P>0(  /P%   9
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;(V446_:,!2%_\I5U(=6VIJ0$*@J
MB$1AU?90J2IK]S#MP4ENB%4G9K8#[;_?M1,RV@+;"[&3>XZ_>XP]V4KUK$M$
M R^5J/74*XU97_N^SDJLF+Z4:ZSI2R%5Q0Q-U<K7:X4L=Z)*^&$0C/R*\=I+
M)N[=O4HFLC&"UWBO0#=5Q=3K#0JYG7H#;_?B@:]*8U_XR63-5KA$\[B^5S3S
M>Y><5UAK+FM06$R]V>!Z'MMZ5_#$<:OWQF [2:5\MI-O^=0++! *S(QU8/38
MX!R%L$:$\;OS]/HEK7!_O'._=;U3+RG3.)?B!\]-.?6N/,BQ8(TP#W+[%;M^
M'& FA7:_L.UJ P^R1AM9=6(BJ'C=/ME+E\.>8# \(@@[0?B_@J@31*[1ELRU
MM6"&)1,EMZ!L-;G9@<O&J:D;7MM=7!I%7SGI3'++N((G)AJ$.V2Z44A;9. S
MS&5M%(7<, %WS#2*&XX:9 &S#>."I0*!_D2P9#188&I@B=FNZGR!AHKT!1D]
M+A=P?G8!9\!K^%[*1K,ZUQ/?$+UE\+..]*8E#8^0+G%]"5'P"<(@'!R0ST_+
M%YB1?.#DP5NY3YGUP85]<*'SB_X=W(+K3$B;G8:?LU2[W'Z=6"/JUXC<&L-C
MS&2^Y::DX&2-\(I,'<JM-1DY$WMJ-TEX-1J-PXF_V<_G0%D81(.@+WO#..P9
MAR<99X5!Y?#2QNQH"SJ:#O?@/K>&\1Y(-(Y'\3O<CU5'2..>-#Y)^D4;3N<>
M<_B[=X?PX@\Y1>$PC,;O^#Z6'8S3WSN;]EZ\8VK%:PT""Q(&EV/R4>U=TTZ,
M7+OCFDI#A]\-2[J>4=D"^EY(:783>P/T%W[R!U!+ P04    "  W@6)3?<@?
M-$0&  # *P  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6S-FEUOVS84
MAO\*8>RB!=)8_)1<) 969]T*M$-1+]W%L O&IA,A^O H.FF!_?A1'_&11XF1
M4U_H)K'D0_J0K_3HO*0N'G-]7]PI9="W-,F*R\F=,=NWTVFQNE.I+,[SK<KL
M-YM<I]+80WT[+;9:R775*$VF) C$-)5Q-IE?5.<^Z_E%OC-)G*G/&A6[-)7Z
M^SN5Y(^7$SQY.O$EOKTSY8GI_&(K;]52F>OM9VV/IOM>UG&JLB+.,Z35YG+R
M,WZ["$79H(KX&JO'HO49E4.YR?/[\N##^G(2E!FI1*U,V86T_Q[40B5)V9/-
MXY^FT\G^-\N&[<]/O;^O!F\'<R,+M<B3/^.UN;N<1!.T5ANY2\R7_/$WU0R(
ME_VM\J2H_J+')C:8H-6N,'G:-+89I'%6_Y??FHEH-<"LIP%I&I"A#6C3@%8#
MK3.KAG4EC9Q?Z/P1Z3+:]E9^J.:F:FU'$V>EC$NC[;>Q;6?F[V6LT5>9[!3Z
MI&2QT\IJ9- ;]'-1*%,\G5PC:5 KMA0 ?5&KG=9Q=HO>R2(NT*LK962<%*]M
M\^OE%7KUT^N+J;%)EC\U734)O:L3(CT)+=7V'-'@#)& X([F"W_S*[6RS7'5
M/#AL/K53LY\?LI\?4O5'GYV?,SO*1&8KA9;5_?6KSG=;._@S]#[.[/E8)FAI
MI*DG<"&WY65:H+\^VA[1!WNZ^-N3#]WG0ZM\6$\^OQ0FMA>O%00RZYKDNA=1
M]5+>R@]S2ABA81#867EHSZ<;24A <="./$B5[5-EWE2K!!_JRV6#9'T]I4_7
M4W4%Z?T5=%->05T#J7^#M]*+,(]FD3L0-Y**,(IP[T#X?B#<.Y!/>::^VYM.
MWUO9-[ML77B$%/M.Q2@NK'"?3_A#@ZS5")TY9C,L!';5<",Q"WC8KT:T3S3R
M)KK(TU3I:E:V<JNT9^RS?9>S46B! Z!R< (UFD[:D_Q_&3I"2@;TJH!;#P[L
M3;%Z0+RYD:M[>S<7Y8T<FUCY;@T,T,7CH"X&[.+3<+?IICW?)(QP!W<[(FV8
M(/W2 'BQG[R+7&]S;;.U!<V-&2@.T!#S<8@#*,7B-.((]V;@(J(=XKB18A9&
MLWYQ@+/8#]KK\^4Y^D-7S\'O [4!-N)H'-H 6O'L--K,W!FW)5S7C>-&,HX/
M;['#6@^P2_S8_3W/WEPO?64CX)'@42A!6I4L.8D233>'8"*'UWZM1$=DGP0
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MI&1YU5Q3DE!> M3[)6/R_:$,T%[<COX'4$L#!!0    ( #>!8E/(&YF%.00
M *<0   9    >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;+58VV[;.!#]%<+H
M0PLDD:B[ ]M ;,78 LUND+3=AV(?:&ML"Y5$+TG'W?WZ'5TLR=;%7AAYB45J
MSLR9X>B0S&C/Q4^Y 5#D5QPE<CS8*+6]US2YW$#,Y!W?0H)O5ES$3.%0K#6Y
M%<""#!1'FJ'KCA:S,!E,1MG<LYB,^$Y%80+/@LA='#/QSQ0BOA\/Z. P\1*N
M-RJ=T":C+5O#*ZAOVV>!(ZWT$H0Q)#+D"1&P&@\>Z/W<R "9Q?<0]K+V3-)4
M%IS_3 >?@_% 3QE!!$N5NF#X\P8SB*+4$_+XNW Z*&.FP/KSP?L\2QZ363 )
M,Q[]&09J,QYX Q+ BNTB]<+WOT&1D)WZ6_)(9G_)/K=U,.)R)Q6/"S".XS#)
M?]FOHA U /II!Q@%P#@%6!T LP"8ET:P"H!U:02[ -B7 IP"X&2USXN55=IG
MBDU&@N^)2*W16_J0+5>&Q@*'2=I9KTK@VQ!Q:O(";Y#L@-R2WYD0+%UF\M$'
MQ<)(?L+9;Z\^^?CA$_E PH1\W?"=9$D@1YK"V*D';5G$F>9QC(XX)GGBB=I(
M\I@$$+3@_7[\L >O8<YEXL8A\:G1Z_ 5MG?$U&^(H1NTA<_L<KC>ELYUT1^O
MBS[OA_NP1#AM@Q_5TBR;R,S\F5W^0LG6:P%KEJD%7Y%#6_WX@J;DLX)8_M43
MR"H#65D@JR/05ZY8A(*6.6_MPASO9/A45=\FE-J>B5F^U1>W:>;8)G6.K?RF
ME6E14W>/S1Y;8EJV-Z2EV5&N=IFKW9OKH80"EGR=A/^V?S6Y#[L6^W8X/"78
M8F1ZKM[.SRGY.;W\?%B!$!#T+H?3B&RYKGU2YDN,YDZCR+;K&NTIN&4*[O4I
MN$UVGG[23_X9HR-V7LG.ZV4W0\$3N/,2)B6H5FY>(^PIL;,6<Z]16%?OHCXL
MJ0][J3\+O@0()%D)'I,M$RH!D>I"%"[Q5 ($-Q&"6U?$%KS8=!CJ!^"11;5U
M^;"1A6'@A]C!DNK5YJ?W\OQ#;9!7180+V:-2M+:ITO<51&I4H8SK>[CP42^@
M,VQV\5FS8X[5]D#-<^T0[+"1)8M WI $5%_JU69 K7>N<J7%M%^,SV\\M"FR
MAJU;)U(\*\SJG]M0M[S3A6@Z<UWJFB>ZWN+,,&VS0Q5II>ST_TG[#9Y$<9PH
MLN4BK75K 9HR[MAZL\?.F1USKJ2<]FOYET)9Y@"2/*"\/")U=3O%6T= ?CQ!
MO #1VPN5+%/OG=NNDE':KZ,7M%U3&CW/Z2JG42FCT:^,WYD(V2("%$>\108@
M6,>Z^X6C.@-4YDX&E88:]/KSS[1P4O\$;NU&T[59T29'K7:/BD&LLQNOQ!+L
M$I6?ALO9\E;]D-TE3^:G]'Y&6^9]>O^8WYDK]_D5_HF)=9A($L$*0^EW+M93
MY+?B?*#X-KO%+;C".V'VN &&"Y,:X/L5Y^HP2 .4_YN8_ =02P,$%     @
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MQ5IHQML4#1OY/"_P&_/=A$7#L*ML4:TK.C_?'-NQ/:VPL9,TPV,IBRO;)Q>
MFPX/9/-VMRC:Q$<-53>>%PU.M+>A*.W0[M%_+8B>5?]B2HH-O;%F;:]I;22T
M><1YN&VB$\$MN"@,@]-5X![T3W-Y^<;D,BL4X;! 'KT-T;+<W0=V RU*VU)C
MH;%!V\<5WJ% &@!^7PBA/P:F2]>WLLE?4$L#!!0    ( #>!8E,,24Y#A0(
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M.;WXA-[G(BR 4P,%F3&=<ZEW"HOPZWZEC<*[]_M,N+@-%[MP@Q/A%O2 1VE
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M$^]0A)JPW49ONYVHV!9!5Y*I]-IXL8UG?J.7+ P"'*;NRS"+L2J(O'#6J][
M!CUL<!*V_3A-AWP*LHT3#9?WH_B(<2S"D>]-(X8]8O@!1&+WSQ18.%XS2(Z+
M-Q:%R2R8!HMZL.@DV -7A(YJ9_<\_P=S-,:9S:)CZ D5#D)_FCKNJ>.3U-]
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M*96&C:!VOZK<HQ[W%GBDF3ARL,U"$FKXFV'^;(!OR% T\4#G>*S0H,$]R>^
M9=X 9"*HF<]Z/-W4R?DQ[]L?\^X/TS<DD'2HHU_%TFIJRU+VK!Y[Y^JY 3M9
M7.*ZB, _[R6\JK1_!YS9C3-;.;-?<*:\D+94#XQRKBO,RIRKS)7K[_,2SJ:N
M99I2^O-ERL8"?0W0\Z;.)?!*FM-(<P:E/01!D18)%B24BZ9L($&,JV592L4I
M92+^I@9T,BO3SL6D;B%R3;.K<S32UR&AXZ%>I6ZCU!U4NB^>!!4XT0EQ.TZG
M4)>ND3A?@T,SJU?"M)$P'92@>C.@$2@X 9AS(K35-^UX1S9RNFI&XOPNSK*N
M4W>EQFO4>/_KK9(-0*?*Z\QBYGA>5]5(G-_%0=,92-*LD34;E+5Y[5LTZQ:+
MYL58SSHK@*=[T[K6$$)V![?MFD.V9_>JAV;;],V7B_261K=-D;X8@=KBY:1M
M70AJG/L";J.Q!Y$&N-48A$.E#2\^?>!P% @GF 7'MK '^A!$K5GTZ]L>;)LL
MM'YNXZOM7:^0,\W:,Q;HZX"FU]_X8-O4X7!7?\19$<G=1\'B[# N3VU7A<YO
MR%/;VN!P;WM]GKH=RI'QU^1I)-#7 2W+[<]3V_3@<-=;TS0O!&%*'(VB6&XE
M1F6K;430^PW9:AL$'.X0K\]6=U%W$(*:;(T$^AJ@[:'^;*%V^4?#R_][(O?B
M1YJ$($YS1I])J8T/[9[:-17!7Y\FU*ZU"/W<--7VKKJ)BS2?*&.!_@A@)<ZX
MV*6GA!W4>0H' 2TR46VJFM'FS.9!G51\-[Z"]VNH&=_ ^VUU(M.:KPZ('C$[
MQ!D'"8FD*_-N*HN*56<NU8V@N3HC>*)"T%1='@D."2L!\GE$J3C?E Z:DZ_E
M?U!+ P04    "  W@6)3S#O;:P\$   _#P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6RE5]N.VS80_15"Z$,"9%=W65[8!M87H0$:=+%NVH>B#[1$
M6T0HT26I]>[?=T3)6CNB%:%YL47JG!F>F1')F9VX^"9S0A1Z+5@IYU:NU/'!
MMF6:DP++>WXD);S9<U%@!4-QL.51$)QI4L%LSW$BN\"TM!8S/?<D%C->*49+
M\B20K(H"B[<E8?PTMUSK//%,#[FJ)^S%[(@/9$O4U^.3@)'=6<EH04I)>8D$
MV<^M1_<A<?V:H!%_4G*2%\^HEK+C_%L]^)S-+:=>$6$D5;4)#'\O9$48JRW!
M.OYMC5J=SYIX^7RVGFCQ(&:')5EQ]A?-5#ZW8@ME9(\KII[YZ5?2"@IK>REG
M4O^B4X.-)A9**ZEXT9)A!04MFW_\V@;B@@!VS 2O)7C?$X(;!+\E^&,]!"TA
M&.LA; GA6$+4$B(=^R98.M)KK/!B)O@)B1H-UNH'G2[-A@#3LJZLK1+PE@)/
M+59$**@_M,0,ERE!6UW.GQ4I)+I#CVDJ*I*AS2M4LB02?5@3@#/Y$5Y^W:[1
MAU\^SFP%ZZBMV6GK<]GX]&[X]-$77JI<HDV9D<S 7P_SIP-\&_1W0?#.05AZ
M@P:WY'B/?.<3\AS/-:QG-9[NF.3\G/?-SWE/ANEKD@+=-=&O8NEW!>5K>_X-
M>]>%]$P85E! :RI3QF4EH(;^?MQ))6!+^6? 7="Y"[2[X(:[<X6FO*A+%#?;
M59FA(WX3G#&D\"N1IAIM[$;:;KW_OBPF40@;,@3AY3)Y(W%)'Q<[D_@2=R4P
M[ 2&HP3"J2!Y)5)X+'!9[2%^E:#E 9'VVS1I;$R'%VOR8G_:US@2E_1Q0>B'
M-S5&G<9H4./O*B<"#IE&Z9"@J+> R/$,@D;B$@,NB&XG;=()F@P*^HW 88<8
MQ3O*J'HS*9GT//N!%_25C,0E?5P0#RB).R7QH)(_N,)L5&KBW@+<Z30P*!H+
M3/I SY\&TYN:IIVFZ0^R(R5BO#S<*2(*=.2BWC5,FJ:]%=RYD6.HM[' Q #T
M@RBZJ<EUW@]RYW]DZA-<(H0@I3(>TTX_%;%__4&W!_)89-(B+_=!SPEB_[;"
MBZN*.ZBPO84@+"5/J3Y73E3E6C/1&S_?(W;UZ5%SK;:.KN0X3D_,JL5%/\"M
M#?9\ VYCL!=<XZY#X[V'QAN1?.@W!)R <"@T44BY-.?=ZRTW-,H?AUL;<*X)
MN#$!)T,!>+]UN/Y@ %98YG#FTPQ!MX5PP:M226A]FNN'XDU$S,7@]Y(2&:/1
MQ\7&:/1QGF.,A@$8FJ)A7]SO"R(.NA.3D%X0V=S,NMFNVWO4/<YW\TOW8>4:
MYM?NPZ;IY=[--ZWE%RP.M(3MDNS!E7,_@=R)IEMK!HH?=7>QXPIZ%?V80X=+
M1 V ]WO.U7E0.^AZYL5_4$L#!!0    ( #>!8E,CVOZ!00P  !A,   9
M>&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;,5<;6_;.!+^*T2P"W2!U!:I%U*+
M-$#K;%NWCI-UTKT/A\-!L9E8J"UY)3EI#OOCCWJQ*9E#2HYC]$L;VS/#>2'G
M>4C1/GN*D^_IG/,,_5@NHO3=R3S+5K_W^^ETSI=!VHM7/!*?W,?),LC$R^2A
MGZX2'LP*I>6B3RS+ZR^#,#HY/RO>NT[.S^)UM@@C?IV@=+U<!LGS![Z(G]Z=
MX)/-&Y/P89[E;_3/SU;! [_AV;?5=2)>];=69N&21VD81RCA]^].WN/?)[Z7
M*Q02?X7\*:W]C?)0[N+X>_YB.'MW8N4>\06?9KF)0/SWR =\L<@M"3_^KHR>
M;,?,%>M_;ZQ_+((7P=P%*1_$BW^%LVS^[H2=H!F_#]:+;!(_?>950&YN;QHO
MTN)?]%3)6B=HNDZS>%DI"P^6853^'_RH$E%3(#H%4BF0'06':13L2L'>'0%K
M%)Q*P>FJX%8*;E<%KU+P=F,@&@5:*="N([!*@755\"L%OZL"MC:5LW94;*W*
MMMA*M;4JFW+CW7H33Z>R*3A6*N[J5#8EQYUKCC=%QTK5J4YE4W:\6W>]RJ;P
MN'/E\:;TN*A]OUR*Q3J^"++@_"R)GU"2RPM[^1]%,RCTQ?(-H[QOW62)^#04
M>MGY*(X>WM[R9(DN^%UVBL:B5;Y%XR!)@KRAH#<7/ O"1?H;^@7U43H/$IZB
M,$+?HC!+3VMOW,[C=1I$L_2LGPF_<NO]:>7#A]('HO'A_2KI(>R>(F(17%H$
MC S,1BX#8<3&I9%O-Q?HS2^_94DP"Z.'_\Z"9^F]=H +\P ?^5T/$=88 +#R
MA]G*!9]NW;3T5CZ:K7Q91\**U6;ED]G*.'[<6,&^*66 Z<\M#@;1)DSLZ1T<
MFJW<\-4V3$/*OW1/EL'*U_WGES%#H^ZQ&4IXN4=L@/KX51)\]2JA7.^_,K3)
M_;.SK>W,UMJ:=)C*%C;DJ"]Z[K;QDFWC)8596^OB78:&49HE:T$#,_3OD1!
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M0Z)"G895=):< )(MVQ,B89288=3JU'"I:;9(D"3L* U7 ATQ UW'AJM"%[/
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M"<"6P&P5(*^,MIIQ2R#S]CSCW8_J>.J1K&NI9&T$R"EI4$4PADXBC+:::9"
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M, 28,H:++5'KP:$T8B#5!S-<I@)GZ4\2#\ TISN)_O>S= D^"9+S_WH"\IJ
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M901UR.LQO'Z0K-1CXYQ)&$+U[8J2A'(%@/<+QN3F02EH_PP9_@M02P,$%
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MQIBXUN+\"HO'VAT\!0-[9)BRSC%7^,85_BVQ\?:4":(_$AMVECAVNY$Y-NS
M)'![YDOJG,6.&R?FV'B_Q5H[[Z!BR(&OJU)-H"7;%+)^'+:C;3DXKHJ@W\8G
MP>TT,(S/=/E852AO]'7M>8_YFJB2@L)*F?+=KKIK>5W.U1W)RJI>>6)253]5
M,U,E,'"]0,VO&)/[CC;0%M6C7U!+ P04    "  W@6)3_B&Q]S0#   K#
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M1J<#(S19=:;50(O2=8,+H4UOZ6XST\VCM O,\Z40>C>P"9K_!Y.?4$L#!!0
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M"B#?+RD5VQOUO;+Y]\+T7U!+ P04    "  W@6)38IK8PHP#   \#   &0
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M(9*2O5 10OGU1FY)FJI ,HT?34RC'5*!I^WWZ*MJ[G(NNY"36YI^3R(1SXS
M !$YA&4JGNCQ@33S\52\/4UY]0F.C18:8%]R0;,&EAED25Y_AS\;'TX Y%X
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MA0:H]VNNXE$/] +-K<SD'U!+ P04    "  W@6)3 $$48(X"  #C!@  &0
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MI2J8M$BF=$Z-G>IY6!::T;0$IUR$O4XG#G/*)1D/Y3*_R4T9S-12FA'I-Z;
MW;ZF(]*-/Y+ T4U4RD;D\?S]SZ4RU^\"=S_[<';6>;RXWK>?5\ %";VD_2-(
M+SL=G!A C#P^COP0-T9]=13U 6:,>+!+W.0(7&W&SCVL"S<>9DJV]8N(,UA^
MFK/@B8H1F5#!IYJ#5T9S+M;.W /#3 FE V,;QP;L@J5\=G#7S:"G:IZ<2Z6K
MV"Z"^SNME^\!FQD(Y$(T GO$&<;#@AK#M+RQDVIQ97P!!?7X85U8A7--U]U>
MG[0.U<T&F2J=,MV$Z9*-:3P4+ ,YFL\7<#>J" $T1N5VD'(Z5Y)6&C8>]<#2
MSI@0]_# _<AVN%?95N4Z4#?9#*V@>NAHW 3XM]D<]S;MZWB#@C\I\V5ITY'5
M'%J-W6F6\54U7V6- (R]B[/3HA#KSX+/9<Y<\D<'' _IQB]8*,V?;31HE9DU
M,$V")Z8-GVU;?FE:/+"5V;33*L,U]TY0\]_=YSF33%.Q+=KV_EO>Y5<KCJ[^
ME>3JO\J^8*_&^A1]ZR+[IR R/@61)]&3@S<I,JS/QJT#>.?X;:P!O.:,R'=X
M;1)MT&"ZY,)P6<\6/$V9?'$*6WI#I_9E>H??KD]91I?"/#3@B+3C6Y;R99XT
MJ^Y@(^I5[?@;I->-FW<L&XO+E*U8.JFG>CZMAH$=V*CU!0[[R$UU^1',QV%^
M!# L#J8 \W%>6)S_*9\!FH_#,&T#+S) ?0:HC_/R(9/J@\7Q^R3V\F>:)%$4
MQ]B.3B9>!1-LW^(8OGXV3!MX8'$@TI_M-5YMO$,.]P%6TT,=@F6*=R*6*;[7
M@/CW#3R2Q%]M+ YX8%7 >@?B^^- 3_E]H@BJBFG#GF <21(,@5[T]V@<([L3
MP\=?'^PIB:(D\2. ^15$$8; TX@CF +0@"%15)V#>^=1N#FGPO87IO%O4$L#
M!!0    ( #>!8E.7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,
M0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BD
MMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G
M<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^
M=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"
MR0_L?@!02P,$%     @ -X%B4W]7B/^5!   +R@   \   !X;"]W;W)K8F]O
M:RYX;6S%FMMNVS@00'^%T,NF0%U;-^>"ND WV>X&Z*9!W<UK04MCFXA$>DG*
M:?+U2\EU,VKMP;Y,]&2+E.4C2N*9&>KM@['W"V/NQ;>ZTFX6K;W?7(S'KEA#
M+=T;LP$=>I;&UM*'3;L:NXT%6;HU@*^K<3*93,>U5#IZ]W9_K%L[QAO&0^&5
MT:&Q;;A3\.">^]M-L55.+52E_.,LZKY7$(E::56K)RAGT202;FT>_C)6/1GM
M934OK*FJ613O.N[ >E7\TCQO(;_(A>M:O%Q\E@%D%DTGX8!+99WO]NB.+P/C
M%L+.NZW&FP^J\F"OI(<_K6DV2J_:PX2S&*/3Z,9A_[D;Q O[?X;1+)>J@"M3
M-#5HOQM'"U4+J-U:;5PDM*QA%EV:+5AQ*U?0GE3XE^MR=X(^D*'ALA<J=-CK
MLF/DY-$E: >E"-^<J509.$KQNZRD+D @R(2 3 :$_)H@R)2 3 >!G+<XX:<(
M,B,@LP$A>R.9$Y#YD) I@IP2D-,A(3,$>4I GO)"?K(KJ=53UR&D#H],XY0&
MYQ#>&8%WQHLW;^I:VD=AEF*N5EJ%GTGMQ?NB,(WV"D&>$Y#GO) ?I++B3E8-
MB+]!NL:V3[/'L_>$FKXGO'2?80NZZ<F$M FW3H*Z0_CPPQ^=D<5U>"3P+1=3
M+HF99?+1Z-7H"]A:7,'"OQ8WT+N8E$%B9H7,U]+":"%WLTH=CN2ZG3 ?)8^8
MV1YS;XK[M:E*L.XW\<>_30CQ,!OEC)A=&G6M?+N3ZV:Z,"O[$.2!+A3T[CW*
M&3&S-&[:AT$7I@9Q4AGG7HE-B 9=>]DQ(F6,F%D9Y)S<BQ!BRASQD.KHQ0@Q
MY8YX$'F(DY"95.!>X?":LDCR,A8YR$7I)!E.)RTKQB33DY=7RL&AI-R2#.26
M[Z 8DU),,H!B#HXEY9ID2->($XQ)V289SC8_/SV4<9*ADA1Q<@6^ATD9)QG4
M.#CA2RCC),S&H3%S7"NAC),R&X?&G&),2D ILX!HS%.,20DH9180C7F&,<D*
M&;>#2,QSC$DY*.5V$('YM<OV?V!2%DJ9+70DMAQU>N\EC2EEH9390D<Q;Z2U
M$N?>*66AE-E"Q&AJ;[&%4LI"*;.%CF*^=PX\3G13RD(ILX7V"<5(7"DG5RL+
MJZX\^FNY*J,LE+U0WK._&=46=D&'JGK19D8Y*&-VT#/D]\*H"\-8@-JV0?%K
MO$2340[*F!V$,,M2M=VRVE_O$(9B3,I!&?<R#9%2!G2,2:[3<"_4D)C7&)-R
M4,:="9&8MQB3<E#&O5A#8?:*6AGEH(S9030F+FIEE(,R9@<=*G>@&11C4@[*
MF!UT&/,R8#Z&9!W/FSGEH)S904<PNQBNO]"44Q;*N3.A8_6CD6B[,"9EH9P[
M$SJ.V=Z@&).R4#Y4-:X+Y!J,25DHY\Z$CF/^HWMK%CGYO@"SA0X6#9]G)(Q)
M62AGMM 1S&Z00Z2$,2D+Y=P6(JN;(XQ)62AGMA!5W0R#BC$I"^7,%J(Q<;PY
MI2PT[2PTWK^@5L)2:2AOPE^XT%[(JKBUHOW8K:]G>;OLM6RJZC*T?=(?C2SW
M[[OMW]5[]Q]02P,$%     @ -X%B4Y@;6I[[ 0  RR,  !H   !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<\W:2VZC0!2%X:U8+"#E^R))*\ZH)YE&V0!R
MR@_%-HBBE63W;3D#YZ >]"2J,T(%XO*//A#P\)P/W;3O3V6W'\KBXW@XE56S
MFZ;A5TIEO<O'KMST0SZ=CVSZ\=A-Y^6X34.W?NNV.>ERV:;Q^XSF\>'[S,7+
MYY#_9V*_V>S7^7>__G/,I^D?@]-[/[Z57<Y3LWCIQFV>5DWZ.%QWEW39R,UY
M<K-X>ETUX].K-*EVD$*0U@\R"++Z00Y!7C\H("CJ![40U-8/NH6@V_I!=Q!T
M5S_H'H+NZP?)$F5<$B3-L";06I!K(?!:$&PA$%N0;"$P6Q!M(5!;D&TA<%L0
M;B&06Y!N(;!;$&\AT%M1;R706U%O)=!;9P_;!'HKZJT$>BOJK01Z*^JM!'HK
MZJT$>BOJK01Z*^JM!'HKZJT$>AOJ;01Z&^IM!'H;ZFT$>MOL90F!WH9Z&X'>
MAGH;@=Z&>AN!WH9Z&X'>AGH;@=Z&>AN!WHYZ.X'>CGH[@=Z.>CN!WHYZ.X'>
M/GO93:"WH]Y.H+>CWDZ@MZ/>3J"WH]Y.H+>CWDZ@=Z#>0:!WH-Y!H'>@WD&@
M=Z#>0:!WH-Y!H'?,/E82Z!VH=Q#H':AW$.@=J'<0Z!VH=Q#HW:+>[4_J7:;/
M0R[7GJ\U7O\GJ9[.Y^;KY2_+KYUXOV@O."?X=^?Q+U!+ P04    "  W@6)3
M=-+&8MX!  !:(P  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VEU/PC 4!N"_
M0G9K6.D7?@2X46_5"_] W0ZPL*U-6Q#^O=T $XT2#2:^-UNVMN<]:Y/G:I/G
MG:,PV#9U&Z;9,D9WPU@HEM28D%M';1J96]^8F![]@CE3K,R"F!B-QJRP;:0V
M#F-7(YM-[FANUG4<W&_3ZU#9=IIYJD,VN-U/[+*FF7&NK@H3TSC;M.6GE.$A
M(4\K^SEA6;EPD29D[,N$;N3[@,.ZQPUY7Y4T>#(^/I@FS6+;FH6XJRGDITM\
MT:.=SZN"2ENLF[0D#\Z3*<.2*#9UOB]Z<3HYIAVF_96?G=^7.1689CYYZT(Z
M,4^_CSL>2;=ZZ%(A\K$Z_8GOB:GTV=]'W6F75/XP.VWOJ_6K_CP"ZV_G[_''
M,WZO_\L^!$@?$J0/!=*'!NEC#-+')4@?5R!]7(/TP4<HC:"(RE%(Y2BF<A14
M.8JJ'(55CN(J1X&5H\@J4&05*+(*%%D%BJP"15:!(JM D56@R"I09!4HLDH4
M626*K!)%5HDBJT215:+(*E%DE2BR2A19)8JL"D56A2*K0I%5H<BJ4&15*+(J
M%%D5BJP*15:%(JM&D56CR*I19-4HLFH4636*K!I%5HTBJT:15:/(.OY/65^L
M7?WUWQ[=/6],U1[S6?]+S>P-4$L! A0#%     @ -X%B4P=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M"  W@6)3;VC?..X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    "  W@6)3F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( #>!8E._
MAW55/P4  &H5   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    "  W@6)3-_C4;Y$&   1&P  &
M    @(&"#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
M-X%B4X^3;H-F P  LPT  !@              ("!210  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( #>!8E-:YO\W; 8  %X;   8
M          " @>47  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    "  W@6)3V27D^6H#   /"P  &               @(&''@  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ -X%B4R7,@$T%"   B2
M !@              ("!)R(  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+
M 0(4 Q0    ( #>!8E/M ]])U @  " S   8              " @6(J  !X
M;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  W@6)3+E2'CI((
M  #?%   &               @(%L,P  >&PO=V]R:W-H965T<R]S:&5E=#@N
M>&UL4$L! A0#%     @ -X%B4\RPG,N'*0  +(4  !@              ("!
M-#P  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( #>!8E,>
M0M%0B04  *D.   9              " @?%E  !X;"]W;W)K<VAE971S+W-H
M965T,3 N>&UL4$L! A0#%     @ -X%B4Q!\=;8>!0  JPP  !D
M     ("!L6L  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #>!8E,N)% ^?P0  /()   9              "
M@8:3  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ -X%B
M4X@CX?HG!0  TPP  !D              ("!/)@  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    "  W@6)3WQ*YT*$L   YD@  &0
M        @(&:G0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( #>!8E/Q("/+_08  *P0   9              " @7+*  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ -X%B4P::AIGL!   !@X
M !D              ("!IM$  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    "  W@6)33):+9U($  #^"0  &0              @(')U@
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( #>!8E,C9\Q0
M8P4  +D.   9              " @5+;  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ -X%B4Z! @8+U!   "PT  !D
M ("![.   'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  W
M@6)3>='15)<$  #Z"P  &0              @($8Y@  >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( #>!8E/=="DK)P,  &T&   9
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M970R.2YX;6Q02P$"% ,4    "  W@6)3_D8GBFX"  #X!@  &0
M    @(&@^@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M #>!8E-99FS!%0(  '8%   9              " @47]  !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ -X%B4\7?_)/+ @  C0<  !D
M             ("!D?\  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    "  W@6)3!K!00K4"  "T!P  &0              @(&3 @$ >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( #>!8E-+Y@M1%@(
M 'P$   9              " @7\% 0!X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ -X%B4_,<K+*_!   SQ<  !D              ("!
MS <! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  W@6)3
M9:<.XY@$  "U%@  &0              @('"# $ >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( #>!8E."Q+?1R (  -4'   9
M      " @9$1 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ -X%B4XN>('!Y @  _ 4  !D              ("!D!0! 'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    "  W@6)3?<@?-$0&  # *P
M&0              @(% %P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( #>!8E.2ME+-MP0  ,05   9              " @;L= 0!X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ -X%B4\@;F84Y
M!   IQ   !D              ("!J2(! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    "  W@6)3H0#+3F4"  #M!0  &0
M@($9)P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( #>!
M8E,(&&C13 (  &0%   9              " @;4I 0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ -X%B4S4[_M,\ P  H0D  !D
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M=#0X+GAM;%!+ 0(4 Q0    ( #>!8E,CVOZ!00P  !A,   9
M  " @0P^ 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
M-X%B4V;S*W>&!   ?Q(  !D              ("!A$H! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    "  W@6)3Y'FT,W\$  #C$P  &0
M            @(%!3P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    ( #>!8E.UQ:NNV@,  )L/   9              " @?=3 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ -X%B4QX/"@Q-!
M&!$  !D              ("!"%@! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    "  W@6)3<O?9/I0#  !@#P  &0              @(&,
M7 $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( #>!8E/^
M(;'W- ,  "L,   9              " @5=@ 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ -X%B4P_S:%JL!0  :A@  !D
M     ("!PF,! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #>!8E,T3M]M) ,  &X2   -              "
M ==W 0!X;"]S='EL97,N>&UL4$L! A0#%     @ -X%B4Y>*NQS     $P(
M  L              ( !)GL! %]R96QS+RYR96QS4$L! A0#%     @ -X%B
M4W]7B/^5!   +R@   \              ( !#WP! 'AL+W=O<FMB;V]K+GAM
M;%!+ 0(4 Q0    ( #>!8E.8&UJ>^P$  ,LC   :              "  =&
M 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( #>!8E-T
MTL9BW@$  %HC   3              "  02# 0!;0V]N=&5N=%]4>7!E<UTN
9>&UL4$L%!@    !$ $0 DQ(  !.% 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>258</ContextCount>
  <ElementCount>355</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>61</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/OrganizationandBusiness</Role>
      <ShortName>Organization and Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2113103 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2119104 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2125105 - Disclosure - Certain Balance Sheet Items</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CertainBalanceSheetItems</Role>
      <ShortName>Certain Balance Sheet Items</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2132106 - Disclosure - Long-Term Debt, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/LongTermDebtNet</Role>
      <ShortName>Long-Term Debt, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2137107 - Disclosure - Share-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SharebasedCompensation</Role>
      <ShortName>Share-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2143108 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2147109 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2150110 - Disclosure - Net Income (loss) per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/NetIncomelosspershare</Role>
      <ShortName>Net Income (loss) per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2314302 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/FairValueMeasurement</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2320303 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/Revenue</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2326304 - Disclosure - Certain Balance Sheet Items (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CertainBalanceSheetItemsTables</Role>
      <ShortName>Certain Balance Sheet Items (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/CertainBalanceSheetItems</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2333305 - Disclosure - Long-Term Debt, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/LongTermDebtNetTables</Role>
      <ShortName>Long-Term Debt, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/LongTermDebtNet</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2338306 - Disclosure - Share-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SharebasedCompensationTables</Role>
      <ShortName>Share-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/SharebasedCompensation</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2344307 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/StockholdersEquity</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2348308 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/CommitmentsandContingencies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2351309 - Disclosure - Net Income (loss) per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/NetIncomelosspershareTables</Role>
      <ShortName>Net Income (loss) per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/NetIncomelosspershare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization and Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/OrganizationandBusinessDetails</Role>
      <ShortName>Organization and Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/OrganizationandBusiness</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRestrictedCashDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Summary of Significant Accounting Policies - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Summary of Significant Accounting Policies - Revenue and Cost of Product Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue and Cost of Product Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2412408 - Disclosure - Summary of Significant Accounting Policies - Adoption and Pending Adoption of Recent Accounting Pronouncement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Adoption and Pending Adoption of Recent Accounting Pronouncement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails</Role>
      <ShortName>Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - Fair Value Measurement - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails</Role>
      <ShortName>Fair Value Measurement - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2417411 - Disclosure - Fair Value Measurement - Contractual Maturities of Available for Sale Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails</Role>
      <ShortName>Fair Value Measurement - Contractual Maturities of Available for Sale Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2418412 - Disclosure - Fair Value Measurement - Assets Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurement - Assets Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - Revenue - Disaggregated Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails</Role>
      <ShortName>Revenue - Disaggregated Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2422414 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2423415 - Disclosure - Revenue - Accounts Receivable, net and Deferred Revenues from Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails</Role>
      <ShortName>Revenue - Accounts Receivable, net and Deferred Revenues from Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2424416 - Disclosure - Revenue - Additional Revenue Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails</Role>
      <ShortName>Revenue - Additional Revenue Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2427417 - Disclosure - Certain Balance Sheet Items - Accounts Receivable, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails</Role>
      <ShortName>Certain Balance Sheet Items - Accounts Receivable, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - Certain Balance Sheet Items - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails</Role>
      <ShortName>Certain Balance Sheet Items - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2429419 - Disclosure - Certain Balance Sheet Items - Prepaid Expenses and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails</Role>
      <ShortName>Certain Balance Sheet Items - Prepaid Expenses and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2430420 - Disclosure - Certain Balance Sheet Items - Property and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails</Role>
      <ShortName>Certain Balance Sheet Items - Property and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2431421 - Disclosure - Certain Balance Sheet Items - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails</Role>
      <ShortName>Certain Balance Sheet Items - Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2434422 - Disclosure - Long-Term Debt, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails</Role>
      <ShortName>Long-Term Debt, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2435423 - Disclosure - Long-Term Debt, Net - Carrying Amount of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails</Role>
      <ShortName>Long-Term Debt, Net - Carrying Amount of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2436424 - Disclosure - Long-Term Debt, Net - Components of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails</Role>
      <ShortName>Long-Term Debt, Net - Components of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2439425 - Disclosure - Share-based Compensation - Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails</Role>
      <ShortName>Share-based Compensation - Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2440426 - Disclosure - Share-based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails</Role>
      <ShortName>Share-based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2441427 - Disclosure - Share-based Compensation - Assumptions Used in the Black-Scholes Model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails</Role>
      <ShortName>Share-based Compensation - Assumptions Used in the Black-Scholes Model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2442428 - Disclosure - Share-based Compensation - Unrecognized Estimated Compensation Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails</Role>
      <ShortName>Share-based Compensation - Unrecognized Estimated Compensation Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2445429 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2446430 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails</Role>
      <ShortName>Stockholders' Equity - Share Repurchase Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2449431 - Disclosure - Commitments and Contingencies - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails</Role>
      <ShortName>Commitments and Contingencies - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2452432 - Disclosure - Net Income (loss) per share - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails</Role>
      <ShortName>Net Income (loss) per share - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/NetIncomelosspershareTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="halo-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2453433 - Disclosure - Net Income (loss) per share - Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/NetIncomelosspershareAntidilutiveSecuritiesDetails</Role>
      <ShortName>Net Income (loss) per share - Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.halozyme.com/role/NetIncomelosspershareTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="halo-20210930.htm">halo-20210930.htm</File>
    <File>ex31110qq32021.htm</File>
    <File>ex31210qq32021.htm</File>
    <File>ex3210qq32021.htm</File>
    <File>halo-20210930.xsd</File>
    <File>halo-20210930_cal.xml</File>
    <File>halo-20210930_def.xml</File>
    <File>halo-20210930_lab.xml</File>
    <File>halo-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>halo-20210930_g1.jpg</File>
    <File>halo-20210930_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "halo-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "contextCount": 258,
   "dts": {
    "calculationLink": {
     "local": [
      "halo-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "halo-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "halo-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "halo-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "halo-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "halo-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 453,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 1,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 6
   },
   "keyCustom": 21,
   "keyStandard": 334,
   "memberCustom": 23,
   "memberStandard": 34,
   "nsprefix": "halo",
   "nsuri": "http://www.halozyme.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.halozyme.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113103 - Disclosure - Fair Value Measurement",
     "role": "http://www.halozyme.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119104 - Disclosure - Revenue",
     "role": "http://www.halozyme.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125105 - Disclosure - Certain Balance Sheet Items",
     "role": "http://www.halozyme.com/role/CertainBalanceSheetItems",
     "shortName": "Certain Balance Sheet Items",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132106 - Disclosure - Long-Term Debt, Net",
     "role": "http://www.halozyme.com/role/LongTermDebtNet",
     "shortName": "Long-Term Debt, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137107 - Disclosure - Share-based Compensation",
     "role": "http://www.halozyme.com/role/SharebasedCompensation",
     "shortName": "Share-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143108 - Disclosure - Stockholders' Equity",
     "role": "http://www.halozyme.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147109 - Disclosure - Commitments and Contingencies",
     "role": "http://www.halozyme.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150110 - Disclosure - Net Income (loss) per share",
     "role": "http://www.halozyme.com/role/NetIncomelosspershare",
     "shortName": "Net Income (loss) per share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314302 - Disclosure - Fair Value Measurement (Tables)",
     "role": "http://www.halozyme.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320303 - Disclosure - Revenue (Tables)",
     "role": "http://www.halozyme.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326304 - Disclosure - Certain Balance Sheet Items (Tables)",
     "role": "http://www.halozyme.com/role/CertainBalanceSheetItemsTables",
     "shortName": "Certain Balance Sheet Items (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333305 - Disclosure - Long-Term Debt, Net (Tables)",
     "role": "http://www.halozyme.com/role/LongTermDebtNetTables",
     "shortName": "Long-Term Debt, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338306 - Disclosure - Share-based Compensation (Tables)",
     "role": "http://www.halozyme.com/role/SharebasedCompensationTables",
     "shortName": "Share-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344307 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.halozyme.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348308 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.halozyme.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351309 - Disclosure - Net Income (loss) per share (Tables)",
     "role": "http://www.halozyme.com/role/NetIncomelosspershareTables",
     "shortName": "Net Income (loss) per share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "halo:RoyaltiesReceivedNumberOfCollaborators",
      "reportCount": 1,
      "unique": true,
      "unitRef": "collaborator",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization and Business (Details)",
     "role": "http://www.halozyme.com/role/OrganizationandBusinessDetails",
     "shortName": "Organization and Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "halo:RoyaltiesReceivedNumberOfCollaborators",
      "reportCount": 1,
      "unique": true,
      "unitRef": "collaborator",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRestrictedCashDetails",
     "shortName": "Summary of Significant Accounting Policies - Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Inventories (Details)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails",
     "shortName": "Summary of Significant Accounting Policies - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i9f30dd7e598c4150bb7ab34c0c700764_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i0bc3fbc4a9c34766bee79a37bf2c3e23_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Summary of Significant Accounting Policies - Leases (Details)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails",
     "shortName": "Summary of Significant Accounting Policies - Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i0bc3fbc4a9c34766bee79a37bf2c3e23_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "halo:RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Summary of Significant Accounting Policies - Revenue and Cost of Product Sales (Details)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails",
     "shortName": "Summary of Significant Accounting Policies - Revenue and Cost of Product Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "halo:RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410406 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails",
     "shortName": "Summary of Significant Accounting Policies - Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412408 - Disclosure - Summary of Significant Accounting Policies - Adoption and Pending Adoption of Recent Accounting Pronouncement (Details)",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails",
     "shortName": "Summary of Significant Accounting Policies - Adoption and Pending Adoption of Recent Accounting Pronouncement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ibaae598c6a0043268b61e55051da6c5b_I20201231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)",
     "role": "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
     "shortName": "Fair Value Measurement - Components of Available-for-sale Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - Fair Value Measurement - Narrative (Details)",
     "role": "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails",
     "shortName": "Fair Value Measurement - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417411 - Disclosure - Fair Value Measurement - Contractual Maturities of Available for Sale Debt Securities (Details)",
     "role": "http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails",
     "shortName": "Fair Value Measurement - Contractual Maturities of Available for Sale Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418412 - Disclosure - Fair Value Measurement - Assets Measured at Fair Value on a Recurring Basis (Details)",
     "role": "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value Measurement - Assets Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - Revenue - Disaggregated Revenues (Details)",
     "role": "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
     "shortName": "Revenue - Disaggregated Revenues (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5c022f7d86dd4437bd0cde070c7fd07c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422414 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.halozyme.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "halo:ProceedsFromPartnerOfLicenseAndCollaborativeAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423415 - Disclosure - Revenue - Accounts Receivable, net and Deferred Revenues from Contracts (Details)",
     "role": "http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails",
     "shortName": "Revenue - Accounts Receivable, net and Deferred Revenues from Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "halo:AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ic2b29c8b2930492d851baa19fbc2b1f5_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424416 - Disclosure - Revenue - Additional Revenue Information (Details)",
     "role": "http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails",
     "shortName": "Revenue - Additional Revenue Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ic2b29c8b2930492d851baa19fbc2b1f5_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "halo:Accountsreceivablefromproductsalestocollaborators",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427417 - Disclosure - Certain Balance Sheet Items - Accounts Receivable, net (Details)",
     "role": "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails",
     "shortName": "Certain Balance Sheet Items - Accounts Receivable, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "halo:Accountsreceivablefromproductsalestocollaborators",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - Certain Balance Sheet Items - Inventories (Details)",
     "role": "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails",
     "shortName": "Certain Balance Sheet Items - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429419 - Disclosure - Certain Balance Sheet Items - Prepaid Expenses and Other Assets (Details)",
     "role": "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
     "shortName": "Certain Balance Sheet Items - Prepaid Expenses and Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430420 - Disclosure - Certain Balance Sheet Items - Property and Equipment, net (Details)",
     "role": "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails",
     "shortName": "Certain Balance Sheet Items - Property and Equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i02e009dc2fa9486680263a15069d178d_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431421 - Disclosure - Certain Balance Sheet Items - Accrued Expenses (Details)",
     "role": "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails",
     "shortName": "Certain Balance Sheet Items - Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i02e009dc2fa9486680263a15069d178d_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434422 - Disclosure - Long-Term Debt, Net - Narrative (Details)",
     "role": "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
     "shortName": "Long-Term Debt, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i0bc7c027cf8d468087b67594cb81b7d1_D20191101-20191130",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)",
     "role": "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435423 - Disclosure - Long-Term Debt, Net - Carrying Amount of Convertible Notes (Details)",
     "role": "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
     "shortName": "Long-Term Debt, Net - Carrying Amount of Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436424 - Disclosure - Long-Term Debt, Net - Components of Interest Expense (Details)",
     "role": "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
     "shortName": "Long-Term Debt, Net - Components of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439425 - Disclosure - Share-based Compensation - Share-based Compensation Expense (Details)",
     "role": "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails",
     "shortName": "Share-based Compensation - Share-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i6935de8b3c224975955d989d869bb9c2_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440426 - Disclosure - Share-based Compensation - Narrative (Details)",
     "role": "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
     "shortName": "Share-based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "icd817f332517429098def9a226790157_D20210201-20210228",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441427 - Disclosure - Share-based Compensation - Assumptions Used in the Black-Scholes Model (Details)",
     "role": "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails",
     "shortName": "Share-based Compensation - Assumptions Used in the Black-Scholes Model (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5cc8bb9a58ee4f22a7917709a47d0c11_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442428 - Disclosure - Share-based Compensation - Unrecognized Estimated Compensation Cost (Details)",
     "role": "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails",
     "shortName": "Share-based Compensation - Unrecognized Estimated Compensation Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5cc8bb9a58ee4f22a7917709a47d0c11_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie0eb7b940b8b45069c49b5e764d38ad3_I20191130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445429 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie0eb7b940b8b45069c49b5e764d38ad3_I20191130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446430 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details)",
     "role": "http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails",
     "shortName": "Stockholders' Equity - Share Repurchase Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449431 - Disclosure - Commitments and Contingencies - Summary (Details)",
     "role": "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails",
     "shortName": "Commitments and Contingencies - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i5b85a13bd91847d9b84fbc1200c1b2b8_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452432 - Disclosure - Net Income (loss) per share - Summary (Details)",
     "role": "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails",
     "shortName": "Net Income (loss) per share - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i065050ada4e544a2be29ac40313d14cf_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453433 - Disclosure - Net Income (loss) per share - Antidilutive Securities (Details)",
     "role": "http://www.halozyme.com/role/NetIncomelosspershareAntidilutiveSecuritiesDetails",
     "shortName": "Net Income (loss) per share - Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ie7d0025c10eb4716a203ab5b04afdd5e_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ic35a7e6ef47d488cada6c8e7fba0110d_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "role": "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "ic35a7e6ef47d488cada6c8e7fba0110d_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Business",
     "role": "http://www.halozyme.com/role/OrganizationandBusiness",
     "shortName": "Organization and Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20210930.htm",
      "contextRef": "i33a8c5dc9b574cc3a3973e23f11ef604_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 61,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "halo_A025ConvertibleSeniorNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.25% Convertible Senior Notes due 2027",
        "label": "0.25% Convertible Senior Notes due 2027 [Member]",
        "terseLabel": "0.25% Convertible Senior Notes due 2027"
       }
      }
     },
     "localname": "A025ConvertibleSeniorNotesDue2027Member",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_A1.25ConvertibleSeniorNotesdue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.25% Convertible Senior Notes due 2024 [Member]",
        "label": "1.25% Convertible Senior Notes due 2024 [Member]",
        "terseLabel": "1.25% Convertible Senior Notes due 2024"
       }
      }
     },
     "localname": "A1.25ConvertibleSeniorNotesdue2024Member",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_A2020ShareRepurchaseProgramBankOfAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Share Repurchase Program - Bank of America",
        "label": "2020 Share Repurchase Program - Bank of America [Member]",
        "terseLabel": "2020 Share Repurchase Program - Bank of America"
       }
      }
     },
     "localname": "A2020ShareRepurchaseProgramBankOfAmericaMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_A2021ESPPPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 ESPP Plan",
        "label": "2021 ESPP Plan [Member]",
        "terseLabel": "2021 ESPP Plan"
       }
      }
     },
     "localname": "A2021ESPPPlanMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_A2021ShareRepurchaseProgramBankOfAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Share Repurchase Program - Bank of America",
        "label": "2021 Share Repurchase Program - Bank of America [Member]",
        "terseLabel": "2021 Share Repurchase Program - Bank of America"
       }
      }
     },
     "localname": "A2021ShareRepurchaseProgramBankOfAmericaMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, after Allowance for Credit Loss, Current, excluding Other Contract Assets",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current, excluding Other Contract Assets",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableafterAllowanceforCreditLossCurrentexcludingOtherContractAssets",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_Accountsreceivablefromcollaborators": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from collaborators, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.",
        "label": "Accounts receivable from collaborators",
        "terseLabel": "Accounts receivable from revenues under collaborative agreements"
       }
      }
     },
     "localname": "Accountsreceivablefromcollaborators",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_Accountsreceivablefromproductsales": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from product sales",
        "label": "Accounts receivable from product sales",
        "terseLabel": "Accounts receivable from other product sales"
       }
      }
     },
     "localname": "Accountsreceivablefromproductsales",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_Accountsreceivablefromproductsalestocollaborators": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from product sales to collaborators",
        "label": "Accounts receivable from product sales to collaborators",
        "terseLabel": "Accounts receivable from product sales to collaborators"
       }
      }
     },
     "localname": "Accountsreceivablefromproductsalestocollaborators",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_Accountsreceivablefromroyalties": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from royalties, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.",
        "label": "Accounts receivable from royalties",
        "terseLabel": "Accounts receivable from royalty payments"
       }
      }
     },
     "localname": "Accountsreceivablefromroyalties",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_AccruedLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Liabilities, Noncurrent",
        "label": "Accrued Liabilities, Noncurrent",
        "negatedTerseLabel": "Less long-term portion"
       }
      }
     },
     "localname": "AccruedLiabilitiesNoncurrent",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_Accruedmanufacturingexpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued manufacturing expenses",
        "label": "Accrued manufacturing expenses",
        "terseLabel": "Accrued outsourced manufacturing expenses"
       }
      }
     },
     "localname": "Accruedmanufacturingexpenses",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_AllowanceforDistributionFeesandDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Discount and Distribution Fees",
        "label": "Allowance for Distribution Fees and Discounts",
        "negatedTerseLabel": "Allowance for distribution fees and discounts"
       }
      }
     },
     "localname": "AllowanceforDistributionFeesandDiscounts",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_BaxaltaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Baxalta [Member]",
        "label": "Baxalta [Member]",
        "terseLabel": "Baxalta"
       }
      }
     },
     "localname": "BaxaltaMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_BulkrHuPH20Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "bulk rHuPH20 for use in collaboration products",
        "label": "bulk rHuPH20 [Member]",
        "terseLabel": "bulk rHuPH20"
       }
      }
     },
     "localname": "BulkrHuPH20Member",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_CollaborativeAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Agreements [Member]",
        "label": "Collaborative Agreements [Member]",
        "terseLabel": "Revenues under collaborative agreements",
        "verboseLabel": "Collaborative Agreements"
       }
      }
     },
     "localname": "CollaborativeAgreementsMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_ComputerAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer and office equipment.",
        "label": "Computer and Office Equipment [Member]",
        "terseLabel": "Computer and office equipment"
       }
      }
     },
     "localname": "ComputerAndOfficeEquipmentMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_DeferredRentPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Rent Payments",
        "label": "Deferred Rent Payments",
        "negatedTerseLabel": "Lease payments deferred"
       }
      }
     },
     "localname": "DeferredRentPayments",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_DevelopmentFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Fees [Member]",
        "label": "Development Fees [Member]",
        "terseLabel": "Event-Based Development Fees"
       }
      }
     },
     "localname": "DevelopmentFeesMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_HylenexRecombinantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hylenex Recombinant [Member]",
        "label": "Hylenex Recombinant [Member]",
        "terseLabel": "Hylenex"
       }
      }
     },
     "localname": "HylenexRecombinantMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_JanssenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Janssen Collaboration [Member]",
        "label": "Janssen [Member]",
        "terseLabel": "Janssen"
       }
      }
     },
     "localname": "JanssenMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_LicenseFeesAndEventBasedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees And Event-Based [Member]",
        "label": "License Fees And Event-Based [Member]",
        "terseLabel": "License Fees And Event-Based [Member]"
       }
      }
     },
     "localname": "LicenseFeesAndEventBasedMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_ManufacturingEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Equipment [Member]",
        "label": "Manufacturing Equipment [Member]",
        "terseLabel": "Manufacturing equipment"
       }
      }
     },
     "localname": "ManufacturingEquipmentMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_OperatingLeaseAccretionOfLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Accretion Of Liability",
        "label": "Operating Lease, Accretion Of Liability",
        "terseLabel": "Expense associated with accretion of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseAccretionOfLiability",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_OthercollaboratorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other collaborators [Member]",
        "label": "Other collaborators [Member]",
        "terseLabel": "Other collaborators"
       }
      }
     },
     "localname": "OthercollaboratorsMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_PendingSettlementofCommonStockRepurchase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Settlement of Common Stock Repurchase",
        "label": "Pending Settlement of Common Stock Repurchase",
        "terseLabel": "Pending settlement of common stock repurchase"
       }
      }
     },
     "localname": "PendingSettlementofCommonStockRepurchase",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_ProceedsFromPartnerOfLicenseAndCollaborativeAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from partner of license and collaborative agreement.",
        "label": "Proceeds from Partner of License and Collaborative Agreement",
        "terseLabel": "Proceeds from partner of license and collaborative agreement"
       }
      }
     },
     "localname": "ProceedsFromPartnerOfLicenseAndCollaborativeAgreement",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "label": "Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Property and equipment, net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_RSURSAandPRSUawardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Unit, Restricted Stock Awards, and Performance Restricted Stock Unit awards [Member]",
        "label": "RSU, RSA, and PRSU awards [Member]",
        "verboseLabel": "RSAs, RSUs, PSUs and ESPP"
       }
      }
     },
     "localname": "RSURSAandPRSUawardsMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_ResearchEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research equipment.",
        "label": "Research Equipment [Member]",
        "terseLabel": "Research equipment"
       }
      }
     },
     "localname": "ResearchEquipmentMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_ResearchandDevelopmentServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Services [Member]",
        "label": "Research and Development Services [Member]",
        "terseLabel": "Research and Development Services"
       }
      }
     },
     "localname": "ResearchandDevelopmentServicesMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_RevenueFromContractWithCustomerVariableConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Variable Consideration",
        "label": "Revenue From Contract With Customer, Variable Consideration",
        "terseLabel": "Variable consideration"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerVariableConsideration",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Remaining Performance Obligation, Period Of Termination By Written Notice",
        "label": "Revenue, Remaining Performance Obligation, Period Of Termination By Written Notice",
        "terseLabel": "Period of contract termination by written notice"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPeriodOfTerminationByWrittenNotice",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "halo_RocheMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Roche",
        "label": "Roche [Member]",
        "terseLabel": "Roche"
       }
      }
     },
     "localname": "RocheMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_RoyaltiesReceivedNumberOfCollaborators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties Received, Number of Collaborators",
        "label": "Royalties Received, Number of Collaborators",
        "terseLabel": "Royalties Received, Number of Collaborators"
       }
      }
     },
     "localname": "RoyaltiesReceivedNumberOfCollaborators",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "halo_RoyaltiesReceivedNumberOfProductsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties Received, Number of Products Sold",
        "label": "Royalties Received, Number of Products Sold",
        "terseLabel": "Royalties Received, Number of Products Sold"
       }
      }
     },
     "localname": "RoyaltiesReceivedNumberOfProductsSold",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "halo_RoyaltybackedLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty-backed Loan [Member]",
        "label": "Royalty-backed Loan [Member]",
        "terseLabel": "Royalty-backed Loan"
       }
      }
     },
     "localname": "RoyaltybackedLoanMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_SalesbasedmilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-based milestone [Member]",
        "label": "Sales-based milestone [Member]",
        "terseLabel": "Sales-based milestone [Member]"
       }
      }
     },
     "localname": "SalesbasedmilestoneMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]",
        "label": "Schedule of Share-based Compensation Arrangements Valuation Inputs [Line Items]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements Valuation Inputs [Line Items]"
       }
      }
     },
     "localname": "ScheduleofSharebasedCompensationArrangementsValuationInputsLineItems",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "halo_ScheduleofSharebasedCompensationArrangementsValuationInputsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]",
        "label": "Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements Valuation Inputs [Table]"
       }
      }
     },
     "localname": "ScheduleofSharebasedCompensationArrangementsValuationInputsTable",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Amount",
        "terseLabel": "Maximum contribution amount"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Minimum Employee Subscription Rate",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Minimum Employee Subscription Rate",
        "terseLabel": "Minimum employee subscription rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumEmployeeSubscriptionRate",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "halo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period",
        "terseLabel": "Purchase period (in months)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "halo_StockOptionsAndRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options And Restricted Stock Units [Member]",
        "label": "Stock Options And Restricted Stock Units [Member]",
        "terseLabel": "Stock options and restricted units"
       }
      }
     },
     "localname": "StockOptionsAndRestrictedStockUnitsMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_TreasuryStockAcquiredFeeCostPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Acquired, Fee Cost Per Share",
        "label": "Treasury Stock Acquired, Fee Cost Per Share",
        "terseLabel": "Fee per share (USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredFeeCostPerShare",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "halo_UpfrontfeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront fees [Member]",
        "label": "Upfront fees [Member]",
        "terseLabel": "Upfront License Fees"
       }
      }
     },
     "localname": "UpfrontfeesMember",
     "nsuri": "http://www.halozyme.com/20210930",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r62",
      "r64",
      "r123",
      "r124",
      "r290",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r130",
      "r138",
      "r144",
      "r235",
      "r409",
      "r410",
      "r411",
      "r433",
      "r434",
      "r448",
      "r451",
      "r453",
      "r454",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r130",
      "r138",
      "r144",
      "r235",
      "r409",
      "r410",
      "r411",
      "r433",
      "r434",
      "r448",
      "r451",
      "r453",
      "r454",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r130",
      "r138",
      "r144",
      "r235",
      "r409",
      "r410",
      "r411",
      "r433",
      "r434",
      "r448",
      "r451",
      "r453",
      "r454",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r289",
      "r316",
      "r384",
      "r386",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r541",
      "r590",
      "r592",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r289",
      "r316",
      "r384",
      "r386",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r541",
      "r590",
      "r592",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r197",
      "r363",
      "r367",
      "r544",
      "r589",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r197",
      "r363",
      "r367",
      "r544",
      "r589",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r289",
      "r316",
      "r375",
      "r384",
      "r386",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r541",
      "r590",
      "r592",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r289",
      "r316",
      "r375",
      "r384",
      "r386",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r541",
      "r590",
      "r592",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r63",
      "r64",
      "r123",
      "r124",
      "r290",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r139",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r139",
      "r144",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r139",
      "r144",
      "r267",
      "r385",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r46",
      "r509"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r27",
      "r200",
      "r201"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Total accounts receivable, net",
        "verboseLabel": "Accounts receivable, net and other contract assets"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Accretion of discounts on marketable securities, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities and Other Liabilities",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Total accrued expenses, current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r45",
      "r259"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r69",
      "r71",
      "r72",
      "r578",
      "r600",
      "r604"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r68",
      "r72",
      "r79",
      "r80",
      "r81",
      "r127",
      "r128",
      "r129",
      "r441",
      "r595",
      "r596",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r409",
      "r410",
      "r411",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r131",
      "r132",
      "r133",
      "r134",
      "r144",
      "r203",
      "r204",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r271",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r431",
      "r432",
      "r433",
      "r434",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r506",
      "r545",
      "r546",
      "r547",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Equity component of convertible notes"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r387",
      "r389",
      "r415",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by (used) in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r389",
      "r401",
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r91",
      "r106",
      "r302",
      "r486"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of Debt Discount (Premium)",
        "verboseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares excluded from per share calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r218",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r120",
      "r181",
      "r190",
      "r195",
      "r231",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r438",
      "r442",
      "r464",
      "r507",
      "r509",
      "r551",
      "r575"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r12",
      "r61",
      "r120",
      "r231",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r438",
      "r442",
      "r464",
      "r507",
      "r509"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Fair value of assets measured on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses",
        "terseLabel": "Unrealized loss position of debt securities"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r208",
      "r243"
     ],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r213",
      "r216",
      "r568"
     ],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "After one but within five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r213",
      "r215",
      "r567"
     ],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r205",
      "r209",
      "r243",
      "r555"
     ],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated Fair Value",
        "totalLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails",
      "http://www.halozyme.com/role/FairValueMeasurementContractualMaturitiesofAvailableforSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r207",
      "r243"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Marketable securities, available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r390",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails",
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails",
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Amounts accrued for purchases of property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r43",
      "r108"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r18",
      "r109",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents and Marketable Securities and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r103",
      "r108",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r103",
      "r476"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r55",
      "r266",
      "r556",
      "r582"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r268",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r509"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r74",
      "r76",
      "r77",
      "r86",
      "r560",
      "r585"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, deferred revenues from contracts with customers, and amounts under collaborative agreements included in transaction price"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r342",
      "r343",
      "r364"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Other contract assets",
        "verboseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccountsReceivablenetDetails",
      "http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Revenue recognized",
        "negatedTerseLabel": "Recognition of deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r283",
      "r286",
      "r287",
      "r289",
      "r293",
      "r294",
      "r295",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r309",
      "r310",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Convertible Debt Securities"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r24",
      "r553",
      "r576",
      "r606"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "terseLabel": "Convertible Notes Payable"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r376",
      "r383",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r89",
      "r544"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales previously expensed as R&amp;D",
        "verboseLabel": "Cost of product sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRevenueandCostofProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r110",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "verboseLabel": "Amount paid for conversion of debt instrument"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r110",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Stock issued for conversion of debt instrument (shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r119",
      "r125",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r309",
      "r310",
      "r311",
      "r312",
      "r489",
      "r552",
      "r553",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r288",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Debt Instrument, Convertible, Conversion Price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r51",
      "r288",
      "r331",
      "r332",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt Instrument, Convertible, Conversion Ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period",
        "terseLabel": "Debt Instrument, Convertible, Remaining Discount Amortization Period"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Debt Instrument, Convertible, Threshold Consecutive Trading Days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Debt Instrument, Convertible, Threshold Trading Days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentCovenantCompliance": {
     "auth_ref": [
      "r24",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "States whether the entity was in compliance with the debt covenants throughout the reporting period, and describes facts and circumstances of any compliance failure.",
        "label": "Debt Instrument, Covenant Compliance",
        "terseLabel": "Debt Instrument, Covenant Compliance"
       }
      }
     },
     "localname": "DebtInstrumentCovenantCompliance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r286",
      "r309",
      "r310",
      "r487",
      "r489",
      "r490"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Total loan balance"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r295",
      "r309",
      "r310",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Lenders fee"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r50",
      "r307",
      "r487",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective rate at end of period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r50",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53",
      "r119",
      "r125",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r309",
      "r310",
      "r311",
      "r312",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentInterest": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to interest.",
        "label": "Debt Instrument, Periodic Payment, Interest",
        "terseLabel": "Debt Instrument, Periodic Payment, Interest"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r119",
      "r125",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r309",
      "r310",
      "r311",
      "r312",
      "r331",
      "r333",
      "r334",
      "r335",
      "r486",
      "r487",
      "r489",
      "r490",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r293",
      "r486",
      "r490"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized discount",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r210",
      "r243",
      "r248",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of available-for-sale marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r220",
      "r244",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "terseLabel": "Fair market value of gross unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r221",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of loss positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredCreditsAndOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities).",
        "label": "Deferred Credits and Other Liabilities",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "DeferredCreditsAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCreditsAndOtherLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income during the current period and current obligations not separately disclosed in the balance sheet (other liabilities, current).",
        "label": "Deferred Credits and Other Liabilities, Current",
        "verboseLabel": "Deferred revenue, current portion"
       }
      }
     },
     "localname": "DeferredCreditsAndOtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r421",
      "r422"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueAccountsReceivablenetandDeferredRevenuesfromContractsDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue, current portion"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r422",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Deferred Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r106",
      "r179"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r363",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregation of revenues"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r87",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r145",
      "r147",
      "r153",
      "r154",
      "r155",
      "r159",
      "r160",
      "r454",
      "r455",
      "r561",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r87",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r147",
      "r153",
      "r154",
      "r155",
      "r159",
      "r160",
      "r454",
      "r455",
      "r561",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and payroll taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized Expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Remaining Weighted-Average Recognition Period (years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options",
        "verboseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails",
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails",
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r79",
      "r80",
      "r81",
      "r127",
      "r128",
      "r129",
      "r132",
      "r141",
      "r143",
      "r165",
      "r235",
      "r330",
      "r336",
      "r409",
      "r410",
      "r411",
      "r433",
      "r434",
      "r453",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r484",
      "r595",
      "r596",
      "r597",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r456",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r295",
      "r309",
      "r310",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r457",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r295",
      "r376",
      "r377",
      "r382",
      "r383",
      "r457",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r295",
      "r309",
      "r310",
      "r376",
      "r377",
      "r382",
      "r383",
      "r457",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r295",
      "r309",
      "r310",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r457",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r295",
      "r309",
      "r310",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "verboseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r494",
      "r499",
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Right-of-use asset amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r218",
      "r219",
      "r227",
      "r228",
      "r229",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r246",
      "r247",
      "r250",
      "r251",
      "r303",
      "r328",
      "r444",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r107",
      "r473",
      "r475"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "terseLabel": "Unrealized gain (loss) on foreign currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Gain on disposal of equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r83",
      "r181",
      "r189",
      "r191",
      "r194",
      "r196",
      "r548",
      "r557",
      "r563",
      "r587"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r142",
      "r143",
      "r180",
      "r423",
      "r435",
      "r436",
      "r588"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax (benefit) expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r78",
      "r419",
      "r420",
      "r426",
      "r427",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "negatedTerseLabel": "Value of deferred tax assets"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net and other contract assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedTerseLabel": "Deferred income taxes (benefits from valuation allowance release)"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive potential common stock outstanding (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InducedConversionOfConvertibleDebtExpense": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms.",
        "label": "Induced Conversion of Convertible Debt Expense",
        "negatedTerseLabel": "Inducement expense related to convertible notes",
        "terseLabel": "Induced conversion expense related to convertible notes"
       }
      }
     },
     "localname": "InducedConversionOfConvertibleDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r82",
      "r178",
      "r485",
      "r488",
      "r562"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r91",
      "r300",
      "r308",
      "r311",
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense recognized"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Interest Income and Interest Expense Disclosure"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r35",
      "r254"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r59",
      "r509"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r60",
      "r116",
      "r164",
      "r252",
      "r253",
      "r255",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r37",
      "r254"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r36",
      "r254"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of contractual maturities of available-for-sale debt securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, Fair Value Disclosure"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of approximate annual future minimum operating lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Term of leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r120",
      "r231",
      "r464",
      "r509",
      "r554",
      "r580"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r49",
      "r120",
      "r231",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r439",
      "r442",
      "r443",
      "r464",
      "r507",
      "r508",
      "r509"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r24",
      "r294",
      "r304",
      "r309",
      "r310",
      "r553",
      "r577"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt, net",
        "verboseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/LongTermDebtNetCarryingAmountofConvertibleNotesDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-Term Debt, Net"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r53",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetComponentsofInterestExpenseDetails",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "verboseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r166",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "Organization and Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r103",
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r73",
      "r75",
      "r81",
      "r84",
      "r107",
      "r120",
      "r131",
      "r136",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r152",
      "r181",
      "r189",
      "r191",
      "r194",
      "r196",
      "r231",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r455",
      "r464",
      "r558",
      "r583"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r138",
      "r144",
      "r159",
      "r203",
      "r204",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r271",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r431",
      "r432",
      "r433",
      "r434",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r506",
      "r545",
      "r546",
      "r547",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Adoption and Pending Adoption of Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r181",
      "r189",
      "r191",
      "r194",
      "r196"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r500",
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Total operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Loss on impairment of right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "netLabel": "Total",
        "verboseLabel": "Lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails",
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r495",
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts related to leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails": {
       "order": 2.0,
       "parentTag": "halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r503",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CommitmentsandContingenciesSummaryDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r48"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r21",
      "r550",
      "r574"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r79",
      "r80",
      "r85",
      "r230",
      "r477",
      "r482",
      "r484",
      "r559",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r66",
      "r70",
      "r474",
      "r483"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r67",
      "r69"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Investment and other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r257"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other prepaid expenses"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock",
        "terseLabel": "Payments for repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payment of debt issuance cost",
        "terseLabel": "Payments of Debt Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "terseLabel": "Payments for tax withholding for restricted stock units vested, net"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r93",
      "r96",
      "r206"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares [Member]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r390",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r509"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock - $0.001 par value; 20,000 shares authorized; no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.",
        "label": "Prepaid Expense and Other Assets",
        "totalLabel": "Total prepaid expenses and other assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r41",
      "r42"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Total prepaid expenses and other assets, current",
        "verboseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": {
     "auth_ref": [
      "r21",
      "r550",
      "r574"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      },
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Noncurrent",
        "negatedTerseLabel": "Less long-term portion",
        "verboseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r256",
      "r257"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid manufacturing expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from Convertible Debt"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from issuance of long-term debt, net"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r98",
      "r404"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r93",
      "r94",
      "r206"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r98",
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "verboseLabel": "Net proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product sales, net"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r45",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r44",
      "r258"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r260",
      "r509",
      "r569",
      "r581"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails": {
       "order": 1.0,
       "parentTag": "halo_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r19",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r19",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]",
        "terseLabel": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]",
        "terseLabel": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "terseLabel": "Repayments of Convertible Debt"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r418",
      "r543",
      "r611"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "verboseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r13",
      "r21",
      "r108",
      "r113",
      "r607"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock",
        "verboseLabel": "RSAs"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails",
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units",
        "verboseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r336",
      "r412",
      "r509",
      "r579",
      "r599",
      "r604"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r127",
      "r128",
      "r129",
      "r132",
      "r141",
      "r143",
      "r235",
      "r409",
      "r410",
      "r411",
      "r433",
      "r434",
      "r453",
      "r595",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r176",
      "r177",
      "r188",
      "r192",
      "r193",
      "r197",
      "r198",
      "r199",
      "r362",
      "r363",
      "r544"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails",
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "verboseLabel": "Revenue and Cost of Product Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r353",
      "r366",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Deferred revenue, remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Deferred revenue, remaining performance obligation, expected timing"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueAdditionalRevenueInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r502",
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligation"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/RevenueDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of accrued expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Schedule of Available-for-sale Securities"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r214",
      "r217",
      "r222",
      "r223",
      "r224",
      "r225",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/OrganizationandBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of share-based compensation expense by type"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of numerators and denominators of basic and diluted computations"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareTables",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r147",
      "r151",
      "r153",
      "r155",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r389",
      "r400",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r389",
      "r400",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of share-based compensation expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r17",
      "r38",
      "r39",
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Schedule of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r135",
      "r138",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of adoption and pending adoption of recent accounting pronouncements"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of prepaid expenses and other assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r45",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPropertyandEquipmentnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r390",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used in Black-Scholes model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of share repurchases"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Schedule of unrecognized estimated compensation cost by type"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum employee subscription rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Stock options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r393",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "verboseLabel": "Outstanding stock options and restricted stock units (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r388",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails",
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails",
      "http://www.halozyme.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails",
      "http://www.halozyme.com/role/SharebasedCompensationUnrecognizedEstimatedCompensationCostDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Stock options weighted average exercise price (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r396",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Average expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationAssumptionsUsedintheBlackScholesModelDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "ESPP purchase price of common stock, percent of market price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Equity, ending balance (in shares)",
        "periodStartLabel": "Equity, beginning balance (in shares)",
        "terseLabel": "Shares, Outstanding"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "verboseLabel": "Number of RSUs withheld to pay for minimum withholding taxes (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r114",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r57",
      "r79",
      "r80",
      "r81",
      "r127",
      "r128",
      "r129",
      "r132",
      "r141",
      "r143",
      "r165",
      "r235",
      "r330",
      "r336",
      "r409",
      "r410",
      "r411",
      "r433",
      "r434",
      "r453",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r484",
      "r595",
      "r596",
      "r597",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r165",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItemsPrepaidExpensesandOtherAssetsDetails",
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Common stock issued for induced conversion related to convertible notes"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r56",
      "r297",
      "r330",
      "r331",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r25",
      "r26",
      "r330",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock awards, net (shares)",
        "verboseLabel": "Stock issued during period, shares, restricted stock award, net of forfeitures (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r330",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r330",
      "r336",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Number of shares of common stock issued as a result of stock option exercises (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r57",
      "r330",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Stock Issued During Period, Value, Conversion of Convertible Securities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r330",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock awards, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r57",
      "r330",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount (shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Stock Repurchase Program, Period in Force"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r25",
      "r26",
      "r330",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r25",
      "r26",
      "r330",
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r25",
      "r26",
      "r330",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Total Number of Shares Purchased (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r120",
      "r202",
      "r231",
      "r464",
      "r509"
     ],
     "calculation": {
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Equity, ending balance",
        "periodStartLabel": "Equity, beginning balance",
        "terseLabel": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity (deficit) (textual)",
        "verboseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r315",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r336",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Certain Balance Sheet Items"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CertainBalanceSheetItems"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r218",
      "r219",
      "r227",
      "r228",
      "r229",
      "r303",
      "r328",
      "r444",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Weighted-Average Price paid Per Share (USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails",
      "http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r26",
      "r330",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Stock repurchased (shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails",
      "http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r330",
      "r336",
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method",
        "verboseLabel": "Total Cost"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails",
      "http://www.halozyme.com/role/StockholdersEquityNarrativeDetails",
      "http://www.halozyme.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r131",
      "r132",
      "r133",
      "r134",
      "r144",
      "r203",
      "r204",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r271",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r431",
      "r432",
      "r433",
      "r434",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r506",
      "r545",
      "r546",
      "r547",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesAdoptionandPendingAdoptionofRecentAccountingPronouncementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r122",
      "r376",
      "r383",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/FairValueMeasurementAssetsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.halozyme.com/role/FairValueMeasurementComponentsofAvailableforsaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/LongTermDebtNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r146",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "verboseLabel": "Weighted average common shares outstanding for diluted net income (loss) per share (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r145",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Weighted average common shares outstanding for basic net income (loss) per share (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.halozyme.com/role/NetIncomelosspershareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Shares used in computing net income per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.halozyme.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467568&loc=d3e6835-112609"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(g)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r612": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r613": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r614": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r615": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r616": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r617": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r618": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r619": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r620": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r621": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r622": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r623": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r624": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001159036-21-000050-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001159036-21-000050-xbrl.zip
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MZ[>^'9%_NG<U[%LCQ_\#4$L#!!0    ( #>!8E,R=D&WD@@  $4R   2
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MF*U]0-7'/ [ -$KO8,IC-<>7= Z@H8<;T9A&@@83&N_NF =&JVP4U>93!)+
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M=#OOJT(.'RPH(Y,*N5P11&>< J5H,,$H3V$.R)&SVJ"7SWCK<&8J0IBDJ63
M9$XP%<0EYWR21&B3JPU14X%XP Q: 6,LLJLDJGUAA8M,&$,<%X'%P*VV$,%4
MH(CK3%H!8_0-/4F&RA"BHR(%97,2 ?I&)@7&N*N ;SA[5L 8BY'*8*)PB1IM
M!$LY7R?Y*(+2-M"4*K N.E-JYY<(<RFN77+1Z6V![>'1>T>VB5<)9+)".LC-
M,RQ8RA/)?>R99:0"]OA+US]8Z\3\(T<<OKC6]\&&>K<#IW77^PR#5\>=^#-!
MO#N?N6;O']<ZAA>G%[_^A6_C>N'@] U\@=;5<5R<M-DY.A[TRS-H16R> "J
M][FKM1.6*>]%;MS+ I'XP52@4=$XJ,7&Q3J/P+:SPBG:)60(XEVP20!0IY+6
M*04?/.>H5F:?4^:8.!:I0:-RZ-F[[.6[*#@7.JFDG!&C]K,SK=P7@#\9,U!2
M J!S,]P4A/;,!%%NH 01=>X;.ON<L@#\R7!*TBD2 IXQ37(?(N<BH KP3H*6
M2-/9YY0Y)D[0C)D,[MYHD22B/G'HQP7N@$9.[>QKXTF [E@YI9I!S;P9CGG)
MA"9$$!^<!V*C]M%)SBVKPM)FU?"^FHP2K *B3.1:>A$E\5:K"))H(Q-QI@*(
M,K^T$8$EKW-6HHF"QNAI-"Y$I4(0D*B>?56\0/O)K)%01@61N62_$TQXH] V
M &<"UT'S\[+5\\XH<XOV8[0?K7$ :"OFF@V((<;$1*@'D_L\L%'<;Z8997YI
M8X@P45O@6B=AI;,6!#6!Q<ALCO+,OB:>*;2?P47Q,5H&#BT"$B1-8(5VQH2D
M<]5^YXB)4(65GID"_+GF%0**\P0AU_(46GLKM1/22 ' !1<5V$Z^P)5)Z2#/
M0Z1:<BJ5%-9:XZ.E2@2M#0\*JI +M<"5"?%*3N]12$207@D6J#,::1F)9P2U
MD:Y">G:E<*7:N>+!QER02U*'GH?7QCDMO1<I^,30ZC5/@ULFARS5YA:ODN4>
M_Z,F9^)JF\ [:91R.E J%I&O.>"6,>8XNJ"CTB(J)H7Q!'UH010-WG/*F:[
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M]C?-S2J-QK=53B64'4$IC8"NAT1*N: Y%9+J8%VJ0/F$N].H[CK'&?&.>XB
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M&4<HFTFG*4U<,",B"YZC"Z@C$)M;VW,]VD^WX) I<<C5S7*7B?X+^[*L N=
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M4P]/S/*VR+NMT_WVB(9/MG76>N J:Y__4DK!UX\T.4T5Q,)[H0MAI2B<5KX
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MA@S<<O[*;5<[Y3BVOLT^6DEH^N#IY,D!TZ?3C]J ]-Y"P7*_!L$%%%8Z5K"
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MXGBEP6XBAMC:.5%?=7MY%]JW/1GKX ??/HT\S@7LW0/V&B\OF62<6:69M$5
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M^P^'^;U_[)&#/_9Q^NYTO?^]>'-RB@__/HP''?2E\ET?HT]O(\8F2*Y 21J
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MF+ ;6U(4K*\.UA?K^BL(;R+")XY"+BV6*G (TB6$2\S!H%!AW3/O!..4YHA
MVB !/T]'8./]&;_W^NG/;BNAH!^Z[DMKV$^?EG,D$W:-?W\U&.9,RV77_EIO
M(IQSN%[L? X>OH9^[Z$$F;EPO!)VQ@OA9+(.MF^60>'"*;GPN.;*<-1[QH4!
MS@D')J(%3;F%9,%RA63ZVXB-Q'N*8/+KG++35[2"Q0K"?<$.C8+K)>,:U>)V
MK?3<.< XQ[1Y1T A04 $H8@0QFJ6R_/=E3@/MV(*FIN[>2_>85%0_62HGO@F
M$/8TB!  6:Z!<4O!AHA $H%56M66Y4C5V>N.%V@W>*->F(>B0/K)(#UQ1A!E
M+29< 2-4 HL)S9IY \S0:#S23FI_WUGB4O;I$E51157$;_P3):"BX8Z(VWQW
M'Z>-+N/:!3N9^D)LTQ!;/7,P>,$I"02\RZ4UI0A@H@W@J)"*2N-)/D>9N:AF
M.4MIL%1YNB")@N&GP_#$BV"XY%&+"():#,QS HI9"=0Q$@735B.WL74W*:X<
MA386OHMU(A30+@JTI.;2)P8IK-.>BZIH)0^&"PO2^8@XPM'B?+S9I,Y%!;H-
M=!*4G7?A()ZX!42:)YN,'4CF?P*Q2GNP<5I#=-1J++ FCFQLZ6;LO',*3FBN
M*^"D-S3G]R8G/44,PH_>-TUU[^>5L3K_ 6KVCM#8ZDOW>)-+W-IC]H0O-8\*
M8D([:S0(PB4PRQ5H*PA8R[WU4O%D7X]K,>F9"Y7,'4I+/D JI%I(=<7+/152
MG1NIHEIE%.4\-;EQI<Z547)NCQ(>)/'$TZ@1(W%CB_(V9X53"Z<63ET!KV/A
MU&5P:BV%BGM$5!" F?; B+&@D"203!#N3 S:132N-H58(=5"JH54FY_55DAU
M&:0Z\0@[IFCD 0'22 -C4H#ES(%6@C"A)4&&;&QQT<:S5REM#*>6+H+?[R+X
M;%H(\KFT$%0;6Z6%X/-I(;A]_)_6[R^._CYN?#.^->\;F"YUP5T"]281C^H2
M*.5F,C;GWA\.;7(JYMX?3FU2\A0=#25F3W*M4_6R^V:OPV2TCA;1WZ[?^_1M
M$,E*=3)Z9!NW;T<</^&(/[!SW%*MTV\'^WX3['Y=/=N0K553K=*-K'0C>U#Y
MW\O03P9,,I:RQ?JQ*G[SN(J_#XT1?,!GS&UA-NLBGT]1Z1E[W,WHJ7T&OM8U
M]9:6%B=?CG;&_M&+@Z]O_GB-COXX_71Z\N'+P?M7YP=_[['TO>^/=E]=O-E]
M_?7TQ)&CW8-/$__H>>?TXO B/9X^>__+FY,_/Q_^<9"^XZ_SP]UM_.9D^]/!
M^P_I/;^=?>L?/?K[OYU3\N;L\.OAAX/W_TVOWT.G7\\O#O]^C0YV_SH_V-W^
M<G1RR@[^^/UV45YETX1(CT&)W*G.:0-6(PJ(\N",B"Q@/K<6)\U+D"]DM*YD
M5'J1K H9U5K*)=*AB8Z I^T#F,XY.(I3B!YK2],<ZNJP9BZ]2!J:W]]L93BI
M7E$=S/1#PISKG(=6]T8RYL?S7\X,SEJ7_=['C@^^9;^T?KH:!/]S>E6KUT2K
MI=&?,=<ZEK+)*^SXS/0#6#,Z[;NX#-U!53>E5*U<'^E>S?%O>8IW:C-<MLUI
MMLU;W::9#$%2!X(9#<Q(!48C"S1:[)6)C$>6ZUNUA9Y7W%B#)'Q!\7(T;T'Q
M/% \$;_,<:2U(J"9,) PFX.46.X93[57)"(F?*X]V49HYAXY#16_S98FN^$R
M"=[.N)YVU[?,12]=VM?'ZY/GG9C?6'U2G^CT^WFH"O=U_79MO@O/3<-S]7Q,
M*CU5P7)P#@=@TDK0CA"03$FE*;/&RXTMTB9D9K%2:FTT&-(+%2L%TO.'=*UL
MMG7$DVR $!V!4:]S\Y\ 0=O$W"$@Y46&-%--@O3S<:K45WFK%Q.,[+#E.P.7
M[J[T UDCY5*?Z*.XFZ9Y=SS++_OAHG-U43AN"HX[JA^4"ISV)ALC:&Q8XC@:
MP$HJ@ JFG72&,)0+<[:%+#Z6=<;S0F5+P?.<\3S1+$%JA!-8DV91!!B+%'34
M!BA'BG"L;.+BC2V,VKQ1<0\_$"W7V0#I8L,_<T#S7OE\/$G;SO7#C1@;(WKP
MW<[S[7R@6AQ,#9=I-X4?I^'WZX7P#=%?+XEDH8Z)?K#?_1C&1^^%]*<@_8.3
M[>%!!WVNB'_[K8MYBFT$3DB2<89$4,%I2(QOG&=(<N(2[;?3WPTR50O>FR?C
MOE/HM4!Z(9 ^W+F!-';.,L\$,&EP@C0V8%BT(*2)R%/*O(@;6TS.G-^_.-]3
M\\39$\JXE76KY<K-6;3E4>@-S'E6<^%_KSJ7I<WN"NBUA[79K;473_Q\%%_V
M<_3B\,O+<],=[EU/=J'OJ>A[OZ[(C.=:*2I!V)R!H*,!13$%*:*T)'CIF2R]
M=%<5TTMMT5? ^R3@K6DO'BGA"C&@6"4!1I+LLD(@H(1:ZWA(]*PWM@2]&Z[?
MQ$Y\S1-3Q7MVEU)>!==[U^U,#C-CZ/>#;_7#Q]"]"JWB*7M:EIYW?Z.=].GY
M>__N#,]VK@9I%$+_1<?8SGEG^.75:%+'<]ZDYBBKP=9_UJ66==)'QB)@:2FP
M++JTE P2O1**&$W[K=K8TO>4P2^MR=8#NPLN:%F _83 KLDP8I(%I;$ 'H0$
MQH,!8YD#SI%E(5JF#-O8HFTE[YYEKG+OHQ50*R^"&836I?DRRIJ\5BO%/;0:
M(N7,G/=^V1U/VJLTA2_',UGH:BJZ>EW7(=YCKXD)P*)+/T3Z801#D$1(^H\B
M(02;B_(VI'][@6<#=4B!YWSA65,3'FN?W:X0D/# C(M@I$IJPD2'B.0&YTPT
MR6?IHU@RT!ZC)7J#*DJH<W%I.OV\SK,#I!HBZ$6X2D+## 8E5FA-SIYNJOM5
M&G+_9M)+D9FI^>VT+C\4\3@B2X%BP8!ACD%3@4 SZ2GF5@DFYG;B5/PA#4;R
MO ^<"F+GB-B:(G&*"J^Q D=(4B3(8E 1"= &.Z=Y6JP")X.A4=W9RUG3&GAO
M]KO^RHT:CZ1K&F0^"9]SL8O0JGJ'I*=&#4JJ*\YAVU77DN+=62$!]@,O]G@)
M[-RL@*.X,YGOG).S-UH1A>"G(OAWMX* K.<^[;K  B+ B(VY31,'3)63.@9A
M",L%OMM:-"D;IT"[>8KL8;950?53H;HFVQBS1DHKP+!0-5]#8 BU8#CF&@7%
M3#1-#.U[/AZE:]?I3?%.\SE]^$\V=$/L# >MV.]=M#Z:\ZMQU:/S\]XGTW65
M^LDFSAV'7S%0FW:.-974<?T\J[MA].]^]WI]C*H;G^3540AQ*D+\,)$Y)]OD
M\.3U6X($EM(E0M32 *,X@*&,@)+4<A((YSJQ(F:Y7LHL<9/%\U1T3H'TDT#Z
M1N-D2+\_?4MUE)&1 $A%!<QX!9KK*A)'!.P98TXUT:/\?!PY1\.ST"]NF::+
ME>\DU5:S=^-<W[ZI&K]C!F>_)TEZ?-T N##98\7)]ENKD4(.(W!2)NI""H,5
M6J<_== B2!.LW]BZ6]VHQ.2L!WJ?+"6^H/?)=<CV6^2%Q0P1T)XET\(+!$HX
M!,93(221/'*;RT<W [[/IV7*SIGIODL?=[OO28[2&51%I,_' ?&E!\H">Z!P
MWN0EL^W&!:'ZP87.QUP-JBH!5:V77B;3BKDS@,<KJ0C;I@O;F;QPUPOBU<UZ
M*#OE-#OE^[VZS@T\>A<L!HT\ ^:0 $-8!*&L)$PI23'._K<V%0V)<"V(;J#8
M+8A>+J+KVI<C&DPN."ZM!X:Q!.L# T$1"38PZ83)Z6^)F9L!Z'G*WV9KF5SC
MK#OL]3N/#(HJ)PK-KF!YE]IJ,UXX;2I.NU4626EOF+<!N,VQ$UIQ,+DV$I&.
M$(VP421Q&F]C3AITH%!@O6Y*I<#Y\7"N2Q1+6%!> A6!CKN[4<: 2VT0M43H
M?$)(5)O26;)>&WHVV&R-\K(?+DW'7T=V#VI^EN)>>0;NE?'\7P=&C ,_M[N^
M.KC8KI9 X;ZIN.^@+F4T\E)HF\\BK  6K 1#>/[38V4%4Y0E*2/:O"FG$P7B
MZZ9B"L2? .+U D1.$.)UPK1$%EA:,&"Q", 26W.?@$US'4C<YF*6VF+% S/+
M:=*E^5(U%JE:USK7OPH3R5-\,TU7./-QSEPOAI>CM9 [8(Y6PHO),73AP:EX
M\%:%11*DT5(3X%8F,R]2 PIC 989Q%2:6:%"[A)'D6B&E5>PWD"I4[#>6*S7
M:U\;[1E5%AS+R1R.>K R*,#4AF@5#SR0C2V&VIC.$C39/)=.<[7.81BVG!F<
MM2[[O8\=GP2._5(/N[H)/5RV1\?V^C[T(8W4+WDR![WSCF]=C\\*$F1CO3UI
M1>0PTY?C]?#;E]>#G/IR3S1JH<*IJ/!604?N@L3&!W ($V#*$]"&2R">2\D$
M%5)E[S86;4WFU1[WP1!:(2_0<Z:%A7J("BT\&2W4RS8%JZ(T+C%"SB@)08/2
M+  GQDE".":2)874YO<(I(:2PIS\1LV54*.FA+?5TM(#TQ\TK<N.6I_^(N=Y
MQ-KL+(B75WUW9O+9:B_>W^1XV8I\!7?7YIZQ7E=A/NEMN_^]ZO3#]D?3.<\S
M_GNOGWMQ'=_,>RZU4_;8J?98=^MPU1I&',FE$94!Q@T%B_*?RG"&I)21\AQ8
M0MN4E]S-=47W0L5S0??3HKM>0<L8S;#"@*2)N12[!VUSUHI0S&+/D<%^8PL+
MW&:J(=T2GD]J9[(>TZ7[<96LA)[QHI^OQGG>)R_-E3CCR?\]S?VHNVAAP3FR
MX.WJH(A28K@&RZ, YIT%JPR#Z(QS'"M3U1'$4K85O1M"5J+AUP?BB]4Y!>)/
M"_&:T#%8:T4Y3AI'Y5*A7H!!CH.F5B=3)@K#DAF3E%";LA6J\KZN+IS+<2?M
M*I@L7'?2+CZ<=?;AW.J>OMWUI8'ZXWCO5M$M2:UD5%/PCCA@-C)01F#@@;M(
MG%#"A1PX2W1#4I<+K!OHO"G(71!RZQE]5"NB2 07-,ME?#U8XCU(J[B,*@I'
MQ<:60G?52G'++- MD_O7] ;F?,ZJI9AL3>N6=]=:*[0W%]K[NET7+)%+PRF7
MH"4.P(A&8)$BP+VG6D?JC$!-+'5<@-T\7TP!\*( 7-,MU')/@U00G$' C!&@
M9/J-"TJ)\UX$JI)N$7=;#ZR\EZ6YFN4F</VGJT'5C>7G6R'LG7N"LI;M;%FW
M6-45R.?[3M3J3<A>B5I])$'>J@])*,X!J@B\(#@9=MZ H8DE)>,"!6N4POFT
M"8FV(G>;T4UMW)4X]N9S0V./J HC/!DCU"23MMH0*2(XK14PB2B8M(C!R.@#
M<L%SGRO&ZK:^IX))"61?#F9_[W1-UY5 ]@8$LC>O@_5R>EVODM^T,QA<59T>
M>[%UWNN^@V'H7Z2-R@ZK6O3+MC[67$0L+90MQ[$D47$4]\?SO],;E-)(4XJ'
M6R5!N"+*661 <">!&8% Q^ !,<6\$-:B'-DB%6LK.7-D2SGH;3"H%]7SL>!Y
M[GBN&0.82BR%8\ 1MSEBPX&-1( P5G@6E)%S[/58#H ?@<E7X7(4 7%7NY2S
MWJ;[1:?0+3?S/#B*521N\"4,=VIRNU7(@T2-@F4DI^AG3T>DH+CBV0OJ"$=1
M6Y_$"A6ZC41#BAH5%#<P(*V@>.$HKDF42+!F)OID:.1<0>T]6$PX*!<HU4FQ
M2*(K?R47LQQ@-.^ =P7$R<N)-,F"9.)G<4F8%Z]*T^7)_9&V1S%35C&Q'L]?
MIW45(BS2A"H)T8NL0H( 99G/:4&6VH $)W)CB]U32JR$Q#<6J(WTE!3\S@V_
M-?TAM.':!0M4!Y>M" 0F_0TV1,(XL@P;5UPD2W:1C-/YLA!QO8N+7KZ&GOM0
M/"1-ER"/R.'[O=>?S/A1W*GF^SA/=Z&YJ6CN=NDE1=/.Q#A$'B6P&!EHYWD5
M6(MY9![S'"BF=%O26=I>%&=)DP&]E-)+!=!S W2]HKL.C >DP&#'@ 6'0%NK
M(4B.+5/$TUS1/9%R6\OB.&E,>$I=OB2H^M"ODON&.6[>);1T/H;6Y7GZZBIR
M);]C:#Z'W!"GXUO]<&Z&P;>&O>K)P9GIYY)-P^%Y*"4-UC?.Y=K6.XK'><8'
MK_.RV;]>+MM=7SW\6V)7G\@U-TDR^69R)M(@O>S\*L]*1;A'E_F)8B].Q[NW
MZCL%@52,R(-Q.-F+CAG04@1(6VI47&GA4.)=U4Y;;8.LQ<(&S7;[%#98(3:H
M)R@&HB2/ 3!C$1@Q'"RR%J3ES*/$!5HG-N"H+6:O!-4\YU%S!=B]S74F^8KQ
MGGC[93N3GG,>4A/:[-SD8)0\I$<RXZUB4=H%*HSGP+VQP)*U"H93"XA;2XA)
MMBN/&UN$TK:2,RNE:2&T0BZI=:.%%6A/6 CBR0BB'OBC$6(\<G Z_6"6"M"*
M!N A"&]0X%2QG&O05FJ6LE2+HH9G4?:A,V[<V?K)CUMW_IP>JY16>Z2WLC/K
M8X)$;N*<*U<E V78[[CLM<K/+]M%M6YLVEB1E0DT_W]OLAY>W2R%_$0R5&\_
M4'OERS08/7^W2^S8>-W[[,Y,]UUX989A+\;@2@#F-#R</JLNU*P-R :A0#I%
M@ 4=0"<V!BZ)D!8CSH/>V**,MK6Z>Y#0T(SQ0BW/0:@5DFDTR=3$'J%<<>XP
M>"\2R5 IP0H20%G+N:%81.\VMCAK,SJ'UC#-$WNKYC_;>;"B:YEARX9WG6XW
MN]-RX=(*5\OVIJT@X4[!MXB$1*+>D6@T4T(HE/C78(Z$]E@J_W8_TRPF%"]+
MPA6RG(HL;Q7U2O.(G/8:(C4RD:5E8-(4@V'<Z33-SJK<7X*I-D&EA<P:P]S1
MH+2)C 7)F-?:))N-4^VDX!1CK3/,L2XP7R&8UY/S+=>&*PV4"YH,KXA!.8/!
M&.)04,KH'$F "6H+>;>A0BEPVA#Q$]+#L\F>'QBA3VMXWC?T2^7'_WDRM3_%
M0F_XQL"3 C"86J^Q8M)KJUBT+E$%<M@2JRK]MU077MD8IMH8]F]583(N"AX9
MB"@",&$T:(,E",TX1B9019+^8YJTL5J9&HZ%# L9/@T9$DXI,X8S:0-SWI@8
M:?J=^V",4R*,C.%"ABM$AO7\S&"I-]&"<[G"M60*M-(.G$)&:4^5RUVEA6@3
M-G,7@ 6[#Z\O9+SP=45T2ZBA.N<ZK#2-BN]=Y7;2#:X6^]"K7'MKY_CJ\G*4
M/V+.<P<J=]X;7/6K9)4$):C,G%I/AV3MW!<]^;AJQ0\]?EOUSW@^R=K;%^DV
MLK'L7/\J6<EIBVU=/E$WUA\0P\R^PQ56@_?=XMH(OKF7QMDQEYW$?GN?+T/7
M=X:)_7*FQ%6_'_QO5\/#WO T#%^:CB\Z;BH==ZM:'[(R6IO4FU$QZ3B&!"A.
M$22YS@*B'@EM<[XJ:9"GLQ!1(:*%MI4K1/1$1%0_=G%:(LPU.!D4,($3)1DI
M $<E.6><*QDVMCA=PYYR*Z ?7^7?H1?A:A!:9C (24OV[-"D%^;4K588AV55
MPO*\BD7NV73-58[C,DY?UIF\[[O%]2'O>:O(:ND>Q=>#L)W7[=%XU>YWKT,)
M?^_UCY+M8[(A_2(OW1<=8SOGG>&7PN=3\?FM HPH3:2-Q( (40,S&(/6C '#
M04E+&&)";6Q1?#>N<.73\0LWK2LW+;:J=2&NA1%738AZ18P.V .-(0)SR2*V
M0A (W'IO//96Y<K7;3%[>^,Y4M?S<66^S#98]UVMP-*= D[]F[IFQ8%9_ ;+
M2L6[6S/XS)SW?AFOW^.;Y=NKU]Z;E.0K'#X5A]\NJVDDH](*\(A[8-Y9T!@[
M()%C(4VTG/BY50\NGLW"4&LE0 M-/25-U:2F%2ZI2&% J=S7T=D 1J$ 45 K
M*'-12+:Q1=J\4<<OI5/O&CAT=^IZ.5="'0<%=+K^RN4P^EXW7>L@\U&MO.GH
MT6$GA^=T>\-'5N<J[I-GZCY9:*F+:I_:KU8V+IO45)O4K8IA 4F%F,XYXC)M
M4I;9G K%@005K+6"L4 WMF1;B2:54BQ<5+BH$?V!"@W-0$/U@'/#O0HT]T!'
M$1CV @S&#(17CBDF*#9F!1L"-4\#STTM-^^"I[RU?PU-$KKI7]_YN/7O]./Z
M'1>F_Z[3O8Y7KR^(7.XY]!=/?Z0*&0\A!_CV+M)W?\DN\DJBCW6[#]W!2-=7
MB1.5HA]'C)OS=*7I@:HMR.8-2+Z]Z_%W49$NYK(WZ&1@_5(9!YV/X==/'3\\
MN^;AVKM&:/@%3=YB;+J"J^'WW]*4\12WAZ+^,U]MQ> H<F*#"<A9DO81J1CU
M0B=%RX2/R;Y_2_'&]9O.;E)++LV[ +8?S <P,=W@+^;\D_DRV/C7[666UEA]
MT+\=K]&H;/W;]M/[[KG4^U<L6<J*E?>.\'^V7QR].3W8:YW\9^_5]LN]UR?[
M.\?MUO[ASO>784-O9><H;6:'QWN[K?3;\=&+_=WMD_3'\4GZYV#O\.2X=?1[
M^NMHY__^Y^C%[MZKXVJKDK^V]OY\O7]RVEJU^_WI===<^4ZBD9];/W6ZK>%9
M[RI]GA_\_) [X=^YDXIQ)]11I06E.SHWEX/PR_4OOUXS=J=;75?UIE_'GS[F
MF_P%WSI;\O>-GIY :1.-X#3>QL;?/'YZLWKJ&[4P>H[B3<V^_S3:Q(]\3A'Z
MJ'?^T\7*32$?>SV+OE:Q0N.J-C%>E6O%>!.K5;E8O<DE69%KQ6A3,OV@C_V!
M8)XBS^W'+[W[VGN\$R/>78P-+S?YCS:6BHI/SOI)QQZDUYT-6GO=W"3B.%PF
M=6I#OT51NY5]@[<LN?OS=C'YA\3=*=- %S4B][LU[C=>'[,J],03-D4R==-7
MS/@LX_BAO6<?<NO_A,%^[].=2FAK-)S;Z6JSH6;.*\LB)[; ?K?Z?9P(\T^#
M_-C!><X#[MS5Q55UR%:-\M'P+/1'XYUL^7XX2Z9[;D#XHC?XQP.W,O0S#_UN
MB!W7^<>\YS+*TV_IO>&83"J./NN=IUL;C W@ZO&]JMGF W9U@LNN/N/6MB*+
M9M1&;Q'[^1H.WJC>PV,7UX+J:"\7?[]MO]@^W-EK;5>>N?^^/MR[W[J8=SV<
M=6HN]="Q_N[!;-4K>?#-V:Q V!,CK<$Q,N*4\D)[(;5GRD8FK\LHBMG"0ZIO
M/KH:#H:FBG1LRN'LUX/C\>'L>_<E'Z:>?GUS?O#U'3W]^N>GT[_WV>G74WY*
M7GTX^/NP<_IUFQ]\/>S<',Y>O.H<_G& #D\^?#[\^N'3P=<_T_-[[&#W[/SH
M9!N]>?\.G_Z]]_GTY.S\V\/9-W_LH_0=^.ADCZ;7?CW<_?#UX.3=IZ,_7O.#
MW5<71[M_G9V>_'YV],=?\> +^E(=S!ZC3V^5)R1HJ8%8)X Q*L'(X(!I&B@W
M6CK#<F'L7!AQ7NG;C2F,6& _EWB,QV/^GG"+L< <B<J"Z^EPC6YP+2PV1D8&
MP6H&C'L.6N2.1-HHF0/UA!OANF"Z8/H>3"MFG%1,4JDL(SIJ+ 6ERN,@7=!!
MSF<?+X"?$?#D!O!2*RD04F"XSZ&>5H 1AD*N8,V=LU3$!'@F<%MI64#_?$ _
M3=,QACVE. :&(V%!>X-0P"YR@ITCU-OOH_ZFUUA!^'P1SFX0[HPDB9,18.]S
M#7,O0$D:06N#=9HXH6C..&(KT-FUX'JQN':.1R5XU!Q;AH70+@:L+.':(*^X
M?P"NR[:^0-!_/J@U=0[1<1,$D-S)AC$BP5+,P7F+F'#&:^IR,U'2)N)N3YN"
M_77$_A30]\Y$&0SG2"%&J54Z.)^L0^\(CDRS(N0;@OA)UA81Q/LDPR 96Q98
MY %,;NB.L-;I"8*<SEVLL&Y+)E9%RJ]QPD%Y92,SN9M]A%6=88 UH\2.B\O0
M'50%-ULA5ZI]9/6CAQ;=?T#O[57<%L<99"N?N5KFJ<Q3$^9IFHY1A%I*G*"$
M,4:YU5%YAKB/)GHO_'5] #F?^@#;_OW58%CEO)WT)C&/.=QQOSL.=*P(MN+7
MG1J]OLK],0:=83@._8\=%T8MZU\%UWO7K3[E+W-^U9C"."NA7@^/:VYHQ+ ,
MW"B(R";MJJP&[;P'KU%,NM8)(>G&%F]3/7/_U<('A;?+/)5Y6MUYFF)_#=(C
M1+C#*%@FL3 $46.Y12QOL#R4_76=]]>Z=TB@R&)4 DQT#!A-/[2VZ3>%4<0:
M6:)#\W;8XOXIKWPJ]\\J1C#GJD*FZ\*=^M>75_W\S#"7_@B?0]]U!M6+1L_V
M+C..!U6GO^O^D>G)_DV;W/'K\DXR:+>ZX4G: $YS]K)6^_*](<_2!F.=%B)B
MQKS3FE&$.3.$2VFD0@_8FK];=FKWJI\&;[2)CJ*>JY^_?;OME@UUF@VU'@#-
MF%4RY!A)&WS:3@,!2ST"K*W2PI@8$,W'JS/W.FE>J>EG"^.[\GH.&)ZZI%P=
MVY4JKIX[&C'\WICZ&].7;E60/0F!#BKPR!B%@((!9HP%11$"Z13CTC,FE%OC
M0O(%W4MR3A>(/S'$:][F9 R;R"4(R73>O#48D6QA0HS#WG"+B-[88FU1MN_5
M _CCO)AEGLH\E7E:*6]SV3"?>,.LNX\C1B29M B$=FG+1)R!(18#Q3SX!&2.
M#&[>EEG<Q^65)7IPPN63'D[9_7O+@UP"!^>92_-4'M]IM\?)A/OMKG\5AIW^
M?=[ALC-.L3,>'=?\P,0[Q*27X#E6P&PTH''$H*-+1B3%E'*36\=R06=(LBDQ
M%LV!]I-X@1\#W1(2\0CD3OR\1EC*HXT0K$&Y1[T Q00#QY&+C$6,52YU45"[
MIJA=@G>W0/HI(#WQZRI, _*4 G=,)DAS#99[ 9'F8YLTK8ZHC2W!VA+?;5RV
M%K@NGU%X;OE.N<)S3\%S=7<<=0BG_QB(+C!@3%FP&@N@'%O+45(P+HZ9[FZJ
M[U*8[EF$YU5EO*N\S$D)[TXW_?VXO,QG?O)03HC*/)5Y*O/TW.9I"G''5?",
M$X2C,4SQ:*VCQ A'HZ9<*S6UZZG:P6[UH-BO]J_<B.*WD(1@.#&?BW*;IDK+
MR?;P:%*7B85D? HAP3">E!NV$:R+#+ -DA++C-+988P:=(I:8%OH=8WF:;&V
M<Z'7IZ?7@Y/][ !,%+O]-E#'G$,<:.0D\2MA8*TRP)*EC*/RBAO7,'Y]%J$'
MAV$XBRG\S!U^)36_S%.9IS)/99[*/#5QGJ9I$6&X$AX%@9,!3"S7DFC/A+#.
M&1WPG,_=D^R8*.PBK*<2UGO#2ER/A37E7DG/(J19\L \M=F%H8%)IK"@ BGF
M-[8(%FVN9NX441#<8 0O]D2Y('@V!$],8VNQC(EM(<U= (8P!16E!"H]82B@
M$+QN(H*?Q='Q[=Z4QWLO3_8.?MM[51I4-J-:B[/1<,J#()*P*)U&06J?X"09
M2OAQXWKX,P;/E :5,]%=HKI)B(PB!D?$!;@@(C#G RA&,42$@Z>2!QU1;F6'
MVEJL3#G\ OR%*IW'H[XTNI@SL@\G1ZA2H01MZ2%ZJX!QE2NT, 1IEJ20RJ(X
M0G9I/%M0?6^^CM?:Y'XVFG/&B+?.1>V4ED;Q9+:H^>SE!?(S0WZRF0<<HS7(
M@,B=[!BV :P0!$A,)@W3(@CJ-[88DFU"9JY?6F"_.K"?)A(>2V6"#%11BQDU
MPFCII3"<&**44?C[N"]M*I\*X[7(*&.B(T:K)--1KE#,/"1F]H"Q0<A;;-,4
MY6V]-*LKR/X&V509'ATRDJF8D!UL6D(126VQ$-+=M)W^)V27K7VA=GKM8($$
M(CR/"I)='A+ND[#7W"N@$46)"1-IA2?<$]X6ZF[?^0+^=03_-"'05G&#J?4:
M*Y:D?<)^M"[W+W?8$EO4?&,@/SF)B%;*[$@!'IQ)D.<&3"0,L-$H()WG,?>D
M5K@MY-W]OJ%R?GQ,<7TAX_4L*E#?SPE3I,!.DRT[N5&:;L7WKNQYN'.GY3O+
M=\[U.W]P2C?7Z[S[VGNV-1?2+M%?UKXF[X^"38^T#M++S@:MO:X/OG4<+H?A
MPH;^_2=]]Y,*)@]@E94X]KR?RQ^S*/2/XS*FV0*:OI)V1K7;CA]:N^TAM_Y/
MV.SW/CTX_F6=QGG2QNK?MO^OK=S+"O:[U>_CCE;_-/IS'[4R1?=,D7-7%U?G
M9AA\-2]5DLUHAFYEXN< HC)9#9NLW1 [KO./_8;*O"Q@7DYZPS'%U6W=*OY:
M_EH]/K)['Z!.""[J9,:=>$46S2A@:1'R8PT';_LB4<I#&JT]QMQ:QZ#(W;V=
M<4PDKBPE5&(BEQH321R*2@8::51,.J>H]L&&P)50+C!4>5X1)A27F,BE.5Y=
M/2;2$TV=R6WJ5"X;)K4![02!7#,D>HR=]_FHA?(VHO/*D"[G+:L,_'OJICX:
M]>5(9<[(KL5$6FVYDEB!$$P LU*,3E2H94A92ZFPHD)V075!]7T1%&D;",9@
MZ9#*.5W*IY\X)N//82J#GL]>7B _,^0GFSES2EJ=,"ZTQ< 4$F"-XH"YMHXX
M)RE)F[D@O,W4W>8#!?8%]AL=*YGV+'B*)&>&1NUXD)8;0DC0:065S7QAR*Y%
M0@9M$2>( Q>Y/Z7'#"Q/6MU:%5T,.#V+-K;(W6"H NJU!?54#4G2/FX#DH8[
MQQBG)HT((CA@YW3:&_Y!HI=PR.68Z+5PR"@C-E(&X)'99*-C BI$!DF<,>P5
MLX;+C2TF69OK67H*%?"O#OBGP'YNTXBT=R0:S900"A%!#>9(:(^E\D7(-P7R
MDW!()Y-F%]EXYR)!'F,'*J;]/EBGD&264\V3\<YQ&[&9"S,L.!QRO:L:[HS.
MLG-T@?'OKP;#B] =MF*_=Y'^[E7]9W.GQ>WCU]6!!2#QI-4/RV<\BUH]TVC!
MB+AQ#A&)>++PM% D!B>4T1I1PQ$O6K!1&\.[NH>'NV $,P1(;F7%L%:@4?0@
MB4Q[.K-$R&0'"M[F]_AU2S^K0B3S3+-QS.JD(HF)@1FE%'+.!$2])<HRCHNN
M; 9]U$U)QE ^$_+@<9# D$9@.7,@B--($2(<5SFSKJWES+4R&DPB:PK>:52
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MF>;3O!AA9B/C[TQ*?S37C[FG&^;L'GA49#+7MK#,FKAB/*UB5D59!)R=1+%
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M+T"7E\N5%W+]B 'AUXL?Z>\N>G %^R1)1_OD$W7Q-W)H'.3K2Q@@=W#S#L]
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MH+Q1*)G(P7 '"NUD)PJ MS;*BA36PJ[H^WN7,)W,[ 11,5Z4?8T]_XCV,M^
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M8X.O=K^'GX=QNS;W"U4\[.N6XY')BQNC\-<<W_FG@S.U@T_J[O6"/T.3-PD
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M' ^Y^^TW".![OY[7YLW,-37H?;K_!@C 1GO@YV5MC3=>M\T!T<'KZ>TNHTS
MG[J.0N.0FFNDV_DM3[=?FC[?2+>G4E0F+3(C>,6%SJM45VF:<E64J9*I'U+S
M&8VTI]1S\Z5XYPRPEW#O1W,0P/?/$KMX]O[DE<FB0G,M6:X46F+6,IF7,<NJ
M2%5Q:K,JEG?$$G.4GP#IX2F7F5]>9J3PK&_+( LY'%>026^\HC=V+6==D\"
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M'=XRM EH-?^[\;)?7\*JNCEAM5QNH^1IEMPGEVA M26C-B"BLIDQ4#%[%;Z
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M*Y)GS(N4F#-,U CA,B-Z+N2O/:7&2R \<$& 14]\TOA%".NUR=SG$O('T>;
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M*_<Q3B9IJQ=V'FL0Y27:)_-!YLIO=^"W[B]S)@IZ6L++[(BUR1+P(A+/ R=
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MIO2J*?,D,'[EL9O-IB>G6^3HX1]X=+<T3:?=4P0^UC@X*FDZ9TOU:@M2%[]
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ME373QF?X7+JN5;:K;/>,(TZ5[1;-=G.5A"':;*(F23-+P.A(O#$:OVAOHJ)
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MTZOB=U'XG6M':SA-Z%T2$<NF"X-8\*M(-H+1A*R<\9&M\;9DBVJ']8PR_9?
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M!&#$U)5<E/;AJA3J%/=?IBUYQ?T7Y_Y3PNK&>4:M0,)C#N[OP/T38>#^$L=
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M+ E*2.QT7-O ZU=[Q=7  EMC2YG'!"35G%COK<:"NPAWSB7&5AE'*0M*5B:
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M2&(A2H(2H5FVBGFD=:"(*4HTM5(9@O/F12FNI@.6=/-B ;L"=BM8/%G [I'
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M@5VW.C]1;VLI/A$NSMW8^ (LQM>.BHVM3;K/X5N6,XI",@9QY4C>(T$180H
MT89D757;.Z,&[ (HUA]8>$"($%%ZPH$5\BB%%40D2R+3(1A"_(A:LS&U?I@I
M_#ERC-^[G>,I>\\6\HK-89OO<T 0'F!^)#3FBD!*D G>(T]IDL12RAF8 X23
MZ]<)'HSL8;WV=ZS!H^GD3M>Y #_4<E%V_B" 1H"!GJ"/[_3Z &UY@3FCRSQF
M \;B$PF.4!]XM,QR200$N=I*2IU?M-F,DE>[J<*2T?7GM<*ER6<]@]D<B'U/
MC)616T1T[HA.DLJ%I!)YIX1(4F(LPNQ"A4M&LS7#,/(D>?N,8[N9B\5>3LV
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MTJ /MW>AKK*ZP#P([4[>;G3A\D8G<[$64SKG\D>#:@3RW;;A=D8C=O&NA[<
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MR3H-<0ZV225L"?-2:!HPNXL)ENT6BS;);=;XL$^]#D[Z@$A.S?,@' +42HC
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M]UV**A+'4&X'AC@!?]+)8<2PE\#='<R@=FV#27.;(OA,6+YA8A_78.>_:O"
M1F5JYUKY(UHP^M3VR.(F2#BITMZ>791]]2N5<5<M..]?;/NTAILM='+]HT&,
M83))#"NQR2NVXH.\FDYU#!A+CICB6?XI)F0PU@A31H.!P!-F![!BA=?I[<T^
MAGO/A\F]8<R42P8O;&6WWG<'%1 .2^A& 5:OEU^\:%S7VM:0ZRS8O/ABS:LB
M.[WMZKY>LY%]PXW3?:$-%2PP9%B6^ D4(ZN$1U[A:(.E1!.\MF'69Q#;BS8V
M8;E7$G+=.*K*G?3=Z(/E]9I^5,[F "/#."+/II-/,9@A73"*^(=99'A_=-(<
M*[='$WB57\[QU^2[5:1N<\/ 0>L<P:]!TF[TG6[N/[B\/4A'5SZY\"OS_[MA
M;_O7:]L_WA&@ 8PD2CW0 )CO@09(JU#N(9A1E*= N<;&#7M?E^>\RL_9&(>Y
M=[E?@Z"(1QJ1T<XAJYD3U!EG \L])V?LK[QQP^6,B" .1WP\D?;&<VF5%=VM
MRF7AE<YQK/TT^NAY82P\NY!?J""GUVDU0Q5V5$7JQ\/E@U3;G>SMGKLUZECU
MY=J+/L?A80^F9)O=B_7$%U![-/$/+LKDY/O,Y9H3%:0K7ZIR= .XTN'U=[I-
MB!H!K(%5'/=N)M O(O8L8@Y+"!6[>]OT18@Y/&YKUT^CY1"8:FRW>P:$[:\,
M$+W-=G@';I9O*_P.N#%\=;0-[MS*>GO9]U]Q2UC:^+#OM1(48P]Q&LYZJ]XC
M2X1"DKL4K24>VW2YQ>OR(MV<$AV-V*^-+:<VC.-[4Q/@1;1?$9626S?D^?$-
MCW)$U<+2A<DU^_R,9: ,&+8WVKM1A3&CH<K4('.+T/39XZH )N]BS*N8%=6H
M$DRTFDRB[>;2PM YR71B\]/G:CL&PG)TO/%2&QDU4(>YV@*?",/UMF[L=SOC
M1NHY$ -.,R0WU1&K&;\'GTIYS6VR^#O9;M*OION?JM<[ QC*T/MY4>J YT]V
M>)+S*@<(T+HH]YRT)[WX9OS+6QBADY8]>]-L5\^I^M+;B[I0N1R@>@I F$<G
MKDXX?'M4*6#8NB(L%POTN_ OC$\\JB-8K^H(?NF'J^])LR[4]6_C=7+/]X2^
MWU%ONEA"U[FB"[]8L@Z3[.-<[-T.^TOUU(9/#FPC6^+_6V-KDQJ2D-?YW^ :
MJ6QK?+S%?)2>?,\??GNEKN:RV0TM;M&HI6]K%E\5P4SD1X&65F4P&1G.G?;U
M#<@$(V>/QBTFY:S_=M %[ ]H=,'>QYC2VQL&H17352CJG#S]-%8-P)^7UCG>
MW,$8;KWK.UC)M<<8@7R>*. @M2I>KHW'81$G>)Z+G-N04O6_RX94R_]5RVQ0
ML^/[>UG5I2&X_,#F&3I<NZ,G/@X8W7'L_G5YF.:ZQ>E;JW:T+]6]S9%M-=0[
MR7)-<:*<"FH#$X((HEPBEFH]TGB]G&1EBQ6M8ZL9Q1Y^.?[>VCUJM1I[FS\:
M>]O?=[<V26/O V_0;='X\=?1U^/?X5I:\.^ -NCG\^_ N09?Z6>Y^_=GLK.U
M0W:.WO&=K<^DD<][](TU_FX<?_G[KZ/=_&_K"_N:)6":^.R/O7?]G4_X=#]H
M3GWN1.\Q$XA'ZY C$ 1KXYT13 :JT]J&P77#KNH1#Y-E#['_,3K.X0<%C0H:
MW5XCP2GAUI+H\\Z30!P7%@<AM$]$<.U': 3_5]#HV=$(GZ.1XS+E=BPH4)5[
M@!""M.(<*:4"M=$S#@\LBV_F0LPE@J,%11PK011GZ,@_:OA!YQO&F3"]TE@6
MO,CMFXA@3/*(HQ'6&&-5M)81P+;"K)8&R\ZFF)6B003+'$J$FRROPI'+!<,&
M?L, ;1QBKK4-C<4BL.P&/'DL:E7\]X[^ZX/VCFKGN$F<^^AB\#)RS*B*D1I\
M-RZ2FM]C0#]BMU-<]W%<=T)#))9&58JZ7'G$<<A=R("&1!95Q#IA@=G:1B5F
M2=\ND>LN,E]%V#+SD+VL/EN;Y$&'%O\<":MKLXJO(7B\X\V_&"@73@M+F N&
M:*Z"<9HGYTDN("".NI+D6AH\;_PV1<6BB%)K(1"%N1?Q*!ER0=G\0TKK6=(Z
M A4S8H%9KKNYQI+GOPJXO2)P4S@1YQRC5$E.@;5J$0F-@5#*3%*AY,R6"-PF
M9)7+*&A@ &DV9FT^X*E62X*$\UXR0#:!U:)S9H\+;B,:>TE=A?!A<='3+QR_
M^&,L*&Y8WG#A,X!0!Z[EQ[B7Q;C)P/TJ)VZ955_,,5Y36GM1]0^W^.J#4V$K
MS*MFW>)RLZ>?EKL 8@K6MD: 5GC4/#QJ.E^?4[(N>(>P# QQEK>D">:RT+%1
M1).0L%W;('4Y0]'CYQ5.U!=$>JF(] Q%$ 61'HQ(D\C.$N$I"1JQ&##B&F.D
MK1/(PZ3"N'6,10R(A.N47%5&>19(>DT%LXNJ@[@KB;]I'?6NY6JKC6?/4 A1
M\.QA>+8[G8;'4D1.O$ 2BX2X,![9Y+/0DPX6")=VN>D@T77!KV;A[XYGRU=F
M^L)]>&EK(8KW/MA[)VQ$VT"S1 =*(NO=4QF13M@@[R+XM94T6+.PHH@EK<U<
MA:*(P76YSN=(9[W.!<3Y;GZYP7VN@//IRR,*Q#\0XC]-$33J<V$J4XB[" &G
MHT#0>$B \\H)DN Q^IACGSIE"P@XEZ-"H@!< ;AE+I$H /=@@)MP6.^QIB)W
M^C*,(JZ\1E9:B3Q.N2;?>N_DXC)J*U EL0JKT,MRC!<O*_';166D9U>56.IC
MO*94=]&&*+NQEUX;XH].^V O=H\K1?%A)Z9"E.;9 ;6WW=]IXN\56=K,PHA!
M9/%)KG*RGMF @.PZ9"%&E-C&$(3)-?-U*JYKR[#"&?L"12\4BIZD)J) T<.A
MJ/';.11I+0/C6L!PVXBX-P1IK"C\R0/&"GMOZ=H&YZ:NM%DB+'I-Y;-%%>(E
MJD), UE!L+D0;&>:3"7*: J<(Z,UD"F*+7+4*\2%M$%:'[T$!%-:UKG@2[2A
MO'CMBM4_%(=]@,-.40YLHJ:1>T0ER3(01B%-M41$&*$C%A(@MBA /'^QPR4Q
M]R( 4?9(K[X Q!23KHCTG_8LB^,7/)\+SS],$["8!'6,6^2=9Q!"!HZ /2>D
M(W.2Y5X].F>SE*@K?'5[SS)NDB[H5M!M)14@"KHM!MVFV*I-B7BL%7(NUS;0
MI)")61$"?I.:>F:Y7'2"; 6*&U9A&7E9CO'B)2!^G[1XFC2P[=I\\;56_">V
M>K6?_LC_K=&?BRK$$]3!K$1:NZA"E#W82U_Y<%E3:]3PL3"JN1B5GXX7F03:
M:RU&C)#<%H-19(*7B%FF-:%:NIS_(Y+6L;RNU_H*)^P+'KU0/'J6OA@%C^Z'
M1]/K$3)YFZA#25:;+T5 !EN/0HA.&LR9LVEM0TM25VR9\.@U5<D608B76 )1
MP&P18'8P3:XTD5QQ[)'*ZZK<$H*L]0*YR*)6V$K- ,P4(W7V$FM+BP,_5V>,
MXKOW\]TI(F(<,1#*,D1,WB(<B$<F"8D\\8I%:IG2LJA /']AQ.6.]OU>W[:K
M9&?[N9)8KW,I\25ME5ZV0HF"[XO ]V_3W P;XPP/"MFH<GVJ<,@J$I'T#EL6
MO8F$Y6T_K,[)@Y<2BQ!$0;?EN>ME*Y0HZ+88=)MBKU*&D%)4*"2J(?)DJJH
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M[WT(3OJ\DD2U0? P"7*!*R1EM"Y I.:PSLYD;G2FUU3?^-3;]A]&E%<+6(+
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MN65'JVG)):XES"LV(<4X1MQ2CAP'RJ:(MT8SF?E;CE&5*NH2R^:)0CJ=!*-
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M;$ABBEV.DHB&@5Y%@3#=HG.F(<?5G3Y6ODGG=K_QWNKA6 TO7 .HINM.]&:
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M=:/,2#S4%"2);$Q2+F.C#-<Z ^'%1!-LW/GVIF>#X>AHH=7GNT[BTO93-70
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M;_BM:"P5=<NKO7[Z]I]6")6RCFT\7C70UK@L06STX<>&K\_$4D>;+JL1=R5
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M*DY4D#%B$YJ"R2N,Q*29X)K6S[.U^[?[C?=6#\=J>%%T*P81Z2KQ@?0[_='
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M(M&)I6#=V1C^\# 61!D.QEY".>-"!!EW@-6R&8?),[#MG,?YAT-C6  )L3K
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M9<7.BADP@(0DH>"6<*L"HA/-2!1'"C8V8T(R8.?X:;+S6L,_#2"HM4AX=)%
M*Y% =6P2S@U)69H0'HF8Z"Q&X-V(QHI2&H2)T_!W3IM:BX3G*A+N#@&U%@F/
M+A+"2B0D$>X138G6B, =8I-/$6<D!(,_988)RL2+UW+CP5&?[DLB3&<9^/#
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M<DBL:/</MBE11>G;T.4(3HHPP"_HE55_LP4\C4[>4).RCN[%E04]-Q$5->$
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M^P6T]<@QJ(O2E8BDDP %LG'U)/1I0%58C#THA[2+\9,4H:)5[D+YZ"3[.,D
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M--CS%P;$U-$@!_>TYPZ]\1# GJN>!;\T1\']<HM\>YN^PD?U[1D&R3OJL#]
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M7/V1<33O,U[BTFK4;0Z,]J($CX#L&^815<,.P>A@M&B@1VA)6Q-#*X&';.'
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M+W,PA],RG)8_RVDY.(E>O7KU5(\+&:5_(WS1$Z>4ZX%V*0J4"K&^.7@QWK?
M4H%LWA*DRL2H"S-:(F<2U08)U)-Z,J:(-F7\Y1Q&Z.,[M8Y54)$"@ZR\SL:)
M8CS_L+A.*G@)C.IV/H]+-V89?(!*A9&5O"' )8^P<N2I3(IGDDJAH$&QB/]:
M?4+[Q1++D1HU+>* .<\R+%>J%)%:,@_3HDA,54L/50*DUG,/"8OK:ICMB>"^
M\KEJ#HN]';/=$X2%2F%J)42%KUV![:5Q)!P/"W47O.;(CI7+HJ?!6%TQ\'5
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M>^Y42W)YEBS0D*K9%QO,Y@><O]V?"V]_XF!_1L\^?/_O\6+Y[=GSKFH-[.I
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M;E<PO:I!=@M!#JYYS*;SXH8"1KTN6.<A=.QP-#9;1'6QG-C*4BZ]3_6BQD7
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MKM"WHV>'S_V!S/#U_E!<F1:.Q7\JKSONSLFZP6ORYQE="]=]+/(MU04L&9Q
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MZU&6FY\>7!;]99+Z(&MT>>Y^!4*V%!+R /:PAF2J$_?Q@&18/P#G8$>*X!0
M84-](I.Q1\V)=]-659MGEVF"+*QXT:0$C"1^TV?X>S9-7\<UIW*0"CR-\Y@9
M9/77S]WM':)+QYR%_4CF0'C:J/5(WW>$WG3Z_4^_^@+>&PC5;@?RF35PZ76F
M6H"?Q4!5D&15-S@+T*?A4+GB1R(U-@6.Y(<S5VKB 8J\XG*/NC/:I)4XK8,M
MW32A@0_ (C1-7TSG9H$-3(@GT-]E/G#PU"*C[E..'7UM FL G%C R<G3!)P\
MT'))&LPU(-23I5>JD_Q&=%-P1_H:Q-Z63D3=YU!\)VE!=(12HU=5F Q2%F(]
M'KUQE- K=:,59)@'3>\>I;:*%>L?_'<#\V2MQ6:7_DY.K%"_$^/OC(XSVUQI
M-6?L.5K]W3M<<\_]62"+E2^V-&K^/GJ6/D>OVQDVI2&W%QTL+$ALM#L$J0>-
M:X8+(464V' I;3_.50H&VA.IVL"<6H:JTYLHFEC(X^I:,Q5AI%&  RMK'!&U
M'?@6U;<C'$=[($K,L9T5%@ 1^FZDJ&_]U?+IE47XV[/T\CFE5#LE&)XL!2MR
MA]:@'S2XT:5H$U]Z,V V)@J-+YO1[\9RV^!9GXQ1"'*5D1:/9FKLR;26\]I*
M%OVDJ_?L)R%MTX8X?DU[PVN=6)/1<=2*%M=+Q>?5)C.?-(7U-SVZXDB"]S:W
MJ#)H/Q.!%%S"\N/O Z9B+I!T;G0@#.$IMB*3TID6U'M^@;7X71E>:ZY8:+1G
M.&YZT<0052 <+"YHR>ADBIQRU(%\YR#IO.F!H5\5)]C5D[OT2=R)MT*H&%+'
M3JJK+_@.UO18CW*A12^NV#_V4K5RSH(B1>V80)/07=*<O?39:!U,G"IJ(B;8
MT$@,HT#6QA4J!<A@4RG%-6###CU &G=D9X>[I]:N#ZC#7@01(44_A*67'O$U
MG&H8W*(*PF"3U?67!>,AMGUZ&-WQJITVW$9KN)7$D/6?L5D71+XAW76X64K7
MG [5\&0?V$B3%TJ9Q%4J7B/?F8P]8<!2%J]%2?6$O-V-:,OIEZ4>G-ZT^?:8
M';F!>Q]L6]CVAV>]T,"-;H=OM5R"[UQ>%X[=H@T\G6]2HMIU;G-A6(%B^(%J
MP1CCPZG#+/V$6Y/$"V1DYTRD8S1G5=IYD$75K7S"^9XB)2/)@]SAEN6K3=6M
MM^B+EK6*HJ_Z*C/EUO$$.5(FZXCLPDB,0OAU//T$$XU08:C%@//T9):WZ'ID
MEU8]F7F<S<AH) 1<,"H,0V-, ]P',EG\3 !KY,!;K8,*\RY&=VUUN1?:H21[
MU51+YH'5[,9Z&JWNK)VT]KU CL-M$\R//Y+ILOFL((EIZI-9M8ZT<U?:.VN/
M0:>+B.2M7!L< DQ+$])-[XC0#M?N(PKOH=AUCQW)N^:9B-3O&G,;NQ6BHYXU
MP@6VP&JP96;6+6 5^)%71O"=C++RK6G!"=HB"=M=&D/]L]XBBQK6SM0$NKW(
M^;U2D8%VB.'F'?@;!G.J)K1<*7,37Z:HA(E!BNREO,<-(55/4=].Q-?T*2BO
MVTY/\-;"9]B[8:^5G^6URT#KF3FN7=.BJK7(,)%?.H-5PQU&7(@AB29F[E>C
M2I4A!P7G-F"M62.^6@JL2<DN<3FU$PA[%:H+ P!J%N><A%D48OQ[\?0J12F)
M<U,T%2WW-8O)S5_!GS6U#3)R]:,#+8DL<BV.I7-:L,5G$[:*2^"3*0[-9<II
M1TYW! VP;?6OEXCOKQY& /,4.T-KC-[[&]@-J;D4:@+=15Y[@@]Y7<EX<VD;
M@KUM.9Y=#R46)6D=<E6"?-RN46I2+[)1NP:*+Q+S3B,<Q)YF$Y,.%[5I]7R2
MPG:9K^OP),RF&X<V04/$,-=:V<-5XQ "VU5Q]Q-4^L#N=<J-[+00>(PO1TUD
M?63JR,:\U(*CQ3:OVKT[+:?-HB*$?G6+I;AJ R%(GURBA<YKHA&HJL;_7*Q&
M3,$%LG(%WHZ(I313, K.=&46^/>@%K<VTWD.-\[%;E9H!8RW-\\R^OD7ZQ.8
M'-OH.320"J&O09WS&4+TNX58Z(/JI1NC':([XY+A'DD=<1:*E>D5H_O72,!G
M(JG_)>*78R(BDM*"7;!@;/RCDE-EA=GR U (M0U3PM55JEHG_QPH\UC\;N1Z
MMKDF_9U26^@:66-5[P^N;1^P<\0U6%Z=AR]X:(;HNCPSXXMQY'_2<^B5,JZ+
MZ+9196[7%<;$!)7F!7\D'LP=V+;ZL@]ILZK<EU+J2EEY8Y$;[HJ[/B$/IU<*
M/X_1HX>G5#5Q-=M!/(_N\VCU'2L').X[Z 3Y\:%@)C.7TL6\3O=LTA9^F!0)
MPA9KRK :*MVIN5)7; ?DXJ4[@ PJ6D'<>FFL:?D<?_CO__S]_,QYIV[X!,Y!
M$\.$5ZW]JL5!X@=_%;19Z#H'14@<;;0Q: :?6]P@&3TFY1I(>%8DX65/?PHF
M&,UY)3J<"6)*2@@]@4C;IKT:Q'W;(KK:*Y26FMR)R<BTTS H1MA<V2!VX4J4
M(A:[Z.6F@24'VY93;MT]D[I.F2<^PVT CD0CB=>L.WW4$<.$>8K0UFE-U\8@
M-L7HUFFP:Q!H_&<:EIC>2C&"3&E3Y=/U?3W#UHE/C"9- ;G.)0S25L9?QR'5
M;U/]+X94_PV6RTHH9<X1-1JGE2-@"PI7^TJ_17H;CH#Z0,4.16)1>K#:D/=S
M/33-<?9&73JT/L"R1_+;BKXS)2[>Y)SCRFO"]6_P=BH%<'OQU>V;ZSTET_\7
M/Y9GW275C?*+="ILG)A180O HQ!!DP4I1>"BA%'.4I,ERKGJ7*J.(^55!6OQ
MKU=AB:%?:UZT&8\I?-!CUB&&G(U(\QD65]LI]4TDW/MK1LK1.W8V/4R_]P ;
M7XH\Z7<US<((0LN*IM:"(R^]M:P[X7,@)J]HD%V?VBB(GUWTR9I+O1.%_$HR
MK2J)@9[!GS+JQ2Z;A%WXJDJSODV^,. G(K,]28U)8#\NRN+*;ZP1V<T*RDN#
MNE,&AT=^.([9'GPP$U<!A[QF+@CG!,[U;.3Z/YRJ<-M2 DPCDP*IY_AAKK$>
M/E2^:2 '3%=-LB\,MK$I4?]!FO#E)W#N"Q_1,K.M/8)P>^J/4#,+_.$^-L9
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M4(:_W5O&QH>MOM56,ZU)JX(<O ZD4?$T#WG^) 571?E)X)MXPT?6%"-K$+X
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ME\=5(2T?2GR6K1O?>,3< CT#ZEL/2SX@)36]M4?O"+)-S<(+^J_-FV%W0YY
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MN5!+*E,UT'P61&5SIEZ'($P@9,55;HE;;/%! ?9?D3!3E-<@'IR%"Q)-;J=
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MYE^(?)?2Q(3%W$6PSR\M)"H5KTS^(:+I2\1E@2X,L5SOPA7PAW',O<0:!P<
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MLE!4&60)]FI1<.1R=W A7"":%R:?<OL'?:= P$;/>)8AU%$:46;8"+9L+C2
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M:/O4W&B 8M2^-Q_T>ZWJH+_'+NB.3C-RW#=V+- %RANB#A?:R,Q\]O5ZX%7
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M_Q"_H=UB0@(,MX '#^)1:C&$C%[8*YIF&)83[9-/])56% 4/P5]@H _]"A%
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MT&L=M]25RWB;T>ZVVW8UM%,Y*!BA5-*A=^=C<1OXT,()U*$OY L#$,E=('8
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M0K%!F@]:8+3G&-1;Y3%P,*[I6'8W.\G/QV,?UV_RS*KVV ,6;?GU7B!<**O
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M*<C>&U#HR98[IT$6%X+2(JD<'R7]8C")"?MSY,;ATWYJZ'48?<E(\Z BNAC
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MDN-1F.,/8158'M=#P[-FU#)8F[CTD!)+H!3-T<C)(,CB'08GDTY]YL!F/$_
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MF\%NF:9_#='%.6TRPK 8R#VN50F)5EV7789DG,L*HS?Z4)P?X+9@/Z*TU<R
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MG#A(X/>Y(#KGPJOI](I@0?0EQ^*8Q11ID9JSF# S4+ED;676+O;#@P6@\^/
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MM;<VE602)J'RX)'//C3^=+L]R&0"H_>+]@\O1GD^,F/]7_]&7TTAS2O$OR2
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M2'OG[[/AQ;P1W,W"YNZ/!8A"<V#" AW6H4@650!R?Z 8F7ARJ<VEMX=0'2M
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M@R-WF[QO[7+M$AU8W3Y82<IX)]2:NM".&O-MC?&<N-5(,PT2M.MDL/#,"R1
M#8D1 %>'4QH&Z 2)(]@L$F$4;2):&R'U5R34?,\Y2-JG$,NZ:4?T+N$()L/Q
MW(54JM[ZYXX96QL4ALQ9K#TN ^04E8-"'D1G)OM:",>K"NI$L^,N)=RQ@WV-
MX_?1]",F,C,Q+Y.;VX#J//:U$4[_D; .5#5N)>?>2."42=(0SX.LL\*T$34M
M'<F3Y0(<\)A"A^]^O\I_('[6E^YW$6\CG?\TGI#S.;VN)^'H5<I0+\75D7 J
MT$%H-6?@"BW5*1W45C;E3@J_BZ'?0$U'REFC[@,DVT]/H^TB#-=-FF"4W^!\
M L?U3\:E]J2X\V\F]-,K\J+JN],\VG,PLMYB0]W*<"62Y$3(9'R8% !T2BJ2
M$1)2R:(HAS&5+2-)!V,\=.30OS=\_O3UY-I_O_T;0W+OB4I?;/@Z>Z>@"<R;
MV@/%J\(B3W4 H50\<Q6];^/;' R]P4@;[J7":",S!LD#Y3HQ3PX.4YK[4B]!
MZM2H?<HC(VWZB 'TRZ6U4PWWUT:#F-*ML-?/0XC+BL:!%LI*+PNSBEP7';RA
MY8KY5[1O!&,4;].0>3V>Y\:3#K32(';T\WCTOE9HS><9)FU"TE&P8A/64<'(
M0J#59NU\$D%X$]KL(K=1/#=>[*V!!JW<]Y7$(DHB(4+2(C$M+5G0.6@6G;:,
M_"B5O:$EE'!2)W*O$<GCLJP_S9Y"9'.KWLA9).X#CRQ#K971]5WC4C/,D1PU
MK3VY<YWYOJ?<EKY';NS:Q7X7'1VG%?DV"+]VL=];I[OW)-]'(<>A3HE)%P'
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M@;"3.K=((.RCBP9AJ'70Y/7-(.&, % LQU*KV9QGWL3$1)1%1.]$@387^QX
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MBI#K&JLA.?@L::LSCO )RXUI-0_V,6S/CC4[*>,^74P+VV7>/.)7G%TSFD"
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MY\&4SO5PGRNA4ZZ\^P!T(%Z#'' CL]%%LQ*<6#1Z#Y)KAAIT"#Z9)-K$>!X
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ML[ML3Z6UY]UUO,6,EQ^_I [GO>&D<.2AU]&!\]A?'3<&*65FBTNA>*\#]E%
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M%YDL?N!,1]IA@HJ:T1H07/(2]5;5"EOI[\ZC^SM"#Q+^N O)=6CDSH' IUM
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M"EHY((N*9\:-RPE5\&[;5-S32\;NI*"]DK&[2/=8R5A?K,7":>TZ8)W.X%E
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M'A5+L7@Z/N<7P8ICR93L+'*;XJK=>381^)T4M%<$?A?I'BL"[UP0')'6'D@
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M'AN-_.T(=&1$:ZFF%OVX=F11&_K/TO1BNKE'O4YR=)%9JUBL^>^$$GD&[T.
M%%64$GG)^JAI5+V=Q/WX1L:A!DII4'N\BW)S:%.(F>ID5'!UR2H7#=$*0H:!
M9T]6,N=&#6[WP7EZ8@RANT?HT5WP+=(R]F^(B1,L><P62B$CIV)@X#.Y<Q0B
M>!-$<*Q1J^T#@%X%(TX1?HMGJ)MGN@, WW[?.&/O+L+R>B0N!LF82G0*R@A*
M.@.>/"]@FI,X3"D8V\1E)X ]5R9XT\.FM9*>9T:WETJB21:TH&74KD+@9$I
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MV"CW&.Z=PL-1 ?>PX>"QX:!?  H @$.$^P?\U@O W8-'0$1"1KF/B@9;4/4
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M36_/&"\Q+3OBKIC1SO[R;3N,.I%5P6H]>!! F18@SRC>$ER;:9BC_9JAR\V
M&V#:*=[^;$XP?REDU\$R_+VRX;<5U=""G;.MHO6YJ8P0IL@])DL6YZ37.6UN
M>B9K)$^=TI_T8JU(.M0_V?8TR+2S\LBU=)J?'2)EX%E]M@W?C8:17_QD,R;R
M_AG/[.!C"RU=06E648THM+QK7RDPAY[^P)<C]QG" ]5VJT_"J)\>11&K,4*!
M1K2-!ZZO.QR0B7:8*C /B*2OH4 0OX/<2&CC'JPDP73#59%T2&V3Q'T.]U]L
M('.LD(!H)O=HXQ5C5&KD78\_H1KPII2BU5+$BB.D?G'=[<2,>\^:-V(@G9_E
M91S)S$GCH^50B=_:<R6Q1'ZFJW4XYMF<S3/PQ?6X0(NGTMCB M=1%IV3'^)\
M@'GI;J&J]^%!OB(I4S7N#!^5C;%/;M+NAX_;.M<E)_R91/F3U6$7QZ=\]#\\
M5R'B(>AX1X?#'R7.^''8#)>OOGK;R^Q:C-"E]-&BIR"DVNNJJO%^?Q(W'**B
MIPPR\822A$0L:?+F9-+9NI/<GPIUVFS;><-8,Y*>Q3H6YT\S13AH:X@^".G0
M#X<L"&GY&\BS8S_#O;+!;TW![*(C$RC.DQ,='+C8<A@+O2OAU*^_NO;)59;$
MU628PAMP;\LT*ZUIB5T9?978/-$:69C?X!^-]#V:'PA--X@=F= HR)U;M$QR
M[3&7E^D/6GIJ?X3?>]OB[.]19%%%E ,%BL0*""??Q_+AK5]!]&]#?,AJCP]>
ME;Z75A1%##373YSCP[G7$RGJB.298I[N$U17@@D2+$[W(%F<TY,+&H^38)GM
M%5YDCQ0W=C@VB=)G$;QMA&SS^]B]JHOU#Z$O5 I(&<^RNY3[5)-V5\B26_ZR
M&(=MH=;GA5,F^/X@HS*FS+$E<7[V<$-EB,Q*D!.IB</]$_2,/$H<Y!JYV;09
MM+S;ACR31*[4<DJC]$^YDKCV7\K:WQ/3M^>C R*!MCNL2KJD.Q^:<GE.H8!?
MC=&8BN1+9SP7RB[%!*F8AJA 73>4M<T*'(ZS8L'V20-%'_ZU^KH/:&_GW[A)
MR7QZB[00+MMC[3>;<K10'X&=/9=&TJPH+%!K(?,\W3U\V?LHQ6NE#&YX?>S4
M8=FLYN:9TZL7UKZ$2S-/[PN%'@*V;B8C#?2\'V_W[8UQ7 ABFSTA=/HP@Q M
MP$('P.TQ"U\@2/+ I\]4'=R?4@=,HY4EE O3\:! =V(1>$H4?(<__CR"^X-7
ME(!C6U\IN%US>?$:"P2^)**X'(8"]PV#P5LBV5!@R12\:LCU%*&&*XOW2+B\
MNTV5?ZR"XQ1PX7%W]]+A"_H&(MA8HTLPNN$Z0$NQG0U=%7[5'+B.&W=R&Q&O
MO>YAHWPB^AX*O"GI:#DE'X$"AYQB1YD0G!9,*/#-2QY6775#@<YFN^KA,Z&^
M=T5[W+MU&[XK6AE^B9D"G81P44.D(S-;]=FG%=)F.0MZLO VB8_\4CH]EGU)
MR;$,G\K?/ ZY 4=.N.GOP<A$_"T9:T7>:W%4[3EV+C2'MPD;+T9$T[UFBV2M
M,G;B1P;(XI(]'&@PJDV#D)R(-H, >W<1;PR^#\.Z0\>(J9.>C.#$4_ MK0\9
M%/AX'@\S=A04"*,XC+UT@P3,&$*0I"$\)^^^G9F5676.LB'F^RMLS)^CDU(D
M$^Y^5?=?L"IXXS_!\#CIZ9MP'N9^;X#,0EN2KA(*/!(^KG=UA@)<VQ&7<K="
M4$!BCPT*P%-# 6*Q9:;#@SODRI9;](A;JXW=,":5RL;PD9WV';1$A_4.&N;B
M*WY"54Y']USYC)U(@Z_FHLD>9&,='*V'[&[DO5+*/[03<0)Y"IF%U1ZB,!);
M4.!O: 18V5=WKK71^\JN$\F1?3I*K=M.<0K1K*P+F6!*9%F7]WB'+=?]1(#,
MWI/42QUL,@)Q53[?L[LZ;WFX;?<WJ&?WV)Z/HF+(=6Y\Z[XOX8 FW4#F$#6D
MXSWQ/E^K#]VMWF:],:9Z2M6""#TX'!>[9\WY#$]LFAN<?LQT8UO?LG]^]F^8
MU[9AQ(5,U&*EI;2^*MKP#,3-' CQ#0<=67A63D;//,U>Z'%"0=)2G>_[*%H0
M&M$9\3V)MT5LC6+6Y<#._"I=^J]#@*\OR_+YG"3"C/>8D\)7X["EER,/[)^$
MFJ8<=7EJ<^NK,EU^-QNUP]F7G(O;@[]/ZM2M9QJ.M68!Z<F\A0*18)M)*)#^
M;[B01%6MKF2]!0W^]W5\XV"CEYSB(EQ[&B22XZHS),&C;/AH_@7H.?/^W;K[
M@?QM0]8NN7=1LG9BW?+"Q>>Y,!F@P%\+,;=UG9KZA??"TV7NH9(#KFIK[PCI
M*BI*SV8X@]FPBPR;<46Z8F/XCE'"DCNA4(09-=VG[+L8Z2N8HT*!?U>$-_6\
MGS&.M15S%J1=J YDR)$P^X8>.43S"]\0&V_''] V6IDX#CGSB6?@]W>,2XG:
MM:>?*U)LW@;<V+;<WMP.9;7\1\^Q^(/52U*E@\XZ["=6I<;0>S_-<%C>^$>+
MTYCPTY![ATGPQGS6G:D:Z$QWP47=X(U=-GN^M%0LTRF!8#(3W6O1E.\C?E+X
M9'P41@/\ES02M@H@G;FW_1%[.RW=$;EB?[,X\X8X_80=LE!P^_;:Z8]>^9_B
M^BH\1*SL,RP>L?X=[*G@9=*)\R^+4S-!T^'48F:OQ8A6P]T1[A"?VF59:OIH
M3G/??+X][&1C1+)C9^C :]U$+A94 YO"+)^>'@6>U0IK2M_P?O0'/Y#^HP5?
M;PD+%94EL$;X*"#C^%E"@09^Y(W5<!3A<QX5%E:SJK@-(0^#!1R$\GR<M\H*
M:0&BIQ,O)/?$NLG=].U@F3?N[Q,\I'NLI6+BYD9T][M-J)X'QGI*BO=WDQ(*
MG6@PUBYO)I^@Y"FUB>Q-G[EAK,>K-6>R(4M#6/AO;L+"TSWBZN(J7>JOPU.P
M;7G>=AU^UN+Z36]O,;&0YDNUT(#6+>FGSQ_'Y/6XD16Z$B@[,-ZG#C0RWL\R
M9=<S#75*$BN'J7MHJ%NLNHSBY.!$-.IOQ0 U5-25UEIY[7H4Y3Q'D^;$-4I+
M(;<DSHX9M=RQCD]75QI$^?<\ #PU!NNWW]]XEAQ3;P_]3>X4I/^'-XK5Y$,!
M*M&4O^72)"/BNR6XO^,G]O\_L1>X"E:GYGND3]><UZ09\-VEF<78.H4N':50
M]#9KE6A?P@*,8^C&#0K,Q/:%]#UZ\CXOVPN<..D_L/FNA%B)P0 *Q YIP[JM
M+Z)O8?4\0)^1D;9!HH;AP"AUOW7.(69O5[8R=@IG6*VSP/S6,:'K51ROI-@[
M0+U5 @B7V )).<2W[S-]S AA#,)5%RK2Z1PT9%Q9?E8[].%CQ>K=<(QBS80U
MZRLMU573@0OC1&(^,<F7&(85J27F)FPVBO+QB89C39*X:L2!N&\"5?O% =.8
MF0KEMY6-D/WE')7QI<!UE3,S!*S!),7O0KR@8?4]MCV[54YM/6G!SQVXUGNB
MP=_&0W11?F'[EQ%TL"=F&O-=5'.&%W(P.-A_LYJBR9-[EWLCA74IY[-X/K#:
M,PL%R),K.A?96NZ<-ZH:%3=@-RL!MS6]]YKM*R9\L:6V1%?'')U>D[PYU"MX
M@JZ-Y<_L6&X3PDM';!5S^_6S!QT=NGBFI?@"("T4B1UO8_/9MEVVCV_#-T+H
MB[EJ?_# 1/<5?/S8RO <*QT*2%99:2B'0($UA8F6[Q1BD/>6(_%'U#NA!6!4
M@]"K@_877VU6R1Y;O5.ESZP/2Y,E9,R;'XOYIFF6>9FI7#?.X\[S"40>@U%9
M)HG@R/E.?1]> %VK@J.''[D&T$R:E/18"M/IT!BIW"VA?3R.IT#GP?@F!<\D
M'*5[D&NRR3O,4VV3S7MZ]GCL4IC'LC3L<^>VB(\GS6#P5SYJ_8JZ\HIQ:^(-
M%CGM3<-*:5PWF58/5:8*1"$UF]F4L8N+\Z3BY,(9;4N-B->/1E>\/MNJPKDP
M2UYT%Z[9=L&+*"%7.=&UUI?KDWCH+#!(9=2[DB7?F3"8V:;;^Z6<K3FH5=EA
MZH$T"ES.DZWZ3+AT*ZO[IV0U\]G-5#$%MOV9"$>S]@C[1@_!GX8%QV,^K&.<
M>E[Q7.] @8'4V_K.V,^6_2Q5:)(WK T@#^8*A3+FSZ2ZIB[S88OLPIC*!F?O
M"O6^KB@*]C@KRDV,S2[,R7)K$LC;N@EG1[_4"UMD(S4-3RCT6_*6J+QDC=X9
M:-Q:^O"%Z$(J1O2+26S7PI*O['GNG#N:6M QX:.DD359YF'A,B&$-U\<'CGN
MU*+M=HM4?%4 #0=HI"UFP.(M]P4V?Q6]75/C0MQ5?*KAB\/$$7#E4LM8,<_9
MES0/)ZH$UZN4VUFGVV?J;*A#B*'7XV_B(W46]&::FJJ6(SV, M"+(;[LA/,C
M'ZL/;=9O=%(YCP?/T9+];,[?AOH91X;Z+D>R=Q_X,QQ=4D%6SB?0A!J8$O;-
MHK$=2$2_1.%64)L]A?>+ZL1T+P([9ZRL;]YYSQ+Z7/5R/9^TN8"4U&5^E+EF
MSAE]/K&G4FQM'C34UW"BVJE)B<2<J#8?1*0J,ZA+JI$>R&;#S>]<@&&H4N'1
M4OGUBQ%K]+/*"!.FAU31F0Y=?>F>ZY\.7;.Y73FSXMJ9^LSK.;G?,&,S='!%
M\W=**XS%D6/9J!ZC>6'8R286XX6Z1RM$?XQ#?-W4YYNUYHMEK*@HHYKT>F31
M6P1<LATOY_)QM0^CNN' KB7WS$3*2@2"4C\:=Z+$]U3S1CG^[A,RQ]4S6V0?
M+!IT^*3QR9)3)BB ,7_I.JKR]"X*P5%'B#'+L=$#Q\9^4<#[BU^E(_^ @RLQ
MPHS_@B+9>*6&AC3.0J^>=$_[DLV"FXE?C>A'M0D?O/HQEQMO)N6&\GJK-R<X
M*PRRH:QST7.V"B:$9L@B]2]B^0V.XV8@AKE+/6$Z*=6AHBQ\VR6[DU:9PV?I
M.!;?K.+B-?DFLJE:HCY9R3Y;8M(-/$EA,$9M!D@=8@)")_D^#> 'V#DA5>5K
MSU6MWS6TE\X7+G'*%9Y4,#Q"6CQXF>:^4G=CB&Q9$U8H?4]J9.OJ9*5G[I*&
M+(#T;L1++: MWLKB0I/O7&/B:$;"]5C&E))FCK+]D\"0@1CQ(+=%NW#*7<N
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M=]H&0"%@IN@V[_KM7OPCH$3]4OZT:.*O5.U_!?2+*P,VYTPO597_;E?>]1%
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M?Z'OPO9D?"_A"962PMO12%DO><T:SB[\YJX7@9H*A$B3D_K5/G&O,W<N5G!
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M(I(7&1FITB[_UKC_+_BN_T+C>O47&I?'ZK]NH/V_1^.2_P>-*TM* !]:L;<
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MY:TA"%X5[CRW\'@!<+V7^M,?WB2G]L]_M+Q;5>7E%IV[L8S_B8^*;,W. Z-
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M00U>D6VIV[I'^LR1/*V'FABVFU*,3X!F//1S-PX@JQO9FE<:N-3=[>-<\!/
M)E3BXLZK(,*#.OZCZ7?&_>ZXP+'A. _*,TV=XR4VF@:O;\F[:B":X&;LPP)4
MHY^R*"ETC3*5BF*DPP_"IYMZ_>]A^B<Q[X*KKY/&AS[_: M_/0I[MVMNOHJ]
M*6<]-\;5\UXDX6P(A-4[0IJGGK9[;A6.A YEYX,<P23:_%N@?'BHGZP,Y/*"
M<Y(_2-)8BXVB[OX*.'074C8/M\5#C4<>K_A%]*4E218Y8!EQ)/%8V!*)<ZOG
MM]1<A>N%3FT,_2K]]>CA5*AS7))15R@.,;N18Z$XLCK*K=_&=IAQMV>=QYA
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M/1D79$@.=W",B J[YF1)#C8RR)>6>*=-7ZI<T9.NR6S6>$Y-:Q#]Q6Y!7&#
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M[T1OK^2N_7"? ),*"D^ ;N?L!\^:Z@?UTB= #].&%\SK X@G_T5;G/1+<:*
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MVFKBQ'PO?E/T-_J!WRW"/Y5S[GP )#[7G!KOBC=M5-8&G XF%4E=:Z2C=YX
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MN:IJ;31-ZT;0"#/C-S83WA482U=YKKT3;Z1 IDBV]-K*/<=(T[@SE2.)$"[
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MV.*Y,<MT>&# +_F$DC492+')E>(;7I5T\D'W!"S"K' >DG)(CI$*D8HVL(=
M?9@L)M]>8V#9*&(BJ%>$8;;R2G53(1VE)8'^"5!/V_0#,G\N0P,)E=R1)L%4
MC<O?(1QP'$6H?!,;9&?><GKI^2F='L!\':9DR!!,+824M A#KO47&+!_3ZH:
MU-^!=7H2RESE3*AYSWCH%K,J_/:3!WZ2MRR,V@!Q(YQ_&RDJ PEE(A"L,6U=
M<72R&0IB/F:Y(NDWKGO;G/PV3:M#]8(LP69BA=9SZPVRX<OG#CQY0:>E9:ZA
M9VI%S+29MU[</H<*RI),N_B99A 0*N&Q$H>P++S3[NEET)"]/X+[ X(@^HXK
MP^5 ^:#U9U8E;D+_-I4Z4;*6P3OE82+'*@0T9'MI&<]8K2;1TRA#F*[TJ.\@
MT"$O4.X.'>#VKL72FPBTR2*_H#)?P5+MO,1R@Z'PRQ6;L!\O>DHV']G:%H>&
MIE,,^S#B N87RKO18'G"?+D$WXKAFYN:[83M:9FITNSX>2K(94X,$4T4"GD+
MVHA 7S@KV/!B[.MG9AP;"JMLT#:%9[#"(VK+L//8 <IB_0"W2TWL#F3BXSH>
M"F)0FOKTT'5*0A^77C])*TPZ^*T4IH1N+;.Z+)O_^[2!F4=2J^M5YAD77=A^
MU780!%2-TL?T_D@*ASBY'H1I&@JY2+1W73?=1FJ;:U<JLER0LW%=4%E^[Y$E
ME?1]P9'1 B'UBS1C02 "):+XH*2&,]Q$::Z)C/> 52*OQ?)<FH1_K_@T/F9Q
MMX['1[2/X*:IB9SX'K\3BHL2I[?,TYY\C@(%1C^4JC</0H;\Q04$J&O,3C^U
M.=G6_5(L=D\PJ2VNFUUFYHK?-1*0=<UF\X3;,6$UT2K'J2&U*T#('W5IO9<E
M\>0/@GH$C(J%!3B:=B[SKL^Q1'HVK\\>VOZ%-AX9+D5$AY38!3=X;DRQKQ"X
M[5AC-_[(847H]I.M].4Z#[Q6HCP7=5U"KZ=F(-?N,R%!!?ST6W\"O%H!U>_G
M*;Y7>&5K'G.MO7VQFZ!%JUA-/LH*_%YK#^_9LA,"N&DT,;BAI>,-E[<DXO5,
M-:I'9"?Y\T/6MY"-H@*QJ-K\#5E2_2Y#HX9?HQT'(@@<S$9L'(N0LFRW@E=V
M?@;?G(O33Q\#4=*F39R<.&4+JB$RF6]'VW>4E%%='A0W1&]EK[P86!-6O= #
M([^]H[O)D24!$?8B1;UR%\9!GD3=;LVL> _N2(-3M39'[TAIZ7]GW*+]@54^
M:^) !$^KI_F6!R+D>%GX39W9_1(IP2?$7NETQZ::_$2A;MHX>?9U,4.LY3>6
M'B52;8SOL8XU@DY-'EW"#"F^V/-@1?,UM5EN.+X^R6"STW51JLWW?GPML>L[
M<^I7L-D^M77OKE==9 ^<%==GHP$]D-SOLB&$B%S#-<@4Q@CXOR_NE1#78+\(
M5.7,"A28\;K9KF'R3P"; !J,5O0%"_IN;=%Y>AB-&>&V2$IP.PY:",E'*PQ=
M00M%KB-H(JP4RXW__!HR2.1M;)C:<O=G',"S>_8I":5RIW=$0)>ING8X',0$
M,>_)+"54F;;OVA%'=IHD'FV[3=SPHM]*T&UKP=V\4- ]2.%"[T*):)&=2#Y\
M$TGSY3NV6"F;,XL<ZS&8C%]'T;FU; TF*51)+-MIJNNJ:1^EMN6!S.1LJ!KC
M>K-1.?>;93D4'0P8\]S$.-B*T4U.+6 X7Z=4-PYT,>3>9H<U60$\F?\7NH^?
M_LG<S<[1AAZJWMU\'@PG'9[>R@BY(-GUR<?X6:-+1(EG)?T?>'V*%+B5&1O.
M@5]^4+)VF85WD=X _5$ (O_ ,#%*H[&??/%JM(PL?YD/!>COL"\K=$_L\U_(
M*+2AFM^<]5WV%%]KULSJ+ :\A^H5%%$[1</D!ERS.L*F_;DM2RIMX2>5)JUU
M64SI'IK.CCT;4X,E-(&,.O\3T?9__3#R/.>R4M%EP]TYVG^DZ']-6/^93 KQ
MW]F&/H;]D?=K%4T2^1<EJ5N>[]?V6^%AD7)Z I#7/0%:O^K\.Y/L[<W7A/SF
MYR^X_K.@^F?&S/>[O8W=7YLN^%=K_!, [V),=7,\L\B]Y7*A+FF]*:Z;9]*>
MMX;?FE4 $*LSG\DPYQK8DJ0SNU^P"W>:W,^+@,S^8QX>TWQ&7FE5\<'FR/9*
MUJ*U-4H;ZO'RL!99S$T>PM$L<-_W\!@4,]#R@T?X]<?Q7$%N#OU#S<\O;+W!
MNIK1>O)N#F!"F*!I@IRM/3_@C;,=D2);F'G++&7_7&N/C@"ME#DG1%T<%H=.
M8X<<*(.:&SG@2]6L]9&<I$[T:U/RX9IO12_'A^$JPU>9%=Y]4-1UCR$]I\+R
MID#N$0B;R];&O6 ZJEK@YF4W"8SKV.SEV/!K,&2 *U0X6J^F<XJ-3;$R EHO
M3@!)17SCOHSZA?Q]]7 +4@P*P)@MIFK72A?F\VZEP:NML[97<.VH>0T"[-W9
M(M(8($U@MT?@CZ @M-+T=&E?\-1[KZLO8^/QE:KM7D$.29$8DH!$'.Q31W^G
M@%F[%^-,:XB@LSI6/BXD@#77#MI=;0XP )(@VCI!#$R0Z$BK!%6KKY30P%FI
MP-^KB2 D;D4SZA6)0'5-S&_!5Q)3U1@+=F" TJ;2:[F-V^VEXO0A UHKV63]
M(@_,B*BPH":2R;V,Z&7O]HO6E*@KP:&')P"F= *,NS$<:<(1CRG8ZUO\HN_.
M#]*6V"H IAB$:)^' M?=%;WR&'S ;&,6<6A6JS"T?@%,YIQ*Q!GU-4E@1__2
MAHD 5+6Y8D/K9DG^D6@YG\*"KVA37-]+6E88-$ @M.U]2X-T8D(ZB6*(<QNK
MU?PS%$NGYTU#:VM;(!1NZ\3$K2*"].$58U6?-;NC[^>X%_S=Y&RS1]ZJE8HN
M[ZJ%8Y*;^+C$3J%_,N%;F( F*/()I8NR&U[.ZPS;CU<R?8]833-;G39V$A'C
M3"DQ@D%N+P<2XQ1*K-<%,.7(/ 1^:=C /OV</SXJF"80N-S53M VCBJ_&^Z"
M!.-)VQ\NO502%A\"[#4\UX"';C5W.!L+3;.%S;(L*NLKNC!Y;?UQLRPH+S)Z
M.I6);>D$G4WGK0(89.IEI4BAY#7"GZ9[F:B)@?^5+.7&EL9FCWX)FP8V<&0.
M9GD@VO#2%SD<6.CU_,#KENX[8T<6I4!Z_TG3,Z37Z)QKNB"[IX.\I:$>W#+I
M/%1Y],F&*F&<5\'O!C^*37R&C!X)D8W$ZNUT']0B#+X-;FOF;714*OF1N7T>
MU>*,R_X!6O$")9V&1%:@+,[]0I.EW,#/7$?!K+!LR#>V!'UUF3&>ND>H<_5A
M"B(>UX<S AFQ.0[)+'%QL$$W^SY:N1,51EGJ\#B%''7535VBN&&'LVS0[2$2
M4C3B8L>6B7EB0>1> +$Y[#/E%1,@W59&X\&)NM+RG::>GK^>4%IA@>_,G0_2
M1RW+_XCA#L-6-Z9#+B:1WG0$/?<*G3.;NDO.5AHS52@+2Z;Z,C>C1J':V+=1
M[GIW'^Q'I3T 9_KV,\P$ OD$&MUT)&:?\3;%$^Q[2<]'/8X'Y\LH,-R]#U^O
M96(H\J50!=^@CHMR*JN5+B\.#2=@>^'1(V6WGO&%2Q?:&$&EHC,'H94Z1CRO
M*7DOB%"YMO^<&EN7;!61;F]TL)U]JLU;_C4%:K6Y.M3=+W7"GU^S@(&H^(C<
M+O05<.(_ >R:W?>R^H_@ILT7VXTANW=^[E.!:PRT'M?,BY?+/I;)P_-^@A.-
MH4H-'ZC2O8WNXB_.>3VK1Y?)14Q^B9'NEFZISSCS==X3#Q\X>2'XZP'\IK8R
M+S)<O@"V&A\N8KZ0,R_8G!"3*8G5![#L!-@6A*F"7('CN"]Q@'9&3LUD.9@V
MK')(+@\">7*ERX=L^2"XCPMNZ.8^-#?9$O+R\QJ161<2\A9 ?8BYTLP"9)/K
M1*6RDX_FH)HT485#,^W/7WP;5"IN9^,D$O1U_G=(Y!IH$TN9NR[OSEU3E3C8
MF%:I=3QGFV!?22'W,&5AVD#7BH#W6C,Y)C<!NK\L/3Q,I"5(3:$L_GGF)TMG
M2+LHR,W!Q2H75+.LSV$5GE\?;6#\2<X<B=EI0OB7W)=P6@\5;FW@P,U+!&OG
MH9/_9JO%Q+UHX/@)("/;<,G&N2).WXM"R1S1MQT_B3D_AH^P-[3^QP#VZ7NO
M7Z6<"W8JZ?RFOKD&WE> "'PI$47NQ7?1UNT'L/%"]\*,OI@+F:0N[K)/Z8FK
M%1?;V&X00+\.RY]!2"9JW7;,C5L9+;/ @#==7)'3BV2G WHQ5%)YJ4#$8KO6
M1NBS$5R!RAL,,.5#+.XXW:TM#HOH4;12GBG0]6#=T-</&1T5FJ*,T(S_:)J(
M\:HJ,IC*(0''2PK@T;KO2ZV>[-HPAY5?(&_S5O6S]R33J'=V@T?0'LI4I$=&
ME::'4 ;<3OD],L'(9JE+I+Z(V.[P'/@*G(44_]BZ4RS.<2@1#J0DEW0AKW_^
MN<$@XX6=N8H&N,SGMN35\8&9SS]!%D[T+0D(%$L_XK!7(!>O[!T/7X90:N9/
M_0?FJCV-+*2Y1*G)!!L[386"& RO;%9+8UY[]*$$0BBWBEJ-U!!KKR5CU_9"
MWD+V@0C?PC%WNMQ;J<:?^LG)Y_IR?MOM3:]U^RGMF#](%!V(&6.+#;U<9@#8
M=(:X_(JD$%7NF*?IU+;>5(_4<#&DPV49@E8WU*JRC?H:B9E2U7P55I)<R-6V
M28 9=C9&FRKR5(#K,;IVPO$^G7 VE \CM(U2TIAY[%[<GF@:-A ^"-M1'YR&
M\V"UQJ/@9#)+?4%EEO5SU"+@"$0?Q[(\6&5N]M'PX=*I!=>U-X:""EZMIN;#
MB'N6-$PEI.GT$O*1W2#<""-Z!X_TDY5&<W[@:N"\;35-;5--6QL;@DQ4D02B
M../VZ*ACO_&7.*9I[GNE&E#C=2"H2NC;O"BO!\;0.U0^+G(Y82>]Z,Y8'K3(
M>XE?XC%D5$"MPE0[A7&R/&W4Q6!WLQ&4(7NGQ";"T>@M??D58P4X^1!=9S1P
M1H-,638A+)Z&W(IP,&6T] ;9_V%Q",".9B;E,=OYRL7GO=>][D\J6S!5"3<'
M%,9]\ZJ76!?6YGN.X1:W4P19(3P4IT1(EMMBT7W$0RA9I=V)B2:KX/0)EZ@H
MC'+#$TTEC4-#NY$2P^YT42*B]A>FCMBT>S I :U9).K510PYVDH<I 7J$WW1
M*G0D,J"U6Z=P"G2XN&;7>I"<LS,R,\0837%4P'?]Q0>MW+#?(P*]:XQ%=J%2
MOSU(?&X<&S1)LSCFCH')\S"IVGN7".ZT8*>OH?SYRD<Y?8^?+SA?9:<J8T;%
MI]47W(X>0C</.+206V/DB/<]-H)Y-R2E6,5ZB?@&_;%%Y[^DCVPCE?Q7]/HR
MOC2ST&(!1?D!Z-EGM;)EB3H4 5MIF3>>I:M*/ V:3E"=G]MGW:V"SB[22:%'
M].:4F%F<GQB*9EI?RY5S!AN0GC:<*Y(2\\;2P)ICS!2TPJ,;0Z%=V-CSJD%+
M 2<J?CUT&VN_ :#L6S2*6\W,E5N+?A'\IH2CU?X2WEH'.[)[D ,X(\^\%1/(
M>L%[=!>+K<:*/X .S69I:U,T>%L;="_:-U0TX>QZX ?+/ICXEE%[\5REM+1]
MP=C#:5UMP_*2NS'UXO=C%,R^_? @^ 00P^)Z @"VG@ O94ZSPS[81*-]/'@"
MB#@\ 4(<#C;6"-[KK2AXE3-_7I(A:TSC>;,*L2T$X1:BI0?8[0R0-B)17$5U
MR=.^UXS(G8:>]/[R,V/\:-Q4.^]" >:4H@[V -IQ]%K;TRKKC\^9H;C!T1JR
M7<F'*89CRMA>NKOW!.^_MW6-O7..?6# "?5F;WJ!9 E53IW+-.&=.C930: T
MB<-@56J^JGJW('Z6&1O%TAXY<M=PFXK'5&R>)DI)3V**Y9F;765X=+0D@'P]
M<UH56]Z]";,:^2.JZ2]9K(2U,I!;6CCKM"P41S99$A_!<+Z\SBQ)XBL^23[M
ML^A%[\?(!V]@>V&@X$"6E9JO1-N0I?8+'Y<C_!1['N!=C$Q*H9/]B"N*_028
MQ%!\ G1]>#;1=M'I?'YQ*87Q@MV1^<^?6;J*?#J6YJOG0?CI4/<G@%N-* 0(
MX K\'+Z<MDHP)21E[F+UTTFM)>UZ@RIB7L "3QQ=U[V771T).-+I0&E!BC(T
M!*=;":L/.\__M-631:[K@3YYN2Z1@?LU>T.^@^AT9/CL771A0_R6)X;ED-[E
M<T]910\BIZ4 \39Z_LGSLVC5]VG2U>Z88TM_88)V8CC"0CSZIM,5X4N/"\%E
M)(N;=$>*"G@2/-A@Y8^:[5(F*3P5.TSCX/:C'/#@/YV Y#!)+UQP7W-M_ZCF
M_ 18),=_?4?W<5IHC6OX_.';C1VLTY9CP9(E]I.GRK*[5\]\()=+(8C]A:E6
M/J<X\8DK_TM. ;J:$[TT=R6M5+C=%3T8!]SKN<#,PD,J0MP=M\5:<@2$^G<B
M96^P9-H(*BVH=B5K;#+!?,19Q>,MVBV^Y\1MUS=,7Y'"+R@ 6XO_XI'GJ.1]
M FR\/KWY [@\^1_4O6547-_3+M@XP>G@+DUP@KL3/&B"-A;<&G>7X-Y $R1
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M\-Z._\4^$.O'8\4PZQE -VWBRX_I4K/^YANB*L )O OZO8")VY4>,%&&.19
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MTLC3,IQRANZ"IE9W_^OCXZJO;P0<,3(]*@5%P#,_8#6W85\-6#&+&1O<DO)
M\-$I8"UZ_)*'O1\7>4-R[=YJ7)DD&J'G5@Y>.:RCV):HI2 \L_QP@?$MU#LO
M7L13X=/RG9P =_]T/^FR3[$.1EZRNI$M/^RW6$7.%K:#,<[JBNT(?H@:@2%Q
M=1R!:-^^AYS_09.Z2^YP;#-J.]59?P9EUG0?Z 8HREVG&>-+NK?XGME4B;8;
MNY-8@DF(=#B1.M^KI$>WI3EZ]3;V!:V]P-E7SI[7Z2&HZ[^..+W/C@%"(L\
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M%6.A<]YZUB%#)WS(AYL1H;J7/@LW_56,LZU>BQ#MO3MOX2L[.^5=^XM4Z",
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M,ZXM+X1%9>[:#]'2*7X[GW\I"8TSETGK34!!V[1F*>_R7L9$9>NFD;Q314S
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MGK:J9B-N?>2KDQ'?;M,%PAM-SBLO+?SGNK5OW^[6W81.XIU;.M7V>27S?;T
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MBWE'Q4=N6@\^*_=MBF3D*11.HJ+!@,-,.O(_/ILHQ.WNM,\F)WD)(6H+MDY
MB)MO+7%(PD]2W"J?#M9@6H68X;::9[S5KDNP94G9@GRRC+@/[SSS*^74" DG
M_QGZ4RKN876APKP/Z:4(MQ7D=)&FIM35B'5G3M*$T0IU8 AQ,7*MNE. QA'
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MB 7Q93M<ZHPS,;^VTJ-\1NUN3BPO1RUPZ")!ZMM*#DXPY(E_=KGK[]QY;Y9
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M2N6(.NLJCAX!';4KZEV4M.]@+S4[Y$0K;?[^(8E%H^,B7@:U[U@>3]NC#TB
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M;"UOJ&#]1I#4&3W$\6T:16?KVAIC+4X1^D_+\A/426*WN:EBBCA<NP*%8U.
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MP3<P@J_6SQT_-_<F19:J/=5<FE,6\"YQTPL9K>?[<V5GBBP_)X8&)8-(8VY
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MSG!SE1C)W),.)4@TM70;A5'FEPHZ($E.YQ=NR>6XICA>[N>FSWR^,\W]_Z8
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MW\\J<N)%YQ4A(@YAPC@S[KKDM@/<3=_2>2I@K[B27OJ4+YSU0E_T3<'\"HB
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M-&N-M^GGQ[>C'XR> +L%56)OGP"%?S;"^_-?;P0OX9_JIOB'(509N&^_()\
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M-T4N70G9[2)P5YJC,5QTABT!-S]^+,YNOES>6$Y9<6=<+:.9X46DY2QFWA/
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M%$OEEON]P!W<7&_Y!( D;8W08?1)9ED^7':V&\C?<%V!5[4%H9<U)U^#5)X
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M8ZA6E68!O&W3N=HQ\DOK>%SC2HFXCGO:#AY2TM"9CGJ3AK0QM*.P*]5Z]KI
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M%R#94!7T:8Z':)>64+>0)&J:PBV^KVG>??Q,]Y2N1FI+OVZ;IK9G.^I=6"B
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M>G;1FRE5S!"2LA:DKWZ6R-QE7K3+M%MLQ*T*Y^QZU2L+M!\9!JD1IJ'MW(U
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M9/]Y%:@:P7!%,>6233K!%# NN,HI(6//(9_8Y&#]/-VO<&GO;&F5LCD&+^Z
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MLS"*]ZC@+%JB/30J27%^\<OUBQP<C%\QW/\G4HB+ 2NY05S1\B&Z[WYW@C+
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M\1. 07[#I? GX?<3\ ?C5^K@$^QS<]<B*'WU)P P5T,^T$7V^4;L%?JYMTN
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M!H"X)*;GA"1:H4' \YK'07[2S<>#0/W'/ M(GQ#1PA?.H#ZTQ6/5R=:..A2
ME7T-J,2SZ6BY%@W=']MANH)<OS;6N\X8D-F5M0Z1)N#)S1H@[?=/_@FPVQ<
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MCV/2Y/:6%C4U_2SF_$+W=#.&8I5@F'KXS$3Q25TW1H2[!!E7ID0_$:XIO#U
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M'6N!:^B3<%L833@_( %$;2F_Q#H6#TOIWHT!H M:/K5[Y8^Y^'!K^MX;[>-
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M.)6089)"AA1.52(9\XN<<AQW:IYI"[MQF3K@3>..#CKXO0/O&5/E.A5N*CL
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MV+BN1$&4XQC2B.8P(2P7&68TCJ5S;:_A<$YM*=<";E)%;)/5.CVYANI1TVK
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MO&GCB]I2X+<+6=<1;/(>9[%,(Z)8!'.&$42*IY#%QAE(29J3*&5:"\\>*/V
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M@B0BSR@7U.OP[\Q8DW.<+#80^XG".2[=9"$00P,+PU80;D #] :TA VPD^O
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M.U(1]AS\TJ#CGHT[4G!P7NYZW14+GELARK62.T-U+2\H3LUW)\IM]D,=^I)
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M37>4C'P+?WJCF)Y@-_I2-J9X%PCUGP8WH1F8VJ%/8]I*"GJODL(?^Y44-C:
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M+0<)WNP#8L!FQ0?"7K!)\;')_<V)3UP?FWS3+A>WI?Q-+D5.D0$&%AI@0DK
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MJZ+R6T#UR)@:[71J9?>N-$4;G+"P6H.-Z]6GK-X1^7&GH/5CF"L!&YA0/NZ
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M:$L*N\.0>O.:U]:3@+DI=*D00,8.%^9( R99[LZQ!505*\H<79,^>TF!J1T
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MJ_;V"VZ"!CK5(X+Q/0>@GW*'@75@,DV$:%#@?AA(5T?Q>XH;+:0_S/S#^/[
M.^-<T#_TY@VO?WQ>KW[.E5:O'_^LM?JP_'3O>OI8\KNUI/>SZ=TY@\@(#BD!
M3!028$P1H(CF@)NJX+A02*"@!L'^HH.(:83Z2E;S3%K5L_M.=[<]N=KJG?&=
MXF'.8L!8^+F#PR \,$<Y<)W6V><#<%\YS;/Y\K=LIWQV>QGF8(\N'+&D/EN
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MB@)C@"M4 :X9!=P4I1$E9SD)VJ\_(V=J_NA'O;38U9G15Q7:V>,8LZ45A<[
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M^6?=O7&5XKD2T+4XAA7 FE6 $EP EZFL<\2(8$$%%P^>/;5/U:IF_QN84WP
ME=_'&0G P)]F:_L 7^8)<].F]!X\?]R<W6/#CI)R3UP2]T6ZV7RM?]@)??Y3
M?VC.-?_0FT_F&_\U(ZB$!<D-R"F# #,BK<?([<1J8&XT5:4Q0>&#/;*"OMC1
M@@;EH<+=J6_85]P'K]]7G0BT@;_R)UIF'[KS\8_N?/PF<X4!5L8EJ]QDMYO-
M>BX>-DW!T<W*+C[25N/W@"LI2_3)&Y4U/ Q_SB(^MR0M3K)K_')0$$,P40AE
M.%"X9 !SR0#G)@<50X44.894I2A.<D+TU#CG9'&25P_;^AEFUU$I<9F24Z/B
MZ7$,@O70#DE_F9)]XZH1RY3T(#9&F9)3XJ=0IJ0'%L\R)7U/B*.V)GCZ!'.Z
MN6[+GFW!)_OSM>:U?JO;_]Z*>K.VW^X,VU5/CJH*0*IS@"G20% E09DSB0BG
MN$!!)\G7JS2U!5.;6W#*_>J"[OXCC/D2#)H?(XX[% ,S93L*GJY=]M?6@H1K
MO'1P)J71!&J-2J_I8'Q.NPF?'%DXWAT[?ZCK!ZW>/JS;NJ!66AM0V)Y9U_/5
M\I,Y.+_^JJ6]M/%SD!"%Y @!5A4%P 7A0.00@9)6)::D8I2&]7&Z2IVIT7 ;
M]M&:D[7V=&4G;[IPW&W\B#/*$<&!6=G>KL 2]-<-J1]1CS=00Q_X#CU&X>7L
MDT";MLS]=2J-6_X^"7Q'9?'3/#5VDW%]OW)Q(BZD:/_4;G>;0UX80Q4PPN4)
M&EP @84&5)8N44CBRA0A'-PK;6H4NU,V4RXRKX[DS'Z$?7<:$^$V^%[C%K(F
MF'&OZ0"'#%Z8)-Y0[),X\I:BA_''FXH^-\7QR'L^7_\OOGC0;^>UM.O A_5A
M3QJJ!!64V'5T :%=5LL<"&TQ5EH;7L*2V_\/X9%>:5/C$:=LUFB;_6[=:ZOK
M7=^^>@2\?B22#+2!2>0 KP--!VKPXP5*4A;IES@JBW@9_YQ%_&Z*KIW2]*3_
MS!_=*=2;KBEVA8D2KNVC0B5QH<$EH)SFH%1<*9WG"H>FQYX6%/(1C),'N]4S
MNV\5#:Z-<@I./[JX'J*!>6*'3:>A74RE;B#>CT'J\B:G1(U=SZ3'W!,%3/JN
MCDT%NU]K.6]"&.W?%[J)95RJV[N57?G\NPTI)JS40O <<)B7 !>4 *JE115+
MI&0!N:SR,#[P$3L]=CC4NBG\PP_4#4W6\L"=(8-<H0*@&S=.5A*P@E8 %A(+
M),L<LL \N[2HCY-,-R[F?F2=&LF!J?M0W9MLIW"#YZT/GA&9;/X )4Y7\Q \
M<DZ:/Q3'B6<!]UZYDKRM:[VINR63^K3\XE:LZZX"P>'BLM"Z+%D!#"VE926J
M 666FG0IB<B-@O;_HA:7G@I,C:$.:Y3SQH3LKK,AXYO,N.75SV9YY;ZX;+VU
MJJFB$KBY%3Q8@4O5 89@M-7K3=9JOUWU*X?WSH"F0$H]:'_O6!2'6>[Z*O$R
M*^! B,XNBD.?$YU;([56]7MKT,&I@-O7FPFI!2D5 [ DN76.2]?) C) -*XX
MI';AC(-J^_7(FAKS;57-W$ _.4QSV@;GX)R%V(_$$@$W,%]%8A:3K7,)C=2Y
M.V?EC9W)<\GP$WD]%V^)WF!K.R!J=2X^9'OTIPD3D@K H.MX4>0,, D+8-=[
M.2I5Q331(33B+7EJI'*@>'8J[,K%TP1ORWD.@O=.77IHA]Z\^_3FPYF,@P'.
M"H,12KVUYRE][-V^,%!.;  &/B".M)['IWU8?K"<N+1#[H**I""T$CD%C!,%
M,'19"L@80"I<T:H0QHABMM3?G9I^5-4KS^L;8NTW="AUN$_I0+DP'NK'U8][
MKL=J'+[9ZIF]VFKZ6S9?9C[8!;.-%R9)&:9?XJBLXF7\<R;QN^F*K(!V6383
MN8%0TPHH;## V"C C#! X]+^I[)_Y.'A_>VSI^:VM*Y*N_\3$9'? >9' I$P
M#/S)MPC<]B,0%_?^U-;T >S=\\>/1']JV,F0\F>71)00>ZM_ZL7JOJMROHV$
M4PP+*' %H,P1P!46@+JH0X(@1HQB6KE6Z)[UOTZ*F-HG^LY1'&C*LF0'"KOB
M^YZ?; ^<_5]N&I &/R5ZBDE,ZZHS[YI_A:JK01JIO%0X6&$EH7IQZ*WG=/K.
M\8HQ]6K^I))2_Y7151SN5LLFQONHE/:LP@IR4VA0*E( +!@#%CH!#"',L+SD
MN,C#XJO/"YL:^W7MN1ME]_D0!PH'EW,XCS.75:5+94#)D ;8OJ&NK*0" FF<
M0RBX@2@L8"05TN,$BG18URW6)YHHO)IO>RL$5AWOA=W/>TP%Y<"S4?S[&E,I
MXR(BJ4MEG!<X=JV,BZ:?*)9Q^9XX]OZVYLO:6#:\7:JO>OUS[A+6/YDN=YTO
M#II^?[,2ZM._>KNZX_/E3'$F:(XA($5EV1YJ""P=&8 *19$I2Z9-%<+V*96;
MVNRPT_1I7_56V<!F]$D'T8_37FIH!N; R%$))L AX$M*F$D5')5@AX#V.2$/
M(B/6_:XWG\P_5RNU5T;77U<+-2/6#2PHKH!I-ARXL,ZW5O9O#!4,500+;$*=
MPG/"IN@2UDU]B/O#6J6AOM]9;$T))2^5!J*2'. 28>MKJPK TG"MM11$!YT>
MIT%VG&5-BVN#IT57_YRO'NK%X[:]K<IXG7WY;_SN_G^\30:WKZ.= L3!W>P6
MOT;-)B!XJVCF-$WI9%]"([&+?5;<R [V);./W>N+=\1Q\Q?]4R\?=+TKY&-7
MXH:Y+6"$(0-8V&4ZSYG]HRJ)*!$K827#&/FYB.GQ\%;#P+))1]CY4< U> S\
MX6]5&Z1:T3F[DW[B1T)&_;#/F?C\<SY[78K>76WIBKGLRLQ_6-HI5]>;F9(4
M00)=@5I2 5Q1#5A.#1 DQYA*1*NPQGY>4J?F&APU>-KJO>WS<)-M5;^FT]:Y
M,?!CB.3(#GY(=#VH5_;%N@#2@-VOSDE^P1Y7%\#H[V1UZ>8!"I%]L<]?S^5&
MJ^:RIC%&4Q[M_6IM]'SCTMMG7"@B42& TLHN9R#2@!<Y!UQ"P4M,.6%!YS17
M:S0U:G.VV 5\DW.TWNG?'CADW%G0]L&([,-\_0A"Q4U1(>M+$F27^(H)('3!
M[&<FC/U)R7-9AKF6HX[A.+YH6[!LWA8L4VW!LONN8%G='7B<'MUV<.W@F[U]
M\8=*UP^WWUPWZA ./ _Z%)O;F]2UC>SZ2G6E0@\,&ZGD7 C&XU6=\])J.H7G
M0D ,JCT7]."(.+!M 8FUEGK^TR4!.,O7JT>^:,I%$I)3:'(!.&1VT8 A!Y0I
MR]GV"ZB08L1MT/I&A%T0-K4)=5?<9*]OFZ'5:OSH"L(TN^0!L5"7\.XGS=0H
M#LR'%P#T#I;W0BX@GBPA@B-%EMW>M4"JA^<(WF1_SS<_["R_6NKL4?.UFT4V
M/W0F^*+Q!NL?VDXMRA4$?+5:-[]:KM9W?)&MK%]A];:3E'R4KG;/WS_F\H>V
M?H[U/[+%:OE=KW]SWD3VO=D(MG^IM_O UJ^0BX<F;F6SYDH?#'']FQ7"-]D/
M_M-JH?4R4WHQMT]UV=?V$:Y_LM7W0!$[&O9K=HJ+AWJ^U'7]CT01<YXCW1L[
M=^D9XT71>5KS))[.]Y[().@'L9C+/S?S15/&<)LQ\.B.%+O#>JTQ@II(Z_"C
M$F">$^O_DQQ4U-"R0+@L%0[*A;XH<FKSR$[%R-@)#Y#]?.VTT T\>02@%IX(
M[0U$VGSHRV+'38OVAN$H.]K_SNCJ"G9VVCQ^MN_$YG:IWOW7P[P)"MZ7,:FT
MS#&%!!!*#<!51=O62,AP%[:;$TB"-H0NBYP:L1Q6F;GOM&^.:_56];C&IY>0
M]V2;I'@.S#9;96^R1MT&Q9W"@U:(\8<I=6V&2V+'+M'@"<.)2@V^=T;N77>?
MV2?SCJ^7UN6M[0J]69Z_G2\>-JZ=4AO^^F;!Z[IY52PY00@-+X"%(@=8.Z\G
MYQ@P+C$298[*W&O=?(4.4V:KK1%N>ZS=&KO).D-N7,.Q+M"[,<8='FW7&M_^
M7K4_S'[7FQ\KU7V9@0Y5S(!Z[F8..TQ#[U^^Q B%[V;&8YQV_S)"CW%W+..!
M.MJCO.)1T04G5G?ZZX9OFE+M']UKX0H>MNN=4J-"FE( 81"WBTH# 7>=,1@R
MROX*PUP'^7Z]TJ9&I%V3L9VVV5;=R/5E/]1^Q)<,P,%7E='8Q=2@N(Q)ZAH4
M/1+'KD%QV?@3-2@\;HHEE)^ZWC3[]2?*Y\\*7.D""@A*+%U9"JD )Q4"98GL
M*E-P5<J@5F?]XJ9'*3MM;[*3S1]"*:47;%].207A"%M5D>A%D(H/*(E9I5?D
MR+3B8_XQKWC=%9G>PNL?[Q>KO_^P%MB_MK)<3]VE.M%?=R]V%S8LM98PIQ@@
MY!K>YD8"FFL!%!*2$4556;*@1(TK%9H:.7U]N+]?-!,"7V1JIZY;I2Q72] T
M!9]OC6QV;DXU P\,[KYZ5/TX;LRQ&I@%FZ[ASI:;K+,F^_!D5$[U#C_@R$&"
MSE/AFS8/Y5JEQLU6203A44Y+JN<F/F'X0V]FE$I-A%! 02$!9@4!7&$-4$DT
MJ2#+"U<(:64)Z<JS!2LLB&YW(H>D6]&(271LX."\\L @$*27/"IH OE&.!PX
M@&2<8P$G<!H' @>F>Q\%'-YS10G#SVM]S^?J79M&NNWE99>'1:FLPP9A90"6
M' -A" 6,PKQD1.9*!55[/R]J:IY96][OOE5UFUT;4^KP-+!^M)$&KH%)HT6J
MTS+KU!R@6]IE,-)72CPM;OS"B;UFGZRCV'_'%43Q<<Y%%QOAW)ON?8;$VB94
M"0S)F=NU%H!+;ET+S7!>E?;_PXK/G!<U3:)P(87 BKO+%GNE(]CB-+H!;'$U
M9J.PQ8&6[9)J$++HQ2(]69P6-SY9])I]DBSZ[T@6>]\5 VEJ5VQ6<K6PU[N.
MT:MU/<LY5))! UAN2H!%P0''2@&B*4884@2EUTY1G/BID<K9\/(G]51<4X,G
M9EP=<]XW0OTD-#SN Q/3%"&_.O _$?1CI0(D'H(4 ?4>"$:$V/<]]:6#[CTL
M]@C#]WE*;-'$IOW9XT%%QEMI5\-KK6:YRJM*& H(K[@K! &M!PHYR#5F>6[?
M/\J""D'TR)K:E-&F7%JOWS[P1U/T.RX9N@]>/S\T$6@#\_U6R^<E5[>JIBPW
M>!&/Q-4#S\L;N1C@1<./:_M=ON7J4->[^\7J4>NNUE0CI2F3[SH,V=5R,\O=
M+A9=B,8G\T7+U??E_-]:M?FKKF15%SM9( 5)CA' 6AI7B:ZR#BQ7@$I=8@XU
M)*R,#(9-I^7DJ,K9 D1#4ETMCNQVO;:7Z':C^=VNF-U296_X_7S#%\ZPFZS-
M%KPZ-C;A&^#'B2\^K@.SZ?!#>DTP;7K(APJW3:CI2P7DI@>[)V1W &$I"I5]
MG"_UAXV^JV<X)R672H&<FB9;(@?,$.N1*BD)ED3B*BA'](R<J5'\L[I9V5].
MTZQ1-9"USP'KQ[L)X!J8.:.0NK*DV!$. Q81V\MZP;)A1P;W%PH[OCR.%)YG
M%.PBJ PI.*/,52&E"F")C-OM9$!KBK'10K(J*"3WG*"IT8(K!31OX]3O];HM
MWQ08O7864S]"2('4P(QPG)\T2/S8)222<L)98:.2PB63G[/"Q>L3QV?]<[VJ
MK<N@M"9<:U!0+@"NH%U3,I4#FN>($X.AX4$)EOWBID81G\]D>W]?!W?"OH"S
M'V&D0V]@VK@0O/7/7OS2A6\]@66< *Y6Y#1"N)Z8[QW$]?2N,%91>CY[VQW0
M_#\/?&T_TL7C%WV_6F]F A6:&D( HM@Y&X4&M((::%3DR@A&B5^N=H^,J?''
M5LULIV?6*NK''7UH]A-&(HR&7FX$P^--#1X G."#6LM_?%_]_._V[I8*[%\:
M!FB^_;YGCO+!>QBU_<I]+HUV&*36JGYOU?K*W<;'[4\^7[AMB_>KM?O)5RT?
MUFTTN5W)S(R"A$!& "T4 9B4$# ""\ *S24IA$:(![H000I,C12V^K?'R7=\
MT^GJ$FWN^/I?>M,<-M<[(X(=C;#Q\78]!D-]>&?D '"GJH.ZV>O8ZWR3[>P!
M9K4&[K XJ8<2A5YJGR5,B;&]F"B(3O@U<<\)]W3>+3?SS6-O7]!<Z;R@K !0
M5](Z/;H$3&(*BJ+0$C-8">-50<%/W-2HKM5X6\3DR>%V>/M;3\0O.T9I<1QZ
M ^9*"(,\)G]DHIPGC\>/YD?YFWKH4@7<%=_$S_6>ZHXH]TV/<J@J1',)#,0Y
MP$W#.:0%8!71+$<<HCRP8=0Y42$O_SC%^C_M*NAN<U]"LXS/H>KG^Z1 :F":
M:%1LMUDZ)8?)\[V 1/(^<B>%C=Y%KL_D4SWD>J^//]/=.R[/79H_EVO=QC!\
M7-7UYU4]=T?,?SS<";W^9+;_KF=2%@7*!0&%=*6"2T0!KR %><4I+K5".0E:
MBR71:FI>2ZN@6R,LK-K9_5;/\+/BZP?,CZ!&'X:A-X8NK\UNLKU9F;,KVQIR
MD^T'\//%L8LZO4Z&=?*S[NLU&_UD/!F8I\[1TST\CK:[>!^M3H<#=9/$3 H&
MRXHH0&') -:\ AQ3"7*%D"9%"4D9%)GC)W9JQ'L8N"</U-VZ?6$$[ F]'\.F
M!W1@"O4-@DQ'C&$0)64^3]&C4EL8',^Y*_#NB+3(+]O>%%^:7!FM=M379<LT
M[;:AHI!KR8&DKE^\H3G@JJ@ TXP3! M"D']C(B^14R.EG=+95NLG#D:G>7_'
M[ECT^[EI&$P'YJ67A#,@A3$YK".E+:: -RQ5,0BIWO1$OR>-EY(89-F3-,2P
M.V-W"I<_]7HSMQ[M4T?W=^UDS9#6)->H $@1ZU+F4 -*[5)?"9-;+U.5R@2%
M=5Z0-S7:/E#W^5%?Z-YA/\Z^6XC)T!M\)_$L<-E?K;9)-Q2]<$F\K]@O<^3M
M12\ CG<9_6Z+< RW&2TKT_B>XBB%9;^*J%V)U^:''Y;W#YOZXRXC(N>Y,MAP
M ''AFA!C"AAB')BR<K%>A=#2*_DYF493XZ?#)A"':[5#NPX7;'6VLRQK38O(
M8TDWOAZ>Z=BC-O2"^G_O 0OP?<<>N)%<XT/TFW:;*48T5:)H<N![/>TD@L9S
MQ%/B\L1/3_K@^$CI]_-:\D6;!/K>_JR>53K/I<'694=E!;"=,0&'UIE!%$IH
M/7M!"Z\2=KU2IC8E[L*!6TV[GNY9HVMXP/0QJ/US5C*HACX;BT$I*F[Z+ I7
M14X?/W7TV.FSAIV*GCY_<<RFZ]<_OWR]Y4OUV?Z-NR[SVV6DHJHHE1( 584!
M&%%7"KO(04Y5CJG,RPH+O_B>?D'3B^ZQ>M8WF573_OG9_ME&L7S]_#ED_^\L
MKCY;J"FP&GK;].N?#J/;FP8=IVC6:GIY31[T%@;LD*9 ;:Q=45UOUG.YL<Y=
M6YKJS^5\8_%\_N/;QHP.8[TVKF^Z:^Y^\G[O 0C<3[V$:_\>ZMF[1]PWO63!
MT[W2BU='YKL;HUU; ]UVN_K&?WWA&_UFM=S,EP_SY?<NJ- %V6"2$R($ 5@J
M;;E7(4 US8' F$,*"2L4#,J ]Q8]-1=LI_DV,W[#?V565WWC<N1E7UG<:P?!
M;Q]U&&@')N\]JEU?/*MVYO1VAS3V@YHOYKR-7/I\ >3PQ/I@O-*FVON+'S?Y
M/AB6HW3\\"=$1A!U)2V_[$I:-@FZV^+]7+(<%5*#0G+K-RHH 3/6@\QQ@3CE
ML$*Y"FFATB\NB*\FVT3E J1^3)0.J('99U?)=J_I32:T=6YTYL),_FY<'+<A
M]F:MU7S31%,.T#/!#["T<4'](L>-!_(R_R@.R.^NB*7H9]WDJWS5FTW;]6UE
M#O):ONQJM\Z0(@66B /K)7& :<D!DX8#31DO.:M8K@OOHQQ?J5-SC#J]LWJG
MN-LUEFU65OVLW&W 4LQ[%#S6L4-@.S W;6']^@36PV2W[,N@L 8L>(> =Z3U
M;QJ8P]:QH7#U+FN]'S;>*C?4OB>+WN";HWW'M6X.,NY6Z\W\WUWA2=?DKYE5
M;NVJ>ZWOY@]W]4'O5N=3,LBK O""V46QD 0(5_E)(N52EB5B$LZ6^KN+3_7V
M*B,4\?J26/LE':HSJ"_5VN&^'[75/K/_/EFYX29;]K2I2SEDWC[K4,,PFB_;
MX?_JT(3?FH(.N^%HMN\Z.VZR TN2.K-7()G:R8U196SG]PJX3CC%USPMC$OK
M]6;VQCU6K^_Y>O/XAWT];W_-ZUE1DHI*;("6!%F65 @PF!= %GF1ET6I.?8*
ML#PG8&HN\*&.F5,R^\NIZ7GP<!;&?N9* <[ G!2,BS?97#*^CT;LO0<48O_U
MG#[./GP48KADVO:3OWA=G&/T3SY?NFV.3\NV1,R38GB[2G@SP\NRRJWG4U+N
M2E=);EVBT@"J95E2@EF.BS!'R$_P]!P?I[=S<ZS/<[^J^<)-N+N"F&$>CB?V
M?AY-0CS'88L&R%=.Y=\<GF\;/.=;EW)7<+0MF_GN(L+!CDL88$D=%4_1HSHF
M87 \=T0"[XY.]&@*2/SG?//CS4.]6=WI]6U=:]=M>;MEG4-BD.#"$94!V)6(
M80(R4!C$%)5*&5&$5H>Y*'5ZH21;I3/N- U/]+B(<TEX;KT^"@H[#P"L& 04
M8P(J:23'4!:L"FJQDQCE\7K,RJ&1]J/_Q/@-[BEVH/UMU<VV^MYDC<8W&3=V
M_$8]D@F +W4&SD6Y8V?A^ )Q(A/'^];("8#7/]S_W(3RT\XSS7'0-B#)_<*N
M=Y_^X.#*F2JA0M0UPB:R +B@&-#"8" $H9(2Z\0J.+MOPAN_;JR+[4E<U^@4
M\DD^UVS K],J>9-)^V?CV7:Z-IM)ZWW\5_-[OLF$_CY?NH+\SFUKE0PDP:M&
M5>9*4&F7(DI7$& I"D %I  J6E6:EP7FN!O5=TO/M<G(8[K5:RHCJNV/7V0L
M/:>ZL49GZ$FP&13W9W:@X)-@S.:7;I2>_^S@AH238 I@TTZ/5VDT[L29 KRC
M*37)0V-76[MCN,]\_6EM9QXKPR7_Z&WGE1FA1F-"&4"$28"QR0'EI; CB84F
MRC!<!,6+>LB<VBK@:3U:JW7F$NH:O9LL.;UO&!2Z-KB,/^.Z8!@2H)6TDY]1
M!@BF[3^YAE@JS# RH:O=I",PUFIW'WURD]W;,?C9(/_JH5;[EE:!+9=]\/==
MFR7%=/"UV?4O=,3ZRQNBQ.NORW)'7G]Y W&\_O*_-2),[C@ KUFF[U;I=I'>
MKM$_[L/R]"^Y>'#Q'<U>R7:!V"P*ZUFIH=*YG3(TTP)@J!40KN@?R8FDDA@"
M*?(.ITNMW=2FF5WLZOH@=M4[IF*8 >QGOQ<?EH%Y\F0TL>_.U4VVLS)K]Q%W
M6V*W ?N(PXQK0"C@2X[O2"&#+S3.83&&0XU#;RQB<J'CQ2P.A=>3V,;!A Q1
M.'VGU?M#K6:2"".PYJ"4% .LA:L-0B$02%*1&PJ17_FB:Y28VES<?>BN)GIH
M#;6H,?!;90R-[,#3J5>E\[.$.U95\WX81RQB?D:1"=4L[X<JK$3YA6?%\>'I
M@L('E6Y>/^XOZ2I'-WGQ[_E\W2RK+"T_W-TWN8U?YO6_WJ^U_N "M'2]<3F0
MO_-?\[N'NUF!"T&+DH"JP!7 ')9 B*H$E>%Y!2NA<A5T5CZ6XE/C7:<J,%;7
M;-XIVV5DW[7ZAE'Q:,/O1]]3'-2!*=^GU%@F'I^4)-M5<'>FWV3.^&Y7ZL#\
MF\P!D#D$LBT$39KY3?;[A5<E>+X8>]R2SC&C*3_JO#3VD#R?RT:7'SG_N?U!
M)_N3:5/W;Y>-PFO]P^J\2^C?M0AC"/'20 VPY!)@*"#@"") 3"ZYP<R(,JB.
M<J#\J<U&._6[#,*]WMOB%AY]QY(,C.<$,QS<0\\3*9 .)_8XO-+R<Z .X])L
M'$!';!GYF,A$T&8GI=MLV7U!2%:YR54.E&088"4)H,3^@1@C99%#5L@\[!SU
MI)P)GIRV"G;!JX'-)$]CZ<=&5^,S].Y^H]]N'W<0ANG%(&UFY$E)XR8^]AE[
ME-?8>W'\]N>'I7U4<VCP12O=>EAM0<M/2]U5_J,(8\:4 3C7+E:4YX!"+( I
M"E4A216!0:MU3[E3<V^Z:JI6O_ =3A^8_3<U$X,WQC[F7F47SK=5^B;;@SI
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MZ_1=?_SU/[I/]/],UN:__L?_ U!+ P04    "  W@6)3S2)%;Z^*  "<4 8
M%0   &AA;&\M,C R,3 Y,S!?<')E+GAM;.R]6;=;R8TN^%Z_(MOWM>&,>:A5
M57=)RDQ;W7)*+2G+M_J%*P:$Q&L>4D7RR))_?2/(,T_BL(,[E.XJI\3#0W%C
M^ (!( #$O_W/+V>S'S[C<C5=S/_]#_R/[ \_X#PM\G3^X=__\-O[7\#]X7_^
MQ[_\R[_]'P#_Z_G;5S_\M$CG9SA?__!BB6&-^8>_3]<??_AKQM7??BC+Q=D/
M?UTL_S;]' #^8_./7BP^?5U./WQ<_R"8X'=_N_Q7DZS"K!VP$B4HM 6<\PYL
MD<@T"XIG^7]^^%<,)BO)%00O,B@1%40E+:! SJV-,MNX^=+9=/ZW?ZU_Q+#"
M'XBY^6KSX[__X>-Z_>E??_SQ[W__^Q^_Q.7LCXOEAQ\%8_+'RT__X>+C7^Y]
M_N]R\VGNO?]Q\]NKCZZF#WV0OI;_^+_^\NI=^HAG :;SU3K,4WW :OJOJ\V;
MKQ8IK#<R_R9=/SSZB?H37'X,ZEO !4C^QR^K_(?_^)<??MB*8[F8X5LL/]2_
M?WO[\M8C/X;9XA]?S_"/:7'V8_W CR\6!(<WX4,E=_//UU\_X;__834]^S2[
M>N_C$@M]#_UCJ'IE7K+ZT/]Q_8]_O'[^IR6N"#(;?E_1&Q??49]V&"WX98WS
MC%L>+Y\R6Z1;'YI5"2^6E_]R%B+.-N].,DXGFV]^%E?K94CKB?)*LB0"E*P%
M*)T->%8(CR:J*%10/KL[K!/9*Z)[HY 5IC]^6'S^D;[XQRJ.^F(CEXU,[CUN
M*YO#Z+Y<?^_ILY,8HLJ.1\""M"H\<@A!(%@N!?<IJ"+R463??-IMJF_J]-DR
M_;!89ER2 ;E\7%BF>_J]#=Z+3_SX*2SIBR!]G,ZNB*V69 A=K1<#2&ZK%B+W
M#S\0UP672\ROMEIYE+D-9VLRJ[CYY! :_W_.PY*^<?;U+7Y:+-<35Y+T#CV8
MH!4HA0R\8QJD]#J8()(92/EW'KP3#D3_.#A&GIU X@TNIXO\\SS_1%OQQ#DC
M16$(!9D%E1DQH(T!X;*1Q7+:4=4@@+CUV)W@(/N'P^&R[ 0,[Y=AOII6P5\
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MT!55(K8INC@FPS]N)G903!V@AC[Q='.O9QPC=S4V8=Q2J$(VV)NL@06-S.?
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M=XM9GH0LF;.AGLEZ!<K4V3OD"4 .5DF>BLK89NK\XS2-:YZ&T?H#4!I  5V
MZ2WI@TCX2(S\1-9WMOBT*;[=BFMBL@J(3H,SAHRK5!RBLQ&PGNI)Z;1K=*[Y
M)%GCVJ4FD!I.#5V@ZAW.Z%<?_H1S7(89,?4LGTWGTRJH&J1>\E5TS+P.").L
MWA,325A>8J+8E">F@K8FLS:1W4[TC5O&TP1G#133!>#N"FOB @7%F9:,R8Z1
M(>8:/!,&DE11!BN+U:U*PFY3,FX53[/][V!A=S#"^Z+Z8/[A^EJ.22@Y,JUI
MI\ZYD#PD!Q]4 *[I_Y,-294V>'F F.[*!X_QNX\5=@]XJ?>Y;,E_:"D))8HU
M(H(TB9-TI(7 A <G0W+<EF:[V--T=5<^>!2*AE-!![G+#3>_+N:+VVOC<O=5
M6+(3R$#HFM)@3D(07@/+&#%;;G2CGN2GZ1HWDAL2 0^!:QAU=.$,O9SG\[0I
MOJ-O79%^7I?MZ_4TSK#>=WW)6K!,BX+$E1$!E%(DM9@*Z-IDB;9D44JC.K@=
M21PWUFL(NC9*VA]_?HN_.7ZH19KO![-Q+^=D+W%UQ46*(LFD:9-G]9H7$P1$
MSR.$5&Q"[8C#-D;M#B'C.E=- 76XP'N"S:67>'D*,)V?DTF^KAA^CF6QO+A1
M[WWX@JN?OY#P2''3>5A^W;@:]?;U>GZPV 2[EX*96)9]%M:"C+5K3E%HZ^MY
M@>">;+S.VI@VV=&&3'57[W^,E]>+\CN(.:Y8O%C.SW&.9;J>:*R4E@0%O0<5
M'$*4C$%2+A5N*71OU.[_"$&=3&H;$G_'";V#\.)77-\(ME7)7!L7@;%"P;95
M"J)A#CP&XQ.SA/XV&^\M,CJ9OC8,3@X7< >6Y?*ZT,MF\NN3^Q(R:B2)&"4(
MY>1GNNPX%,M%T*[DW*A0\S&*.IFK-@QF!A%[!\;E+A_/PVJ:)H$60/::1.%X
M+8H/"CPO'*P*F!277F";0/)!<D:>1#.(IK\!G_W%WB%V?IK.SBEZF&AK>:D7
MY27M:%U9DHG/Q@&BE+2D2%*YS0C:1P@:-^EP$OP<(OH.$/17G'[X2'0_^TP1
MP0?\];S6.+\N]QJ%+]C[:;I*L\7J?+DUX#>*U'AVS/G:1FSKS52IUJ<%L-DF
MD5&15-J8JV'H[V1:Y# ;XP@J_8Z O+7SUB>MHD80N38 ><XA9LW 2E/OU;+)
M-;I5>"\RQ]UVQ\#1@5#>7ZG](O9"G/='-40CF8Q6@ R9=JLBR"8PY8%GE;@F
M.9*<3XG9QP@==[/O%[6#*/:[G<%1!TDN\2-]9OH9KX/]M@,YOOG0TTSGV(_W
MX6_MNSH?>8"0*\1;#"%KPKDJF?Y@7$%T2D+AJ*(76<ILFYB7/0D=-IFG:3VK
MP!GP6F1,ZXV!$\F#L2;'I"6SL8WCNG\R[Q0W\PV.E*<S??M(OXM*@,UQXR/+
MF5A[7=Z'+Q013A>9WE]B6.%/N/W[2GH1>> 2/8FKWA MG0"GF ;I9$Q>^*QB
MFT.SXVGOI'_E!# ]L9X[\$8?X_BW.;$UJ\,M_[R857?E3V$ZKV)X/7^'Z7PY
M74]Q]6PY756?BGZ<?]C*Y5)*$V]D5E(B1"48R<%$B$:3=R.\J9-5.?DX)\7[
ML1QU4+9U0F3NN#!."I..E\OFK'VQI A@_N*<Z)JGK^^78;Z:;0&2__?Y:KWM
M./\R(6\_^#IJ6"A;#11SY/=+ =KZ+$Q).?$V$Z '(+Z#,K+^%D$KY?=33?00
M=R1-XNYRO5\;@@DWM9'**PA*VNTPY&C04B"M,X70=<Q.FZ;O?:CLH'QM/" W
M4V<'%OH!J5YM-L4[93#2DHM!U7MT#<24&>B8DXDEU#FHC9J9'B6JDR:5$SC7
M0VEFL-J/D^?"PNKC+[/%WUMGO^X_YD3YKF_P-WR&Z^J)5P!-*K!$( (;6"9K
M520X0E"]LD:0U8H26]\B]@!5 ^2NZG>^62X^3TE^S[_^1EIX.;]J"7M&MOOS
MUM6^JH#VR'3& &;3;.'K);N^>*#UR3EJ:9QJTX>W/ZW=9,&.0],#*:^62NLB
M+W8[K<>$PFQE@.RSJ3)BX*.ES4&C0*]JBWV;FMJ.DJJMM?YD7G4?!72!G^O8
M:/5^\1;38IZF,[S%U/O%OO+,VL=(W$*)NH!24D/(O#95(^J )%IL,[6[!3?C
M!MPG1O/H<.AB45S6)>+&$R>/:Z/NB60F9J=(DIQ8J,/7P1D6:PN&4"DASZ%-
M[<K#](QK9L='RD-7;!RGM"[ ]Q/2L]-T0SV]GN%&H_/\[&RQ7$__L>4J9XE.
M9PW>U_L;T= KS1&TS-%8(8QU;9S+7:@;UV)V!\S!%=H%3&]2_[K4+M]:T;,X
MGZ_?+/%L>GXVX4'8DDL$@<R#XD%!M*E.58DI.Z=%:#2(Y)NDC9OQZ0Z@PZJR
M#W2FM-RNL]N\7?!59_Y<\+9Z.?^,%^J8F!AL(/\==*Q;!#><UF.6("S&6MNH
MO6VSPQ]&[[B#4?K#<7NE'WL@- BX;YSPAAF^+B1?DNCZZYM9V-XVOAFY-PF1
M)UUD <P\@;(Y0)"ZGG9E;Z2F"!7;Y-IWHV_<?N_NP-M J5V ]:'QQZ^F(4YG
MT_77BS')5?X?YINS+NVR*RXY8&AI?RFQC@C)$1"5<>2L,]YHLL%^=([;+-X=
M>!LJ>?PC^,W5%#]=//HM"?U-^+K=.;S@1BO-P#%M0(FZ&!.GC807J:-GWL:[
MY^P/7_'QT+>/VV?>#<2&D?[X*+HJ/+B4SZM:3/#R[%.8+C<M:#5]G+BRR%@"
M;2P'E6*]^ 83%&6\5Q%-48T&\#U!U;C-Z]T <7 %=E"JL?OH+E6393YQX(K6
M&7$3P.OBP$:F91*>H6@U]&K(^6K-6DF[@VD;U7:!V=OU6"_GE[O#C6%*$^DU
M!E0,:*>MAR"V0(R"_&3'#8DM%:U:X74'\G9+W;-_(K .K=..-OQ::?B X"YK
M':[*'R:AQ. T<Z"MTQ3;Q0)>6@&E!$W.CK9!-RQ+WH7$W7#[SW/FU$:W71K9
M*RY?A$_3=9A=WT+M=*!56*<S"G+#2[$0,U)LI[*R6E@?&EV;NCN-N\'VG^=$
MJI%VN\C\W^?M6=JF?TGR./V\N7#0&1N**AQ2'5&J&$\0C)(@,Q=:,8TLM6F-
MVH6ZT2^;;X*-;T+P2#5UD>R\SU4]:)C3/Z*E._'*>N;(Z)MH)"A9%$1A#:!R
MG*.WCH=F4UL?)VO<T_K1X':H8CK%V9LE?@K3?.DV7\1VS^9YXZ+4:P;7JTD*
MO)1<$O#@39W3DB$H)@@QP2;NM/*FS8G\8?2.>TP_&C('5V6GD+TT^&_"UVKM
M:T5,2LMS>M[%R4%=FE(YEFS1X%$K4$(J"+0F@22*.?&8@CJ5=[D+O>.>R(^^
M=P^FRBY<R=UK;R?H:KM?(?FYZ"IO'IRNWK@K:".WQK@VA2.[TSBN-3U]57X+
MU74P]/@1SK8%+0\+DAB0Q 6"5S7W$!7M%9H<'1N3TTPYHUV;0I#]:>UFT,E)
M.I&&4EH7UO+R7/;]XEGZ[_/I$I]]#M-9W0Y^62QK3<OU.(IZ^C#16G 4G(/E
M]8)9J>MUU]H#K6Q4.10I1!MG=$]"N^QF&@PYB],IL9^4/$DS(>;-W1S;:JMO
ML.F#<!J+(1\I<E#!DK?$96W#SSQS3&ARF].D?2GMLEFI&5A;JK&#)/R]Q7BK
M)K#>NG15%NB%8;F.7(V9@D#%M*['"PI$41[K_QG5IN-N=QJ[]#]/9D>'45T7
MD?S]9?<X<ZDDS@P:L%C3%,$EB*)N$DJ8ZMY[AFT2[7L0.6[,/KK-'$9Y'9C+
MW24Y,5$S;4EN1M:[ A#KP&J?P=NBG'1>*]ZFSFYW&L<MCS\Q*ANIKM]P_9?I
M/,S3(R>[UD8T(8/5D38$6SPMNR A!71>)AZL:C;$84]:NQF==))P?2BE]1&N
MW]@(JG.\&03U<K4Z)Q;QQ6*U7DV"L<IZP\ PXD1Y8BP@1X@L"I=DYE:TR1M]
MF[8N@_+!\/'$GCV JCK8JM_BIPL'^779Q&B8-P&:P>"CUPB69UJJP0N2$E.0
MF8_,,G(\>)N<T",$=1E.MX+9$$KI(T"Y8J/2?WNA2.F0N8"@F:S%SH'B+FL2
MR8O8M,&23]OF+H\GB.HR,FYFS 923D?9Q N.?EDL:0F=+]/'L,):;7]VMIB_
M6R_2WR;">Q*5K;?U.DN^,6H(,GBH$V>=M:;>A]84=8_3UF7TVQI\ ZFJ#VMW
MPSNX7$Z7U^[\-L^;2]J)Y^GG>BS_\)"<&OJOZ&.S\SI ?".'UY\VMU1/9/8E
M6UT@BYJ=JC,@?,U3Q: *(]=":=,F4F[*5I?!]2G<QW$!TH'GN;OL)Z[4@3Q*
MD-^3:D*C< @B$*.!=J+HLS6B3>G1[C2.VX9^8APW4ET'2:+*5OVOIEX_AQEN
MJJ!)8M-$FT3]!2W,VV_<^.3#4\JO%NO/7VB3FW_ M[3A_%P*UL'EGM>Q4@&8
M2K3/94/2L2X"UXZ[7/_7:#+M:?D<U[-IEISJ&"S?^U*:*.MU44F"#+J&NF@A
M>&] ZVQ0!<52:C2>_ABRQ_5F^@3Z7JH\&+>?-LN))+!<=X#>A"8*KB3MJTF1
ML+T";PANDA6=@LV%-?+5VZ.WF0_3*7KW4>61Z/UY/M"@IPOQ_;J8)WIY?78W
MSP^X:-?7OUY)&R5&[VH?8ZPY;)(N./(0P:3 L]:T'4G?#+['4#[NI)ZF"#Z9
M0CL(#2]:)#;]-GFZ)DYJR%MOZ,G/S]>_+M;_A>LW89HG!;FR C6X.J95E23
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M$X!VHG.@X3XWGW4]<*@">Y[?W.#@=;D87A5FU[.(KF\>P*PSQ9'@4^WORR9
MM%X N>122(RY^#:>PR#D'^U%A9J>?%TNY@;6BSN44<%(+\$SHT!9X2#69+PT
MAG$A/-.ET?46]V@9MZ3X]/BZYV0=IYT!/:W3F+.?:@ON;$BK=OF-+8W;@U1W
M9>,\*X&<* WDBM?&'=H/@Q4"!'?1.$$RU&T&P'=AX]ZECYC/9YO[O&;T^\5R
MT\[V;+FL0U.WCYKG.O/PD5^_IU<K(J0NP&TGE.)*.,8,+6I'7FJL;H70#)Q+
M,BA!/FQL4XD\/"^_!QN[#[[O.8WCHF/L)MS%^9R^B92U_OIK.,--CS+WQ15!
M^..YT!XC-'$BG 4=?2I)<HUBP*[N!R@8N25M9$0L!E3/R/"Z/N9Y]F&)&^'<
M9>FB/5F'$%R.C%BI7<,&$1RS 3SRS=EX8FZGFS!WPMS.9(W8U7VTYA>MU3#V
MG/#GX4N8K<-%VWGB9.=Y%I"+15#(!?&@-7"I?# \<G%OKNG#P\!O?>UX &BD
ML\4@ AQ;]6\79*,OZ+:.UTA*@DD45BD6'03G,S 9C'.\2./O-@X\K/@;7SI.
M\^&)U'ZH\,96^O]%NRKIX8)R)K)-R.O]<YILH9<10O8<DB^^Q(Q.9[63VF]]
M[3B=>"=2_.$"[."\;P!?[-75B %5I"C$'Q@;ZEDGUJ2,H!]9,#%E)(>L37'%
MD%R,/#BK#R]Y='B,;17?+K[2)CZMI=4)B;G\ZWE=WC?5LEBNZG6=13A%/&"]
M]C#6\3]9*L*I$4&X+'BZV]G_V"ZYR_-&OFEJ-# LVFJF6["]62[R>5JOWBUF
M>5(T-SK*>ME0;?6KTQ)#2@BF:.4"INC5W4&5>V+MYN-&OA&J;Z@=K)=>+U5Y
M=WYV%I9?%^7=],-\6J8IS-?/4JJ>4JT=7<RFJ7;E'G""L.,W#W*2< @7 YTH
MW'_,]7T7%.AE&R@"5%:#4KH0_&2&P+5G0B++V&B^QJ,T'9W[?TJ^[TFDS^G3
M?YLDG[1DSH!6TH%*M#*<I# ('4H9HI>FU=R;G>@;=S<="#'W$N_#JZ;? \_=
M%GQ[\S6&&1O+G(54@O"&MKOH:+O+A"&7BH)4=,K">L4:]3BW,V?/PVJZ>EWN
M/.#K]L_K->.DC5BS.E+[VD 9"@0?-=CD5?*94S#5QISM1E^WYFP?Q-PU9PU4
MTT6E[*U3V;O<>.N%3-I"%#5B+V2A ^<>$H7Q7"@;*9!OE$=YG*IQ X)&\!I,
M#1VD\GY;X>OR\VH]/0MK7$U\L2*B-E"<#;5X7(*G**C.WN"%15%X:M.?=YN.
M<8>P-8+-$:+N "CU/E**H^M?M9[W<YC5R/JZW_KAWV]7QR1REXPRG(RL9;0H
MBJQ=A-4W%4QFC"K>NQUX(-MT!-7CSD9K9;M.I<8.(/M+F"XWO:LW*I9>SHG3
M\[,;3,D@@\TJ "M"4-R$&FH<!2:6R'U&S+)-T?%.Y(T[TZP1"(=73!?N6;VC
M>4X?N>=H<E\\CW5JBA6T;I"P$ MG($R)'@6+.>U44+,WQ!ZC:-R)8XU0-8CX
MNP#2*URM$%_5'IW576:T$<F3%PEV<ZT2)VL<I*7U0298VJ),YFUF,SY!U+AS
MP1K!:2@E=+ 1OD5:&>?X"XF.8I>-:/XZ77]\<;Y:+\YP>6^]2+2T2#*P7'ER
MB5%<3)@0WO)(MCB$T";WO!^=XX[Q:H2ZAJKJPK21IXE$0O4Q?R)69XM/F^MV
MO]1YCWBQ\9><M.216-&NT,;/-<1LB2G:]H/W(;!&XS9V(&[<,5O-0#>L4KI
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M?S&P)CI T[5PR%F=Y[#,J]\^97);2=^,F0NF3$'/Z@2U(K( Q:.'J+@!3<X
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MS[$I.Y,FUCW ]LB^3JK(,PDLO6>A1&L@.A=J(3U"P&))PI'KC)XK;/,L9*S
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MJ+N>RF92#8+)V@AGK$'9>H#0ZQ2>Q77J/FAZ>:3&B*KJ(EM[^SJ'<9<$)9_
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M5G=[MB\?WE+C]J#/BG;2&",A1&]!91; ,<?J4QDKLE<.U;"^D->^Y2RBLD,
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M%4Y'ZZ)[=&U'7N@27=(I +ED2Q& 4A"C]Y"\U(6)Q$JCY\Q#J.L)8<<C8B_
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M6!Z#EB9KCVU*%;N43/MF?.SBUE%R[J Z\9#^;0@M>-&,DF'(NN[C*#I 9%Z
MYL8R9)P)E9HCI8>"UG&Z?04H!PBZ ZA0QI67BTWS6 R+/_\H1 7FRL_[7W_X
MX^.MI40N,6<'@CBXF;3A!08H)J&(TFK7Z)YZ$'G] .H0##RMCXZLD Y0]MA
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MB[3W;"]RO8%X\(!1<IY#9A*,-'2<O?+U?D^"])K2NTB6WYST5OPH;J9UVT>
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M4'?X4:BB:JB2(X+4SEJG4]1^HLF[Y]X1N0^X3M$1N8^F.T#[RVUUW&6F$[?
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M)_JG-V^59J$HDTQQ@+IV9XB<B4F7@6M6G!(>%6\SK>,@<J=]]=@)1D?1Y?Z
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M.3,P+FAT;5!+ 0(4 Q0    ( #>!8E,BO9!'X@\  )JJ   1
M  "  :N; @!H86QO+3(P,C$P.3,P+GAS9%!+ 0(4 Q0    ( #>!8E,9F*3O
M0QX  'LJ 0 5              "  ;RK @!H86QO+3(P,C$P.3,P7V-A;"YX
M;6Q02P$"% ,4    "  W@6)3BX6F/N-5  !FS , %0              @ $R
MR@( :&%L;RTR,#(Q,#DS,%]D968N>&UL4$L! A0#%     @ -X%B4PG,;&'L
M" $ <T$! !0              ( !2" # &AA;&\M,C R,3 Y,S!?9S$N:G!G
M4$L! A0#%     @ -X%B4YM3ORA)]0  Q#<! !0              ( !9BD$
M &AA;&\M,C R,3 Y,S!?9S(N:G!G4$L! A0#%     @ -X%B4\16#'?8U
ML+<( !4              ( !X1X% &AA;&\M,C R,3 Y,S!?;&%B+GAM;%!+
M 0(4 Q0    ( #>!8E/-(D5OKXH  )Q0!@ 5              "  >SS!0!H
J86QO+3(P,C$P.3,P7W!R92YX;6Q02P4&      L "P#- @  SGX&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
